data_2n3j_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n3j _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.4 mmm-85 . . . . . 0 N--CA 1.469 0.485 0 CA-C-O 121.296 0.57 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.549 ' CZ2' ' CG2' ' A' ' 148' ' ' VAL . 0.0 OUTLIER -96.58 158.82 15.25 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.969 177.07 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -151.88 104.14 2.98 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.508 -177.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.539 HG22 ' CZ3' ' A' ' 95' ' ' TRP . 0.8 OUTLIER -121.14 152.46 24.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.133 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 4.4 m -122.45 140.81 52.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.49 63.92 0.74 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.31 174.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.15 108.27 3.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.617 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -159.36 -31.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 120.751 0.31 . . . . 0.0 110.94 176.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.613 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -56.55 5.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -177.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.532 ' H ' ' C ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -61.73 -30.98 71.13 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 118.824 -1.15 . . . . 0.0 108.284 176.046 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.491 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 14.9 m-85 -88.93 5.19 45.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.943 176.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -167.39 92.36 0.7 Allowed Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.9 -48.58 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.432 2.088 . . . . 0.0 111.159 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 109' ' ' LEU . 1.6 t70 -98.26 -31.9 11.83 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -75.73 36.74 0.14 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.289 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.524 ' CD1' ' HB3' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -125.25 138.42 54.1 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.58 112.6 11.61 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.22 129.58 39.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.87 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.458 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.1 OUTLIER -136.52 125.2 23.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.934 0.397 . . . . 0.0 111.359 -179.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.0 m -108.18 115.0 29.31 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.3 91.77 3.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.888 0.375 . . . . 0.0 111.686 -176.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.7 t0 40.18 69.24 0.33 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.243 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.41 ' HA2' HG13 ' A' ' 148' ' ' VAL . . . 82.08 -17.61 16.66 Favored Glycine 0 C--N 1.312 -0.771 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.6 t -88.68 109.65 20.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.008 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.7 t -98.71 115.21 38.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.851 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.641 ' CD ' ' HZ1' ' A' ' 141' ' ' LYS . 0.3 OUTLIER -125.66 139.4 53.59 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.337 0.589 . . . . 0.0 110.711 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.2 mp -116.32 111.24 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.912 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.458 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -91.84 116.24 28.74 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.821 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.37 125.7 2.0 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.163 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 137' ' ' CYS . 0.0 OUTLIER -134.95 137.87 43.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 177.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' A' ' 104' ' ' PHE . 29.7 t60 -80.11 168.28 19.33 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.643 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.481 ' O ' ' C ' ' A' ' 126' ' ' GLU . 2.4 tp10 -113.41 131.85 55.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.315 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 125' ' ' GLU . 5.3 tt0 -19.3 99.8 0.02 OUTLIER 'General case' 0 C--N 1.349 0.548 0 O-C-N 123.563 0.539 . . . . 0.0 111.995 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.428 ' HG2' ' CD2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.84 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.701 0 N-CA-C 112.654 -0.178 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 8.8 m-30 -94.97 109.42 21.44 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.39 154.82 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -175.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.78 152.38 26.87 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.441 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.419 ' NH2' ' CE2' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -143.8 175.35 10.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.687 -177.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 32.0 p -137.68 133.86 34.73 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.54 138.97 42.8 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.472 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.84 114.68 7.74 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.718 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.558 ' NH2' ' OH ' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -120.22 126.04 49.64 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.641 ' HZ1' ' CD ' ' A' ' 119' ' ' GLU . 2.0 ttmm -120.06 107.44 13.07 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 120.756 0.312 . . . . 0.0 111.091 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.558 ' OH ' ' NH2' ' A' ' 140' ' ' ARG . 4.2 m-30 -103.1 99.13 8.99 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.47 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.1 OUTLIER -87.56 88.93 7.81 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 mp -113.23 90.79 17.38 Favored Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.598 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 15.8 Cg_exo -67.93 -57.43 0.16 Allowed 'Trans proline' 0 C--N 1.287 -2.689 0 C-N-CA 122.164 1.91 . . . . 0.0 113.537 175.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.598 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 28.8 Cg_endo -98.45 43.65 0.09 OUTLIER 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.61 2.873 . . . . 0.0 112.413 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.33 -8.25 0.04 OUTLIER Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.137 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.549 ' CG2' ' CZ2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -138.37 127.09 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 117.4 0.6 . . . . 0.0 111.129 178.193 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -87.89 138.49 31.15 Favored Pre-proline 0 N--CA 1.484 1.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.057 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -81.99 -21.77 5.54 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.016 1.811 . . . . 0.0 113.075 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.14 -37.92 13.07 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.442 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 27.0 mt-30 -103.61 11.76 35.75 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.447 ' HA ' ' HB3' ' A' ' 167' ' ' ALA . 22.5 t -95.04 118.48 41.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.844 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.9 173.35 6.47 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.5 p -141.68 137.43 31.75 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.961 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.401 ' CB ' ' HG1' ' A' ' 164' ' ' THR . 0.0 OUTLIER -108.23 133.41 52.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.996 177.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.495 HD11 ' H ' ' A' ' 158' ' ' SER . 33.9 tp -131.1 136.99 48.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.097 0.475 . . . . 0.0 110.331 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.495 ' H ' HD11 ' A' ' 157' ' ' LEU . 1.8 t -123.71 146.56 50.76 Favored Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.825 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -40.01 -34.07 0.87 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.683 2.255 . . . . 0.0 111.676 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -62.29 -7.44 4.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.641 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.564 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . 76.31 33.61 48.31 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 112.22 -0.352 . . . . 0.0 112.22 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.2 t -100.63 116.74 33.26 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 98' ' ' SER . 1.4 tm? -110.56 99.86 8.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.543 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.401 ' HG1' ' CB ' ' A' ' 156' ' ' SER . 0.7 OUTLIER -94.68 127.6 40.76 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 121.343 -0.143 . . . . 0.0 110.714 179.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.464 ' O ' ' CG2' ' A' ' 165' ' ' VAL . 3.2 m -108.51 103.13 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 167' ' ' ALA . 2.7 pp20? -114.34 147.58 38.9 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.786 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 166' ' ' GLU . . . 166.19 166.33 0.1 OUTLIER Pre-proline 0 CA--C 1.515 -0.371 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.785 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -82.18 133.15 7.47 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 123.804 3.003 . . . . 0.0 109.665 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.442 ' SD ' ' N ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -128.69 146.92 62.18 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -174.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo . . . . . 0 N--CA 1.494 1.556 0 C-N-CA 123.461 2.774 . . . . 0.0 111.843 177.746 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . 0.587 HH12 ' CD ' ' B' ' 166' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.514 -0.431 0 CA-C-O 120.587 0.232 . . . . 0.0 110.923 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' TRP . . . . . 0.47 ' CD1' HG23 ' B' ' 97' ' ' VAL . 14.6 t-105 -114.16 155.49 25.97 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 39.8 ttt85 -134.96 98.74 4.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.239 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.47 HG23 ' CD1' ' B' ' 95' ' ' TRP . 0.2 OUTLIER -101.49 151.13 5.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 2.5 m -128.28 143.41 51.02 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.423 HD22 ' HB ' ' B' ' 120' ' ' ILE . 0.4 OUTLIER -119.3 137.15 53.88 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.297 174.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -122.89 116.16 23.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.373 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . 0.467 ' N ' ' CE1' ' B' ' 103' ' ' HIS . 0.0 OUTLIER -171.37 -45.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 120.785 0.326 . . . . 0.0 111.663 178.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.599 ' H ' ' ND2' ' B' ' 102' ' ' ASN . 0.0 OUTLIER -53.38 -1.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -175.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' HIS . . . . . 0.467 ' CE1' ' N ' ' B' ' 101' ' ' VAL . 0.1 OUTLIER -62.13 -26.12 68.13 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 118.51 -1.276 . . . . 0.0 108.409 175.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -84.42 -13.0 53.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.798 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.66 97.81 0.88 Allowed Pre-proline 0 CA--C 1.516 -0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.154 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.07 -42.74 0.37 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.352 2.035 . . . . 0.0 111.039 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' B' ' 107' ' ' ASP . 0.7 OUTLIER -94.83 -31.43 13.72 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.485 -178.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 37.33 0.74 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.367 0.603 . . . . 0.0 110.444 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' B' ' 102' ' ' ASN . 0.5 OUTLIER -117.11 146.62 43.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.033 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.411 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 1.2 m -136.88 120.94 17.72 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.889 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.77 121.47 50.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.511 ' NZ ' ' HB2' ' B' ' 119' ' ' GLU . 14.8 pttp -132.47 120.94 22.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.107 0.48 . . . . 0.0 111.333 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.7 117.56 28.66 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 1.3 ttmt -116.11 91.34 3.57 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.898 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' B' ' 114' ' ' LYS . 0.9 OUTLIER 28.73 63.98 0.12 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.457 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.52 -21.14 42.54 Favored Glycine 0 C--N 1.316 -0.534 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' B' ' 114' ' ' LYS . 2.8 t -87.65 119.41 35.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.301 177.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 75.4 t -106.51 114.85 46.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.511 ' HB2' ' NZ ' ' B' ' 112' ' ' LYS . 1.1 mt-10 -130.45 145.14 51.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.227 0.537 . . . . 0.0 110.62 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.499 HG21 HD12 ' B' ' 109' ' ' LEU . 1.3 mp -116.94 118.98 60.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.791 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -95.7 123.87 39.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.341 -178.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -147.22 118.49 1.02 Allowed Glycine 0 C--N 1.333 0.393 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.56 143.31 24.58 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -123.97 158.6 31.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.91 0.386 . . . . 0.0 111.409 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.517 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.9 OUTLIER -95.35 145.1 25.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.284 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . 0.583 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 0.6 OUTLIER -1.65 96.94 0.01 OUTLIER 'General case' 0 C--O 1.238 0.485 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -97.97 143.78 28.18 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.037 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -71.76 157.62 37.58 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' B' ' 130' ' ' GLU . 0.8 OUTLIER -157.19 168.96 25.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.036 0.446 . . . . 0.0 110.774 -178.495 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . 0.521 ' N ' ' CG ' ' B' ' 129' ' ' ASP . 0.9 OUTLIER -63.42 -34.84 78.62 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.609 -177.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' HIS . . . . . 0.476 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 82.2 m-70 -121.54 39.9 3.73 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.006 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . 0.513 ' HA3' ' CE1' ' A' ' 142' ' ' TYR . . . 135.65 -162.67 24.94 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.434 -1.365 . . . . 0.0 112.475 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -114.15 120.72 41.49 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . 0.434 HG23 ' HB3' ' B' ' 129' ' ' ASP . 0.0 OUTLIER -134.63 121.84 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -172.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' SER . . . . . 0.583 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -124.99 144.56 50.32 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 174.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -137.31 160.65 38.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.971 0.415 . . . . 0.0 111.296 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 22.4 p -120.37 133.47 55.43 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.99 137.05 52.45 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.816 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.75 123.41 15.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.044 177.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.45 124.18 42.3 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 174.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -117.15 127.1 53.79 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.716 0.293 . . . . 0.0 110.757 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' TYR . . . . . 0.483 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 4.3 m-85 -116.71 97.98 6.28 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.565 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.3 OUTLIER -92.19 98.22 11.39 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . 0.401 ' C ' ' HD2' ' B' ' 146' ' ' PRO . 7.1 mp -109.98 91.69 11.5 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . 0.565 ' HD3' ' O ' ' B' ' 143' ' ' THR . 28.0 Cg_exo -64.73 -36.68 39.84 Favored 'Trans proline' 0 C--N 1.287 -2.708 0 C-N-CA 122.909 2.406 . . . . 0.0 113.303 175.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 65.4 Cg_exo -43.08 -12.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 122.142 1.895 . . . . 0.0 111.962 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 112.0 48.09 0.68 Allowed Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.607 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' VAL . . . . . 0.508 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -68.39 97.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 174.016 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . 0.487 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 0.1 OUTLIER -51.81 125.7 30.72 Favored Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.396 -170.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 2.8 Cg_exo -76.35 -29.43 6.19 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.375 2.05 . . . . 0.0 112.012 -177.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.8 -28.59 61.72 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.243 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' GLN . . . . . 0.409 ' O ' ' HB3' ' B' ' 167' ' ' ALA . 2.1 mt-30 -113.19 12.64 19.07 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -173.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . 0.437 ' HA ' ' CB ' ' B' ' 167' ' ' ALA . 25.1 t -106.28 113.77 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.127 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.93 173.76 6.22 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.31 135.57 27.07 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' SER . . . . . 0.411 ' CB ' ' HG1' ' B' ' 164' ' ' THR . 0.0 OUTLIER -107.22 140.9 39.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.586 176.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . 0.51 HD12 ' N ' ' B' ' 158' ' ' SER . 13.0 tp -134.86 126.62 29.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.619 0.247 . . . . 0.0 110.775 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' SER . . . . . 0.51 ' N ' HD12 ' B' ' 157' ' ' LEU . 1.5 t -114.0 148.9 40.98 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -40.97 -27.48 0.32 Allowed 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.982 2.455 . . . . 0.0 111.985 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' B' ' 160' ' ' GLU . 4.3 mp0 -63.58 -9.53 13.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.297 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' GLY . . . . . 0.52 ' O ' ' ND2' ' B' ' 102' ' ' ASN . . . 78.66 23.96 63.57 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 40.2 p -88.24 102.55 14.93 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.064 -0.568 . . . . 0.0 109.512 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.472 ' CD1' ' C ' ' B' ' 163' ' ' LEU . 1.7 tm? -99.91 95.1 6.66 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 0.411 ' HG1' ' CB ' ' B' ' 156' ' ' SER . 0.7 OUTLIER -87.68 126.51 35.01 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.676 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . 0.467 ' O ' ' CG2' ' B' ' 165' ' ' VAL . 2.7 m -108.67 99.61 9.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.587 ' CD ' HH12 ' B' ' 94' ' ' ARG . 0.1 OUTLIER -108.26 135.63 49.25 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.988 -175.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' B' ' 153' ' ' VAL . . . 176.85 167.42 0.45 Allowed Pre-proline 0 N--CA 1.445 -0.697 0 C-N-CA 119.533 -0.867 . . . . 0.0 113.128 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 167' ' ' ALA . 1.3 Cg_endo -80.97 134.96 9.67 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 124.097 3.198 . . . . 0.0 109.467 174.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.699 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.378 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.423 ' NH2' ' OE2' ' A' ' 166' ' ' GLU . 4.3 mmm-85 . . . . . 0 C--O 1.236 0.386 0 CA-C-O 120.392 0.139 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.633 ' CH2' HG23 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -77.38 158.61 30.0 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 174.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.1 ttm-85 -152.84 99.21 2.41 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.146 -175.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.456 ' CG2' ' CZ3' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -119.83 157.83 21.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 176.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 27.7 m -131.4 144.55 51.28 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.426 ' CD2' HG13 ' A' ' 120' ' ' ILE . 1.4 mp -117.1 65.39 0.72 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.066 173.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.58 93.55 3.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.906 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.591 ' C ' ' H ' ' A' ' 103' ' ' HIS . 1.6 t -150.52 -43.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 121.14 0.495 . . . . 0.0 110.967 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 161' ' ' GLY . 0.0 OUTLIER -54.47 13.6 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -175.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.591 ' H ' ' C ' ' A' ' 101' ' ' VAL . 8.3 t-160 -49.72 -21.24 1.01 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.874 0.369 . . . . 0.0 110.453 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -101.98 1.67 36.93 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.821 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -141.93 89.21 8.99 Favored Pre-proline 0 CA--C 1.517 -0.313 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.755 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.5 -41.66 0.79 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.467 2.111 . . . . 0.0 111.456 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 109' ' ' LEU . 14.3 t70 -105.22 -31.93 8.88 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.071 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -80.32 40.8 0.5 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.451 0.644 . . . . 0.0 110.441 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.503 HD11 ' HB3' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -124.7 141.61 51.98 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.471 176.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.488 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -141.18 115.72 9.54 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.772 0.32 . . . . 0.0 110.819 -178.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.0 t -92.37 131.52 39.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.405 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.39 132.46 31.48 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.527 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.1 m -107.5 115.97 31.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.133 178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.41 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -117.74 79.25 1.33 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.05 0.452 . . . . 0.0 111.085 -177.164 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.8 t70 45.14 69.55 0.43 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.083 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.46 -22.25 14.06 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 21.6 t -87.1 113.16 24.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 65.2 t -102.28 112.79 36.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.49 ' HG2' ' HA ' ' A' ' 141' ' ' LYS . 42.4 mt-10 -125.93 149.04 49.04 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.283 0.563 . . . . 0.0 111.095 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.426 HG13 ' CD2' ' A' ' 99' ' ' LEU . 1.0 OUTLIER -122.47 143.13 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.218 178.644 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -121.31 106.79 11.8 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.095 -178.262 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -138.51 128.77 4.26 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.32 128.83 11.41 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.702 0.401 . . . . 0.0 110.362 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.433 ' CD2' ' HA ' ' A' ' 135' ' ' SER . 1.4 p-80 -100.0 137.16 38.83 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 41.4 mt-10 -60.82 -27.48 68.09 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -174.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 0.8 OUTLIER 172.52 120.76 0.02 OUTLIER 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.329 0.513 . . . . 0.0 111.837 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.688 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.844 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.233 175.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.609 ' HA3' ' CE1' ' B' ' 142' ' ' TYR . . . . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 114.295 0.478 . . . . 0.0 114.295 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -95.07 109.84 21.84 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.471 HG23 HD11 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -120.66 157.19 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -172.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.433 ' HA ' ' CD2' ' A' ' 124' ' ' HIS . 3.6 t -155.4 154.1 31.42 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.773 173.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.477 ' NH1' ' CZ ' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -147.0 174.74 11.25 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.336 -179.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 25.0 p -128.93 125.47 37.57 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -95.8 128.96 43.13 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.99 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.29 105.84 8.17 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.304 176.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.56 ' NH1' ' OH ' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -101.08 149.6 23.79 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.316 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.561 ' HZ1' ' CD ' ' B' ' 126' ' ' GLU . 1.6 ttpt -149.91 102.58 3.14 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.068 0.461 . . . . 0.0 110.506 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.56 ' OH ' ' NH1' ' A' ' 140' ' ' ARG . 10.6 m-85 -97.57 100.66 12.08 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.437 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.51 89.37 7.96 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.192 0.52 . . . . 0.0 109.784 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.92 92.18 29.42 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.568 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 15.1 Cg_exo -68.02 -58.31 0.13 Allowed 'Trans proline' 0 C--N 1.285 -2.776 0 C-N-CA 122.141 1.894 . . . . 0.0 113.965 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.568 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 48.0 Cg_endo -100.51 51.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 123.406 2.737 . . . . 0.0 112.781 -175.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.67 -13.38 0.02 OUTLIER Glycine 0 N--CA 1.463 0.454 0 C-N-CA 120.237 -0.983 . . . . 0.0 112.269 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.633 HG23 ' CH2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -128.64 127.3 66.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.42 0.61 . . . . 0.0 110.861 178.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 18.8 t70 -83.5 140.75 41.63 Favored Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.557 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 3.0 Cg_exo -82.17 -25.04 3.53 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.18 1.92 . . . . 0.0 112.545 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.97 -36.68 13.29 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -175.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.4 ' O ' ' CB ' ' A' ' 167' ' ' ALA . 8.9 mt-30 -109.29 31.84 5.43 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -173.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 39.5 t -115.47 124.88 72.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.716 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.69 -178.42 4.14 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.71 140.88 30.23 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.048 -0.661 . . . . 0.0 112.38 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.98 131.67 52.19 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.242 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.415 ' CD2' HD23 ' A' ' 109' ' ' LEU . 26.1 tp -129.87 125.52 35.81 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.021 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.593 ' HB3' ' OG1' ' A' ' 162' ' ' THR . 0.0 OUTLIER -106.04 162.23 20.37 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.4 -9.55 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.211 1.941 . . . . 0.0 110.786 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.468 ' H ' ' C ' ' A' ' 158' ' ' SER . 3.6 mp0 -87.13 0.37 55.39 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.519 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.53 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . 68.52 15.5 68.45 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -175.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.593 ' OG1' ' HB3' ' A' ' 158' ' ' SER . 3.0 p -74.0 99.25 3.24 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 98' ' ' SER . 1.7 tm? -102.08 92.12 4.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.871 -176.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.98 125.9 35.18 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.28 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.612 HG22 ' CZ2' ' A' ' 95' ' ' TRP . 5.3 m -103.3 103.03 14.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -119.41 148.72 42.9 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.12 -176.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 166' ' ' GLU . . . 170.2 167.32 0.19 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.232 0.539 . . . . 0.0 112.138 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -89.67 109.12 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.508 2.805 . . . . 0.0 110.065 176.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.3 169.91 14.89 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.136 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo . . . . . 0 N--CA 1.499 1.814 0 C-N-CA 123.281 2.654 . . . . 0.0 112.675 -178.196 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . 0.516 ' NH1' ' OE1' ' B' ' 166' ' ' GLU . 8.4 mmt85 . . . . . 0 N--CA 1.466 0.329 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' TRP . . . . . 0.465 ' O ' ' HA ' ' B' ' 166' ' ' GLU . 0.0 OUTLIER -72.48 145.85 47.26 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.036 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -133.84 109.05 8.82 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.387 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.14 156.23 18.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 3.3 m -134.2 149.89 51.03 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -174.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.41 96.09 4.9 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.334 174.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . 0.462 ' CG ' ' HE2' ' B' ' 103' ' ' HIS . 18.3 t70 -97.18 93.6 6.64 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.277 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -162.92 6.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-O 120.858 0.361 . . . . 0.0 111.103 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' B' ' 102' ' ' ASN . 0.0 OUTLIER -90.46 -10.08 45.06 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -173.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' HIS . . . . . 0.462 ' HE2' ' CG ' ' B' ' 100' ' ' ASP . 0.8 OUTLIER -42.73 -29.01 0.27 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.591 ' HB2' ' CE1' ' B' ' 124' ' ' HIS . 59.6 m-85 -101.25 25.35 8.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -170.28 93.75 0.48 Allowed Pre-proline 0 C--O 1.223 -0.297 0 CA-C-O 120.673 0.273 . . . . 0.0 111.633 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.6 -60.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.436 2.091 . . . . 0.0 111.558 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . 0.586 ' C ' ' H ' ' B' ' 109' ' ' LEU . 19.7 t70 -91.74 -30.98 15.96 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.945 0.403 . . . . 0.0 110.458 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -73.68 32.9 0.08 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.376 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.586 ' H ' ' C ' ' B' ' 107' ' ' ASP . 0.4 OUTLIER -128.54 128.71 44.82 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.543 177.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.4 130.15 50.15 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.974 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 1.9 t -105.09 114.08 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.02 134.46 54.84 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.518 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.02 115.46 29.01 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.535 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' B' ' 116' ' ' GLY . 0.0 OUTLIER -113.66 -171.43 1.89 Allowed 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' B' ' 117' ' ' VAL . 14.4 p-10 -64.53 70.25 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' B' ' 114' ' ' LYS . . . 78.97 -8.32 45.32 Favored Glycine 0 CA--C 1.498 -1.008 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.419 ' H ' ' C ' ' B' ' 115' ' ' ASP . 2.0 t -88.45 112.23 23.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.424 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 78.4 t -97.09 110.61 25.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 29.5 mt-10 -126.76 117.36 22.52 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.168 0.509 . . . . 0.0 111.448 -176.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 6.1 mm -88.25 135.61 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.209 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.9 OUTLIER -115.7 111.51 20.7 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.445 -178.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.28 132.33 5.28 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -135.66 128.63 31.41 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . 0.591 ' CE1' ' HB2' ' B' ' 104' ' ' PHE . 28.3 m-70 -91.66 140.73 29.43 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.554 -177.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.5 OUTLIER -87.96 143.96 26.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.924 -178.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . 0.561 ' CD ' ' HZ1' ' A' ' 141' ' ' LYS . 2.5 tt0 -17.46 102.21 0.02 OUTLIER 'General case' 0 C--N 1.351 0.632 0 O-C-N 123.447 0.467 . . . . 0.0 112.068 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' ARG . . . . . 0.406 ' NH1' ' CE1' ' B' ' 104' ' ' PHE . 0.0 OUTLIER -94.86 149.98 20.67 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.055 -179.279 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -97.02 114.18 25.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.748 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.91 166.51 23.14 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -57.84 -26.9 62.67 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.955 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' HIS . . . . . 0.533 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 60.4 m-70 -80.07 14.31 1.91 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.652 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.78 -138.99 14.2 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -100.26 147.8 25.35 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . 0.43 HD12 HG23 ' B' ' 134' ' ' ILE . 0.0 OUTLIER -156.04 117.54 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -175.244 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' SER . . . . . 0.413 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -131.04 153.3 49.42 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -155.91 156.99 35.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.043 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 28.1 p -100.71 136.83 39.96 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . 0.477 ' CZ ' ' NH1' ' A' ' 136' ' ' ARG . 0.6 OUTLIER -114.64 123.51 49.49 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.576 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.6 118.2 20.66 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.281 0.563 . . . . 0.0 110.893 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 134' ' ' ILE . 0.0 OUTLIER -115.88 121.51 42.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . 0.469 ' HA ' ' HG2' ' B' ' 119' ' ' GLU . 3.6 ttpp -112.85 116.34 29.88 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 123.244 0.34 . . . . 0.0 110.958 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' TYR . . . . . 0.609 ' CE1' ' HA3' ' A' ' 132' ' ' GLY . 5.3 m-30 -107.56 97.54 7.26 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.55 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.2 OUTLIER -90.77 96.67 10.76 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 175.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . 0.453 ' C ' ' HD2' ' B' ' 146' ' ' PRO . 7.0 mp -108.44 94.46 13.71 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.821 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . 0.559 ' N ' ' HD2' ' B' ' 146' ' ' PRO . 24.0 Cg_exo -66.33 -34.42 35.21 Favored 'Trans proline' 0 C--N 1.287 -2.704 0 C-N-CA 122.636 2.224 . . . . 0.0 113.316 175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' B' ' 145' ' ' PRO . 27.7 Cg_exo -43.76 -10.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.991 1.794 . . . . 0.0 112.293 -178.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 111.36 44.65 0.9 Allowed Glycine 0 C--N 1.339 0.729 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.69 174.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' VAL . . . . . 0.498 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -68.51 101.83 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 175.141 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . 0.449 ' O ' ' CG2' ' B' ' 153' ' ' VAL . 13.5 t70 -52.31 126.4 36.97 Favored Pre-proline 0 C--O 1.221 -0.431 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.07 -172.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 5.1 Cg_exo -79.34 -18.98 10.67 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.11 1.873 . . . . 0.0 112.098 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.57 -38.25 12.61 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.558 -178.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -100.83 17.52 21.89 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . 0.471 ' HA ' ' HB3' ' B' ' 167' ' ' ALA . 49.8 t -108.95 91.11 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.689 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.68 -166.08 1.51 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' B' ' 164' ' ' THR . 0.4 OUTLIER -163.57 142.54 8.08 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.751 -179.101 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.81 144.63 40.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.028 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . 0.413 HD21 HD22 ' B' ' 109' ' ' LEU . 42.1 tp -130.76 117.09 18.89 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.57 152.01 38.78 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.813 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' PRO . . . . . 0.625 ' C ' ' H ' ' B' ' 161' ' ' GLY . 94.5 Cg_exo -44.11 -32.82 5.12 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.45 2.1 . . . . 0.0 110.972 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -68.5 22.04 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.087 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' GLY . . . . . 0.625 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 41.91 27.28 0.36 Allowed Glycine 0 CA--C 1.523 0.561 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.627 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 9.0 t -88.14 118.55 27.8 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' B' ' 98' ' ' SER . 2.9 tm? -105.97 103.93 13.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.831 -177.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' B' ' 155' ' ' SER . 0.7 OUTLIER -94.53 125.49 39.21 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.033 0.208 . . . . 0.0 111.341 -179.051 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' B' ' 165' ' ' VAL . 2.7 m -111.81 105.65 19.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 173.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.516 ' OE1' ' NH1' ' B' ' 94' ' ' ARG . 0.0 OUTLIER -114.29 137.61 51.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.722 -176.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' B' ' 169' ' ' MET . . . -168.75 158.21 7.94 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.83 30.44 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 123.871 3.047 . . . . 0.0 110.329 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' MET . . . . . 0.516 ' H ' ' C ' ' B' ' 167' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.441 -0.915 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.759 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 85.0 mmt-85 . . . . . 0 C--O 1.237 0.414 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.02 140.14 32.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.1 ttp85 -131.71 117.65 18.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.977 0.418 . . . . 0.0 111.48 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.13 134.85 65.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.192 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.6 m -111.11 135.34 51.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.44 ' CD2' ' HB3' ' A' ' 140' ' ' ARG . 0.4 OUTLIER -111.86 72.98 0.8 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.851 175.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -77.56 110.57 12.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.999 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.531 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -160.48 -49.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.251 0.548 . . . . 0.0 110.907 177.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.591 HD21 ' H ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -58.6 14.07 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -174.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.531 ' H ' ' C ' ' A' ' 101' ' ' VAL . 0.9 OUTLIER -43.31 -41.67 4.14 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.348 0.594 . . . . 0.0 110.11 178.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.2 -4.24 52.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.453 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -133.15 73.46 74.64 Favored Pre-proline 0 CA--C 1.511 -0.543 0 CA-C-O 120.938 0.399 . . . . 0.0 112.031 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.5 -40.24 5.98 Favored 'Trans proline' 0 C--N 1.299 -2.073 0 C-N-CA 122.54 2.16 . . . . 0.0 111.565 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -99.74 -27.52 13.61 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.638 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -88.53 35.41 0.77 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.092 0.472 . . . . 0.0 110.627 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.445 ' CD1' ' HB3' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -122.47 132.8 54.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.628 179.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 114.99 20.18 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-O 120.718 0.294 . . . . 0.0 110.609 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.7 130.17 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 pttm -140.23 128.78 22.86 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.606 -0.437 . . . . 0.0 111.462 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.07 115.3 24.37 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.563 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.4 OUTLIER -110.86 73.0 0.8 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.18 0.514 . . . . 0.0 110.27 -177.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.413 ' HA ' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER 34.54 67.98 0.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.389 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.56 -23.62 27.16 Favored Glycine 0 N--CA 1.465 0.611 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 3.5 t -87.23 113.05 24.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.3 t -100.55 112.78 34.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.513 ' HG2' ' HA ' ' A' ' 141' ' ' LYS . 37.1 mt-10 -128.89 142.82 50.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.427 0.632 . . . . 0.0 111.628 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.1 mp -116.27 115.74 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.39 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.45 116.9 29.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.569 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.18 136.9 5.88 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.881 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.19 159.31 35.58 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -97.72 135.27 39.74 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.738 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.47 ' O ' ' C ' ' A' ' 126' ' ' GLU . 6.1 tp10 -68.25 135.73 52.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 125' ' ' GLU . 10.6 tt0 -34.83 99.03 0.02 OUTLIER 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.742 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.757 -176.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.588 0 N-CA-C 112.686 -0.166 . . . . 0.0 112.686 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -94.57 109.64 21.52 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -119.33 137.99 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -172.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.412 ' OG ' ' N ' ' A' ' 136' ' ' ARG . 6.3 t -142.75 171.28 14.27 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.013 170.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -161.92 -176.82 5.43 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.868 -177.175 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.5 p -138.61 121.61 16.71 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -98.03 132.41 43.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.712 0.292 . . . . 0.0 111.501 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.63 101.17 7.31 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.497 ' NH1' ' OH ' ' A' ' 142' ' ' TYR . 1.9 ttt-85 -107.33 103.63 13.03 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.513 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 7.5 ttpt -112.72 129.83 56.27 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.033 0.444 . . . . 0.0 112.124 -175.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.497 ' OH ' ' NH1' ' A' ' 140' ' ' ARG . 22.3 m-85 -118.11 99.79 7.11 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.595 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.462 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.3 OUTLIER -90.76 89.97 7.73 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.93 92.98 15.98 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.569 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 18.6 Cg_exo -65.77 -55.4 0.43 Allowed 'Trans proline' 0 C--N 1.289 -2.567 0 C-N-CA 121.86 1.706 . . . . 0.0 112.632 175.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.569 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 50.6 Cg_endo -103.84 92.06 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.78 2.986 . . . . 0.0 111.517 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.94 -16.31 1.19 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.216 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.751 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 0.9 OUTLIER -131.34 129.52 62.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-N 117.332 0.566 . . . . 0.0 111.077 177.567 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 13.4 t70 -94.37 143.55 26.52 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.165 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 3.3 Cg_exo -81.96 -26.02 3.18 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.823 1.682 . . . . 0.0 112.928 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.14 -37.35 16.25 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -107.2 27.99 8.51 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -172.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.448 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 51.2 t -116.08 113.11 42.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.15 176.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.01 -173.01 2.2 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.29 131.82 11.34 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.837 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.76 139.67 39.98 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.728 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.57 HD11 ' N ' ' A' ' 158' ' ' SER . 14.9 tp -133.95 129.29 36.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.016 0.436 . . . . 0.0 110.85 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.57 ' N ' HD11 ' A' ' 157' ' ' LEU . 0.2 OUTLIER -113.9 148.97 41.06 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.969 178.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.472 ' C ' ' H ' ' A' ' 161' ' ' GLY . 76.9 Cg_exo -40.04 -33.88 0.86 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.807 2.338 . . . . 0.0 112.11 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -74.21 31.43 0.08 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.396 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.482 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 43.91 25.83 0.71 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.388 -0.369 . . . . 0.0 112.992 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.4 t -87.58 101.51 13.7 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 117.228 0.514 . . . . 0.0 109.693 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.445 ' C ' ' CD1' ' A' ' 163' ' ' LEU . 1.5 tm? -100.92 102.37 13.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.051 -177.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 p -97.62 123.05 41.37 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.703 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.476 ' O ' ' CG2' ' A' ' 165' ' ' VAL . 1.4 m -101.85 98.97 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.03 136.72 53.37 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.229 -174.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . . . -176.42 166.42 1.57 Allowed Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.068 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -85.49 109.36 1.12 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.169 2.579 . . . . 0.0 110.126 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.751 ' SD ' ' HA ' ' A' ' 148' ' ' VAL . 37.8 mmt -87.22 152.69 53.2 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.79 -174.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo . . . . . 0 N--CA 1.495 1.607 0 C-N-CA 122.906 2.404 . . . . 0.0 111.708 178.413 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' TRP . . . . . 0.443 ' HB2' ' CG ' ' B' ' 169' ' ' MET . 0.6 OUTLIER -81.3 128.16 33.51 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.891 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -127.47 101.93 6.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.583 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.22 156.6 17.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 4.8 p -124.92 151.41 45.43 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.617 ' O ' ' NH2' ' B' ' 140' ' ' ARG . 0.6 OUTLIER -122.85 43.47 2.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.777 172.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . 0.472 ' CG ' ' HG1' ' B' ' 162' ' ' THR . 5.5 m-20 -62.77 97.81 0.11 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.635 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . 0.464 ' C ' ' H ' ' B' ' 103' ' ' HIS . 2.5 t -158.62 -28.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.401 0.619 . . . . 0.0 109.486 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' B' ' 105' ' ' ALA . 17.0 t30 -66.92 8.94 0.22 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.741 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' HIS . . . . . 0.464 ' H ' ' C ' ' B' ' 101' ' ' VAL . 25.9 m80 -39.64 -21.88 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' B' ' 102' ' ' ASN . 28.0 p90 -92.36 -34.56 14.13 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -176.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . 0.576 ' O ' ' ND2' ' B' ' 102' ' ' ASN . . . -113.52 76.64 2.91 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.3 -39.13 49.41 Favored 'Trans proline' 0 C--N 1.295 -2.259 0 C-N-CA 122.359 2.039 . . . . 0.0 112.237 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -102.0 -27.31 13.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.79 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.563 ' OE1' ' NZ ' ' B' ' 123' ' ' LYS . 32.3 mt-10 -92.69 41.58 1.08 Allowed 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.804 0.335 . . . . 0.0 111.206 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.49 HD12 ' CG2' ' B' ' 120' ' ' ILE . 0.4 OUTLIER -123.51 136.36 54.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.242 179.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.86 131.23 47.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.737 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.01 119.46 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.37 135.26 53.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 0.0 111.312 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.66 115.33 29.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.369 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' LYS . . . . . 0.518 ' CB ' ' HZ2' ' B' ' 114' ' ' LYS . 0.0 OUTLIER -116.0 90.5 3.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.377 -177.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 18.9 t0 33.48 69.21 0.14 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.07 -21.44 16.07 Favored Glycine 0 C--N 1.316 -0.572 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.498 ' HB ' ' HD2' ' B' ' 114' ' ' LYS . 3.8 t -87.49 112.59 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 75.4 t -97.98 119.8 46.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.46 ' HG2' ' HB2' ' B' ' 141' ' ' LYS . 33.7 mt-10 -133.96 139.88 46.39 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.49 0.662 . . . . 0.0 111.134 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.49 ' CG2' HD12 ' B' ' 109' ' ' LEU . 1.0 OUTLIER -116.78 137.46 50.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.494 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.82 119.53 35.69 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.281 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -142.87 124.7 2.42 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' LYS . . . . . 0.563 ' NZ ' ' OE1' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -150.66 140.51 21.86 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -116.94 157.94 24.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.224 0.535 . . . . 0.0 112.397 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.452 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.8 OUTLIER -68.52 145.49 53.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.275 179.082 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . 0.553 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 4.9 tt0 -29.98 102.1 0.02 OUTLIER 'General case' 0 C--N 1.349 0.546 0 CA-C-O 120.832 0.349 . . . . 0.0 111.174 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' B' ' 133' ' ' TYR . 0.2 OUTLIER -89.65 136.37 33.07 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.913 -177.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -90.7 117.28 29.22 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 172.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.75 171.95 10.23 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.134 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -56.45 -31.78 64.3 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -174.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' HIS . . . . . 0.444 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 74.0 m80 -111.73 36.39 3.3 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -175.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 121.85 -173.29 15.74 Favored Glycine 0 C--N 1.305 -1.18 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.426 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' B' ' 127' ' ' ARG . 13.6 m-30 -95.94 118.92 33.5 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . 0.498 ' O ' ' NH2' ' B' ' 136' ' ' ARG . 0.1 OUTLIER -133.74 112.26 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -173.173 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' SER . . . . . 0.553 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -127.9 164.1 23.0 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.032 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . 0.498 ' NH2' ' O ' ' B' ' 134' ' ' ILE . 0.0 OUTLIER -161.76 161.94 29.43 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.588 -176.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 26.8 p -113.47 128.16 56.35 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -107.99 137.93 45.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -176.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.55 123.64 19.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.282 0.563 . . . . 0.0 111.046 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . 0.617 ' NH2' ' O ' ' B' ' 99' ' ' LEU . 0.0 OUTLIER -124.54 118.65 27.05 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . 0.46 ' HB2' ' HG2' ' B' ' 119' ' ' GLU . 1.1 ttpp -114.11 124.65 52.61 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.823 0.344 . . . . 0.0 110.874 -175.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' TYR . . . . . 0.54 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 3.3 m-85 -114.27 98.27 6.83 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.245 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.551 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.3 OUTLIER -91.33 101.49 14.18 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 mp -107.35 96.49 16.09 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . 0.56 ' C ' ' H ' ' B' ' 147' ' ' GLY . 36.0 Cg_exo -62.26 -38.18 56.53 Favored 'Trans proline' 0 C--N 1.286 -2.76 0 C-N-CA 123.375 2.717 . . . . 0.0 114.198 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 50.1 Cg_exo -47.34 -8.61 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.619 1.546 . . . . 0.0 111.515 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' B' ' 145' ' ' PRO . . . 97.83 56.73 1.07 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.2 -0.524 . . . . 0.0 111.979 175.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' VAL . . . . . 0.51 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -69.86 100.76 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 176.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . 0.436 ' O ' ' CG2' ' B' ' 153' ' ' VAL . 0.9 OUTLIER -33.83 120.23 0.5 Allowed Pre-proline 0 C--O 1.219 -0.509 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.411 -173.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 8.5 Cg_exo -71.86 -42.39 1.67 Allowed 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.425 2.083 . . . . 0.0 111.841 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -47.6 25.23 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.642 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.35 18.69 2.57 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.629 -1.169 . . . . 0.0 113.473 -172.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . 0.464 ' HA ' ' CB ' ' B' ' 167' ' ' ALA . 33.4 t -114.0 106.65 21.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.471 177.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' SER . . . . . 0.415 ' C ' ' HG ' ' B' ' 155' ' ' SER . 0.1 OUTLIER -100.44 -169.31 1.7 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' SER . . . . . 0.415 ' HG ' ' C ' ' B' ' 154' ' ' SER . 0.8 OUTLIER -162.72 146.47 11.37 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.612 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.67 144.77 48.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.684 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' B' ' 162' ' ' THR . 23.5 tp -134.9 148.65 50.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.342 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.02 156.81 79.64 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' PRO . . . . . 0.613 ' C ' ' H ' ' B' ' 161' ' ' GLY . 75.5 Cg_exo -39.61 -43.43 3.05 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.702 2.268 . . . . 0.0 111.402 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -66.97 26.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.21 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' GLY . . . . . 0.613 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 41.65 24.48 0.15 Allowed Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.734 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' THR . . . . . 0.472 ' HG1' ' CG ' ' B' ' 100' ' ' ASP . 11.6 t -77.03 130.4 37.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' B' ' 98' ' ' SER . 2.7 tm? -126.46 105.39 8.73 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.145 -175.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.28 121.8 38.46 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . 0.45 ' O ' ' CG2' ' B' ' 165' ' ' VAL . 3.2 m -105.51 98.94 7.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 0.0 OUTLIER -116.43 127.3 54.48 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.504 -175.058 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' ALA . . . . . 0.464 ' CB ' ' HA ' ' B' ' 153' ' ' VAL . . . -171.1 158.06 5.07 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -82.49 126.47 4.75 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.478 2.785 . . . . 0.0 110.005 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' MET . . . . . 0.534 ' N ' ' SD ' ' B' ' 169' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.0 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.993 -176.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.517 HH21 ' CD ' ' A' ' 166' ' ' GLU . 30.4 mmm-85 . . . . . 0 C--O 1.238 0.483 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.497 ' NE1' ' CG2' ' A' ' 97' ' ' VAL . 37.7 t-105 -117.71 118.22 31.49 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.22 104.76 14.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.097 -175.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.497 ' CG2' ' NE1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -110.74 139.13 35.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 174.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 15.4 m -111.36 154.06 25.11 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.43 -0.508 . . . . 0.0 112.368 -176.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.502 HD23 HG12 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -131.05 67.13 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.591 176.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.19 89.48 4.27 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.86 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.516 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.2 OUTLIER -142.75 -36.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 121.226 0.536 . . . . 0.0 110.42 177.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.504 ' OD1' ' CD1' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -64.45 13.41 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.56 -176.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.516 ' H ' ' C ' ' A' ' 101' ' ' VAL . 2.1 p80 -54.63 -20.1 7.41 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.723 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.458 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 32.6 p90 -107.2 3.65 25.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.712 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.85 81.39 16.52 Favored Pre-proline 0 CA--C 1.518 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 111.223 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.99 -44.38 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.685 2.257 . . . . 0.0 111.324 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 109' ' ' LEU . 2.4 m-20 -104.6 -31.13 9.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.346 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.36 36.25 0.47 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.086 0.47 . . . . 0.0 110.655 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.504 ' CD1' ' OD1' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -117.9 135.9 53.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.938 178.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.436 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 1.2 m -127.68 126.83 42.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.841 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.4 t -104.09 126.97 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.409 ' NZ ' ' CB ' ' A' ' 119' ' ' GLU . 3.4 pttp -133.17 130.95 39.85 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.058 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 45.3 m -112.05 109.17 18.76 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.59 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.498 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 3.3 ttmm -114.43 99.89 7.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.257 -177.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 114' ' ' LYS . 15.6 t0 26.1 64.23 0.07 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.86 -19.81 52.07 Favored Glycine 0 N--CA 1.461 0.308 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 2.7 t -88.67 112.55 24.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.537 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.12 114.6 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 140' ' ' ARG . 46.1 mt-10 -127.46 133.57 49.9 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.266 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.502 HG12 HD23 ' A' ' 99' ' ' LEU . 4.0 mm -104.25 137.19 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.979 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -118.89 107.59 13.77 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.192 -178.133 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -135.17 115.03 1.32 Allowed Glycine 0 N--CA 1.461 0.357 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 159.58 41.22 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 104' ' ' PHE . 1.7 t60 -139.72 141.49 36.9 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.416 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.502 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.3 OUTLIER -81.45 150.22 28.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.063 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.502 ' C ' ' O ' ' A' ' 125' ' ' GLU . 4.9 tt0 -1.4 108.93 0.01 OUTLIER 'General case' 0 C--N 1.349 0.556 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? . . . . . 0 C--O 1.233 0.197 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.565 176.172 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.436 ' HA3' ' CZ ' ' B' ' 142' ' ' TYR . . . . . . . . 0 C--O 1.221 -0.718 0 N-CA-C 112.158 -0.377 . . . . 0.0 112.158 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -92.35 107.85 19.52 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.589 ' O ' ' NH2' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -125.93 117.53 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -174.289 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -109.17 149.57 29.16 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.401 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.589 ' NH2' ' O ' ' A' ' 134' ' ' ILE . 0.0 OUTLIER -133.16 172.43 12.67 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -174.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 23.7 p -141.13 131.75 25.55 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.407 ' CD2' HG11 ' A' ' 101' ' ' VAL . 7.3 m-85 -107.09 139.48 41.44 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.136 -0.225 . . . . 0.0 111.034 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.8 104.47 6.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.395 0.617 . . . . 0.0 110.364 175.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.569 ' NE ' ' OH ' ' A' ' 142' ' ' TYR . 12.5 ttt180 -108.01 100.54 9.88 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.48 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.416 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 6.6 ttpt -107.67 116.04 31.23 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.287 -175.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.569 ' OH ' ' NE ' ' A' ' 140' ' ' ARG . 19.9 m-30 -114.52 99.6 7.67 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.3 0.571 . . . . 0.0 110.144 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.459 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -86.29 89.03 7.73 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.377 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mp -112.1 91.52 16.03 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.593 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 15.3 Cg_exo -68.18 -56.41 0.2 Allowed 'Trans proline' 0 C--N 1.294 -2.311 0 C-N-CA 122.359 2.039 . . . . 0.0 113.831 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.593 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 37.4 Cg_endo -99.3 53.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 123.327 2.685 . . . . 0.0 112.408 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -171.45 -12.91 0.02 OUTLIER Glycine 0 CA--C 1.521 0.429 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.569 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.567 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 1.0 OUTLIER -130.26 125.11 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 117.68 0.74 . . . . 0.0 111.187 178.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.481 ' HB2' ' HD3' ' A' ' 170' ' ' PRO . 14.2 t70 -81.91 140.69 46.85 Favored Pre-proline 0 N--CA 1.478 0.962 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.293 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -81.1 -26.45 3.46 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.027 1.818 . . . . 0.0 113.0 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.413 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 0.8 OUTLIER -91.19 -36.38 13.98 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -176.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 167' ' ' ALA . 4.6 mt-30 -107.72 27.22 9.4 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -172.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.3 104.94 17.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.67 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.412 ' C ' ' HG ' ' A' ' 155' ' ' SER . 0.7 OUTLIER -95.31 -161.77 0.89 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.717 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 154' ' ' SER . 0.3 OUTLIER -165.1 132.07 2.94 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.335 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -100.82 139.81 35.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.591 177.459 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.469 HD13 ' H ' ' A' ' 158' ' ' SER . 42.1 tp -137.53 138.13 39.33 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.176 0.513 . . . . 0.0 110.981 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.583 ' O ' ' N ' ' A' ' 161' ' ' GLY . 23.1 m -121.88 146.06 45.07 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.631 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 161' ' ' GLY . 75.4 Cg_exo -41.27 -34.8 1.86 Allowed 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.065 1.843 . . . . 0.0 110.897 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -65.31 2.86 0.75 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.076 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 158' ' ' SER . . . 67.09 21.2 71.62 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.894 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.496 HG23 ' HB2' ' A' ' 158' ' ' SER . 0.7 OUTLIER -77.24 106.82 9.21 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 98' ' ' SER . 1.2 tm? -106.94 101.52 10.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.752 -175.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.42 120.24 39.29 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 121.289 -0.165 . . . . 0.0 110.66 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.495 ' O ' ' CG2' ' A' ' 165' ' ' VAL . 1.5 m -100.93 99.18 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.517 ' CD ' HH21 ' A' ' 94' ' ' ARG . 1.4 pp20? -112.71 146.21 39.12 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.674 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 152' ' ' GLN . . . 175.13 166.64 0.37 Allowed Pre-proline 0 N--CA 1.437 -1.103 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.206 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -86.41 106.33 0.77 Allowed 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.803 2.335 . . . . 0.0 108.735 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.567 ' SD ' ' HA ' ' A' ' 148' ' ' VAL . 20.5 mmt -74.66 153.95 87.39 Favored Pre-proline 0 C--N 1.31 -1.126 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.554 -174.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 149' ' ' ASP . 38.4 Cg_endo . . . . . 0 C--N 1.303 -1.854 0 C-N-CA 122.626 2.217 . . . . 0.0 111.684 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . 0.478 ' NH1' ' OE1' ' B' ' 166' ' ' GLU . 9.0 mmt85 . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' TRP . . . . . 0.669 ' HB2' ' SD ' ' B' ' 169' ' ' MET . 0.3 OUTLIER -55.51 151.11 10.89 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.133 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . 0.583 ' HB2' ' NH1' ' B' ' 96' ' ' ARG . 16.3 ttm105 -150.13 109.4 3.96 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.684 -176.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 t -119.1 152.27 21.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 1.5 m -126.05 144.29 50.78 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -176.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.512 ' CD2' ' HB2' ' B' ' 140' ' ' ARG . 0.3 OUTLIER -115.39 54.64 0.79 Allowed 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.447 176.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . 0.462 ' O ' HG23 ' B' ' 101' ' ' VAL . 0.1 OUTLIER -62.32 96.96 0.08 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.018 -178.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . 0.487 ' CG2' ' CZ ' ' B' ' 140' ' ' ARG . 0.6 OUTLIER -162.0 -6.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 176.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.55 ' OD1' ' HA2' ' B' ' 161' ' ' GLY . 0.4 OUTLIER -90.5 10.15 26.52 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -175.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' HIS . . . . . 0.5 ' N ' ' HA3' ' B' ' 161' ' ' GLY . 0.2 OUTLIER -39.63 -35.04 0.27 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.72 0.295 . . . . 0.0 111.155 179.472 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.6 -8.83 51.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' B' ' 102' ' ' ASN . . . -138.72 93.34 10.88 Favored Pre-proline 0 CA--C 1.515 -0.383 0 CA-C-O 120.696 0.284 . . . . 0.0 111.298 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -81.17 -48.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.967 0 C-N-CA 122.68 2.253 . . . . 0.0 110.933 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -90.29 -31.2 17.05 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.523 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.518 ' OE2' ' NZ ' ' B' ' 123' ' ' LYS . 2.8 mt-10 -84.63 45.09 1.1 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.369 0.604 . . . . 0.0 109.897 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' B' ' 121' ' ' THR . 0.5 OUTLIER -129.44 135.98 49.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.013 178.321 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.96 121.73 22.06 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.571 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 1.5 t -98.99 131.78 45.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.814 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.463 ' HZ2' ' CD ' ' B' ' 119' ' ' GLU . 2.9 pttp -139.78 122.28 16.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.101 0.477 . . . . 0.0 111.755 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.7 117.54 34.27 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' LYS . . . . . 0.558 ' O ' ' N ' ' B' ' 117' ' ' VAL . 1.3 ttpm? -128.96 112.01 13.62 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.348 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.476 ' CG ' ' O ' ' B' ' 115' ' ' ASP . 0.3 OUTLIER 34.64 59.89 0.64 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.91 0.862 . . . . 0.0 112.481 176.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.91 -12.1 31.55 Favored Glycine 0 C--N 1.314 -0.657 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' B' ' 114' ' ' LYS . 9.0 t -87.47 115.46 28.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.762 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.505 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 54.2 t -103.66 112.67 38.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.571 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.57 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 49.4 mt-10 -125.96 146.47 49.85 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.599 0.714 . . . . 0.0 111.546 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.79 121.56 66.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.307 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -97.44 124.3 41.58 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.2 117.59 0.86 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' LYS . . . . . 0.518 ' NZ ' ' OE2' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -152.82 135.5 15.31 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.363 0.265 . . . . 0.0 110.489 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . 0.515 ' O ' ' CB ' ' B' ' 135' ' ' SER . 0.1 OUTLIER -111.96 123.55 50.49 Favored 'General case' 0 C--O 1.21 -0.989 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.4 ' H ' ' HG3' ' B' ' 125' ' ' GLU . 4.9 mt-10 -54.05 -21.43 8.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -176.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 178.61 131.11 0.07 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.989 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' ARG . . . . . 0.472 ' HD3' ' CE1' ' B' ' 124' ' ' HIS . 38.9 mtp180 -123.69 132.08 53.75 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.146 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -81.56 138.7 35.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.936 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . 0.506 ' CG ' ' N ' ' B' ' 130' ' ' GLU . 9.2 t70 -157.37 165.89 34.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.205 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . 0.506 ' N ' ' CG ' ' B' ' 129' ' ' ASP . 0.7 OUTLIER -61.4 -28.28 69.14 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.639 -177.119 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' HIS . . . . . 0.48 ' O ' ' CE1' ' A' ' 142' ' ' TYR . 10.6 m-70 -74.78 -12.55 60.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.758 0.313 . . . . 0.0 111.013 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.74 -136.95 8.96 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -112.25 134.99 53.48 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 175.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' B' ' 127' ' ' ARG . 0.4 OUTLIER -146.75 125.76 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -176.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' B' ' 124' ' ' HIS . 0.6 OUTLIER -142.99 158.01 44.0 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.029 0.442 . . . . 0.0 111.283 174.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . 0.472 ' CZ ' ' CZ ' ' B' ' 138' ' ' PHE . 0.2 OUTLIER -141.77 173.7 11.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.865 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 31.9 p -123.74 129.91 51.82 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . 0.472 ' CZ ' ' CZ ' ' B' ' 136' ' ' ARG . 1.1 m-85 -104.86 122.35 45.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.936 -176.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 134' ' ' ILE . 0.0 OUTLIER -124.83 99.47 6.16 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.137 174.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . 0.512 ' HB2' ' CD2' ' B' ' 99' ' ' LEU . 0.0 OUTLIER -106.63 119.58 39.68 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.288 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . 0.57 ' HA ' ' HG2' ' B' ' 119' ' ' GLU . 2.7 ttpt -120.19 130.72 54.68 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.07 0.462 . . . . 0.0 111.206 -176.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 7.8 m-85 -120.27 98.74 6.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.961 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.422 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 1.3 m -93.52 93.66 8.22 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -110.95 90.95 11.86 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.584 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . 0.583 ' HD2' ' CD ' ' B' ' 146' ' ' PRO . 16.2 Cg_exo -68.72 -41.19 6.18 Favored 'Trans proline' 0 C--N 1.279 -3.096 0 C-N-CA 122.06 1.84 . . . . 0.0 112.125 167.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' PRO . . . . . 0.583 ' CD ' ' HD2' ' B' ' 145' ' ' PRO . 74.2 Cg_exo -43.21 -11.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 123.325 2.683 . . . . 0.0 114.606 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 149.02 44.64 0.03 OUTLIER Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 118.239 -1.934 . . . . 0.0 115.447 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.29 116.56 52.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 118.73 -1.188 . . . . 0.0 110.667 173.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 19.3 t70 -80.02 140.33 53.71 Favored Pre-proline 0 C--O 1.221 -0.407 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.03 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 4.2 Cg_exo -81.4 -23.89 4.78 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.074 1.85 . . . . 0.0 112.9 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.15 -43.68 9.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.975 0.417 . . . . 0.0 112.072 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -94.93 18.97 10.94 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 42.5 t -108.83 104.94 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.088 0.471 . . . . 0.0 109.888 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' SER . . . . . 0.406 ' C ' ' HG ' ' B' ' 155' ' ' SER . 0.0 OUTLIER -97.43 -175.38 3.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.237 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' SER . . . . . 0.406 ' HG ' ' C ' ' B' ' 154' ' ' SER . 0.7 OUTLIER -158.01 132.79 8.46 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.717 -0.793 . . . . 0.0 112.291 -178.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.56 139.84 40.39 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.222 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . 0.404 HD11 ' OD1' ' B' ' 102' ' ' ASN . 33.0 tp -131.08 143.12 50.43 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' SER . . . . . 0.408 ' OG ' ' HD2' ' B' ' 159' ' ' PRO . 0.2 OUTLIER -135.58 154.38 78.22 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.639 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' PRO . . . . . 0.58 ' C ' ' H ' ' B' ' 161' ' ' GLY . 1.2 Cg_endo -44.8 -34.79 8.87 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.693 2.262 . . . . 0.0 111.491 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -68.74 24.12 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.034 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' GLY . . . . . 0.58 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 44.03 34.03 2.95 Favored Glycine 0 C--O 1.241 0.532 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.638 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 7.4 t -97.16 121.46 39.08 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' B' ' 98' ' ' SER . 1.8 tm? -115.84 103.86 11.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.953 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.59 121.72 39.82 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 121.13 -0.228 . . . . 0.0 110.803 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . 0.441 ' O ' ' CG2' ' B' ' 165' ' ' VAL . 3.1 m -106.49 103.33 15.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.478 ' OE1' ' NH1' ' B' ' 94' ' ' ARG . 2.0 pp20? -113.22 151.84 30.5 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.278 -177.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -174.62 154.25 1.89 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 0.0 111.628 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.06 -4.7 11.24 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 123.018 2.479 . . . . 0.0 109.906 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' MET . . . . . 0.669 ' SD ' ' HB2' ' B' ' 95' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.388 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.429 ' NH1' ' HD3' ' A' ' 168' ' ' PRO . 10.9 mmt180 . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.566 ' CB ' ' SD ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -68.45 145.17 54.32 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.129 -179.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -138.66 105.96 5.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.487 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.22 155.11 13.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 175.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.62 148.64 51.53 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -174.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.417 ' CD2' ' HB2' ' A' ' 140' ' ' ARG . 0.7 OUTLIER -130.13 118.91 22.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.102 174.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.431 ' CG ' ' HE2' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -112.28 114.08 26.66 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.536 -178.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.609 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -161.14 -43.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 120.89 0.376 . . . . 0.0 111.445 179.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.603 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -60.27 17.0 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.609 ' H ' ' C ' ' A' ' 101' ' ' VAL . 12.0 m80 -52.67 -38.09 59.88 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -105.69 -15.14 15.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.645 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -118.13 81.93 17.22 Favored Pre-proline 0 CA--C 1.516 -0.346 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -74.36 -44.66 0.4 Allowed 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 122.612 2.208 . . . . 0.0 110.924 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -92.55 -31.47 15.19 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.759 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -89.44 45.86 1.32 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.151 0.5 . . . . 0.0 111.14 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.545 HD13 ' HB3' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -133.34 130.29 38.64 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 m -128.61 124.56 36.16 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 120.783 0.325 . . . . 0.0 110.512 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.51 127.4 48.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.984 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.85 130.13 43.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.856 0.36 . . . . 0.0 111.406 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.91 104.0 13.37 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.559 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -109.43 103.32 12.21 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.528 -175.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.474 ' CG ' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER 36.06 41.44 0.13 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 177.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.03 -11.52 57.32 Favored Glycine 0 C--N 1.314 -0.651 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 2.6 t -86.73 117.25 30.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 55.4 t -102.81 116.51 46.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 141' ' ' LYS . 2.2 mt-10 -133.51 140.2 47.09 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.272 0.558 . . . . 0.0 111.521 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.44 115.54 50.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.154 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -92.0 118.67 31.0 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.776 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.17 129.99 4.28 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.118 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.72 159.28 44.63 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -133.68 162.13 32.79 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.36 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.523 ' O ' ' C ' ' A' ' 126' ' ' GLU . 1.5 tt0 -90.28 143.33 26.86 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.851 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.523 ' C ' ' O ' ' A' ' 125' ' ' GLU . 1.0 OUTLIER -18.12 105.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.645 0.591 . . . . 0.0 111.846 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.514 -0.436 0 CA-C-O 120.897 0.379 . . . . 0.0 110.428 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.443 ' HA3' ' CZ ' ' B' ' 142' ' ' TYR . . . . . . . . 0 N--CA 1.439 -1.102 0 N-CA-C 112.014 -0.435 . . . . 0.0 112.014 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -92.2 109.71 21.08 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.502 HG23 HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -122.47 159.34 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -169.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.9 t -155.06 154.81 33.02 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.762 170.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.55 172.27 15.76 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.928 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.5 p -125.97 128.36 47.38 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -102.68 142.25 34.14 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.352 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.55 103.02 3.63 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.086 0.47 . . . . 0.0 111.554 176.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.55 ' NH2' ' OH ' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -104.16 119.63 39.37 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 174.336 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.479 ' HB2' ' HG2' ' A' ' 119' ' ' GLU . 2.7 ttpt -118.4 123.58 45.59 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 123.21 0.319 . . . . 0.0 110.666 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.55 ' OH ' ' NH2' ' A' ' 140' ' ' ARG . 3.2 m-85 -112.96 99.16 7.66 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.993 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.431 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -92.0 90.25 7.32 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.548 178.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.44 91.94 21.69 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.59 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 16.0 Cg_exo -67.47 -56.94 0.19 Allowed 'Trans proline' 0 C--N 1.288 -2.641 0 C-N-CA 122.349 2.033 . . . . 0.0 114.207 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.59 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 41.8 Cg_endo -100.61 56.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.482 0.815 0 C-N-CA 123.377 2.718 . . . . 0.0 113.035 -175.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 169' ' ' MET . . . -176.76 -14.35 0.02 OUTLIER Glycine 0 N--CA 1.466 0.634 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.713 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.03 132.21 68.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 117.539 0.67 . . . . 0.0 110.153 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -93.44 141.15 23.54 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.204 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.66 -21.4 5.08 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.095 1.863 . . . . 0.0 112.7 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.45 -41.69 10.71 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.386 -175.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.415 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 1.8 mt-30 -101.29 14.44 31.96 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -171.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.423 ' HA ' ' HB3' ' A' ' 167' ' ' ALA . 24.9 t -102.75 117.09 47.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.387 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.02 166.69 11.18 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.62 137.46 35.33 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.112 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.57 138.57 47.94 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.872 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.417 ' CD2' HD21 ' A' ' 109' ' ' LEU . 14.8 tp -125.13 121.77 35.18 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.388 0.43 . . . . 0.0 110.364 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 161' ' ' GLY . 0.2 OUTLIER -96.07 138.28 21.65 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 161' ' ' GLY . 74.8 Cg_exo -39.95 -33.19 0.7 Allowed 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.556 2.171 . . . . 0.0 111.185 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -59.23 -5.54 0.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.344 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.537 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . 76.69 34.41 43.87 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.4 t -109.89 118.76 37.33 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.418 ' C ' ' CD1' ' A' ' 163' ' ' LEU . 2.1 tm? -104.25 108.65 20.14 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.597 -174.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.468 ' H ' ' HG1' ' A' ' 164' ' ' THR . 3.4 p -95.43 127.94 41.88 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.605 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' A' ' 165' ' ' VAL . 2.7 m -113.47 103.33 15.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 1.6 pp20? -119.11 141.82 48.45 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.201 -176.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . . . -174.48 157.85 2.44 Favored Pre-proline 0 C--N 1.332 -0.193 0 C-N-CA 120.024 -0.671 . . . . 0.0 112.618 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.429 ' HD3' ' NH1' ' A' ' 94' ' ' ARG . 61.6 Cg_endo -83.35 108.73 1.55 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.736 2.291 . . . . 0.0 108.84 172.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.566 ' SD ' ' CB ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -87.59 156.09 53.43 Favored Pre-proline 0 C--N 1.305 -1.337 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.745 -174.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 C--N 1.312 -1.351 0 C-N-CA 122.673 2.248 . . . . 0.0 111.43 179.677 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . 0.444 HH11 ' HB3' ' B' ' 94' ' ' ARG . 0.2 OUTLIER . . . . . 0 CA--C 1.516 -0.361 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' TRP . . . . . 0.654 ' HB2' ' SD ' ' B' ' 169' ' ' MET . 0.1 OUTLIER -63.83 139.99 58.82 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 19.7 ttm105 -134.45 99.08 4.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.138 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 t -105.87 152.21 7.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 9.0 m -129.17 144.26 51.15 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -175.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.47 HD22 ' NE ' ' B' ' 140' ' ' ARG . 0.5 OUTLIER -113.79 52.54 0.81 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.527 175.119 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -59.48 97.09 0.04 OUTLIER 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.9 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -167.93 -2.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.622 ' OD1' ' HA2' ' B' ' 161' ' ' GLY . 0.4 OUTLIER -90.99 11.95 21.27 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.616 178.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -59.16 -14.38 10.26 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.438 ' N ' ' C ' ' B' ' 102' ' ' ASN . 13.7 t80 -85.67 -9.97 56.41 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.603 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 102' ' ' ASN . . . -169.68 98.12 0.48 Allowed Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.423 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . 0.445 ' HA ' ' ND2' ' B' ' 102' ' ' ASN . 57.7 Cg_endo -76.3 -40.94 0.53 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.672 2.248 . . . . 0.0 111.875 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.17 -32.21 12.59 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.367 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.586 ' CD ' ' HZ1' ' B' ' 123' ' ' LYS . 1.9 mm-40 -89.8 49.67 1.76 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.485 0.659 . . . . 0.0 110.358 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.473 HD11 ' CG2' ' B' ' 120' ' ' ILE . 0.4 OUTLIER -129.36 135.22 48.44 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.575 178.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.7 121.95 34.92 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -100.32 131.64 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.448 ' NZ ' ' OG1' ' B' ' 121' ' ' THR . 0.0 OUTLIER -134.89 124.12 24.51 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.354 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.6 m -94.63 116.32 28.62 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' B' ' 116' ' ' GLY . 1.5 ttmp? -120.02 143.8 47.88 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -22.85 71.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' B' ' 114' ' ' LYS . . . 83.07 -2.51 86.79 Favored Glycine 0 N--CA 1.472 1.09 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' B' ' 114' ' ' LYS . 2.3 t -102.93 114.47 42.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 48.0 t -98.11 120.02 46.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 33.7 mt-10 -133.5 136.14 44.89 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.179 0.514 . . . . 0.0 110.62 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.473 ' CG2' HD11 ' B' ' 109' ' ' LEU . 3.2 mm -111.82 138.07 41.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.622 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' THR . . . . . 0.448 ' OG1' ' NZ ' ' B' ' 112' ' ' LYS . 0.2 OUTLIER -115.89 120.28 38.71 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.133 -179.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.8 135.64 5.51 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.768 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' LYS . . . . . 0.586 ' HZ1' ' CD ' ' B' ' 108' ' ' GLU . 0.2 OUTLIER -150.2 159.08 44.7 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.219 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . 0.488 ' CG ' ' HD2' ' B' ' 127' ' ' ARG . 2.0 t60 -132.72 156.34 47.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.674 0.273 . . . . 0.0 110.273 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.546 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.6 OUTLIER -92.24 131.68 37.27 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.346 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . 0.546 ' C ' ' O ' ' B' ' 125' ' ' GLU . 1.5 tt0 -3.11 97.7 0.01 OUTLIER 'General case' 0 C--N 1.344 0.334 0 O-C-N 123.751 0.657 . . . . 0.0 112.47 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' ARG . . . . . 0.488 ' HD2' ' CG ' ' B' ' 124' ' ' HIS . 31.5 mtp180 -90.16 146.9 23.93 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.095 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -88.8 131.78 34.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.325 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -134.71 163.36 29.96 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.052 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.65 -14.12 60.56 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.042 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' HIS . . . . . 0.521 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 69.2 m-70 -114.04 29.03 8.31 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.491 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.71 -153.12 17.36 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 119.728 -1.225 . . . . 0.0 111.611 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -112.89 127.94 56.33 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.29 123.48 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -175.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' SER . . . . . 0.543 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.1 OUTLIER -134.32 160.43 37.94 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 174.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . 0.478 ' HD2' ' CE2' ' B' ' 138' ' ' PHE . 10.4 ptp85 -156.85 166.07 34.42 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.563 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 27.5 p -117.84 136.42 53.44 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . 0.478 ' CE2' ' HD2' ' B' ' 136' ' ' ARG . 11.1 m-85 -106.89 138.18 43.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.276 -177.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.15 126.18 10.56 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.951 174.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . 0.47 ' NE ' HD22 ' B' ' 99' ' ' LEU . 0.0 OUTLIER -131.23 112.92 13.23 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . 0.403 ' HA ' ' HG2' ' B' ' 119' ' ' GLU . 11.3 ttmt -101.28 119.08 38.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.931 0.395 . . . . 0.0 110.556 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' TYR . . . . . 0.512 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 4.3 m-85 -109.48 97.58 7.12 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.429 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.0 OUTLIER -91.66 96.59 10.53 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 177.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.87 90.23 12.78 Favored Pre-proline 0 CA--C 1.514 -0.409 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.429 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . 0.58 ' HD2' ' CD ' ' B' ' 146' ' ' PRO . 17.1 Cg_exo -68.49 -40.6 7.6 Favored 'Trans proline' 0 C--N 1.285 -2.793 0 C-N-CA 122.38 2.053 . . . . 0.0 112.127 168.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' PRO . . . . . 0.58 ' CD ' ' HD2' ' B' ' 145' ' ' PRO . 71.4 Cg_exo -43.07 -8.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 123.554 2.836 . . . . 0.0 114.194 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 134.69 64.77 0.07 OUTLIER Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 118.964 -1.588 . . . . 0.0 114.879 176.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' VAL . . . . . . . . . . . . . 1.1 t -123.74 108.55 21.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.365 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 149' ' ' ASP . 10.7 p-10 -76.9 127.89 82.79 Favored Pre-proline 0 N--CA 1.472 0.659 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.885 -176.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 3.0 Cg_exo -75.81 -30.47 6.03 Favored 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 122.156 1.904 . . . . 0.0 113.848 -173.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 1.2 p -76.64 -36.57 57.32 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.883 0.373 . . . . 0.0 110.889 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -101.74 1.81 37.78 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 42.2 t -96.15 103.12 14.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.777 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.14 177.28 4.89 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.4 138.98 33.36 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.423 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.97 132.43 54.22 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.464 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . 0.541 ' CD1' ' OD1' ' B' ' 102' ' ' ASN . 25.0 tp -125.57 142.13 51.67 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.055 0.455 . . . . 0.0 110.744 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' SER . . . . . 0.475 ' O ' ' N ' ' B' ' 161' ' ' GLY . 0.2 OUTLIER -132.51 141.01 39.66 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.172 178.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' B' ' 161' ' ' GLY . 73.2 Cg_exo -38.35 -35.27 0.43 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 123.18 2.587 . . . . 0.0 112.448 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.57 -5.07 1.07 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.612 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' GLY . . . . . 0.622 ' HA2' ' OD1' ' B' ' 102' ' ' ASN . . . 76.08 33.0 51.21 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.662 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' THR . . . . . 0.426 ' O ' HG21 ' B' ' 162' ' ' THR . 15.1 t -98.7 114.97 27.7 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.14 0.495 . . . . 0.0 110.377 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' B' ' 98' ' ' SER . 1.9 tm? -109.2 102.93 11.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.103 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.94 126.96 43.59 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 3.6 m -108.33 108.05 24.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 0.8 OUTLIER -117.34 143.13 46.28 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.278 -174.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -171.2 157.25 4.8 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-O 121.088 0.47 . . . . 0.0 111.995 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.1 -18.07 10.22 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 123.443 2.762 . . . . 0.0 110.933 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' MET . . . . . 0.654 ' SD ' ' HB2' ' B' ' 95' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.929 176.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 . . . . . 0 CA--C 1.5 -0.975 0 CA-C-O 120.677 0.275 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.502 ' CH2' HG23 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -91.64 151.98 20.45 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.207 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.64 98.87 3.26 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.432 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.441 HG23 ' CZ3' ' A' ' 95' ' ' TRP . 2.0 t -111.65 150.66 13.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.1 139.48 51.17 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.483 HD23 HG12 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -115.08 74.0 0.86 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.741 175.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.437 ' OD1' ' NH2' ' A' ' 140' ' ' ARG . 12.0 p-10 -70.8 112.96 7.4 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.579 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -173.25 -40.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.565 ' ND2' ' O ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -41.32 -19.64 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.462 -1.699 . . . . 0.0 110.815 178.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 101' ' ' VAL . 5.0 t60 -45.67 -33.89 3.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.41 ' CZ ' ' NH1' ' A' ' 136' ' ' ARG . 52.6 m-85 -83.94 12.37 6.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.7 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 102' ' ' ASN . . . -179.19 96.71 0.2 Allowed Pre-proline 0 C--N 1.333 -0.143 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.55 ' HA ' HD22 ' A' ' 102' ' ' ASN . 47.6 Cg_endo -70.99 -48.5 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.452 2.101 . . . . 0.0 111.209 176.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -99.44 -30.93 11.91 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.038 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -81.63 47.98 1.13 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.02 0.438 . . . . 0.0 110.245 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.471 HD23 HD23 ' A' ' 157' ' ' LEU . 0.4 OUTLIER -131.57 138.54 48.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.255 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -128.38 123.03 32.82 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.631 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.81 122.38 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.423 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -127.6 134.78 49.68 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.817 -178.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 m -102.84 118.06 36.01 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.587 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.2 OUTLIER -115.84 83.16 1.89 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.219 0.533 . . . . 0.0 110.335 -176.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.4 t0 30.46 68.24 0.1 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.445 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.34 -23.08 29.19 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.587 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 2.7 t -87.97 117.3 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 42.1 t -101.42 116.45 45.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 140' ' ' ARG . 8.9 mt-10 -133.1 134.16 43.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.941 0.401 . . . . 0.0 111.206 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.483 HG12 HD23 ' A' ' 99' ' ' LEU . 4.4 mm -106.33 142.65 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.863 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.423 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -123.64 115.46 21.5 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.201 -178.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.16 127.8 2.51 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.222 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.41 130.13 27.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.536 ' ND1' ' N ' ' A' ' 125' ' ' GLU . 48.7 t-80 -92.6 161.44 14.59 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.222 0.534 . . . . 0.0 111.744 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.536 ' N ' ' ND1' ' A' ' 124' ' ' HIS . 0.0 OUTLIER -87.46 149.26 24.53 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.892 177.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.501 ' CD ' ' HZ3' ' B' ' 141' ' ' LYS . 4.8 tt0 -28.72 98.79 0.01 OUTLIER 'General case' 0 C--N 1.348 0.542 0 CA-C-O 120.915 0.388 . . . . 0.0 111.21 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.541 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 2.3 mtp-105 . . . . . 0 CA--C 1.506 -0.717 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.852 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.093 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -96.42 109.16 21.75 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 172.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.523 ' CD1' ' NH2' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -129.6 119.02 46.94 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -170.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.49 ' HG ' ' C ' ' A' ' 125' ' ' GLU . 4.1 m -127.15 154.74 44.39 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.523 ' NH2' ' CD1' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -141.51 -179.33 6.09 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.935 -175.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 27.8 p -129.34 123.4 31.67 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.401 ' CD2' ' CG1' ' A' ' 101' ' ' VAL . 4.4 m-85 -100.14 140.15 34.78 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.309 -176.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.72 117.53 11.65 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.489 0.662 . . . . 0.0 111.052 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 119' ' ' GLU . 2.0 mtt180 -108.05 143.33 36.92 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.337 177.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.555 ' HZ3' ' HB2' ' A' ' 141' ' ' LYS . 7.7 ttmm -138.36 112.95 8.89 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.989 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.483 ' HB2' ' HB ' ' A' ' 118' ' ' VAL . 2.0 m-85 -114.72 99.83 7.8 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.102 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.488 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.0 OUTLIER -91.06 91.31 8.23 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mp -112.24 89.99 13.19 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.717 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.591 ' HD2' ' CD ' ' A' ' 146' ' ' PRO . 11.8 Cg_exo -72.22 -50.88 0.23 Allowed 'Trans proline' 0 C--N 1.287 -2.708 0 C-N-CA 122.461 2.107 . . . . 0.0 113.591 171.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.591 ' CD ' ' HD2' ' A' ' 145' ' ' PRO . 24.7 Cg_exo -55.34 -14.53 9.48 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.67 2.247 . . . . 0.0 115.401 -174.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.68 43.07 0.13 Allowed Glycine 0 C--N 1.341 0.818 0 C-N-CA 116.833 -2.603 . . . . 0.0 116.378 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.502 HG23 ' CH2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -135.25 131.29 51.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 117.859 0.829 . . . . 0.0 110.561 171.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -95.59 143.59 26.37 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.321 -178.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 6.1 Cg_exo -80.32 -47.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.334 2.023 . . . . 0.0 113.231 -176.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -37.6 59.95 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.739 -175.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.42 11.68 27.58 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -172.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.433 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 40.7 t -108.64 115.25 48.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.938 0.399 . . . . 0.0 110.16 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.94 177.32 4.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.294 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.3 143.55 35.91 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.789 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.11 144.97 42.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.471 HD23 HD23 ' A' ' 109' ' ' LEU . 34.7 tp -138.14 136.86 37.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.808 0.337 . . . . 0.0 111.196 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.401 ' H ' HD11 ' A' ' 157' ' ' LEU . 0.3 OUTLIER -117.09 149.48 44.38 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.68 178.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -40.38 -43.91 4.12 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 123.205 2.603 . . . . 0.0 112.206 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -53.33 -14.94 0.83 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.832 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.508 ' O ' ' HB3' ' A' ' 102' ' ' ASN . . . 85.02 33.13 18.97 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.797 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.0 t -96.18 128.51 43.15 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.411 ' C ' ' CD1' ' A' ' 163' ' ' LEU . 1.8 tm? -118.15 107.78 14.38 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.857 -175.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.2 p -99.22 127.86 45.26 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.419 HG23 ' CZ2' ' A' ' 95' ' ' TRP . 4.4 m -105.26 98.34 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 173.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -114.33 141.39 47.66 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.671 -174.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . . . 177.5 167.8 0.49 Allowed Pre-proline 0 C--O 1.234 0.281 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.34 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -90.3 121.58 0.9 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 123.943 3.095 . . . . 0.0 109.404 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.16 166.38 11.34 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-O 121.073 0.463 . . . . 0.0 112.067 -173.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo . . . . . 0 C--N 1.309 -1.518 0 C-N-CA 122.879 2.386 . . . . 0.0 112.188 -179.478 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' B' ' 94' ' ' ARG . 9.0 mmt180 . . . . . 0 C--O 1.237 0.433 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' TRP . . . . . 0.462 ' CH2' HG23 ' B' ' 148' ' ' VAL . 0.0 OUTLIER -72.47 153.83 41.17 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -152.02 105.3 3.07 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.577 -174.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 t -121.05 154.69 24.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 15.2 m -127.13 144.23 51.08 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.53 HD21 ' NE ' ' B' ' 140' ' ' ARG . 0.3 OUTLIER -114.05 122.78 47.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.53 174.114 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -112.72 114.75 27.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.119 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . 0.645 ' C ' ' H ' ' B' ' 103' ' ' HIS . 0.1 OUTLIER -169.56 -56.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.793 0.806 . . . . 0.0 110.378 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.572 ' OD1' ' CD1' ' B' ' 109' ' ' LEU . 0.0 OUTLIER -56.66 14.09 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.565 -177.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' HIS . . . . . 0.645 ' H ' ' C ' ' B' ' 101' ' ' VAL . 19.2 m170 -46.68 -28.99 1.66 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.97 0.414 . . . . 0.0 110.331 178.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.417 ' HB3' ' CD2' ' B' ' 124' ' ' HIS . 24.8 t80 -120.04 24.18 10.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.711 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.02 91.15 4.92 Favored Pre-proline 0 CA--C 1.513 -0.467 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.168 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.88 -45.99 0.11 Allowed 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.447 2.098 . . . . 0.0 110.86 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' B' ' 107' ' ' ASP . 8.2 p-10 -98.58 -31.25 12.05 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.77 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.85 48.97 1.53 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.779 0.8 . . . . 0.0 110.248 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.572 ' CD1' ' OD1' ' B' ' 102' ' ' ASN . 0.4 OUTLIER -138.2 139.34 39.25 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.663 178.067 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.503 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -132.05 113.52 13.46 Favored 'General case' 0 C--N 1.31 -1.116 0 O-C-N 123.352 0.407 . . . . 0.0 110.091 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.81 119.09 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -129.75 129.41 44.1 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.454 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.1 m -98.05 122.91 41.76 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' LYS . . . . . 0.462 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 0.3 OUTLIER -111.99 -162.17 0.79 Allowed 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -178.286 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' B' ' 117' ' ' VAL . 2.8 p-10 -65.07 69.49 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.368 0.604 . . . . 0.0 112.174 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.25 -8.43 39.42 Favored Glycine 0 CA--C 1.499 -0.934 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' B' ' 114' ' ' LYS . 2.1 t -88.64 115.4 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.68 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 41.4 t -98.59 118.87 45.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.629 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 41.1 mt-10 -133.77 143.46 48.44 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.282 0.563 . . . . 0.0 110.835 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.496 HG12 ' CD2' ' B' ' 99' ' ' LEU . 2.4 mm -115.61 140.2 38.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.12 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.55 111.87 19.15 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.57 145.69 13.93 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.59 -177.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.51 159.72 43.78 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . 0.524 ' O ' ' HB3' ' B' ' 135' ' ' SER . 3.7 m-70 -116.92 137.51 52.17 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.208 -177.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.5 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.5 OUTLIER -69.67 138.0 52.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.306 178.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' B' ' 125' ' ' GLU . 1.0 OUTLIER -17.21 98.37 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' ARG . . . . . 0.405 ' NH1' ' CE1' ' B' ' 104' ' ' PHE . 6.8 mtp85 -83.77 149.54 26.37 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.289 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' GLN . . . . . 0.545 ' HG2' ' N ' ' B' ' 129' ' ' ASP . 3.9 tt0 -99.72 151.87 20.74 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.14 0.495 . . . . 0.0 111.174 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . 0.545 ' N ' ' HG2' ' B' ' 128' ' ' GLN . 19.6 t70 -161.38 169.29 22.26 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.514 175.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . 0.498 ' N ' ' CG ' ' B' ' 129' ' ' ASP . 4.2 tp10 -80.65 -11.42 59.64 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.435 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' HIS . . . . . 0.418 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 55.5 m-70 -115.93 31.41 6.74 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.251 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.55 164.16 11.86 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.672 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' TYR . . . . . 0.404 ' CE2' ' HG3' ' B' ' 128' ' ' GLN . 69.5 m-85 -95.68 139.32 32.09 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.06 126.38 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -170.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' SER . . . . . 0.524 ' HB3' ' O ' ' B' ' 124' ' ' HIS . 0.0 OUTLIER -128.98 157.78 40.71 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -154.06 159.59 41.61 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.336 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 21.4 p -112.96 138.1 50.35 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.59 149.13 41.88 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.822 -176.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.74 134.51 17.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.678 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . 0.53 ' NE ' HD21 ' B' ' 99' ' ' LEU . 0.0 OUTLIER -135.8 107.62 7.06 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . 0.629 ' HA ' ' HG2' ' B' ' 119' ' ' GLU . 32.2 ttmt -96.86 113.94 25.52 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.038 0.447 . . . . 0.0 110.996 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' TYR . . . . . 0.447 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 2.4 m-85 -104.29 98.86 8.6 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.195 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.427 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.2 OUTLIER -92.53 96.81 10.44 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.1 mp -113.25 90.48 16.78 Favored Pre-proline 0 CA--C 1.511 -0.538 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.12 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . 0.58 ' HD2' ' CD ' ' B' ' 146' ' ' PRO . 15.9 Cg_exo -69.88 -42.89 2.9 Favored 'Trans proline' 0 C--N 1.277 -3.2 0 C-N-CA 122.19 1.927 . . . . 0.0 112.679 169.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' PRO . . . . . 0.58 ' CD ' ' HD2' ' B' ' 145' ' ' PRO . 76.3 Cg_exo -42.82 -15.83 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 123.001 2.467 . . . . 0.0 114.333 -176.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 151.76 58.13 0.01 OUTLIER Glycine 0 C--N 1.343 0.972 0 C-N-CA 118.199 -1.953 . . . . 0.0 115.201 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' VAL . . . . . 0.462 HG23 ' CH2' ' B' ' 95' ' ' TRP . 0.9 OUTLIER -123.34 113.1 36.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.573 172.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 24.4 t70 -77.44 137.91 63.66 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.569 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 5.3 Cg_exo -81.12 -23.8 5.06 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.122 1.881 . . . . 0.0 112.891 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.33 -41.24 11.63 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.269 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -97.42 15.5 22.91 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 30.6 t -103.91 117.2 49.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.01 171.1 7.8 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.29 130.79 33.49 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.423 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' SER . . . . . 0.547 ' CB ' ' HG1' ' B' ' 164' ' ' THR . 0.0 OUTLIER -100.05 134.79 42.44 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.652 176.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . 0.465 HD22 ' CD2' ' B' ' 109' ' ' LEU . 29.8 tp -128.36 131.55 48.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.939 0.399 . . . . 0.0 110.652 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.41 149.97 45.66 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.349 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' B' ' 161' ' ' GLY . 85.5 Cg_exo -42.6 -34.34 3.32 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.419 2.079 . . . . 0.0 110.686 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.97 29.56 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.38 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' GLY . . . . . 0.617 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 34.98 34.1 0.04 OUTLIER Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.585 0.612 . . . . 0.0 112.927 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 9.0 t -97.2 117.06 30.55 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' B' ' 98' ' ' SER . 2.7 tm? -108.21 103.08 12.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.505 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 0.547 ' HG1' ' CB ' ' B' ' 156' ' ' SER . 0.5 OUTLIER -92.08 124.46 36.19 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 121.246 -0.181 . . . . 0.0 110.637 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' B' ' 165' ' ' VAL . 3.1 m -105.83 109.63 28.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.42 ' OE1' ' NH1' ' B' ' 94' ' ' ARG . 1.8 pp20? -120.2 154.99 34.05 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.601 -176.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . 177.93 157.02 0.54 Allowed Pre-proline 0 CA--C 1.518 -0.25 0 CA-C-O 120.989 0.423 . . . . 0.0 111.212 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' PRO . . . . . 0.546 ' C ' ' HG3' ' B' ' 169' ' ' MET . 81.5 Cg_endo -80.41 -24.24 5.52 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.905 2.403 . . . . 0.0 110.043 174.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' MET . . . . . 0.546 ' HG3' ' C ' ' B' ' 168' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.544 0.74 0 CA-C-N 114.528 -1.214 . . . . 0.0 113.131 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.402 HH21 ' CD ' ' A' ' 166' ' ' GLU . 8.8 mmm180 . . . . . 0 CA--C 1.51 -0.559 0 CA-C-O 120.896 0.379 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.592 ' NE1' ' CG2' ' A' ' 97' ' ' VAL . 46.8 t-105 -86.7 142.87 27.88 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 -136.42 117.13 13.99 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.592 ' CG2' ' NE1' ' A' ' 95' ' ' TRP . 1.1 t -132.09 158.2 43.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.578 175.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 3.0 m -130.48 157.61 42.17 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -175.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.502 HD23 HG12 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -136.79 94.52 2.99 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.632 175.458 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -97.08 119.38 35.45 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.312 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.614 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -174.34 -50.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.643 0.735 . . . . 0.0 110.649 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.527 ' OD1' ' CD1' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -54.52 17.68 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.708 -1.133 . . . . 0.0 113.761 -176.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.614 ' H ' ' C ' ' A' ' 101' ' ' VAL . 57.5 m-70 -39.33 -50.1 2.01 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.009 0.433 . . . . 0.0 111.198 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -92.05 -6.13 51.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.901 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -116.88 90.32 32.03 Favored Pre-proline 0 CA--C 1.511 -0.534 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.633 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.32 -51.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.461 2.107 . . . . 0.0 110.922 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 109' ' ' LEU . 12.9 t70 -95.02 -31.18 13.72 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.432 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.451 ' N ' ' CD ' ' A' ' 108' ' ' GLU . 20.0 mp0 -77.88 28.87 0.17 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.161 0.505 . . . . 0.0 110.927 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.527 ' CD1' ' OD1' ' A' ' 102' ' ' ASN . 0.8 OUTLIER -114.51 134.9 54.68 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 176.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.87 113.27 18.29 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.092 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.4 129.13 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -140.35 134.22 30.6 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.138 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.56 119.94 35.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 176.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.569 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.3 OUTLIER -116.59 80.75 1.51 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.252 0.549 . . . . 0.0 110.059 -177.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.2 t70 29.5 65.54 0.12 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.717 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.407 ' HA2' HG12 ' A' ' 148' ' ' VAL . . . 97.77 -24.21 32.63 Favored Glycine 0 C--N 1.313 -0.707 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 178.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 2.2 t -88.16 115.76 28.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.239 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 59.1 t -101.98 115.65 44.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.681 ' CD ' ' HZ3' ' A' ' 141' ' ' LYS . 66.5 mt-10 -130.61 142.32 50.45 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.467 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.502 HG12 HD23 ' A' ' 99' ' ' LEU . 3.5 mm -111.81 142.51 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.763 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.25 117.85 26.24 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.648 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.09 135.61 5.33 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.925 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.0 144.92 25.2 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.066 0.946 . . . . 0.0 108.503 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.479 ' HB3' ' NH2' ' A' ' 127' ' ' ARG . 49.9 t60 -115.69 165.79 12.65 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.834 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.515 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.7 OUTLIER -90.16 132.54 35.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.689 -178.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.515 ' C ' ' O ' ' A' ' 125' ' ' GLU . 11.7 tt0 -7.58 111.82 0.01 OUTLIER 'General case' 0 C--N 1.348 0.509 0 C-N-CA 123.326 0.65 . . . . 0.0 112.638 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.479 ' NH2' ' HB3' ' A' ' 124' ' ' HIS . 26.4 mtm180 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.039 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.205 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -94.75 117.22 29.78 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 172.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.436 HG22 HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -131.57 123.16 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -171.234 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.18 164.19 26.07 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.3 ptt180 -150.5 177.14 10.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.115 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 25.6 p -120.52 148.44 43.84 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -121.81 128.5 51.75 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.296 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.08 120.12 24.16 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.304 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.579 ' NH2' ' OH ' ' A' ' 142' ' ' TYR . 1.2 mmm180 -117.9 139.36 51.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.681 ' HZ3' ' CD ' ' A' ' 119' ' ' GLU . 12.9 ttmm -133.38 110.6 10.14 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.847 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.579 ' OH ' ' NH2' ' A' ' 140' ' ' ARG . 30.0 m-85 -106.07 99.26 8.86 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.444 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -90.54 89.14 7.43 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.528 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.3 mp -112.41 92.3 18.99 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.575 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 16.7 Cg_exo -67.65 -55.87 0.25 Allowed 'Trans proline' 0 C--N 1.288 -2.625 0 C-N-CA 122.139 1.893 . . . . 0.0 113.045 175.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.575 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 56.5 Cg_endo -100.93 76.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.329 -0.491 0 C-N-CA 123.271 2.647 . . . . 0.0 112.251 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 164.5 -17.43 0.11 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.49 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.407 HG12 ' HA2' ' A' ' 116' ' ' GLY . 1.0 OUTLIER -125.81 126.75 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 117.599 0.699 . . . . 0.0 111.045 178.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -87.1 145.28 37.81 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.637 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.86 -28.79 2.42 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.872 1.715 . . . . 0.0 112.567 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.61 -41.31 10.83 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.632 -174.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -98.77 22.54 9.92 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -172.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.492 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 39.9 t -103.6 119.74 52.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.093 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.402 ' C ' ' HG ' ' A' ' 155' ' ' SER . 0.2 OUTLIER -102.33 179.48 4.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.52 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' SER . . . . . 0.402 ' HG ' ' C ' ' A' ' 154' ' ' SER . 0.9 OUTLIER -158.81 124.86 4.5 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.419 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.25 139.21 39.59 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.306 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.44 HD13 ' H ' ' A' ' 158' ' ' SER . 30.7 tp -131.62 135.35 46.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.315 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.44 ' H ' HD13 ' A' ' 157' ' ' LEU . 0.4 OUTLIER -121.56 150.97 56.12 Favored Pre-proline 0 C--N 1.313 -0.995 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.619 ' C ' ' H ' ' A' ' 161' ' ' GLY . 82.3 Cg_exo -41.28 -35.51 2.17 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.323 2.015 . . . . 0.0 110.738 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 162' ' ' THR . 1.8 mp0 -67.28 28.76 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.485 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.619 ' H ' ' C ' ' A' ' 159' ' ' PRO . . . 35.73 31.45 0.03 OUTLIER Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.636 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 160' ' ' GLU . 14.0 t -91.35 115.29 27.91 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 98' ' ' SER . 2.9 tm? -109.05 104.03 13.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.687 -176.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.28 123.39 38.77 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.597 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.474 ' O ' ' CG2' ' A' ' 165' ' ' VAL . 2.9 m -107.29 99.23 8.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 1.7 pp20? -118.38 150.83 38.88 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.822 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.492 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . . . 174.08 167.74 0.31 Allowed Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.255 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -88.1 117.48 1.07 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 123.619 2.879 . . . . 0.0 108.9 175.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.489 ' CB ' ' CD ' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -109.21 175.07 2.09 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.407 -172.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 169' ' ' MET . 14.1 Cg_exo . . . . . 0 C--N 1.311 -1.442 0 C-N-CA 122.932 2.421 . . . . 0.0 110.692 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? . . . . . 0 CA--C 1.5 -0.943 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' TRP . . . . . 0.609 ' HB2' ' SD ' ' B' ' 169' ' ' MET . 28.2 t-105 -125.67 152.72 44.86 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -145.53 102.41 3.69 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.269 -177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.504 ' CG2' ' NE1' ' B' ' 95' ' ' TRP . 0.2 OUTLIER -116.0 157.88 16.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.021 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 2.3 m -130.25 148.84 52.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.501 HD23 ' CE1' ' B' ' 142' ' ' TYR . 0.3 OUTLIER -122.58 117.85 26.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.128 174.747 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.99 115.35 27.5 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -167.72 -34.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.561 ' OD1' ' HA2' ' B' ' 161' ' ' GLY . 0.4 OUTLIER -80.8 16.6 1.38 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -174.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' HIS . . . . . 0.545 ' N ' ' HA3' ' B' ' 161' ' ' GLY . 11.5 m80 -43.03 -39.91 2.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.105 0.478 . . . . 0.0 110.174 177.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -92.41 -1.14 57.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.251 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . 0.512 ' C ' HD21 ' B' ' 102' ' ' ASN . . . -135.11 77.47 55.43 Favored Pre-proline 0 CA--C 1.511 -0.538 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.9 -38.17 3.15 Favored 'Trans proline' 0 C--N 1.295 -2.272 0 C-N-CA 122.48 2.12 . . . . 0.0 110.92 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -96.04 -26.86 15.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.003 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -95.85 49.02 1.14 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.111 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.497 ' CD1' ' HB3' ' B' ' 102' ' ' ASN . 0.5 OUTLIER -125.18 143.69 50.82 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.174 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.422 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -139.04 112.37 8.14 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.371 -177.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.55 125.6 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -133.62 133.25 41.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.758 0.313 . . . . 0.0 111.293 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.16 122.58 39.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' B' ' 117' ' ' VAL . 2.5 ttpt -126.37 91.44 3.37 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-O 120.847 0.356 . . . . 0.0 110.881 -176.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' B' ' 117' ' ' VAL . 6.7 p-10 34.58 66.55 0.28 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.07 -15.59 8.38 Favored Glycine 0 C--N 1.307 -1.055 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' B' ' 114' ' ' LYS . 7.2 t -87.44 114.36 26.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 42.8 t -99.25 121.05 49.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.135 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.429 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 76.8 mt-10 -130.27 140.11 50.71 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.303 0.573 . . . . 0.0 111.025 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 1.3 mp -114.96 117.04 54.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.093 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.83 120.0 37.44 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.02 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -146.68 126.95 2.58 Favored Glycine 0 N--CA 1.452 -0.272 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' LYS . . . . . 0.414 ' C ' ' HD1' ' B' ' 124' ' ' HIS . 0.4 OUTLIER -133.11 159.35 40.37 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.424 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . 0.428 ' CB ' ' HD2' ' B' ' 127' ' ' ARG . 3.6 m-70 -123.05 130.9 53.39 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.245 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' B' ' 126' ' ' GLU . 4.5 tp10 -70.79 137.62 49.71 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . 0.562 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 5.1 tt0 -11.91 99.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.481 0.488 . . . . 0.0 111.737 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' ARG . . . . . 0.573 ' HB2' ' NH1' ' B' ' 127' ' ' ARG . 0.2 OUTLIER -89.12 128.86 35.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.499 -178.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -75.53 127.43 33.08 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.27 164.72 28.51 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -70.49 -36.0 73.58 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.965 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' HIS . . . . . 0.483 ' O ' ' OH ' ' A' ' 142' ' ' TYR . 73.0 m-70 -100.16 40.36 1.25 Allowed 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 120.669 0.271 . . . . 0.0 110.572 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 114.46 174.16 18.35 Favored Glycine 0 C--N 1.299 -1.473 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.251 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -95.09 114.7 26.53 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . 0.548 HD13 ' NH2' ' B' ' 136' ' ' ARG . 0.0 OUTLIER -127.35 118.6 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -173.031 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' SER . . . . . 0.562 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.3 OUTLIER -126.61 154.8 43.46 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.004 176.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . 0.548 ' NH2' HD13 ' B' ' 134' ' ' ILE . 9.8 ptp85 -144.85 163.59 33.62 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.943 0.401 . . . . 0.0 111.483 -177.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 30.3 p -117.79 130.3 56.21 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -104.06 144.04 32.09 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.456 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.39 113.71 6.63 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.75 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . 0.493 ' NH2' ' OH ' ' B' ' 142' ' ' TYR . 0.0 OUTLIER -121.13 119.15 31.57 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . 0.469 ' HZ2' ' CD ' ' A' ' 126' ' ' GLU . 11.9 ttmt -110.81 121.37 45.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.945 0.403 . . . . 0.0 110.747 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' TYR . . . . . 0.501 ' CE1' HD23 ' B' ' 99' ' ' LEU . 1.7 m-85 -109.28 99.53 8.78 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.975 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.531 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.3 OUTLIER -90.29 99.69 12.66 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.141 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 7.4 mp -109.59 94.54 16.75 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' B' ' 147' ' ' GLY . 24.7 Cg_exo -66.21 -38.56 20.8 Favored 'Trans proline' 0 C--N 1.287 -2.678 0 C-N-CA 123.151 2.567 . . . . 0.0 114.513 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 34.4 Cg_exo -42.91 -13.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 121.458 1.439 . . . . 0.0 111.746 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 113.66 42.62 0.86 Allowed Glycine 0 C--N 1.343 0.943 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.52 172.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' VAL . . . . . 0.471 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -57.13 101.32 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . 0.494 ' O ' ' CG2' ' B' ' 153' ' ' VAL . 14.5 t0 -41.77 119.12 2.01 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.869 -172.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 5.2 Cg_exo -74.96 -26.54 10.91 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.23 1.953 . . . . 0.0 112.027 -178.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.56 -32.41 16.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.007 -177.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -107.31 19.2 20.64 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . 0.511 ' HA ' ' HB3' ' B' ' 167' ' ' ALA . 27.9 t -105.46 95.37 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.324 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.05 -173.9 4.24 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.74 138.38 10.63 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.734 -0.786 . . . . 0.0 112.056 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.14 136.38 47.09 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.053 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . 0.412 HD11 ' OD1' ' B' ' 102' ' ' ASN . 25.5 tp -124.95 131.58 53.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.908 0.385 . . . . 0.0 110.413 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.39 152.99 44.28 Favored Pre-proline 0 C--N 1.315 -0.931 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' B' ' 161' ' ' GLY . 9.7 Cg_endo -53.25 -20.58 15.07 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.069 1.846 . . . . 0.0 110.613 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -77.5 27.1 0.16 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.217 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' GLY . . . . . 0.561 ' HA2' ' OD1' ' B' ' 102' ' ' ASN . . . 41.72 34.5 1.25 Allowed Glycine 0 N--CA 1.462 0.396 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.945 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 15.1 t -104.32 124.44 49.18 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' B' ' 98' ' ' SER . 2.5 tm? -114.87 109.73 18.59 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.204 -174.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.9 129.06 42.06 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.708 0.231 . . . . 0.0 110.476 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . 0.417 ' O ' ' CG2' ' B' ' 165' ' ' VAL . 3.2 m -113.44 103.99 16.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 1.7 pp20? -118.22 141.41 48.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.894 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' ALA . . . . . 0.511 ' HB3' ' HA ' ' B' ' 153' ' ' VAL . . . -177.98 159.14 1.22 Allowed Pre-proline 0 N--CA 1.453 -0.281 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -77.64 81.01 2.78 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 123.72 2.947 . . . . 0.0 109.94 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' MET . . . . . 0.609 ' SD ' ' HB2' ' B' ' 95' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.31 -1.147 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.55 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 . . . . . 0 CA--C 1.517 -0.292 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.471 ' HB2' ' HG3' ' A' ' 169' ' ' MET . 0.0 OUTLIER -61.52 113.25 2.58 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -109.61 100.02 9.12 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.902 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -106.77 135.47 45.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 2.4 m -108.82 141.2 41.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.842 0.353 . . . . 0.0 111.945 -176.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.582 ' CD2' ' HB3' ' A' ' 140' ' ' ARG . 0.4 OUTLIER -119.41 56.31 0.93 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.518 175.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -62.0 109.96 1.43 Allowed 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.329 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.473 ' HA ' ' CE1' ' A' ' 103' ' ' HIS . 11.8 p -171.15 -17.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.563 ' OD1' ' HA2' ' A' ' 161' ' ' GLY . 0.8 OUTLIER -90.52 16.79 8.3 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.684 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.549 ' N ' ' HA3' ' A' ' 161' ' ' GLY . 0.0 OUTLIER -41.03 -34.24 0.4 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.829 0.347 . . . . 0.0 111.026 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -101.87 11.42 38.66 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.806 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.438 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -143.3 86.52 8.99 Favored Pre-proline 0 CA--C 1.512 -0.515 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.433 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.37 -42.8 0.42 Allowed 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 122.44 2.093 . . . . 0.0 111.338 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -98.08 -31.79 11.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.583 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -81.31 51.16 1.57 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.448 0.642 . . . . 0.0 110.347 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 121' ' ' THR . 0.5 OUTLIER -137.63 124.83 21.67 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.69 178.08 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.49 115.12 21.04 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.616 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.7 t -96.97 123.23 49.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.28 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.482 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 1.6 pttm -133.51 135.14 44.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.826 0.346 . . . . 0.0 111.081 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -109.61 114.84 28.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.3 ttpp -118.98 80.01 1.48 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.772 0.32 . . . . 0.0 111.652 -176.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.9 t0 49.77 69.57 0.59 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.156 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.1 -20.52 9.86 Favored Glycine 0 C--N 1.32 -0.339 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.7 t -86.86 111.26 21.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.634 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.4 t -102.7 112.49 36.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 140' ' ' ARG . 40.6 mt-10 -124.41 133.55 53.36 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.351 0.596 . . . . 0.0 111.53 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.1 mp -108.05 118.54 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.926 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.482 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -97.7 122.81 41.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.501 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.31 134.0 4.6 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.626 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.488 ' HZ2' ' HB2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -131.5 159.76 37.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -125.71 136.88 53.68 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.96 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.533 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -88.81 134.77 33.82 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' A' ' 125' ' ' GLU . 2.8 tt0 -1.9 98.85 0.01 OUTLIER 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.759 0.662 . . . . 0.0 112.548 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 11.0 mtp-105 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 120.907 0.384 . . . . 0.0 111.081 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.982 0 CA-C-O 121.257 0.365 . . . . 0.0 113.594 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 12.6 m-30 -96.36 113.77 25.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.462 HD11 HG22 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -120.07 145.16 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -176.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.11 156.34 44.31 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.24 -178.45 6.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.825 0.345 . . . . 0.0 111.443 -175.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.4 p -139.76 134.0 31.24 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -100.36 141.04 33.75 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.76 99.19 4.86 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.103 172.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.676 ' NH2' ' CD1' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -104.81 99.92 9.55 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.001 -179.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.536 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 13.8 ttpt -112.34 127.89 56.13 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.713 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.676 ' CD1' ' NH2' ' A' ' 140' ' ' ARG . 11.9 m-85 -127.25 100.02 5.9 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.515 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.493 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -85.4 89.79 7.77 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.498 179.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.3 mp -108.69 93.4 12.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.332 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.567 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 16.7 Cg_exo -66.95 -54.93 0.36 Allowed 'Trans proline' 0 C--N 1.294 -2.332 0 C-N-CA 122.143 1.895 . . . . 0.0 112.798 175.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.567 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 57.6 Cg_endo -102.87 89.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.556 2.838 . . . . 0.0 111.729 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.86 -19.57 0.76 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.922 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.62 128.83 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 117.121 0.46 . . . . 0.0 110.511 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 151' ' ' THR . 13.0 t70 -92.88 143.13 26.42 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.044 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 2.4 Cg_endo -82.54 -22.61 4.53 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.877 1.718 . . . . 0.0 112.362 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.416 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -91.67 -41.04 10.95 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.212 -175.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -106.5 23.77 13.67 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -172.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.432 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 42.8 t -110.67 111.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.921 0.391 . . . . 0.0 110.878 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.62 -178.0 3.47 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.92 139.3 26.15 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.048 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.54 137.66 47.94 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.413 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.49 HD12 ' OD1' ' A' ' 102' ' ' ASN . 31.4 tp -128.43 145.45 51.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.896 0.379 . . . . 0.0 110.726 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.29 155.23 81.79 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.815 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.576 ' C ' ' H ' ' A' ' 161' ' ' GLY . 91.8 Cg_exo -42.27 -42.58 7.63 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.905 2.403 . . . . 0.0 111.865 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -62.54 10.77 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.644 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 159' ' ' PRO . . . 59.39 33.57 76.72 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 112.06 -0.416 . . . . 0.0 112.06 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.2 t -95.18 114.85 26.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.453 . . . . 0.0 109.919 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 99' ' ' LEU . 2.1 tm? -108.49 104.78 14.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.875 -177.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.7 p -99.42 116.79 32.38 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.441 ' O ' ' CG2' ' A' ' 165' ' ' VAL . 3.5 m -95.45 99.69 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -115.02 138.31 51.01 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.022 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.432 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . . . -178.11 162.83 1.25 Allowed Pre-proline 0 C--N 1.32 -0.7 0 CA-C-O 121.313 0.578 . . . . 0.0 111.771 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -87.77 109.16 0.65 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 123.257 2.638 . . . . 0.0 108.229 175.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.518 ' HB3' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -109.39 169.15 6.74 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.506 -173.004 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 169' ' ' MET . 19.5 Cg_endo . . . . . 0 N--CA 1.503 2.08 0 C-N-CA 123.222 2.615 . . . . 0.0 112.065 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . 0.425 ' NH2' ' OE2' ' B' ' 166' ' ' GLU . 7.9 mmm180 . . . . . 0 CA--C 1.512 -0.519 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' TRP . . . . . 0.559 ' NE1' ' CG2' ' B' ' 97' ' ' VAL . 63.2 t-105 -115.8 113.9 24.03 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -119.83 104.72 10.45 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.579 -175.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.559 ' CG2' ' NE1' ' B' ' 95' ' ' TRP . 0.2 OUTLIER -112.59 158.12 13.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 16.1 m -134.31 142.52 47.3 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -176.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.409 ' CD2' HH11 ' B' ' 140' ' ' ARG . 0.4 OUTLIER -112.97 79.89 1.29 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.472 174.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -86.36 102.76 14.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.86 0.362 . . . . 0.0 111.143 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . 0.545 ' C ' ' H ' ' B' ' 103' ' ' HIS . 0.0 OUTLIER -163.94 -40.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.765 0.317 . . . . 0.0 111.463 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' B' ' 161' ' ' GLY . 0.0 OUTLIER -60.25 11.16 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -175.282 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' HIS . . . . . 0.545 ' H ' ' C ' ' B' ' 101' ' ' VAL . 3.1 p80 -52.4 -19.07 1.93 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.137 0.494 . . . . 0.0 109.87 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.432 ' CE2' ' NH2' ' B' ' 136' ' ' ARG . 47.9 p90 -94.48 -9.26 36.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.138 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.51 91.8 5.68 Favored Pre-proline 0 CA--C 1.516 -0.351 0 CA-C-O 120.826 0.346 . . . . 0.0 111.536 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.95 -49.77 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.471 2.114 . . . . 0.0 111.266 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -89.66 -31.2 17.62 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.225 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -87.08 49.84 1.9 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.311 0.577 . . . . 0.0 110.135 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' B' ' 121' ' ' THR . 0.4 OUTLIER -133.18 142.6 48.7 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.111 178.405 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.49 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -137.05 120.25 16.74 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.432 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.2 125.37 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.358 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -136.4 142.11 43.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.665 0.269 . . . . 0.0 111.145 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.91 114.95 29.35 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' LYS . . . . . 0.535 ' NZ ' ' CB ' ' B' ' 114' ' ' LYS . 0.0 OUTLIER -111.81 92.91 4.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.117 -177.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 29.5 t70 32.77 66.35 0.2 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.273 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.52 -21.93 19.29 Favored Glycine 0 N--CA 1.466 0.665 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' B' ' 114' ' ' LYS . 5.9 t -87.79 120.43 36.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 54.3 t -106.49 123.73 61.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.442 ' OE2' ' NZ ' ' B' ' 114' ' ' LYS . 2.8 mt-10 -135.66 140.65 44.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.973 0.416 . . . . 0.0 110.767 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 1.2 mp -117.72 117.75 56.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.791 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -91.16 123.29 34.5 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.443 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.07 116.5 0.78 Allowed Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' LYS . . . . . 0.532 ' O ' ' NZ ' ' B' ' 123' ' ' LYS . 0.1 OUTLIER -140.86 126.3 18.8 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.282 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . 0.621 ' H ' ' CD2' ' B' ' 124' ' ' HIS . 0.2 OUTLIER -95.77 134.84 38.25 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.371 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' B' ' 126' ' ' GLU . 3.2 tp10 -69.36 136.41 51.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.383 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . 0.531 ' C ' ' O ' ' B' ' 125' ' ' GLU . 39.3 tt0 -1.62 98.39 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.797 0.685 . . . . 0.0 112.111 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' B' ' 127' ' ' ARG . 3.7 mtm180 -93.02 129.93 38.78 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.079 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -77.52 122.6 25.47 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -120.29 173.02 7.38 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.866 0.365 . . . . 0.0 110.766 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.58 -30.97 70.14 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -174.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' HIS . . . . . 0.529 ' O ' ' CE1' ' A' ' 142' ' ' TYR . 75.0 m-70 -110.82 24.68 12.64 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 132.84 -149.88 19.64 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 120.228 -0.987 . . . . 0.0 111.955 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' TYR . . . . . 0.554 ' O ' ' NH1' ' A' ' 140' ' ' ARG . 63.4 m-85 -111.18 125.16 53.5 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . 0.479 ' HB ' ' NH1' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -145.96 121.56 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 120.659 0.266 . . . . 0.0 111.092 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' SER . . . . . 0.457 ' HG ' ' C ' ' B' ' 134' ' ' ILE . 0.7 OUTLIER -150.51 157.75 43.37 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 178.417 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . 0.595 ' HD3' ' CE1' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -145.53 171.52 14.55 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.113 0.482 . . . . 0.0 111.65 -177.071 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 29.5 p -107.93 132.13 53.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.693 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . 0.595 ' CE1' ' HD3' ' B' ' 136' ' ' ARG . 0.3 OUTLIER -108.78 139.76 43.15 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.774 0.321 . . . . 0.0 110.903 -178.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.64 103.95 3.57 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.259 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . 0.595 ' NH1' ' OH ' ' B' ' 142' ' ' TYR . 0.0 OUTLIER -104.91 123.85 48.45 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -113.54 118.19 33.75 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' TYR . . . . . 0.595 ' OH ' ' NH1' ' B' ' 140' ' ' ARG . 2.1 m-30 -106.04 97.88 7.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.739 0.304 . . . . 0.0 110.192 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.503 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.2 OUTLIER -90.98 100.27 13.17 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -109.73 92.54 12.53 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.825 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . 0.575 ' O ' ' N ' ' B' ' 147' ' ' GLY . 24.6 Cg_exo -65.76 -39.85 19.07 Favored 'Trans proline' 0 C--N 1.287 -2.705 0 C-N-CA 122.527 2.151 . . . . 0.0 112.428 171.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 83.7 Cg_exo -41.59 -8.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 123.296 2.664 . . . . 0.0 113.506 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 116.4 69.65 0.43 Allowed Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.101 -1.047 . . . . 0.0 113.989 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.5 OUTLIER -112.76 112.4 40.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . 0.46 ' O ' ' CG2' ' B' ' 153' ' ' VAL . 19.1 t70 -64.39 135.51 96.38 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.692 -176.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 3.8 Cg_exo -78.58 -26.2 6.02 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.922 1.748 . . . . 0.0 113.188 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.93 -42.32 10.65 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -94.49 15.97 16.52 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -174.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' B' ' 149' ' ' ASP . 37.1 t -101.34 89.6 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.442 177.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.41 178.43 8.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.38 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.78 133.65 10.27 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.472 -178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.31 142.8 45.41 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.369 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . 0.451 HD11 ' H ' ' B' ' 158' ' ' SER . 35.0 tp -128.88 148.7 50.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 110.291 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' SER . . . . . 0.451 ' H ' HD11 ' B' ' 157' ' ' LEU . 0.3 OUTLIER -134.77 154.02 79.15 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.504 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' PRO . . . . . 0.58 ' C ' ' H ' ' B' ' 161' ' ' GLY . 80.5 Cg_exo -41.05 -40.45 3.89 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.739 2.293 . . . . 0.0 111.239 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.27 17.64 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.376 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' GLY . . . . . 0.58 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 49.72 31.33 15.71 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' THR . . . . . 0.447 ' CG2' ' HB2' ' B' ' 158' ' ' SER . 15.0 t -90.57 120.77 31.92 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' B' ' 98' ' ' SER . 3.1 tm? -115.77 102.65 9.91 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.88 125.42 37.47 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.12 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . 0.43 ' O ' ' CG2' ' B' ' 165' ' ' VAL . 3.0 m -112.6 100.03 9.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 174.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 0.0 OUTLIER -110.01 132.74 53.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.937 -176.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' ALA . . . . . 0.437 ' HB1' ' HA ' ' B' ' 153' ' ' VAL . . . -164.0 150.24 9.65 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.65 67.19 6.47 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 123.867 3.045 . . . . 0.0 109.98 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' MET . . . . . 0.479 ' HG2' ' CB ' ' B' ' 95' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.193 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.454 ' NH1' ' OE1' ' A' ' 166' ' ' GLU . 6.5 mmt85 . . . . . 0 CA--C 1.501 -0.917 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.515 ' CH2' ' CG2' ' A' ' 148' ' ' VAL . 0.0 OUTLIER -86.13 160.12 19.33 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 96' ' ' ARG . 21.3 ttp-105 -151.37 99.66 2.66 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.128 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.496 HG23 ' CZ3' ' A' ' 95' ' ' TRP . 1.3 t -116.27 148.1 19.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 176.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.23 150.1 30.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.936 0.398 . . . . 0.0 111.878 -175.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.41 HD22 HG12 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -128.82 91.16 3.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.643 175.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.408 ' C ' ' CG2' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -81.56 124.78 29.8 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.477 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.585 ' HA ' ' CE1' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -178.72 -40.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-O 122.403 1.097 . . . . 0.0 108.434 178.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -58.92 -14.27 8.67 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 113.373 -1.739 . . . . 0.0 111.683 -178.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.585 ' CE1' ' HA ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -45.14 -22.78 0.12 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.567 -178.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.32 17.27 12.26 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.88 86.31 3.84 Favored Pre-proline 0 N--CA 1.467 0.409 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.875 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.499 ' HA ' HD22 ' A' ' 102' ' ' ASN . 51.3 Cg_endo -70.95 -47.28 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.511 2.141 . . . . 0.0 111.517 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -94.81 -30.46 14.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.347 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.478 ' CD ' ' HZ2' ' A' ' 123' ' ' LYS . 24.9 mt-10 -85.98 41.29 0.91 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.048 0.451 . . . . 0.0 110.822 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -129.2 133.89 47.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.047 178.799 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.73 129.06 46.46 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.245 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.3 t -109.47 120.88 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.56 ' NZ ' ' HB2' ' A' ' 119' ' ' GLU . 9.8 pttp -134.26 128.33 33.63 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.403 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -97.15 134.24 40.74 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.097 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 116' ' ' GLY . 0.3 OUTLIER -120.46 -176.74 3.29 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -57.28 69.85 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.303 0.573 . . . . 0.0 111.639 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 114' ' ' LYS . . . 83.69 -5.99 75.89 Favored Glycine 0 C--N 1.32 -0.356 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 1.7 t -92.49 110.81 23.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.2 t -96.06 117.75 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.56 ' HB2' ' NZ ' ' A' ' 112' ' ' LYS . 81.6 mt-10 -129.48 133.6 47.36 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.114 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.41 HG12 HD22 ' A' ' 99' ' ' LEU . 4.6 mm -107.18 141.38 22.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.417 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -121.69 114.31 20.96 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.329 -178.015 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -144.85 130.07 3.76 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.899 -0.48 . . . . 0.0 111.899 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.54 ' O ' ' NZ ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -151.13 132.28 14.41 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.129 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.505 ' ND1' ' HG2' ' A' ' 127' ' ' ARG . 54.6 t-80 -102.59 141.2 35.81 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -56.81 -33.78 67.05 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -176.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 0.3 OUTLIER 173.21 103.51 0.01 OUTLIER 'General case' 0 C--N 1.356 0.853 0 CA-C-N 118.748 0.704 . . . . 0.0 111.23 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.505 ' HG2' ' ND1' ' A' ' 124' ' ' HIS . 9.7 mtp-105 . . . . . 0 N--CA 1.47 0.568 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.589 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.138 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -96.1 126.79 41.57 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 172.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -130.43 123.92 56.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -170.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.432 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 3.1 m -131.57 147.04 52.5 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.199 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.442 ' NH1' ' CE2' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -143.75 170.48 15.79 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.755 -178.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 25.1 p -112.02 122.77 48.68 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.486 ' CD2' ' CG1' ' A' ' 101' ' ' VAL . 5.7 m-85 -95.78 128.78 42.96 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.765 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.58 105.65 5.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.886 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.476 ' NH2' ' OH ' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -104.67 105.14 15.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.864 178.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.418 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 14.2 ttmt -99.04 112.38 24.53 Favored 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 123.186 0.304 . . . . 0.0 110.75 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.668 ' CE1' ' HA3' ' B' ' 132' ' ' GLY . 5.9 m-30 -106.15 99.3 8.9 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.446 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.1 OUTLIER -87.74 89.32 7.95 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mp -113.33 91.35 19.33 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.574 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 13.2 Cg_exo -69.13 -57.27 0.13 Allowed 'Trans proline' 0 C--N 1.29 -2.529 0 C-N-CA 122.457 2.105 . . . . 0.0 114.641 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.574 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 12.6 Cg_endo -93.0 22.69 0.57 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 C-N-CA 122.969 2.446 . . . . 0.0 113.562 -174.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -142.22 -13.27 0.41 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 119.827 -1.178 . . . . 0.0 112.968 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.515 ' CG2' ' CH2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -131.75 128.19 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.713 0.756 . . . . 0.0 110.644 178.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 151' ' ' THR . 12.8 t70 -89.26 140.96 28.78 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.226 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -82.35 -18.92 6.87 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.063 1.842 . . . . 0.0 112.991 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.441 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 0.2 OUTLIER -92.46 -37.2 12.67 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.173 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -109.83 27.9 9.11 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -173.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.481 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 45.2 t -111.65 120.8 62.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.673 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.81 -173.72 2.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.318 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.48 153.17 31.06 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.215 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.82 136.46 53.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.617 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 31.0 tp -124.89 110.91 14.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.84 0.353 . . . . 0.0 110.131 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.86 145.07 31.18 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.664 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.63 ' C ' ' H ' ' A' ' 161' ' ' GLY . 84.4 Cg_exo -41.02 -34.06 1.34 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.646 2.231 . . . . 0.0 110.753 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.61 27.61 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.387 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 159' ' ' PRO . . . 38.41 33.96 0.21 Allowed Glycine 0 CA--C 1.53 1.008 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.601 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 9.8 t -102.03 125.37 48.7 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -107.04 110.01 22.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.786 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.35 125.38 45.0 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.46 ' O ' ' CG2' ' A' ' 165' ' ' VAL . 1.2 m -106.69 107.28 22.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 1.5 pp20? -121.63 152.83 38.87 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.056 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.481 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . . . 168.44 167.97 0.14 Allowed Pre-proline 0 C--O 1.238 0.463 0 CA-C-O 121.158 0.504 . . . . 0.0 112.213 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -89.53 109.46 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 123.452 2.768 . . . . 0.0 109.168 174.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.5 ' CE ' ' H ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -107.18 170.8 5.26 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.874 -175.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo . . . . . 0 C--N 1.31 -1.448 0 C-N-CA 122.249 1.966 . . . . 0.0 110.688 178.452 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . 0.42 ' NE ' ' HB3' ' B' ' 168' ' ' PRO . 24.5 mmt-85 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.075 0.464 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' TRP . . . . . 0.498 ' HB2' ' HG3' ' B' ' 169' ' ' MET . 0.1 OUTLIER -62.31 141.13 58.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.339 -177.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' B' ' 96' ' ' ARG . 25.0 ttm105 -135.29 106.78 6.86 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.167 -177.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.85 150.9 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 17.6 m -126.95 148.91 50.05 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -174.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.9 55.03 1.29 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.465 174.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.25 93.95 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.835 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . 0.566 ' C ' ' H ' ' B' ' 103' ' ' HIS . 2.6 t -145.15 -26.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.642 ' H ' ' ND2' ' B' ' 102' ' ' ASN . 0.0 OUTLIER -54.86 3.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' HIS . . . . . 0.566 ' H ' ' C ' ' B' ' 101' ' ' VAL . 2.4 m-70 -41.91 -46.55 4.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.998 0.428 . . . . 0.0 110.848 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.06 8.32 38.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.144 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' B' ' 102' ' ' ASN . . . -159.07 89.75 2.06 Favored Pre-proline 0 CA--C 1.513 -0.444 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.58 -44.48 0.38 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.323 2.015 . . . . 0.0 110.866 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -98.15 -31.46 12.09 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.119 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -83.09 37.99 0.57 Allowed 'General case' 0 C--O 1.242 0.676 0 CA-C-O 121.018 0.437 . . . . 0.0 110.728 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.494 HD13 ' OD1' ' B' ' 102' ' ' ASN . 0.4 OUTLIER -121.4 135.35 55.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.06 124.23 38.79 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 120.5 0.191 . . . . 0.0 110.852 -177.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.74 129.61 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.969 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -139.43 134.88 32.97 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.686 0.279 . . . . 0.0 110.759 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 5.2 m -102.94 108.0 19.02 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.801 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' LYS . . . . . 0.543 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 21.5 ttmt -104.32 87.68 2.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.822 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 3.4 t70 30.66 67.35 0.12 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.655 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.41 -22.45 23.7 Favored Glycine 0 N--CA 1.466 0.693 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' B' ' 114' ' ' LYS . 8.8 t -87.55 109.77 19.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.429 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 56.1 t -96.65 127.05 49.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.974 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.537 ' CD ' ' HZ3' ' B' ' 141' ' ' LYS . 74.4 mt-10 -139.36 146.96 40.88 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.275 -178.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.412 HD11 ' O ' ' B' ' 119' ' ' GLU . 1.3 mp -121.46 131.23 73.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.434 177.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -104.01 120.38 40.93 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.669 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -140.42 129.2 4.1 Favored Glycine 0 N--CA 1.466 0.66 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.16 157.78 43.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' B' ' 126' ' ' GLU . 8.8 t-80 -145.02 127.91 16.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -56.01 -10.08 0.74 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -176.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . 0.578 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 0.5 OUTLIER 175.31 145.62 0.07 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 111.571 179.074 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' ARG . . . . . 0.588 ' NH1' ' HA ' ' B' ' 135' ' ' SER . 26.1 mtt85 -135.19 107.57 7.3 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.658 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -65.73 130.52 43.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.527 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.29 149.0 28.87 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -62.26 -31.46 72.03 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -92.27 25.17 3.03 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.488 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . 0.668 ' HA3' ' CE1' ' A' ' 142' ' ' TYR . . . 122.77 165.01 12.28 Favored Glycine 0 N--CA 1.429 -1.821 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.152 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -94.69 112.74 24.48 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . 0.516 HD12 ' NH1' ' B' ' 136' ' ' ARG . 0.0 OUTLIER -115.03 113.9 44.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.977 0.418 . . . . 0.0 111.864 -174.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' SER . . . . . 0.588 ' HA ' ' NH1' ' B' ' 127' ' ' ARG . 0.8 OUTLIER -116.71 152.32 34.54 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.876 175.661 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . 0.516 ' NH1' HD12 ' B' ' 134' ' ' ILE . 2.4 ptt180 -155.67 145.55 21.39 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.759 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 28.5 p -92.5 129.81 38.33 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . 0.442 ' CE2' ' NH1' ' A' ' 136' ' ' ARG . 15.1 m-85 -98.21 137.72 36.54 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -177.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.83 101.07 3.6 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.172 176.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . 0.484 ' NH2' ' OH ' ' B' ' 142' ' ' TYR . 0.1 OUTLIER -98.91 150.2 22.16 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 173.365 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . 0.537 ' HZ3' ' CD ' ' B' ' 119' ' ' GLU . 13.6 ttmm -140.42 122.67 15.87 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.486 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' B' ' 142' ' ' TYR . 0.5 OUTLIER -114.92 99.0 7.15 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.452 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.0 OUTLIER -88.59 89.59 8.05 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.542 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.54 93.3 19.03 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.724 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . 0.524 ' CD ' ' HD3' ' B' ' 146' ' ' PRO . 16.5 Cg_exo -67.24 -54.97 0.33 Allowed 'Trans proline' 0 C--N 1.287 -2.667 0 C-N-CA 121.664 1.576 . . . . 0.0 112.345 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' PRO . . . . . 0.524 ' HD3' ' CD ' ' B' ' 145' ' ' PRO . 56.8 Cg_endo -98.72 89.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.103 2.535 . . . . 0.0 112.106 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.76 -20.55 1.29 Allowed Glycine 0 C--O 1.223 -0.534 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.669 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.26 122.92 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 117.579 0.69 . . . . 0.0 110.813 177.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' B' ' 151' ' ' THR . 12.0 t70 -93.58 148.08 34.81 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.05 -24.11 4.91 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.651 1.568 . . . . 0.0 112.756 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' THR . . . . . 0.447 ' N ' ' OD1' ' B' ' 149' ' ' ASP . 0.2 OUTLIER -91.36 -35.36 14.45 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' GLN . . . . . 0.401 ' O ' ' CB ' ' B' ' 167' ' ' ALA . 0.0 OUTLIER -103.53 14.49 31.15 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -175.342 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 39.1 t -107.9 120.46 59.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.438 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.83 -172.94 2.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.763 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.67 138.28 18.73 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.491 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.57 144.68 35.94 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.331 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . 0.408 HD11 ' N ' ' B' ' 158' ' ' SER . 15.4 tp -136.44 118.47 15.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.814 0.34 . . . . 0.0 110.249 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' SER . . . . . 0.408 ' N ' HD11 ' B' ' 157' ' ' LEU . 1.6 t -105.29 149.2 37.44 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -41.77 -26.39 0.43 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.64 2.227 . . . . 0.0 111.828 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . 0.408 ' CD ' ' N ' ' B' ' 160' ' ' GLU . 29.2 mp0 -66.04 -8.02 20.76 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.685 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' GLY . . . . . 0.594 ' O ' ' ND2' ' B' ' 102' ' ' ASN . . . 76.57 27.41 61.24 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 28.8 p -87.58 99.84 12.35 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' B' ' 98' ' ' SER . 1.3 tm? -96.35 92.86 6.54 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.31 127.0 41.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.452 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . 0.462 ' O ' ' CG2' ' B' ' 165' ' ' VAL . 2.6 m -105.45 99.09 7.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.08 134.82 54.54 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.357 -176.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' B' ' 152' ' ' GLN . . . -170.46 160.99 6.22 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.28 0.562 . . . . 0.0 111.889 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' PRO . . . . . 0.42 ' HB3' ' NE ' ' B' ' 94' ' ' ARG . 57.0 Cg_endo -84.95 59.95 5.62 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 123.262 2.641 . . . . 0.0 109.237 176.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' MET . . . . . 0.498 ' HG3' ' HB2' ' B' ' 95' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 CA-C-N 113.457 -1.701 . . . . 0.0 111.011 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.514 -0.408 0 CA-C-O 120.59 0.233 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.569 ' HB3' ' SD ' ' A' ' 169' ' ' MET . 54.1 t-105 -105.04 168.43 9.06 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.482 ' N ' ' CG ' ' A' ' 95' ' ' TRP . 1.7 ttm105 -150.51 108.72 3.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.368 -176.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.489 HG21 ' NE1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -116.44 150.06 18.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 174.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 14.7 m -131.52 157.64 43.03 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.23 89.98 2.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.155 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -92.92 94.54 8.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.437 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -153.31 -23.51 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.563 ' OD1' ' HA2' ' A' ' 161' ' ' GLY . 0.1 OUTLIER -83.17 9.28 10.89 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.195 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.592 ' N ' ' HA3' ' A' ' 161' ' ' GLY . 22.9 p-80 -48.53 -35.38 13.14 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.113 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -80.96 -3.4 51.45 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.832 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 102' ' ' ASN . . . -146.73 79.33 10.3 Favored Pre-proline 0 CA--C 1.512 -0.518 0 CA-C-O 120.772 0.32 . . . . 0.0 111.482 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.51 -39.81 11.67 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.513 2.142 . . . . 0.0 111.486 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -101.52 -31.66 10.77 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.978 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -79.28 46.17 0.7 Allowed 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.164 0.506 . . . . 0.0 110.05 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.468 ' CD1' ' HB3' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -133.21 135.66 45.18 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.471 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.7 116.85 17.85 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.153 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.93 124.95 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.555 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -127.97 136.76 51.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.999 0.428 . . . . 0.0 111.369 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.66 116.07 31.29 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.569 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 2.5 ttpt -111.41 80.76 1.35 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.356 0.598 . . . . 0.0 109.753 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 33.84 68.19 0.18 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.176 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.02 -23.59 25.8 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 4.9 t -87.12 114.19 25.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.9 t -102.04 120.17 51.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.837 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.568 ' CD ' ' HD3' ' A' ' 141' ' ' LYS . 26.8 mt-10 -132.78 145.59 51.12 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.139 0.495 . . . . 0.0 110.948 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.1 mp -113.35 122.94 68.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.016 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.555 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -101.55 115.5 30.66 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.0 128.09 2.6 Favored Glycine 0 C--O 1.239 0.424 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.138 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.46 124.18 9.17 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.495 ' CG ' ' HD3' ' A' ' 127' ' ' ARG . 0.9 OUTLIER -91.04 151.99 20.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.045 0.45 . . . . 0.0 111.515 -177.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.559 ' O ' ' C ' ' A' ' 126' ' ' GLU . 6.1 tp10 -75.61 134.64 40.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.501 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.559 ' C ' ' O ' ' A' ' 125' ' ' GLU . 9.4 tt0 -2.65 97.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.808 0.693 . . . . 0.0 111.74 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.495 ' HD3' ' CG ' ' A' ' 124' ' ' HIS . 1.2 mtm-85 . . . . . 0 CA--C 1.514 -0.43 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.135 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.319 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' B' ' 141' ' ' LYS . 30.6 m-85 -95.21 121.1 36.51 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 172.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.439 HD11 HG23 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -134.99 126.2 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -169.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.503 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -126.38 154.28 43.79 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.669 174.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.44 179.34 7.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.266 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.6 p -139.75 127.1 21.37 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -100.86 136.19 41.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.95 101.54 6.36 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.505 174.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.563 ' HA ' ' NH1' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -101.69 141.36 34.67 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.568 ' HD3' ' CD ' ' A' ' 119' ' ' GLU . 2.7 ttpp -140.85 125.25 17.64 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.315 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.427 ' HE1' ' HE ' ' A' ' 140' ' ' ARG . 57.9 m-85 -120.44 99.13 6.38 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.45 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -89.75 88.92 7.55 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.4 mp -112.43 92.74 20.24 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.578 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 17.0 Cg_exo -65.9 -58.36 0.19 Allowed 'Trans proline' 0 C--N 1.286 -2.753 0 C-N-CA 121.89 1.726 . . . . 0.0 113.497 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.578 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 5.7 Cg_endo -90.5 -13.31 2.34 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 122.774 2.316 . . . . 0.0 114.159 -175.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -104.38 3.0 43.17 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.722 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.47 136.09 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 118.024 0.912 . . . . 0.0 111.005 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 29.0 t70 -96.38 141.97 23.88 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.954 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 2.8 Cg_endo -82.69 -22.32 4.53 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.876 1.717 . . . . 0.0 112.547 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.84 -39.43 12.34 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.233 -174.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -106.33 22.63 15.45 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 19.9 t -109.53 109.39 28.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.977 0.418 . . . . 0.0 110.094 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -169.58 1.6 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.02 139.38 14.76 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.756 -0.778 . . . . 0.0 112.431 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.447 ' CB ' ' HG1' ' A' ' 164' ' ' THR . 0.0 OUTLIER -105.59 130.51 53.62 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.418 177.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.422 HD12 ' OD1' ' A' ' 102' ' ' ASN . 40.0 tp -123.75 109.2 13.37 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.989 0.423 . . . . 0.0 110.355 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.36 147.39 35.33 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.237 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' A' ' 161' ' ' GLY . 87.4 Cg_exo -40.35 -38.52 2.37 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.599 2.199 . . . . 0.0 111.612 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -70.03 29.98 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.742 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.592 ' HA3' ' N ' ' A' ' 103' ' ' HIS . . . 43.93 34.62 3.05 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.06 -0.518 . . . . 0.0 113.039 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.1 t -100.47 99.59 10.23 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.3 0.571 . . . . 0.0 109.598 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 98' ' ' SER . 2.9 tm? -91.12 106.16 18.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.803 -176.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.447 ' HG1' ' CB ' ' A' ' 156' ' ' SER . 0.7 OUTLIER -99.54 124.38 44.66 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.431 ' O ' ' CG2' ' A' ' 165' ' ' VAL . 3.1 m -105.54 100.59 10.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -114.28 139.66 49.24 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.06 -176.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 178.17 166.68 0.58 Allowed Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.999 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -81.39 108.75 2.0 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.074 2.516 . . . . 0.0 110.13 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.569 ' SD ' ' HB3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -92.89 147.76 34.59 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.825 -176.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo . . . . . 0 C--N 1.305 -1.717 0 C-N-CA 122.713 2.275 . . . . 0.0 111.693 178.721 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.33 118.09 14.79 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -114.21 113.39 24.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.829 -175.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.7 t -119.25 156.86 21.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 3.7 m -129.64 134.49 47.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -174.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . 0.413 HD23 ' HB ' ' B' ' 120' ' ' ILE . 0.4 OUTLIER -103.16 97.23 7.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.632 175.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -88.75 103.25 15.79 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.677 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' VAL . . . . . 0.405 ' CG2' ' HD3' ' B' ' 140' ' ' ARG . 0.1 OUTLIER -170.46 -39.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-O 121.833 0.825 . . . . 0.0 109.417 179.036 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' ASN . . . . . 0.611 HD22 ' HA ' ' B' ' 106' ' ' PRO . 0.2 OUTLIER -38.94 -26.45 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.148 -177.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -53.18 -23.76 9.19 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 119.592 -0.843 . . . . 0.0 108.927 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.531 ' HB3' ' CZ ' ' B' ' 136' ' ' ARG . 27.3 m-85 -71.81 -13.13 61.6 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.715 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' B' ' 102' ' ' ASN . . . -174.61 94.26 0.3 Allowed Pre-proline 0 C--O 1.223 -0.336 0 O-C-N 123.308 0.38 . . . . 0.0 111.708 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . 0.611 ' HA ' HD22 ' B' ' 102' ' ' ASN . 41.3 Cg_endo -71.57 -44.39 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.493 2.128 . . . . 0.0 111.833 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -30.75 22.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.948 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' B' ' 123' ' ' LYS . 16.7 mt-10 -102.19 56.73 0.8 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.081 0.467 . . . . 0.0 110.985 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' LEU . . . . . 0.43 HD23 HD22 ' B' ' 157' ' ' LEU . 0.4 OUTLIER -127.9 145.58 50.91 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.31 116.72 10.14 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.916 -177.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.03 123.01 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.786 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' LYS . . . . . 0.453 ' NZ ' ' OG1' ' B' ' 121' ' ' THR . 6.1 pttm -130.9 119.69 22.53 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.237 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.35 120.14 23.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' LYS . . . . . 0.477 ' NZ ' ' OE1' ' B' ' 119' ' ' GLU . 0.8 OUTLIER -121.26 82.49 1.94 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.537 -174.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 32.8 t70 32.56 68.91 0.13 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.345 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . 0.425 ' HA2' HG11 ' B' ' 148' ' ' VAL . . . 86.52 -22.61 12.58 Favored Glycine 0 C--N 1.315 -0.598 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 6.4 t -87.42 120.71 37.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 72.5 t -107.7 108.44 25.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.319 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' GLU . . . . . 0.477 ' OE1' ' NZ ' ' B' ' 114' ' ' LYS . 2.9 mt-10 -124.5 146.77 48.78 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.966 0.412 . . . . 0.0 110.612 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' ILE . . . . . 0.413 ' HB ' HD23 ' B' ' 99' ' ' LEU . 1.3 mp -119.96 117.29 53.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.452 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' THR . . . . . 0.453 ' OG1' ' NZ ' ' B' ' 112' ' ' LYS . 0.2 OUTLIER -89.81 121.48 31.99 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.755 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -144.33 101.17 0.25 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -131.0 143.32 50.64 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' HIS . . . . . 0.457 ' CD2' ' CZ ' ' B' ' 127' ' ' ARG . 0.2 OUTLIER -119.48 151.96 37.71 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.574 -179.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' GLU . . . . . 0.467 ' O ' ' C ' ' B' ' 126' ' ' GLU . 4.0 mt-10 -91.17 126.84 36.37 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.642 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' GLU . . . . . 0.526 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 3.4 tt0 14.79 99.46 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' ARG . . . . . 0.457 ' CZ ' ' CD2' ' B' ' 124' ' ' HIS . 12.6 mtp180 -97.67 141.19 31.0 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.142 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' GLN . . . . . 0.457 ' HG2' ' N ' ' B' ' 129' ' ' ASP . 0.0 OUTLIER -86.74 136.91 32.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ASP . . . . . 0.522 ' CG ' ' N ' ' B' ' 130' ' ' GLU . 0.1 OUTLIER -133.45 169.26 17.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.845 174.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' B' ' 130' ' ' GLU . 0.0 OUTLIER -67.81 -31.98 72.21 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -174.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' HIS . . . . . 0.408 ' N ' ' OD2' ' B' ' 129' ' ' ASP . 96.6 m-70 -111.29 20.24 17.51 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -175.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 147.08 178.25 22.24 Favored Glycine 0 C--N 1.307 -1.036 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.614 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -96.01 134.81 38.58 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . 0.482 ' HB ' ' NH1' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -145.97 116.41 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.886 0.375 . . . . 0.0 111.831 -175.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -132.81 156.66 46.72 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' ARG . . . . . 0.531 ' CZ ' ' HB3' ' B' ' 104' ' ' PHE . 0.0 OUTLIER -151.63 167.81 26.95 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.162 0.505 . . . . 0.0 111.932 -178.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 20.5 p -118.58 129.86 55.57 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.12 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -106.05 143.76 33.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.384 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.11 121.28 7.78 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.857 0.36 . . . . 0.0 111.493 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' ARG . . . . . 0.462 ' NH2' ' OH ' ' B' ' 142' ' ' TYR . 0.0 OUTLIER -118.02 144.57 45.45 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 133' ' ' TYR . 9.1 ttpp -133.01 124.66 28.11 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 123.136 0.272 . . . . 0.0 111.027 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' B' ' 142' ' ' TYR . 3.1 m-85 -118.33 98.64 6.38 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.03 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' THR . . . . . 0.532 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.3 OUTLIER -90.42 100.88 13.64 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.43 96.72 16.87 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.073 -177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' B' ' 147' ' ' GLY . 36.8 Cg_exo -62.98 -41.92 26.56 Favored 'Trans proline' 0 C--N 1.286 -2.747 0 C-N-CA 123.223 2.615 . . . . 0.0 114.251 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 36.3 Cg_exo -43.23 -11.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.916 1.744 . . . . 0.0 112.304 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 109.11 44.13 1.12 Allowed Glycine 0 C--O 1.218 -0.87 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.209 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' VAL . . . . . 0.53 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -60.68 96.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . 0.496 ' CG ' ' HG3' ' B' ' 152' ' ' GLN . 10.3 t70 -50.66 129.16 26.92 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.183 -171.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 11.4 Cg_exo -71.16 -25.95 21.76 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.149 1.899 . . . . 0.0 113.053 -177.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.31 -49.87 6.29 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.363 0.602 . . . . 0.0 111.213 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' GLN . . . . . 0.496 ' HG3' ' CG ' ' B' ' 149' ' ' ASP . 1.7 mt-30 -79.57 10.59 3.76 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.582 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 17.9 t -101.64 119.57 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.42 155.8 27.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' B' ' 164' ' ' THR . 1.2 m -132.99 132.77 42.29 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.399 -176.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.47 145.17 35.08 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.477 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' LEU . . . . . 0.43 HD22 HD23 ' B' ' 109' ' ' LEU . 31.7 tp -130.96 128.42 40.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.336 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' SER . . . . . 0.479 ' O ' ' N ' ' B' ' 161' ' ' GLY . 0.6 OUTLIER -114.14 150.32 43.44 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.123 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' PRO . . . . . 0.564 ' C ' ' H ' ' B' ' 161' ' ' GLY . 87.3 Cg_exo -43.15 -34.14 4.05 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.782 2.321 . . . . 0.0 111.462 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.33 2.19 0.27 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.445 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' GLY . . . . . 0.564 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 63.38 27.81 71.35 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.712 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 6.0 t -93.87 120.66 34.43 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' LEU . . . . . 0.438 ' CD1' ' C ' ' B' ' 163' ' ' LEU . 2.2 tm? -108.63 106.6 16.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.814 -176.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' B' ' 155' ' ' SER . 0.7 OUTLIER -95.5 127.99 42.0 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.106 -179.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' VAL . . . . . 0.438 ' O ' ' CG2' ' B' ' 165' ' ' VAL . 2.6 m -112.99 107.58 23.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -121.57 144.7 48.58 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.439 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -168.61 152.7 5.74 Favored Pre-proline 0 C--O 1.235 0.29 0 C-N-CA 120.463 -0.495 . . . . 0.0 112.16 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -87.68 47.98 1.52 Allowed 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 123.364 2.709 . . . . 0.0 109.59 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' MET . . . . . . . . . . . . . 3.1 ptm . . . . . 0 C--N 1.316 -0.886 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.631 -176.336 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.516 ' SD ' ' N ' ' A' ' 81' ' ' LEU . 1.4 ppp? . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.51 ' H ' ' CD ' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -53.37 -45.83 69.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.224 -178.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.516 ' N ' ' SD ' ' A' ' 79' ' ' MET . 7.4 mt 62.49 176.46 0.14 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.081 -178.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.77 50.57 0.13 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.136 0.493 . . . . 0.0 110.268 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.47 65.52 0.05 OUTLIER 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.667 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -61.53 -37.17 93.72 Favored Glycine 0 CA--C 1.517 0.168 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.26 156.83 42.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 m -100.6 73.96 1.65 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.896 0.379 . . . . 0.0 110.756 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -67.59 57.09 0.06 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.201 0.524 . . . . 0.0 110.031 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.1 tp -82.86 82.66 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.936 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -110.72 97.49 6.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.879 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.475 ' C ' ' H ' ' A' ' 92' ' ' ALA . 2.7 t-80 -81.5 33.4 0.36 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.956 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.15 51.7 0.09 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' A' ' 90' ' ' HIS . . . -114.01 72.15 0.77 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.88 -174.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.58 -42.25 96.3 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 172.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.4 mmm-85 68.65 135.94 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.399 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.549 ' CZ2' ' CG2' ' A' ' 148' ' ' VAL . 0.0 OUTLIER -96.58 158.82 15.25 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.969 177.07 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -151.88 104.14 2.98 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.508 -177.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.539 HG22 ' CZ3' ' A' ' 95' ' ' TRP . 0.8 OUTLIER -121.14 152.46 24.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.133 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 4.4 m -122.45 140.81 52.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.49 63.92 0.74 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.31 174.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.15 108.27 3.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.617 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -159.36 -31.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 120.751 0.31 . . . . 0.0 110.94 176.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.613 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -56.55 5.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -177.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.532 ' H ' ' C ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -61.73 -30.98 71.13 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 118.824 -1.15 . . . . 0.0 108.284 176.046 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.491 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 14.9 m-85 -88.93 5.19 45.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.943 176.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -167.39 92.36 0.7 Allowed Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.9 -48.58 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.432 2.088 . . . . 0.0 111.159 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 109' ' ' LEU . 1.6 t70 -98.26 -31.9 11.83 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 54.7 mp0 -75.73 36.74 0.14 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.289 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.524 ' CD1' ' HB3' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -125.25 138.42 54.1 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.58 112.6 11.61 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.22 129.58 39.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.87 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.458 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.1 OUTLIER -136.52 125.2 23.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.934 0.397 . . . . 0.0 111.359 -179.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.0 m -108.18 115.0 29.31 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.3 91.77 3.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.888 0.375 . . . . 0.0 111.686 -176.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.7 t0 40.18 69.24 0.33 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.243 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.41 ' HA2' HG13 ' A' ' 148' ' ' VAL . . . 82.08 -17.61 16.66 Favored Glycine 0 C--N 1.312 -0.771 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 178.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.6 t -88.68 109.65 20.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.008 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.7 t -98.71 115.21 38.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.851 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.641 ' CD ' ' HZ1' ' A' ' 141' ' ' LYS . 0.3 OUTLIER -125.66 139.4 53.59 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.337 0.589 . . . . 0.0 110.711 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.2 mp -116.32 111.24 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.912 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.458 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -91.84 116.24 28.74 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.821 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.37 125.7 2.0 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.163 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 137' ' ' CYS . 0.0 OUTLIER -134.95 137.87 43.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 177.656 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' A' ' 104' ' ' PHE . 29.7 t60 -80.11 168.28 19.33 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.643 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.481 ' O ' ' C ' ' A' ' 126' ' ' GLU . 2.4 tp10 -113.41 131.85 55.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.315 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 125' ' ' GLU . 5.3 tt0 -19.3 99.8 0.02 OUTLIER 'General case' 0 C--N 1.349 0.548 0 O-C-N 123.563 0.539 . . . . 0.0 111.995 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.428 ' HG2' ' CD2' ' A' ' 124' ' ' HIS . 0.2 OUTLIER -69.8 156.41 39.07 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.84 178.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -127.54 95.2 4.18 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -135.09 146.39 48.85 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.92 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.51 ' OE2' ' N ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -51.75 -22.57 3.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.794 -176.591 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -92.91 5.37 51.61 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.493 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 136.03 154.59 6.93 Favored Glycine 0 C--N 1.312 -0.769 0 C-N-CA 120.138 -1.029 . . . . 0.0 112.654 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.491 ' HH ' ' C ' ' B' ' 176' ' ' SER . 8.8 m-30 -94.97 109.42 21.44 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.39 154.82 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -175.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.78 152.38 26.87 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.441 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.419 ' NH2' ' CE2' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -143.8 175.35 10.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.687 -177.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 32.0 p -137.68 133.86 34.73 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.54 138.97 42.8 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.472 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.84 114.68 7.74 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.718 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.558 ' NH2' ' OH ' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -120.22 126.04 49.64 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.641 ' HZ1' ' CD ' ' A' ' 119' ' ' GLU . 2.0 ttmm -120.06 107.44 13.07 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 120.756 0.312 . . . . 0.0 111.091 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.558 ' OH ' ' NH2' ' A' ' 140' ' ' ARG . 4.2 m-30 -103.1 99.13 8.99 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.47 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.1 OUTLIER -87.56 88.93 7.81 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 mp -113.23 90.79 17.38 Favored Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.598 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 15.8 Cg_exo -67.93 -57.43 0.16 Allowed 'Trans proline' 0 C--N 1.287 -2.689 0 C-N-CA 122.164 1.91 . . . . 0.0 113.537 175.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.598 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 28.8 Cg_endo -98.45 43.65 0.09 OUTLIER 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.61 2.873 . . . . 0.0 112.413 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.33 -8.25 0.04 OUTLIER Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.137 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.549 ' CG2' ' CZ2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -138.37 127.09 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 117.4 0.6 . . . . 0.0 111.129 178.193 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -87.89 138.49 31.15 Favored Pre-proline 0 N--CA 1.484 1.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.057 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -81.99 -21.77 5.54 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.016 1.811 . . . . 0.0 113.075 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.14 -37.92 13.07 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.442 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 27.0 mt-30 -103.61 11.76 35.75 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.447 ' HA ' ' HB3' ' A' ' 167' ' ' ALA . 22.5 t -95.04 118.48 41.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.844 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.9 173.35 6.47 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.5 p -141.68 137.43 31.75 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.961 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.401 ' CB ' ' HG1' ' A' ' 164' ' ' THR . 0.0 OUTLIER -108.23 133.41 52.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.996 177.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.495 HD11 ' H ' ' A' ' 158' ' ' SER . 33.9 tp -131.1 136.99 48.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.097 0.475 . . . . 0.0 110.331 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.495 ' H ' HD11 ' A' ' 157' ' ' LEU . 1.8 t -123.71 146.56 50.76 Favored Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.825 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -40.01 -34.07 0.87 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.683 2.255 . . . . 0.0 111.676 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -62.29 -7.44 4.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.641 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.564 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . 76.31 33.61 48.31 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 112.22 -0.352 . . . . 0.0 112.22 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.2 t -100.63 116.74 33.26 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 98' ' ' SER . 1.4 tm? -110.56 99.86 8.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.543 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.401 ' HG1' ' CB ' ' A' ' 156' ' ' SER . 0.7 OUTLIER -94.68 127.6 40.76 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 121.343 -0.143 . . . . 0.0 110.714 179.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.464 ' O ' ' CG2' ' A' ' 165' ' ' VAL . 3.2 m -108.51 103.13 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 167' ' ' ALA . 2.7 pp20? -114.34 147.58 38.9 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.786 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 166' ' ' GLU . . . 166.19 166.33 0.1 OUTLIER Pre-proline 0 CA--C 1.515 -0.371 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.785 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -82.18 133.15 7.47 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 123.804 3.003 . . . . 0.0 109.665 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.442 ' SD ' ' N ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -128.69 146.92 62.18 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -174.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.62 101.74 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 123.461 2.774 . . . . 0.0 111.843 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.542 ' HZ1' ' CB ' ' A' ' 171' ' ' LYS . 0.8 OUTLIER -67.04 84.66 0.13 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.04 165.44 11.31 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.394 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.555 ' C ' ' HG1' ' A' ' 174' ' ' THR . . . -119.14 101.7 8.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.049 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.555 ' HG1' ' C ' ' A' ' 173' ' ' ALA . 0.2 OUTLIER 56.79 -165.45 0.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.33 -179.275 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -124.33 171.16 10.12 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.209 -1.031 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.659 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' MET . . . . . 0.525 ' O ' ' N ' ' B' ' 81' ' ' LEU . 2.8 mtp . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 60.66 -63.22 0.07 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.975 0.417 . . . . 0.0 111.212 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' B' ' 79' ' ' MET . 2.0 mt -68.86 57.82 0.09 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.687 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 75.7 m -47.57 -35.61 9.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.867 0.365 . . . . 0.0 110.163 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -24.9 48.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.02 -1.74 90.64 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' B' ' 87' ' ' GLU . 4.3 m -134.19 -43.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.608 0.242 . . . . 0.0 110.889 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.95 -54.24 0.31 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.862 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' B' ' 85' ' ' VAL . 1.1 mm-40 -63.68 144.06 57.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.674 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -70.16 -43.11 79.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -109.92 140.42 43.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.452 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -140.53 159.92 41.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.035 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.89 88.77 2.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.967 0.413 . . . . 0.0 110.621 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.95 -159.37 1.03 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.64 66.38 1.21 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.732 0.301 . . . . 0.0 110.766 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . 0.587 HH12 ' CD ' ' B' ' 166' ' ' GLU . 0.1 OUTLIER -138.02 131.14 30.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.923 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' TRP . . . . . 0.47 ' CD1' HG23 ' B' ' 97' ' ' VAL . 14.6 t-105 -114.16 155.49 25.97 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 39.8 ttt85 -134.96 98.74 4.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.239 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.47 HG23 ' CD1' ' B' ' 95' ' ' TRP . 0.2 OUTLIER -101.49 151.13 5.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 2.5 m -128.28 143.41 51.02 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.423 HD22 ' HB ' ' B' ' 120' ' ' ILE . 0.4 OUTLIER -119.3 137.15 53.88 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.297 174.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -122.89 116.16 23.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.373 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . 0.467 ' N ' ' CE1' ' B' ' 103' ' ' HIS . 0.0 OUTLIER -171.37 -45.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 120.785 0.326 . . . . 0.0 111.663 178.732 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.599 ' H ' ' ND2' ' B' ' 102' ' ' ASN . 0.0 OUTLIER -53.38 -1.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -175.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.467 ' CE1' ' N ' ' B' ' 101' ' ' VAL . 0.1 OUTLIER -62.13 -26.12 68.13 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 118.51 -1.276 . . . . 0.0 108.409 175.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -84.42 -13.0 53.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.798 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.66 97.81 0.88 Allowed Pre-proline 0 CA--C 1.516 -0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.154 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.07 -42.74 0.37 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.352 2.035 . . . . 0.0 111.039 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' B' ' 107' ' ' ASP . 0.7 OUTLIER -94.83 -31.43 13.72 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.485 -178.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 37.33 0.74 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.367 0.603 . . . . 0.0 110.444 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' B' ' 102' ' ' ASN . 0.5 OUTLIER -117.11 146.62 43.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.033 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.411 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 1.2 m -136.88 120.94 17.72 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.889 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.77 121.47 50.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.511 ' NZ ' ' HB2' ' B' ' 119' ' ' GLU . 14.8 pttp -132.47 120.94 22.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.107 0.48 . . . . 0.0 111.333 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.7 117.56 28.66 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 1.3 ttmt -116.11 91.34 3.57 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.898 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' B' ' 114' ' ' LYS . 0.9 OUTLIER 28.73 63.98 0.12 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.457 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.52 -21.14 42.54 Favored Glycine 0 C--N 1.316 -0.534 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' B' ' 114' ' ' LYS . 2.8 t -87.65 119.41 35.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.301 177.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 75.4 t -106.51 114.85 46.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.511 ' HB2' ' NZ ' ' B' ' 112' ' ' LYS . 1.1 mt-10 -130.45 145.14 51.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.227 0.537 . . . . 0.0 110.62 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.499 HG21 HD12 ' B' ' 109' ' ' LEU . 1.3 mp -116.94 118.98 60.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.791 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -95.7 123.87 39.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.341 -178.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -147.22 118.49 1.02 Allowed Glycine 0 C--N 1.333 0.393 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.56 143.31 24.58 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -123.97 158.6 31.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.91 0.386 . . . . 0.0 111.409 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.517 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.9 OUTLIER -95.35 145.1 25.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.284 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . 0.583 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 0.6 OUTLIER -1.65 96.94 0.01 OUTLIER 'General case' 0 C--O 1.238 0.485 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -97.97 143.78 28.18 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.037 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -71.76 157.62 37.58 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' B' ' 130' ' ' GLU . 0.8 OUTLIER -157.19 168.96 25.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.036 0.446 . . . . 0.0 110.774 -178.495 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . 0.521 ' N ' ' CG ' ' B' ' 129' ' ' ASP . 0.9 OUTLIER -63.42 -34.84 78.62 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.609 -177.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' HIS . . . . . 0.476 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 82.2 m-70 -121.54 39.9 3.73 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.006 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . 0.513 ' HA3' ' CE1' ' A' ' 142' ' ' TYR . . . 135.65 -162.67 24.94 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.434 -1.365 . . . . 0.0 112.475 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -114.15 120.72 41.49 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . 0.434 HG23 ' HB3' ' B' ' 129' ' ' ASP . 0.0 OUTLIER -134.63 121.84 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -172.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' SER . . . . . 0.583 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -124.99 144.56 50.32 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 174.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -137.31 160.65 38.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.971 0.415 . . . . 0.0 111.296 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 22.4 p -120.37 133.47 55.43 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.99 137.05 52.45 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.816 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.75 123.41 15.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.044 177.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.45 124.18 42.3 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 174.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . . . . . . . . . 3.5 ttpp -117.15 127.1 53.79 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.716 0.293 . . . . 0.0 110.757 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' TYR . . . . . 0.483 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 4.3 m-85 -116.71 97.98 6.28 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.565 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.3 OUTLIER -92.19 98.22 11.39 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . 0.401 ' C ' ' HD2' ' B' ' 146' ' ' PRO . 7.1 mp -109.98 91.69 11.5 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.565 ' HD3' ' O ' ' B' ' 143' ' ' THR . 28.0 Cg_exo -64.73 -36.68 39.84 Favored 'Trans proline' 0 C--N 1.287 -2.708 0 C-N-CA 122.909 2.406 . . . . 0.0 113.303 175.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 65.4 Cg_exo -43.08 -12.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 122.142 1.895 . . . . 0.0 111.962 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 112.0 48.09 0.68 Allowed Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.607 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' VAL . . . . . 0.508 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -68.39 97.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 174.016 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . 0.487 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 0.1 OUTLIER -51.81 125.7 30.72 Favored Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.396 -170.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 2.8 Cg_exo -76.35 -29.43 6.19 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.375 2.05 . . . . 0.0 112.012 -177.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.8 -28.59 61.72 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.243 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' GLN . . . . . 0.409 ' O ' ' HB3' ' B' ' 167' ' ' ALA . 2.1 mt-30 -113.19 12.64 19.07 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -173.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . 0.437 ' HA ' ' CB ' ' B' ' 167' ' ' ALA . 25.1 t -106.28 113.77 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.127 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.93 173.76 6.22 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.31 135.57 27.07 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' SER . . . . . 0.411 ' CB ' ' HG1' ' B' ' 164' ' ' THR . 0.0 OUTLIER -107.22 140.9 39.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.586 176.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . 0.51 HD12 ' N ' ' B' ' 158' ' ' SER . 13.0 tp -134.86 126.62 29.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.619 0.247 . . . . 0.0 110.775 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.51 ' N ' HD12 ' B' ' 157' ' ' LEU . 1.5 t -114.0 148.9 40.98 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -40.97 -27.48 0.32 Allowed 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.982 2.455 . . . . 0.0 111.985 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' B' ' 160' ' ' GLU . 4.3 mp0 -63.58 -9.53 13.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.297 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' GLY . . . . . 0.52 ' O ' ' ND2' ' B' ' 102' ' ' ASN . . . 78.66 23.96 63.57 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 40.2 p -88.24 102.55 14.93 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.064 -0.568 . . . . 0.0 109.512 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.472 ' CD1' ' C ' ' B' ' 163' ' ' LEU . 1.7 tm? -99.91 95.1 6.66 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 0.411 ' HG1' ' CB ' ' B' ' 156' ' ' SER . 0.7 OUTLIER -87.68 126.51 35.01 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.676 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . 0.467 ' O ' ' CG2' ' B' ' 165' ' ' VAL . 2.7 m -108.67 99.61 9.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.587 ' CD ' HH12 ' B' ' 94' ' ' ARG . 0.1 OUTLIER -108.26 135.63 49.25 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.988 -175.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' B' ' 153' ' ' VAL . . . 176.85 167.42 0.45 Allowed Pre-proline 0 N--CA 1.445 -0.697 0 C-N-CA 119.533 -0.867 . . . . 0.0 113.128 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 167' ' ' ALA . 1.3 Cg_endo -80.97 134.96 9.67 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 124.097 3.198 . . . . 0.0 109.467 174.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.12 157.71 31.33 Favored Pre-proline 0 N--CA 1.445 -0.699 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.378 -178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' PRO . . . . . 0.402 ' O ' ' N ' ' B' ' 172' ' ' LEU . 12.0 Cg_endo -55.3 112.74 1.13 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 123.467 2.778 . . . . 0.0 111.905 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -65.15 56.03 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.728 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' B' ' 170' ' ' PRO . 2.6 mp -87.04 -40.52 14.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.689 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 172' ' ' LEU . . . 32.54 66.11 0.2 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.743 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' B' ' 175' ' ' GLN . 1.7 t -95.59 -125.35 0.12 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.168 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' GLN . . . . . 0.498 ' N ' ' OG1' ' B' ' 174' ' ' THR . 7.4 pt20 -80.53 -158.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.684 0.278 . . . . 0.0 110.684 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' SER . . . . . 0.491 ' C ' ' HH ' ' A' ' 133' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--O 1.209 -1.051 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.602 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.497 ' N ' ' O ' ' A' ' 85' ' ' VAL . 6.1 mmt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 63.61 166.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.628 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.7 mt -68.22 56.69 0.07 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.19 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.7 p -95.16 -102.0 0.15 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.01 47.86 0.8 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.078 0.466 . . . . 0.0 109.788 176.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.09 -74.96 1.23 Allowed Glycine 0 CA--C 1.519 0.282 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.497 ' O ' ' N ' ' A' ' 79' ' ' MET . 0.0 OUTLIER -149.66 -90.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.188 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.82 118.99 22.1 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.615 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 1.7 pm0 -73.06 126.71 30.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.375 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.6 tt -114.71 153.17 16.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.099 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.404 ' HE ' ' HB3' ' A' ' 89' ' ' ARG . 11.7 mmm180 -119.49 150.7 39.81 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.208 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.462 ' O ' ' C ' ' A' ' 91' ' ' THR . 10.8 m-70 -51.99 122.4 8.35 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.494 HG22 ' NH1' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -28.77 111.72 0.06 Allowed 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.36 0.413 . . . . 0.0 112.113 -176.157 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.52 -161.95 0.32 Allowed 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.821 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 168' ' ' PRO . 4.2 m-20 -53.03 125.81 18.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.779 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.494 ' NH1' HG22 ' A' ' 91' ' ' THR . 4.3 mmm-85 -85.94 110.73 19.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.633 ' CH2' HG23 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -77.38 158.61 30.0 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 174.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.1 ttm-85 -152.84 99.21 2.41 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.146 -175.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.456 ' CG2' ' CZ3' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -119.83 157.83 21.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 176.579 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 27.7 m -131.4 144.55 51.28 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.426 ' CD2' HG13 ' A' ' 120' ' ' ILE . 1.4 mp -117.1 65.39 0.72 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.066 173.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.58 93.55 3.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.906 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.591 ' C ' ' H ' ' A' ' 103' ' ' HIS . 1.6 t -150.52 -43.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 121.14 0.495 . . . . 0.0 110.967 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 161' ' ' GLY . 0.0 OUTLIER -54.47 13.6 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -175.801 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.591 ' H ' ' C ' ' A' ' 101' ' ' VAL . 8.3 t-160 -49.72 -21.24 1.01 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.874 0.369 . . . . 0.0 110.453 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -101.98 1.67 36.93 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.821 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -141.93 89.21 8.99 Favored Pre-proline 0 CA--C 1.517 -0.313 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.755 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.5 -41.66 0.79 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.467 2.111 . . . . 0.0 111.456 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 109' ' ' LEU . 14.3 t70 -105.22 -31.93 8.88 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.071 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -80.32 40.8 0.5 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.451 0.644 . . . . 0.0 110.441 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.503 HD11 ' HB3' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -124.7 141.61 51.98 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.471 176.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.488 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -141.18 115.72 9.54 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.772 0.32 . . . . 0.0 110.819 -178.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.0 t -92.37 131.52 39.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.405 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.39 132.46 31.48 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.527 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.1 m -107.5 115.97 31.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.133 178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.41 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -117.74 79.25 1.33 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.05 0.452 . . . . 0.0 111.085 -177.164 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.8 t70 45.14 69.55 0.43 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.083 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.46 -22.25 14.06 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 21.6 t -87.1 113.16 24.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 65.2 t -102.28 112.79 36.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.49 ' HG2' ' HA ' ' A' ' 141' ' ' LYS . 42.4 mt-10 -125.93 149.04 49.04 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.283 0.563 . . . . 0.0 111.095 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.426 HG13 ' CD2' ' A' ' 99' ' ' LEU . 1.0 OUTLIER -122.47 143.13 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.218 178.644 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -121.31 106.79 11.8 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.095 -178.262 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -138.51 128.77 4.26 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.32 128.83 11.41 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.702 0.401 . . . . 0.0 110.362 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.433 ' CD2' ' HA ' ' A' ' 135' ' ' SER . 1.4 p-80 -100.0 137.16 38.83 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 41.4 mt-10 -60.82 -27.48 68.09 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -174.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 0.8 OUTLIER 172.52 120.76 0.02 OUTLIER 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.329 0.513 . . . . 0.0 111.837 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.688 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -97.98 145.58 26.35 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.233 175.633 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -99.26 117.44 33.73 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 120.839 0.352 . . . . 0.0 110.922 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.43 ' OD2' ' NH1' ' A' ' 127' ' ' ARG . 8.9 m-20 -130.61 135.9 48.33 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.073 175.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.6 -26.21 1.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.719 -176.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.481 ' O ' ' CZ ' ' B' ' 142' ' ' TYR . 78.0 m80 -106.02 19.75 20.04 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.678 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.609 ' HA3' ' CE1' ' B' ' 142' ' ' TYR . . . 148.71 149.1 4.89 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.185 -1.483 . . . . 0.0 114.295 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -95.07 109.84 21.84 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.471 HG23 HD11 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -120.66 157.19 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -172.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.433 ' HA ' ' CD2' ' A' ' 124' ' ' HIS . 3.6 t -155.4 154.1 31.42 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.773 173.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.477 ' NH1' ' CZ ' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -147.0 174.74 11.25 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.336 -179.158 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 25.0 p -128.93 125.47 37.57 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -95.8 128.96 43.13 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.99 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.29 105.84 8.17 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.304 176.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.56 ' NH1' ' OH ' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -101.08 149.6 23.79 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.316 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.561 ' HZ1' ' CD ' ' B' ' 126' ' ' GLU . 1.6 ttpt -149.91 102.58 3.14 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.068 0.461 . . . . 0.0 110.506 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.56 ' OH ' ' NH1' ' A' ' 140' ' ' ARG . 10.6 m-85 -97.57 100.66 12.08 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.437 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.51 89.37 7.96 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.192 0.52 . . . . 0.0 109.784 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.92 92.18 29.42 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.568 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 15.1 Cg_exo -68.02 -58.31 0.13 Allowed 'Trans proline' 0 C--N 1.285 -2.776 0 C-N-CA 122.141 1.894 . . . . 0.0 113.965 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.568 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 48.0 Cg_endo -100.51 51.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 123.406 2.737 . . . . 0.0 112.781 -175.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.67 -13.38 0.02 OUTLIER Glycine 0 N--CA 1.463 0.454 0 C-N-CA 120.237 -0.983 . . . . 0.0 112.269 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.633 HG23 ' CH2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -128.64 127.3 66.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.42 0.61 . . . . 0.0 110.861 178.523 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 18.8 t70 -83.5 140.75 41.63 Favored Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.557 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 3.0 Cg_exo -82.17 -25.04 3.53 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.18 1.92 . . . . 0.0 112.545 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.97 -36.68 13.29 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -175.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.4 ' O ' ' CB ' ' A' ' 167' ' ' ALA . 8.9 mt-30 -109.29 31.84 5.43 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -173.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 39.5 t -115.47 124.88 72.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.716 177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.69 -178.42 4.14 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.71 140.88 30.23 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.048 -0.661 . . . . 0.0 112.38 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.98 131.67 52.19 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.242 176.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.415 ' CD2' HD23 ' A' ' 109' ' ' LEU . 26.1 tp -129.87 125.52 35.81 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.021 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.593 ' HB3' ' OG1' ' A' ' 162' ' ' THR . 0.0 OUTLIER -106.04 162.23 20.37 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.4 -9.55 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.211 1.941 . . . . 0.0 110.786 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.468 ' H ' ' C ' ' A' ' 158' ' ' SER . 3.6 mp0 -87.13 0.37 55.39 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.519 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.53 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . 68.52 15.5 68.45 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -175.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.593 ' OG1' ' HB3' ' A' ' 158' ' ' SER . 3.0 p -74.0 99.25 3.24 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 98' ' ' SER . 1.7 tm? -102.08 92.12 4.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.871 -176.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.98 125.9 35.18 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.28 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.612 HG22 ' CZ2' ' A' ' 95' ' ' TRP . 5.3 m -103.3 103.03 14.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -119.41 148.72 42.9 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.12 -176.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 166' ' ' GLU . . . 170.2 167.32 0.19 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.232 0.539 . . . . 0.0 112.138 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 93' ' ' ASP . 60.9 Cg_endo -89.67 109.12 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.508 2.805 . . . . 0.0 110.065 176.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.483 ' O ' ' N ' ' A' ' 171' ' ' LYS . 0.0 OUTLIER -72.3 169.91 14.89 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.136 -177.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.4 50.01 0.08 OUTLIER 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 123.281 2.654 . . . . 0.0 112.675 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 169' ' ' MET . 3.4 mmmp? -70.15 51.63 0.12 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.896 0.379 . . . . 0.0 110.198 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.496 ' O ' ' N ' ' A' ' 174' ' ' THR . 0.8 OUTLIER -156.68 -57.48 0.09 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.091 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.41 69.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.899 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.496 ' N ' ' O ' ' A' ' 172' ' ' LEU . 11.2 t -79.64 -157.06 0.12 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.639 -178.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -140.26 178.63 7.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.993 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.21 -0.991 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.5 179.858 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' MET . . . . . 0.415 ' N ' ' SD ' ' B' ' 79' ' ' MET . 14.6 mmm . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.412 ' O ' ' HB3' ' B' ' 90' ' ' HIS . 14.2 mt-30 -58.96 93.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.86 -121.81 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.363 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' SER . . . . . 0.46 ' C ' ' H ' ' B' ' 84' ' ' GLY . 0.0 OUTLIER -135.48 -73.22 0.46 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.951 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.85 46.18 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.669 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' B' ' 82' ' ' SER . . . -92.5 166.18 29.12 Favored Glycine 0 C--N 1.322 -0.224 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 6.7 m -47.45 -39.6 6.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.872 0.368 . . . . 0.0 110.764 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -19.64 65.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.221 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 55.11 48.51 19.49 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.146 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.453 ' C ' ' H ' ' B' ' 90' ' ' HIS . 9.9 mm -122.51 134.56 65.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.395 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' B' ' 89' ' ' ARG . 0.0 OUTLIER -67.56 45.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.699 178.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' HIS . . . . . 0.453 ' H ' ' C ' ' B' ' 88' ' ' ILE . 0.1 OUTLIER -55.0 -65.42 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.343 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 4.6 m -110.71 96.21 6.03 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.053 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -134.69 116.81 15.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.044 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -54.89 109.51 0.53 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.556 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . 0.516 ' NH1' ' OE1' ' B' ' 166' ' ' GLU . 8.4 mmt85 -148.54 89.51 1.71 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.595 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' TRP . . . . . 0.465 ' O ' ' HA ' ' B' ' 166' ' ' GLU . 0.0 OUTLIER -72.48 145.85 47.26 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.036 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 -133.84 109.05 8.82 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.387 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.14 156.23 18.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 3.3 m -134.2 149.89 51.03 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -174.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.41 96.09 4.9 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.334 174.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . 0.462 ' CG ' ' HE2' ' B' ' 103' ' ' HIS . 18.3 t70 -97.18 93.6 6.64 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.277 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -162.92 6.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-O 120.858 0.361 . . . . 0.0 111.103 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.564 ' ND2' ' O ' ' B' ' 102' ' ' ASN . 0.0 OUTLIER -90.46 -10.08 45.06 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -173.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.462 ' HE2' ' CG ' ' B' ' 100' ' ' ASP . 0.8 OUTLIER -42.73 -29.01 0.27 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.591 ' HB2' ' CE1' ' B' ' 124' ' ' HIS . 59.6 m-85 -101.25 25.35 8.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -170.28 93.75 0.48 Allowed Pre-proline 0 C--O 1.223 -0.297 0 CA-C-O 120.673 0.273 . . . . 0.0 111.633 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.6 -60.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.436 2.091 . . . . 0.0 111.558 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . 0.586 ' C ' ' H ' ' B' ' 109' ' ' LEU . 19.7 t70 -91.74 -30.98 15.96 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.945 0.403 . . . . 0.0 110.458 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -73.68 32.9 0.08 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.376 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.586 ' H ' ' C ' ' B' ' 107' ' ' ASP . 0.4 OUTLIER -128.54 128.71 44.82 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.543 177.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.4 130.15 50.15 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.974 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 1.9 t -105.09 114.08 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.02 134.46 54.84 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.518 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.02 115.46 29.01 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.535 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' B' ' 116' ' ' GLY . 0.0 OUTLIER -113.66 -171.43 1.89 Allowed 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' B' ' 117' ' ' VAL . 14.4 p-10 -64.53 70.25 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' B' ' 114' ' ' LYS . . . 78.97 -8.32 45.32 Favored Glycine 0 CA--C 1.498 -1.008 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.419 ' H ' ' C ' ' B' ' 115' ' ' ASP . 2.0 t -88.45 112.23 23.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.424 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 78.4 t -97.09 110.61 25.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 29.5 mt-10 -126.76 117.36 22.52 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.168 0.509 . . . . 0.0 111.448 -176.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 6.1 mm -88.25 135.61 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.209 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.9 OUTLIER -115.7 111.51 20.7 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.445 -178.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.28 132.33 5.28 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -135.66 128.63 31.41 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . 0.591 ' CE1' ' HB2' ' B' ' 104' ' ' PHE . 28.3 m-70 -91.66 140.73 29.43 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.554 -177.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.5 OUTLIER -87.96 143.96 26.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.924 -178.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . 0.561 ' CD ' ' HZ1' ' A' ' 141' ' ' LYS . 2.5 tt0 -17.46 102.21 0.02 OUTLIER 'General case' 0 C--N 1.351 0.632 0 O-C-N 123.447 0.467 . . . . 0.0 112.068 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' ARG . . . . . 0.406 ' NH1' ' CE1' ' B' ' 104' ' ' PHE . 0.0 OUTLIER -94.86 149.98 20.67 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.055 -179.279 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -97.02 114.18 25.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.748 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.91 166.51 23.14 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -57.84 -26.9 62.67 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.955 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' HIS . . . . . 0.533 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 60.4 m-70 -80.07 14.31 1.91 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.652 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.78 -138.99 14.2 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -100.26 147.8 25.35 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . 0.43 HD12 HG23 ' B' ' 134' ' ' ILE . 0.0 OUTLIER -156.04 117.54 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -175.244 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' SER . . . . . 0.413 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -131.04 153.3 49.42 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -155.91 156.99 35.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.043 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 28.1 p -100.71 136.83 39.96 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . 0.477 ' CZ ' ' NH1' ' A' ' 136' ' ' ARG . 0.6 OUTLIER -114.64 123.51 49.49 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.576 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.6 118.2 20.66 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.281 0.563 . . . . 0.0 110.893 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 134' ' ' ILE . 0.0 OUTLIER -115.88 121.51 42.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . 0.469 ' HA ' ' HG2' ' B' ' 119' ' ' GLU . 3.6 ttpp -112.85 116.34 29.88 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 123.244 0.34 . . . . 0.0 110.958 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' TYR . . . . . 0.609 ' CE1' ' HA3' ' A' ' 132' ' ' GLY . 5.3 m-30 -107.56 97.54 7.26 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.55 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.2 OUTLIER -90.77 96.67 10.76 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 175.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . 0.453 ' C ' ' HD2' ' B' ' 146' ' ' PRO . 7.0 mp -108.44 94.46 13.71 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.821 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.559 ' N ' ' HD2' ' B' ' 146' ' ' PRO . 24.0 Cg_exo -66.33 -34.42 35.21 Favored 'Trans proline' 0 C--N 1.287 -2.704 0 C-N-CA 122.636 2.224 . . . . 0.0 113.316 175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' B' ' 145' ' ' PRO . 27.7 Cg_exo -43.76 -10.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.991 1.794 . . . . 0.0 112.293 -178.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 111.36 44.65 0.9 Allowed Glycine 0 C--N 1.339 0.729 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.69 174.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' VAL . . . . . 0.498 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -68.51 101.83 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 175.141 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . 0.449 ' O ' ' CG2' ' B' ' 153' ' ' VAL . 13.5 t70 -52.31 126.4 36.97 Favored Pre-proline 0 C--O 1.221 -0.431 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.07 -172.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 5.1 Cg_exo -79.34 -18.98 10.67 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.11 1.873 . . . . 0.0 112.098 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.57 -38.25 12.61 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.558 -178.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -100.83 17.52 21.89 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . 0.471 ' HA ' ' HB3' ' B' ' 167' ' ' ALA . 49.8 t -108.95 91.11 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.689 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.68 -166.08 1.51 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' B' ' 164' ' ' THR . 0.4 OUTLIER -163.57 142.54 8.08 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.751 -179.101 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.81 144.63 40.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.028 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . 0.413 HD21 HD22 ' B' ' 109' ' ' LEU . 42.1 tp -130.76 117.09 18.89 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.57 152.01 38.78 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.813 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.625 ' C ' ' H ' ' B' ' 161' ' ' GLY . 94.5 Cg_exo -44.11 -32.82 5.12 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.45 2.1 . . . . 0.0 110.972 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -68.5 22.04 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.087 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' GLY . . . . . 0.625 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 41.91 27.28 0.36 Allowed Glycine 0 CA--C 1.523 0.561 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.627 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 9.0 t -88.14 118.55 27.8 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' B' ' 98' ' ' SER . 2.9 tm? -105.97 103.93 13.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.831 -177.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' B' ' 155' ' ' SER . 0.7 OUTLIER -94.53 125.49 39.21 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.033 0.208 . . . . 0.0 111.341 -179.051 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' B' ' 165' ' ' VAL . 2.7 m -111.81 105.65 19.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 173.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.516 ' OE1' ' NH1' ' B' ' 94' ' ' ARG . 0.0 OUTLIER -114.29 137.61 51.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.722 -176.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' B' ' 169' ' ' MET . . . -168.75 158.21 7.94 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.83 30.44 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 123.871 3.047 . . . . 0.0 110.329 174.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' MET . . . . . 0.516 ' H ' ' C ' ' B' ' 167' ' ' ALA . 0.6 OUTLIER -67.97 159.0 81.89 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.759 -179.404 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -44.0 143.0 3.46 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 123.397 2.731 . . . . 0.0 111.904 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -91.44 27.91 1.84 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.295 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.5 97.62 5.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.83 0.348 . . . . 0.0 110.34 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -59.03 -66.74 0.46 Allowed 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.112 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.96 62.77 1.16 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.695 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -52.1 -86.7 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.589 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.21 -1.009 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.55 179.664 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.502 ' N ' ' SD ' ' A' ' 79' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 120.589 0.233 . . . . 0.0 110.632 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.463 ' N ' ' OG ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -168.18 -145.54 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.457 ' H ' ' CD ' ' A' ' 80' ' ' GLN . 12.8 mt -56.06 -47.12 78.51 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.92 66.43 9.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.603 ' C ' ' H ' ' A' ' 85' ' ' VAL . 13.2 m -123.96 -34.29 3.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.759 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.74 30.19 0.28 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.603 ' H ' ' C ' ' A' ' 83' ' ' SER . 2.1 m -136.15 47.83 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.233 0.54 . . . . 0.0 109.568 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.87 127.43 28.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.377 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -60.95 135.01 57.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.193 -179.217 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.49 HG23 HD11 ' A' ' 88' ' ' ILE . 0.3 OUTLIER -67.36 50.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.196 0.522 . . . . 0.0 109.983 178.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.561 ' NE ' ' H ' ' A' ' 90' ' ' HIS . 0.0 OUTLIER -163.34 153.99 16.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.808 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.561 ' H ' ' NE ' ' A' ' 89' ' ' ARG . 76.0 m-70 -97.09 152.06 19.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.868 0.366 . . . . 0.0 110.512 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.9 p -129.6 -165.12 1.48 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.298 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.595 ' O ' ' NH1' ' A' ' 94' ' ' ARG . . . -57.15 133.69 55.24 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.444 ' O ' ' NH1' ' A' ' 94' ' ' ARG . 3.0 t0 -73.41 -155.88 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.777 0.322 . . . . 0.0 110.854 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.595 ' NH1' ' O ' ' A' ' 92' ' ' ALA . 85.0 mmt-85 -143.5 101.81 3.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.07 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.02 140.14 32.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.1 ttp85 -131.71 117.65 18.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.977 0.418 . . . . 0.0 111.48 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.13 134.85 65.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.192 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.6 m -111.11 135.34 51.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.44 ' CD2' ' HB3' ' A' ' 140' ' ' ARG . 0.4 OUTLIER -111.86 72.98 0.8 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.851 175.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -77.56 110.57 12.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.999 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.531 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -160.48 -49.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.251 0.548 . . . . 0.0 110.907 177.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.591 HD21 ' H ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -58.6 14.07 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -174.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.531 ' H ' ' C ' ' A' ' 101' ' ' VAL . 0.9 OUTLIER -43.31 -41.67 4.14 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.348 0.594 . . . . 0.0 110.11 178.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.2 -4.24 52.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.453 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -133.15 73.46 74.64 Favored Pre-proline 0 CA--C 1.511 -0.543 0 CA-C-O 120.938 0.399 . . . . 0.0 112.031 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.5 -40.24 5.98 Favored 'Trans proline' 0 C--N 1.299 -2.073 0 C-N-CA 122.54 2.16 . . . . 0.0 111.565 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -99.74 -27.52 13.61 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.638 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -88.53 35.41 0.77 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.092 0.472 . . . . 0.0 110.627 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.445 ' CD1' ' HB3' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -122.47 132.8 54.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.628 179.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 114.99 20.18 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-O 120.718 0.294 . . . . 0.0 110.609 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.7 130.17 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 pttm -140.23 128.78 22.86 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.606 -0.437 . . . . 0.0 111.462 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.07 115.3 24.37 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.563 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.4 OUTLIER -110.86 73.0 0.8 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.18 0.514 . . . . 0.0 110.27 -177.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.413 ' HA ' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER 34.54 67.98 0.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.389 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.56 -23.62 27.16 Favored Glycine 0 N--CA 1.465 0.611 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 3.5 t -87.23 113.05 24.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.3 t -100.55 112.78 34.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.513 ' HG2' ' HA ' ' A' ' 141' ' ' LYS . 37.1 mt-10 -128.89 142.82 50.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.427 0.632 . . . . 0.0 111.628 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.1 mp -116.27 115.74 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.39 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.45 116.9 29.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.569 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.18 136.9 5.88 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.881 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.19 159.31 35.58 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -97.72 135.27 39.74 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.738 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.47 ' O ' ' C ' ' A' ' 126' ' ' GLU . 6.1 tp10 -68.25 135.73 52.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 125' ' ' GLU . 10.6 tt0 -34.83 99.03 0.02 OUTLIER 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.742 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -81.71 155.56 25.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.757 -176.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -116.59 110.45 18.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.592 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -127.92 136.77 51.81 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.036 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.417 ' OE2' ' N ' ' A' ' 130' ' ' GLU . 0.7 OUTLIER -47.83 -24.85 1.09 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.959 -178.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.418 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 9.8 m-70 -97.76 10.24 40.58 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.953 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 140.66 154.41 6.23 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.686 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -94.57 109.64 21.52 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -119.33 137.99 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -172.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.412 ' OG ' ' N ' ' A' ' 136' ' ' ARG . 6.3 t -142.75 171.28 14.27 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.013 170.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -161.92 -176.82 5.43 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.868 -177.175 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.5 p -138.61 121.61 16.71 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -98.03 132.41 43.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.712 0.292 . . . . 0.0 111.501 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.63 101.17 7.31 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.497 ' NH1' ' OH ' ' A' ' 142' ' ' TYR . 1.9 ttt-85 -107.33 103.63 13.03 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.513 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 7.5 ttpt -112.72 129.83 56.27 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.033 0.444 . . . . 0.0 112.124 -175.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.497 ' OH ' ' NH1' ' A' ' 140' ' ' ARG . 22.3 m-85 -118.11 99.79 7.11 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.595 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.462 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.3 OUTLIER -90.76 89.97 7.73 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.93 92.98 15.98 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.569 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 18.6 Cg_exo -65.77 -55.4 0.43 Allowed 'Trans proline' 0 C--N 1.289 -2.567 0 C-N-CA 121.86 1.706 . . . . 0.0 112.632 175.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.569 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 50.6 Cg_endo -103.84 92.06 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.78 2.986 . . . . 0.0 111.517 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.94 -16.31 1.19 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.216 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.751 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 0.9 OUTLIER -131.34 129.52 62.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-N 117.332 0.566 . . . . 0.0 111.077 177.567 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 13.4 t70 -94.37 143.55 26.52 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.165 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 3.3 Cg_exo -81.96 -26.02 3.18 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.823 1.682 . . . . 0.0 112.928 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.14 -37.35 16.25 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -107.2 27.99 8.51 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -172.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.448 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 51.2 t -116.08 113.11 42.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.15 176.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.01 -173.01 2.2 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.29 131.82 11.34 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.837 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.76 139.67 39.98 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.728 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.57 HD11 ' N ' ' A' ' 158' ' ' SER . 14.9 tp -133.95 129.29 36.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.016 0.436 . . . . 0.0 110.85 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.57 ' N ' HD11 ' A' ' 157' ' ' LEU . 0.2 OUTLIER -113.9 148.97 41.06 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.969 178.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.472 ' C ' ' H ' ' A' ' 161' ' ' GLY . 76.9 Cg_exo -40.04 -33.88 0.86 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.807 2.338 . . . . 0.0 112.11 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -74.21 31.43 0.08 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.396 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.482 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 43.91 25.83 0.71 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.388 -0.369 . . . . 0.0 112.992 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.4 t -87.58 101.51 13.7 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 117.228 0.514 . . . . 0.0 109.693 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.445 ' C ' ' CD1' ' A' ' 163' ' ' LEU . 1.5 tm? -100.92 102.37 13.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.051 -177.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 p -97.62 123.05 41.37 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.703 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.476 ' O ' ' CG2' ' A' ' 165' ' ' VAL . 1.4 m -101.85 98.97 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.03 136.72 53.37 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.229 -174.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.448 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . . . -176.42 166.42 1.57 Allowed Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.068 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -85.49 109.36 1.12 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.169 2.579 . . . . 0.0 110.126 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.751 ' SD ' ' HA ' ' A' ' 148' ' ' VAL . 37.8 mmt -87.22 152.69 53.2 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.79 -174.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.11 -165.89 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.906 2.404 . . . . 0.0 111.708 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -96.11 179.75 4.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.42 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 174' ' ' THR . 0.5 OUTLIER 49.34 48.4 21.17 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.039 0.447 . . . . 0.0 110.94 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.12 58.9 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.266 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 172' ' ' LEU . 7.3 m 70.75 138.57 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.191 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -76.84 0.06 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.599 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 C--O 1.212 -0.907 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.106 179.806 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' MET . . . . . . . . . . . . . 7.9 mtt . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -66.84 -61.84 1.75 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -109.08 68.79 0.69 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 1.5 m -72.89 -25.65 61.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.083 -178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.42 171.86 1.32 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.026 0.441 . . . . 0.0 110.902 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.13 -45.6 0.02 OUTLIER Glycine 0 C--N 1.321 -0.293 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 m -68.92 -32.77 55.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.22 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.83 -68.23 0.19 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.942 0.401 . . . . 0.0 110.578 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 54.32 12.59 0.52 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.713 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 1.2 mt -69.58 54.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 121.386 0.612 . . . . 0.0 110.214 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -131.32 78.55 1.84 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.344 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -66.85 48.18 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.18 -178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -80.22 0.08 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -166.72 129.39 1.83 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.683 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -174.56 -179.28 1.49 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.052 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 65.1 120.86 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 123.727 0.642 . . . . 0.0 109.693 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' TRP . . . . . 0.443 ' HB2' ' CG ' ' B' ' 169' ' ' MET . 0.6 OUTLIER -81.3 128.16 33.51 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.891 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -127.47 101.93 6.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.583 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.22 156.6 17.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 4.8 p -124.92 151.41 45.43 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.617 ' O ' ' NH2' ' B' ' 140' ' ' ARG . 0.6 OUTLIER -122.85 43.47 2.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.777 172.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . 0.472 ' CG ' ' HG1' ' B' ' 162' ' ' THR . 5.5 m-20 -62.77 97.81 0.11 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.635 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . 0.464 ' C ' ' H ' ' B' ' 103' ' ' HIS . 2.5 t -158.62 -28.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.401 0.619 . . . . 0.0 109.486 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.576 ' ND2' ' O ' ' B' ' 105' ' ' ALA . 17.0 t30 -66.92 8.94 0.22 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.741 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.464 ' H ' ' C ' ' B' ' 101' ' ' VAL . 25.9 m80 -39.64 -21.88 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' B' ' 102' ' ' ASN . 28.0 p90 -92.36 -34.56 14.13 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -176.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . 0.576 ' O ' ' ND2' ' B' ' 102' ' ' ASN . . . -113.52 76.64 2.91 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.3 -39.13 49.41 Favored 'Trans proline' 0 C--N 1.295 -2.259 0 C-N-CA 122.359 2.039 . . . . 0.0 112.237 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -102.0 -27.31 13.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.79 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.563 ' OE1' ' NZ ' ' B' ' 123' ' ' LYS . 32.3 mt-10 -92.69 41.58 1.08 Allowed 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.804 0.335 . . . . 0.0 111.206 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.49 HD12 ' CG2' ' B' ' 120' ' ' ILE . 0.4 OUTLIER -123.51 136.36 54.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.242 179.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.86 131.23 47.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.737 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.01 119.46 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.37 135.26 53.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 0.0 111.312 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.66 115.33 29.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.369 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.518 ' CB ' ' HZ2' ' B' ' 114' ' ' LYS . 0.0 OUTLIER -116.0 90.5 3.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.377 -177.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 18.9 t0 33.48 69.21 0.14 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.07 -21.44 16.07 Favored Glycine 0 C--N 1.316 -0.572 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.498 ' HB ' ' HD2' ' B' ' 114' ' ' LYS . 3.8 t -87.49 112.59 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 75.4 t -97.98 119.8 46.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.46 ' HG2' ' HB2' ' B' ' 141' ' ' LYS . 33.7 mt-10 -133.96 139.88 46.39 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.49 0.662 . . . . 0.0 111.134 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.49 ' CG2' HD12 ' B' ' 109' ' ' LEU . 1.0 OUTLIER -116.78 137.46 50.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.494 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.82 119.53 35.69 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.281 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -142.87 124.7 2.42 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' LYS . . . . . 0.563 ' NZ ' ' OE1' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -150.66 140.51 21.86 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -116.94 157.94 24.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.224 0.535 . . . . 0.0 112.397 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.452 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.8 OUTLIER -68.52 145.49 53.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.275 179.082 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . 0.553 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 4.9 tt0 -29.98 102.1 0.02 OUTLIER 'General case' 0 C--N 1.349 0.546 0 CA-C-O 120.832 0.349 . . . . 0.0 111.174 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' B' ' 133' ' ' TYR . 0.2 OUTLIER -89.65 136.37 33.07 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.913 -177.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -90.7 117.28 29.22 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 172.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.75 171.95 10.23 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.134 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -56.45 -31.78 64.3 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -174.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' HIS . . . . . 0.444 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 74.0 m80 -111.73 36.39 3.3 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -175.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 121.85 -173.29 15.74 Favored Glycine 0 C--N 1.305 -1.18 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.426 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' B' ' 127' ' ' ARG . 13.6 m-30 -95.94 118.92 33.5 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . 0.498 ' O ' ' NH2' ' B' ' 136' ' ' ARG . 0.1 OUTLIER -133.74 112.26 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -173.173 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' SER . . . . . 0.553 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -127.9 164.1 23.0 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.032 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . 0.498 ' NH2' ' O ' ' B' ' 134' ' ' ILE . 0.0 OUTLIER -161.76 161.94 29.43 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.588 -176.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 26.8 p -113.47 128.16 56.35 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -107.99 137.93 45.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -176.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.55 123.64 19.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.282 0.563 . . . . 0.0 111.046 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . 0.617 ' NH2' ' O ' ' B' ' 99' ' ' LEU . 0.0 OUTLIER -124.54 118.65 27.05 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . 0.46 ' HB2' ' HG2' ' B' ' 119' ' ' GLU . 1.1 ttpp -114.11 124.65 52.61 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.823 0.344 . . . . 0.0 110.874 -175.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' TYR . . . . . 0.54 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 3.3 m-85 -114.27 98.27 6.83 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.245 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.551 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.3 OUTLIER -91.33 101.49 14.18 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 mp -107.35 96.49 16.09 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.56 ' C ' ' H ' ' B' ' 147' ' ' GLY . 36.0 Cg_exo -62.26 -38.18 56.53 Favored 'Trans proline' 0 C--N 1.286 -2.76 0 C-N-CA 123.375 2.717 . . . . 0.0 114.198 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 50.1 Cg_exo -47.34 -8.61 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.619 1.546 . . . . 0.0 111.515 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.56 ' H ' ' C ' ' B' ' 145' ' ' PRO . . . 97.83 56.73 1.07 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.2 -0.524 . . . . 0.0 111.979 175.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' VAL . . . . . 0.51 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -69.86 100.76 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 176.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . 0.436 ' O ' ' CG2' ' B' ' 153' ' ' VAL . 0.9 OUTLIER -33.83 120.23 0.5 Allowed Pre-proline 0 C--O 1.219 -0.509 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.411 -173.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 8.5 Cg_exo -71.86 -42.39 1.67 Allowed 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.425 2.083 . . . . 0.0 111.841 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -47.6 25.23 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.642 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -85.35 18.69 2.57 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.629 -1.169 . . . . 0.0 113.473 -172.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . 0.464 ' HA ' ' CB ' ' B' ' 167' ' ' ALA . 33.4 t -114.0 106.65 21.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.471 177.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' SER . . . . . 0.415 ' C ' ' HG ' ' B' ' 155' ' ' SER . 0.1 OUTLIER -100.44 -169.31 1.7 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' SER . . . . . 0.415 ' HG ' ' C ' ' B' ' 154' ' ' SER . 0.8 OUTLIER -162.72 146.47 11.37 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.612 -179.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -120.67 144.77 48.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.684 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' B' ' 162' ' ' THR . 23.5 tp -134.9 148.65 50.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.342 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.02 156.81 79.64 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.613 ' C ' ' H ' ' B' ' 161' ' ' GLY . 75.5 Cg_exo -39.61 -43.43 3.05 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.702 2.268 . . . . 0.0 111.402 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -66.97 26.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.21 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' GLY . . . . . 0.613 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 41.65 24.48 0.15 Allowed Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.734 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' THR . . . . . 0.472 ' HG1' ' CG ' ' B' ' 100' ' ' ASP . 11.6 t -77.03 130.4 37.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' B' ' 98' ' ' SER . 2.7 tm? -126.46 105.39 8.73 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.145 -175.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.28 121.8 38.46 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . 0.45 ' O ' ' CG2' ' B' ' 165' ' ' VAL . 3.2 m -105.51 98.94 7.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 0.0 OUTLIER -116.43 127.3 54.48 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.504 -175.058 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . 0.464 ' CB ' ' HA ' ' B' ' 153' ' ' VAL . . . -171.1 158.06 5.07 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -82.49 126.47 4.75 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.478 2.785 . . . . 0.0 110.005 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' MET . . . . . 0.623 ' CB ' ' HD2' ' B' ' 170' ' ' PRO . 0.0 OUTLIER -123.99 176.43 2.27 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.993 -176.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' PRO . . . . . 0.623 ' HD2' ' CB ' ' B' ' 169' ' ' MET . 21.4 Cg_exo -25.78 97.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 124.317 3.344 . . . . 0.0 112.074 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -51.5 -23.66 4.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.952 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.55 152.09 40.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.927 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' B' ' 175' ' ' GLN . . . -86.3 164.04 17.35 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.577 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 20.8 p -68.77 44.71 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.04 0.448 . . . . 0.0 110.709 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' GLN . . . . . 0.514 ' H ' ' C ' ' B' ' 173' ' ' ALA . 15.9 mt-30 -148.64 171.32 16.36 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.773 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' SER . . . . . 0.465 ' HG ' ' C ' ' B' ' 175' ' ' GLN . 62.0 p . . . . . 0 C--O 1.206 -1.21 0 CA-C-O 118.493 -0.765 . . . . 0.0 111.635 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -93.03 -146.34 0.23 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.402 ' C ' ' HG ' ' A' ' 82' ' ' SER . 43.3 mt -103.75 162.53 13.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.421 ' C ' ' HG ' ' A' ' 83' ' ' SER . 18.9 m -161.89 -179.29 7.06 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.377 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.421 ' HG ' ' C ' ' A' ' 82' ' ' SER . 0.1 OUTLIER 52.26 29.43 6.66 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.376 0.607 . . . . 0.0 110.242 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.32 -150.31 19.38 Favored Glycine 0 C--N 1.321 -0.305 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.7 t 38.3 39.97 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.911 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.1 m -115.34 137.99 51.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.444 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -161.89 85.9 0.62 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.13 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.34 143.67 21.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.384 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 91' ' ' THR . 8.3 mtm180 -139.18 0.07 1.88 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.693 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -60.09 64.74 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.589 ' N ' ' O ' ' A' ' 89' ' ' ARG . 6.9 p -138.04 -126.28 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.909 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 61.76 -56.69 0.12 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.649 0.261 . . . . 0.0 111.594 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 91' ' ' THR . 11.4 t70 -66.95 104.43 1.37 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.252 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.517 HH21 ' CD ' ' A' ' 166' ' ' GLU . 30.4 mmm-85 -148.52 126.17 11.77 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.789 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.497 ' NE1' ' CG2' ' A' ' 97' ' ' VAL . 37.7 t-105 -117.71 118.22 31.49 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.22 104.76 14.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.097 -175.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.497 ' CG2' ' NE1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -110.74 139.13 35.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 174.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 15.4 m -111.36 154.06 25.11 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.43 -0.508 . . . . 0.0 112.368 -176.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.502 HD23 HG12 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -131.05 67.13 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.591 176.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.19 89.48 4.27 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.86 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.516 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.2 OUTLIER -142.75 -36.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 121.226 0.536 . . . . 0.0 110.42 177.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.504 ' OD1' ' CD1' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -64.45 13.41 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.56 -176.256 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.516 ' H ' ' C ' ' A' ' 101' ' ' VAL . 2.1 p80 -54.63 -20.1 7.41 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.723 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.458 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 32.6 p90 -107.2 3.65 25.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.712 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.85 81.39 16.52 Favored Pre-proline 0 CA--C 1.518 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 111.223 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.99 -44.38 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.685 2.257 . . . . 0.0 111.324 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 109' ' ' LEU . 2.4 m-20 -104.6 -31.13 9.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.346 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.36 36.25 0.47 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.086 0.47 . . . . 0.0 110.655 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.504 ' CD1' ' OD1' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -117.9 135.9 53.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.938 178.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.436 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 1.2 m -127.68 126.83 42.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.841 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 7.4 t -104.09 126.97 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.409 ' NZ ' ' CB ' ' A' ' 119' ' ' GLU . 3.4 pttp -133.17 130.95 39.85 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.058 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 45.3 m -112.05 109.17 18.76 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.59 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.498 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 3.3 ttmm -114.43 99.89 7.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.257 -177.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 114' ' ' LYS . 15.6 t0 26.1 64.23 0.07 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.86 -19.81 52.07 Favored Glycine 0 N--CA 1.461 0.308 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 2.7 t -88.67 112.55 24.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.537 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.12 114.6 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 140' ' ' ARG . 46.1 mt-10 -127.46 133.57 49.9 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.266 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.502 HG12 HD23 ' A' ' 99' ' ' LEU . 4.0 mm -104.25 137.19 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.979 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -118.89 107.59 13.77 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.192 -178.133 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -135.17 115.03 1.32 Allowed Glycine 0 N--CA 1.461 0.357 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 159.58 41.22 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 104' ' ' PHE . 1.7 t60 -139.72 141.49 36.9 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.416 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.502 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.3 OUTLIER -81.45 150.22 28.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.063 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.502 ' C ' ' O ' ' A' ' 125' ' ' GLU . 4.9 tt0 -1.4 108.93 0.01 OUTLIER 'General case' 0 C--N 1.349 0.556 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -98.96 137.37 37.6 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.565 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -92.9 116.47 29.07 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -174.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 132' ' ' GLY . 4.6 m-20 -140.09 129.09 23.51 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 174.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -51.14 -26.68 7.04 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -104.45 29.1 6.35 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.539 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 129' ' ' ASP . . . 135.1 131.04 3.02 Favored Glycine 0 C--N 1.303 -1.261 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.158 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -92.35 107.85 19.52 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.589 ' O ' ' NH2' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -125.93 117.53 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -174.289 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -109.17 149.57 29.16 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.401 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.589 ' NH2' ' O ' ' A' ' 134' ' ' ILE . 0.0 OUTLIER -133.16 172.43 12.67 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -174.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 23.7 p -141.13 131.75 25.55 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.407 ' CD2' HG11 ' A' ' 101' ' ' VAL . 7.3 m-85 -107.09 139.48 41.44 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.136 -0.225 . . . . 0.0 111.034 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.8 104.47 6.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.395 0.617 . . . . 0.0 110.364 175.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.569 ' NE ' ' OH ' ' A' ' 142' ' ' TYR . 12.5 ttt180 -108.01 100.54 9.88 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.48 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.416 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 6.6 ttpt -107.67 116.04 31.23 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.287 -175.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.569 ' OH ' ' NE ' ' A' ' 140' ' ' ARG . 19.9 m-30 -114.52 99.6 7.67 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.3 0.571 . . . . 0.0 110.144 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.459 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -86.29 89.03 7.73 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.377 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mp -112.1 91.52 16.03 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.593 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 15.3 Cg_exo -68.18 -56.41 0.2 Allowed 'Trans proline' 0 C--N 1.294 -2.311 0 C-N-CA 122.359 2.039 . . . . 0.0 113.831 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.593 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 37.4 Cg_endo -99.3 53.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 123.327 2.685 . . . . 0.0 112.408 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -171.45 -12.91 0.02 OUTLIER Glycine 0 CA--C 1.521 0.429 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.569 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.567 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 1.0 OUTLIER -130.26 125.11 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 117.68 0.74 . . . . 0.0 111.187 178.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.481 ' HB2' ' HD3' ' A' ' 170' ' ' PRO . 14.2 t70 -81.91 140.69 46.85 Favored Pre-proline 0 N--CA 1.478 0.962 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.293 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -81.1 -26.45 3.46 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.027 1.818 . . . . 0.0 113.0 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.413 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 0.8 OUTLIER -91.19 -36.38 13.98 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -176.257 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 167' ' ' ALA . 4.6 mt-30 -107.72 27.22 9.4 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -172.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 41.7 t -113.3 104.94 17.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.67 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.412 ' C ' ' HG ' ' A' ' 155' ' ' SER . 0.7 OUTLIER -95.31 -161.77 0.89 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.717 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 154' ' ' SER . 0.3 OUTLIER -165.1 132.07 2.94 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.335 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -100.82 139.81 35.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.591 177.459 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.469 HD13 ' H ' ' A' ' 158' ' ' SER . 42.1 tp -137.53 138.13 39.33 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.176 0.513 . . . . 0.0 110.981 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.583 ' O ' ' N ' ' A' ' 161' ' ' GLY . 23.1 m -121.88 146.06 45.07 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.631 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 161' ' ' GLY . 75.4 Cg_exo -41.27 -34.8 1.86 Allowed 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.065 1.843 . . . . 0.0 110.897 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -65.31 2.86 0.75 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.076 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 158' ' ' SER . . . 67.09 21.2 71.62 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.894 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.496 HG23 ' HB2' ' A' ' 158' ' ' SER . 0.7 OUTLIER -77.24 106.82 9.21 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 98' ' ' SER . 1.2 tm? -106.94 101.52 10.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.752 -175.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.42 120.24 39.29 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 121.289 -0.165 . . . . 0.0 110.66 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.495 ' O ' ' CG2' ' A' ' 165' ' ' VAL . 1.5 m -100.93 99.18 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.517 ' CD ' HH21 ' A' ' 94' ' ' ARG . 1.4 pp20? -112.71 146.21 39.12 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.674 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 152' ' ' GLN . . . 175.13 166.64 0.37 Allowed Pre-proline 0 N--CA 1.437 -1.103 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.206 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -86.41 106.33 0.77 Allowed 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.803 2.335 . . . . 0.0 108.735 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.567 ' SD ' ' HA ' ' A' ' 148' ' ' VAL . 20.5 mmt -74.66 153.95 87.39 Favored Pre-proline 0 C--N 1.31 -1.126 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.554 -174.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 149' ' ' ASP . 38.4 Cg_endo -69.68 134.7 28.8 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.626 2.217 . . . . 0.0 111.684 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -63.49 -175.41 0.12 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.929 178.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.0 mp -64.97 57.79 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.913 0.387 . . . . 0.0 110.608 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 171' ' ' LYS . . . -61.03 -23.39 65.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.654 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.432 ' HG1' ' C ' ' A' ' 173' ' ' ALA . 25.3 p 54.7 110.52 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.57 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.23 -3.79 38.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.761 0.315 . . . . 0.0 110.711 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 82.0 p . . . . . 0 C--O 1.214 -0.802 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.52 -179.585 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' MET . . . . . 0.513 ' N ' ' OE1' ' B' ' 80' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' B' ' 79' ' ' MET . 0.0 OUTLIER -126.57 8.57 7.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.643 179.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.433 ' N ' ' CD2' ' B' ' 81' ' ' LEU . 3.7 mm? -71.42 51.53 0.18 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.735 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -53.93 51.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.896 0.379 . . . . 0.0 110.638 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.82 134.95 24.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.217 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.97 29.72 2.71 Favored Glycine 0 N--CA 1.46 0.253 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 8.3 m -72.19 54.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.905 0.383 . . . . 0.0 110.402 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 2.2 m 55.3 -154.79 0.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.138 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' B' ' 89' ' ' ARG . 26.4 mt-10 -54.88 126.6 25.02 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.443 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' B' ' 90' ' ' HIS . 16.5 mm -69.48 59.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.056 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.532 ' O ' ' NH1' ' B' ' 89' ' ' ARG . 0.0 OUTLIER -63.77 59.45 0.02 OUTLIER 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.105 179.383 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' HIS . . . . . 0.605 ' CG ' ' H ' ' B' ' 91' ' ' THR . 7.9 t-80 -159.71 -168.17 2.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.023 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.605 ' H ' ' CG ' ' B' ' 90' ' ' HIS . 0.0 OUTLIER -66.22 72.06 0.07 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' B' ' 90' ' ' HIS . . . -58.42 -175.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.885 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' B' ' 94' ' ' ARG . 17.1 t70 -33.87 -57.9 0.45 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.976 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . 0.478 ' NH1' ' OE1' ' B' ' 166' ' ' GLU . 9.0 mmt85 17.7 110.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 124.265 0.978 . . . . 0.0 112.472 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' TRP . . . . . 0.669 ' HB2' ' SD ' ' B' ' 169' ' ' MET . 0.3 OUTLIER -55.51 151.11 10.89 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.133 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.583 ' HB2' ' NH1' ' B' ' 96' ' ' ARG . 16.3 ttm105 -150.13 109.4 3.96 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.684 -176.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 t -119.1 152.27 21.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 1.5 m -126.05 144.29 50.78 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -176.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.512 ' CD2' ' HB2' ' B' ' 140' ' ' ARG . 0.3 OUTLIER -115.39 54.64 0.79 Allowed 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.447 176.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . 0.462 ' O ' HG23 ' B' ' 101' ' ' VAL . 0.1 OUTLIER -62.32 96.96 0.08 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.018 -178.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . 0.487 ' CG2' ' CZ ' ' B' ' 140' ' ' ARG . 0.6 OUTLIER -162.0 -6.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 176.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.55 ' OD1' ' HA2' ' B' ' 161' ' ' GLY . 0.4 OUTLIER -90.5 10.15 26.52 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -175.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.5 ' N ' ' HA3' ' B' ' 161' ' ' GLY . 0.2 OUTLIER -39.63 -35.04 0.27 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.72 0.295 . . . . 0.0 111.155 179.472 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.6 -8.83 51.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' B' ' 102' ' ' ASN . . . -138.72 93.34 10.88 Favored Pre-proline 0 CA--C 1.515 -0.383 0 CA-C-O 120.696 0.284 . . . . 0.0 111.298 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -81.17 -48.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.967 0 C-N-CA 122.68 2.253 . . . . 0.0 110.933 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -90.29 -31.2 17.05 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.523 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.518 ' OE2' ' NZ ' ' B' ' 123' ' ' LYS . 2.8 mt-10 -84.63 45.09 1.1 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.369 0.604 . . . . 0.0 109.897 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' B' ' 121' ' ' THR . 0.5 OUTLIER -129.44 135.98 49.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.013 178.321 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.96 121.73 22.06 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.571 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 1.5 t -98.99 131.78 45.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.814 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.463 ' HZ2' ' CD ' ' B' ' 119' ' ' GLU . 2.9 pttp -139.78 122.28 16.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.101 0.477 . . . . 0.0 111.755 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.7 117.54 34.27 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.558 ' O ' ' N ' ' B' ' 117' ' ' VAL . 1.3 ttpm? -128.96 112.01 13.62 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.348 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.476 ' CG ' ' O ' ' B' ' 115' ' ' ASP . 0.3 OUTLIER 34.64 59.89 0.64 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.91 0.862 . . . . 0.0 112.481 176.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.91 -12.1 31.55 Favored Glycine 0 C--N 1.314 -0.657 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' B' ' 114' ' ' LYS . 9.0 t -87.47 115.46 28.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.762 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.505 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 54.2 t -103.66 112.67 38.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.571 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.57 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 49.4 mt-10 -125.96 146.47 49.85 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.599 0.714 . . . . 0.0 111.546 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.79 121.56 66.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.307 178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -97.44 124.3 41.58 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.2 117.59 0.86 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' LYS . . . . . 0.518 ' NZ ' ' OE2' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -152.82 135.5 15.31 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.363 0.265 . . . . 0.0 110.489 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . 0.515 ' O ' ' CB ' ' B' ' 135' ' ' SER . 0.1 OUTLIER -111.96 123.55 50.49 Favored 'General case' 0 C--O 1.21 -0.989 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.4 ' H ' ' HG3' ' B' ' 125' ' ' GLU . 4.9 mt-10 -54.05 -21.43 8.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -176.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 178.61 131.11 0.07 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.989 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' ARG . . . . . 0.472 ' HD3' ' CE1' ' B' ' 124' ' ' HIS . 38.9 mtp180 -123.69 132.08 53.75 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.146 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -81.56 138.7 35.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.936 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . 0.506 ' CG ' ' N ' ' B' ' 130' ' ' GLU . 9.2 t70 -157.37 165.89 34.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.205 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . 0.506 ' N ' ' CG ' ' B' ' 129' ' ' ASP . 0.7 OUTLIER -61.4 -28.28 69.14 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.639 -177.119 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' HIS . . . . . 0.48 ' O ' ' CE1' ' A' ' 142' ' ' TYR . 10.6 m-70 -74.78 -12.55 60.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.758 0.313 . . . . 0.0 111.013 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.74 -136.95 8.96 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -112.25 134.99 53.48 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 175.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' B' ' 127' ' ' ARG . 0.4 OUTLIER -146.75 125.76 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -176.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' B' ' 124' ' ' HIS . 0.6 OUTLIER -142.99 158.01 44.0 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.029 0.442 . . . . 0.0 111.283 174.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . 0.472 ' CZ ' ' CZ ' ' B' ' 138' ' ' PHE . 0.2 OUTLIER -141.77 173.7 11.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.865 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 31.9 p -123.74 129.91 51.82 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . 0.472 ' CZ ' ' CZ ' ' B' ' 136' ' ' ARG . 1.1 m-85 -104.86 122.35 45.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.936 -176.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 134' ' ' ILE . 0.0 OUTLIER -124.83 99.47 6.16 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.137 174.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . 0.512 ' HB2' ' CD2' ' B' ' 99' ' ' LEU . 0.0 OUTLIER -106.63 119.58 39.68 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.288 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . 0.57 ' HA ' ' HG2' ' B' ' 119' ' ' GLU . 2.7 ttpt -120.19 130.72 54.68 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.07 0.462 . . . . 0.0 111.206 -176.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 7.8 m-85 -120.27 98.74 6.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.961 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.422 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 1.3 m -93.52 93.66 8.22 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -110.95 90.95 11.86 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.584 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.583 ' HD2' ' CD ' ' B' ' 146' ' ' PRO . 16.2 Cg_exo -68.72 -41.19 6.18 Favored 'Trans proline' 0 C--N 1.279 -3.096 0 C-N-CA 122.06 1.84 . . . . 0.0 112.125 167.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' PRO . . . . . 0.583 ' CD ' ' HD2' ' B' ' 145' ' ' PRO . 74.2 Cg_exo -43.21 -11.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 123.325 2.683 . . . . 0.0 114.606 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 149.02 44.64 0.03 OUTLIER Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 118.239 -1.934 . . . . 0.0 115.447 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.29 116.56 52.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 118.73 -1.188 . . . . 0.0 110.667 173.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 19.3 t70 -80.02 140.33 53.71 Favored Pre-proline 0 C--O 1.221 -0.407 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.03 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 4.2 Cg_exo -81.4 -23.89 4.78 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.074 1.85 . . . . 0.0 112.9 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.15 -43.68 9.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.975 0.417 . . . . 0.0 112.072 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -94.93 18.97 10.94 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 42.5 t -108.83 104.94 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.088 0.471 . . . . 0.0 109.888 176.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' SER . . . . . 0.406 ' C ' ' HG ' ' B' ' 155' ' ' SER . 0.0 OUTLIER -97.43 -175.38 3.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.237 179.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' SER . . . . . 0.406 ' HG ' ' C ' ' B' ' 154' ' ' SER . 0.7 OUTLIER -158.01 132.79 8.46 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.717 -0.793 . . . . 0.0 112.291 -178.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.56 139.84 40.39 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.222 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . 0.404 HD11 ' OD1' ' B' ' 102' ' ' ASN . 33.0 tp -131.08 143.12 50.43 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.408 ' OG ' ' HD2' ' B' ' 159' ' ' PRO . 0.2 OUTLIER -135.58 154.38 78.22 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.639 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.58 ' C ' ' H ' ' B' ' 161' ' ' GLY . 1.2 Cg_endo -44.8 -34.79 8.87 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.693 2.262 . . . . 0.0 111.491 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -68.74 24.12 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.034 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' GLY . . . . . 0.58 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 44.03 34.03 2.95 Favored Glycine 0 C--O 1.241 0.532 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.638 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 7.4 t -97.16 121.46 39.08 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' B' ' 98' ' ' SER . 1.8 tm? -115.84 103.86 11.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.953 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.59 121.72 39.82 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 121.13 -0.228 . . . . 0.0 110.803 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . 0.441 ' O ' ' CG2' ' B' ' 165' ' ' VAL . 3.1 m -106.49 103.33 15.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.478 ' OE1' ' NH1' ' B' ' 94' ' ' ARG . 2.0 pp20? -113.22 151.84 30.5 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.278 -177.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -174.62 154.25 1.89 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 0.0 111.628 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.06 -4.7 11.24 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 123.018 2.479 . . . . 0.0 109.906 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' MET . . . . . 0.669 ' SD ' ' HB2' ' B' ' 95' ' ' TRP . 0.0 OUTLIER 57.09 179.39 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.388 177.024 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' B' ' 169' ' ' MET . 31.7 Cg_exo -58.02 172.87 1.07 Allowed 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.642 2.228 . . . . 0.0 112.433 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 51.88 0.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.991 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 28.0 mt -64.64 -43.5 93.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.329 0.585 . . . . 0.0 109.848 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -153.24 -164.66 1.97 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.394 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.49 77.58 0.57 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.957 0.408 . . . . 0.0 110.222 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -174.61 0.1 Allowed 'General case' 0 C--O 1.242 0.664 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.405 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.214 -0.788 0 CA-C-O 118.11 -0.947 . . . . 0.0 110.147 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.493 ' N ' ' SD ' ' A' ' 79' ' ' MET . 2.1 mpt? . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 57.23 68.66 0.82 Allowed 'General case' 0 C--O 1.24 0.563 0 CA-C-O 120.873 0.368 . . . . 0.0 111.483 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.9 -103.87 0.19 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.39 -48.04 52.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 176.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER 37.78 41.91 0.36 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.314 178.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.39 -51.74 0.44 Allowed Glycine 0 C--N 1.32 -0.34 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' A' ' 83' ' ' SER . 9.5 p -166.34 65.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.972 0.415 . . . . 0.0 110.871 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.588 ' C ' ' H ' ' A' ' 88' ' ' ILE . 0.7 OUTLIER -64.78 -169.31 0.04 OUTLIER 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -66.1 37.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.778 0.323 . . . . 0.0 111.297 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.588 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -101.36 8.92 8.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.753 178.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.514 ' NH1' ' O ' ' A' ' 88' ' ' ILE . 90.7 mmt-85 -134.64 172.62 12.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.665 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.461 ' ND1' ' N ' ' A' ' 90' ' ' HIS . 1.6 m80 50.48 23.43 1.29 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.7 p -54.33 -70.53 0.1 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.445 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.27 89.61 2.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.329 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.45 -67.47 0.54 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.26 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.429 ' NH1' ' HD3' ' A' ' 168' ' ' PRO . 10.9 mmt180 53.73 100.38 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -177.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.566 ' CB ' ' SD ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -68.45 145.17 54.32 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.129 -179.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -138.66 105.96 5.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.487 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.22 155.11 13.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 175.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.62 148.64 51.53 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -174.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.417 ' CD2' ' HB2' ' A' ' 140' ' ' ARG . 0.7 OUTLIER -130.13 118.91 22.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.102 174.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.431 ' CG ' ' HE2' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -112.28 114.08 26.66 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.536 -178.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.609 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -161.14 -43.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 120.89 0.376 . . . . 0.0 111.445 179.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.603 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -60.27 17.0 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.609 ' H ' ' C ' ' A' ' 101' ' ' VAL . 12.0 m80 -52.67 -38.09 59.88 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -105.69 -15.14 15.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.645 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -118.13 81.93 17.22 Favored Pre-proline 0 CA--C 1.516 -0.346 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -74.36 -44.66 0.4 Allowed 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 122.612 2.208 . . . . 0.0 110.924 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -92.55 -31.47 15.19 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.759 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -89.44 45.86 1.32 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.151 0.5 . . . . 0.0 111.14 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.545 HD13 ' HB3' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -133.34 130.29 38.64 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.185 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 m -128.61 124.56 36.16 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 120.783 0.325 . . . . 0.0 110.512 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -96.51 127.4 48.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.984 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.85 130.13 43.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.856 0.36 . . . . 0.0 111.406 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.91 104.0 13.37 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.559 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.8 OUTLIER -109.43 103.32 12.21 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.528 -175.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.474 ' CG ' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER 36.06 41.44 0.13 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 177.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.03 -11.52 57.32 Favored Glycine 0 C--N 1.314 -0.651 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 2.6 t -86.73 117.25 30.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 55.4 t -102.81 116.51 46.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 141' ' ' LYS . 2.2 mt-10 -133.51 140.2 47.09 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.272 0.558 . . . . 0.0 111.521 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.44 115.54 50.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.154 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -92.0 118.67 31.0 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.776 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.17 129.99 4.28 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.118 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.72 159.28 44.63 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -133.68 162.13 32.79 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.36 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.523 ' O ' ' C ' ' A' ' 126' ' ' GLU . 1.5 tt0 -90.28 143.33 26.86 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.851 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.523 ' C ' ' O ' ' A' ' 125' ' ' GLU . 1.0 OUTLIER -18.12 105.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.645 0.591 . . . . 0.0 111.846 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.25 128.94 35.15 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 120.897 0.379 . . . . 0.0 110.428 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -75.32 118.48 18.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.357 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 132' ' ' GLY . 1.6 m-20 -150.82 116.33 5.43 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -49.4 -25.27 2.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.73 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -90.38 19.18 5.38 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.373 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 129' ' ' ASP . . . 137.1 129.5 2.77 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.014 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -92.2 109.71 21.08 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.502 HG23 HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -122.47 159.34 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -169.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.9 t -155.06 154.81 33.02 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.762 170.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.55 172.27 15.76 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.928 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.5 p -125.97 128.36 47.38 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -102.68 142.25 34.14 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.352 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.55 103.02 3.63 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.086 0.47 . . . . 0.0 111.554 176.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.55 ' NH2' ' OH ' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -104.16 119.63 39.37 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 174.336 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.479 ' HB2' ' HG2' ' A' ' 119' ' ' GLU . 2.7 ttpt -118.4 123.58 45.59 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 123.21 0.319 . . . . 0.0 110.666 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.55 ' OH ' ' NH2' ' A' ' 140' ' ' ARG . 3.2 m-85 -112.96 99.16 7.66 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.993 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.431 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -92.0 90.25 7.32 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.548 178.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.44 91.94 21.69 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.59 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 16.0 Cg_exo -67.47 -56.94 0.19 Allowed 'Trans proline' 0 C--N 1.288 -2.641 0 C-N-CA 122.349 2.033 . . . . 0.0 114.207 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.59 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 41.8 Cg_endo -100.61 56.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.482 0.815 0 C-N-CA 123.377 2.718 . . . . 0.0 113.035 -175.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 169' ' ' MET . . . -176.76 -14.35 0.02 OUTLIER Glycine 0 N--CA 1.466 0.634 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.713 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.03 132.21 68.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 117.539 0.67 . . . . 0.0 110.153 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -93.44 141.15 23.54 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.204 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.66 -21.4 5.08 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.095 1.863 . . . . 0.0 112.7 -177.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.45 -41.69 10.71 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.386 -175.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.415 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 1.8 mt-30 -101.29 14.44 31.96 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -171.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.423 ' HA ' ' HB3' ' A' ' 167' ' ' ALA . 24.9 t -102.75 117.09 47.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.387 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.02 166.69 11.18 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.62 137.46 35.33 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.112 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.57 138.57 47.94 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.872 177.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.417 ' CD2' HD21 ' A' ' 109' ' ' LEU . 14.8 tp -125.13 121.77 35.18 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.388 0.43 . . . . 0.0 110.364 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 161' ' ' GLY . 0.2 OUTLIER -96.07 138.28 21.65 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.686 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 161' ' ' GLY . 74.8 Cg_exo -39.95 -33.19 0.7 Allowed 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.556 2.171 . . . . 0.0 111.185 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -59.23 -5.54 0.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.344 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.537 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . 76.69 34.41 43.87 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.4 t -109.89 118.76 37.33 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.418 ' C ' ' CD1' ' A' ' 163' ' ' LEU . 2.1 tm? -104.25 108.65 20.14 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.597 -174.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.468 ' H ' ' HG1' ' A' ' 164' ' ' THR . 3.4 p -95.43 127.94 41.88 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.605 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' A' ' 165' ' ' VAL . 2.7 m -113.47 103.33 15.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 1.6 pp20? -119.11 141.82 48.45 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.201 -176.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . . . -174.48 157.85 2.44 Favored Pre-proline 0 C--N 1.332 -0.193 0 C-N-CA 120.024 -0.671 . . . . 0.0 112.618 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.429 ' HD3' ' NH1' ' A' ' 94' ' ' ARG . 61.6 Cg_endo -83.35 108.73 1.55 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.736 2.291 . . . . 0.0 108.84 172.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.566 ' SD ' ' CB ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -87.59 156.09 53.43 Favored Pre-proline 0 C--N 1.305 -1.337 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.745 -174.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.428 ' O ' ' NE2' ' A' ' 90' ' ' HIS . 3.0 Cg_endo -50.19 -51.12 11.6 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.673 2.248 . . . . 0.0 111.43 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' A' ' 175' ' ' GLN . 0.0 OUTLIER -168.34 135.75 2.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.327 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.0 -47.14 87.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.18 0.514 . . . . 0.0 109.736 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.19 100.32 1.28 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.959 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -55.2 135.91 49.08 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.549 ' C ' ' HG ' ' A' ' 176' ' ' SER . 22.6 mt-30 63.38 172.53 0.16 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.051 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.549 ' HG ' ' C ' ' A' ' 175' ' ' GLN . 14.3 p . . . . . 0 C--O 1.208 -1.126 0 CA-C-O 117.988 -1.006 . . . . 0.0 111.085 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' MET . . . . . . . . . . . . . 1.6 ppp? . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.84 -95.21 0.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.99 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.489 ' CD1' ' N ' ' B' ' 81' ' ' LEU . 0.0 OUTLIER -149.17 164.21 35.39 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.517 177.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.0 -49.33 0.22 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.477 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 66.75 129.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.645 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.15 49.49 0.39 Allowed Glycine 0 C--N 1.319 -0.382 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 1.3 p -46.81 108.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' SER . . . . . 0.42 ' C ' ' H ' ' B' ' 88' ' ' ILE . 0.0 OUTLIER -124.94 -83.29 0.64 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.663 -176.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 51.92 14.38 0.31 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.954 0.407 . . . . 0.0 110.067 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.45 ' CG2' ' H ' ' B' ' 89' ' ' ARG . 4.6 tt -97.92 -57.31 4.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.643 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.547 ' C ' ' H ' ' B' ' 91' ' ' THR . 0.1 OUTLIER -83.93 -166.14 1.33 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.063 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' HIS . . . . . 0.439 ' ND1' ' N ' ' B' ' 90' ' ' HIS . 0.0 OUTLIER -65.9 6.53 0.36 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.448 177.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.547 ' H ' ' C ' ' B' ' 89' ' ' ARG . 0.7 OUTLIER -52.0 117.14 2.55 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.602 179.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 62.62 -149.49 0.36 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.975 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.413 ' CG ' ' HZ2' ' B' ' 171' ' ' LYS . 0.1 OUTLIER -165.77 171.0 13.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.893 0.378 . . . . 0.0 111.245 -179.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . 0.444 HH11 ' HB3' ' B' ' 94' ' ' ARG . 0.2 OUTLIER -124.94 102.97 7.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.567 178.416 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' TRP . . . . . 0.654 ' HB2' ' SD ' ' B' ' 169' ' ' MET . 0.1 OUTLIER -63.83 139.99 58.82 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 19.7 ttm105 -134.45 99.08 4.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.138 -175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 t -105.87 152.21 7.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 9.0 m -129.17 144.26 51.15 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -175.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.47 HD22 ' NE ' ' B' ' 140' ' ' ARG . 0.5 OUTLIER -113.79 52.54 0.81 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.527 175.119 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -59.48 97.09 0.04 OUTLIER 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.9 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -167.93 -2.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.622 ' OD1' ' HA2' ' B' ' 161' ' ' GLY . 0.4 OUTLIER -90.99 11.95 21.27 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.616 178.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -59.16 -14.38 10.26 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.438 ' N ' ' C ' ' B' ' 102' ' ' ASN . 13.7 t80 -85.67 -9.97 56.41 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.603 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' B' ' 102' ' ' ASN . . . -169.68 98.12 0.48 Allowed Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.423 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . 0.445 ' HA ' ' ND2' ' B' ' 102' ' ' ASN . 57.7 Cg_endo -76.3 -40.94 0.53 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.672 2.248 . . . . 0.0 111.875 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.17 -32.21 12.59 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.367 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.586 ' CD ' ' HZ1' ' B' ' 123' ' ' LYS . 1.9 mm-40 -89.8 49.67 1.76 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.485 0.659 . . . . 0.0 110.358 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.473 HD11 ' CG2' ' B' ' 120' ' ' ILE . 0.4 OUTLIER -129.36 135.22 48.44 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.575 178.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.7 121.95 34.92 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -100.32 131.64 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.448 ' NZ ' ' OG1' ' B' ' 121' ' ' THR . 0.0 OUTLIER -134.89 124.12 24.51 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.354 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.6 m -94.63 116.32 28.62 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' B' ' 116' ' ' GLY . 1.5 ttmp? -120.02 143.8 47.88 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -22.85 71.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' B' ' 114' ' ' LYS . . . 83.07 -2.51 86.79 Favored Glycine 0 N--CA 1.472 1.09 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' B' ' 114' ' ' LYS . 2.3 t -102.93 114.47 42.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 48.0 t -98.11 120.02 46.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 33.7 mt-10 -133.5 136.14 44.89 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.179 0.514 . . . . 0.0 110.62 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.473 ' CG2' HD11 ' B' ' 109' ' ' LEU . 3.2 mm -111.82 138.07 41.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.622 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' THR . . . . . 0.448 ' OG1' ' NZ ' ' B' ' 112' ' ' LYS . 0.2 OUTLIER -115.89 120.28 38.71 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.133 -179.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.8 135.64 5.51 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.768 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' LYS . . . . . 0.586 ' HZ1' ' CD ' ' B' ' 108' ' ' GLU . 0.2 OUTLIER -150.2 159.08 44.7 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.219 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . 0.488 ' CG ' ' HD2' ' B' ' 127' ' ' ARG . 2.0 t60 -132.72 156.34 47.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.674 0.273 . . . . 0.0 110.273 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.546 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.6 OUTLIER -92.24 131.68 37.27 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.346 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . 0.546 ' C ' ' O ' ' B' ' 125' ' ' GLU . 1.5 tt0 -3.11 97.7 0.01 OUTLIER 'General case' 0 C--N 1.344 0.334 0 O-C-N 123.751 0.657 . . . . 0.0 112.47 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' ARG . . . . . 0.488 ' HD2' ' CG ' ' B' ' 124' ' ' HIS . 31.5 mtp180 -90.16 146.9 23.93 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.095 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -88.8 131.78 34.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.325 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -134.71 163.36 29.96 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.052 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.65 -14.12 60.56 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.042 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' HIS . . . . . 0.521 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 69.2 m-70 -114.04 29.03 8.31 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.491 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.71 -153.12 17.36 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 119.728 -1.225 . . . . 0.0 111.611 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -112.89 127.94 56.33 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.29 123.48 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -175.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' SER . . . . . 0.543 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.1 OUTLIER -134.32 160.43 37.94 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 174.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . 0.478 ' HD2' ' CE2' ' B' ' 138' ' ' PHE . 10.4 ptp85 -156.85 166.07 34.42 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.563 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 27.5 p -117.84 136.42 53.44 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . 0.478 ' CE2' ' HD2' ' B' ' 136' ' ' ARG . 11.1 m-85 -106.89 138.18 43.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.276 -177.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.15 126.18 10.56 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.951 174.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . 0.47 ' NE ' HD22 ' B' ' 99' ' ' LEU . 0.0 OUTLIER -131.23 112.92 13.23 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . 0.403 ' HA ' ' HG2' ' B' ' 119' ' ' GLU . 11.3 ttmt -101.28 119.08 38.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.931 0.395 . . . . 0.0 110.556 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' TYR . . . . . 0.512 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 4.3 m-85 -109.48 97.58 7.12 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.429 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.0 OUTLIER -91.66 96.59 10.53 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 177.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.87 90.23 12.78 Favored Pre-proline 0 CA--C 1.514 -0.409 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.429 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.58 ' HD2' ' CD ' ' B' ' 146' ' ' PRO . 17.1 Cg_exo -68.49 -40.6 7.6 Favored 'Trans proline' 0 C--N 1.285 -2.793 0 C-N-CA 122.38 2.053 . . . . 0.0 112.127 168.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' PRO . . . . . 0.58 ' CD ' ' HD2' ' B' ' 145' ' ' PRO . 71.4 Cg_exo -43.07 -8.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 123.554 2.836 . . . . 0.0 114.194 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 134.69 64.77 0.07 OUTLIER Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 118.964 -1.588 . . . . 0.0 114.879 176.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' VAL . . . . . . . . . . . . . 1.1 t -123.74 108.55 21.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.365 172.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 149' ' ' ASP . 10.7 p-10 -76.9 127.89 82.79 Favored Pre-proline 0 N--CA 1.472 0.659 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.885 -176.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 3.0 Cg_exo -75.81 -30.47 6.03 Favored 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 122.156 1.904 . . . . 0.0 113.848 -173.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 1.2 p -76.64 -36.57 57.32 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.883 0.373 . . . . 0.0 110.889 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -101.74 1.81 37.78 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 42.2 t -96.15 103.12 14.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.777 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.14 177.28 4.89 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.4 138.98 33.36 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.423 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.97 132.43 54.22 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.464 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . 0.541 ' CD1' ' OD1' ' B' ' 102' ' ' ASN . 25.0 tp -125.57 142.13 51.67 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.055 0.455 . . . . 0.0 110.744 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.475 ' O ' ' N ' ' B' ' 161' ' ' GLY . 0.2 OUTLIER -132.51 141.01 39.66 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.172 178.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' B' ' 161' ' ' GLY . 73.2 Cg_exo -38.35 -35.27 0.43 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 123.18 2.587 . . . . 0.0 112.448 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.57 -5.07 1.07 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.612 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' GLY . . . . . 0.622 ' HA2' ' OD1' ' B' ' 102' ' ' ASN . . . 76.08 33.0 51.21 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.662 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' THR . . . . . 0.426 ' O ' HG21 ' B' ' 162' ' ' THR . 15.1 t -98.7 114.97 27.7 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.14 0.495 . . . . 0.0 110.377 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' B' ' 98' ' ' SER . 1.9 tm? -109.2 102.93 11.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.103 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.94 126.96 43.59 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 3.6 m -108.33 108.05 24.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 174.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 0.8 OUTLIER -117.34 143.13 46.28 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.278 -174.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -171.2 157.25 4.8 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-O 121.088 0.47 . . . . 0.0 111.995 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . 0.4 ' O ' ' CE ' ' B' ' 171' ' ' LYS . 83.6 Cg_endo -80.1 -18.07 10.22 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 123.443 2.762 . . . . 0.0 110.933 176.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' MET . . . . . 0.654 ' SD ' ' HB2' ' B' ' 95' ' ' TRP . 0.0 OUTLIER 60.36 158.09 0.11 Allowed Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.929 176.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -82.64 11.77 3.11 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.707 2.272 . . . . 0.0 111.476 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' LYS . . . . . 0.413 ' HZ2' ' CG ' ' B' ' 93' ' ' ASP . 0.4 OUTLIER 38.6 54.76 1.91 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.359 0.599 . . . . 0.0 110.439 -179.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.68 50.86 0.13 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.267 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' B' ' 175' ' ' GLN . . . 46.31 39.24 6.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.879 0.371 . . . . 0.0 110.37 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 1.9 m -63.0 57.87 0.01 OUTLIER 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.512 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' GLN . . . . . 0.547 ' N ' ' O ' ' B' ' 173' ' ' ALA . 0.1 OUTLIER -110.34 -36.12 5.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.348 -179.382 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.207 -1.182 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.411 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -68.21 -4.64 14.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.366 . . . . 0.0 110.403 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.1 mt -66.46 71.58 0.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.637 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.17 -25.41 13.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.92 0.39 . . . . 0.0 110.005 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.87 157.49 33.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.916 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 144.04 -50.08 0.68 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.41 154.33 24.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.712 0.292 . . . . 0.0 110.39 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.3 m -66.08 111.7 3.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.447 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.505 ' CD ' HH21 ' A' ' 89' ' ' ARG . 12.9 mt-10 -59.02 143.42 48.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.236 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.48 ' O ' ' NH2' ' A' ' 94' ' ' ARG . 1.2 mt -39.84 -40.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.383 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.505 HH21 ' CD ' ' A' ' 87' ' ' GLU . 0.6 OUTLIER -60.6 -22.78 64.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.835 -179.167 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.476 ' CE1' ' H ' ' A' ' 87' ' ' GLU . 16.3 m170 -58.58 146.92 34.16 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.774 0.321 . . . . 0.0 110.571 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.52 50.88 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.116 0.484 . . . . 0.0 111.27 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.45 ' O ' ' NE ' ' A' ' 94' ' ' ARG . . . -90.3 104.4 16.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.351 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 48.52 93.93 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.658 0.599 . . . . 0.0 111.247 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.48 ' NH2' ' O ' ' A' ' 88' ' ' ILE . 11.7 mmt85 -140.24 133.23 29.35 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.732 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.502 ' CH2' HG23 ' A' ' 148' ' ' VAL . 0.0 OUTLIER -91.64 151.98 20.45 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.207 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.64 98.87 3.26 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.432 -177.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.441 HG23 ' CZ3' ' A' ' 95' ' ' TRP . 2.0 t -111.65 150.66 13.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.1 139.48 51.17 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.483 HD23 HG12 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -115.08 74.0 0.86 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.741 175.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.437 ' OD1' ' NH2' ' A' ' 140' ' ' ARG . 12.0 p-10 -70.8 112.96 7.4 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.579 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -173.25 -40.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.565 ' ND2' ' O ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -41.32 -19.64 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.462 -1.699 . . . . 0.0 110.815 178.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 101' ' ' VAL . 5.0 t60 -45.67 -33.89 3.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.41 ' CZ ' ' NH1' ' A' ' 136' ' ' ARG . 52.6 m-85 -83.94 12.37 6.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.7 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 102' ' ' ASN . . . -179.19 96.71 0.2 Allowed Pre-proline 0 C--N 1.333 -0.143 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.55 ' HA ' HD22 ' A' ' 102' ' ' ASN . 47.6 Cg_endo -70.99 -48.5 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.452 2.101 . . . . 0.0 111.209 176.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -99.44 -30.93 11.91 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.038 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -81.63 47.98 1.13 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.02 0.438 . . . . 0.0 110.245 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.471 HD23 HD23 ' A' ' 157' ' ' LEU . 0.4 OUTLIER -131.57 138.54 48.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.255 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -128.38 123.03 32.82 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.631 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.81 122.38 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.423 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -127.6 134.78 49.68 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.817 -178.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 m -102.84 118.06 36.01 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.587 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.2 OUTLIER -115.84 83.16 1.89 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.219 0.533 . . . . 0.0 110.335 -176.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.4 t0 30.46 68.24 0.1 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.445 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.34 -23.08 29.19 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.587 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 2.7 t -87.97 117.3 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 42.1 t -101.42 116.45 45.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 140' ' ' ARG . 8.9 mt-10 -133.1 134.16 43.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.941 0.401 . . . . 0.0 111.206 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.483 HG12 HD23 ' A' ' 99' ' ' LEU . 4.4 mm -106.33 142.65 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.863 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.423 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -123.64 115.46 21.5 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.201 -178.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.16 127.8 2.51 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.222 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.41 130.13 27.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.536 ' ND1' ' N ' ' A' ' 125' ' ' GLU . 48.7 t-80 -92.6 161.44 14.59 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.222 0.534 . . . . 0.0 111.744 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.536 ' N ' ' ND1' ' A' ' 124' ' ' HIS . 0.0 OUTLIER -87.46 149.26 24.53 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.892 177.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.501 ' CD ' ' HZ3' ' B' ' 141' ' ' LYS . 4.8 tt0 -28.72 98.79 0.01 OUTLIER 'General case' 0 C--N 1.348 0.542 0 CA-C-O 120.915 0.388 . . . . 0.0 111.21 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.541 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 2.3 mtp-105 -83.35 146.0 28.73 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.852 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -86.03 123.83 31.79 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.75 172.19 12.27 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.869 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -71.04 -37.59 72.55 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -175.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -114.98 42.85 2.09 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.18 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.25 168.96 12.47 Favored Glycine 0 C--N 1.306 -1.114 0 C-N-CA 119.995 -1.097 . . . . 0.0 110.929 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -96.42 109.16 21.75 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 172.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.523 ' CD1' ' NH2' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -129.6 119.02 46.94 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -170.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.49 ' HG ' ' C ' ' A' ' 125' ' ' GLU . 4.1 m -127.15 154.74 44.39 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.523 ' NH2' ' CD1' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -141.51 -179.33 6.09 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.935 -175.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 27.8 p -129.34 123.4 31.67 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.401 ' CD2' ' CG1' ' A' ' 101' ' ' VAL . 4.4 m-85 -100.14 140.15 34.78 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.309 -176.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.72 117.53 11.65 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.489 0.662 . . . . 0.0 111.052 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 119' ' ' GLU . 2.0 mtt180 -108.05 143.33 36.92 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.337 177.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.555 ' HZ3' ' HB2' ' A' ' 141' ' ' LYS . 7.7 ttmm -138.36 112.95 8.89 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.989 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.483 ' HB2' ' HB ' ' A' ' 118' ' ' VAL . 2.0 m-85 -114.72 99.83 7.8 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.102 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.488 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.0 OUTLIER -91.06 91.31 8.23 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mp -112.24 89.99 13.19 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.717 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.591 ' HD2' ' CD ' ' A' ' 146' ' ' PRO . 11.8 Cg_exo -72.22 -50.88 0.23 Allowed 'Trans proline' 0 C--N 1.287 -2.708 0 C-N-CA 122.461 2.107 . . . . 0.0 113.591 171.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.591 ' CD ' ' HD2' ' A' ' 145' ' ' PRO . 24.7 Cg_exo -55.34 -14.53 9.48 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.67 2.247 . . . . 0.0 115.401 -174.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.68 43.07 0.13 Allowed Glycine 0 C--N 1.341 0.818 0 C-N-CA 116.833 -2.603 . . . . 0.0 116.378 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.502 HG23 ' CH2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -135.25 131.29 51.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 117.859 0.829 . . . . 0.0 110.561 171.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -95.59 143.59 26.37 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.321 -178.606 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 6.1 Cg_exo -80.32 -47.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.334 2.023 . . . . 0.0 113.231 -176.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -37.6 59.95 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.739 -175.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.42 11.68 27.58 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -172.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.433 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 40.7 t -108.64 115.25 48.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.938 0.399 . . . . 0.0 110.16 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.94 177.32 4.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.294 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.3 143.55 35.91 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.789 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.11 144.97 42.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.471 HD23 HD23 ' A' ' 109' ' ' LEU . 34.7 tp -138.14 136.86 37.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.808 0.337 . . . . 0.0 111.196 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.401 ' H ' HD11 ' A' ' 157' ' ' LEU . 0.3 OUTLIER -117.09 149.48 44.38 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.68 178.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -40.38 -43.91 4.12 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 123.205 2.603 . . . . 0.0 112.206 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -53.33 -14.94 0.83 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.832 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.508 ' O ' ' HB3' ' A' ' 102' ' ' ASN . . . 85.02 33.13 18.97 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.797 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 2.0 t -96.18 128.51 43.15 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.411 ' C ' ' CD1' ' A' ' 163' ' ' LEU . 1.8 tm? -118.15 107.78 14.38 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.857 -175.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.2 p -99.22 127.86 45.26 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.419 HG23 ' CZ2' ' A' ' 95' ' ' TRP . 4.4 m -105.26 98.34 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 173.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -114.33 141.39 47.66 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.671 -174.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . . . 177.5 167.8 0.49 Allowed Pre-proline 0 C--O 1.234 0.281 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.34 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -90.3 121.58 0.9 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 123.943 3.095 . . . . 0.0 109.404 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.16 166.38 11.34 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-O 121.073 0.463 . . . . 0.0 112.067 -173.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -49.97 -71.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.879 2.386 . . . . 0.0 112.188 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -175.53 162.29 2.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.101 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -85.81 145.78 27.06 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -110.61 -121.41 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.482 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 176' ' ' SER . 0.0 OUTLIER -49.63 -46.08 49.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.723 0.297 . . . . 0.0 110.728 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.13 -65.83 0.21 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.674 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 174' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.211 -0.966 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.588 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -153.94 -81.16 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.106 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 51.2 mt 58.02 -157.13 0.31 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.765 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.28 176.58 9.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.851 0.357 . . . . 0.0 111.079 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.3 119.51 17.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.859 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.61 -138.28 48.4 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.926 -0.469 . . . . 0.0 111.926 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 2.2 t 71.13 124.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 122.753 0.421 . . . . 0.0 110.676 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 1.7 m -65.96 84.39 0.08 Allowed 'General case' 0 C--O 1.243 0.711 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.17 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.13 -169.37 0.09 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.132 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.506 ' C ' ' H ' ' B' ' 90' ' ' HIS . 0.6 OUTLIER -42.53 131.46 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.41 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -68.91 44.91 0.05 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.966 0.412 . . . . 0.0 110.581 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' HIS . . . . . 0.506 ' H ' ' C ' ' B' ' 88' ' ' ILE . 0.1 OUTLIER -89.18 -50.29 6.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.452 178.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 9.2 t -172.71 -165.53 0.32 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.853 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 35.33 62.51 0.58 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.102 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.561 ' CG ' ' H ' ' B' ' 94' ' ' ARG . 9.6 p-10 -81.73 -125.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . 0.561 ' H ' ' CG ' ' B' ' 93' ' ' ASP . 9.0 mmt180 -149.75 97.95 2.68 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' TRP . . . . . 0.462 ' CH2' HG23 ' B' ' 148' ' ' VAL . 0.0 OUTLIER -72.47 153.83 41.17 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -152.02 105.3 3.07 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.577 -174.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 t -121.05 154.69 24.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 15.2 m -127.13 144.23 51.08 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.53 HD21 ' NE ' ' B' ' 140' ' ' ARG . 0.3 OUTLIER -114.05 122.78 47.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.53 174.114 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -112.72 114.75 27.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.119 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . 0.645 ' C ' ' H ' ' B' ' 103' ' ' HIS . 0.1 OUTLIER -169.56 -56.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.793 0.806 . . . . 0.0 110.378 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.572 ' OD1' ' CD1' ' B' ' 109' ' ' LEU . 0.0 OUTLIER -56.66 14.09 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.565 -177.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.645 ' H ' ' C ' ' B' ' 101' ' ' VAL . 19.2 m170 -46.68 -28.99 1.66 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.97 0.414 . . . . 0.0 110.331 178.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.417 ' HB3' ' CD2' ' B' ' 124' ' ' HIS . 24.8 t80 -120.04 24.18 10.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.711 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.02 91.15 4.92 Favored Pre-proline 0 CA--C 1.513 -0.467 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.168 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.88 -45.99 0.11 Allowed 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.447 2.098 . . . . 0.0 110.86 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' B' ' 107' ' ' ASP . 8.2 p-10 -98.58 -31.25 12.05 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.77 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.85 48.97 1.53 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.779 0.8 . . . . 0.0 110.248 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.572 ' CD1' ' OD1' ' B' ' 102' ' ' ASN . 0.4 OUTLIER -138.2 139.34 39.25 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.663 178.067 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.503 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -132.05 113.52 13.46 Favored 'General case' 0 C--N 1.31 -1.116 0 O-C-N 123.352 0.407 . . . . 0.0 110.091 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.81 119.09 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -129.75 129.41 44.1 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.454 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.1 m -98.05 122.91 41.76 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.462 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 0.3 OUTLIER -111.99 -162.17 0.79 Allowed 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -178.286 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' B' ' 117' ' ' VAL . 2.8 p-10 -65.07 69.49 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.368 0.604 . . . . 0.0 112.174 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.25 -8.43 39.42 Favored Glycine 0 CA--C 1.499 -0.934 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' B' ' 114' ' ' LYS . 2.1 t -88.64 115.4 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.68 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 41.4 t -98.59 118.87 45.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.629 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 41.1 mt-10 -133.77 143.46 48.44 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.282 0.563 . . . . 0.0 110.835 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.496 HG12 ' CD2' ' B' ' 99' ' ' LEU . 2.4 mm -115.61 140.2 38.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.12 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.55 111.87 19.15 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.57 145.69 13.93 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.59 -177.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.51 159.72 43.78 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . 0.524 ' O ' ' HB3' ' B' ' 135' ' ' SER . 3.7 m-70 -116.92 137.51 52.17 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.208 -177.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.5 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.5 OUTLIER -69.67 138.0 52.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.306 178.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' B' ' 125' ' ' GLU . 1.0 OUTLIER -17.21 98.37 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' ARG . . . . . 0.405 ' NH1' ' CE1' ' B' ' 104' ' ' PHE . 6.8 mtp85 -83.77 149.54 26.37 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.289 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' GLN . . . . . 0.545 ' HG2' ' N ' ' B' ' 129' ' ' ASP . 3.9 tt0 -99.72 151.87 20.74 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.14 0.495 . . . . 0.0 111.174 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . 0.545 ' N ' ' HG2' ' B' ' 128' ' ' GLN . 19.6 t70 -161.38 169.29 22.26 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.514 175.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . 0.498 ' N ' ' CG ' ' B' ' 129' ' ' ASP . 4.2 tp10 -80.65 -11.42 59.64 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.435 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' HIS . . . . . 0.418 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 55.5 m-70 -115.93 31.41 6.74 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.251 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.55 164.16 11.86 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.672 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' TYR . . . . . 0.404 ' CE2' ' HG3' ' B' ' 128' ' ' GLN . 69.5 m-85 -95.68 139.32 32.09 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.06 126.38 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -170.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' SER . . . . . 0.524 ' HB3' ' O ' ' B' ' 124' ' ' HIS . 0.0 OUTLIER -128.98 157.78 40.71 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -154.06 159.59 41.61 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.336 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 21.4 p -112.96 138.1 50.35 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.59 149.13 41.88 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.822 -176.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.74 134.51 17.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.678 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . 0.53 ' NE ' HD21 ' B' ' 99' ' ' LEU . 0.0 OUTLIER -135.8 107.62 7.06 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . 0.629 ' HA ' ' HG2' ' B' ' 119' ' ' GLU . 32.2 ttmt -96.86 113.94 25.52 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.038 0.447 . . . . 0.0 110.996 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' TYR . . . . . 0.447 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 2.4 m-85 -104.29 98.86 8.6 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.195 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.427 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.2 OUTLIER -92.53 96.81 10.44 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.1 mp -113.25 90.48 16.78 Favored Pre-proline 0 CA--C 1.511 -0.538 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.12 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.58 ' HD2' ' CD ' ' B' ' 146' ' ' PRO . 15.9 Cg_exo -69.88 -42.89 2.9 Favored 'Trans proline' 0 C--N 1.277 -3.2 0 C-N-CA 122.19 1.927 . . . . 0.0 112.679 169.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' PRO . . . . . 0.58 ' CD ' ' HD2' ' B' ' 145' ' ' PRO . 76.3 Cg_exo -42.82 -15.83 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 123.001 2.467 . . . . 0.0 114.333 -176.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 151.76 58.13 0.01 OUTLIER Glycine 0 C--N 1.343 0.972 0 C-N-CA 118.199 -1.953 . . . . 0.0 115.201 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' VAL . . . . . 0.462 HG23 ' CH2' ' B' ' 95' ' ' TRP . 0.9 OUTLIER -123.34 113.1 36.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.573 172.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 24.4 t70 -77.44 137.91 63.66 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.569 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 5.3 Cg_exo -81.12 -23.8 5.06 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.122 1.881 . . . . 0.0 112.891 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.33 -41.24 11.63 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.269 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -97.42 15.5 22.91 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 30.6 t -103.91 117.2 49.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.01 171.1 7.8 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.29 130.79 33.49 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.423 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' SER . . . . . 0.547 ' CB ' ' HG1' ' B' ' 164' ' ' THR . 0.0 OUTLIER -100.05 134.79 42.44 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.652 176.546 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . 0.465 HD22 ' CD2' ' B' ' 109' ' ' LEU . 29.8 tp -128.36 131.55 48.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.939 0.399 . . . . 0.0 110.652 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.41 149.97 45.66 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.349 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' B' ' 161' ' ' GLY . 85.5 Cg_exo -42.6 -34.34 3.32 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.419 2.079 . . . . 0.0 110.686 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.97 29.56 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.38 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' GLY . . . . . 0.617 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 34.98 34.1 0.04 OUTLIER Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.585 0.612 . . . . 0.0 112.927 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 9.0 t -97.2 117.06 30.55 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' B' ' 98' ' ' SER . 2.7 tm? -108.21 103.08 12.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.505 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 0.547 ' HG1' ' CB ' ' B' ' 156' ' ' SER . 0.5 OUTLIER -92.08 124.46 36.19 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 121.246 -0.181 . . . . 0.0 110.637 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' B' ' 165' ' ' VAL . 3.1 m -105.83 109.63 28.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.42 ' OE1' ' NH1' ' B' ' 94' ' ' ARG . 1.8 pp20? -120.2 154.99 34.05 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.601 -176.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . 177.93 157.02 0.54 Allowed Pre-proline 0 CA--C 1.518 -0.25 0 CA-C-O 120.989 0.423 . . . . 0.0 111.212 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . 0.546 ' C ' ' HG3' ' B' ' 169' ' ' MET . 81.5 Cg_endo -80.41 -24.24 5.52 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.905 2.403 . . . . 0.0 110.043 174.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' MET . . . . . 0.546 ' HG3' ' C ' ' B' ' 168' ' ' PRO . 0.5 OUTLIER 41.42 176.23 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.528 -1.214 . . . . 0.0 113.131 175.469 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' B' ' 172' ' ' LEU . 7.4 Cg_exo -71.87 75.26 2.2 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.166 1.911 . . . . 0.0 109.257 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' LYS . . . . . 0.457 ' HG3' ' H ' ' B' ' 93' ' ' ASP . 0.1 OUTLIER -57.84 68.32 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.27 -175.056 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.553 ' N ' ' O ' ' B' ' 170' ' ' PRO . 10.9 mt -94.16 162.53 13.82 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' B' ' 175' ' ' GLN . . . -82.08 21.32 0.9 Allowed 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.994 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.64 41.22 0.03 OUTLIER 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.975 0.417 . . . . 0.0 111.373 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' GLN . . . . . 0.509 ' H ' ' C ' ' B' ' 173' ' ' ALA . 34.8 mt-30 -68.45 -60.63 2.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.216 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.204 -1.312 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.313 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.491 ' N ' ' SD ' ' A' ' 79' ' ' MET . 4.7 mpp? . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -55.11 -34.71 63.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.879 0.371 . . . . 0.0 110.367 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -95.14 -72.03 0.64 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.133 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.422 ' OG ' ' N ' ' A' ' 79' ' ' MET . 1.3 m 49.95 -146.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.87 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.37 175.19 5.56 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.58 37.65 0.32 Allowed Glycine 0 C--N 1.32 -0.345 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 87' ' ' GLU . 11.4 t -144.91 143.96 22.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.6 m 67.34 -56.41 0.45 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.361 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.487 ' O ' ' N ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -91.85 -78.61 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.218 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.405 ' H ' ' CD ' ' A' ' 87' ' ' GLU . 0.8 OUTLIER 64.81 -56.91 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -177.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -112.59 78.07 1.1 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.28 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.453 ' CD2' ' HB2' ' A' ' 87' ' ' GLU . 10.0 m80 -53.84 -53.49 51.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.128 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.28 73.39 0.18 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.051 0.453 . . . . 0.0 110.642 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.78 159.22 1.71 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.744 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 168' ' ' PRO . 0.4 OUTLIER -62.57 138.11 58.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.791 179.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.402 HH21 ' CD ' ' A' ' 166' ' ' GLU . 8.8 mmm180 -102.61 113.66 27.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.896 0.379 . . . . 0.0 110.09 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.592 ' NE1' ' CG2' ' A' ' 97' ' ' VAL . 46.8 t-105 -86.7 142.87 27.88 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 -136.42 117.13 13.99 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.592 ' CG2' ' NE1' ' A' ' 95' ' ' TRP . 1.1 t -132.09 158.2 43.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.578 175.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 3.0 m -130.48 157.61 42.17 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -175.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.502 HD23 HG12 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -136.79 94.52 2.99 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.632 175.458 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -97.08 119.38 35.45 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.312 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.614 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -174.34 -50.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.643 0.735 . . . . 0.0 110.649 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.527 ' OD1' ' CD1' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -54.52 17.68 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.708 -1.133 . . . . 0.0 113.761 -176.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.614 ' H ' ' C ' ' A' ' 101' ' ' VAL . 57.5 m-70 -39.33 -50.1 2.01 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.009 0.433 . . . . 0.0 111.198 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -92.05 -6.13 51.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.901 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -116.88 90.32 32.03 Favored Pre-proline 0 CA--C 1.511 -0.534 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.633 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.32 -51.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.461 2.107 . . . . 0.0 110.922 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 109' ' ' LEU . 12.9 t70 -95.02 -31.18 13.72 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.432 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.451 ' N ' ' CD ' ' A' ' 108' ' ' GLU . 20.0 mp0 -77.88 28.87 0.17 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.161 0.505 . . . . 0.0 110.927 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.527 ' CD1' ' OD1' ' A' ' 102' ' ' ASN . 0.8 OUTLIER -114.51 134.9 54.68 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 176.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.87 113.27 18.29 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.092 -178.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.4 129.13 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -140.35 134.22 30.6 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.138 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.56 119.94 35.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 176.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.569 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.3 OUTLIER -116.59 80.75 1.51 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.252 0.549 . . . . 0.0 110.059 -177.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.2 t70 29.5 65.54 0.12 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.717 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.407 ' HA2' HG12 ' A' ' 148' ' ' VAL . . . 97.77 -24.21 32.63 Favored Glycine 0 C--N 1.313 -0.707 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 178.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 2.2 t -88.16 115.76 28.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.239 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 59.1 t -101.98 115.65 44.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.681 ' CD ' ' HZ3' ' A' ' 141' ' ' LYS . 66.5 mt-10 -130.61 142.32 50.45 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.467 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.502 HG12 HD23 ' A' ' 99' ' ' LEU . 3.5 mm -111.81 142.51 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.763 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.25 117.85 26.24 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.648 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.09 135.61 5.33 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.925 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.0 144.92 25.2 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.066 0.946 . . . . 0.0 108.503 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.479 ' HB3' ' NH2' ' A' ' 127' ' ' ARG . 49.9 t60 -115.69 165.79 12.65 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.834 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.515 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.7 OUTLIER -90.16 132.54 35.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.689 -178.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.515 ' C ' ' O ' ' A' ' 125' ' ' GLU . 11.7 tt0 -7.58 111.82 0.01 OUTLIER 'General case' 0 C--N 1.348 0.509 0 C-N-CA 123.326 0.65 . . . . 0.0 112.638 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.479 ' NH2' ' HB3' ' A' ' 124' ' ' HIS . 26.4 mtm180 -107.63 112.96 25.93 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.039 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.23 133.87 52.44 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -140.37 172.14 13.15 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.743 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.57 -24.59 63.72 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.159 0.504 . . . . 0.0 111.18 -177.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -109.78 39.53 2.1 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.859 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.18 172.65 19.59 Favored Glycine 0 C--N 1.301 -1.367 0 C-N-CA 119.537 -1.316 . . . . 0.0 111.092 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -94.75 117.22 29.78 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 172.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.436 HG22 HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -131.57 123.16 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -171.234 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.18 164.19 26.07 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.3 ptt180 -150.5 177.14 10.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.115 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 25.6 p -120.52 148.44 43.84 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -121.81 128.5 51.75 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.296 -179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.08 120.12 24.16 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.304 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.579 ' NH2' ' OH ' ' A' ' 142' ' ' TYR . 1.2 mmm180 -117.9 139.36 51.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.681 ' HZ3' ' CD ' ' A' ' 119' ' ' GLU . 12.9 ttmm -133.38 110.6 10.14 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.847 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.579 ' OH ' ' NH2' ' A' ' 140' ' ' ARG . 30.0 m-85 -106.07 99.26 8.86 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.444 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -90.54 89.14 7.43 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.528 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.3 mp -112.41 92.3 18.99 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.575 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 16.7 Cg_exo -67.65 -55.87 0.25 Allowed 'Trans proline' 0 C--N 1.288 -2.625 0 C-N-CA 122.139 1.893 . . . . 0.0 113.045 175.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.575 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 56.5 Cg_endo -100.93 76.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.329 -0.491 0 C-N-CA 123.271 2.647 . . . . 0.0 112.251 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 164.5 -17.43 0.11 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.49 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.407 HG12 ' HA2' ' A' ' 116' ' ' GLY . 1.0 OUTLIER -125.81 126.75 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 117.599 0.699 . . . . 0.0 111.045 178.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -87.1 145.28 37.81 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.637 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.86 -28.79 2.42 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.872 1.715 . . . . 0.0 112.567 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.61 -41.31 10.83 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.632 -174.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -98.77 22.54 9.92 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -172.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.492 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 39.9 t -103.6 119.74 52.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.093 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.402 ' C ' ' HG ' ' A' ' 155' ' ' SER . 0.2 OUTLIER -102.33 179.48 4.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.52 -179.165 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.402 ' HG ' ' C ' ' A' ' 154' ' ' SER . 0.9 OUTLIER -158.81 124.86 4.5 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.419 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.25 139.21 39.59 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.306 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.44 HD13 ' H ' ' A' ' 158' ' ' SER . 30.7 tp -131.62 135.35 46.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.315 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.44 ' H ' HD13 ' A' ' 157' ' ' LEU . 0.4 OUTLIER -121.56 150.97 56.12 Favored Pre-proline 0 C--N 1.313 -0.995 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.619 ' C ' ' H ' ' A' ' 161' ' ' GLY . 82.3 Cg_exo -41.28 -35.51 2.17 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.323 2.015 . . . . 0.0 110.738 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.408 ' O ' ' N ' ' A' ' 162' ' ' THR . 1.8 mp0 -67.28 28.76 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.485 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.619 ' H ' ' C ' ' A' ' 159' ' ' PRO . . . 35.73 31.45 0.03 OUTLIER Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.636 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 160' ' ' GLU . 14.0 t -91.35 115.29 27.91 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 98' ' ' SER . 2.9 tm? -109.05 104.03 13.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.687 -176.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -95.28 123.39 38.77 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.597 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.474 ' O ' ' CG2' ' A' ' 165' ' ' VAL . 2.9 m -107.29 99.23 8.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 1.7 pp20? -118.38 150.83 38.88 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.822 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.492 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . . . 174.08 167.74 0.31 Allowed Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.255 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 93' ' ' ASP . 73.9 Cg_endo -88.1 117.48 1.07 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 123.619 2.879 . . . . 0.0 108.9 175.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.489 ' CB ' ' CD ' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -109.21 175.07 2.09 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.407 -172.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 169' ' ' MET . 14.1 Cg_exo -65.15 116.52 3.9 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.932 2.421 . . . . 0.0 110.692 178.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.442 ' CB ' ' HZ2' ' A' ' 171' ' ' LYS . 0.0 OUTLIER -54.27 99.94 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.658 -179.247 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.67 178.52 6.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.169 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.03 -101.02 0.18 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.377 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.07 -161.59 0.76 Allowed 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.475 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.447 ' C ' ' HG ' ' A' ' 176' ' ' SER . 2.3 mm100 57.65 -174.75 0.08 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.235 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.447 ' HG ' ' C ' ' A' ' 175' ' ' GLN . 0.7 OUTLIER . . . . . 0 C--O 1.212 -0.917 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.401 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' MET . . . . . . . . . . . . . 9.4 mmt . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -64.5 -15.54 61.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.682 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.524 ' C ' ' H ' ' B' ' 83' ' ' SER . 2.6 mp 58.94 -164.25 0.21 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.752 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.53 40.94 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.716 0.293 . . . . 0.0 110.835 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' SER . . . . . 0.524 ' H ' ' C ' ' B' ' 81' ' ' LEU . 0.7 OUTLIER -114.24 121.1 42.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.813 0.34 . . . . 0.0 110.325 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.34 -66.25 0.39 Allowed Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' B' ' 83' ' ' SER . 0.3 OUTLIER 40.09 36.64 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.928 0.394 . . . . 0.0 110.486 179.595 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -43.5 -43.13 5.26 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.87 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.87 178.32 3.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.84 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.491 ' O ' ' NE ' ' B' ' 89' ' ' ARG . 35.3 pt -60.15 -25.39 33.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.482 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.491 ' NE ' ' O ' ' B' ' 88' ' ' ILE . 0.0 OUTLIER -157.69 -95.33 0.03 OUTLIER 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.459 0.647 . . . . 0.0 110.119 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' HIS . . . . . 0.408 ' O ' ' C ' ' B' ' 91' ' ' THR . 0.2 OUTLIER -154.9 96.7 1.88 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.408 ' C ' ' O ' ' B' ' 90' ' ' HIS . 33.0 p 38.4 -109.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.064 -175.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 41.67 27.71 0.07 Allowed 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.069 0.461 . . . . 0.0 110.702 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' B' ' 168' ' ' PRO . 41.8 p-10 -106.95 22.28 16.23 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.562 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -107.05 137.67 44.69 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.602 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' TRP . . . . . 0.609 ' HB2' ' SD ' ' B' ' 169' ' ' MET . 28.2 t-105 -125.67 152.72 44.86 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -145.53 102.41 3.69 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.269 -177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.504 ' CG2' ' NE1' ' B' ' 95' ' ' TRP . 0.2 OUTLIER -116.0 157.88 16.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.021 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 2.3 m -130.25 148.84 52.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.501 HD23 ' CE1' ' B' ' 142' ' ' TYR . 0.3 OUTLIER -122.58 117.85 26.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.128 174.747 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.99 115.35 27.5 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -167.72 -34.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.561 ' OD1' ' HA2' ' B' ' 161' ' ' GLY . 0.4 OUTLIER -80.8 16.6 1.38 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -174.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.545 ' N ' ' HA3' ' B' ' 161' ' ' GLY . 11.5 m80 -43.03 -39.91 2.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.105 0.478 . . . . 0.0 110.174 177.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -92.41 -1.14 57.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.251 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . 0.512 ' C ' HD21 ' B' ' 102' ' ' ASN . . . -135.11 77.47 55.43 Favored Pre-proline 0 CA--C 1.511 -0.538 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.9 -38.17 3.15 Favored 'Trans proline' 0 C--N 1.295 -2.272 0 C-N-CA 122.48 2.12 . . . . 0.0 110.92 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -96.04 -26.86 15.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.003 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -95.85 49.02 1.14 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.111 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.497 ' CD1' ' HB3' ' B' ' 102' ' ' ASN . 0.5 OUTLIER -125.18 143.69 50.82 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.174 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.422 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -139.04 112.37 8.14 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.371 -177.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.55 125.6 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -133.62 133.25 41.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.758 0.313 . . . . 0.0 111.293 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.16 122.58 39.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' B' ' 117' ' ' VAL . 2.5 ttpt -126.37 91.44 3.37 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-O 120.847 0.356 . . . . 0.0 110.881 -176.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' B' ' 117' ' ' VAL . 6.7 p-10 34.58 66.55 0.28 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.07 -15.59 8.38 Favored Glycine 0 C--N 1.307 -1.055 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' B' ' 114' ' ' LYS . 7.2 t -87.44 114.36 26.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 42.8 t -99.25 121.05 49.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.135 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.429 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 76.8 mt-10 -130.27 140.11 50.71 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.303 0.573 . . . . 0.0 111.025 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 1.3 mp -114.96 117.04 54.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.093 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.83 120.0 37.44 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.02 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -146.68 126.95 2.58 Favored Glycine 0 N--CA 1.452 -0.272 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' LYS . . . . . 0.414 ' C ' ' HD1' ' B' ' 124' ' ' HIS . 0.4 OUTLIER -133.11 159.35 40.37 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.424 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . 0.428 ' CB ' ' HD2' ' B' ' 127' ' ' ARG . 3.6 m-70 -123.05 130.9 53.39 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.245 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' B' ' 126' ' ' GLU . 4.5 tp10 -70.79 137.62 49.71 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . 0.562 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 5.1 tt0 -11.91 99.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.481 0.488 . . . . 0.0 111.737 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' ARG . . . . . 0.573 ' HB2' ' NH1' ' B' ' 127' ' ' ARG . 0.2 OUTLIER -89.12 128.86 35.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.499 -178.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -75.53 127.43 33.08 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -138.27 164.72 28.51 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -70.49 -36.0 73.58 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.965 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' HIS . . . . . 0.483 ' O ' ' OH ' ' A' ' 142' ' ' TYR . 73.0 m-70 -100.16 40.36 1.25 Allowed 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 120.669 0.271 . . . . 0.0 110.572 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 114.46 174.16 18.35 Favored Glycine 0 C--N 1.299 -1.473 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.251 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -95.09 114.7 26.53 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . 0.548 HD13 ' NH2' ' B' ' 136' ' ' ARG . 0.0 OUTLIER -127.35 118.6 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -173.031 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' SER . . . . . 0.562 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.3 OUTLIER -126.61 154.8 43.46 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.004 176.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . 0.548 ' NH2' HD13 ' B' ' 134' ' ' ILE . 9.8 ptp85 -144.85 163.59 33.62 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.943 0.401 . . . . 0.0 111.483 -177.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 30.3 p -117.79 130.3 56.21 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -104.06 144.04 32.09 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.456 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.39 113.71 6.63 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.75 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . 0.493 ' NH2' ' OH ' ' B' ' 142' ' ' TYR . 0.0 OUTLIER -121.13 119.15 31.57 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . 0.469 ' HZ2' ' CD ' ' A' ' 126' ' ' GLU . 11.9 ttmt -110.81 121.37 45.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.945 0.403 . . . . 0.0 110.747 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' TYR . . . . . 0.501 ' CE1' HD23 ' B' ' 99' ' ' LEU . 1.7 m-85 -109.28 99.53 8.78 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.975 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.531 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.3 OUTLIER -90.29 99.69 12.66 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.141 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 7.4 mp -109.59 94.54 16.75 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' B' ' 147' ' ' GLY . 24.7 Cg_exo -66.21 -38.56 20.8 Favored 'Trans proline' 0 C--N 1.287 -2.678 0 C-N-CA 123.151 2.567 . . . . 0.0 114.513 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 34.4 Cg_exo -42.91 -13.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 121.458 1.439 . . . . 0.0 111.746 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 113.66 42.62 0.86 Allowed Glycine 0 C--N 1.343 0.943 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.52 172.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' VAL . . . . . 0.471 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -57.13 101.32 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . 0.494 ' O ' ' CG2' ' B' ' 153' ' ' VAL . 14.5 t0 -41.77 119.12 2.01 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.869 -172.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 5.2 Cg_exo -74.96 -26.54 10.91 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.23 1.953 . . . . 0.0 112.027 -178.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.56 -32.41 16.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.007 -177.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -107.31 19.2 20.64 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -175.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . 0.511 ' HA ' ' HB3' ' B' ' 167' ' ' ALA . 27.9 t -105.46 95.37 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.324 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.05 -173.9 4.24 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.74 138.38 10.63 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.734 -0.786 . . . . 0.0 112.056 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.14 136.38 47.09 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.053 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . 0.412 HD11 ' OD1' ' B' ' 102' ' ' ASN . 25.5 tp -124.95 131.58 53.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.908 0.385 . . . . 0.0 110.413 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.39 152.99 44.28 Favored Pre-proline 0 C--N 1.315 -0.931 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' B' ' 161' ' ' GLY . 9.7 Cg_endo -53.25 -20.58 15.07 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.069 1.846 . . . . 0.0 110.613 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -77.5 27.1 0.16 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.217 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' GLY . . . . . 0.561 ' HA2' ' OD1' ' B' ' 102' ' ' ASN . . . 41.72 34.5 1.25 Allowed Glycine 0 N--CA 1.462 0.396 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.945 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 15.1 t -104.32 124.44 49.18 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' B' ' 98' ' ' SER . 2.5 tm? -114.87 109.73 18.59 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.204 -174.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.9 129.06 42.06 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.708 0.231 . . . . 0.0 110.476 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . 0.417 ' O ' ' CG2' ' B' ' 165' ' ' VAL . 3.2 m -113.44 103.99 16.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 1.7 pp20? -118.22 141.41 48.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.894 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . 0.511 ' HB3' ' HA ' ' B' ' 153' ' ' VAL . . . -177.98 159.14 1.22 Allowed Pre-proline 0 N--CA 1.453 -0.281 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' B' ' 93' ' ' ASP . 88.9 Cg_endo -77.64 81.01 2.78 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 123.72 2.947 . . . . 0.0 109.94 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' MET . . . . . 0.609 ' SD ' ' HB2' ' B' ' 95' ' ' TRP . 0.0 OUTLIER -93.08 164.42 21.64 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.55 -175.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' PRO . . . . . 0.526 ' CD ' ' O ' ' B' ' 147' ' ' GLY . 85.2 Cg_endo -82.35 103.87 1.31 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 123.263 2.642 . . . . 0.0 111.648 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -69.95 47.92 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.147 0.499 . . . . 0.0 110.144 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.47 ' H ' ' C ' ' B' ' 170' ' ' PRO . 1.9 mm? -69.06 -10.77 59.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.565 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.18 53.23 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.458 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 2.6 p -95.19 100.19 12.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.921 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -42.05 -33.15 0.53 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.789 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 2.6 m . . . . . 0 C--O 1.209 -1.073 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.499 178.967 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.466 ' N ' ' OE1' ' A' ' 80' ' ' GLN . 14.2 tpp . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 82' ' ' SER . 0.9 OUTLIER -121.2 -58.34 1.8 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.008 179.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.24 -71.35 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.792 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' GLN . 3.9 m -49.2 -67.08 0.3 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.367 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 82' ' ' SER . 15.7 m -162.83 143.73 9.76 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.043 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.1 67.49 0.55 Allowed Glycine 0 C--N 1.319 -0.391 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.4 m -41.67 -37.22 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.684 0.278 . . . . 0.0 110.933 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.568 ' C ' ' H ' ' A' ' 88' ' ' ILE . 1.2 m 40.66 49.51 2.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.511 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.84 31.32 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.139 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.568 ' H ' ' C ' ' A' ' 86' ' ' SER . 4.8 pt -80.99 58.04 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -61.91 58.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.176 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.555 ' N ' ' O ' ' A' ' 88' ' ' ILE . 10.0 m-70 -71.29 79.04 0.73 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.348 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.74 162.25 0.93 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.694 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -132.15 169.21 16.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.664 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' A' ' 94' ' ' ARG . 0.4 OUTLIER -60.75 -75.56 0.06 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.215 178.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.417 ' H ' ' CG ' ' A' ' 93' ' ' ASP . 1.2 mmm180 70.27 118.42 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.047 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.471 ' HB2' ' HG3' ' A' ' 169' ' ' MET . 0.0 OUTLIER -61.52 113.25 2.58 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -109.61 100.02 9.12 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.902 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -106.77 135.47 45.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 2.4 m -108.82 141.2 41.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.842 0.353 . . . . 0.0 111.945 -176.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.582 ' CD2' ' HB3' ' A' ' 140' ' ' ARG . 0.4 OUTLIER -119.41 56.31 0.93 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.518 175.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -62.0 109.96 1.43 Allowed 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.329 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.473 ' HA ' ' CE1' ' A' ' 103' ' ' HIS . 11.8 p -171.15 -17.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.563 ' OD1' ' HA2' ' A' ' 161' ' ' GLY . 0.8 OUTLIER -90.52 16.79 8.3 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.684 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.549 ' N ' ' HA3' ' A' ' 161' ' ' GLY . 0.0 OUTLIER -41.03 -34.24 0.4 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.829 0.347 . . . . 0.0 111.026 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -101.87 11.42 38.66 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.806 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.438 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -143.3 86.52 8.99 Favored Pre-proline 0 CA--C 1.512 -0.515 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.433 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.37 -42.8 0.42 Allowed 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 122.44 2.093 . . . . 0.0 111.338 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -98.08 -31.79 11.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.583 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -81.31 51.16 1.57 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.448 0.642 . . . . 0.0 110.347 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 121' ' ' THR . 0.5 OUTLIER -137.63 124.83 21.67 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.69 178.08 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.49 115.12 21.04 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.616 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.7 t -96.97 123.23 49.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.28 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.482 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 1.6 pttm -133.51 135.14 44.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.826 0.346 . . . . 0.0 111.081 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -109.61 114.84 28.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.3 ttpp -118.98 80.01 1.48 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.772 0.32 . . . . 0.0 111.652 -176.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.9 t0 49.77 69.57 0.59 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.156 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.1 -20.52 9.86 Favored Glycine 0 C--N 1.32 -0.339 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.7 t -86.86 111.26 21.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.634 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.4 t -102.7 112.49 36.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 140' ' ' ARG . 40.6 mt-10 -124.41 133.55 53.36 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.351 0.596 . . . . 0.0 111.53 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.1 mp -108.05 118.54 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.926 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.482 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -97.7 122.81 41.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.501 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.31 134.0 4.6 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.626 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.488 ' HZ2' ' HB2' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -131.5 159.76 37.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -125.71 136.88 53.68 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.96 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.533 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -88.81 134.77 33.82 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' A' ' 125' ' ' GLU . 2.8 tt0 -1.9 98.85 0.01 OUTLIER 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.759 0.662 . . . . 0.0 112.548 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 11.0 mtp-105 -96.47 139.44 32.58 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 120.907 0.384 . . . . 0.0 111.081 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -79.84 130.25 35.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.779 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.437 ' OD2' ' NH2' ' B' ' 140' ' ' ARG . 0.0 OUTLIER -136.56 144.66 44.32 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.168 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -47.78 -27.47 2.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.147 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.447 ' O ' ' CZ ' ' B' ' 142' ' ' TYR . 42.1 m-70 -120.67 39.84 3.66 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.673 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.2 167.84 11.77 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.594 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 12.6 m-30 -96.36 113.77 25.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.462 HD11 HG22 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -120.07 145.16 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -176.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.11 156.34 44.31 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.24 -178.45 6.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.825 0.345 . . . . 0.0 111.443 -175.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.4 p -139.76 134.0 31.24 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -100.36 141.04 33.75 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.76 99.19 4.86 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.103 172.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.676 ' NH2' ' CD1' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -104.81 99.92 9.55 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.001 -179.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.536 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 13.8 ttpt -112.34 127.89 56.13 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.713 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.676 ' CD1' ' NH2' ' A' ' 140' ' ' ARG . 11.9 m-85 -127.25 100.02 5.9 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.515 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.493 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -85.4 89.79 7.77 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.498 179.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.3 mp -108.69 93.4 12.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.332 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.567 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 16.7 Cg_exo -66.95 -54.93 0.36 Allowed 'Trans proline' 0 C--N 1.294 -2.332 0 C-N-CA 122.143 1.895 . . . . 0.0 112.798 175.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.567 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 57.6 Cg_endo -102.87 89.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.556 2.838 . . . . 0.0 111.729 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.86 -19.57 0.76 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.922 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.62 128.83 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 117.121 0.46 . . . . 0.0 110.511 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 151' ' ' THR . 13.0 t70 -92.88 143.13 26.42 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.044 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 2.4 Cg_endo -82.54 -22.61 4.53 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.877 1.718 . . . . 0.0 112.362 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.416 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -91.67 -41.04 10.95 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.212 -175.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -106.5 23.77 13.67 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -172.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.432 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 42.8 t -110.67 111.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.921 0.391 . . . . 0.0 110.878 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.62 -178.0 3.47 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.92 139.3 26.15 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.048 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.54 137.66 47.94 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.413 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.49 HD12 ' OD1' ' A' ' 102' ' ' ASN . 31.4 tp -128.43 145.45 51.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.896 0.379 . . . . 0.0 110.726 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.29 155.23 81.79 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.815 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.576 ' C ' ' H ' ' A' ' 161' ' ' GLY . 91.8 Cg_exo -42.27 -42.58 7.63 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.905 2.403 . . . . 0.0 111.865 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -62.54 10.77 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.644 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 159' ' ' PRO . . . 59.39 33.57 76.72 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 112.06 -0.416 . . . . 0.0 112.06 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 6.2 t -95.18 114.85 26.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.453 . . . . 0.0 109.919 177.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 99' ' ' LEU . 2.1 tm? -108.49 104.78 14.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.875 -177.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.7 p -99.42 116.79 32.38 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.441 ' O ' ' CG2' ' A' ' 165' ' ' VAL . 3.5 m -95.45 99.69 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -115.02 138.31 51.01 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.022 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.432 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . . . -178.11 162.83 1.25 Allowed Pre-proline 0 C--N 1.32 -0.7 0 CA-C-O 121.313 0.578 . . . . 0.0 111.771 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -87.77 109.16 0.65 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 123.257 2.638 . . . . 0.0 108.229 175.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.518 ' HB3' ' HD2' ' A' ' 170' ' ' PRO . 0.0 OUTLIER -109.39 169.15 6.74 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.506 -173.004 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 169' ' ' MET . 19.5 Cg_endo -62.05 50.1 0.1 Allowed 'Trans proline' 0 N--CA 1.503 2.08 0 C-N-CA 123.222 2.615 . . . . 0.0 112.065 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 169' ' ' MET . 6.0 mtpm? -36.24 -55.6 0.79 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.93 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.5 mt -116.84 43.67 2.21 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.857 0.36 . . . . 0.0 111.144 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.13 -61.61 1.72 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.29 159.15 14.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.741 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.04 -173.96 1.14 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.209 -1.038 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.838 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' MET . . . . . 0.421 ' N ' ' OD2' ' B' ' 93' ' ' ASP . 4.3 ttp . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 61.35 168.49 0.1 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.661 0.267 . . . . 0.0 110.506 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.425 ' N ' ' CD2' ' B' ' 81' ' ' LEU . 2.0 mm? -77.92 -160.45 0.2 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' SER . . . . . 0.458 ' O ' ' N ' ' B' ' 84' ' ' GLY . 0.6 OUTLIER -70.29 164.01 25.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 6.4 m -67.74 53.77 0.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.061 0.458 . . . . 0.0 110.531 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' B' ' 82' ' ' SER . . . 158.48 80.48 0.03 OUTLIER Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 34.5 m 43.6 -155.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 122.613 0.365 . . . . 0.0 111.544 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' SER . . . . . 0.473 ' C ' ' H ' ' B' ' 88' ' ' ILE . 0.8 OUTLIER -75.45 69.18 2.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.775 0.322 . . . . 0.0 111.273 -178.119 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . 0.447 ' O ' ' NH2' ' B' ' 89' ' ' ARG . 6.3 tt0 -77.15 30.9 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.595 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . 0.585 ' O ' ' NE ' ' B' ' 89' ' ' ARG . 6.9 mt 57.25 165.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.992 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.585 ' NE ' ' O ' ' B' ' 88' ' ' ILE . 0.0 OUTLIER 56.48 -5.99 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 178.06 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' HIS . . . . . 0.572 ' H ' ' C ' ' B' ' 88' ' ' ILE . 0.6 OUTLIER -38.39 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.003 0.43 . . . . 0.0 111.645 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.434 ' N ' ' O ' ' B' ' 89' ' ' ARG . 2.0 m -146.4 127.06 14.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.148 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -152.02 -84.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.911 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.421 ' OD2' ' N ' ' B' ' 79' ' ' MET . 21.6 m-20 -62.63 87.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.933 0.396 . . . . 0.0 110.929 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . 0.425 ' NH2' ' OE2' ' B' ' 166' ' ' GLU . 7.9 mmm180 -129.99 144.77 51.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.587 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' TRP . . . . . 0.559 ' NE1' ' CG2' ' B' ' 97' ' ' VAL . 63.2 t-105 -115.8 113.9 24.03 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -119.83 104.72 10.45 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.579 -175.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.559 ' CG2' ' NE1' ' B' ' 95' ' ' TRP . 0.2 OUTLIER -112.59 158.12 13.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 16.1 m -134.31 142.52 47.3 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -176.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.409 ' CD2' HH11 ' B' ' 140' ' ' ARG . 0.4 OUTLIER -112.97 79.89 1.29 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.472 174.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -86.36 102.76 14.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.86 0.362 . . . . 0.0 111.143 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . 0.545 ' C ' ' H ' ' B' ' 103' ' ' HIS . 0.0 OUTLIER -163.94 -40.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.765 0.317 . . . . 0.0 111.463 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' B' ' 161' ' ' GLY . 0.0 OUTLIER -60.25 11.16 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -175.282 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.545 ' H ' ' C ' ' B' ' 101' ' ' VAL . 3.1 p80 -52.4 -19.07 1.93 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.137 0.494 . . . . 0.0 109.87 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.432 ' CE2' ' NH2' ' B' ' 136' ' ' ARG . 47.9 p90 -94.48 -9.26 36.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.138 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.51 91.8 5.68 Favored Pre-proline 0 CA--C 1.516 -0.351 0 CA-C-O 120.826 0.346 . . . . 0.0 111.536 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.95 -49.77 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.471 2.114 . . . . 0.0 111.266 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -89.66 -31.2 17.62 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.225 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -87.08 49.84 1.9 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.311 0.577 . . . . 0.0 110.135 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' B' ' 121' ' ' THR . 0.4 OUTLIER -133.18 142.6 48.7 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.111 178.405 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.49 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -137.05 120.25 16.74 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.432 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.2 125.37 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.358 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -136.4 142.11 43.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.665 0.269 . . . . 0.0 111.145 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.91 114.95 29.35 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.535 ' NZ ' ' CB ' ' B' ' 114' ' ' LYS . 0.0 OUTLIER -111.81 92.91 4.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.117 -177.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 29.5 t70 32.77 66.35 0.2 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.273 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.52 -21.93 19.29 Favored Glycine 0 N--CA 1.466 0.665 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' B' ' 114' ' ' LYS . 5.9 t -87.79 120.43 36.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 54.3 t -106.49 123.73 61.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.442 ' OE2' ' NZ ' ' B' ' 114' ' ' LYS . 2.8 mt-10 -135.66 140.65 44.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.973 0.416 . . . . 0.0 110.767 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . . . . . . . . . 1.2 mp -117.72 117.75 56.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.791 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -91.16 123.29 34.5 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.443 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.07 116.5 0.78 Allowed Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' LYS . . . . . 0.532 ' O ' ' NZ ' ' B' ' 123' ' ' LYS . 0.1 OUTLIER -140.86 126.3 18.8 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.282 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . 0.621 ' H ' ' CD2' ' B' ' 124' ' ' HIS . 0.2 OUTLIER -95.77 134.84 38.25 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.371 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' B' ' 126' ' ' GLU . 3.2 tp10 -69.36 136.41 51.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.383 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . 0.531 ' C ' ' O ' ' B' ' 125' ' ' GLU . 39.3 tt0 -1.62 98.39 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.797 0.685 . . . . 0.0 112.111 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' B' ' 127' ' ' ARG . 3.7 mtm180 -93.02 129.93 38.78 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.079 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -77.52 122.6 25.47 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -120.29 173.02 7.38 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.866 0.365 . . . . 0.0 110.766 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.58 -30.97 70.14 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -174.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' HIS . . . . . 0.529 ' O ' ' CE1' ' A' ' 142' ' ' TYR . 75.0 m-70 -110.82 24.68 12.64 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 132.84 -149.88 19.64 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 120.228 -0.987 . . . . 0.0 111.955 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' TYR . . . . . 0.554 ' O ' ' NH1' ' A' ' 140' ' ' ARG . 63.4 m-85 -111.18 125.16 53.5 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . 0.479 ' HB ' ' NH1' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -145.96 121.56 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 120.659 0.266 . . . . 0.0 111.092 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' SER . . . . . 0.457 ' HG ' ' C ' ' B' ' 134' ' ' ILE . 0.7 OUTLIER -150.51 157.75 43.37 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 178.417 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . 0.595 ' HD3' ' CE1' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -145.53 171.52 14.55 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.113 0.482 . . . . 0.0 111.65 -177.071 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 29.5 p -107.93 132.13 53.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.693 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . 0.595 ' CE1' ' HD3' ' B' ' 136' ' ' ARG . 0.3 OUTLIER -108.78 139.76 43.15 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.774 0.321 . . . . 0.0 110.903 -178.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.64 103.95 3.57 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.259 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . 0.595 ' NH1' ' OH ' ' B' ' 142' ' ' TYR . 0.0 OUTLIER -104.91 123.85 48.45 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . . . . . . . . . 1.5 ttpp -113.54 118.19 33.75 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' TYR . . . . . 0.595 ' OH ' ' NH1' ' B' ' 140' ' ' ARG . 2.1 m-30 -106.04 97.88 7.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.739 0.304 . . . . 0.0 110.192 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.503 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.2 OUTLIER -90.98 100.27 13.17 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -109.73 92.54 12.53 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.825 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.575 ' O ' ' N ' ' B' ' 147' ' ' GLY . 24.6 Cg_exo -65.76 -39.85 19.07 Favored 'Trans proline' 0 C--N 1.287 -2.705 0 C-N-CA 122.527 2.151 . . . . 0.0 112.428 171.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 83.7 Cg_exo -41.59 -8.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 123.296 2.664 . . . . 0.0 113.506 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 116.4 69.65 0.43 Allowed Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.101 -1.047 . . . . 0.0 113.989 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.5 OUTLIER -112.76 112.4 40.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . 0.46 ' O ' ' CG2' ' B' ' 153' ' ' VAL . 19.1 t70 -64.39 135.51 96.38 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.692 -176.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 3.8 Cg_exo -78.58 -26.2 6.02 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.922 1.748 . . . . 0.0 113.188 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.93 -42.32 10.65 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -94.49 15.97 16.52 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -174.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . 0.46 ' CG2' ' O ' ' B' ' 149' ' ' ASP . 37.1 t -101.34 89.6 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.442 177.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.41 178.43 8.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.38 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.78 133.65 10.27 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.472 -178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.31 142.8 45.41 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.369 179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . 0.451 HD11 ' H ' ' B' ' 158' ' ' SER . 35.0 tp -128.88 148.7 50.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 110.291 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.451 ' H ' HD11 ' B' ' 157' ' ' LEU . 0.3 OUTLIER -134.77 154.02 79.15 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.504 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.58 ' C ' ' H ' ' B' ' 161' ' ' GLY . 80.5 Cg_exo -41.05 -40.45 3.89 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.739 2.293 . . . . 0.0 111.239 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.27 17.64 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.376 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' GLY . . . . . 0.58 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 49.72 31.33 15.71 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' THR . . . . . 0.447 ' CG2' ' HB2' ' B' ' 158' ' ' SER . 15.0 t -90.57 120.77 31.92 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' B' ' 98' ' ' SER . 3.1 tm? -115.77 102.65 9.91 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.88 125.42 37.47 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.12 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . 0.43 ' O ' ' CG2' ' B' ' 165' ' ' VAL . 3.0 m -112.6 100.03 9.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 174.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 0.0 OUTLIER -110.01 132.74 53.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.937 -176.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . 0.437 ' HB1' ' HA ' ' B' ' 153' ' ' VAL . . . -164.0 150.24 9.65 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.65 67.19 6.47 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 123.867 3.045 . . . . 0.0 109.98 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' MET . . . . . 0.479 ' HG2' ' CB ' ' B' ' 95' ' ' TRP . 0.1 OUTLIER -46.91 158.71 0.41 Allowed Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.193 -176.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' B' ' 172' ' ' LEU . 8.3 Cg_endo -51.73 148.44 21.76 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.873 2.382 . . . . 0.0 111.373 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.77 64.79 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.629 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.465 ' N ' ' O ' ' B' ' 170' ' ' PRO . 3.1 mm? -89.5 72.3 7.91 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.76 87.96 1.74 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.63 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.91 111.74 5.84 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -80.17 -85.83 0.09 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.24 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.208 -1.086 0 CA-C-O 118.289 -0.863 . . . . 0.0 111.424 -178.766 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.473 ' N ' ' SD ' ' A' ' 79' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -41.6 -81.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.986 0.422 . . . . 0.0 111.421 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.4 mt -54.64 -17.24 3.12 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.437 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.91 -15.45 41.68 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.076 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 79' ' ' MET . 0.0 OUTLIER -97.11 -170.19 1.99 Allowed 'General case' 0 C--O 1.239 0.542 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.071 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.1 -54.71 0.81 Allowed Glycine 0 CA--C 1.518 0.279 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.498 ' C ' ' HG ' ' A' ' 86' ' ' SER . 2.4 p -130.38 150.75 34.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.498 ' HG ' ' C ' ' A' ' 85' ' ' VAL . 2.9 m -166.59 90.16 0.39 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.112 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 89' ' ' ARG . 9.2 mm-40 -57.18 152.76 13.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.182 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.9 tt -66.13 58.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.417 0.627 . . . . 0.0 110.731 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 87' ' ' GLU . 11.7 mtp180 -77.38 133.14 38.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.069 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.432 ' ND1' ' N ' ' A' ' 91' ' ' THR . 1.8 t60 -154.94 133.2 11.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.903 0.383 . . . . 0.0 110.825 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.432 ' N ' ' ND1' ' A' ' 90' ' ' HIS . 0.0 OUTLIER -70.31 63.64 0.25 Allowed 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 90' ' ' HIS . . . -38.17 -38.05 0.31 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.087 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 168' ' ' PRO . 1.8 m-20 -59.48 90.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.04 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.454 ' NH1' ' OE1' ' A' ' 166' ' ' GLU . 6.5 mmt85 -128.5 117.2 20.91 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.515 ' CH2' ' CG2' ' A' ' 148' ' ' VAL . 0.0 OUTLIER -86.13 160.12 19.33 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 96' ' ' ARG . 21.3 ttp-105 -151.37 99.66 2.66 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.128 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.496 HG23 ' CZ3' ' A' ' 95' ' ' TRP . 1.3 t -116.27 148.1 19.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 176.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.23 150.1 30.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.936 0.398 . . . . 0.0 111.878 -175.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.41 HD22 HG12 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -128.82 91.16 3.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.643 175.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.408 ' C ' ' CG2' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -81.56 124.78 29.8 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.477 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.585 ' HA ' ' CE1' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -178.72 -40.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-O 122.403 1.097 . . . . 0.0 108.434 178.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.575 ' ND2' ' O ' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -58.92 -14.27 8.67 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 113.373 -1.739 . . . . 0.0 111.683 -178.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.585 ' CE1' ' HA ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -45.14 -22.78 0.12 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.567 -178.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.32 17.27 12.26 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.88 86.31 3.84 Favored Pre-proline 0 N--CA 1.467 0.409 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.875 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.499 ' HA ' HD22 ' A' ' 102' ' ' ASN . 51.3 Cg_endo -70.95 -47.28 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.511 2.141 . . . . 0.0 111.517 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -94.81 -30.46 14.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.347 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.478 ' CD ' ' HZ2' ' A' ' 123' ' ' LYS . 24.9 mt-10 -85.98 41.29 0.91 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.048 0.451 . . . . 0.0 110.822 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.507 ' CD1' ' HB2' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -129.2 133.89 47.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.047 178.799 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.73 129.06 46.46 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.245 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.3 t -109.47 120.88 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.56 ' NZ ' ' HB2' ' A' ' 119' ' ' GLU . 9.8 pttp -134.26 128.33 33.63 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.403 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -97.15 134.24 40.74 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.097 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 116' ' ' GLY . 0.3 OUTLIER -120.46 -176.74 3.29 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -57.28 69.85 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.303 0.573 . . . . 0.0 111.639 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 114' ' ' LYS . . . 83.69 -5.99 75.89 Favored Glycine 0 C--N 1.32 -0.356 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 1.7 t -92.49 110.81 23.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.2 t -96.06 117.75 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.56 ' HB2' ' NZ ' ' A' ' 112' ' ' LYS . 81.6 mt-10 -129.48 133.6 47.36 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.114 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.41 HG12 HD22 ' A' ' 99' ' ' LEU . 4.6 mm -107.18 141.38 22.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.417 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -121.69 114.31 20.96 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.329 -178.015 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -144.85 130.07 3.76 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.899 -0.48 . . . . 0.0 111.899 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.54 ' O ' ' NZ ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -151.13 132.28 14.41 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.129 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.505 ' ND1' ' HG2' ' A' ' 127' ' ' ARG . 54.6 t-80 -102.59 141.2 35.81 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -56.81 -33.78 67.05 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -176.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 0.3 OUTLIER 173.21 103.51 0.01 OUTLIER 'General case' 0 C--N 1.356 0.853 0 CA-C-N 118.748 0.704 . . . . 0.0 111.23 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.505 ' HG2' ' ND1' ' A' ' 124' ' ' HIS . 9.7 mtp-105 -94.42 149.21 21.46 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.589 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -83.54 136.87 34.1 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -136.65 151.32 49.17 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.252 0.548 . . . . 0.0 110.293 177.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.48 -29.8 7.24 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.119 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.519 ' H ' ' CG ' ' A' ' 129' ' ' ASP . 50.5 m-70 -120.17 40.5 3.44 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.851 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.17 172.97 13.28 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 119.689 -1.243 . . . . 0.0 112.092 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -96.1 126.79 41.57 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 172.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -130.43 123.92 56.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -170.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.432 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 3.1 m -131.57 147.04 52.5 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.199 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.442 ' NH1' ' CE2' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -143.75 170.48 15.79 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.755 -178.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 25.1 p -112.02 122.77 48.68 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.486 ' CD2' ' CG1' ' A' ' 101' ' ' VAL . 5.7 m-85 -95.78 128.78 42.96 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.765 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.58 105.65 5.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.886 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.476 ' NH2' ' OH ' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -104.67 105.14 15.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.864 178.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.418 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 14.2 ttmt -99.04 112.38 24.53 Favored 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 123.186 0.304 . . . . 0.0 110.75 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.668 ' CE1' ' HA3' ' B' ' 132' ' ' GLY . 5.9 m-30 -106.15 99.3 8.9 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.446 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.1 OUTLIER -87.74 89.32 7.95 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mp -113.33 91.35 19.33 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.574 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 13.2 Cg_exo -69.13 -57.27 0.13 Allowed 'Trans proline' 0 C--N 1.29 -2.529 0 C-N-CA 122.457 2.105 . . . . 0.0 114.641 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.574 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 12.6 Cg_endo -93.0 22.69 0.57 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 C-N-CA 122.969 2.446 . . . . 0.0 113.562 -174.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -142.22 -13.27 0.41 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 119.827 -1.178 . . . . 0.0 112.968 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.515 ' CG2' ' CH2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -131.75 128.19 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.713 0.756 . . . . 0.0 110.644 178.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 151' ' ' THR . 12.8 t70 -89.26 140.96 28.78 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.226 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -82.35 -18.92 6.87 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.063 1.842 . . . . 0.0 112.991 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.441 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 0.2 OUTLIER -92.46 -37.2 12.67 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.173 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -109.83 27.9 9.11 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -173.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.481 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 45.2 t -111.65 120.8 62.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.673 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.81 -173.72 2.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.318 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.48 153.17 31.06 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.215 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.82 136.46 53.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.617 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 31.0 tp -124.89 110.91 14.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.84 0.353 . . . . 0.0 110.131 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.86 145.07 31.18 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.664 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.63 ' C ' ' H ' ' A' ' 161' ' ' GLY . 84.4 Cg_exo -41.02 -34.06 1.34 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.646 2.231 . . . . 0.0 110.753 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.61 27.61 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.387 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 159' ' ' PRO . . . 38.41 33.96 0.21 Allowed Glycine 0 CA--C 1.53 1.008 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.601 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 9.8 t -102.03 125.37 48.7 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -107.04 110.01 22.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.786 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.35 125.38 45.0 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.46 ' O ' ' CG2' ' A' ' 165' ' ' VAL . 1.2 m -106.69 107.28 22.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 1.5 pp20? -121.63 152.83 38.87 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.056 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.481 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . . . 168.44 167.97 0.14 Allowed Pre-proline 0 C--O 1.238 0.463 0 CA-C-O 121.158 0.504 . . . . 0.0 112.213 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 93' ' ' ASP . 37.7 Cg_endo -89.53 109.46 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 123.452 2.768 . . . . 0.0 109.168 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.5 ' CE ' ' H ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -107.18 170.8 5.26 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.874 -175.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -54.91 -20.41 22.7 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.249 1.966 . . . . 0.0 110.688 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.1 tttt 72.95 143.39 0.07 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.222 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.48 106.61 3.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.223 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -130.17 -21.37 2.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.958 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 17.2 p -79.29 -94.36 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.208 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -85.17 -124.39 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.852 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.214 -0.777 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.069 179.769 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' MET . . . . . . . . . . . . . 15.6 mmm . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.601 ' C ' ' H ' ' B' ' 82' ' ' SER . 26.2 mt-30 -44.43 127.67 5.97 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 mm? 66.73 -35.65 0.25 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.947 0.403 . . . . 0.0 110.466 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' SER . . . . . 0.601 ' H ' ' C ' ' B' ' 80' ' ' GLN . 0.9 OUTLIER 60.26 -157.37 0.33 Allowed 'General case' 0 C--O 1.239 0.55 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 178.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.98 139.99 48.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.154 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.58 86.57 0.27 Allowed Glycine 0 C--N 1.318 -0.453 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 5.4 m -61.32 165.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.142 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -33.52 76.23 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.446 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 65.83 -140.8 0.19 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.597 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 pt 32.27 45.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.926 0.393 . . . . 0.0 111.993 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 49.88 25.14 1.49 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.914 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -118.06 67.34 0.76 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.832 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 76.7 p -81.76 -85.86 0.1 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 163.83 -29.18 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.317 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.636 ' CG ' ' H ' ' B' ' 94' ' ' ARG . 5.0 p-10 -68.86 -93.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.772 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . 0.636 ' H ' ' CG ' ' B' ' 93' ' ' ASP . 24.5 mmt-85 11.17 84.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 123.727 0.642 . . . . 0.0 110.454 -177.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' TRP . . . . . 0.498 ' HB2' ' HG3' ' B' ' 169' ' ' MET . 0.1 OUTLIER -62.31 141.13 58.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.339 -177.77 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.447 HH11 ' HD2' ' B' ' 96' ' ' ARG . 25.0 ttm105 -135.29 106.78 6.86 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.167 -177.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.85 150.9 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 17.6 m -126.95 148.91 50.05 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -174.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.9 55.03 1.29 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.465 174.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.25 93.95 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.835 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . 0.566 ' C ' ' H ' ' B' ' 103' ' ' HIS . 2.6 t -145.15 -26.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.642 ' H ' ' ND2' ' B' ' 102' ' ' ASN . 0.0 OUTLIER -54.86 3.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.566 ' H ' ' C ' ' B' ' 101' ' ' VAL . 2.4 m-70 -41.91 -46.55 4.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.998 0.428 . . . . 0.0 110.848 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.06 8.32 38.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.144 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' B' ' 102' ' ' ASN . . . -159.07 89.75 2.06 Favored Pre-proline 0 CA--C 1.513 -0.444 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.58 -44.48 0.38 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.323 2.015 . . . . 0.0 110.866 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -98.15 -31.46 12.09 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.119 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -83.09 37.99 0.57 Allowed 'General case' 0 C--O 1.242 0.676 0 CA-C-O 121.018 0.437 . . . . 0.0 110.728 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.494 HD13 ' OD1' ' B' ' 102' ' ' ASN . 0.4 OUTLIER -121.4 135.35 55.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.06 124.23 38.79 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 120.5 0.191 . . . . 0.0 110.852 -177.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.74 129.61 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.969 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -139.43 134.88 32.97 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.686 0.279 . . . . 0.0 110.759 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 5.2 m -102.94 108.0 19.02 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.801 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.543 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 21.5 ttmt -104.32 87.68 2.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.822 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 3.4 t70 30.66 67.35 0.12 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.655 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.41 -22.45 23.7 Favored Glycine 0 N--CA 1.466 0.693 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' B' ' 114' ' ' LYS . 8.8 t -87.55 109.77 19.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.429 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 56.1 t -96.65 127.05 49.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.974 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.537 ' CD ' ' HZ3' ' B' ' 141' ' ' LYS . 74.4 mt-10 -139.36 146.96 40.88 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.275 -178.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.412 HD11 ' O ' ' B' ' 119' ' ' GLU . 1.3 mp -121.46 131.23 73.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.434 177.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -104.01 120.38 40.93 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.669 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -140.42 129.2 4.1 Favored Glycine 0 N--CA 1.466 0.66 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.16 157.78 43.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' B' ' 126' ' ' GLU . 8.8 t-80 -145.02 127.91 16.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -56.01 -10.08 0.74 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -176.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . 0.578 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 0.5 OUTLIER 175.31 145.62 0.07 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 111.571 179.074 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' ARG . . . . . 0.588 ' NH1' ' HA ' ' B' ' 135' ' ' SER . 26.1 mtt85 -135.19 107.57 7.3 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.658 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -65.73 130.52 43.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.527 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.29 149.0 28.87 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -62.26 -31.46 72.03 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -92.27 25.17 3.03 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.488 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . 0.668 ' HA3' ' CE1' ' A' ' 142' ' ' TYR . . . 122.77 165.01 12.28 Favored Glycine 0 N--CA 1.429 -1.821 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.152 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -94.69 112.74 24.48 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . 0.516 HD12 ' NH1' ' B' ' 136' ' ' ARG . 0.0 OUTLIER -115.03 113.9 44.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.977 0.418 . . . . 0.0 111.864 -174.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' SER . . . . . 0.588 ' HA ' ' NH1' ' B' ' 127' ' ' ARG . 0.8 OUTLIER -116.71 152.32 34.54 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.876 175.661 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . 0.516 ' NH1' HD12 ' B' ' 134' ' ' ILE . 2.4 ptt180 -155.67 145.55 21.39 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.759 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 28.5 p -92.5 129.81 38.33 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . 0.442 ' CE2' ' NH1' ' A' ' 136' ' ' ARG . 15.1 m-85 -98.21 137.72 36.54 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -177.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.83 101.07 3.6 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.172 176.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . 0.517 HH22 ' HB2' ' A' ' 131' ' ' HIS . 0.1 OUTLIER -98.91 150.2 22.16 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 173.365 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . 0.537 ' HZ3' ' CD ' ' B' ' 119' ' ' GLU . 13.6 ttmm -140.42 122.67 15.87 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.486 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' TYR . . . . . 0.513 ' CD1' ' N ' ' B' ' 142' ' ' TYR . 0.5 OUTLIER -114.92 99.0 7.15 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.452 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.0 OUTLIER -88.59 89.59 8.05 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.542 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.54 93.3 19.03 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.724 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.524 ' CD ' ' HD3' ' B' ' 146' ' ' PRO . 16.5 Cg_exo -67.24 -54.97 0.33 Allowed 'Trans proline' 0 C--N 1.287 -2.667 0 C-N-CA 121.664 1.576 . . . . 0.0 112.345 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' PRO . . . . . 0.524 ' HD3' ' CD ' ' B' ' 145' ' ' PRO . 56.8 Cg_endo -98.72 89.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.103 2.535 . . . . 0.0 112.106 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.76 -20.55 1.29 Allowed Glycine 0 C--O 1.223 -0.534 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.669 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.26 122.92 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 117.579 0.69 . . . . 0.0 110.813 177.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' B' ' 151' ' ' THR . 12.0 t70 -93.58 148.08 34.81 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.05 -24.11 4.91 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.651 1.568 . . . . 0.0 112.756 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' THR . . . . . 0.447 ' N ' ' OD1' ' B' ' 149' ' ' ASP . 0.2 OUTLIER -91.36 -35.36 14.45 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' GLN . . . . . 0.401 ' O ' ' CB ' ' B' ' 167' ' ' ALA . 0.0 OUTLIER -103.53 14.49 31.15 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -175.342 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 39.1 t -107.9 120.46 59.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.438 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.83 -172.94 2.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.763 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.67 138.28 18.73 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.491 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.57 144.68 35.94 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.331 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . 0.408 HD11 ' N ' ' B' ' 158' ' ' SER . 15.4 tp -136.44 118.47 15.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.814 0.34 . . . . 0.0 110.249 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.408 ' N ' HD11 ' B' ' 157' ' ' LEU . 1.6 t -105.29 149.2 37.44 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -41.77 -26.39 0.43 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.64 2.227 . . . . 0.0 111.828 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . 0.408 ' CD ' ' N ' ' B' ' 160' ' ' GLU . 29.2 mp0 -66.04 -8.02 20.76 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.685 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' GLY . . . . . 0.594 ' O ' ' ND2' ' B' ' 102' ' ' ASN . . . 76.57 27.41 61.24 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 28.8 p -87.58 99.84 12.35 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' B' ' 98' ' ' SER . 1.3 tm? -96.35 92.86 6.54 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.31 127.0 41.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.452 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . 0.462 ' O ' ' CG2' ' B' ' 165' ' ' VAL . 2.6 m -105.45 99.09 7.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.08 134.82 54.54 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.357 -176.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . 0.401 ' CB ' ' O ' ' B' ' 152' ' ' GLN . . . -170.46 160.99 6.22 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.28 0.562 . . . . 0.0 111.889 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . 0.42 ' HB3' ' NE ' ' B' ' 94' ' ' ARG . 57.0 Cg_endo -84.95 59.95 5.62 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 123.262 2.641 . . . . 0.0 109.237 176.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' MET . . . . . 0.634 ' O ' ' N ' ' B' ' 171' ' ' LYS . 0.2 OUTLIER -65.97 167.25 12.3 Favored Pre-proline 0 C--N 1.302 -1.477 0 CA-C-N 113.457 -1.701 . . . . 0.0 111.011 -176.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -51.39 63.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 123.415 2.743 . . . . 0.0 112.579 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' LYS . . . . . 0.634 ' N ' ' O ' ' B' ' 169' ' ' MET . 7.8 tptp -44.67 -52.92 7.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.736 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -51.4 -46.42 62.85 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.26 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -59.09 -36.61 75.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.69 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' THR . . . . . 0.555 ' OG1' ' NZ ' ' B' ' 171' ' ' LYS . 75.8 p -75.62 0.66 16.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.588 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' GLN . . . . . 0.583 ' O ' ' NZ ' ' B' ' 171' ' ' LYS . 43.3 mt-30 41.57 -138.75 0.15 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.01 -178.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.209 -1.038 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.637 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 5.0 ttm . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 81' ' ' LEU . 32.2 mt-30 -142.27 -163.72 1.66 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.697 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 80' ' ' GLN . 51.1 mt -28.57 -84.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.208 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER -134.02 31.72 3.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.172 -178.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.49 56.07 0.08 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.141 0.496 . . . . 0.0 110.36 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 86' ' ' SER . . . -178.27 173.58 46.01 Favored Glycine 0 C--N 1.316 -0.569 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.0 m -36.19 91.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.961 0.41 . . . . 0.0 111.391 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 84' ' ' GLY . 0.9 OUTLIER -86.23 -18.71 31.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.291 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -4.96 26.9 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.559 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.4 tt -34.9 101.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.31 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.576 ' NH2' ' O ' ' A' ' 91' ' ' THR . 0.6 OUTLIER 41.26 34.24 0.31 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.432 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' A' ' 91' ' ' THR . 0.1 OUTLIER -46.88 -28.55 1.62 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.015 0.436 . . . . 0.0 110.383 179.309 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.627 ' N ' ' ND1' ' A' ' 90' ' ' HIS . 0.2 OUTLIER -52.18 132.8 33.83 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.837 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -150.51 134.2 16.62 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -104.32 161.97 13.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.947 0.403 . . . . 0.0 110.566 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.18 144.52 47.04 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.466 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.569 ' HB3' ' SD ' ' A' ' 169' ' ' MET . 54.1 t-105 -105.04 168.43 9.06 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.482 ' N ' ' CG ' ' A' ' 95' ' ' TRP . 1.7 ttm105 -150.51 108.72 3.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.368 -176.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.489 HG21 ' NE1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -116.44 150.06 18.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 174.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 14.7 m -131.52 157.64 43.03 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.23 89.98 2.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.155 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -92.92 94.54 8.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.437 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -153.31 -23.51 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.563 ' OD1' ' HA2' ' A' ' 161' ' ' GLY . 0.1 OUTLIER -83.17 9.28 10.89 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.195 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.592 ' N ' ' HA3' ' A' ' 161' ' ' GLY . 22.9 p-80 -48.53 -35.38 13.14 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.113 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -80.96 -3.4 51.45 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.832 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 102' ' ' ASN . . . -146.73 79.33 10.3 Favored Pre-proline 0 CA--C 1.512 -0.518 0 CA-C-O 120.772 0.32 . . . . 0.0 111.482 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.51 -39.81 11.67 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.513 2.142 . . . . 0.0 111.486 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -101.52 -31.66 10.77 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.978 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -79.28 46.17 0.7 Allowed 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.164 0.506 . . . . 0.0 110.05 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.468 ' CD1' ' HB3' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -133.21 135.66 45.18 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.471 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.7 116.85 17.85 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.153 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.93 124.95 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.555 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -127.97 136.76 51.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.999 0.428 . . . . 0.0 111.369 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.66 116.07 31.29 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.569 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 2.5 ttpt -111.41 80.76 1.35 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.356 0.598 . . . . 0.0 109.753 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 33.84 68.19 0.18 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.176 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.02 -23.59 25.8 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 4.9 t -87.12 114.19 25.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.9 t -102.04 120.17 51.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.837 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.568 ' CD ' ' HD3' ' A' ' 141' ' ' LYS . 26.8 mt-10 -132.78 145.59 51.12 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.139 0.495 . . . . 0.0 110.948 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.1 mp -113.35 122.94 68.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.016 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.555 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -101.55 115.5 30.66 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.0 128.09 2.6 Favored Glycine 0 C--O 1.239 0.424 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.138 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.46 124.18 9.17 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.495 ' CG ' ' HD3' ' A' ' 127' ' ' ARG . 0.9 OUTLIER -91.04 151.99 20.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.045 0.45 . . . . 0.0 111.515 -177.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.559 ' O ' ' C ' ' A' ' 126' ' ' GLU . 6.1 tp10 -75.61 134.64 40.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.501 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.559 ' C ' ' O ' ' A' ' 125' ' ' GLU . 9.4 tt0 -2.65 97.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.808 0.693 . . . . 0.0 111.74 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.495 ' HD3' ' CG ' ' A' ' 124' ' ' HIS . 1.2 mtm-85 -92.27 134.4 34.93 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.135 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -78.32 129.81 35.46 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.21 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -131.24 167.5 19.09 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.03 -28.58 66.69 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -173.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -118.94 41.09 3.13 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.251 -177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.47 160.27 9.34 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.278 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' B' ' 141' ' ' LYS . 30.6 m-85 -95.21 121.1 36.51 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 172.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.439 HD11 HG23 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -134.99 126.2 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -169.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.503 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -126.38 154.28 43.79 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.669 174.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.44 179.34 7.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.266 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.6 p -139.75 127.1 21.37 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -100.86 136.19 41.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.95 101.54 6.36 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.505 174.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.563 ' HA ' ' NH1' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -101.69 141.36 34.67 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.568 ' HD3' ' CD ' ' A' ' 119' ' ' GLU . 2.7 ttpp -140.85 125.25 17.64 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.315 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.427 ' HE1' ' HE ' ' A' ' 140' ' ' ARG . 57.9 m-85 -120.44 99.13 6.38 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.45 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -89.75 88.92 7.55 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.4 mp -112.43 92.74 20.24 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.578 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 17.0 Cg_exo -65.9 -58.36 0.19 Allowed 'Trans proline' 0 C--N 1.286 -2.753 0 C-N-CA 121.89 1.726 . . . . 0.0 113.497 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.578 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 5.7 Cg_endo -90.5 -13.31 2.34 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 122.774 2.316 . . . . 0.0 114.159 -175.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -104.38 3.0 43.17 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.722 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.47 136.09 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 118.024 0.912 . . . . 0.0 111.005 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 29.0 t70 -96.38 141.97 23.88 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.954 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 2.8 Cg_endo -82.69 -22.32 4.53 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.876 1.717 . . . . 0.0 112.547 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.84 -39.43 12.34 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.233 -174.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -106.33 22.63 15.45 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 19.9 t -109.53 109.39 28.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.977 0.418 . . . . 0.0 110.094 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -169.58 1.6 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.02 139.38 14.76 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.756 -0.778 . . . . 0.0 112.431 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.447 ' CB ' ' HG1' ' A' ' 164' ' ' THR . 0.0 OUTLIER -105.59 130.51 53.62 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.418 177.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.422 HD12 ' OD1' ' A' ' 102' ' ' ASN . 40.0 tp -123.75 109.2 13.37 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.989 0.423 . . . . 0.0 110.355 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.36 147.39 35.33 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.237 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' A' ' 161' ' ' GLY . 87.4 Cg_exo -40.35 -38.52 2.37 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.599 2.199 . . . . 0.0 111.612 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -70.03 29.98 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.742 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.592 ' HA3' ' N ' ' A' ' 103' ' ' HIS . . . 43.93 34.62 3.05 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.06 -0.518 . . . . 0.0 113.039 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.1 t -100.47 99.59 10.23 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.3 0.571 . . . . 0.0 109.598 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' A' ' 98' ' ' SER . 2.9 tm? -91.12 106.16 18.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.803 -176.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.447 ' HG1' ' CB ' ' A' ' 156' ' ' SER . 0.7 OUTLIER -99.54 124.38 44.66 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.431 ' O ' ' CG2' ' A' ' 165' ' ' VAL . 3.1 m -105.54 100.59 10.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -114.28 139.66 49.24 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.06 -176.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 178.17 166.68 0.58 Allowed Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.999 -177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -81.39 108.75 2.0 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.074 2.516 . . . . 0.0 110.13 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.569 ' SD ' ' HB3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -92.89 147.76 34.59 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.825 -176.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.434 ' O ' ' HB2' ' A' ' 171' ' ' LYS . 21.6 Cg_endo -64.88 -1.39 4.15 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.713 2.275 . . . . 0.0 111.693 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 170' ' ' PRO . 5.0 mmtp 78.73 -104.57 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.098 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 6.9 mp 51.14 34.11 10.54 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.004 0.43 . . . . 0.0 110.119 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.93 117.53 15.82 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.077 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 176' ' ' SER . 0.0 OUTLIER -54.71 -34.1 61.93 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.702 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 62.46 -65.83 0.09 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.751 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 174' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.208 -1.111 0 CA-C-O 118.375 -0.822 . . . . 0.0 110.48 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' MET . . . . . 0.474 ' SD ' ' HB2' ' B' ' 81' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.428 ' OE1' ' N ' ' B' ' 80' ' ' GLN . 1.6 mm100 -77.8 35.89 0.21 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.008 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.488 ' C ' ' HG ' ' B' ' 82' ' ' SER . 0.1 OUTLIER -59.36 125.16 22.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.157 179.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' SER . . . . . 0.488 ' HG ' ' C ' ' B' ' 81' ' ' LEU . 0.3 OUTLIER 68.91 80.17 0.2 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.215 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -43.98 -27.32 0.35 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.595 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -145.95 -66.22 0.01 OUTLIER Glycine 0 C--N 1.321 -0.286 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 5.3 m -123.16 167.79 16.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -47.22 114.56 0.89 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -37.56 -43.54 0.61 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.475 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 8.6 pt -142.58 149.24 19.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.446 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.84 144.61 27.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' HIS . . . . . 0.536 ' CG ' ' H ' ' B' ' 91' ' ' THR . 8.0 t-80 -106.94 -146.56 0.4 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.536 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.598 ' CB ' ' HZ1' ' B' ' 171' ' ' LYS . 0.6 OUTLIER -60.51 77.39 0.01 OUTLIER 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.128 0.489 . . . . 0.0 110.438 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' B' ' 90' ' ' HIS . . . -155.99 -53.41 0.08 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.832 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 t70 53.44 -132.02 2.0 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.557 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -121.82 105.3 10.24 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.33 118.09 14.79 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -114.21 113.39 24.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.829 -175.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.7 t -119.25 156.86 21.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 3.7 m -129.64 134.49 47.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -174.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . 0.413 HD23 ' HB ' ' B' ' 120' ' ' ILE . 0.4 OUTLIER -103.16 97.23 7.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.632 175.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -88.75 103.25 15.79 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.677 -179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' VAL . . . . . 0.405 ' CG2' ' HD3' ' B' ' 140' ' ' ARG . 0.1 OUTLIER -170.46 -39.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-O 121.833 0.825 . . . . 0.0 109.417 179.036 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . 0.611 HD22 ' HA ' ' B' ' 106' ' ' PRO . 0.2 OUTLIER -38.94 -26.45 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.148 -177.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -53.18 -23.76 9.19 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 119.592 -0.843 . . . . 0.0 108.927 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.531 ' HB3' ' CZ ' ' B' ' 136' ' ' ARG . 27.3 m-85 -71.81 -13.13 61.6 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.715 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' B' ' 102' ' ' ASN . . . -174.61 94.26 0.3 Allowed Pre-proline 0 C--O 1.223 -0.336 0 O-C-N 123.308 0.38 . . . . 0.0 111.708 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . 0.611 ' HA ' HD22 ' B' ' 102' ' ' ASN . 41.3 Cg_endo -71.57 -44.39 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.493 2.128 . . . . 0.0 111.833 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -30.75 22.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.948 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' B' ' 123' ' ' LYS . 16.7 mt-10 -102.19 56.73 0.8 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.081 0.467 . . . . 0.0 110.985 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' LEU . . . . . 0.43 HD23 HD22 ' B' ' 157' ' ' LEU . 0.4 OUTLIER -127.9 145.58 50.91 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.31 116.72 10.14 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.916 -177.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.03 123.01 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.786 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . 0.453 ' NZ ' ' OG1' ' B' ' 121' ' ' THR . 6.1 pttm -130.9 119.69 22.53 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.237 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.35 120.14 23.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' LYS . . . . . 0.477 ' NZ ' ' OE1' ' B' ' 119' ' ' GLU . 0.8 OUTLIER -121.26 82.49 1.94 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.537 -174.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 32.8 t70 32.56 68.91 0.13 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.345 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . 0.425 ' HA2' HG11 ' B' ' 148' ' ' VAL . . . 86.52 -22.61 12.58 Favored Glycine 0 C--N 1.315 -0.598 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' VAL . . . . . . . . . . . . . 6.4 t -87.42 120.71 37.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 72.5 t -107.7 108.44 25.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.319 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' GLU . . . . . 0.477 ' OE1' ' NZ ' ' B' ' 114' ' ' LYS . 2.9 mt-10 -124.5 146.77 48.78 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.966 0.412 . . . . 0.0 110.612 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ILE . . . . . 0.413 ' HB ' HD23 ' B' ' 99' ' ' LEU . 1.3 mp -119.96 117.29 53.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.452 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' THR . . . . . 0.453 ' OG1' ' NZ ' ' B' ' 112' ' ' LYS . 0.2 OUTLIER -89.81 121.48 31.99 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.755 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -144.33 101.17 0.25 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' LYS . . . . . 0.484 ' O ' ' HB3' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -131.0 143.32 50.64 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' HIS . . . . . 0.457 ' CD2' ' CZ ' ' B' ' 127' ' ' ARG . 0.2 OUTLIER -119.48 151.96 37.71 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.574 -179.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' GLU . . . . . 0.467 ' O ' ' C ' ' B' ' 126' ' ' GLU . 4.0 mt-10 -91.17 126.84 36.37 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.642 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' GLU . . . . . 0.526 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 3.4 tt0 14.79 99.46 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' ARG . . . . . 0.457 ' CZ ' ' CD2' ' B' ' 124' ' ' HIS . 12.6 mtp180 -97.67 141.19 31.0 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.142 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' GLN . . . . . 0.457 ' HG2' ' N ' ' B' ' 129' ' ' ASP . 0.0 OUTLIER -86.74 136.91 32.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . 0.522 ' CG ' ' N ' ' B' ' 130' ' ' GLU . 0.1 OUTLIER -133.45 169.26 17.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.845 174.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' B' ' 130' ' ' GLU . 0.0 OUTLIER -67.81 -31.98 72.21 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -174.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' HIS . . . . . 0.408 ' N ' ' OD2' ' B' ' 129' ' ' ASP . 96.6 m-70 -111.29 20.24 17.51 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -175.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 147.08 178.25 22.24 Favored Glycine 0 C--N 1.307 -1.036 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.614 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -96.01 134.81 38.58 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . 0.482 ' HB ' ' NH1' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -145.97 116.41 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.886 0.375 . . . . 0.0 111.831 -175.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -132.81 156.66 46.72 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' ARG . . . . . 0.531 ' CZ ' ' HB3' ' B' ' 104' ' ' PHE . 0.0 OUTLIER -151.63 167.81 26.95 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.162 0.505 . . . . 0.0 111.932 -178.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 20.5 p -118.58 129.86 55.57 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.12 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -106.05 143.76 33.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.384 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.11 121.28 7.78 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.857 0.36 . . . . 0.0 111.493 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' ARG . . . . . 0.462 ' NH2' ' OH ' ' B' ' 142' ' ' TYR . 0.0 OUTLIER -118.02 144.57 45.45 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 133' ' ' TYR . 9.1 ttpp -133.01 124.66 28.11 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 123.136 0.272 . . . . 0.0 111.027 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' B' ' 142' ' ' TYR . 3.1 m-85 -118.33 98.64 6.38 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.03 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' THR . . . . . 0.532 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.3 OUTLIER -90.42 100.88 13.64 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.43 96.72 16.87 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.073 -177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' B' ' 147' ' ' GLY . 36.8 Cg_exo -62.98 -41.92 26.56 Favored 'Trans proline' 0 C--N 1.286 -2.747 0 C-N-CA 123.223 2.615 . . . . 0.0 114.251 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 36.3 Cg_exo -43.23 -11.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.916 1.744 . . . . 0.0 112.304 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 109.11 44.13 1.12 Allowed Glycine 0 C--O 1.218 -0.87 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.209 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' VAL . . . . . 0.53 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -60.68 96.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . 0.496 ' CG ' ' HG3' ' B' ' 152' ' ' GLN . 10.3 t70 -50.66 129.16 26.92 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.183 -171.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 11.4 Cg_exo -71.16 -25.95 21.76 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.149 1.899 . . . . 0.0 113.053 -177.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.31 -49.87 6.29 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.363 0.602 . . . . 0.0 111.213 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' GLN . . . . . 0.496 ' HG3' ' CG ' ' B' ' 149' ' ' ASP . 1.7 mt-30 -79.57 10.59 3.76 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.582 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 17.9 t -101.64 119.57 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.42 155.8 27.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' B' ' 164' ' ' THR . 1.2 m -132.99 132.77 42.29 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.399 -176.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.47 145.17 35.08 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.477 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' LEU . . . . . 0.43 HD22 HD23 ' B' ' 109' ' ' LEU . 31.7 tp -130.96 128.42 40.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.336 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.479 ' O ' ' N ' ' B' ' 161' ' ' GLY . 0.6 OUTLIER -114.14 150.32 43.44 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.123 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' PRO . . . . . 0.564 ' C ' ' H ' ' B' ' 161' ' ' GLY . 87.3 Cg_exo -43.15 -34.14 4.05 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.782 2.321 . . . . 0.0 111.462 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.33 2.19 0.27 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.445 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' GLY . . . . . 0.564 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 63.38 27.81 71.35 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.712 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 6.0 t -93.87 120.66 34.43 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' LEU . . . . . 0.438 ' CD1' ' C ' ' B' ' 163' ' ' LEU . 2.2 tm? -108.63 106.6 16.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.814 -176.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' B' ' 155' ' ' SER . 0.7 OUTLIER -95.5 127.99 42.0 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.106 -179.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . 0.438 ' O ' ' CG2' ' B' ' 165' ' ' VAL . 2.6 m -112.99 107.58 23.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -121.57 144.7 48.58 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.439 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' ALA . . . . . . . . . . . . . . . -168.61 152.7 5.74 Favored Pre-proline 0 C--O 1.235 0.29 0 C-N-CA 120.463 -0.495 . . . . 0.0 112.16 -177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -87.68 47.98 1.52 Allowed 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 123.364 2.709 . . . . 0.0 109.59 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' MET . . . . . 0.466 ' CB ' ' HD2' ' B' ' 170' ' ' PRO . 3.1 ptm -49.64 163.92 0.37 Allowed Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.631 -176.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' PRO . . . . . 0.568 ' CG ' ' O ' ' B' ' 147' ' ' GLY . 6.6 Cg_endo -47.21 128.42 14.29 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 124.008 3.139 . . . . 0.0 112.442 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' LYS . . . . . 0.598 ' HZ1' ' CB ' ' B' ' 91' ' ' THR . 2.4 tmtm? -69.05 55.4 0.09 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' B' ' 170' ' ' PRO . 0.3 OUTLIER -76.92 29.21 0.13 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.176 0.512 . . . . 0.0 110.199 179.418 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . 0.501 ' H ' ' C ' ' B' ' 171' ' ' LYS . . . -77.54 45.51 0.49 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.192 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.12 132.02 50.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.192 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' B' ' 173' ' ' ALA . 8.7 mm-40 -77.84 109.84 12.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.199 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' B' ' 175' ' ' GLN . 1.6 m . . . . . 0 C--O 1.209 -1.045 0 CA-C-O 118.362 -0.828 . . . . 0.0 110.974 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.4 mmm-85 . . . . . 0 N--CA 1.469 0.485 0 CA-C-O 121.296 0.57 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.678 ' CZ3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -96.58 158.82 15.25 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.969 177.07 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -151.88 104.14 2.98 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.508 -177.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.678 HG21 ' CZ3' ' A' ' 95' ' ' TRP . 0.8 OUTLIER -121.14 152.46 24.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.133 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 4.4 m -122.45 140.81 52.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.579 HD22 ' HB ' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -117.49 63.92 0.74 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.31 174.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.15 108.27 3.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.617 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.66 ' HA ' ' CE1' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -159.36 -31.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 120.751 0.31 . . . . 0.0 110.94 176.729 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.973 ' HB3' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -56.55 5.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -177.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.66 ' CE1' ' HA ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -61.73 -30.98 71.13 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 118.824 -1.15 . . . . 0.0 108.284 176.046 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.491 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 14.9 m-85 -88.93 5.19 45.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.943 176.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.479 ' HB1' ' HB2' ' A' ' 108' ' ' GLU . . . -167.39 92.36 0.7 Allowed Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.9 -48.58 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.432 2.088 . . . . 0.0 111.159 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 109' ' ' LEU . 1.6 t70 -98.26 -31.9 11.83 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.479 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 54.7 mp0 -75.73 36.74 0.14 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.289 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.973 HD13 ' HB3' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -125.25 138.42 54.1 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.651 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.58 112.6 11.61 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.22 129.58 39.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.87 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.458 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.1 OUTLIER -136.52 125.2 23.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.934 0.397 . . . . 0.0 111.359 -179.335 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.0 m -108.18 115.0 29.31 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.3 91.77 3.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.888 0.375 . . . . 0.0 111.686 -176.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.7 t0 40.18 69.24 0.33 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.243 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.08 -17.61 16.66 Favored Glycine 0 C--N 1.312 -0.771 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.6 t -88.68 109.65 20.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.008 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.7 t -98.71 115.21 38.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.851 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.638 ' CD ' ' NZ ' ' A' ' 141' ' ' LYS . 0.3 OUTLIER -125.66 139.4 53.59 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.337 0.589 . . . . 0.0 110.711 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.579 ' HB ' HD22 ' A' ' 99' ' ' LEU . 1.2 mp -116.32 111.24 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.912 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.458 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -91.84 116.24 28.74 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.821 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.37 125.7 2.0 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.163 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 137' ' ' CYS . 0.0 OUTLIER -134.95 137.87 43.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 177.656 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' A' ' 104' ' ' PHE . 29.7 t60 -80.11 168.28 19.33 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.643 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.481 ' O ' ' C ' ' A' ' 126' ' ' GLU . 2.4 tp10 -113.41 131.85 55.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.315 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 125' ' ' GLU . 5.3 tt0 -19.3 99.8 0.02 OUTLIER 'General case' 0 C--N 1.349 0.548 0 O-C-N 123.563 0.539 . . . . 0.0 111.995 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.462 ' HB2' ' H ' ' A' ' 134' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.84 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.701 0 N-CA-C 112.654 -0.178 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 8.8 m-30 -94.97 109.42 21.44 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.462 ' H ' ' HB2' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -117.39 154.82 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -175.206 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.78 152.38 26.87 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.441 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.419 ' NH2' ' CE2' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -143.8 175.35 10.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.687 -177.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 32.0 p -137.68 133.86 34.73 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.626 ' CD1' HG11 ' A' ' 101' ' ' VAL . 1.6 m-85 -107.54 138.97 42.8 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.472 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.84 114.68 7.74 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.718 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.558 ' NH2' ' OH ' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -120.22 126.04 49.64 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.638 ' NZ ' ' CD ' ' A' ' 119' ' ' GLU . 2.0 ttmm -120.06 107.44 13.07 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 120.756 0.312 . . . . 0.0 111.091 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.558 ' OH ' ' NH2' ' A' ' 140' ' ' ARG . 4.2 m-30 -103.1 99.13 8.99 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.511 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.1 OUTLIER -87.56 88.93 7.81 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.51 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 mp -113.23 90.79 17.38 Favored Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.657 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 15.8 Cg_exo -67.93 -57.43 0.16 Allowed 'Trans proline' 0 C--N 1.287 -2.689 0 C-N-CA 122.164 1.91 . . . . 0.0 113.537 175.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.657 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 28.8 Cg_endo -98.45 43.65 0.09 OUTLIER 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.61 2.873 . . . . 0.0 112.413 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.33 -8.25 0.04 OUTLIER Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.137 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.549 ' CG2' ' CZ2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -138.37 127.09 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 117.4 0.6 . . . . 0.0 111.129 178.193 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.421 ' OD2' ' N ' ' A' ' 152' ' ' GLN . 13.7 t70 -87.89 138.49 31.15 Favored Pre-proline 0 N--CA 1.484 1.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.057 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -81.99 -21.77 5.54 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.016 1.811 . . . . 0.0 113.075 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.14 -37.92 13.07 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.421 ' N ' ' OD2' ' A' ' 149' ' ' ASP . 25.6 mt-30 -103.61 11.76 35.75 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 22.5 t -95.04 118.48 41.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.844 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.9 173.35 6.47 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.5 p -141.68 137.43 31.75 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.961 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.23 133.41 52.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.996 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.628 HD22 HD22 ' A' ' 109' ' ' LEU . 33.9 tp -131.1 136.99 48.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.097 0.475 . . . . 0.0 110.331 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.581 ' H ' HD12 ' A' ' 157' ' ' LEU . 1.8 t -123.71 146.56 50.76 Favored Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.825 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -40.01 -34.07 0.87 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.683 2.255 . . . . 0.0 111.676 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -62.29 -7.44 4.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.641 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.564 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . 76.31 33.61 48.31 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 112.22 -0.352 . . . . 0.0 112.22 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.2 t -100.63 116.74 33.26 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.579 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.4 tm? -110.56 99.86 8.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.543 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.68 127.6 40.76 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 121.343 -0.143 . . . . 0.0 110.714 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 165' ' ' VAL . 3.2 m -108.51 103.13 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.68 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 2.7 pp20? -114.34 147.58 38.9 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.786 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.68 ' HB2' ' O ' ' A' ' 166' ' ' GLU . . . 166.19 166.33 0.1 OUTLIER Pre-proline 0 CA--C 1.515 -0.371 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.785 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.663 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 84.1 Cg_endo -82.18 133.15 7.47 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 123.804 3.003 . . . . 0.0 109.665 173.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.442 ' SD ' ' N ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -128.69 146.92 62.18 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -174.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo . . . . . 0 N--CA 1.494 1.556 0 C-N-CA 123.461 2.774 . . . . 0.0 111.843 177.746 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 94' ' ' ARG . . . . . 0.601 HH12 ' CD ' ' B' ' 166' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.514 -0.431 0 CA-C-O 120.587 0.232 . . . . 0.0 110.923 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 95' ' ' TRP . . . . . 0.781 ' NE1' HG22 ' B' ' 97' ' ' VAL . 14.6 t-105 -114.16 155.49 25.97 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 39.8 ttt85 -134.96 98.74 4.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.239 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.781 HG22 ' NE1' ' B' ' 95' ' ' TRP . 0.2 OUTLIER -101.49 151.13 5.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.391 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 2.5 m -128.28 143.41 51.02 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.467 HD22 ' HB ' ' B' ' 120' ' ' ILE . 0.4 OUTLIER -119.3 137.15 53.88 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.297 174.029 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.563 ' C ' HG22 ' B' ' 101' ' ' VAL . 9.7 p-10 -122.89 116.16 23.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.373 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.563 HG22 ' C ' ' B' ' 100' ' ' ASP . 0.0 OUTLIER -171.37 -45.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 120.785 0.326 . . . . 0.0 111.663 178.732 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.88 ' HB3' HD13 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -53.38 -1.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -175.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 103' ' ' HIS . . . . . 0.467 ' CE1' ' N ' ' B' ' 101' ' ' VAL . 0.1 OUTLIER -62.13 -26.12 68.13 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 118.51 -1.276 . . . . 0.0 108.409 175.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -84.42 -13.0 53.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.798 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' B' ' 102' ' ' ASN . . . -164.66 97.81 0.88 Allowed Pre-proline 0 CA--C 1.516 -0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.154 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.07 -42.74 0.37 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.352 2.035 . . . . 0.0 111.039 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.83 -31.43 13.72 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.485 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 37.33 0.74 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.367 0.603 . . . . 0.0 110.444 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.88 HD13 ' HB3' ' B' ' 102' ' ' ASN . 0.5 OUTLIER -117.11 146.62 43.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.033 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.444 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 1.2 m -136.88 120.94 17.72 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.889 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.416 HG13 HD11 ' B' ' 120' ' ' ILE . 0.5 OUTLIER -99.77 121.47 50.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.545 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.541 ' NZ ' ' HB2' ' B' ' 119' ' ' GLU . 14.8 pttp -132.47 120.94 22.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.107 0.48 . . . . 0.0 111.333 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.7 117.56 28.66 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' LYS . . . . . 0.575 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 1.3 ttmt -116.11 91.34 3.57 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.898 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' B' ' 114' ' ' LYS . 0.9 OUTLIER 28.73 63.98 0.12 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.457 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.52 -21.14 42.54 Favored Glycine 0 C--N 1.316 -0.534 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.607 HG22 HG23 ' B' ' 143' ' ' THR . 2.8 t -87.65 119.41 35.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.301 177.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 75.4 t -106.51 114.85 46.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.541 ' HB2' ' NZ ' ' B' ' 112' ' ' LYS . 1.1 mt-10 -130.45 145.14 51.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.227 0.537 . . . . 0.0 110.62 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.595 HG23 HD11 ' B' ' 109' ' ' LEU . 1.3 mp -116.94 118.98 60.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.791 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -95.7 123.87 39.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.341 -178.214 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -147.22 118.49 1.02 Allowed Glycine 0 C--N 1.333 0.393 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.56 143.31 24.58 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -123.97 158.6 31.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.91 0.386 . . . . 0.0 111.409 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.517 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.9 OUTLIER -95.35 145.1 25.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.284 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 126' ' ' GLU . . . . . 0.629 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 0.6 OUTLIER -1.65 96.94 0.01 OUTLIER 'General case' 0 C--O 1.238 0.485 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 127' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 127' ' ' ARG . 1.5 mtm180 -97.97 143.78 28.18 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.037 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -71.76 157.62 37.58 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' B' ' 130' ' ' GLU . 0.8 OUTLIER -157.19 168.96 25.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.036 0.446 . . . . 0.0 110.774 -178.495 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 130' ' ' GLU . . . . . 0.521 ' N ' ' CG ' ' B' ' 129' ' ' ASP . 0.9 OUTLIER -63.42 -34.84 78.62 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.609 -177.551 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 131' ' ' HIS . . . . . 0.476 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 82.2 m-70 -121.54 39.9 3.73 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.006 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 132' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 142' ' ' TYR . . . 135.65 -162.67 24.94 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.434 -1.365 . . . . 0.0 112.475 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -114.15 120.72 41.49 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' ILE . . . . . 0.471 HG22 ' HB3' ' B' ' 129' ' ' ASP . 0.0 OUTLIER -134.63 121.84 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -172.606 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 135' ' ' SER . . . . . 0.629 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -124.99 144.56 50.32 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 174.331 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -137.31 160.65 38.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.971 0.415 . . . . 0.0 111.296 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 22.4 p -120.37 133.47 55.43 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.99 137.05 52.45 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.816 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.75 123.41 15.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.044 177.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.45 124.18 42.3 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 174.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 141' ' ' LYS . . . . . 0.428 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 3.5 ttpp -117.15 127.1 53.79 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.716 0.293 . . . . 0.0 110.757 -175.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 142' ' ' TYR . . . . . 0.531 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 4.3 m-85 -116.71 97.98 6.28 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 143' ' ' THR . . . . . 0.607 HG23 HG22 ' B' ' 117' ' ' VAL . 0.3 OUTLIER -92.19 98.22 11.39 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.063 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 144' ' ' LEU . . . . . 0.423 ' C ' ' HD2' ' B' ' 146' ' ' PRO . 7.1 mp -109.98 91.69 11.5 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 145' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' B' ' 143' ' ' THR . 28.0 Cg_exo -64.73 -36.68 39.84 Favored 'Trans proline' 0 C--N 1.287 -2.708 0 C-N-CA 122.909 2.406 . . . . 0.0 113.303 175.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 146' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 65.4 Cg_exo -43.08 -12.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 122.142 1.895 . . . . 0.0 111.962 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 112.0 48.09 0.68 Allowed Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.607 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 148' ' ' VAL . . . . . 0.508 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -68.39 97.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 174.016 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 149' ' ' ASP . . . . . 0.506 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 0.1 OUTLIER -51.81 125.7 30.72 Favored Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.396 -170.484 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 2.8 Cg_exo -76.35 -29.43 6.19 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.375 2.05 . . . . 0.0 112.012 -177.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.8 -28.59 61.72 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.243 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 152' ' ' GLN . . . . . 0.558 ' O ' ' HB1' ' B' ' 167' ' ' ALA . 2.1 mt-30 -113.19 12.64 19.07 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -173.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 153' ' ' VAL . . . . . 0.474 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 25.1 t -106.28 113.77 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.127 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.93 173.76 6.22 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.31 135.57 27.07 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.22 140.9 39.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.586 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 157' ' ' LEU . . . . . 0.665 HD22 HD22 ' B' ' 109' ' ' LEU . 13.0 tp -134.86 126.62 29.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.619 0.247 . . . . 0.0 110.775 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 158' ' ' SER . . . . . 0.541 ' N ' HD12 ' B' ' 157' ' ' LEU . 1.5 t -114.0 148.9 40.98 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 159' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -40.97 -27.48 0.32 Allowed 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.982 2.455 . . . . 0.0 111.985 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 160' ' ' GLU . . . . . 0.515 ' H ' ' CD ' ' B' ' 160' ' ' GLU . 4.3 mp0 -63.58 -9.53 13.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.297 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 161' ' ' GLY . . . . . 0.52 ' O ' ' ND2' ' B' ' 102' ' ' ASN . . . 78.66 23.96 63.57 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 40.2 p -88.24 102.55 14.93 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.064 -0.568 . . . . 0.0 109.512 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.642 HD13 ' C ' ' B' ' 163' ' ' LEU . 1.7 tm? -99.91 95.1 6.66 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.68 126.51 35.01 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.676 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.599 ' O ' HG23 ' B' ' 165' ' ' VAL . 2.7 m -108.67 99.61 9.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 0.601 ' CD ' HH12 ' B' ' 94' ' ' ARG . 0.1 OUTLIER -108.26 135.63 49.25 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.988 -175.636 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 167' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' B' ' 152' ' ' GLN . . . 176.85 167.42 0.45 Allowed Pre-proline 0 N--CA 1.445 -0.697 0 C-N-CA 119.533 -0.867 . . . . 0.0 113.128 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 168' ' ' PRO . . . . . 0.451 ' HD2' ' HB1' ' B' ' 167' ' ' ALA . 1.3 Cg_endo -80.97 134.96 9.67 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 124.097 3.198 . . . . 0.0 109.467 174.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.699 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.378 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.423 ' NH2' ' OE2' ' A' ' 166' ' ' GLU . 4.3 mmm-85 . . . . . 0 C--O 1.236 0.386 0 CA-C-O 120.392 0.139 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.653 ' CZ3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -77.38 158.61 30.0 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 174.605 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.1 ttm-85 -152.84 99.21 2.41 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.146 -175.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.653 HG21 ' CZ3' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -119.83 157.83 21.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 176.579 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 27.7 m -131.4 144.55 51.28 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.878 HD22 HG13 ' A' ' 120' ' ' ILE . 1.4 mp -117.1 65.39 0.72 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.066 173.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.58 93.55 3.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.906 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' A' ' 103' ' ' HIS . 1.6 t -150.52 -43.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 121.14 0.495 . . . . 0.0 110.967 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.644 ' ND2' ' CD1' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -54.47 13.6 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -175.801 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.555 ' H ' ' C ' ' A' ' 101' ' ' VAL . 8.3 t-160 -49.72 -21.24 1.01 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.874 0.369 . . . . 0.0 110.453 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -101.98 1.67 36.93 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.821 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -141.93 89.21 8.99 Favored Pre-proline 0 CA--C 1.517 -0.313 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.755 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.5 -41.66 0.79 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.467 2.111 . . . . 0.0 111.456 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.429 ' C ' ' H ' ' A' ' 109' ' ' LEU . 14.3 t70 -105.22 -31.93 8.88 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.071 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -80.32 40.8 0.5 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.451 0.644 . . . . 0.0 110.441 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.85 HD22 HD22 ' A' ' 157' ' ' LEU . 0.7 OUTLIER -124.7 141.61 51.98 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.471 176.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.52 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -141.18 115.72 9.54 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.772 0.32 . . . . 0.0 110.819 -178.701 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.0 t -92.37 131.52 39.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.405 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.39 132.46 31.48 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.527 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.1 m -107.5 115.97 31.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.133 178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.441 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -117.74 79.25 1.33 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.05 0.452 . . . . 0.0 111.085 -177.164 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.8 t70 45.14 69.55 0.43 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.083 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.46 -22.25 14.06 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.5 HG22 HG23 ' A' ' 143' ' ' THR . 21.6 t -87.1 113.16 24.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 65.2 t -102.28 112.79 36.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 141' ' ' LYS . 42.4 mt-10 -125.93 149.04 49.04 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.283 0.563 . . . . 0.0 111.095 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.878 HG13 HD22 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -122.47 143.13 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.218 178.644 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -121.31 106.79 11.8 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.095 -178.262 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -138.51 128.77 4.26 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.32 128.83 11.41 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.702 0.401 . . . . 0.0 110.362 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.453 ' CD2' ' HA ' ' A' ' 135' ' ' SER . 1.4 p-80 -100.0 137.16 38.83 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 41.4 mt-10 -60.82 -27.48 68.09 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -174.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 0.8 OUTLIER 172.52 120.76 0.02 OUTLIER 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.329 0.513 . . . . 0.0 111.837 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.739 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.844 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.233 175.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.65 ' HA3' ' CE1' ' B' ' 142' ' ' TYR . . . . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 114.295 0.478 . . . . 0.0 114.295 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -95.07 109.84 21.84 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.677 HD12 ' NH1' ' B' ' 140' ' ' ARG . 0.0 OUTLIER -120.66 157.19 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -172.524 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.453 ' HA ' ' CD2' ' A' ' 124' ' ' HIS . 3.6 t -155.4 154.1 31.42 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.773 173.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.477 ' NH1' ' CZ ' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -147.0 174.74 11.25 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.336 -179.158 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 25.0 p -128.93 125.47 37.57 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -95.8 128.96 43.13 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.99 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.29 105.84 8.17 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.304 176.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.586 ' HG3' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -101.08 149.6 23.79 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.316 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.523 ' NZ ' ' OE1' ' B' ' 126' ' ' GLU . 1.6 ttpt -149.91 102.58 3.14 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.068 0.461 . . . . 0.0 110.506 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.56 ' OH ' ' NH1' ' A' ' 140' ' ' ARG . 10.6 m-85 -97.57 100.66 12.08 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.437 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.5 HG23 HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -88.51 89.37 7.96 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.192 0.52 . . . . 0.0 109.784 179.345 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.92 92.18 29.42 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.625 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 15.1 Cg_exo -68.02 -58.31 0.13 Allowed 'Trans proline' 0 C--N 1.285 -2.776 0 C-N-CA 122.141 1.894 . . . . 0.0 113.965 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.625 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 48.0 Cg_endo -100.51 51.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 123.406 2.737 . . . . 0.0 112.781 -175.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.67 -13.38 0.02 OUTLIER Glycine 0 N--CA 1.463 0.454 0 C-N-CA 120.237 -0.983 . . . . 0.0 112.269 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.629 HG21 ' CH2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -128.64 127.3 66.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.42 0.61 . . . . 0.0 110.861 178.523 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 18.8 t70 -83.5 140.75 41.63 Favored Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.557 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 3.0 Cg_exo -82.17 -25.04 3.53 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.18 1.92 . . . . 0.0 112.545 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.97 -36.68 13.29 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -175.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.763 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 8.9 mt-30 -109.29 31.84 5.43 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -173.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.41 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 39.5 t -115.47 124.88 72.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.716 177.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.69 -178.42 4.14 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.71 140.88 30.23 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.048 -0.661 . . . . 0.0 112.38 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -104.98 131.67 52.19 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.242 176.471 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.85 HD22 HD22 ' A' ' 109' ' ' LEU . 26.1 tp -129.87 125.52 35.81 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.021 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.587 ' HB3' ' OG1' ' A' ' 162' ' ' THR . 0.0 OUTLIER -106.04 162.23 20.37 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.559 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.4 -9.55 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.211 1.941 . . . . 0.0 110.786 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 158' ' ' SER . 3.6 mp0 -87.13 0.37 55.39 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.519 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.478 ' HA2' HD11 ' A' ' 157' ' ' LEU . . . 68.52 15.5 68.45 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -175.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.587 ' OG1' ' HB3' ' A' ' 158' ' ' SER . 3.0 p -74.0 99.25 3.24 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.616 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.7 tm? -102.08 92.12 4.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.871 -176.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.98 125.9 35.18 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.28 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 165' ' ' VAL . 5.3 m -103.3 103.03 14.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.595 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -119.41 148.72 42.9 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.12 -176.566 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.763 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 170.2 167.32 0.19 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.232 0.539 . . . . 0.0 112.138 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.568 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 60.9 Cg_endo -89.67 109.12 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.508 2.805 . . . . 0.0 110.065 176.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.3 169.91 14.89 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.136 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo . . . . . 0 N--CA 1.499 1.814 0 C-N-CA 123.281 2.654 . . . . 0.0 112.675 -178.196 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 94' ' ' ARG . . . . . 0.516 ' NH1' ' OE1' ' B' ' 166' ' ' GLU . 8.4 mmt85 . . . . . 0 N--CA 1.466 0.329 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' TRP . . . . . 0.499 ' O ' ' HA ' ' B' ' 166' ' ' GLU . 0.0 OUTLIER -72.48 145.85 47.26 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.036 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.415 ' HD3' HH11 ' B' ' 96' ' ' ARG . 11.2 ttm180 -133.84 109.05 8.82 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.387 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.14 156.23 18.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 98' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 3.3 m -134.2 149.89 51.03 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -174.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.709 HD22 ' CG1' ' B' ' 120' ' ' ILE . 0.5 OUTLIER -122.41 96.09 4.9 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.334 174.69 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.476 ' CG ' ' HE2' ' B' ' 103' ' ' HIS . 18.3 t70 -97.18 93.6 6.64 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.277 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.45 HG11 ' CE2' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -162.92 6.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-O 120.858 0.361 . . . . 0.0 111.103 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.841 ' HB2' HD13 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -90.46 -10.08 45.06 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -173.616 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 103' ' ' HIS . . . . . 0.476 ' HE2' ' CG ' ' B' ' 100' ' ' ASP . 0.8 OUTLIER -42.73 -29.01 0.27 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.611 ' HB2' ' CE1' ' B' ' 124' ' ' HIS . 59.6 m-85 -101.25 25.35 8.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -170.28 93.75 0.48 Allowed Pre-proline 0 C--O 1.223 -0.297 0 CA-C-O 120.673 0.273 . . . . 0.0 111.633 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.6 -60.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.436 2.091 . . . . 0.0 111.558 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' B' ' 109' ' ' LEU . 19.7 t70 -91.74 -30.98 15.96 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.945 0.403 . . . . 0.0 110.458 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -73.68 32.9 0.08 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.376 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.841 HD13 ' HB2' ' B' ' 102' ' ' ASN . 0.4 OUTLIER -128.54 128.71 44.82 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.543 177.089 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.4 130.15 50.15 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.974 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.566 HG13 ' CD1' ' B' ' 120' ' ' ILE . 1.9 t -105.09 114.08 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.02 134.46 54.84 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.518 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.02 115.46 29.01 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.535 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' LYS . . . . . 0.543 ' NZ ' ' OE2' ' B' ' 119' ' ' GLU . 0.0 OUTLIER -113.66 -171.43 1.89 Allowed 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -64.53 70.25 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' B' ' 114' ' ' LYS . . . 78.97 -8.32 45.32 Favored Glycine 0 CA--C 1.498 -1.008 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.52 HG22 HG23 ' B' ' 143' ' ' THR . 2.0 t -88.45 112.23 23.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.424 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 78.4 t -97.09 110.61 25.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.543 ' OE2' ' NZ ' ' B' ' 114' ' ' LYS . 29.5 mt-10 -126.76 117.36 22.52 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.168 0.509 . . . . 0.0 111.448 -176.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.709 ' CG1' HD22 ' B' ' 99' ' ' LEU . 6.1 mm -88.25 135.61 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.209 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.9 OUTLIER -115.7 111.51 20.7 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.445 -178.495 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.28 132.33 5.28 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -135.66 128.63 31.41 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' HIS . . . . . 0.611 ' CE1' ' HB2' ' B' ' 104' ' ' PHE . 28.3 m-70 -91.66 140.73 29.43 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.554 -177.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.5 OUTLIER -87.96 143.96 26.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.924 -178.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 126' ' ' GLU . . . . . 0.523 ' OE1' ' NZ ' ' A' ' 141' ' ' LYS . 2.5 tt0 -17.46 102.21 0.02 OUTLIER 'General case' 0 C--N 1.351 0.632 0 O-C-N 123.447 0.467 . . . . 0.0 112.068 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' ARG . . . . . 0.406 ' NH1' ' CE1' ' B' ' 104' ' ' PHE . 0.0 OUTLIER -94.86 149.98 20.67 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.055 -179.279 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -97.02 114.18 25.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.748 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.91 166.51 23.14 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -57.84 -26.9 62.67 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.955 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' HIS . . . . . 0.533 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 60.4 m-70 -80.07 14.31 1.91 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.652 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.78 -138.99 14.2 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -100.26 147.8 25.35 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' ILE . . . . . 0.535 HG23 ' O ' ' B' ' 134' ' ' ILE . 0.0 OUTLIER -156.04 117.54 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -175.244 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 135' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -131.04 153.3 49.42 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.061 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 136' ' ' ARG . . . . . 0.415 ' NH1' HD11 ' B' ' 134' ' ' ILE . 2.0 ptt180 -155.91 156.99 35.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.043 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 28.1 p -100.71 136.83 39.96 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 138' ' ' PHE . . . . . 0.477 ' CZ ' ' NH1' ' A' ' 136' ' ' ARG . 0.6 OUTLIER -114.64 123.51 49.49 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.576 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.6 118.2 20.66 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.281 0.563 . . . . 0.0 110.893 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 140' ' ' ARG . . . . . 0.677 ' NH1' HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -115.88 121.51 42.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 141' ' ' LYS . . . . . 0.49 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 3.6 ttpp -112.85 116.34 29.88 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 123.244 0.34 . . . . 0.0 110.958 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 142' ' ' TYR . . . . . 0.65 ' CE1' ' HA3' ' A' ' 132' ' ' GLY . 5.3 m-30 -107.56 97.54 7.26 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 143' ' ' THR . . . . . 0.594 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.2 OUTLIER -90.77 96.67 10.76 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 175.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 144' ' ' LEU . . . . . 0.479 ' C ' ' HD2' ' B' ' 146' ' ' PRO . 7.0 mp -108.44 94.46 13.71 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.821 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 145' ' ' PRO . . . . . 0.598 ' N ' ' HD2' ' B' ' 146' ' ' PRO . 24.0 Cg_exo -66.33 -34.42 35.21 Favored 'Trans proline' 0 C--N 1.287 -2.704 0 C-N-CA 122.636 2.224 . . . . 0.0 113.316 175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 146' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' B' ' 145' ' ' PRO . 27.7 Cg_exo -43.76 -10.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.991 1.794 . . . . 0.0 112.293 -178.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 111.36 44.65 0.9 Allowed Glycine 0 C--N 1.339 0.729 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.69 174.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 148' ' ' VAL . . . . . 0.498 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -68.51 101.83 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 175.141 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 149' ' ' ASP . . . . . 0.501 ' O ' HG23 ' B' ' 153' ' ' VAL . 13.5 t70 -52.31 126.4 36.97 Favored Pre-proline 0 C--O 1.221 -0.431 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.07 -172.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 5.1 Cg_exo -79.34 -18.98 10.67 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.11 1.873 . . . . 0.0 112.098 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.57 -38.25 12.61 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.558 -178.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 152' ' ' GLN . . . . . 0.453 ' N ' ' OD1' ' B' ' 149' ' ' ASP . 14.4 mt-30 -100.83 17.52 21.89 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 153' ' ' VAL . . . . . 0.501 HG23 ' O ' ' B' ' 149' ' ' ASP . 49.8 t -108.95 91.11 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.689 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.68 -166.08 1.51 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 155' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' B' ' 164' ' ' THR . 0.4 OUTLIER -163.57 142.54 8.08 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.751 -179.101 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 156' ' ' SER . . . . . 0.6 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.0 OUTLIER -111.81 144.63 40.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.028 178.017 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 157' ' ' LEU . . . . . 0.624 HD22 HD22 ' B' ' 109' ' ' LEU . 42.1 tp -130.76 117.09 18.89 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 158' ' ' SER . . . . . 0.403 ' HB3' HG22 ' B' ' 162' ' ' THR . 0.3 OUTLIER -103.57 152.01 38.78 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.813 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 159' ' ' PRO . . . . . 0.613 ' C ' ' H ' ' B' ' 161' ' ' GLY . 94.5 Cg_exo -44.11 -32.82 5.12 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.45 2.1 . . . . 0.0 110.972 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -68.5 22.04 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.087 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 161' ' ' GLY . . . . . 0.613 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 41.91 27.28 0.36 Allowed Glycine 0 CA--C 1.523 0.561 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.627 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 162' ' ' THR . . . . . 0.403 HG22 ' HB3' ' B' ' 158' ' ' SER . 9.0 t -88.14 118.55 27.8 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.656 HD13 ' C ' ' B' ' 163' ' ' LEU . 2.9 tm? -105.97 103.93 13.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.831 -177.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 164' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' B' ' 155' ' ' SER . 0.7 OUTLIER -94.53 125.49 39.21 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.033 0.208 . . . . 0.0 111.341 -179.051 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.567 ' O ' HG23 ' B' ' 165' ' ' VAL . 2.7 m -111.81 105.65 19.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 173.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 0.516 ' OE1' ' NH1' ' B' ' 94' ' ' ARG . 0.0 OUTLIER -114.29 137.61 51.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.722 -176.336 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 167' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' B' ' 169' ' ' MET . . . -168.75 158.21 7.94 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 168' ' ' PRO . . . . . 0.432 ' HD2' ' HB1' ' B' ' 167' ' ' ALA . 72.0 Cg_endo -75.83 30.44 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 123.871 3.047 . . . . 0.0 110.329 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 169' ' ' MET . . . . . 0.489 ' H ' ' C ' ' B' ' 167' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.441 -0.915 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.759 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.401 ' NH1' ' HB3' ' A' ' 168' ' ' PRO . 85.0 mmt-85 . . . . . 0 C--O 1.237 0.414 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.02 140.14 32.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.1 ttp85 -131.71 117.65 18.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.977 0.418 . . . . 0.0 111.48 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.13 134.85 65.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.192 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.6 m -111.11 135.34 51.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.573 HD22 ' HB ' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -111.86 72.98 0.8 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.851 175.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.458 ' O ' HG22 ' A' ' 101' ' ' VAL . 9.1 p-10 -77.56 110.57 12.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.999 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.488 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -160.48 -49.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.251 0.548 . . . . 0.0 110.907 177.829 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.764 HD22 ' H ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -58.6 14.07 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -174.778 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.488 ' H ' ' C ' ' A' ' 101' ' ' VAL . 0.9 OUTLIER -43.31 -41.67 4.14 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.348 0.594 . . . . 0.0 110.11 178.234 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.2 -4.24 52.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.453 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -133.15 73.46 74.64 Favored Pre-proline 0 CA--C 1.511 -0.543 0 CA-C-O 120.938 0.399 . . . . 0.0 112.031 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.5 -40.24 5.98 Favored 'Trans proline' 0 C--N 1.299 -2.073 0 C-N-CA 122.54 2.16 . . . . 0.0 111.565 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -99.74 -27.52 13.61 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.638 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.544 ' OE1' ' NZ ' ' A' ' 123' ' ' LYS . 70.5 mm-40 -88.53 35.41 0.77 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.092 0.472 . . . . 0.0 110.627 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -122.47 132.8 54.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.628 179.174 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 114.99 20.18 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-O 120.718 0.294 . . . . 0.0 110.609 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.505 HG13 HD11 ' A' ' 120' ' ' ILE . 2.4 t -95.7 130.17 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 pttm -140.23 128.78 22.86 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.606 -0.437 . . . . 0.0 111.462 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.07 115.3 24.37 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.59 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.4 OUTLIER -110.86 73.0 0.8 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.18 0.514 . . . . 0.0 110.27 -177.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER 34.54 67.98 0.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.389 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.56 -23.62 27.16 Favored Glycine 0 N--CA 1.465 0.611 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.636 HG22 HG23 ' A' ' 143' ' ' THR . 3.5 t -87.23 113.05 24.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 67.3 t -100.55 112.78 34.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.51 ' HG2' ' HB2' ' A' ' 141' ' ' LYS . 37.1 mt-10 -128.89 142.82 50.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.427 0.632 . . . . 0.0 111.628 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.573 ' HB ' HD22 ' A' ' 99' ' ' LEU . 1.1 mp -116.27 115.74 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.39 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -93.45 116.9 29.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.569 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.18 136.9 5.88 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.881 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.544 ' NZ ' ' OE1' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -128.19 159.31 35.58 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.151 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -97.72 135.27 39.74 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.738 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.47 ' O ' ' C ' ' A' ' 126' ' ' GLU . 6.1 tp10 -68.25 135.73 52.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 125' ' ' GLU . 10.6 tt0 -34.83 99.03 0.02 OUTLIER 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.77 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.757 -176.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.588 0 N-CA-C 112.686 -0.166 . . . . 0.0 112.686 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -94.57 109.64 21.52 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -119.33 137.99 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -172.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.412 ' OG ' ' N ' ' A' ' 136' ' ' ARG . 6.3 t -142.75 171.28 14.27 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.013 170.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.48 HH11 ' HD3' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -161.92 -176.82 5.43 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.868 -177.175 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.5 p -138.61 121.61 16.71 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -98.03 132.41 43.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.712 0.292 . . . . 0.0 111.501 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.63 101.17 7.31 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.497 ' NH1' ' OH ' ' A' ' 142' ' ' TYR . 1.9 ttt-85 -107.33 103.63 13.03 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.51 ' HB2' ' HG2' ' A' ' 119' ' ' GLU . 7.5 ttpt -112.72 129.83 56.27 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.033 0.444 . . . . 0.0 112.124 -175.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.497 ' OH ' ' NH1' ' A' ' 140' ' ' ARG . 22.3 m-85 -118.11 99.79 7.11 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.595 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.636 HG23 HG22 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -90.76 89.97 7.73 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.324 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.93 92.98 15.98 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.623 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 18.6 Cg_exo -65.77 -55.4 0.43 Allowed 'Trans proline' 0 C--N 1.289 -2.567 0 C-N-CA 121.86 1.706 . . . . 0.0 112.632 175.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.623 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 50.6 Cg_endo -103.84 92.06 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.78 2.986 . . . . 0.0 111.517 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.94 -16.31 1.19 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.216 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.771 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 0.9 OUTLIER -131.34 129.52 62.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-N 117.332 0.566 . . . . 0.0 111.077 177.567 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 13.4 t70 -94.37 143.55 26.52 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.165 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.456 ' HB3' ' HA ' ' A' ' 115' ' ' ASP . 3.3 Cg_exo -81.96 -26.02 3.18 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.823 1.682 . . . . 0.0 112.928 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.14 -37.35 16.25 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.735 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 20.5 mt-30 -107.2 27.99 8.51 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -172.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.572 HG22 ' HE3' ' A' ' 169' ' ' MET . 51.2 t -116.08 113.11 42.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.15 176.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.01 -173.01 2.2 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.29 131.82 11.34 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.837 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.76 139.67 39.98 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.728 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.641 HD22 HD22 ' A' ' 109' ' ' LEU . 14.9 tp -133.95 129.29 36.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.016 0.436 . . . . 0.0 110.85 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.593 ' N ' HD12 ' A' ' 157' ' ' LEU . 0.2 OUTLIER -113.9 148.97 41.06 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.969 178.422 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 161' ' ' GLY . 76.9 Cg_exo -40.04 -33.88 0.86 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.807 2.338 . . . . 0.0 112.11 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -74.21 31.43 0.08 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.396 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.51 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 43.91 25.83 0.71 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.388 -0.369 . . . . 0.0 112.992 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.4 t -87.58 101.51 13.7 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 117.228 0.514 . . . . 0.0 109.693 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.597 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.5 tm? -100.92 102.37 13.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.051 -177.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 p -97.62 123.05 41.37 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.703 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 165' ' ' VAL . 1.4 m -101.85 98.97 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.405 ' H ' ' HG2' ' A' ' 166' ' ' GLU . 0.1 OUTLIER -118.03 136.72 53.37 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.229 -174.627 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.791 ' HB3' ' HE3' ' A' ' 169' ' ' MET . . . -176.42 166.42 1.57 Allowed Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.068 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.545 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 58.6 Cg_endo -85.49 109.36 1.12 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.169 2.579 . . . . 0.0 110.126 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.791 ' HE3' ' HB3' ' A' ' 167' ' ' ALA . 37.8 mmt -87.22 152.69 53.2 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.79 -174.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo . . . . . 0 N--CA 1.495 1.607 0 C-N-CA 122.906 2.404 . . . . 0.0 111.708 178.413 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' TRP . . . . . 0.44 ' HB2' ' CG ' ' B' ' 169' ' ' MET . 0.6 OUTLIER -81.3 128.16 33.51 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.891 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -127.47 101.93 6.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.583 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.22 156.6 17.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 4.8 p -124.92 151.41 45.43 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.845 HD22 HG13 ' B' ' 120' ' ' ILE . 0.6 OUTLIER -122.85 43.47 2.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.777 172.323 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.77 97.81 0.11 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.635 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.432 ' C ' ' H ' ' B' ' 103' ' ' HIS . 2.5 t -158.62 -28.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.401 0.619 . . . . 0.0 109.486 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.599 HD21 ' C ' ' B' ' 105' ' ' ALA . 17.0 t30 -66.92 8.94 0.22 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.741 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' HIS . . . . . 0.432 ' H ' ' C ' ' B' ' 101' ' ' VAL . 25.9 m80 -39.64 -21.88 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' B' ' 102' ' ' ASN . 28.0 p90 -92.36 -34.56 14.13 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -176.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' ALA . . . . . 0.599 ' C ' HD21 ' B' ' 102' ' ' ASN . . . -113.52 76.64 2.91 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.3 -39.13 49.41 Favored 'Trans proline' 0 C--N 1.295 -2.259 0 C-N-CA 122.359 2.039 . . . . 0.0 112.237 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -102.0 -27.31 13.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.79 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.563 ' OE1' ' NZ ' ' B' ' 123' ' ' LYS . 32.3 mt-10 -92.69 41.58 1.08 Allowed 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.804 0.335 . . . . 0.0 111.206 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.739 HD22 HD22 ' B' ' 157' ' ' LEU . 0.4 OUTLIER -123.51 136.36 54.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.242 179.55 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.414 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -128.86 131.23 47.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.737 -179.352 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.01 119.46 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.37 135.26 53.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 0.0 111.312 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.66 115.33 29.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.369 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' LYS . . . . . 0.521 ' HD2' ' HB ' ' B' ' 117' ' ' VAL . 0.0 OUTLIER -116.0 90.5 3.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.377 -177.782 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 18.9 t0 33.48 69.21 0.14 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.07 -21.44 16.07 Favored Glycine 0 C--N 1.316 -0.572 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.642 HG22 HG23 ' B' ' 143' ' ' THR . 3.8 t -87.49 112.59 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.59 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 75.4 t -97.98 119.8 46.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.497 ' OE2' ' NZ ' ' B' ' 114' ' ' LYS . 33.7 mt-10 -133.96 139.88 46.39 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.49 0.662 . . . . 0.0 111.134 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.845 HG13 HD22 ' B' ' 99' ' ' LEU . 1.0 OUTLIER -116.78 137.46 50.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.494 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.82 119.53 35.69 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.281 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -142.87 124.7 2.42 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' LYS . . . . . 0.563 ' NZ ' ' OE1' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -150.66 140.51 21.86 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -116.94 157.94 24.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.224 0.535 . . . . 0.0 112.397 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.452 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.8 OUTLIER -68.52 145.49 53.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.275 179.082 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 126' ' ' GLU . . . . . 0.581 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 4.9 tt0 -29.98 102.1 0.02 OUTLIER 'General case' 0 C--N 1.349 0.546 0 CA-C-O 120.832 0.349 . . . . 0.0 111.174 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' B' ' 134' ' ' ILE . 0.2 OUTLIER -89.65 136.37 33.07 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.913 -177.882 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -90.7 117.28 29.22 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 172.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ASP . . . . . 0.465 ' HB2' HG22 ' B' ' 134' ' ' ILE . 0.6 OUTLIER -125.75 171.95 10.23 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.134 178.794 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -56.45 -31.78 64.3 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -174.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 131' ' ' HIS . . . . . 0.444 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 74.0 m80 -111.73 36.39 3.3 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -175.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 121.85 -173.29 15.74 Favored Glycine 0 C--N 1.305 -1.18 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.426 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' B' ' 127' ' ' ARG . 13.6 m-30 -95.94 118.92 33.5 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 134' ' ' ILE . . . . . 0.512 HG23 ' O ' ' B' ' 134' ' ' ILE . 0.1 OUTLIER -133.74 112.26 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -173.173 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 135' ' ' SER . . . . . 0.581 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -127.9 164.1 23.0 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.032 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 136' ' ' ARG . . . . . 0.498 ' NH2' ' O ' ' B' ' 134' ' ' ILE . 0.0 OUTLIER -161.76 161.94 29.43 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.588 -176.827 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 26.8 p -113.47 128.16 56.35 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -107.99 137.93 45.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -176.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.55 123.64 19.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.282 0.563 . . . . 0.0 111.046 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 140' ' ' ARG . . . . . 0.617 ' NH2' ' O ' ' B' ' 99' ' ' LEU . 0.0 OUTLIER -124.54 118.65 27.05 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 141' ' ' LYS . . . . . 0.468 ' HB2' ' HG2' ' B' ' 119' ' ' GLU . 1.1 ttpp -114.11 124.65 52.61 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.823 0.344 . . . . 0.0 110.874 -175.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 142' ' ' TYR . . . . . 0.59 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 3.3 m-85 -114.27 98.27 6.83 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.245 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 143' ' ' THR . . . . . 0.642 HG23 HG22 ' B' ' 117' ' ' VAL . 0.3 OUTLIER -91.33 101.49 14.18 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.727 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 mp -107.35 96.49 16.09 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 145' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' B' ' 143' ' ' THR . 36.0 Cg_exo -62.26 -38.18 56.53 Favored 'Trans proline' 0 C--N 1.286 -2.76 0 C-N-CA 123.375 2.717 . . . . 0.0 114.198 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 146' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 50.1 Cg_exo -47.34 -8.61 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.619 1.546 . . . . 0.0 111.515 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 97.83 56.73 1.07 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.2 -0.524 . . . . 0.0 111.979 175.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 148' ' ' VAL . . . . . 0.51 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -69.86 100.76 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 176.672 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 149' ' ' ASP . . . . . 0.504 ' O ' HG23 ' B' ' 153' ' ' VAL . 0.9 OUTLIER -33.83 120.23 0.5 Allowed Pre-proline 0 C--O 1.219 -0.509 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.411 -173.545 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 8.5 Cg_exo -71.86 -42.39 1.67 Allowed 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.425 2.083 . . . . 0.0 111.841 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -47.6 25.23 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.642 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 152' ' ' GLN . . . . . 0.665 ' O ' ' HB1' ' B' ' 167' ' ' ALA . 5.2 mt-30 -85.35 18.69 2.57 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.629 -1.169 . . . . 0.0 113.473 -172.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 153' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' B' ' 167' ' ' ALA . 33.4 t -114.0 106.65 21.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.471 177.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.44 -169.31 1.7 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -162.72 146.47 11.37 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.612 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 156' ' ' SER . . . . . 0.639 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.7 OUTLIER -120.67 144.77 48.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.684 177.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 157' ' ' LEU . . . . . 0.739 HD22 HD22 ' B' ' 109' ' ' LEU . 23.5 tp -134.9 148.65 50.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.342 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.02 156.81 79.64 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 159' ' ' PRO . . . . . 0.591 ' C ' ' H ' ' B' ' 161' ' ' GLY . 75.5 Cg_exo -39.61 -43.43 3.05 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.702 2.268 . . . . 0.0 111.402 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -66.97 26.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.21 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 161' ' ' GLY . . . . . 0.599 ' HA2' HD11 ' B' ' 157' ' ' LEU . . . 41.65 24.48 0.15 Allowed Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.734 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 162' ' ' THR . . . . . 0.516 ' O ' HD12 ' B' ' 157' ' ' LEU . 11.6 t -77.03 130.4 37.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.639 HD22 ' O ' ' B' ' 156' ' ' SER . 2.7 tm? -126.46 105.39 8.73 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.145 -175.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.28 121.8 38.46 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.575 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.2 m -105.51 98.94 7.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 0.0 OUTLIER -116.43 127.3 54.48 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.504 -175.058 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 167' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' B' ' 152' ' ' GLN . . . -171.1 158.06 5.07 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -82.49 126.47 4.75 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.478 2.785 . . . . 0.0 110.005 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 169' ' ' MET . . . . . 0.534 ' N ' ' SD ' ' B' ' 169' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.0 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.993 -176.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.528 HH21 ' CD ' ' A' ' 166' ' ' GLU . 30.4 mmm-85 . . . . . 0 C--O 1.238 0.483 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.497 ' NE1' ' CG2' ' A' ' 97' ' ' VAL . 37.7 t-105 -117.71 118.22 31.49 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.22 104.76 14.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.097 -175.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.497 ' CG2' ' NE1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -110.74 139.13 35.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 174.22 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 15.4 m -111.36 154.06 25.11 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.43 -0.508 . . . . 0.0 112.368 -176.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.751 HD22 HG12 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -131.05 67.13 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.591 176.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.19 89.48 4.27 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.86 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.484 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.2 OUTLIER -142.75 -36.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 121.226 0.536 . . . . 0.0 110.42 177.486 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.658 ' OD1' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -64.45 13.41 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.56 -176.256 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.484 ' H ' ' C ' ' A' ' 101' ' ' VAL . 2.1 p80 -54.63 -20.1 7.41 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.723 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.533 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 32.6 p90 -107.2 3.65 25.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.712 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.85 81.39 16.52 Favored Pre-proline 0 CA--C 1.518 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 111.223 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.99 -44.38 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.685 2.257 . . . . 0.0 111.324 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -104.6 -31.13 9.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.346 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.36 36.25 0.47 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.086 0.47 . . . . 0.0 110.655 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.695 ' CD2' HD22 ' A' ' 157' ' ' LEU . 0.3 OUTLIER -117.9 135.9 53.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.938 178.186 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.481 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 1.2 m -127.68 126.83 42.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.841 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.419 HG13 ' CD1' ' A' ' 120' ' ' ILE . 7.4 t -104.09 126.97 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.409 ' NZ ' ' CB ' ' A' ' 119' ' ' GLU . 3.4 pttp -133.17 130.95 39.85 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.058 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 45.3 m -112.05 109.17 18.76 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.59 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.522 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 3.3 ttmm -114.43 99.89 7.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.257 -177.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 114' ' ' LYS . 15.6 t0 26.1 64.23 0.07 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.86 -19.81 52.07 Favored Glycine 0 N--CA 1.461 0.308 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 2.7 t -88.67 112.55 24.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.537 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.12 114.6 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 140' ' ' ARG . 46.1 mt-10 -127.46 133.57 49.9 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.266 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.751 HG12 HD22 ' A' ' 99' ' ' LEU . 4.0 mm -104.25 137.19 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.979 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -118.89 107.59 13.77 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.192 -178.133 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -135.17 115.03 1.32 Allowed Glycine 0 N--CA 1.461 0.357 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 159.58 41.22 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 104' ' ' PHE . 1.7 t60 -139.72 141.49 36.9 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.416 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.502 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.3 OUTLIER -81.45 150.22 28.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.063 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.531 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 4.9 tt0 -1.4 108.93 0.01 OUTLIER 'General case' 0 C--N 1.349 0.556 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? . . . . . 0 C--O 1.233 0.197 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.565 176.172 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.45 ' HA3' ' CZ ' ' B' ' 142' ' ' TYR . . . . . . . . 0 C--O 1.221 -0.718 0 N-CA-C 112.158 -0.377 . . . . 0.0 112.158 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -92.35 107.85 19.52 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.634 HD13 ' NH2' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -125.93 117.53 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -174.289 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.531 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -109.17 149.57 29.16 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.401 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.634 ' NH2' HD13 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -133.16 172.43 12.67 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -174.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 23.7 p -141.13 131.75 25.55 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.426 ' CD2' HG11 ' A' ' 101' ' ' VAL . 7.3 m-85 -107.09 139.48 41.44 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.136 -0.225 . . . . 0.0 111.034 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.8 104.47 6.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.395 0.617 . . . . 0.0 110.364 175.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.6 ' HD3' HD23 ' A' ' 99' ' ' LEU . 12.5 ttt180 -108.01 100.54 9.88 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.48 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 6.6 ttpt -107.67 116.04 31.23 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.287 -175.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.569 ' OH ' ' NE ' ' A' ' 140' ' ' ARG . 19.9 m-30 -114.52 99.6 7.67 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.3 0.571 . . . . 0.0 110.144 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.497 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -86.29 89.03 7.73 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.377 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mp -112.1 91.52 16.03 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.656 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 15.3 Cg_exo -68.18 -56.41 0.2 Allowed 'Trans proline' 0 C--N 1.294 -2.311 0 C-N-CA 122.359 2.039 . . . . 0.0 113.831 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.656 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 37.4 Cg_endo -99.3 53.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 123.327 2.685 . . . . 0.0 112.408 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -171.45 -12.91 0.02 OUTLIER Glycine 0 CA--C 1.521 0.429 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.569 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.587 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 1.0 OUTLIER -130.26 125.11 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 117.68 0.74 . . . . 0.0 111.187 178.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.497 ' HB2' ' HD3' ' A' ' 170' ' ' PRO . 14.2 t70 -81.91 140.69 46.85 Favored Pre-proline 0 N--CA 1.478 0.962 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.293 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 5.8 Cg_exo -81.1 -26.45 3.46 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.027 1.818 . . . . 0.0 113.0 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.411 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 0.8 OUTLIER -91.19 -36.38 13.98 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -176.257 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.689 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 4.6 mt-30 -107.72 27.22 9.4 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -172.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 41.7 t -113.3 104.94 17.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.67 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.31 -161.77 0.89 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.717 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.1 132.07 2.94 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.335 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -100.82 139.81 35.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.591 177.459 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.695 HD22 ' CD2' ' A' ' 109' ' ' LEU . 42.1 tp -137.53 138.13 39.33 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.176 0.513 . . . . 0.0 110.981 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.729 ' HB2' HG22 ' A' ' 162' ' ' THR . 23.1 m -121.88 146.06 45.07 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.631 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 161' ' ' GLY . 75.4 Cg_exo -41.27 -34.8 1.86 Allowed 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.065 1.843 . . . . 0.0 110.897 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.411 ' CD ' ' H ' ' A' ' 160' ' ' GLU . 2.1 mp0 -65.31 2.86 0.75 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.076 177.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 158' ' ' SER . . . 67.09 21.2 71.62 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.894 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.729 HG22 ' HB2' ' A' ' 158' ' ' SER . 0.7 OUTLIER -77.24 106.82 9.21 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.568 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.2 tm? -106.94 101.52 10.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.752 -175.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.42 120.24 39.29 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 121.289 -0.165 . . . . 0.0 110.66 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 165' ' ' VAL . 1.5 m -100.93 99.18 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.528 ' CD ' HH21 ' A' ' 94' ' ' ARG . 1.4 pp20? -112.71 146.21 39.12 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.674 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 175.13 166.64 0.37 Allowed Pre-proline 0 N--CA 1.437 -1.103 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.206 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.586 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 72.8 Cg_endo -86.41 106.33 0.77 Allowed 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.803 2.335 . . . . 0.0 108.735 175.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.587 ' SD ' ' HA ' ' A' ' 148' ' ' VAL . 20.5 mmt -74.66 153.95 87.39 Favored Pre-proline 0 C--N 1.31 -1.126 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.554 -174.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 149' ' ' ASP . 38.4 Cg_endo . . . . . 0 C--N 1.303 -1.854 0 C-N-CA 122.626 2.217 . . . . 0.0 111.684 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' ARG . . . . . 0.478 ' NH1' ' OE1' ' B' ' 166' ' ' GLU . 9.0 mmt85 . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' TRP . . . . . 0.685 ' HB2' ' SD ' ' B' ' 169' ' ' MET . 0.3 OUTLIER -55.51 151.11 10.89 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.133 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.607 ' HB2' ' NH1' ' B' ' 96' ' ' ARG . 16.3 ttm105 -150.13 109.4 3.96 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.684 -176.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 t -119.1 152.27 21.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 1.5 m -126.05 144.29 50.78 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -176.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.689 HD23 ' NE ' ' B' ' 140' ' ' ARG . 0.3 OUTLIER -115.39 54.64 0.79 Allowed 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.447 176.442 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.55 ' O ' HG22 ' B' ' 101' ' ' VAL . 0.1 OUTLIER -62.32 96.96 0.08 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.018 -178.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.55 HG22 ' O ' ' B' ' 100' ' ' ASP . 0.6 OUTLIER -162.0 -6.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 176.48 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.697 ' CB ' HD13 ' B' ' 109' ' ' LEU . 0.4 OUTLIER -90.5 10.15 26.52 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -175.019 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 103' ' ' HIS . . . . . 0.504 ' N ' ' HA3' ' B' ' 161' ' ' GLY . 0.2 OUTLIER -39.63 -35.04 0.27 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.72 0.295 . . . . 0.0 111.155 179.472 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.6 -8.83 51.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' B' ' 102' ' ' ASN . . . -138.72 93.34 10.88 Favored Pre-proline 0 CA--C 1.515 -0.383 0 CA-C-O 120.696 0.284 . . . . 0.0 111.298 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -81.17 -48.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.967 0 C-N-CA 122.68 2.253 . . . . 0.0 110.933 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -90.29 -31.2 17.05 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.523 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.518 ' OE2' ' NZ ' ' B' ' 123' ' ' LYS . 2.8 mt-10 -84.63 45.09 1.1 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.369 0.604 . . . . 0.0 109.897 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.697 HD13 ' CB ' ' B' ' 102' ' ' ASN . 0.5 OUTLIER -129.44 135.98 49.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.013 178.321 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.96 121.73 22.06 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.571 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 1.5 t -98.99 131.78 45.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.814 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.443 ' HZ3' ' CD ' ' B' ' 119' ' ' GLU . 2.9 pttp -139.78 122.28 16.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.101 0.477 . . . . 0.0 111.755 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.7 117.54 34.27 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' LYS . . . . . 0.558 ' O ' ' N ' ' B' ' 117' ' ' VAL . 1.3 ttpm? -128.96 112.01 13.62 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.348 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' ASP . . . . . 0.492 ' OD1' ' NZ ' ' B' ' 114' ' ' LYS . 0.3 OUTLIER 34.64 59.89 0.64 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.91 0.862 . . . . 0.0 112.481 176.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.91 -12.1 31.55 Favored Glycine 0 C--N 1.314 -0.657 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 1.028 HG22 HG23 ' B' ' 143' ' ' THR . 9.0 t -87.47 115.46 28.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.762 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 54.2 t -103.66 112.67 38.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.571 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.591 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 49.4 mt-10 -125.96 146.47 49.85 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.599 0.714 . . . . 0.0 111.546 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.532 ' HB ' HD22 ' B' ' 99' ' ' LEU . 1.3 mp -119.79 121.56 66.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.307 178.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -97.44 124.3 41.58 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.2 117.59 0.86 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' LYS . . . . . 0.518 ' NZ ' ' OE2' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -152.82 135.5 15.31 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.363 0.265 . . . . 0.0 110.489 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 124' ' ' HIS . . . . . 0.515 ' O ' ' CB ' ' B' ' 135' ' ' SER . 0.1 OUTLIER -111.96 123.55 50.49 Favored 'General case' 0 C--O 1.21 -0.989 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.343 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.477 ' H ' ' HG3' ' B' ' 125' ' ' GLU . 4.9 mt-10 -54.05 -21.43 8.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -176.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 178.61 131.11 0.07 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.989 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' ARG . . . . . 0.483 ' HD3' ' CE1' ' B' ' 124' ' ' HIS . 38.9 mtp180 -123.69 132.08 53.75 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.146 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -81.56 138.7 35.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.936 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ASP . . . . . 0.506 ' CG ' ' N ' ' B' ' 130' ' ' GLU . 9.2 t70 -157.37 165.89 34.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.205 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 130' ' ' GLU . . . . . 0.506 ' N ' ' CG ' ' B' ' 129' ' ' ASP . 0.7 OUTLIER -61.4 -28.28 69.14 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.639 -177.119 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 131' ' ' HIS . . . . . 0.48 ' O ' ' CE1' ' A' ' 142' ' ' TYR . 10.6 m-70 -74.78 -12.55 60.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.758 0.313 . . . . 0.0 111.013 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.74 -136.95 8.96 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -112.25 134.99 53.48 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 175.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' B' ' 127' ' ' ARG . 0.4 OUTLIER -146.75 125.76 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -176.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 135' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' B' ' 124' ' ' HIS . 0.6 OUTLIER -142.99 158.01 44.0 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.029 0.442 . . . . 0.0 111.283 174.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 136' ' ' ARG . . . . . 0.472 ' CZ ' ' CZ ' ' B' ' 138' ' ' PHE . 0.2 OUTLIER -141.77 173.7 11.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.865 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 31.9 p -123.74 129.91 51.82 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 138' ' ' PHE . . . . . 0.472 ' CZ ' ' CZ ' ' B' ' 136' ' ' ARG . 1.1 m-85 -104.86 122.35 45.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.936 -176.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 139' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 134' ' ' ILE . 0.0 OUTLIER -124.83 99.47 6.16 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.137 174.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 140' ' ' ARG . . . . . 0.689 ' NE ' HD23 ' B' ' 99' ' ' LEU . 0.0 OUTLIER -106.63 119.58 39.68 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.288 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 141' ' ' LYS . . . . . 0.591 ' HA ' ' HG2' ' B' ' 119' ' ' GLU . 2.7 ttpt -120.19 130.72 54.68 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.07 0.462 . . . . 0.0 111.206 -176.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 142' ' ' TYR . . . . . 0.572 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 7.8 m-85 -120.27 98.74 6.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.961 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 143' ' ' THR . . . . . 1.028 HG23 HG22 ' B' ' 117' ' ' VAL . 1.3 m -93.52 93.66 8.22 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -110.95 90.95 11.86 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.584 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 145' ' ' PRO . . . . . 0.611 ' HD2' ' CD ' ' B' ' 146' ' ' PRO . 16.2 Cg_exo -68.72 -41.19 6.18 Favored 'Trans proline' 0 C--N 1.279 -3.096 0 C-N-CA 122.06 1.84 . . . . 0.0 112.125 167.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 146' ' ' PRO . . . . . 0.611 ' CD ' ' HD2' ' B' ' 145' ' ' PRO . 74.2 Cg_exo -43.21 -11.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 123.325 2.683 . . . . 0.0 114.606 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 149.02 44.64 0.03 OUTLIER Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 118.239 -1.934 . . . . 0.0 115.447 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.29 116.56 52.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 118.73 -1.188 . . . . 0.0 110.667 173.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 149' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 19.3 t70 -80.02 140.33 53.71 Favored Pre-proline 0 C--O 1.221 -0.407 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.03 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 4.2 Cg_exo -81.4 -23.89 4.78 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.074 1.85 . . . . 0.0 112.9 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.15 -43.68 9.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.975 0.417 . . . . 0.0 112.072 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -94.93 18.97 10.94 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 153' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 42.5 t -108.83 104.94 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.088 0.471 . . . . 0.0 109.888 176.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.43 -175.38 3.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.237 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.01 132.79 8.46 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.717 -0.793 . . . . 0.0 112.291 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 156' ' ' SER . . . . . 0.453 ' HG ' ' HG1' ' B' ' 164' ' ' THR . 0.0 OUTLIER -106.56 139.84 40.39 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.222 179.383 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 157' ' ' LEU . . . . . 0.671 HD22 HD22 ' B' ' 109' ' ' LEU . 33.0 tp -131.08 143.12 50.43 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 158' ' ' SER . . . . . 0.416 ' OG ' ' HD2' ' B' ' 159' ' ' PRO . 0.2 OUTLIER -135.58 154.38 78.22 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.639 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 159' ' ' PRO . . . . . 0.57 ' C ' ' H ' ' B' ' 161' ' ' GLY . 1.2 Cg_endo -44.8 -34.79 8.87 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.693 2.262 . . . . 0.0 111.491 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -68.74 24.12 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.034 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 161' ' ' GLY . . . . . 0.612 ' HA2' ' OD1' ' B' ' 102' ' ' ASN . . . 44.03 34.03 2.95 Favored Glycine 0 C--O 1.241 0.532 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.638 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 7.4 t -97.16 121.46 39.08 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.623 HD13 ' C ' ' B' ' 163' ' ' LEU . 1.8 tm? -115.84 103.86 11.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.953 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 164' ' ' THR . . . . . 0.453 ' HG1' ' HG ' ' B' ' 156' ' ' SER . 0.8 OUTLIER -97.59 121.72 39.82 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 121.13 -0.228 . . . . 0.0 110.803 179.561 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.587 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.1 m -106.49 103.33 15.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 0.478 ' OE1' ' NH1' ' B' ' 94' ' ' ARG . 2.0 pp20? -113.22 151.84 30.5 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.278 -177.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 167' ' ' ALA . . . . . 0.632 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -174.62 154.25 1.89 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 0.0 111.628 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.06 -4.7 11.24 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 123.018 2.479 . . . . 0.0 109.906 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 169' ' ' MET . . . . . 0.685 ' SD ' ' HB2' ' B' ' 95' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.388 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 94' ' ' ARG . 10.9 mmt180 . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.566 ' CB ' ' SD ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -68.45 145.17 54.32 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.129 -179.479 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -138.66 105.96 5.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.487 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.22 155.11 13.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 175.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.62 148.64 51.53 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -174.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.656 HD23 ' NE ' ' A' ' 140' ' ' ARG . 0.7 OUTLIER -130.13 118.91 22.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.102 174.381 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.461 ' CG ' ' HE2' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -112.28 114.08 26.66 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.536 -178.359 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.581 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -161.14 -43.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 120.89 0.376 . . . . 0.0 111.445 179.549 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.683 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -60.27 17.0 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.581 ' H ' ' C ' ' A' ' 101' ' ' VAL . 12.0 m80 -52.67 -38.09 59.88 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -105.69 -15.14 15.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.645 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -118.13 81.93 17.22 Favored Pre-proline 0 CA--C 1.516 -0.346 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -74.36 -44.66 0.4 Allowed 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 122.612 2.208 . . . . 0.0 110.924 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -92.55 -31.47 15.19 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.759 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -89.44 45.86 1.32 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.151 0.5 . . . . 0.0 111.14 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.789 HD22 HD22 ' A' ' 157' ' ' LEU . 0.4 OUTLIER -133.34 130.29 38.64 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.185 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 m -128.61 124.56 36.16 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 120.783 0.325 . . . . 0.0 110.512 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.41 HG13 HD11 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -96.51 127.4 48.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.984 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.85 130.13 43.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.856 0.36 . . . . 0.0 111.406 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.91 104.0 13.37 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.625 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -109.43 103.32 12.21 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.528 -175.871 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.474 ' CG ' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER 36.06 41.44 0.13 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 177.075 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.03 -11.52 57.32 Favored Glycine 0 C--N 1.314 -0.651 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.716 HG22 HG23 ' A' ' 143' ' ' THR . 2.6 t -86.73 117.25 30.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.581 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 55.4 t -102.81 116.51 46.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.504 ' OE1' ' NZ ' ' A' ' 114' ' ' LYS . 2.2 mt-10 -133.51 140.2 47.09 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.272 0.558 . . . . 0.0 111.521 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.41 HD11 HG13 ' A' ' 111' ' ' VAL . 1.2 mp -111.44 115.54 50.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.154 177.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -92.0 118.67 31.0 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.776 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.17 129.99 4.28 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.118 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.72 159.28 44.63 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -133.68 162.13 32.79 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.36 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.523 ' O ' ' C ' ' A' ' 126' ' ' GLU . 1.5 tt0 -90.28 143.33 26.86 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.851 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.523 ' C ' ' O ' ' A' ' 125' ' ' GLU . 1.0 OUTLIER -18.12 105.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.645 0.591 . . . . 0.0 111.846 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.514 -0.436 0 CA-C-O 120.897 0.379 . . . . 0.0 110.428 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.463 ' HA3' ' CZ ' ' B' ' 142' ' ' TYR . . . . . . . . 0 N--CA 1.439 -1.102 0 N-CA-C 112.014 -0.435 . . . . 0.0 112.014 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -92.2 109.71 21.08 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.47 159.34 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -169.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.9 t -155.06 154.81 33.02 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.762 170.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.55 172.27 15.76 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.928 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.5 p -125.97 128.36 47.38 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -102.68 142.25 34.14 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.352 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.55 103.02 3.63 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.086 0.47 . . . . 0.0 111.554 176.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.656 ' NE ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -104.16 119.63 39.37 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 174.336 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.5 ' NZ ' ' OE1' ' B' ' 126' ' ' GLU . 2.7 ttpt -118.4 123.58 45.59 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 123.21 0.319 . . . . 0.0 110.666 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.581 ' HB2' ' HB ' ' A' ' 118' ' ' VAL . 3.2 m-85 -112.96 99.16 7.66 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.993 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.716 HG23 HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -92.0 90.25 7.32 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.548 178.503 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.44 91.94 21.69 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.643 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 16.0 Cg_exo -67.47 -56.94 0.19 Allowed 'Trans proline' 0 C--N 1.288 -2.641 0 C-N-CA 122.349 2.033 . . . . 0.0 114.207 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.643 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 41.8 Cg_endo -100.61 56.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.482 0.815 0 C-N-CA 123.377 2.718 . . . . 0.0 113.035 -175.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.502 ' O ' ' HB3' ' A' ' 169' ' ' MET . . . -176.76 -14.35 0.02 OUTLIER Glycine 0 N--CA 1.466 0.634 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.713 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.03 132.21 68.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 117.539 0.67 . . . . 0.0 110.153 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 13.0 t70 -93.44 141.15 23.54 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.204 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 2.4 Cg_endo -82.66 -21.4 5.08 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.095 1.863 . . . . 0.0 112.7 -177.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.45 -41.69 10.71 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.386 -175.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -101.29 14.44 31.96 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -171.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.683 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 24.9 t -102.75 117.09 47.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.387 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.02 166.69 11.18 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.62 137.46 35.33 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.112 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.412 ' OG ' ' OG1' ' A' ' 164' ' ' THR . 0.0 OUTLIER -111.57 138.57 47.94 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.872 177.499 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.789 HD22 HD22 ' A' ' 109' ' ' LEU . 14.8 tp -125.13 121.77 35.18 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.388 0.43 . . . . 0.0 110.364 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 161' ' ' GLY . 0.2 OUTLIER -96.07 138.28 21.65 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -39.95 -33.19 0.7 Allowed 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.556 2.171 . . . . 0.0 111.185 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -59.23 -5.54 0.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.344 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.537 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . 76.69 34.41 43.87 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.4 t -109.89 118.76 37.33 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.605 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.1 tm? -104.25 108.65 20.14 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.597 -174.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.412 ' OG1' ' OG ' ' A' ' 156' ' ' SER . 3.4 p -95.43 127.94 41.88 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.605 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 165' ' ' VAL . 2.7 m -113.47 103.33 15.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 1.6 pp20? -119.11 141.82 48.45 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.201 -176.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.683 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . . . -174.48 157.85 2.44 Favored Pre-proline 0 C--N 1.332 -0.193 0 C-N-CA 120.024 -0.671 . . . . 0.0 112.618 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.424 ' HD3' ' NH1' ' A' ' 94' ' ' ARG . 61.6 Cg_endo -83.35 108.73 1.55 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.736 2.291 . . . . 0.0 108.84 172.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.566 ' SD ' ' CB ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -87.59 156.09 53.43 Favored Pre-proline 0 C--N 1.305 -1.337 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.745 -174.007 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 C--N 1.312 -1.351 0 C-N-CA 122.673 2.248 . . . . 0.0 111.43 179.677 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 94' ' ' ARG . . . . . 0.473 HH11 ' HB3' ' B' ' 94' ' ' ARG . 0.2 OUTLIER . . . . . 0 CA--C 1.516 -0.361 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 95' ' ' TRP . . . . . 0.672 ' HB2' ' SD ' ' B' ' 169' ' ' MET . 0.1 OUTLIER -63.83 139.99 58.82 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.192 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.401 ' HD2' HH11 ' B' ' 96' ' ' ARG . 19.7 ttm105 -134.45 99.08 4.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.138 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 t -105.87 152.21 7.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 9.0 m -129.17 144.26 51.15 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -175.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.888 HD22 HG12 ' B' ' 120' ' ' ILE . 0.5 OUTLIER -113.79 52.54 0.81 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.527 175.119 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -59.48 97.09 0.04 OUTLIER 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.9 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.514 HG11 ' HD3' ' B' ' 140' ' ' ARG . 7.2 p -167.93 -2.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.828 ' CB ' HD13 ' B' ' 109' ' ' LEU . 0.4 OUTLIER -90.99 11.95 21.27 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.616 178.227 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -59.16 -14.38 10.26 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.438 ' N ' ' C ' ' B' ' 102' ' ' ASN . 13.7 t80 -85.67 -9.97 56.41 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.603 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.68 98.12 0.48 Allowed Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.423 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.453 ' HA ' ' ND2' ' B' ' 102' ' ' ASN . 57.7 Cg_endo -76.3 -40.94 0.53 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.672 2.248 . . . . 0.0 111.875 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.17 -32.21 12.59 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.367 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.537 ' CD ' ' NZ ' ' B' ' 123' ' ' LYS . 1.9 mm-40 -89.8 49.67 1.76 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.485 0.659 . . . . 0.0 110.358 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.828 HD13 ' CB ' ' B' ' 102' ' ' ASN . 0.4 OUTLIER -129.36 135.22 48.44 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.575 178.8 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.7 121.95 34.92 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.609 HG13 HD12 ' B' ' 120' ' ' ILE . 0.5 OUTLIER -100.32 131.64 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.448 ' NZ ' ' OG1' ' B' ' 121' ' ' THR . 0.0 OUTLIER -134.89 124.12 24.51 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.354 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.6 m -94.63 116.32 28.62 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 114' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' B' ' 116' ' ' GLY . 1.5 ttmp? -120.02 143.8 47.88 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -22.85 71.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' B' ' 114' ' ' LYS . . . 83.07 -2.51 86.79 Favored Glycine 0 N--CA 1.472 1.09 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.624 HG13 HG23 ' B' ' 143' ' ' THR . 2.3 t -102.93 114.47 42.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.598 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 48.0 t -98.11 120.02 46.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.505 ' C ' HD13 ' B' ' 120' ' ' ILE . 33.7 mt-10 -133.5 136.14 44.89 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.179 0.514 . . . . 0.0 110.62 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.888 HG12 HD22 ' B' ' 99' ' ' LEU . 3.2 mm -111.82 138.07 41.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.622 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' THR . . . . . 0.448 ' OG1' ' NZ ' ' B' ' 112' ' ' LYS . 0.2 OUTLIER -115.89 120.28 38.71 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.133 -179.587 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.8 135.64 5.51 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.768 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' LYS . . . . . 0.537 ' NZ ' ' CD ' ' B' ' 108' ' ' GLU . 0.2 OUTLIER -150.2 159.08 44.7 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.219 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 124' ' ' HIS . . . . . 0.486 ' CG ' ' HD2' ' B' ' 127' ' ' ARG . 2.0 t60 -132.72 156.34 47.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.674 0.273 . . . . 0.0 110.273 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.546 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.6 OUTLIER -92.24 131.68 37.27 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.346 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 126' ' ' GLU . . . . . 0.569 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 1.5 tt0 -3.11 97.7 0.01 OUTLIER 'General case' 0 C--N 1.344 0.334 0 O-C-N 123.751 0.657 . . . . 0.0 112.47 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 127' ' ' ARG . . . . . 0.486 ' HD2' ' CG ' ' B' ' 124' ' ' HIS . 31.5 mtp180 -90.16 146.9 23.93 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.095 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -88.8 131.78 34.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.325 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -134.71 163.36 29.96 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.052 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.65 -14.12 60.56 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.042 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' HIS . . . . . 0.521 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 69.2 m-70 -114.04 29.03 8.31 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.491 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.71 -153.12 17.36 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 119.728 -1.225 . . . . 0.0 111.611 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -112.89 127.94 56.33 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 134' ' ' ILE . . . . . 0.506 HD11 ' NH2' ' B' ' 136' ' ' ARG . 0.1 OUTLIER -135.29 123.48 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -175.192 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 135' ' ' SER . . . . . 0.569 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.1 OUTLIER -134.32 160.43 37.94 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 174.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 136' ' ' ARG . . . . . 0.506 ' NH2' HD11 ' B' ' 134' ' ' ILE . 10.4 ptp85 -156.85 166.07 34.42 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.563 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 27.5 p -117.84 136.42 53.44 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 138' ' ' PHE . . . . . 0.497 ' CE2' ' HD2' ' B' ' 136' ' ' ARG . 11.1 m-85 -106.89 138.18 43.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.276 -177.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.15 126.18 10.56 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.951 174.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 140' ' ' ARG . . . . . 0.514 ' HD3' HG11 ' B' ' 101' ' ' VAL . 0.0 OUTLIER -131.23 112.92 13.23 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.553 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 141' ' ' LYS . . . . . 0.437 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 11.3 ttmt -101.28 119.08 38.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.931 0.395 . . . . 0.0 110.556 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 142' ' ' TYR . . . . . 0.598 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 4.3 m-85 -109.48 97.58 7.12 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 143' ' ' THR . . . . . 0.624 HG23 HG13 ' B' ' 117' ' ' VAL . 0.0 OUTLIER -91.66 96.59 10.53 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 177.559 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.87 90.23 12.78 Favored Pre-proline 0 CA--C 1.514 -0.409 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.429 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 145' ' ' PRO . . . . . 0.611 ' HD2' ' CD ' ' B' ' 146' ' ' PRO . 17.1 Cg_exo -68.49 -40.6 7.6 Favored 'Trans proline' 0 C--N 1.285 -2.793 0 C-N-CA 122.38 2.053 . . . . 0.0 112.127 168.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 146' ' ' PRO . . . . . 0.611 ' CD ' ' HD2' ' B' ' 145' ' ' PRO . 71.4 Cg_exo -43.07 -8.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 123.554 2.836 . . . . 0.0 114.194 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 134.69 64.77 0.07 OUTLIER Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 118.964 -1.588 . . . . 0.0 114.879 176.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 148' ' ' VAL . . . . . 0.416 ' O ' HG12 ' B' ' 148' ' ' VAL . 1.1 t -123.74 108.55 21.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.365 172.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 149' ' ' ASP . . . . . 0.485 ' O ' HG23 ' B' ' 153' ' ' VAL . 10.7 p-10 -76.9 127.89 82.79 Favored Pre-proline 0 N--CA 1.472 0.659 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.885 -176.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 3.0 Cg_exo -75.81 -30.47 6.03 Favored 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 122.156 1.904 . . . . 0.0 113.848 -173.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 1.2 p -76.64 -36.57 57.32 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.883 0.373 . . . . 0.0 110.889 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -101.74 1.81 37.78 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 153' ' ' VAL . . . . . 0.711 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 42.2 t -96.15 103.12 14.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.777 175.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.14 177.28 4.89 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.4 138.98 33.36 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.423 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.97 132.43 54.22 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.464 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 157' ' ' LEU . . . . . 0.713 HD11 ' OD1' ' B' ' 102' ' ' ASN . 25.0 tp -125.57 142.13 51.67 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.055 0.455 . . . . 0.0 110.744 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 158' ' ' SER . . . . . 0.475 ' O ' ' N ' ' B' ' 161' ' ' GLY . 0.2 OUTLIER -132.51 141.01 39.66 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.172 178.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 159' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' B' ' 161' ' ' GLY . 73.2 Cg_exo -38.35 -35.27 0.43 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 123.18 2.587 . . . . 0.0 112.448 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.57 -5.07 1.07 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.612 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 161' ' ' GLY . . . . . 0.68 ' HA2' ' OD1' ' B' ' 102' ' ' ASN . . . 76.08 33.0 51.21 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.662 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 15.1 t -98.7 114.97 27.7 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.14 0.495 . . . . 0.0 110.377 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.638 HD13 ' C ' ' B' ' 163' ' ' LEU . 1.9 tm? -109.2 102.93 11.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.103 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.94 126.96 43.59 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.509 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.6 m -108.33 108.05 24.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 174.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 0.8 OUTLIER -117.34 143.13 46.28 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.278 -174.295 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 167' ' ' ALA . . . . . 0.711 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -171.2 157.25 4.8 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-O 121.088 0.47 . . . . 0.0 111.995 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.1 -18.07 10.22 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 123.443 2.762 . . . . 0.0 110.933 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' MET . . . . . 0.672 ' SD ' ' HB2' ' B' ' 95' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.929 176.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 . . . . . 0 CA--C 1.5 -0.975 0 CA-C-O 120.677 0.275 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.661 ' CZ3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -91.64 151.98 20.45 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.207 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -144.64 98.87 3.26 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.432 -177.158 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.661 HG21 ' CZ3' ' A' ' 95' ' ' TRP . 2.0 t -111.65 150.66 13.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.1 139.48 51.17 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.779 HD22 HG12 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -115.08 74.0 0.86 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.741 175.81 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.531 ' C ' HG22 ' A' ' 101' ' ' VAL . 12.0 p-10 -70.8 112.96 7.4 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.579 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.531 HG22 ' C ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -173.25 -40.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.652 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.662 ' OD1' HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -41.32 -19.64 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.462 -1.699 . . . . 0.0 110.815 178.154 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 101' ' ' VAL . 1.5 t-80 -45.67 -33.89 3.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.41 ' CZ ' ' NH1' ' A' ' 136' ' ' ARG . 52.6 m-85 -83.94 12.37 6.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.7 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 102' ' ' ASN . . . -179.19 96.71 0.2 Allowed Pre-proline 0 C--N 1.333 -0.143 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.608 ' HA ' HD21 ' A' ' 102' ' ' ASN . 47.6 Cg_endo -70.99 -48.5 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.452 2.101 . . . . 0.0 111.209 176.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -99.44 -30.93 11.91 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.038 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.449 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 2.4 mp0 -81.63 47.98 1.13 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.02 0.438 . . . . 0.0 110.245 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.662 HD22 ' OD1' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -131.57 138.54 48.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.255 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.418 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 1.3 m -128.38 123.03 32.82 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.631 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.481 HG13 ' CD1' ' A' ' 120' ' ' ILE . 1.9 t -102.81 122.38 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.423 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -127.6 134.78 49.68 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.817 -178.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 m -102.84 118.06 36.01 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.628 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.2 OUTLIER -115.84 83.16 1.89 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.219 0.533 . . . . 0.0 110.335 -176.663 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.4 t0 30.46 68.24 0.1 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.445 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.34 -23.08 29.19 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.63 HG13 HG23 ' A' ' 143' ' ' THR . 2.7 t -87.97 117.3 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 42.1 t -101.42 116.45 45.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.497 ' OE1' ' NZ ' ' A' ' 114' ' ' LYS . 8.9 mt-10 -133.1 134.16 43.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.941 0.401 . . . . 0.0 111.206 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.779 HG12 HD22 ' A' ' 99' ' ' LEU . 4.4 mm -106.33 142.65 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.863 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.423 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -123.64 115.46 21.5 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.201 -178.933 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.16 127.8 2.51 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.222 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.41 130.13 27.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.536 ' ND1' ' N ' ' A' ' 125' ' ' GLU . 48.7 t-80 -92.6 161.44 14.59 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.222 0.534 . . . . 0.0 111.744 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.536 ' N ' ' ND1' ' A' ' 124' ' ' HIS . 0.0 OUTLIER -87.46 149.26 24.53 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.892 177.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.463 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 4.8 tt0 -28.72 98.79 0.01 OUTLIER 'General case' 0 C--N 1.348 0.542 0 CA-C-O 120.915 0.388 . . . . 0.0 111.21 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 2.3 mtp-105 . . . . . 0 CA--C 1.506 -0.717 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.852 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.093 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -96.42 109.16 21.75 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 172.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.598 HD13 ' NH2' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -129.6 119.02 46.94 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -170.61 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 127' ' ' ARG . 4.1 m -127.15 154.74 44.39 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.598 ' NH2' HD13 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -141.51 -179.33 6.09 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.935 -175.708 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 27.8 p -129.34 123.4 31.67 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.504 ' CD2' HG11 ' A' ' 101' ' ' VAL . 4.4 m-85 -100.14 140.15 34.78 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.309 -176.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.72 117.53 11.65 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.489 0.662 . . . . 0.0 111.052 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.487 ' CD ' HD23 ' A' ' 99' ' ' LEU . 2.0 mtt180 -108.05 143.33 36.92 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.337 177.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.573 ' HZ3' ' HB2' ' A' ' 141' ' ' LYS . 7.7 ttmm -138.36 112.95 8.89 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.989 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.531 ' HB2' ' HB ' ' A' ' 118' ' ' VAL . 2.0 m-85 -114.72 99.83 7.8 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.102 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.63 HG23 HG13 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -91.06 91.31 8.23 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.673 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mp -112.24 89.99 13.19 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.717 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.624 ' HD2' ' CD ' ' A' ' 146' ' ' PRO . 11.8 Cg_exo -72.22 -50.88 0.23 Allowed 'Trans proline' 0 C--N 1.287 -2.708 0 C-N-CA 122.461 2.107 . . . . 0.0 113.591 171.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.624 ' CD ' ' HD2' ' A' ' 145' ' ' PRO . 24.7 Cg_exo -55.34 -14.53 9.48 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.67 2.247 . . . . 0.0 115.401 -174.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.68 43.07 0.13 Allowed Glycine 0 C--N 1.341 0.818 0 C-N-CA 116.833 -2.603 . . . . 0.0 116.378 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.541 HG21 ' CH2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -135.25 131.29 51.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 117.859 0.829 . . . . 0.0 110.561 171.809 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -95.59 143.59 26.37 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.321 -178.606 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 6.1 Cg_exo -80.32 -47.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.334 2.023 . . . . 0.0 113.231 -176.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -37.6 59.95 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.739 -175.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.638 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 1.9 mt-30 -93.42 11.68 27.58 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -172.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 40.7 t -108.64 115.25 48.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.938 0.399 . . . . 0.0 110.16 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.94 177.32 4.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.294 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.3 143.55 35.91 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.789 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.512 ' O ' HD22 ' A' ' 163' ' ' LEU . 0.9 OUTLIER -115.11 144.97 42.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.665 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.61 HD22 HD22 ' A' ' 109' ' ' LEU . 34.7 tp -138.14 136.86 37.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.808 0.337 . . . . 0.0 111.196 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.41 ' HB2' HG22 ' A' ' 162' ' ' THR . 0.3 OUTLIER -117.09 149.48 44.38 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.68 178.531 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -40.38 -43.91 4.12 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 123.205 2.603 . . . . 0.0 112.206 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -53.33 -14.94 0.83 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.832 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 102' ' ' ASN . . . 85.02 33.13 18.97 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.797 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.41 HG22 ' HB2' ' A' ' 158' ' ' SER . 2.0 t -96.18 128.51 43.15 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.576 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.8 tm? -118.15 107.78 14.38 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.857 -175.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.2 p -99.22 127.86 45.26 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 165' ' ' VAL . 4.4 m -105.26 98.34 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 173.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -114.33 141.39 47.66 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.671 -174.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 177.5 167.8 0.49 Allowed Pre-proline 0 C--O 1.234 0.281 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.34 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 88.5 Cg_endo -90.3 121.58 0.9 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 123.943 3.095 . . . . 0.0 109.404 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.16 166.38 11.34 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-O 121.073 0.463 . . . . 0.0 112.067 -173.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo . . . . . 0 C--N 1.309 -1.518 0 C-N-CA 122.879 2.386 . . . . 0.0 112.188 -179.478 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 94' ' ' ARG . . . . . 0.474 HH11 ' HD2' ' B' ' 94' ' ' ARG . 9.0 mmt180 . . . . . 0 C--O 1.237 0.433 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' TRP . . . . . 0.605 ' CZ3' HG21 ' B' ' 97' ' ' VAL . 0.0 OUTLIER -72.47 153.83 41.17 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.354 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -152.02 105.3 3.07 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.577 -174.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.605 HG21 ' CZ3' ' B' ' 95' ' ' TRP . 1.4 t -121.05 154.69 24.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 98' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 15.2 m -127.13 144.23 51.08 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.974 HD22 HG12 ' B' ' 120' ' ' ILE . 0.3 OUTLIER -114.05 122.78 47.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.53 174.114 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.548 ' C ' HG22 ' B' ' 101' ' ' VAL . 19.3 p-10 -112.72 114.75 27.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.119 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.626 ' C ' ' H ' ' B' ' 103' ' ' HIS . 0.1 OUTLIER -169.56 -56.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.793 0.806 . . . . 0.0 110.378 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.694 ' OD1' HD13 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -56.66 14.09 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.565 -177.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 103' ' ' HIS . . . . . 0.626 ' H ' ' C ' ' B' ' 101' ' ' VAL . 19.2 m170 -46.68 -28.99 1.66 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.97 0.414 . . . . 0.0 110.331 178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.44 ' HB3' ' CD2' ' B' ' 124' ' ' HIS . 24.8 t80 -120.04 24.18 10.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.711 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.02 91.15 4.92 Favored Pre-proline 0 CA--C 1.513 -0.467 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.168 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.88 -45.99 0.11 Allowed 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.447 2.098 . . . . 0.0 110.86 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' B' ' 107' ' ' ASP . 8.2 p-10 -98.58 -31.25 12.05 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.77 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.85 48.97 1.53 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.779 0.8 . . . . 0.0 110.248 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.694 HD13 ' OD1' ' B' ' 102' ' ' ASN . 0.4 OUTLIER -138.2 139.34 39.25 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.663 178.067 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.545 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -132.05 113.52 13.46 Favored 'General case' 0 C--N 1.31 -1.116 0 O-C-N 123.352 0.407 . . . . 0.0 110.091 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.81 119.09 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -129.75 129.41 44.1 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.454 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.1 m -98.05 122.91 41.76 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 114' ' ' LYS . . . . . 0.484 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 0.3 OUTLIER -111.99 -162.17 0.79 Allowed 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -178.286 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 115' ' ' ASP . . . . . 0.432 ' H ' ' HG2' ' B' ' 114' ' ' LYS . 2.8 p-10 -65.07 69.49 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.368 0.604 . . . . 0.0 112.174 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 116' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' B' ' 114' ' ' LYS . . . 78.25 -8.43 39.42 Favored Glycine 0 CA--C 1.499 -0.934 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' B' ' 114' ' ' LYS . 2.1 t -88.64 115.4 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.68 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 41.4 t -98.59 118.87 45.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.68 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 41.1 mt-10 -133.77 143.46 48.44 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.282 0.563 . . . . 0.0 110.835 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.974 HG12 HD22 ' B' ' 99' ' ' LEU . 2.4 mm -115.61 140.2 38.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.12 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.55 111.87 19.15 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.57 145.69 13.93 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.59 -177.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.51 159.72 43.78 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' HIS . . . . . 0.522 ' O ' ' HB3' ' B' ' 135' ' ' SER . 3.7 m-70 -116.92 137.51 52.17 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.208 -177.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.5 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.5 OUTLIER -69.67 138.0 52.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.306 178.66 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 126' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' B' ' 125' ' ' GLU . 1.0 OUTLIER -17.21 98.37 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 127' ' ' ARG . . . . . 0.405 ' NH1' ' CE1' ' B' ' 104' ' ' PHE . 6.8 mtp85 -83.77 149.54 26.37 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.289 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 128' ' ' GLN . . . . . 0.563 ' HG2' ' N ' ' B' ' 129' ' ' ASP . 34.1 tt0 -99.72 151.87 20.74 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.14 0.495 . . . . 0.0 111.174 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ASP . . . . . 0.563 ' N ' ' HG2' ' B' ' 128' ' ' GLN . 19.6 t70 -161.38 169.29 22.26 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.514 175.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 130' ' ' GLU . . . . . 0.498 ' N ' ' CG ' ' B' ' 129' ' ' ASP . 4.2 tp10 -80.65 -11.42 59.64 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.435 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' HIS . . . . . 0.418 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 55.5 m-70 -115.93 31.41 6.74 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.251 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.55 164.16 11.86 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.672 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' TYR . . . . . 0.415 ' CE2' ' HG3' ' B' ' 128' ' ' GLN . 69.5 m-85 -95.68 139.32 32.09 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.06 126.38 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -170.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 135' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' B' ' 124' ' ' HIS . 0.0 OUTLIER -128.98 157.78 40.71 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.685 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -154.06 159.59 41.61 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.336 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 21.4 p -112.96 138.1 50.35 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 138' ' ' PHE . . . . . 0.437 ' CD2' HG11 ' B' ' 101' ' ' VAL . 0.2 OUTLIER -118.59 149.13 41.88 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.822 -176.514 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.74 134.51 17.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.678 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 140' ' ' ARG . . . . . 0.408 ' CB ' ' HE1' ' B' ' 142' ' ' TYR . 0.0 OUTLIER -135.8 107.62 7.06 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.081 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 141' ' ' LYS . . . . . 0.68 ' HA ' ' HG2' ' B' ' 119' ' ' GLU . 32.2 ttmt -96.86 113.94 25.52 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.038 0.447 . . . . 0.0 110.996 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 142' ' ' TYR . . . . . 0.502 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 2.4 m-85 -104.29 98.86 8.6 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.195 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 143' ' ' THR . . . . . 0.492 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.2 OUTLIER -92.53 96.81 10.44 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.082 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.1 mp -113.25 90.48 16.78 Favored Pre-proline 0 CA--C 1.511 -0.538 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.12 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 145' ' ' PRO . . . . . 0.609 ' HD2' ' CD ' ' B' ' 146' ' ' PRO . 15.9 Cg_exo -69.88 -42.89 2.9 Favored 'Trans proline' 0 C--N 1.277 -3.2 0 C-N-CA 122.19 1.927 . . . . 0.0 112.679 169.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 146' ' ' PRO . . . . . 0.609 ' CD ' ' HD2' ' B' ' 145' ' ' PRO . 76.3 Cg_exo -42.82 -15.83 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 123.001 2.467 . . . . 0.0 114.333 -176.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 151.76 58.13 0.01 OUTLIER Glycine 0 C--N 1.343 0.972 0 C-N-CA 118.199 -1.953 . . . . 0.0 115.201 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 148' ' ' VAL . . . . . 0.461 HG21 ' CH2' ' B' ' 95' ' ' TRP . 0.9 OUTLIER -123.34 113.1 36.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.573 172.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 149' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 24.4 t70 -77.44 137.91 63.66 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.569 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 5.3 Cg_exo -81.12 -23.8 5.06 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.122 1.881 . . . . 0.0 112.891 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.33 -41.24 11.63 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.269 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -97.42 15.5 22.91 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 153' ' ' VAL . . . . . 0.664 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 30.6 t -103.91 117.2 49.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.01 171.1 7.8 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.29 130.79 33.49 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.423 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 156' ' ' SER . . . . . 0.441 ' CB ' ' HG1' ' B' ' 164' ' ' THR . 0.0 OUTLIER -100.05 134.79 42.44 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.652 176.546 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 157' ' ' LEU . . . . . 0.461 HD22 ' CD2' ' B' ' 109' ' ' LEU . 29.8 tp -128.36 131.55 48.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.939 0.399 . . . . 0.0 110.652 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 158' ' ' SER . . . . . 0.425 ' H ' HD12 ' B' ' 157' ' ' LEU . 0.2 OUTLIER -117.41 149.97 45.66 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.349 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 159' ' ' PRO . . . . . 0.595 ' C ' ' H ' ' B' ' 161' ' ' GLY . 85.5 Cg_exo -42.6 -34.34 3.32 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.419 2.079 . . . . 0.0 110.686 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.97 29.56 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.38 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 161' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 34.98 34.1 0.04 OUTLIER Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.585 0.612 . . . . 0.0 112.927 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 162' ' ' THR . . . . . 0.411 ' O ' HG23 ' B' ' 162' ' ' THR . 9.0 t -97.2 117.06 30.55 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.617 HD13 ' C ' ' B' ' 163' ' ' LEU . 2.7 tm? -108.21 103.08 12.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.505 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 164' ' ' THR . . . . . 0.441 ' HG1' ' CB ' ' B' ' 156' ' ' SER . 0.5 OUTLIER -92.08 124.46 36.19 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 121.246 -0.181 . . . . 0.0 110.637 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.508 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.1 m -105.83 109.63 28.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 0.42 ' OE1' ' NH1' ' B' ' 94' ' ' ARG . 1.8 pp20? -120.2 154.99 34.05 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.601 -176.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 167' ' ' ALA . . . . . 0.664 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . 177.93 157.02 0.54 Allowed Pre-proline 0 CA--C 1.518 -0.25 0 CA-C-O 120.989 0.423 . . . . 0.0 111.212 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 168' ' ' PRO . . . . . 0.564 ' C ' ' HG3' ' B' ' 169' ' ' MET . 81.5 Cg_endo -80.41 -24.24 5.52 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.905 2.403 . . . . 0.0 110.043 174.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 169' ' ' MET . . . . . 0.564 ' HG3' ' C ' ' B' ' 168' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.544 0.74 0 CA-C-N 114.528 -1.214 . . . . 0.0 113.131 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 8.8 mmm180 . . . . . 0 CA--C 1.51 -0.559 0 CA-C-O 120.896 0.379 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.592 ' NE1' ' CG2' ' A' ' 97' ' ' VAL . 46.8 t-105 -86.7 142.87 27.88 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 -136.42 117.13 13.99 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.592 ' CG2' ' NE1' ' A' ' 95' ' ' TRP . 1.1 t -132.09 158.2 43.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.578 175.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 3.0 m -130.48 157.61 42.17 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -175.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.839 HD23 ' NE ' ' A' ' 140' ' ' ARG . 0.6 OUTLIER -136.79 94.52 2.99 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.632 175.458 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.591 ' C ' HG22 ' A' ' 101' ' ' VAL . 1.9 p-10 -97.08 119.38 35.45 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.312 -177.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.768 HG11 ' CD2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -174.34 -50.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.643 0.735 . . . . 0.0 110.649 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.801 ' ND2' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -54.52 17.68 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.708 -1.133 . . . . 0.0 113.761 -176.791 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.581 ' H ' ' C ' ' A' ' 101' ' ' VAL . 57.5 m-70 -39.33 -50.1 2.01 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.009 0.433 . . . . 0.0 111.198 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -92.05 -6.13 51.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.901 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -116.88 90.32 32.03 Favored Pre-proline 0 CA--C 1.511 -0.534 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.633 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.32 -51.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.461 2.107 . . . . 0.0 110.922 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 109' ' ' LEU . 12.9 t70 -95.02 -31.18 13.72 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.432 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.451 ' N ' ' CD ' ' A' ' 108' ' ' GLU . 20.0 mp0 -77.88 28.87 0.17 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.161 0.505 . . . . 0.0 110.927 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.801 HD13 ' ND2' ' A' ' 102' ' ' ASN . 0.8 OUTLIER -114.51 134.9 54.68 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 176.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.414 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -123.87 113.27 18.29 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.092 -178.84 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.4 129.13 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -140.35 134.22 30.6 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.138 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.56 119.94 35.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 176.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.607 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.3 OUTLIER -116.59 80.75 1.51 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.252 0.549 . . . . 0.0 110.059 -177.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.2 t70 29.5 65.54 0.12 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.717 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.77 -24.21 32.63 Favored Glycine 0 C--N 1.313 -0.707 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.607 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 2.2 t -88.16 115.76 28.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.239 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 59.1 t -101.98 115.65 44.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.698 ' CD ' ' HZ2' ' A' ' 141' ' ' LYS . 66.5 mt-10 -130.61 142.32 50.45 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.467 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.783 HG12 HD22 ' A' ' 99' ' ' LEU . 3.5 mm -111.81 142.51 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.763 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.25 117.85 26.24 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.648 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.09 135.61 5.33 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.925 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.0 144.92 25.2 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.066 0.946 . . . . 0.0 108.503 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.512 ' HB3' ' NH2' ' A' ' 127' ' ' ARG . 49.9 t60 -115.69 165.79 12.65 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.834 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.515 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.7 OUTLIER -90.16 132.54 35.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.689 -178.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.515 ' C ' ' O ' ' A' ' 125' ' ' GLU . 11.7 tt0 -7.58 111.82 0.01 OUTLIER 'General case' 0 C--N 1.348 0.509 0 C-N-CA 123.326 0.65 . . . . 0.0 112.638 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.512 ' NH2' ' HB3' ' A' ' 124' ' ' HIS . 26.4 mtm180 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.039 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.205 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -94.75 117.22 29.78 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 172.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.57 123.16 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -171.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.18 164.19 26.07 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.3 ptt180 -150.5 177.14 10.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.115 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 25.6 p -120.52 148.44 43.84 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.768 ' CD2' HG11 ' A' ' 101' ' ' VAL . 1.0 OUTLIER -121.81 128.5 51.75 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.296 -179.215 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.08 120.12 24.16 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.304 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.839 ' NE ' HD23 ' A' ' 99' ' ' LEU . 1.2 mmm180 -117.9 139.36 51.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.698 ' HZ2' ' CD ' ' A' ' 119' ' ' GLU . 12.9 ttmm -133.38 110.6 10.14 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.847 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.579 ' OH ' ' NH2' ' A' ' 140' ' ' ARG . 30.0 m-85 -106.07 99.26 8.86 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.485 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -90.54 89.14 7.43 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.528 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.3 mp -112.41 92.3 18.99 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.632 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 16.7 Cg_exo -67.65 -55.87 0.25 Allowed 'Trans proline' 0 C--N 1.288 -2.625 0 C-N-CA 122.139 1.893 . . . . 0.0 113.045 175.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.632 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 56.5 Cg_endo -100.93 76.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.329 -0.491 0 C-N-CA 123.271 2.647 . . . . 0.0 112.251 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 164.5 -17.43 0.11 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.49 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.81 126.75 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 117.599 0.699 . . . . 0.0 111.045 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.408 ' OD1' ' HG3' ' A' ' 152' ' ' GLN . 14.7 t70 -87.1 145.28 37.81 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.637 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.86 -28.79 2.42 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.872 1.715 . . . . 0.0 112.567 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.61 -41.31 10.83 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.632 -174.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.707 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 12.8 mt-30 -98.77 22.54 9.92 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -172.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.5 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 39.9 t -103.6 119.74 52.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.093 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.33 179.48 4.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.52 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 164' ' ' THR . 0.9 OUTLIER -158.81 124.86 4.5 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.419 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.454 ' O ' HD22 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -104.25 139.21 39.59 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.306 178.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.753 HD22 HD22 ' A' ' 109' ' ' LEU . 30.7 tp -131.62 135.35 46.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.315 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.474 ' H ' HD12 ' A' ' 157' ' ' LEU . 0.4 OUTLIER -121.56 150.97 56.12 Favored Pre-proline 0 C--N 1.313 -0.995 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' A' ' 161' ' ' GLY . 82.3 Cg_exo -41.28 -35.51 2.17 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.323 2.015 . . . . 0.0 110.738 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 1.8 mp0 -67.28 28.76 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.485 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.617 ' H ' ' C ' ' A' ' 159' ' ' PRO . . . 35.73 31.45 0.03 OUTLIER Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.636 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 162' ' ' THR . 14.0 t -91.35 115.29 27.91 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.604 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.9 tm? -109.05 104.03 13.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.687 -176.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 155' ' ' SER . 0.8 OUTLIER -95.28 123.39 38.77 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.597 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 165' ' ' VAL . 2.9 m -107.29 99.23 8.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 1.7 pp20? -118.38 150.83 38.88 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.822 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.707 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 174.08 167.74 0.31 Allowed Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.255 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.559 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 73.9 Cg_endo -88.1 117.48 1.07 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 123.619 2.879 . . . . 0.0 108.9 175.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.49 ' SD ' ' HB2' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -109.21 175.07 2.09 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.407 -172.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 169' ' ' MET . 14.1 Cg_exo . . . . . 0 C--N 1.311 -1.442 0 C-N-CA 122.932 2.421 . . . . 0.0 110.692 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? . . . . . 0 CA--C 1.5 -0.943 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 95' ' ' TRP . . . . . 0.629 ' HB2' ' SD ' ' B' ' 169' ' ' MET . 28.2 t-105 -125.67 152.72 44.86 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -145.53 102.41 3.69 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.269 -177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.538 HG22 ' NE1' ' B' ' 95' ' ' TRP . 0.2 OUTLIER -116.0 157.88 16.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.021 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 98' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 2.3 m -130.25 148.84 52.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.501 HD22 ' HB ' ' B' ' 120' ' ' ILE . 0.3 OUTLIER -122.58 117.85 26.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.128 174.747 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.537 ' C ' HG22 ' B' ' 101' ' ' VAL . 0.1 OUTLIER -113.99 115.35 27.5 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.537 HG22 ' C ' ' B' ' 100' ' ' ASP . 0.1 OUTLIER -167.72 -34.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.237 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.614 ' OD1' ' HA2' ' B' ' 161' ' ' GLY . 0.4 OUTLIER -80.8 16.6 1.38 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -174.361 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 103' ' ' HIS . . . . . 0.563 ' N ' ' HA3' ' B' ' 161' ' ' GLY . 11.5 m80 -43.03 -39.91 2.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.105 0.478 . . . . 0.0 110.174 177.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -92.41 -1.14 57.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.251 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' ALA . . . . . 0.547 ' C ' HD22 ' B' ' 102' ' ' ASN . . . -135.11 77.47 55.43 Favored Pre-proline 0 CA--C 1.511 -0.538 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.9 -38.17 3.15 Favored 'Trans proline' 0 C--N 1.295 -2.272 0 C-N-CA 122.48 2.12 . . . . 0.0 110.92 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -96.04 -26.86 15.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.003 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -95.85 49.02 1.14 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.111 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.703 HD22 HD22 ' B' ' 157' ' ' LEU . 0.5 OUTLIER -125.18 143.69 50.82 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.174 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.465 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -139.04 112.37 8.14 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.371 -177.501 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.55 125.6 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -133.62 133.25 41.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.758 0.313 . . . . 0.0 111.293 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.16 122.58 39.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' LYS . . . . . 0.553 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 2.5 ttpt -126.37 91.44 3.37 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-O 120.847 0.356 . . . . 0.0 110.881 -176.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' B' ' 117' ' ' VAL . 6.7 p-10 34.58 66.55 0.28 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.07 -15.59 8.38 Favored Glycine 0 C--N 1.307 -1.055 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.852 HG22 HG23 ' B' ' 143' ' ' THR . 7.2 t -87.44 114.36 26.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 42.8 t -99.25 121.05 49.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.135 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 76.8 mt-10 -130.27 140.11 50.71 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.303 0.573 . . . . 0.0 111.025 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.501 ' HB ' HD22 ' B' ' 99' ' ' LEU . 1.3 mp -114.96 117.04 54.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.093 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -97.83 120.0 37.44 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.02 -178.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -146.68 126.95 2.58 Favored Glycine 0 N--CA 1.452 -0.272 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.11 159.35 40.37 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 124' ' ' HIS . . . . . 0.499 ' ND1' ' HB2' ' B' ' 105' ' ' ALA . 3.6 m-70 -123.05 130.9 53.39 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.245 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' B' ' 126' ' ' GLU . 4.5 tp10 -70.79 137.62 49.71 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' GLU . . . . . 0.587 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 5.1 tt0 -11.91 99.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.481 0.488 . . . . 0.0 111.737 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' ARG . . . . . 0.607 ' HB2' ' NH1' ' B' ' 127' ' ' ARG . 0.2 OUTLIER -89.12 128.86 35.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.499 -178.401 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -75.53 127.43 33.08 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ASP . . . . . 0.52 ' HB2' HG22 ' B' ' 134' ' ' ILE . 0.3 OUTLIER -138.27 164.72 28.51 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -70.49 -36.0 73.58 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.965 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 131' ' ' HIS . . . . . 0.498 ' O ' ' OH ' ' A' ' 142' ' ' TYR . 73.0 m-70 -100.16 40.36 1.25 Allowed 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 120.669 0.271 . . . . 0.0 110.572 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 114.46 174.16 18.35 Favored Glycine 0 C--N 1.299 -1.473 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.251 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -95.09 114.7 26.53 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' ILE . . . . . 0.559 HD11 ' NH2' ' B' ' 136' ' ' ARG . 0.0 OUTLIER -127.35 118.6 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -173.031 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 135' ' ' SER . . . . . 0.587 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.3 OUTLIER -126.61 154.8 43.46 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.004 176.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 136' ' ' ARG . . . . . 0.559 ' NH2' HD11 ' B' ' 134' ' ' ILE . 9.8 ptp85 -144.85 163.59 33.62 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.943 0.401 . . . . 0.0 111.483 -177.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 30.3 p -117.79 130.3 56.21 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -104.06 144.04 32.09 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.456 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.39 113.71 6.63 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.75 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 140' ' ' ARG . . . . . 0.493 ' NH2' ' OH ' ' B' ' 142' ' ' TYR . 0.0 OUTLIER -121.13 119.15 31.57 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.616 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 141' ' ' LYS . . . . . 0.499 ' NZ ' ' OE1' ' A' ' 126' ' ' GLU . 11.9 ttmt -110.81 121.37 45.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.945 0.403 . . . . 0.0 110.747 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 142' ' ' TYR . . . . . 0.548 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 1.7 m-85 -109.28 99.53 8.78 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.975 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 143' ' ' THR . . . . . 0.852 HG23 HG22 ' B' ' 117' ' ' VAL . 0.3 OUTLIER -90.29 99.69 12.66 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.141 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 7.4 mp -109.59 94.54 16.75 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 145' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' B' ' 147' ' ' GLY . 24.7 Cg_exo -66.21 -38.56 20.8 Favored 'Trans proline' 0 C--N 1.287 -2.678 0 C-N-CA 123.151 2.567 . . . . 0.0 114.513 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 146' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' B' ' 145' ' ' PRO . 34.4 Cg_exo -42.91 -13.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 121.458 1.439 . . . . 0.0 111.746 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 113.66 42.62 0.86 Allowed Glycine 0 C--N 1.343 0.943 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.52 172.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 148' ' ' VAL . . . . . 0.471 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -57.13 101.32 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.521 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 149' ' ' ASP . . . . . 0.581 ' O ' HG23 ' B' ' 153' ' ' VAL . 14.5 t0 -41.77 119.12 2.01 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.869 -172.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 5.2 Cg_exo -74.96 -26.54 10.91 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.23 1.953 . . . . 0.0 112.027 -178.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.56 -32.41 16.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.007 -177.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 152' ' ' GLN . . . . . 0.427 ' O ' ' HB1' ' B' ' 167' ' ' ALA . 22.9 mt-30 -107.31 19.2 20.64 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 153' ' ' VAL . . . . . 0.581 HG23 ' O ' ' B' ' 149' ' ' ASP . 27.9 t -105.46 95.37 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.324 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.05 -173.9 4.24 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 155' ' ' SER . . . . . 0.42 ' HB3' HD11 ' B' ' 163' ' ' LEU . 0.5 OUTLIER -159.74 138.38 10.63 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.734 -0.786 . . . . 0.0 112.056 -179.271 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 156' ' ' SER . . . . . 0.434 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.0 OUTLIER -107.14 136.38 47.09 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.053 178.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 157' ' ' LEU . . . . . 0.703 HD22 HD22 ' B' ' 109' ' ' LEU . 25.5 tp -124.95 131.58 53.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.908 0.385 . . . . 0.0 110.413 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 158' ' ' SER . . . . . 0.421 ' HB3' HG22 ' B' ' 162' ' ' THR . 0.3 OUTLIER -111.39 152.99 44.28 Favored Pre-proline 0 C--N 1.315 -0.931 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.146 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 159' ' ' PRO . . . . . 0.455 ' C ' ' H ' ' B' ' 161' ' ' GLY . 9.7 Cg_endo -53.25 -20.58 15.07 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.069 1.846 . . . . 0.0 110.613 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -77.5 27.1 0.16 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.217 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 161' ' ' GLY . . . . . 0.614 ' HA2' ' OD1' ' B' ' 102' ' ' ASN . . . 41.72 34.5 1.25 Allowed Glycine 0 N--CA 1.462 0.396 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.945 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 162' ' ' THR . . . . . 0.421 HG22 ' HB3' ' B' ' 158' ' ' SER . 15.1 t -104.32 124.44 49.18 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.646 HD13 ' C ' ' B' ' 163' ' ' LEU . 2.5 tm? -114.87 109.73 18.59 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.204 -174.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.9 129.06 42.06 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.708 0.231 . . . . 0.0 110.476 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.567 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.2 m -113.44 103.99 16.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 1.7 pp20? -118.22 141.41 48.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.894 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 167' ' ' ALA . . . . . 0.558 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -177.98 159.14 1.22 Allowed Pre-proline 0 N--CA 1.453 -0.281 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 168' ' ' PRO . . . . . 0.472 ' HD2' ' HB1' ' B' ' 167' ' ' ALA . 88.9 Cg_endo -77.64 81.01 2.78 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 123.72 2.947 . . . . 0.0 109.94 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 169' ' ' MET . . . . . 0.629 ' SD ' ' HB2' ' B' ' 95' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.31 -1.147 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.55 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 . . . . . 0 CA--C 1.517 -0.292 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.541 ' HB2' ' HG3' ' A' ' 169' ' ' MET . 0.0 OUTLIER -61.52 113.25 2.58 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.566 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -109.61 100.02 9.12 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.902 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -106.77 135.47 45.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 2.4 m -108.82 141.2 41.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.842 0.353 . . . . 0.0 111.945 -176.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.672 HD22 ' HB ' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -119.41 56.31 0.93 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.518 175.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -62.0 109.96 1.43 Allowed 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.329 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.566 HG21 ' CD2' ' A' ' 138' ' ' PHE . 11.8 p -171.15 -17.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.641 ' OD1' HD11 ' A' ' 157' ' ' LEU . 0.8 OUTLIER -90.52 16.79 8.3 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.684 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.558 ' N ' ' HA3' ' A' ' 161' ' ' GLY . 0.0 OUTLIER -41.03 -34.24 0.4 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.829 0.347 . . . . 0.0 111.026 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -101.87 11.42 38.66 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.806 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -143.3 86.52 8.99 Favored Pre-proline 0 CA--C 1.512 -0.515 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.433 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.37 -42.8 0.42 Allowed 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 122.44 2.093 . . . . 0.0 111.338 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -98.08 -31.79 11.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.583 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 123' ' ' LYS . 2.7 mm-40 -81.31 51.16 1.57 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.448 0.642 . . . . 0.0 110.347 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.746 HD22 HD22 ' A' ' 157' ' ' LEU . 0.5 OUTLIER -137.63 124.83 21.67 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.69 178.08 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.49 115.12 21.04 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.616 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.448 HG13 HD11 ' A' ' 120' ' ' ILE . 1.7 t -96.97 123.23 49.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.28 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.482 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 1.6 pttm -133.51 135.14 44.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.826 0.346 . . . . 0.0 111.081 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -109.61 114.84 28.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.3 ttpp -118.98 80.01 1.48 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.772 0.32 . . . . 0.0 111.652 -176.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.9 t0 49.77 69.57 0.59 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.156 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.1 -20.52 9.86 Favored Glycine 0 C--N 1.32 -0.339 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.863 HG22 HG23 ' A' ' 143' ' ' THR . 16.7 t -86.86 111.26 21.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.634 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.4 t -102.7 112.49 36.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.553 ' HG2' ' HA ' ' A' ' 141' ' ' LYS . 40.6 mt-10 -124.41 133.55 53.36 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.351 0.596 . . . . 0.0 111.53 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.672 ' HB ' HD22 ' A' ' 99' ' ' LEU . 1.1 mp -108.05 118.54 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.926 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.482 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -97.7 122.81 41.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.501 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.31 134.0 4.6 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.626 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -131.5 159.76 37.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -125.71 136.88 53.68 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.96 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.533 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -88.81 134.77 33.82 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' A' ' 125' ' ' GLU . 2.8 tt0 -1.9 98.85 0.01 OUTLIER 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.759 0.662 . . . . 0.0 112.548 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 11.0 mtp-105 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 120.907 0.384 . . . . 0.0 111.081 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.982 0 CA-C-O 121.257 0.365 . . . . 0.0 113.594 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 12.6 m-30 -96.36 113.77 25.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.7 HD11 HH11 ' A' ' 136' ' ' ARG . 0.0 OUTLIER -120.07 145.16 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -176.566 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -144.11 156.34 44.31 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.438 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.7 HH11 HD11 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -152.24 -178.45 6.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.825 0.345 . . . . 0.0 111.443 -175.176 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 26.4 p -139.76 134.0 31.24 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 175.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.566 ' CD2' HG21 ' A' ' 101' ' ' VAL . 46.9 m-85 -100.36 141.04 33.75 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.76 99.19 4.86 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.103 172.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.676 ' NH2' ' CD1' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -104.81 99.92 9.55 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.001 -179.428 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.553 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 13.8 ttpt -112.34 127.89 56.13 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.713 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.676 ' CD1' ' NH2' ' A' ' 140' ' ' ARG . 11.9 m-85 -127.25 100.02 5.9 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.515 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.863 HG23 HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -85.4 89.79 7.77 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.498 179.202 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.3 mp -108.69 93.4 12.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.332 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.63 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 16.7 Cg_exo -66.95 -54.93 0.36 Allowed 'Trans proline' 0 C--N 1.294 -2.332 0 C-N-CA 122.143 1.895 . . . . 0.0 112.798 175.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.63 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 57.6 Cg_endo -102.87 89.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.556 2.838 . . . . 0.0 111.729 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.86 -19.57 0.76 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.922 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.62 128.83 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 117.121 0.46 . . . . 0.0 110.511 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -92.88 143.13 26.42 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.044 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.54 -22.61 4.53 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.877 1.718 . . . . 0.0 112.362 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.67 -41.04 10.95 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.212 -175.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.606 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 3.6 mt-30 -106.5 23.77 13.67 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -172.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.481 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 42.8 t -110.67 111.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.921 0.391 . . . . 0.0 110.878 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.62 -178.0 3.47 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.92 139.3 26.15 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.048 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.54 137.66 47.94 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.413 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.746 HD22 HD22 ' A' ' 109' ' ' LEU . 31.4 tp -128.43 145.45 51.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.896 0.379 . . . . 0.0 110.726 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.29 155.23 81.79 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.815 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.55 ' C ' ' H ' ' A' ' 161' ' ' GLY . 91.8 Cg_exo -42.27 -42.58 7.63 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.905 2.403 . . . . 0.0 111.865 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -62.54 10.77 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.644 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.627 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 59.39 33.57 76.72 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 112.06 -0.416 . . . . 0.0 112.06 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 162' ' ' THR . 6.2 t -95.18 114.85 26.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.453 . . . . 0.0 109.919 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.611 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.1 tm? -108.49 104.78 14.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.875 -177.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.7 p -99.42 116.79 32.38 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 165' ' ' VAL . 3.5 m -95.45 99.69 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -115.02 138.31 51.01 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.022 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.606 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . -178.11 162.83 1.25 Allowed Pre-proline 0 C--N 1.32 -0.7 0 CA-C-O 121.313 0.578 . . . . 0.0 111.771 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 86.6 Cg_endo -87.77 109.16 0.65 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 123.257 2.638 . . . . 0.0 108.229 175.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.595 ' SD ' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -109.39 169.15 6.74 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.506 -173.004 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 169' ' ' MET . 19.5 Cg_endo . . . . . 0 N--CA 1.503 2.08 0 C-N-CA 123.222 2.615 . . . . 0.0 112.065 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' ARG . . . . . 0.485 ' NH2' ' OE2' ' B' ' 166' ' ' GLU . 7.9 mmm180 . . . . . 0 CA--C 1.512 -0.519 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' TRP . . . . . 0.559 ' NE1' ' CG2' ' B' ' 97' ' ' VAL . 63.2 t-105 -115.8 113.9 24.03 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -119.83 104.72 10.45 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.579 -175.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.559 ' CG2' ' NE1' ' B' ' 95' ' ' TRP . 0.2 OUTLIER -112.59 158.12 13.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 98' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 16.1 m -134.31 142.52 47.3 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -176.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.771 HD23 HH11 ' B' ' 140' ' ' ARG . 0.4 OUTLIER -112.97 79.89 1.29 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.472 174.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.489 ' C ' HG22 ' B' ' 101' ' ' VAL . 5.0 p-10 -86.36 102.76 14.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.86 0.362 . . . . 0.0 111.143 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.489 HG22 ' C ' ' B' ' 100' ' ' ASP . 0.0 OUTLIER -163.94 -40.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.765 0.317 . . . . 0.0 111.463 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.619 ' ND2' ' CD1' ' B' ' 109' ' ' LEU . 0.0 OUTLIER -60.25 11.16 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -175.282 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 103' ' ' HIS . . . . . 0.531 ' N ' ' HA3' ' B' ' 161' ' ' GLY . 3.1 p80 -52.4 -19.07 1.93 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.137 0.494 . . . . 0.0 109.87 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.432 ' CE2' ' NH2' ' B' ' 136' ' ' ARG . 47.9 p90 -94.48 -9.26 36.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.138 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.51 91.8 5.68 Favored Pre-proline 0 CA--C 1.516 -0.351 0 CA-C-O 120.826 0.346 . . . . 0.0 111.536 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.95 -49.77 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.471 2.114 . . . . 0.0 111.266 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -89.66 -31.2 17.62 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.225 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.502 ' OE2' ' NZ ' ' B' ' 123' ' ' LYS . 13.2 mt-10 -87.08 49.84 1.9 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.311 0.577 . . . . 0.0 110.135 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.858 HD22 HD22 ' B' ' 157' ' ' LEU . 0.4 OUTLIER -133.18 142.6 48.7 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.111 178.405 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.528 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -137.05 120.25 16.74 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.432 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.462 HG13 HD11 ' B' ' 120' ' ' ILE . 2.5 t -102.2 125.37 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.358 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.413 ' NZ ' ' HB2' ' B' ' 119' ' ' GLU . 14.6 pttp -136.4 142.11 43.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.665 0.269 . . . . 0.0 111.145 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.91 114.95 29.35 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' LYS . . . . . 0.535 ' NZ ' ' CB ' ' B' ' 114' ' ' LYS . 0.0 OUTLIER -111.81 92.91 4.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.117 -177.411 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 29.5 t70 32.77 66.35 0.2 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.273 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.52 -21.93 19.29 Favored Glycine 0 N--CA 1.466 0.665 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.759 HG22 HG23 ' B' ' 143' ' ' THR . 5.9 t -87.79 120.43 36.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 54.3 t -106.49 123.73 61.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.442 ' OE2' ' NZ ' ' B' ' 114' ' ' LYS . 2.8 mt-10 -135.66 140.65 44.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.973 0.416 . . . . 0.0 110.767 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.49 ' HB ' HD22 ' B' ' 99' ' ' LEU . 1.2 mp -117.72 117.75 56.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.791 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -91.16 123.29 34.5 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.443 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.07 116.5 0.78 Allowed Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' LYS . . . . . 0.502 ' NZ ' ' OE2' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -140.86 126.3 18.8 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.282 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 124' ' ' HIS . . . . . 0.707 ' H ' ' CD2' ' B' ' 124' ' ' HIS . 0.2 OUTLIER -95.77 134.84 38.25 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.371 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' B' ' 126' ' ' GLU . 3.2 tp10 -69.36 136.41 51.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.383 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' GLU . . . . . 0.531 ' C ' ' O ' ' B' ' 125' ' ' GLU . 39.3 tt0 -1.62 98.39 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.797 0.685 . . . . 0.0 112.111 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -93.02 129.93 38.78 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.079 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -77.52 122.6 25.47 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ASP . . . . . 0.524 ' HB2' HG22 ' B' ' 134' ' ' ILE . 1.9 t70 -120.29 173.02 7.38 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.866 0.365 . . . . 0.0 110.766 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.58 -30.97 70.14 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -174.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 131' ' ' HIS . . . . . 0.529 ' O ' ' CE1' ' A' ' 142' ' ' TYR . 75.0 m-70 -110.82 24.68 12.64 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 132.84 -149.88 19.64 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 120.228 -0.987 . . . . 0.0 111.955 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' TYR . . . . . 0.554 ' O ' ' NH1' ' A' ' 140' ' ' ARG . 63.4 m-85 -111.18 125.16 53.5 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 134' ' ' ILE . . . . . 0.524 HG22 ' HB2' ' B' ' 129' ' ' ASP . 0.0 OUTLIER -145.96 121.56 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 120.659 0.266 . . . . 0.0 111.092 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 135' ' ' SER . . . . . 0.41 ' HB3' ' CD2' ' B' ' 124' ' ' HIS . 0.7 OUTLIER -150.51 157.75 43.37 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 178.417 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 136' ' ' ARG . . . . . 0.618 ' HD3' ' CE1' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -145.53 171.52 14.55 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.113 0.482 . . . . 0.0 111.65 -177.071 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 29.5 p -107.93 132.13 53.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.693 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 138' ' ' PHE . . . . . 0.618 ' CE1' ' HD3' ' B' ' 136' ' ' ARG . 0.3 OUTLIER -108.78 139.76 43.15 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.774 0.321 . . . . 0.0 110.903 -178.6 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.64 103.95 3.57 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.259 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 140' ' ' ARG . . . . . 0.771 HH11 HD23 ' B' ' 99' ' ' LEU . 0.0 OUTLIER -104.91 123.85 48.45 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 141' ' ' LYS . . . . . 0.41 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 1.5 ttpp -113.54 118.19 33.75 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 142' ' ' TYR . . . . . 0.644 ' OH ' ' NH1' ' B' ' 140' ' ' ARG . 2.1 m-30 -106.04 97.88 7.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.739 0.304 . . . . 0.0 110.192 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 143' ' ' THR . . . . . 0.759 HG23 HG22 ' B' ' 117' ' ' VAL . 0.2 OUTLIER -90.98 100.27 13.17 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.686 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -109.73 92.54 12.53 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.825 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 145' ' ' PRO . . . . . 0.575 ' O ' ' N ' ' B' ' 147' ' ' GLY . 24.6 Cg_exo -65.76 -39.85 19.07 Favored 'Trans proline' 0 C--N 1.287 -2.705 0 C-N-CA 122.527 2.151 . . . . 0.0 112.428 171.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 146' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 83.7 Cg_exo -41.59 -8.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 123.296 2.664 . . . . 0.0 113.506 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 116.4 69.65 0.43 Allowed Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.101 -1.047 . . . . 0.0 113.989 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 148' ' ' VAL . . . . . 0.449 ' O ' HG12 ' B' ' 148' ' ' VAL . 0.5 OUTLIER -112.76 112.4 40.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 149' ' ' ASP . . . . . 0.481 ' O ' HG23 ' B' ' 153' ' ' VAL . 19.1 t70 -64.39 135.51 96.38 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.692 -176.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 3.8 Cg_exo -78.58 -26.2 6.02 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.922 1.748 . . . . 0.0 113.188 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.93 -42.32 10.65 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -94.49 15.97 16.52 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -174.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 153' ' ' VAL . . . . . 0.699 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 37.1 t -101.34 89.6 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.442 177.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.41 178.43 8.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.38 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.78 133.65 10.27 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.472 -178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 156' ' ' SER . . . . . 0.567 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.0 OUTLIER -113.31 142.8 45.41 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.369 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 157' ' ' LEU . . . . . 0.858 HD22 HD22 ' B' ' 109' ' ' LEU . 35.0 tp -128.88 148.7 50.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 110.291 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 158' ' ' SER . . . . . 0.614 ' H ' HD12 ' B' ' 157' ' ' LEU . 0.3 OUTLIER -134.77 154.02 79.15 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.504 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 159' ' ' PRO . . . . . 0.552 ' C ' ' H ' ' B' ' 161' ' ' GLY . 80.5 Cg_exo -41.05 -40.45 3.89 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.739 2.293 . . . . 0.0 111.239 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.27 17.64 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.376 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 161' ' ' GLY . . . . . 0.552 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 49.72 31.33 15.71 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 162' ' ' THR . . . . . 0.497 ' CG2' ' HB2' ' B' ' 158' ' ' SER . 15.0 t -90.57 120.77 31.92 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.604 HD13 ' C ' ' B' ' 163' ' ' LEU . 3.1 tm? -115.77 102.65 9.91 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.88 125.42 37.47 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.12 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.577 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.0 m -112.6 100.03 9.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 174.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 0.485 ' OE2' ' NH2' ' B' ' 94' ' ' ARG . 0.0 OUTLIER -110.01 132.74 53.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.937 -176.15 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 167' ' ' ALA . . . . . 0.699 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -164.0 150.24 9.65 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.65 67.19 6.47 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 123.867 3.045 . . . . 0.0 109.98 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 169' ' ' MET . . . . . 0.506 ' HG2' ' CB ' ' B' ' 95' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.193 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.454 ' NH1' ' OE1' ' A' ' 166' ' ' GLU . 6.5 mmt85 . . . . . 0 CA--C 1.501 -0.917 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.715 ' CZ3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -86.13 160.12 19.33 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 96' ' ' ARG . 21.3 ttp-105 -151.37 99.66 2.66 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.128 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.715 HG21 ' CZ3' ' A' ' 95' ' ' TRP . 1.3 t -116.27 148.1 19.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 176.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.23 150.1 30.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.936 0.398 . . . . 0.0 111.878 -175.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.746 HD22 HG12 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -128.82 91.16 3.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.643 175.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.591 ' C ' HG22 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -81.56 124.78 29.8 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.477 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.591 HG22 ' C ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -178.72 -40.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-O 122.403 1.097 . . . . 0.0 108.434 178.538 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.87 ' HB2' HD13 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -58.92 -14.27 8.67 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 113.373 -1.739 . . . . 0.0 111.683 -178.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.572 ' CE1' ' HA ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -45.14 -22.78 0.12 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.567 -178.394 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.32 17.27 12.26 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.88 86.31 3.84 Favored Pre-proline 0 N--CA 1.467 0.409 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.875 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.533 ' HA ' HD21 ' A' ' 102' ' ' ASN . 51.3 Cg_endo -70.95 -47.28 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.511 2.141 . . . . 0.0 111.517 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -94.81 -30.46 14.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.347 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.545 ' OE2' ' NZ ' ' A' ' 123' ' ' LYS . 24.9 mt-10 -85.98 41.29 0.91 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.048 0.451 . . . . 0.0 110.822 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.87 HD13 ' HB2' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -129.2 133.89 47.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.047 178.799 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.4 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -127.73 129.06 46.46 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.245 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.3 t -109.47 120.88 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.614 ' NZ ' ' HB2' ' A' ' 119' ' ' GLU . 9.8 pttp -134.26 128.33 33.63 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.403 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -97.15 134.24 40.74 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.097 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 116' ' ' GLY . 0.3 OUTLIER -120.46 -176.74 3.29 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -57.28 69.85 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.303 0.573 . . . . 0.0 111.639 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 114' ' ' LYS . . . 83.69 -5.99 75.89 Favored Glycine 0 C--N 1.32 -0.356 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.672 HG13 HG23 ' A' ' 143' ' ' THR . 1.7 t -92.49 110.81 23.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.2 t -96.06 117.75 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.614 ' HB2' ' NZ ' ' A' ' 112' ' ' LYS . 81.6 mt-10 -129.48 133.6 47.36 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.114 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.746 HG12 HD22 ' A' ' 99' ' ' LEU . 4.6 mm -107.18 141.38 22.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.417 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -121.69 114.31 20.96 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.329 -178.015 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -144.85 130.07 3.76 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.899 -0.48 . . . . 0.0 111.899 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.545 ' NZ ' ' OE2' ' A' ' 108' ' ' GLU . 0.1 OUTLIER -151.13 132.28 14.41 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.129 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.531 ' ND1' ' HG2' ' A' ' 127' ' ' ARG . 54.6 t-80 -102.59 141.2 35.81 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -56.81 -33.78 67.05 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -176.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 0.3 OUTLIER 173.21 103.51 0.01 OUTLIER 'General case' 0 C--N 1.356 0.853 0 CA-C-N 118.748 0.704 . . . . 0.0 111.23 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.531 ' HG2' ' ND1' ' A' ' 124' ' ' HIS . 9.7 mtp-105 . . . . . 0 N--CA 1.47 0.568 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.589 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.138 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -96.1 126.79 41.57 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 172.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -130.43 123.92 56.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -170.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 3.1 m -131.57 147.04 52.5 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.199 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.442 ' NH1' ' CE2' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -143.75 170.48 15.79 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.755 -178.835 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 25.1 p -112.02 122.77 48.68 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.486 ' CD2' ' CG1' ' A' ' 101' ' ' VAL . 5.7 m-85 -95.78 128.78 42.96 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.765 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.58 105.65 5.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.886 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.476 ' NH2' ' OH ' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -104.67 105.14 15.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.864 178.137 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.454 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 14.2 ttmt -99.04 112.38 24.53 Favored 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 123.186 0.304 . . . . 0.0 110.75 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.703 ' CE1' ' HA3' ' B' ' 132' ' ' GLY . 5.9 m-30 -106.15 99.3 8.9 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.672 HG23 HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -87.74 89.32 7.95 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.603 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mp -113.33 91.35 19.33 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.645 ' HD2' ' HD3' ' A' ' 146' ' ' PRO . 13.2 Cg_exo -69.13 -57.27 0.13 Allowed 'Trans proline' 0 C--N 1.29 -2.529 0 C-N-CA 122.457 2.105 . . . . 0.0 114.641 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.645 ' HD3' ' HD2' ' A' ' 145' ' ' PRO . 12.6 Cg_endo -93.0 22.69 0.57 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 C-N-CA 122.969 2.446 . . . . 0.0 113.562 -174.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -142.22 -13.27 0.41 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 119.827 -1.178 . . . . 0.0 112.968 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.541 HG21 ' CH2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -131.75 128.19 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.713 0.756 . . . . 0.0 110.644 178.795 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 12.8 t70 -89.26 140.96 28.78 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.226 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 3.6 Cg_exo -82.35 -18.92 6.87 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.063 1.842 . . . . 0.0 112.991 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.46 -37.2 12.67 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.755 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 2.7 mt-30 -109.83 27.9 9.11 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.494 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 45.2 t -111.65 120.8 62.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.673 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.81 -173.72 2.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.318 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.48 153.17 31.06 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.215 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.491 ' O ' HD22 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -124.82 136.46 53.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.617 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.597 HD22 HD22 ' A' ' 109' ' ' LEU . 31.0 tp -124.89 110.91 14.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.84 0.353 . . . . 0.0 110.131 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.425 ' HB3' HG22 ' A' ' 162' ' ' THR . 0.3 OUTLIER -90.86 145.07 31.18 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.664 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.621 ' C ' ' H ' ' A' ' 161' ' ' GLY . 84.4 Cg_exo -41.02 -34.06 1.34 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.646 2.231 . . . . 0.0 110.753 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.61 27.61 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.387 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.621 ' H ' ' C ' ' A' ' 159' ' ' PRO . . . 38.41 33.96 0.21 Allowed Glycine 0 CA--C 1.53 1.008 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.601 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 158' ' ' SER . 9.8 t -102.03 125.37 48.7 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.576 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.1 tm? -107.04 110.01 22.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.786 -175.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.35 125.38 45.0 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.488 ' O ' HG23 ' A' ' 165' ' ' VAL . 1.2 m -106.69 107.28 22.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 1.5 pp20? -121.63 152.83 38.87 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.056 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.755 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 168.44 167.97 0.14 Allowed Pre-proline 0 C--O 1.238 0.463 0 CA-C-O 121.158 0.504 . . . . 0.0 112.213 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 37.7 Cg_endo -89.53 109.46 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 123.452 2.768 . . . . 0.0 109.168 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.548 ' CE ' ' H ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -107.18 170.8 5.26 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.874 -175.121 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 169' ' ' MET . 21.7 Cg_exo . . . . . 0 C--N 1.31 -1.448 0 C-N-CA 122.249 1.966 . . . . 0.0 110.688 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' ARG . . . . . 0.425 ' NE ' ' HB3' ' B' ' 168' ' ' PRO . 24.5 mmt-85 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.075 0.464 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' TRP . . . . . 0.526 ' HB2' ' HG3' ' B' ' 169' ' ' MET . 0.1 OUTLIER -62.31 141.13 58.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.339 -177.77 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 25.0 ttm105 -135.29 106.78 6.86 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.167 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.85 150.9 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 98' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 17.6 m -126.95 148.91 50.05 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -174.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.692 HD21 ' CE1' ' B' ' 142' ' ' TYR . 0.7 OUTLIER -123.9 55.03 1.29 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.465 174.426 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.25 93.95 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.835 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' B' ' 103' ' ' HIS . 2.6 t -145.15 -26.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.775 ' HB3' HD13 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -54.86 3.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.298 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 103' ' ' HIS . . . . . 0.532 ' H ' ' C ' ' B' ' 101' ' ' VAL . 2.4 m-70 -41.91 -46.55 4.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.998 0.428 . . . . 0.0 110.848 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.06 8.32 38.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.144 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.07 89.75 2.06 Favored Pre-proline 0 CA--C 1.513 -0.444 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.58 -44.48 0.38 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.323 2.015 . . . . 0.0 110.866 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -98.15 -31.46 12.09 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.119 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.437 ' OE1' ' NZ ' ' B' ' 123' ' ' LYS . 4.4 mt-10 -83.09 37.99 0.57 Allowed 'General case' 0 C--O 1.242 0.676 0 CA-C-O 121.018 0.437 . . . . 0.0 110.728 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.818 HD22 HD22 ' B' ' 157' ' ' LEU . 0.4 OUTLIER -121.4 135.35 55.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.404 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.06 124.23 38.79 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 120.5 0.191 . . . . 0.0 110.852 -177.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.74 129.61 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.969 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -139.43 134.88 32.97 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.686 0.279 . . . . 0.0 110.759 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 5.2 m -102.94 108.0 19.02 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.801 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' LYS . . . . . 0.568 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 21.5 ttmt -104.32 87.68 2.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.822 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 3.4 t70 30.66 67.35 0.12 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.655 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.41 -22.45 23.7 Favored Glycine 0 N--CA 1.466 0.693 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.568 ' HB ' ' HB3' ' B' ' 114' ' ' LYS . 8.8 t -87.55 109.77 19.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 56.1 t -96.65 127.05 49.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.974 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.571 ' CD ' ' HZ2' ' B' ' 141' ' ' LYS . 74.4 mt-10 -139.36 146.96 40.88 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.275 -178.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.57 HD12 ' O ' ' B' ' 119' ' ' GLU . 1.3 mp -121.46 131.23 73.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.434 177.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -104.01 120.38 40.93 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.669 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -140.42 129.2 4.1 Favored Glycine 0 N--CA 1.466 0.66 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' LYS . . . . . 0.437 ' NZ ' ' OE1' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -150.16 157.78 43.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -178.369 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 124' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' B' ' 126' ' ' GLU . 8.8 t-80 -145.02 127.91 16.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -56.01 -10.08 0.74 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -176.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 126' ' ' GLU . . . . . 0.61 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 0.5 OUTLIER 175.31 145.62 0.07 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 111.571 179.074 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 127' ' ' ARG . . . . . 0.596 ' NH1' ' HA ' ' B' ' 135' ' ' SER . 26.1 mtt85 -135.19 107.57 7.3 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.658 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -65.73 130.52 43.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.527 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.29 149.0 28.87 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -62.26 -31.46 72.03 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 131' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -92.27 25.17 3.03 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.488 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' GLY . . . . . 0.703 ' HA3' ' CE1' ' A' ' 142' ' ' TYR . . . 122.77 165.01 12.28 Favored Glycine 0 N--CA 1.429 -1.821 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.152 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -94.69 112.74 24.48 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 134' ' ' ILE . . . . . 0.523 HD11 ' NH1' ' B' ' 136' ' ' ARG . 0.0 OUTLIER -115.03 113.9 44.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.977 0.418 . . . . 0.0 111.864 -174.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 135' ' ' SER . . . . . 0.61 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.8 OUTLIER -116.71 152.32 34.54 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.876 175.661 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 136' ' ' ARG . . . . . 0.523 ' NH1' HD11 ' B' ' 134' ' ' ILE . 2.4 ptt180 -155.67 145.55 21.39 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.759 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 28.5 p -92.5 129.81 38.33 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 138' ' ' PHE . . . . . 0.442 ' CE2' ' NH1' ' A' ' 136' ' ' ARG . 15.1 m-85 -98.21 137.72 36.54 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -177.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.83 101.07 3.6 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.172 176.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 140' ' ' ARG . . . . . 0.484 ' NH2' ' OH ' ' B' ' 142' ' ' TYR . 0.1 OUTLIER -98.91 150.2 22.16 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 173.365 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 141' ' ' LYS . . . . . 0.571 ' HZ2' ' CD ' ' B' ' 119' ' ' GLU . 13.6 ttmm -140.42 122.67 15.87 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.486 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 142' ' ' TYR . . . . . 0.692 ' CE1' HD21 ' B' ' 99' ' ' LEU . 0.5 OUTLIER -114.92 99.0 7.15 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 143' ' ' THR . . . . . 0.484 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.0 OUTLIER -88.59 89.59 8.05 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.542 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.54 93.3 19.03 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.724 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 145' ' ' PRO . . . . . 0.589 ' CD ' ' HD3' ' B' ' 146' ' ' PRO . 16.5 Cg_exo -67.24 -54.97 0.33 Allowed 'Trans proline' 0 C--N 1.287 -2.667 0 C-N-CA 121.664 1.576 . . . . 0.0 112.345 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 146' ' ' PRO . . . . . 0.589 ' HD3' ' CD ' ' B' ' 145' ' ' PRO . 56.8 Cg_endo -98.72 89.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.103 2.535 . . . . 0.0 112.106 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.76 -20.55 1.29 Allowed Glycine 0 C--O 1.223 -0.534 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.669 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.26 122.92 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 117.579 0.69 . . . . 0.0 110.813 177.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 149' ' ' ASP . . . . . 0.448 ' OD1' ' HG3' ' B' ' 152' ' ' GLN . 12.0 t70 -93.58 148.08 34.81 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.05 -24.11 4.91 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.651 1.568 . . . . 0.0 112.756 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 151' ' ' THR . . . . . 0.436 ' N ' ' OD1' ' B' ' 149' ' ' ASP . 0.2 OUTLIER -91.36 -35.36 14.45 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.354 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 152' ' ' GLN . . . . . 0.677 ' O ' ' HB1' ' B' ' 167' ' ' ALA . 0.6 OUTLIER -103.53 14.49 31.15 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -175.342 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 39.1 t -107.9 120.46 59.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.438 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.83 -172.94 2.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.763 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.67 138.28 18.73 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.491 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.57 144.68 35.94 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.331 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 157' ' ' LEU . . . . . 0.818 HD22 HD22 ' B' ' 109' ' ' LEU . 15.4 tp -136.44 118.47 15.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.814 0.34 . . . . 0.0 110.249 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 158' ' ' SER . . . . . 0.446 ' N ' HD12 ' B' ' 157' ' ' LEU . 1.6 t -105.29 149.2 37.44 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 159' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -41.77 -26.39 0.43 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.64 2.227 . . . . 0.0 111.828 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 160' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' B' ' 160' ' ' GLU . 29.2 mp0 -66.04 -8.02 20.76 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.685 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 161' ' ' GLY . . . . . 0.594 ' O ' ' ND2' ' B' ' 102' ' ' ASN . . . 76.57 27.41 61.24 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 28.8 p -87.58 99.84 12.35 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.609 HD13 ' C ' ' B' ' 163' ' ' LEU . 1.3 tm? -96.35 92.86 6.54 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.31 127.0 41.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.452 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.574 ' O ' HG23 ' B' ' 165' ' ' VAL . 2.6 m -105.45 99.09 7.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.08 134.82 54.54 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.357 -176.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 167' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' B' ' 152' ' ' GLN . . . -170.46 160.99 6.22 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.28 0.562 . . . . 0.0 111.889 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 168' ' ' PRO . . . . . 0.466 ' HD2' ' HB1' ' B' ' 167' ' ' ALA . 57.0 Cg_endo -84.95 59.95 5.62 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 123.262 2.641 . . . . 0.0 109.237 176.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 169' ' ' MET . . . . . 0.526 ' HG3' ' HB2' ' B' ' 95' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 CA-C-N 113.457 -1.701 . . . . 0.0 111.011 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.514 -0.408 0 CA-C-O 120.59 0.233 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.69 ' NE1' HG22 ' A' ' 97' ' ' VAL . 54.1 t-105 -105.04 168.43 9.06 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.482 ' N ' ' CG ' ' A' ' 95' ' ' TRP . 1.7 ttm105 -150.51 108.72 3.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.368 -176.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.69 HG22 ' NE1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -116.44 150.06 18.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 174.899 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 14.7 m -131.52 157.64 43.03 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.573 HD22 ' HB ' ' A' ' 120' ' ' ILE . 0.7 OUTLIER -133.23 89.98 2.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.155 176.43 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -92.92 94.54 8.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.437 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -153.31 -23.51 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.696 ' CB ' HD13 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -83.17 9.28 10.89 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.195 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.608 ' N ' ' HA3' ' A' ' 161' ' ' GLY . 22.9 p-80 -48.53 -35.38 13.14 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.113 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -80.96 -3.4 51.45 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.832 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.491 ' C ' HD22 ' A' ' 102' ' ' ASN . . . -146.73 79.33 10.3 Favored Pre-proline 0 CA--C 1.512 -0.518 0 CA-C-O 120.772 0.32 . . . . 0.0 111.482 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.51 -39.81 11.67 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.513 2.142 . . . . 0.0 111.486 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -101.52 -31.66 10.77 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.978 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.404 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 22.6 mt-10 -79.28 46.17 0.7 Allowed 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.164 0.506 . . . . 0.0 110.05 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.696 HD13 ' CB ' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -133.21 135.66 45.18 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.471 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.7 116.85 17.85 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.153 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.93 124.95 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.517 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -127.97 136.76 51.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.999 0.428 . . . . 0.0 111.369 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.66 116.07 31.29 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.602 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 2.5 ttpt -111.41 80.76 1.35 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.356 0.598 . . . . 0.0 109.753 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 33.84 68.19 0.18 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.176 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.02 -23.59 25.8 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.611 HG22 HG23 ' A' ' 143' ' ' THR . 4.9 t -87.12 114.19 25.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.9 t -102.04 120.17 51.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.837 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.597 ' CD ' ' HD3' ' A' ' 141' ' ' LYS . 26.8 mt-10 -132.78 145.59 51.12 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.139 0.495 . . . . 0.0 110.948 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.573 ' HB ' HD22 ' A' ' 99' ' ' LEU . 1.1 mp -113.35 122.94 68.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.016 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.517 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -101.55 115.5 30.66 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.0 128.09 2.6 Favored Glycine 0 C--O 1.239 0.424 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.138 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.46 124.18 9.17 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.513 ' CD2' ' HG3' ' A' ' 127' ' ' ARG . 0.9 OUTLIER -91.04 151.99 20.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.045 0.45 . . . . 0.0 111.515 -177.708 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.559 ' O ' ' C ' ' A' ' 126' ' ' GLU . 6.1 tp10 -75.61 134.64 40.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.501 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.559 ' C ' ' O ' ' A' ' 125' ' ' GLU . 9.4 tt0 -2.65 97.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.808 0.693 . . . . 0.0 111.74 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.513 ' HG3' ' CD2' ' A' ' 124' ' ' HIS . 1.2 mtm-85 . . . . . 0 CA--C 1.514 -0.43 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.135 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.319 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' B' ' 141' ' ' LYS . 30.6 m-85 -95.21 121.1 36.51 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 172.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.99 126.2 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -169.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.525 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -126.38 154.28 43.79 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.669 174.403 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.44 179.34 7.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.266 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.6 p -139.75 127.1 21.37 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -100.86 136.19 41.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.95 101.54 6.36 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.505 174.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.583 ' HA ' ' NH1' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -101.69 141.36 34.67 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.718 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.597 ' HD3' ' CD ' ' A' ' 119' ' ' GLU . 2.7 ttpp -140.85 125.25 17.64 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.315 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.492 ' HE1' ' HE ' ' A' ' 140' ' ' ARG . 57.9 m-85 -120.44 99.13 6.38 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.611 HG23 HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -89.75 88.92 7.55 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.4 mp -112.43 92.74 20.24 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.634 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 17.0 Cg_exo -65.9 -58.36 0.19 Allowed 'Trans proline' 0 C--N 1.286 -2.753 0 C-N-CA 121.89 1.726 . . . . 0.0 113.497 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.634 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 5.7 Cg_endo -90.5 -13.31 2.34 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 122.774 2.316 . . . . 0.0 114.159 -175.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -104.38 3.0 43.17 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.722 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.47 136.09 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 118.024 0.912 . . . . 0.0 111.005 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 29.0 t70 -96.38 141.97 23.88 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.954 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 2.8 Cg_endo -82.69 -22.32 4.53 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.876 1.717 . . . . 0.0 112.547 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.84 -39.43 12.34 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.233 -174.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.65 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 9.7 mt-30 -106.33 22.63 15.45 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 19.9 t -109.53 109.39 28.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.977 0.418 . . . . 0.0 110.094 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -169.58 1.6 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.02 139.38 14.76 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.756 -0.778 . . . . 0.0 112.431 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.59 130.51 53.62 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.418 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.656 HD22 HD22 ' A' ' 109' ' ' LEU . 40.0 tp -123.75 109.2 13.37 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.989 0.423 . . . . 0.0 110.355 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.416 ' HB3' HG22 ' A' ' 162' ' ' THR . 0.2 OUTLIER -91.36 147.39 35.33 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.237 178.759 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 161' ' ' GLY . 87.4 Cg_exo -40.35 -38.52 2.37 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.599 2.199 . . . . 0.0 111.612 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -70.03 29.98 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.742 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.621 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 43.93 34.62 3.05 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.06 -0.518 . . . . 0.0 113.039 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 162' ' ' THR . 10.1 t -100.47 99.59 10.23 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.3 0.571 . . . . 0.0 109.598 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.611 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.9 tm? -91.12 106.16 18.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.803 -176.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.54 124.38 44.66 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 165' ' ' VAL . 3.1 m -105.54 100.59 10.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -114.28 139.66 49.24 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.06 -176.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.65 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 178.17 166.68 0.58 Allowed Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.999 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.634 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 60.6 Cg_endo -81.39 108.75 2.0 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.074 2.516 . . . . 0.0 110.13 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.599 ' SD ' ' HB3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -92.89 147.76 34.59 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.825 -176.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo . . . . . 0 C--N 1.305 -1.717 0 C-N-CA 122.713 2.275 . . . . 0.0 111.693 178.721 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.33 118.09 14.79 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -114.21 113.39 24.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.829 -175.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.7 t -119.25 156.86 21.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 3.7 m -129.64 134.49 47.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -174.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' LEU . . . . . 0.452 HD22 ' HB ' ' B' ' 120' ' ' ILE . 0.4 OUTLIER -103.16 97.23 7.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.632 175.206 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 100' ' ' ASP . . . . . 0.537 ' C ' HG22 ' B' ' 101' ' ' VAL . 18.9 p-10 -88.75 103.25 15.79 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.677 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' VAL . . . . . 0.537 HG22 ' C ' ' B' ' 100' ' ' ASP . 0.1 OUTLIER -170.46 -39.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-O 121.833 0.825 . . . . 0.0 109.417 179.036 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 102' ' ' ASN . . . . . 0.624 HD21 ' HA ' ' B' ' 106' ' ' PRO . 0.2 OUTLIER -38.94 -26.45 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.148 -177.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -53.18 -23.76 9.19 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 119.592 -0.843 . . . . 0.0 108.927 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.546 ' HB3' ' CZ ' ' B' ' 136' ' ' ARG . 27.3 m-85 -71.81 -13.13 61.6 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.715 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' B' ' 109' ' ' LEU . . . -174.61 94.26 0.3 Allowed Pre-proline 0 C--O 1.223 -0.336 0 O-C-N 123.308 0.38 . . . . 0.0 111.708 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.624 ' HA ' HD21 ' B' ' 102' ' ' ASN . 41.3 Cg_endo -71.57 -44.39 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.493 2.128 . . . . 0.0 111.833 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -30.75 22.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.948 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' B' ' 123' ' ' LYS . 16.7 mt-10 -102.19 56.73 0.8 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.081 0.467 . . . . 0.0 110.985 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 109' ' ' LEU . . . . . 0.6 HD22 HD22 ' B' ' 157' ' ' LEU . 0.4 OUTLIER -127.9 145.58 50.91 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.43 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -141.31 116.72 10.14 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.916 -177.356 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.03 123.01 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.786 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' LYS . . . . . 0.453 ' NZ ' ' OG1' ' B' ' 121' ' ' THR . 6.1 pttm -130.9 119.69 22.53 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.237 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.35 120.14 23.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' LYS . . . . . 0.477 ' NZ ' ' OE1' ' B' ' 119' ' ' GLU . 0.8 OUTLIER -121.26 82.49 1.94 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.537 -174.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 32.8 t70 32.56 68.91 0.13 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.345 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' GLY . . . . . 0.462 ' HA2' HG12 ' B' ' 148' ' ' VAL . . . 86.52 -22.61 12.58 Favored Glycine 0 C--N 1.315 -0.598 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' VAL . . . . . 0.662 HG22 HG23 ' B' ' 143' ' ' THR . 6.4 t -87.42 120.71 37.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 72.5 t -107.7 108.44 25.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.319 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' GLU . . . . . 0.532 ' O ' HD12 ' B' ' 120' ' ' ILE . 2.9 mt-10 -124.5 146.77 48.78 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.966 0.412 . . . . 0.0 110.612 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' ILE . . . . . 0.532 HD12 ' O ' ' B' ' 119' ' ' GLU . 1.3 mp -119.96 117.29 53.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.452 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' THR . . . . . 0.453 ' OG1' ' NZ ' ' B' ' 112' ' ' LYS . 0.2 OUTLIER -89.81 121.48 31.99 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.755 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -144.33 101.17 0.25 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -131.0 143.32 50.64 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.48 151.96 37.71 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.574 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' GLU . . . . . 0.467 ' O ' ' C ' ' B' ' 126' ' ' GLU . 4.0 mt-10 -91.17 126.84 36.37 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.642 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' GLU . . . . . 0.573 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 3.4 tt0 14.79 99.46 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 127' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' B' ' 134' ' ' ILE . 12.6 mtp180 -97.67 141.19 31.0 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.142 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 128' ' ' GLN . . . . . 0.48 ' HG2' ' N ' ' B' ' 129' ' ' ASP . 0.0 OUTLIER -86.74 136.91 32.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ASP . . . . . 0.522 ' CG ' ' N ' ' B' ' 130' ' ' GLU . 0.1 OUTLIER -133.45 169.26 17.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.845 174.658 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 130' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' B' ' 130' ' ' GLU . 0.0 OUTLIER -67.81 -31.98 72.21 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -174.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 131' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -111.29 20.24 17.51 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 147.08 178.25 22.24 Favored Glycine 0 C--N 1.307 -1.036 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.614 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -96.01 134.81 38.58 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' ILE . . . . . 0.519 HG23 ' O ' ' B' ' 134' ' ' ILE . 0.0 OUTLIER -145.97 116.41 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.886 0.375 . . . . 0.0 111.831 -175.831 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 135' ' ' SER . . . . . 0.573 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -132.81 156.66 46.72 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.055 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 136' ' ' ARG . . . . . 0.546 ' CZ ' ' HB3' ' B' ' 104' ' ' PHE . 0.0 OUTLIER -151.63 167.81 26.95 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.162 0.505 . . . . 0.0 111.932 -178.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 137' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' B' ' 123' ' ' LYS . 20.5 p -118.58 129.86 55.57 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.12 176.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -106.05 143.76 33.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.384 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.11 121.28 7.78 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.857 0.36 . . . . 0.0 111.493 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 140' ' ' ARG . . . . . 0.535 ' NH2' ' OH ' ' B' ' 142' ' ' TYR . 0.0 OUTLIER -118.02 144.57 45.45 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.023 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 141' ' ' LYS . . . . . 0.472 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 9.1 ttpp -133.01 124.66 28.11 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 123.136 0.272 . . . . 0.0 111.027 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 142' ' ' TYR . . . . . 0.535 ' OH ' ' NH2' ' B' ' 140' ' ' ARG . 3.1 m-85 -118.33 98.64 6.38 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.03 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 143' ' ' THR . . . . . 0.662 HG23 HG22 ' B' ' 117' ' ' VAL . 0.3 OUTLIER -90.42 100.88 13.64 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.016 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.43 96.72 16.87 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.073 -177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 145' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' B' ' 147' ' ' GLY . 36.8 Cg_exo -62.98 -41.92 26.56 Favored 'Trans proline' 0 C--N 1.286 -2.747 0 C-N-CA 123.223 2.615 . . . . 0.0 114.251 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 146' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 36.3 Cg_exo -43.23 -11.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.916 1.744 . . . . 0.0 112.304 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 147' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 109.11 44.13 1.12 Allowed Glycine 0 C--O 1.218 -0.87 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.209 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 148' ' ' VAL . . . . . 0.53 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -60.68 96.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 149' ' ' ASP . . . . . 0.509 ' CG ' ' HG3' ' B' ' 152' ' ' GLN . 10.3 t70 -50.66 129.16 26.92 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.183 -171.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 11.4 Cg_exo -71.16 -25.95 21.76 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.149 1.899 . . . . 0.0 113.053 -177.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.31 -49.87 6.29 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.363 0.602 . . . . 0.0 111.213 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 152' ' ' GLN . . . . . 0.509 ' HG3' ' CG ' ' B' ' 149' ' ' ASP . 6.0 mt-30 -79.57 10.59 3.76 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.582 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 153' ' ' VAL . . . . . 0.71 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 17.9 t -101.64 119.57 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.42 155.8 27.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 155' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' B' ' 164' ' ' THR . 1.2 m -132.99 132.77 42.29 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.399 -176.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 156' ' ' SER . . . . . 0.554 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.0 OUTLIER -108.47 145.17 35.08 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.477 178.809 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 157' ' ' LEU . . . . . 0.6 HD22 HD22 ' B' ' 109' ' ' LEU . 31.7 tp -130.96 128.42 40.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.336 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 158' ' ' SER . . . . . 0.479 ' O ' ' N ' ' B' ' 161' ' ' GLY . 0.6 OUTLIER -114.14 150.32 43.44 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.123 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 159' ' ' PRO . . . . . 0.538 ' C ' ' H ' ' B' ' 161' ' ' GLY . 87.3 Cg_exo -43.15 -34.14 4.05 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.782 2.321 . . . . 0.0 111.462 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.33 2.19 0.27 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.445 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 161' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 63.38 27.81 71.35 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.712 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 6.0 t -93.87 120.66 34.43 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 163' ' ' LEU . . . . . 0.627 HD13 ' C ' ' B' ' 163' ' ' LEU . 2.2 tm? -108.63 106.6 16.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.814 -176.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 164' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' B' ' 155' ' ' SER . 0.7 OUTLIER -95.5 127.99 42.0 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.106 -179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 165' ' ' VAL . . . . . 0.546 ' O ' HG23 ' B' ' 165' ' ' VAL . 2.6 m -112.99 107.58 23.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -121.57 144.7 48.58 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.439 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 167' ' ' ALA . . . . . 0.71 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -168.61 152.7 5.74 Favored Pre-proline 0 C--O 1.235 0.29 0 C-N-CA 120.463 -0.495 . . . . 0.0 112.16 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -87.68 47.98 1.52 Allowed 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 123.364 2.709 . . . . 0.0 109.59 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 169' ' ' MET . . . . . . . . . . . . . 3.1 ptm . . . . . 0 C--N 1.316 -0.886 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.631 -176.336 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.516 ' SD ' ' N ' ' A' ' 81' ' ' LEU . 1.4 ppp? . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.585 ' CD ' ' H ' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -53.37 -45.83 69.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.224 -178.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.516 ' N ' ' SD ' ' A' ' 79' ' ' MET . 7.4 mt 62.49 176.46 0.14 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.081 -178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 84' ' ' GLY . 0.7 OUTLIER -70.77 50.57 0.13 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.136 0.493 . . . . 0.0 110.268 178.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.47 65.52 0.05 OUTLIER 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.667 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 82' ' ' SER . . . -61.53 -37.17 93.72 Favored Glycine 0 CA--C 1.517 0.168 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.26 156.83 42.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 88' ' ' ILE . 1.4 m -100.6 73.96 1.65 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.896 0.379 . . . . 0.0 110.756 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -67.59 57.09 0.06 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.201 0.524 . . . . 0.0 110.031 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.527 ' O ' HG23 ' A' ' 88' ' ' ILE . 6.1 tp -82.86 82.66 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.936 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -110.72 97.49 6.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.879 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 92' ' ' ALA . 2.7 t-80 -81.5 33.4 0.36 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.956 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.15 51.7 0.09 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 90' ' ' HIS . . . -114.01 72.15 0.77 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.88 -174.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.58 -42.25 96.3 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 172.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.4 mmm-85 68.65 135.94 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.399 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.678 ' CZ3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -96.58 158.82 15.25 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.969 177.07 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -151.88 104.14 2.98 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.508 -177.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.678 HG21 ' CZ3' ' A' ' 95' ' ' TRP . 0.8 OUTLIER -121.14 152.46 24.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.133 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 4.4 m -122.45 140.81 52.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.579 HD22 ' HB ' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -117.49 63.92 0.74 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.31 174.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.15 108.27 3.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.617 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.66 ' HA ' ' CE1' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -159.36 -31.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 120.751 0.31 . . . . 0.0 110.94 176.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.973 ' HB3' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -56.55 5.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -177.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.66 ' CE1' ' HA ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -61.73 -30.98 71.13 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 118.824 -1.15 . . . . 0.0 108.284 176.046 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.491 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 14.9 m-85 -88.93 5.19 45.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.943 176.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.479 ' HB1' ' HB2' ' A' ' 108' ' ' GLU . . . -167.39 92.36 0.7 Allowed Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.9 -48.58 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.432 2.088 . . . . 0.0 111.159 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 109' ' ' LEU . 1.6 t70 -98.26 -31.9 11.83 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.479 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 54.7 mp0 -75.73 36.74 0.14 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.289 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.973 HD13 ' HB3' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -125.25 138.42 54.1 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.651 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.58 112.6 11.61 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.22 129.58 39.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.87 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.458 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.1 OUTLIER -136.52 125.2 23.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.934 0.397 . . . . 0.0 111.359 -179.335 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.0 m -108.18 115.0 29.31 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.3 91.77 3.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.888 0.375 . . . . 0.0 111.686 -176.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.7 t0 40.18 69.24 0.33 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.243 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.08 -17.61 16.66 Favored Glycine 0 C--N 1.312 -0.771 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.6 t -88.68 109.65 20.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.008 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.7 t -98.71 115.21 38.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.851 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.638 ' CD ' ' NZ ' ' A' ' 141' ' ' LYS . 0.3 OUTLIER -125.66 139.4 53.59 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.337 0.589 . . . . 0.0 110.711 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.579 ' HB ' HD22 ' A' ' 99' ' ' LEU . 1.2 mp -116.32 111.24 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.912 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.458 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -91.84 116.24 28.74 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.821 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.37 125.7 2.0 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.163 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 137' ' ' CYS . 0.0 OUTLIER -134.95 137.87 43.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 177.656 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' A' ' 104' ' ' PHE . 29.7 t60 -80.11 168.28 19.33 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.643 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.481 ' O ' ' C ' ' A' ' 126' ' ' GLU . 2.4 tp10 -113.41 131.85 55.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.315 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 125' ' ' GLU . 5.3 tt0 -19.3 99.8 0.02 OUTLIER 'General case' 0 C--N 1.349 0.548 0 O-C-N 123.563 0.539 . . . . 0.0 111.995 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.462 ' HB2' ' H ' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -69.8 156.41 39.07 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.84 178.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -127.54 95.2 4.18 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -135.09 146.39 48.85 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.92 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.51 ' OE2' ' N ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -51.75 -22.57 3.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.794 -176.591 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.423 ' O ' ' OH ' ' B' ' 142' ' ' TYR . 87.1 m-70 -92.91 5.37 51.61 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.493 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 136.03 154.59 6.93 Favored Glycine 0 C--N 1.312 -0.769 0 C-N-CA 120.138 -1.029 . . . . 0.0 112.654 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 8.8 m-30 -94.97 109.42 21.44 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.462 ' H ' ' HB2' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -117.39 154.82 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -175.206 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.78 152.38 26.87 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.441 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.419 ' NH2' ' CE2' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -143.8 175.35 10.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.687 -177.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 32.0 p -137.68 133.86 34.73 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.626 ' CD1' HG11 ' A' ' 101' ' ' VAL . 1.6 m-85 -107.54 138.97 42.8 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.472 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.84 114.68 7.74 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.718 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.558 ' NH2' ' OH ' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -120.22 126.04 49.64 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.638 ' NZ ' ' CD ' ' A' ' 119' ' ' GLU . 2.0 ttmm -120.06 107.44 13.07 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 120.756 0.312 . . . . 0.0 111.091 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.558 ' OH ' ' NH2' ' A' ' 140' ' ' ARG . 4.2 m-30 -103.1 99.13 8.99 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.511 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.1 OUTLIER -87.56 88.93 7.81 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.51 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 mp -113.23 90.79 17.38 Favored Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.657 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 15.8 Cg_exo -67.93 -57.43 0.16 Allowed 'Trans proline' 0 C--N 1.287 -2.689 0 C-N-CA 122.164 1.91 . . . . 0.0 113.537 175.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.657 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 28.8 Cg_endo -98.45 43.65 0.09 OUTLIER 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.61 2.873 . . . . 0.0 112.413 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.33 -8.25 0.04 OUTLIER Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.137 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.549 ' CG2' ' CZ2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -138.37 127.09 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 117.4 0.6 . . . . 0.0 111.129 178.193 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.421 ' OD2' ' N ' ' A' ' 152' ' ' GLN . 13.7 t70 -87.89 138.49 31.15 Favored Pre-proline 0 N--CA 1.484 1.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.057 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -81.99 -21.77 5.54 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.016 1.811 . . . . 0.0 113.075 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.14 -37.92 13.07 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.421 ' N ' ' OD2' ' A' ' 149' ' ' ASP . 25.6 mt-30 -103.61 11.76 35.75 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 22.5 t -95.04 118.48 41.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.844 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.9 173.35 6.47 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.5 p -141.68 137.43 31.75 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.961 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.23 133.41 52.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.996 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.628 HD22 HD22 ' A' ' 109' ' ' LEU . 33.9 tp -131.1 136.99 48.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.097 0.475 . . . . 0.0 110.331 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.581 ' H ' HD12 ' A' ' 157' ' ' LEU . 1.8 t -123.71 146.56 50.76 Favored Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.825 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -40.01 -34.07 0.87 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.683 2.255 . . . . 0.0 111.676 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -62.29 -7.44 4.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.641 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.564 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . 76.31 33.61 48.31 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 112.22 -0.352 . . . . 0.0 112.22 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.2 t -100.63 116.74 33.26 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.579 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.4 tm? -110.56 99.86 8.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.543 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.68 127.6 40.76 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 121.343 -0.143 . . . . 0.0 110.714 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 165' ' ' VAL . 3.2 m -108.51 103.13 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.68 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 2.7 pp20? -114.34 147.58 38.9 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.786 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.68 ' HB2' ' O ' ' A' ' 166' ' ' GLU . . . 166.19 166.33 0.1 OUTLIER Pre-proline 0 CA--C 1.515 -0.371 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.785 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.663 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 84.1 Cg_endo -82.18 133.15 7.47 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 123.804 3.003 . . . . 0.0 109.665 173.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.442 ' SD ' ' N ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -128.69 146.92 62.18 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -174.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.401 ' HB2' HD23 ' A' ' 172' ' ' LEU . 17.9 Cg_endo -58.62 101.74 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 123.461 2.774 . . . . 0.0 111.843 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.04 84.66 0.13 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.401 HD23 ' HB2' ' A' ' 170' ' ' PRO . 2.5 mm? -101.04 165.44 11.31 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.394 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -119.14 101.7 8.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.049 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.79 -165.45 0.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.33 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -124.33 171.16 10.12 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.209 -1.031 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.659 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' MET . . . . . 0.555 ' O ' ' N ' ' B' ' 81' ' ' LEU . 2.8 mtp . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.424 ' O ' ' N ' ' B' ' 82' ' ' SER . 10.3 mp0 60.66 -63.22 0.07 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.975 0.417 . . . . 0.0 111.212 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' B' ' 79' ' ' MET . 2.0 mt -68.86 57.82 0.09 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.687 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' SER . . . . . 0.424 ' N ' ' O ' ' B' ' 80' ' ' GLN . 75.7 m -47.57 -35.61 9.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.867 0.365 . . . . 0.0 110.163 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -24.9 48.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.02 -1.74 90.64 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' B' ' 87' ' ' GLU . 4.3 m -134.19 -43.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.608 0.242 . . . . 0.0 110.889 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.95 -54.24 0.31 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.862 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' B' ' 85' ' ' VAL . 1.1 mm-40 -63.68 144.06 57.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.674 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.433 HG22 ' H ' ' B' ' 88' ' ' ILE . 0.5 OUTLIER -70.16 -43.11 79.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.284 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -109.92 140.42 43.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.452 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -140.53 159.92 41.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.035 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.89 88.77 2.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.967 0.413 . . . . 0.0 110.621 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.95 -159.37 1.03 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.64 66.38 1.21 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.732 0.301 . . . . 0.0 110.766 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' ARG . . . . . 0.601 HH12 ' CD ' ' B' ' 166' ' ' GLU . 0.1 OUTLIER -138.02 131.14 30.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.923 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 95' ' ' TRP . . . . . 0.781 ' NE1' HG22 ' B' ' 97' ' ' VAL . 14.6 t-105 -114.16 155.49 25.97 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 39.8 ttt85 -134.96 98.74 4.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.239 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.781 HG22 ' NE1' ' B' ' 95' ' ' TRP . 0.2 OUTLIER -101.49 151.13 5.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.391 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 2.5 m -128.28 143.41 51.02 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.467 HD22 ' HB ' ' B' ' 120' ' ' ILE . 0.4 OUTLIER -119.3 137.15 53.88 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.297 174.029 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.563 ' C ' HG22 ' B' ' 101' ' ' VAL . 9.7 p-10 -122.89 116.16 23.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.373 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.563 HG22 ' C ' ' B' ' 100' ' ' ASP . 0.0 OUTLIER -171.37 -45.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 120.785 0.326 . . . . 0.0 111.663 178.732 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.88 ' HB3' HD13 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -53.38 -1.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -175.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.467 ' CE1' ' N ' ' B' ' 101' ' ' VAL . 0.1 OUTLIER -62.13 -26.12 68.13 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 118.51 -1.276 . . . . 0.0 108.409 175.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -84.42 -13.0 53.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.798 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' B' ' 102' ' ' ASN . . . -164.66 97.81 0.88 Allowed Pre-proline 0 CA--C 1.516 -0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.154 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.07 -42.74 0.37 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.352 2.035 . . . . 0.0 111.039 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.83 -31.43 13.72 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.485 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 37.33 0.74 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.367 0.603 . . . . 0.0 110.444 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.88 HD13 ' HB3' ' B' ' 102' ' ' ASN . 0.5 OUTLIER -117.11 146.62 43.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.033 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.444 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 1.2 m -136.88 120.94 17.72 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.889 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.416 HG13 HD11 ' B' ' 120' ' ' ILE . 0.5 OUTLIER -99.77 121.47 50.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.541 ' NZ ' ' HB2' ' B' ' 119' ' ' GLU . 14.8 pttp -132.47 120.94 22.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.107 0.48 . . . . 0.0 111.333 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.7 117.56 28.66 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.575 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 1.3 ttmt -116.11 91.34 3.57 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.898 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' B' ' 114' ' ' LYS . 0.9 OUTLIER 28.73 63.98 0.12 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.457 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.52 -21.14 42.54 Favored Glycine 0 C--N 1.316 -0.534 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.607 HG22 HG23 ' B' ' 143' ' ' THR . 2.8 t -87.65 119.41 35.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.301 177.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 75.4 t -106.51 114.85 46.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.541 ' HB2' ' NZ ' ' B' ' 112' ' ' LYS . 1.1 mt-10 -130.45 145.14 51.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.227 0.537 . . . . 0.0 110.62 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.595 HG23 HD11 ' B' ' 109' ' ' LEU . 1.3 mp -116.94 118.98 60.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.791 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -95.7 123.87 39.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.341 -178.214 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -147.22 118.49 1.02 Allowed Glycine 0 C--N 1.333 0.393 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.56 143.31 24.58 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -123.97 158.6 31.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.91 0.386 . . . . 0.0 111.409 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.517 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.9 OUTLIER -95.35 145.1 25.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.284 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 126' ' ' GLU . . . . . 0.629 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 0.6 OUTLIER -1.65 96.94 0.01 OUTLIER 'General case' 0 C--O 1.238 0.485 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 127' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 127' ' ' ARG . 1.5 mtm180 -97.97 143.78 28.18 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.037 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -71.76 157.62 37.58 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' B' ' 130' ' ' GLU . 0.8 OUTLIER -157.19 168.96 25.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.036 0.446 . . . . 0.0 110.774 -178.495 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 130' ' ' GLU . . . . . 0.521 ' N ' ' CG ' ' B' ' 129' ' ' ASP . 0.9 OUTLIER -63.42 -34.84 78.62 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.609 -177.551 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 131' ' ' HIS . . . . . 0.476 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 82.2 m-70 -121.54 39.9 3.73 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.006 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 142' ' ' TYR . . . 135.65 -162.67 24.94 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.434 -1.365 . . . . 0.0 112.475 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -114.15 120.72 41.49 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' ILE . . . . . 0.471 HG22 ' HB3' ' B' ' 129' ' ' ASP . 0.0 OUTLIER -134.63 121.84 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -172.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 135' ' ' SER . . . . . 0.629 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -124.99 144.56 50.32 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 174.331 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -137.31 160.65 38.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.971 0.415 . . . . 0.0 111.296 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 22.4 p -120.37 133.47 55.43 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.99 137.05 52.45 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.816 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.75 123.41 15.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.044 177.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.45 124.18 42.3 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 174.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 141' ' ' LYS . . . . . 0.428 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 3.5 ttpp -117.15 127.1 53.79 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.716 0.293 . . . . 0.0 110.757 -175.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 142' ' ' TYR . . . . . 0.531 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 4.3 m-85 -116.71 97.98 6.28 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.607 HG23 HG22 ' B' ' 117' ' ' VAL . 0.3 OUTLIER -92.19 98.22 11.39 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 144' ' ' LEU . . . . . 0.423 ' C ' ' HD2' ' B' ' 146' ' ' PRO . 7.1 mp -109.98 91.69 11.5 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 145' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' B' ' 143' ' ' THR . 28.0 Cg_exo -64.73 -36.68 39.84 Favored 'Trans proline' 0 C--N 1.287 -2.708 0 C-N-CA 122.909 2.406 . . . . 0.0 113.303 175.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 146' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 65.4 Cg_exo -43.08 -12.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 122.142 1.895 . . . . 0.0 111.962 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 112.0 48.09 0.68 Allowed Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.607 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 148' ' ' VAL . . . . . 0.508 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -68.39 97.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 174.016 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 149' ' ' ASP . . . . . 0.506 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 0.1 OUTLIER -51.81 125.7 30.72 Favored Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.396 -170.484 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 2.8 Cg_exo -76.35 -29.43 6.19 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.375 2.05 . . . . 0.0 112.012 -177.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.8 -28.59 61.72 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.243 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' GLN . . . . . 0.558 ' O ' ' HB1' ' B' ' 167' ' ' ALA . 2.1 mt-30 -113.19 12.64 19.07 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -173.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 153' ' ' VAL . . . . . 0.474 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 25.1 t -106.28 113.77 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.127 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.93 173.76 6.22 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.31 135.57 27.07 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.22 140.9 39.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.586 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 157' ' ' LEU . . . . . 0.665 HD22 HD22 ' B' ' 109' ' ' LEU . 13.0 tp -134.86 126.62 29.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.619 0.247 . . . . 0.0 110.775 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.541 ' N ' HD12 ' B' ' 157' ' ' LEU . 1.5 t -114.0 148.9 40.98 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 159' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -40.97 -27.48 0.32 Allowed 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.982 2.455 . . . . 0.0 111.985 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' GLU . . . . . 0.515 ' H ' ' CD ' ' B' ' 160' ' ' GLU . 4.3 mp0 -63.58 -9.53 13.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.297 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 161' ' ' GLY . . . . . 0.52 ' O ' ' ND2' ' B' ' 102' ' ' ASN . . . 78.66 23.96 63.57 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 40.2 p -88.24 102.55 14.93 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.064 -0.568 . . . . 0.0 109.512 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.642 HD13 ' C ' ' B' ' 163' ' ' LEU . 1.7 tm? -99.91 95.1 6.66 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.68 126.51 35.01 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.676 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.599 ' O ' HG23 ' B' ' 165' ' ' VAL . 2.7 m -108.67 99.61 9.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 0.601 ' CD ' HH12 ' B' ' 94' ' ' ARG . 0.1 OUTLIER -108.26 135.63 49.25 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.988 -175.636 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 167' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' B' ' 152' ' ' GLN . . . 176.85 167.42 0.45 Allowed Pre-proline 0 N--CA 1.445 -0.697 0 C-N-CA 119.533 -0.867 . . . . 0.0 113.128 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 168' ' ' PRO . . . . . 0.451 ' HD2' ' HB1' ' B' ' 167' ' ' ALA . 1.3 Cg_endo -80.97 134.96 9.67 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 124.097 3.198 . . . . 0.0 109.467 174.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.12 157.71 31.33 Favored Pre-proline 0 N--CA 1.445 -0.699 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.378 -178.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 170' ' ' PRO . . . . . 0.607 ' HB2' HD13 ' B' ' 172' ' ' LEU . 12.0 Cg_endo -55.3 112.74 1.13 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 123.467 2.778 . . . . 0.0 111.905 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 171' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -65.15 56.03 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.728 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' B' ' 170' ' ' PRO . 2.6 mp -87.04 -40.52 14.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.689 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 173' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 172' ' ' LEU . . . 32.54 66.11 0.2 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.743 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 174' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' B' ' 175' ' ' GLN . 1.7 t -95.59 -125.35 0.12 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.168 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 175' ' ' GLN . . . . . 0.498 ' N ' ' OG1' ' B' ' 174' ' ' THR . 7.4 pt20 -80.53 -158.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.684 0.278 . . . . 0.0 110.684 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.209 -1.051 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.602 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.559 ' N ' ' O ' ' A' ' 85' ' ' VAL . 6.1 mmt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 82' ' ' SER . 27.9 mt-30 63.61 166.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.628 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.7 mt -68.22 56.69 0.07 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.19 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 80' ' ' GLN . 7.7 p -95.16 -102.0 0.15 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.01 47.86 0.8 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.078 0.466 . . . . 0.0 109.788 176.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.09 -74.96 1.23 Allowed Glycine 0 CA--C 1.519 0.282 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 79' ' ' MET . 0.0 OUTLIER -149.66 -90.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.188 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.82 118.99 22.1 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.702 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 1.7 pm0 -73.06 126.71 30.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.375 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.6 tt -114.71 153.17 16.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.099 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.428 ' HE ' ' HB3' ' A' ' 89' ' ' ARG . 11.7 mmm180 -119.49 150.7 39.81 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.208 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.462 ' O ' ' C ' ' A' ' 91' ' ' THR . 2.7 m80 -51.99 122.4 8.35 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.504 HG21 ' NH1' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -28.77 111.72 0.06 Allowed 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.36 0.413 . . . . 0.0 112.113 -176.157 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.52 -161.95 0.32 Allowed 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.821 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 168' ' ' PRO . 4.2 m-20 -53.03 125.81 18.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.779 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.504 ' NH1' HG21 ' A' ' 91' ' ' THR . 4.3 mmm-85 -85.94 110.73 19.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.653 ' CZ3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -77.38 158.61 30.0 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 174.605 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.1 ttm-85 -152.84 99.21 2.41 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.146 -175.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.653 HG21 ' CZ3' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -119.83 157.83 21.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 176.579 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 27.7 m -131.4 144.55 51.28 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.878 HD22 HG13 ' A' ' 120' ' ' ILE . 1.4 mp -117.1 65.39 0.72 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.066 173.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.58 93.55 3.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.906 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' A' ' 103' ' ' HIS . 1.6 t -150.52 -43.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 121.14 0.495 . . . . 0.0 110.967 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.644 ' ND2' ' CD1' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -54.47 13.6 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -175.801 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.555 ' H ' ' C ' ' A' ' 101' ' ' VAL . 8.3 t-160 -49.72 -21.24 1.01 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.874 0.369 . . . . 0.0 110.453 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -101.98 1.67 36.93 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.821 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -141.93 89.21 8.99 Favored Pre-proline 0 CA--C 1.517 -0.313 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.755 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.5 -41.66 0.79 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.467 2.111 . . . . 0.0 111.456 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.429 ' C ' ' H ' ' A' ' 109' ' ' LEU . 14.3 t70 -105.22 -31.93 8.88 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.071 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -80.32 40.8 0.5 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.451 0.644 . . . . 0.0 110.441 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.85 HD22 HD22 ' A' ' 157' ' ' LEU . 0.7 OUTLIER -124.7 141.61 51.98 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.471 176.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.52 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -141.18 115.72 9.54 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.772 0.32 . . . . 0.0 110.819 -178.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.0 t -92.37 131.52 39.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.405 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.39 132.46 31.48 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.527 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.1 m -107.5 115.97 31.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.133 178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.441 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -117.74 79.25 1.33 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.05 0.452 . . . . 0.0 111.085 -177.164 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.8 t70 45.14 69.55 0.43 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.083 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.46 -22.25 14.06 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.5 HG22 HG23 ' A' ' 143' ' ' THR . 21.6 t -87.1 113.16 24.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 65.2 t -102.28 112.79 36.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 141' ' ' LYS . 42.4 mt-10 -125.93 149.04 49.04 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.283 0.563 . . . . 0.0 111.095 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.878 HG13 HD22 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -122.47 143.13 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.218 178.644 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -121.31 106.79 11.8 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.095 -178.262 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -138.51 128.77 4.26 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.32 128.83 11.41 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.702 0.401 . . . . 0.0 110.362 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.453 ' CD2' ' HA ' ' A' ' 135' ' ' SER . 1.4 p-80 -100.0 137.16 38.83 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 41.4 mt-10 -60.82 -27.48 68.09 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -174.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 0.8 OUTLIER 172.52 120.76 0.02 OUTLIER 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.329 0.513 . . . . 0.0 111.837 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.739 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -97.98 145.58 26.35 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.233 175.633 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -99.26 117.44 33.73 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 120.839 0.352 . . . . 0.0 110.922 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.43 ' OD2' ' NH1' ' A' ' 127' ' ' ARG . 8.9 m-20 -130.61 135.9 48.33 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.073 175.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.6 -26.21 1.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.719 -176.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.481 ' O ' ' CZ ' ' B' ' 142' ' ' TYR . 78.0 m80 -106.02 19.75 20.04 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.678 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.65 ' HA3' ' CE1' ' B' ' 142' ' ' TYR . . . 148.71 149.1 4.89 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.185 -1.483 . . . . 0.0 114.295 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -95.07 109.84 21.84 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.677 HD12 ' NH1' ' B' ' 140' ' ' ARG . 0.0 OUTLIER -120.66 157.19 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -172.524 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.453 ' HA ' ' CD2' ' A' ' 124' ' ' HIS . 3.6 t -155.4 154.1 31.42 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.773 173.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.477 ' NH1' ' CZ ' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -147.0 174.74 11.25 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.336 -179.158 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 25.0 p -128.93 125.47 37.57 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -95.8 128.96 43.13 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.99 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.29 105.84 8.17 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.304 176.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.586 ' HG3' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -101.08 149.6 23.79 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.316 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.523 ' NZ ' ' OE1' ' B' ' 126' ' ' GLU . 1.6 ttpt -149.91 102.58 3.14 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.068 0.461 . . . . 0.0 110.506 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.56 ' OH ' ' NH1' ' A' ' 140' ' ' ARG . 10.6 m-85 -97.57 100.66 12.08 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.437 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.5 HG23 HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -88.51 89.37 7.96 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.192 0.52 . . . . 0.0 109.784 179.345 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.92 92.18 29.42 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.625 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 15.1 Cg_exo -68.02 -58.31 0.13 Allowed 'Trans proline' 0 C--N 1.285 -2.776 0 C-N-CA 122.141 1.894 . . . . 0.0 113.965 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.625 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 48.0 Cg_endo -100.51 51.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 123.406 2.737 . . . . 0.0 112.781 -175.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.67 -13.38 0.02 OUTLIER Glycine 0 N--CA 1.463 0.454 0 C-N-CA 120.237 -0.983 . . . . 0.0 112.269 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.629 HG21 ' CH2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -128.64 127.3 66.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.42 0.61 . . . . 0.0 110.861 178.523 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 18.8 t70 -83.5 140.75 41.63 Favored Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.557 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 3.0 Cg_exo -82.17 -25.04 3.53 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.18 1.92 . . . . 0.0 112.545 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.97 -36.68 13.29 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -175.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.763 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 8.9 mt-30 -109.29 31.84 5.43 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -173.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.41 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 39.5 t -115.47 124.88 72.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.716 177.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.69 -178.42 4.14 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.71 140.88 30.23 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.048 -0.661 . . . . 0.0 112.38 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -104.98 131.67 52.19 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.242 176.471 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.85 HD22 HD22 ' A' ' 109' ' ' LEU . 26.1 tp -129.87 125.52 35.81 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.021 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.587 ' HB3' ' OG1' ' A' ' 162' ' ' THR . 0.0 OUTLIER -106.04 162.23 20.37 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.559 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.4 -9.55 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.211 1.941 . . . . 0.0 110.786 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 158' ' ' SER . 3.6 mp0 -87.13 0.37 55.39 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.519 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.478 ' HA2' HD11 ' A' ' 157' ' ' LEU . . . 68.52 15.5 68.45 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -175.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.587 ' OG1' ' HB3' ' A' ' 158' ' ' SER . 3.0 p -74.0 99.25 3.24 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.616 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.7 tm? -102.08 92.12 4.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.871 -176.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.98 125.9 35.18 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.28 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 165' ' ' VAL . 5.3 m -103.3 103.03 14.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.595 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -119.41 148.72 42.9 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.12 -176.566 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.763 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 170.2 167.32 0.19 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.232 0.539 . . . . 0.0 112.138 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.568 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 60.9 Cg_endo -89.67 109.12 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.508 2.805 . . . . 0.0 110.065 176.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.483 ' O ' ' N ' ' A' ' 171' ' ' LYS . 0.0 OUTLIER -72.3 169.91 14.89 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.136 -177.582 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.4 50.01 0.08 OUTLIER 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 123.281 2.654 . . . . 0.0 112.675 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 169' ' ' MET . 3.4 mmmp? -70.15 51.63 0.12 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.896 0.379 . . . . 0.0 110.198 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 174' ' ' THR . 0.8 OUTLIER -156.68 -57.48 0.09 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.091 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.41 69.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.899 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 172' ' ' LEU . 11.2 t -79.64 -157.06 0.12 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.639 -178.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -140.26 178.63 7.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.993 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.21 -0.991 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.5 179.858 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 79' ' ' MET . . . . . 0.415 ' N ' ' SD ' ' B' ' 79' ' ' MET . 14.6 mmm . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.473 ' O ' ' OG1' ' B' ' 91' ' ' THR . 14.2 mt-30 -58.96 93.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.551 HD12 ' H ' ' B' ' 82' ' ' SER . 0.4 OUTLIER -64.86 -121.81 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.363 -177.711 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 82' ' ' SER . . . . . 0.551 ' H ' HD12 ' B' ' 81' ' ' LEU . 0.0 OUTLIER -135.48 -73.22 0.46 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.951 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.85 46.18 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.669 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' B' ' 82' ' ' SER . . . -92.5 166.18 29.12 Favored Glycine 0 C--N 1.322 -0.224 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 6.7 m -47.45 -39.6 6.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.872 0.368 . . . . 0.0 110.764 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -19.64 65.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.221 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 55.11 48.51 19.49 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.146 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.452 ' O ' ' N ' ' B' ' 90' ' ' HIS . 9.9 mm -122.51 134.56 65.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.395 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.56 45.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.699 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' B' ' 88' ' ' ILE . 0.1 OUTLIER -55.0 -65.42 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.343 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' B' ' 80' ' ' GLN . 4.6 m -110.71 96.21 6.03 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.053 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -134.69 116.81 15.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.044 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -54.89 109.51 0.53 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.556 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' ARG . . . . . 0.516 ' NH1' ' OE1' ' B' ' 166' ' ' GLU . 8.4 mmt85 -148.54 89.51 1.71 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.595 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' TRP . . . . . 0.499 ' O ' ' HA ' ' B' ' 166' ' ' GLU . 0.0 OUTLIER -72.48 145.85 47.26 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.036 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.415 ' HD3' HH11 ' B' ' 96' ' ' ARG . 11.2 ttm180 -133.84 109.05 8.82 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.387 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.14 156.23 18.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 98' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 3.3 m -134.2 149.89 51.03 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -174.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.709 HD22 ' CG1' ' B' ' 120' ' ' ILE . 0.5 OUTLIER -122.41 96.09 4.9 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.334 174.69 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.476 ' CG ' ' HE2' ' B' ' 103' ' ' HIS . 18.3 t70 -97.18 93.6 6.64 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.277 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.45 HG11 ' CE2' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -162.92 6.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-O 120.858 0.361 . . . . 0.0 111.103 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.841 ' HB2' HD13 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -90.46 -10.08 45.06 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -173.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.476 ' HE2' ' CG ' ' B' ' 100' ' ' ASP . 0.8 OUTLIER -42.73 -29.01 0.27 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.611 ' HB2' ' CE1' ' B' ' 124' ' ' HIS . 59.6 m-85 -101.25 25.35 8.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -170.28 93.75 0.48 Allowed Pre-proline 0 C--O 1.223 -0.297 0 CA-C-O 120.673 0.273 . . . . 0.0 111.633 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.6 -60.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.436 2.091 . . . . 0.0 111.558 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' B' ' 109' ' ' LEU . 19.7 t70 -91.74 -30.98 15.96 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.945 0.403 . . . . 0.0 110.458 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -73.68 32.9 0.08 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.376 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.841 HD13 ' HB2' ' B' ' 102' ' ' ASN . 0.4 OUTLIER -128.54 128.71 44.82 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.543 177.089 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.4 130.15 50.15 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.974 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.566 HG13 ' CD1' ' B' ' 120' ' ' ILE . 1.9 t -105.09 114.08 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.02 134.46 54.84 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.518 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.02 115.46 29.01 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.535 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.543 ' NZ ' ' OE2' ' B' ' 119' ' ' GLU . 0.0 OUTLIER -113.66 -171.43 1.89 Allowed 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -64.53 70.25 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' B' ' 114' ' ' LYS . . . 78.97 -8.32 45.32 Favored Glycine 0 CA--C 1.498 -1.008 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.52 HG22 HG23 ' B' ' 143' ' ' THR . 2.0 t -88.45 112.23 23.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.424 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 78.4 t -97.09 110.61 25.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.543 ' OE2' ' NZ ' ' B' ' 114' ' ' LYS . 29.5 mt-10 -126.76 117.36 22.52 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.168 0.509 . . . . 0.0 111.448 -176.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.709 ' CG1' HD22 ' B' ' 99' ' ' LEU . 6.1 mm -88.25 135.61 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.209 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.9 OUTLIER -115.7 111.51 20.7 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.445 -178.495 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.28 132.33 5.28 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -135.66 128.63 31.41 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' HIS . . . . . 0.611 ' CE1' ' HB2' ' B' ' 104' ' ' PHE . 28.3 m-70 -91.66 140.73 29.43 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.554 -177.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.5 OUTLIER -87.96 143.96 26.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.924 -178.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 126' ' ' GLU . . . . . 0.523 ' OE1' ' NZ ' ' A' ' 141' ' ' LYS . 2.5 tt0 -17.46 102.21 0.02 OUTLIER 'General case' 0 C--N 1.351 0.632 0 O-C-N 123.447 0.467 . . . . 0.0 112.068 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' ARG . . . . . 0.406 ' NH1' ' CE1' ' B' ' 104' ' ' PHE . 0.0 OUTLIER -94.86 149.98 20.67 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.055 -179.279 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -97.02 114.18 25.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.748 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.91 166.51 23.14 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -57.84 -26.9 62.67 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.955 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' HIS . . . . . 0.533 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 60.4 m-70 -80.07 14.31 1.91 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.652 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.78 -138.99 14.2 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -100.26 147.8 25.35 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' ILE . . . . . 0.535 HG23 ' O ' ' B' ' 134' ' ' ILE . 0.0 OUTLIER -156.04 117.54 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -175.244 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 135' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -131.04 153.3 49.42 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.061 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 136' ' ' ARG . . . . . 0.415 ' NH1' HD11 ' B' ' 134' ' ' ILE . 2.0 ptt180 -155.91 156.99 35.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.043 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 28.1 p -100.71 136.83 39.96 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' PHE . . . . . 0.477 ' CZ ' ' NH1' ' A' ' 136' ' ' ARG . 0.6 OUTLIER -114.64 123.51 49.49 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.576 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.6 118.2 20.66 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.281 0.563 . . . . 0.0 110.893 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 140' ' ' ARG . . . . . 0.677 ' NH1' HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -115.88 121.51 42.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 141' ' ' LYS . . . . . 0.49 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 3.6 ttpp -112.85 116.34 29.88 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 123.244 0.34 . . . . 0.0 110.958 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 142' ' ' TYR . . . . . 0.65 ' CE1' ' HA3' ' A' ' 132' ' ' GLY . 5.3 m-30 -107.56 97.54 7.26 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.594 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.2 OUTLIER -90.77 96.67 10.76 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 175.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 144' ' ' LEU . . . . . 0.479 ' C ' ' HD2' ' B' ' 146' ' ' PRO . 7.0 mp -108.44 94.46 13.71 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.821 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 145' ' ' PRO . . . . . 0.598 ' N ' ' HD2' ' B' ' 146' ' ' PRO . 24.0 Cg_exo -66.33 -34.42 35.21 Favored 'Trans proline' 0 C--N 1.287 -2.704 0 C-N-CA 122.636 2.224 . . . . 0.0 113.316 175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 146' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' B' ' 145' ' ' PRO . 27.7 Cg_exo -43.76 -10.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.991 1.794 . . . . 0.0 112.293 -178.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 111.36 44.65 0.9 Allowed Glycine 0 C--N 1.339 0.729 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.69 174.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 148' ' ' VAL . . . . . 0.498 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -68.51 101.83 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 175.141 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 149' ' ' ASP . . . . . 0.501 ' O ' HG23 ' B' ' 153' ' ' VAL . 13.5 t70 -52.31 126.4 36.97 Favored Pre-proline 0 C--O 1.221 -0.431 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.07 -172.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 5.1 Cg_exo -79.34 -18.98 10.67 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.11 1.873 . . . . 0.0 112.098 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.57 -38.25 12.61 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.558 -178.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' GLN . . . . . 0.453 ' N ' ' OD1' ' B' ' 149' ' ' ASP . 14.4 mt-30 -100.83 17.52 21.89 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 153' ' ' VAL . . . . . 0.501 HG23 ' O ' ' B' ' 149' ' ' ASP . 49.8 t -108.95 91.11 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.689 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.68 -166.08 1.51 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 155' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' B' ' 164' ' ' THR . 0.4 OUTLIER -163.57 142.54 8.08 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.751 -179.101 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.6 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.0 OUTLIER -111.81 144.63 40.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.028 178.017 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 157' ' ' LEU . . . . . 0.624 HD22 HD22 ' B' ' 109' ' ' LEU . 42.1 tp -130.76 117.09 18.89 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.403 ' HB3' HG22 ' B' ' 162' ' ' THR . 0.3 OUTLIER -103.57 152.01 38.78 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.813 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.613 ' C ' ' H ' ' B' ' 161' ' ' GLY . 94.5 Cg_exo -44.11 -32.82 5.12 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.45 2.1 . . . . 0.0 110.972 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -68.5 22.04 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.087 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' GLY . . . . . 0.613 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 41.91 27.28 0.36 Allowed Glycine 0 CA--C 1.523 0.561 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.627 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 162' ' ' THR . . . . . 0.403 HG22 ' HB3' ' B' ' 158' ' ' SER . 9.0 t -88.14 118.55 27.8 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.656 HD13 ' C ' ' B' ' 163' ' ' LEU . 2.9 tm? -105.97 103.93 13.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.831 -177.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 164' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' B' ' 155' ' ' SER . 0.7 OUTLIER -94.53 125.49 39.21 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.033 0.208 . . . . 0.0 111.341 -179.051 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.567 ' O ' HG23 ' B' ' 165' ' ' VAL . 2.7 m -111.81 105.65 19.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 173.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 0.516 ' OE1' ' NH1' ' B' ' 94' ' ' ARG . 0.0 OUTLIER -114.29 137.61 51.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.722 -176.336 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 167' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' B' ' 169' ' ' MET . . . -168.75 158.21 7.94 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 168' ' ' PRO . . . . . 0.432 ' HD2' ' HB1' ' B' ' 167' ' ' ALA . 72.0 Cg_endo -75.83 30.44 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 123.871 3.047 . . . . 0.0 110.329 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 169' ' ' MET . . . . . 0.489 ' H ' ' C ' ' B' ' 167' ' ' ALA . 0.6 OUTLIER -67.97 159.0 81.89 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.759 -179.404 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 170' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -44.0 143.0 3.46 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 123.397 2.731 . . . . 0.0 111.904 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 171' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -91.44 27.91 1.84 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.295 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.433 HD12 ' N ' ' B' ' 175' ' ' GLN . 0.1 OUTLIER -123.5 97.62 5.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.83 0.348 . . . . 0.0 110.34 178.19 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 173' ' ' ALA . . . . . 0.419 ' O ' ' HG2' ' B' ' 146' ' ' PRO . . . -59.03 -66.74 0.46 Allowed 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.112 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.96 62.77 1.16 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.695 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 175' ' ' GLN . . . . . 0.433 ' N ' HD12 ' B' ' 172' ' ' LEU . 25.6 tp60 -52.1 -86.7 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.589 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 176' ' ' SER . . . . . 0.414 ' HG ' HE21 ' B' ' 175' ' ' GLN . 2.5 m . . . . . 0 C--O 1.21 -1.009 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.55 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' MET . . . . . 1.037 ' N ' ' HG ' ' A' ' 83' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 120.589 0.233 . . . . 0.0 110.632 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' H ' ' HG ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -168.18 -145.54 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.481 ' H ' ' CD ' ' A' ' 80' ' ' GLN . 12.8 mt -56.06 -47.12 78.51 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.92 66.43 9.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 1.037 ' HG ' ' N ' ' A' ' 79' ' ' MET . 13.2 m -123.96 -34.29 3.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.759 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.74 30.19 0.28 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.583 ' H ' ' C ' ' A' ' 83' ' ' SER . 2.1 m -136.15 47.83 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.233 0.54 . . . . 0.0 109.568 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.87 127.43 28.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.377 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -60.95 135.01 57.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.193 -179.217 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.408 HG12 ' H ' ' A' ' 88' ' ' ILE . 0.3 OUTLIER -67.36 50.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.196 0.522 . . . . 0.0 109.983 178.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.585 ' NE ' ' H ' ' A' ' 90' ' ' HIS . 0.0 OUTLIER -163.34 153.99 16.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.808 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.585 ' H ' ' NE ' ' A' ' 89' ' ' ARG . 76.0 m-70 -97.09 152.06 19.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.868 0.366 . . . . 0.0 110.512 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.9 p -129.6 -165.12 1.48 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.298 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.595 ' O ' ' NH1' ' A' ' 94' ' ' ARG . . . -57.15 133.69 55.24 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.449 ' O ' ' NH1' ' A' ' 94' ' ' ARG . 3.0 t0 -73.41 -155.88 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.777 0.322 . . . . 0.0 110.854 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.595 ' NH1' ' O ' ' A' ' 92' ' ' ALA . 85.0 mmt-85 -143.5 101.81 3.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.07 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.02 140.14 32.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.1 ttp85 -131.71 117.65 18.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.977 0.418 . . . . 0.0 111.48 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.13 134.85 65.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.192 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.6 m -111.11 135.34 51.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.573 HD22 ' HB ' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -111.86 72.98 0.8 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.851 175.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.458 ' O ' HG22 ' A' ' 101' ' ' VAL . 9.1 p-10 -77.56 110.57 12.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.999 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.488 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -160.48 -49.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.251 0.548 . . . . 0.0 110.907 177.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.764 HD22 ' H ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -58.6 14.07 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -174.778 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.488 ' H ' ' C ' ' A' ' 101' ' ' VAL . 0.9 OUTLIER -43.31 -41.67 4.14 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.348 0.594 . . . . 0.0 110.11 178.234 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.2 -4.24 52.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.453 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -133.15 73.46 74.64 Favored Pre-proline 0 CA--C 1.511 -0.543 0 CA-C-O 120.938 0.399 . . . . 0.0 112.031 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.5 -40.24 5.98 Favored 'Trans proline' 0 C--N 1.299 -2.073 0 C-N-CA 122.54 2.16 . . . . 0.0 111.565 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -99.74 -27.52 13.61 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.638 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.544 ' OE1' ' NZ ' ' A' ' 123' ' ' LYS . 70.5 mm-40 -88.53 35.41 0.77 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.092 0.472 . . . . 0.0 110.627 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -122.47 132.8 54.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.628 179.174 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 114.99 20.18 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-O 120.718 0.294 . . . . 0.0 110.609 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.505 HG13 HD11 ' A' ' 120' ' ' ILE . 2.4 t -95.7 130.17 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 pttm -140.23 128.78 22.86 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.606 -0.437 . . . . 0.0 111.462 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.07 115.3 24.37 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.59 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.4 OUTLIER -110.86 73.0 0.8 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.18 0.514 . . . . 0.0 110.27 -177.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER 34.54 67.98 0.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.389 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.56 -23.62 27.16 Favored Glycine 0 N--CA 1.465 0.611 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.636 HG22 HG23 ' A' ' 143' ' ' THR . 3.5 t -87.23 113.05 24.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 67.3 t -100.55 112.78 34.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.51 ' HG2' ' HB2' ' A' ' 141' ' ' LYS . 37.1 mt-10 -128.89 142.82 50.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.427 0.632 . . . . 0.0 111.628 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.573 ' HB ' HD22 ' A' ' 99' ' ' LEU . 1.1 mp -116.27 115.74 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.39 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -93.45 116.9 29.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.569 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.18 136.9 5.88 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.881 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.544 ' NZ ' ' OE1' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -128.19 159.31 35.58 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.151 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -97.72 135.27 39.74 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.738 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.47 ' O ' ' C ' ' A' ' 126' ' ' GLU . 6.1 tp10 -68.25 135.73 52.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 125' ' ' GLU . 10.6 tt0 -34.83 99.03 0.02 OUTLIER 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.77 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -81.71 155.56 25.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.757 -176.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -116.59 110.45 18.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.592 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -127.92 136.77 51.81 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.036 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 130' ' ' GLU . 0.7 OUTLIER -47.83 -24.85 1.09 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.959 -178.737 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.418 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 9.8 m-70 -97.76 10.24 40.58 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.953 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 140.66 154.41 6.23 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.686 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -94.57 109.64 21.52 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -119.33 137.99 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -172.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.412 ' OG ' ' N ' ' A' ' 136' ' ' ARG . 6.3 t -142.75 171.28 14.27 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.013 170.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.48 HH11 ' HD3' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -161.92 -176.82 5.43 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.868 -177.175 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.5 p -138.61 121.61 16.71 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -98.03 132.41 43.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.712 0.292 . . . . 0.0 111.501 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.63 101.17 7.31 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.497 ' NH1' ' OH ' ' A' ' 142' ' ' TYR . 1.9 ttt-85 -107.33 103.63 13.03 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.51 ' HB2' ' HG2' ' A' ' 119' ' ' GLU . 7.5 ttpt -112.72 129.83 56.27 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.033 0.444 . . . . 0.0 112.124 -175.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.497 ' OH ' ' NH1' ' A' ' 140' ' ' ARG . 22.3 m-85 -118.11 99.79 7.11 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.595 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.636 HG23 HG22 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -90.76 89.97 7.73 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.324 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.93 92.98 15.98 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.623 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 18.6 Cg_exo -65.77 -55.4 0.43 Allowed 'Trans proline' 0 C--N 1.289 -2.567 0 C-N-CA 121.86 1.706 . . . . 0.0 112.632 175.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.623 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 50.6 Cg_endo -103.84 92.06 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.78 2.986 . . . . 0.0 111.517 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.94 -16.31 1.19 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.216 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.771 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 0.9 OUTLIER -131.34 129.52 62.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-N 117.332 0.566 . . . . 0.0 111.077 177.567 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 13.4 t70 -94.37 143.55 26.52 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.165 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.456 ' HB3' ' HA ' ' A' ' 115' ' ' ASP . 3.3 Cg_exo -81.96 -26.02 3.18 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.823 1.682 . . . . 0.0 112.928 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.14 -37.35 16.25 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.735 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 20.5 mt-30 -107.2 27.99 8.51 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -172.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.572 HG22 ' HE3' ' A' ' 169' ' ' MET . 51.2 t -116.08 113.11 42.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.15 176.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.01 -173.01 2.2 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.29 131.82 11.34 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.837 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.76 139.67 39.98 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.728 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.641 HD22 HD22 ' A' ' 109' ' ' LEU . 14.9 tp -133.95 129.29 36.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.016 0.436 . . . . 0.0 110.85 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.593 ' N ' HD12 ' A' ' 157' ' ' LEU . 0.2 OUTLIER -113.9 148.97 41.06 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.969 178.422 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 161' ' ' GLY . 76.9 Cg_exo -40.04 -33.88 0.86 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.807 2.338 . . . . 0.0 112.11 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -74.21 31.43 0.08 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.396 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.51 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 43.91 25.83 0.71 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.388 -0.369 . . . . 0.0 112.992 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.4 t -87.58 101.51 13.7 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 117.228 0.514 . . . . 0.0 109.693 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.597 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.5 tm? -100.92 102.37 13.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.051 -177.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 p -97.62 123.05 41.37 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.703 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 165' ' ' VAL . 1.4 m -101.85 98.97 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.405 ' H ' ' HG2' ' A' ' 166' ' ' GLU . 0.1 OUTLIER -118.03 136.72 53.37 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.229 -174.627 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.791 ' HB3' ' HE3' ' A' ' 169' ' ' MET . . . -176.42 166.42 1.57 Allowed Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.068 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.545 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 58.6 Cg_endo -85.49 109.36 1.12 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.169 2.579 . . . . 0.0 110.126 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.791 ' HE3' ' HB3' ' A' ' 167' ' ' ALA . 37.8 mmt -87.22 152.69 53.2 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.79 -174.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.11 -165.89 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.906 2.404 . . . . 0.0 111.708 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -96.11 179.75 4.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.42 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 174' ' ' THR . 0.5 OUTLIER 49.34 48.4 21.17 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.039 0.447 . . . . 0.0 110.94 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.12 58.9 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.266 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 172' ' ' LEU . 7.3 m 70.75 138.57 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.191 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -76.84 0.06 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.599 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 C--O 1.212 -0.907 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.106 179.806 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 79' ' ' MET . . . . . 1.144 ' N ' ' HG ' ' B' ' 82' ' ' SER . 7.9 mtt . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -66.84 -61.84 1.75 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -109.08 68.79 0.69 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' SER . . . . . 1.144 ' HG ' ' N ' ' B' ' 79' ' ' MET . 1.5 m -72.89 -25.65 61.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.083 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.42 171.86 1.32 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.026 0.441 . . . . 0.0 110.902 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.13 -45.6 0.02 OUTLIER Glycine 0 C--N 1.321 -0.293 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 m -68.92 -32.77 55.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.22 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.83 -68.23 0.19 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.942 0.401 . . . . 0.0 110.578 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 54.32 12.59 0.52 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.713 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 1.2 mt -69.58 54.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 121.386 0.612 . . . . 0.0 110.214 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' B' ' 91' ' ' THR . 0.4 OUTLIER -131.32 78.55 1.84 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.344 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 90' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -66.85 48.18 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.18 -178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.455 ' N ' ' O ' ' B' ' 89' ' ' ARG . 0.6 OUTLIER -74.13 -80.22 0.08 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.127 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -166.72 129.39 1.83 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.683 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -174.56 -179.28 1.49 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.052 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 65.1 120.86 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 123.727 0.642 . . . . 0.0 109.693 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' TRP . . . . . 0.44 ' HB2' ' CG ' ' B' ' 169' ' ' MET . 0.6 OUTLIER -81.3 128.16 33.51 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.891 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -127.47 101.93 6.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.583 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.22 156.6 17.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 4.8 p -124.92 151.41 45.43 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.845 HD22 HG13 ' B' ' 120' ' ' ILE . 0.6 OUTLIER -122.85 43.47 2.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.777 172.323 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.77 97.81 0.11 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.635 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.432 ' C ' ' H ' ' B' ' 103' ' ' HIS . 2.5 t -158.62 -28.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.401 0.619 . . . . 0.0 109.486 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.599 HD21 ' C ' ' B' ' 105' ' ' ALA . 17.0 t30 -66.92 8.94 0.22 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.741 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.432 ' H ' ' C ' ' B' ' 101' ' ' VAL . 25.9 m80 -39.64 -21.88 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' B' ' 102' ' ' ASN . 28.0 p90 -92.36 -34.56 14.13 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -176.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ALA . . . . . 0.599 ' C ' HD21 ' B' ' 102' ' ' ASN . . . -113.52 76.64 2.91 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.3 -39.13 49.41 Favored 'Trans proline' 0 C--N 1.295 -2.259 0 C-N-CA 122.359 2.039 . . . . 0.0 112.237 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -102.0 -27.31 13.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.79 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.563 ' OE1' ' NZ ' ' B' ' 123' ' ' LYS . 32.3 mt-10 -92.69 41.58 1.08 Allowed 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.804 0.335 . . . . 0.0 111.206 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.739 HD22 HD22 ' B' ' 157' ' ' LEU . 0.4 OUTLIER -123.51 136.36 54.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.242 179.55 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.414 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -128.86 131.23 47.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.737 -179.352 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.01 119.46 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.37 135.26 53.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 0.0 111.312 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.66 115.33 29.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.369 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.521 ' HD2' ' HB ' ' B' ' 117' ' ' VAL . 0.0 OUTLIER -116.0 90.5 3.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.377 -177.782 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 18.9 t0 33.48 69.21 0.14 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.07 -21.44 16.07 Favored Glycine 0 C--N 1.316 -0.572 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.642 HG22 HG23 ' B' ' 143' ' ' THR . 3.8 t -87.49 112.59 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.59 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 75.4 t -97.98 119.8 46.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.497 ' OE2' ' NZ ' ' B' ' 114' ' ' LYS . 33.7 mt-10 -133.96 139.88 46.39 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.49 0.662 . . . . 0.0 111.134 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.845 HG13 HD22 ' B' ' 99' ' ' LEU . 1.0 OUTLIER -116.78 137.46 50.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.494 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.82 119.53 35.69 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.281 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -142.87 124.7 2.42 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' LYS . . . . . 0.563 ' NZ ' ' OE1' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -150.66 140.51 21.86 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -116.94 157.94 24.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.224 0.535 . . . . 0.0 112.397 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.452 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.8 OUTLIER -68.52 145.49 53.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.275 179.082 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 126' ' ' GLU . . . . . 0.581 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 4.9 tt0 -29.98 102.1 0.02 OUTLIER 'General case' 0 C--N 1.349 0.546 0 CA-C-O 120.832 0.349 . . . . 0.0 111.174 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' B' ' 134' ' ' ILE . 0.2 OUTLIER -89.65 136.37 33.07 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.913 -177.882 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -90.7 117.28 29.22 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 172.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ASP . . . . . 0.465 ' HB2' HG22 ' B' ' 134' ' ' ILE . 0.6 OUTLIER -125.75 171.95 10.23 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.134 178.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -56.45 -31.78 64.3 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -174.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' HIS . . . . . 0.444 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 74.0 m80 -111.73 36.39 3.3 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -175.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 121.85 -173.29 15.74 Favored Glycine 0 C--N 1.305 -1.18 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.426 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' B' ' 127' ' ' ARG . 13.6 m-30 -95.94 118.92 33.5 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 134' ' ' ILE . . . . . 0.512 HG23 ' O ' ' B' ' 134' ' ' ILE . 0.1 OUTLIER -133.74 112.26 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -173.173 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 135' ' ' SER . . . . . 0.581 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -127.9 164.1 23.0 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.032 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 136' ' ' ARG . . . . . 0.498 ' NH2' ' O ' ' B' ' 134' ' ' ILE . 0.0 OUTLIER -161.76 161.94 29.43 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.588 -176.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 26.8 p -113.47 128.16 56.35 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -107.99 137.93 45.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -176.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.55 123.64 19.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.282 0.563 . . . . 0.0 111.046 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 140' ' ' ARG . . . . . 0.617 ' NH2' ' O ' ' B' ' 99' ' ' LEU . 0.0 OUTLIER -124.54 118.65 27.05 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 141' ' ' LYS . . . . . 0.468 ' HB2' ' HG2' ' B' ' 119' ' ' GLU . 1.1 ttpp -114.11 124.65 52.61 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.823 0.344 . . . . 0.0 110.874 -175.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 142' ' ' TYR . . . . . 0.59 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 3.3 m-85 -114.27 98.27 6.83 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.245 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.642 HG23 HG22 ' B' ' 117' ' ' VAL . 0.3 OUTLIER -91.33 101.49 14.18 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.727 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 mp -107.35 96.49 16.09 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' B' ' 143' ' ' THR . 36.0 Cg_exo -62.26 -38.18 56.53 Favored 'Trans proline' 0 C--N 1.286 -2.76 0 C-N-CA 123.375 2.717 . . . . 0.0 114.198 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 146' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 50.1 Cg_exo -47.34 -8.61 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.619 1.546 . . . . 0.0 111.515 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 97.83 56.73 1.07 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.2 -0.524 . . . . 0.0 111.979 175.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 148' ' ' VAL . . . . . 0.51 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -69.86 100.76 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 176.672 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 149' ' ' ASP . . . . . 0.504 ' O ' HG23 ' B' ' 153' ' ' VAL . 0.9 OUTLIER -33.83 120.23 0.5 Allowed Pre-proline 0 C--O 1.219 -0.509 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.411 -173.545 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 8.5 Cg_exo -71.86 -42.39 1.67 Allowed 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.425 2.083 . . . . 0.0 111.841 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -47.6 25.23 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.642 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 152' ' ' GLN . . . . . 0.665 ' O ' ' HB1' ' B' ' 167' ' ' ALA . 5.2 mt-30 -85.35 18.69 2.57 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.629 -1.169 . . . . 0.0 113.473 -172.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 153' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' B' ' 167' ' ' ALA . 33.4 t -114.0 106.65 21.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.471 177.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.44 -169.31 1.7 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -162.72 146.47 11.37 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.612 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.639 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.7 OUTLIER -120.67 144.77 48.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.684 177.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 157' ' ' LEU . . . . . 0.739 HD22 HD22 ' B' ' 109' ' ' LEU . 23.5 tp -134.9 148.65 50.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.342 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.02 156.81 79.64 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.591 ' C ' ' H ' ' B' ' 161' ' ' GLY . 75.5 Cg_exo -39.61 -43.43 3.05 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.702 2.268 . . . . 0.0 111.402 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -66.97 26.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.21 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' GLY . . . . . 0.599 ' HA2' HD11 ' B' ' 157' ' ' LEU . . . 41.65 24.48 0.15 Allowed Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.734 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 162' ' ' THR . . . . . 0.516 ' O ' HD12 ' B' ' 157' ' ' LEU . 11.6 t -77.03 130.4 37.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.639 HD22 ' O ' ' B' ' 156' ' ' SER . 2.7 tm? -126.46 105.39 8.73 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.145 -175.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.28 121.8 38.46 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.575 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.2 m -105.51 98.94 7.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 0.0 OUTLIER -116.43 127.3 54.48 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.504 -175.058 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 167' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' B' ' 152' ' ' GLN . . . -171.1 158.06 5.07 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -82.49 126.47 4.75 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.478 2.785 . . . . 0.0 110.005 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' MET . . . . . 0.638 ' CB ' ' HD2' ' B' ' 170' ' ' PRO . 0.0 OUTLIER -123.99 176.43 2.27 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.993 -176.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 170' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' B' ' 169' ' ' MET . 21.4 Cg_exo -25.78 97.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 124.317 3.344 . . . . 0.0 112.074 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 171' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -51.5 -23.66 4.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.952 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.55 152.09 40.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.927 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 173' ' ' ALA . . . . . 0.483 ' C ' ' H ' ' B' ' 175' ' ' GLN . . . -86.3 164.04 17.35 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.577 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 20.8 p -68.77 44.71 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.04 0.448 . . . . 0.0 110.709 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' GLN . . . . . 0.483 ' H ' ' C ' ' B' ' 173' ' ' ALA . 67.2 mt-30 -148.64 171.32 16.36 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.773 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 176' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' B' ' 175' ' ' GLN . 62.0 p . . . . . 0 C--O 1.206 -1.21 0 CA-C-O 118.493 -0.765 . . . . 0.0 111.635 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -93.03 -146.34 0.23 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.414 HD12 HG11 ' A' ' 85' ' ' VAL . 43.3 mt -103.75 162.53 13.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.9 m -161.89 -179.29 7.06 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.377 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.26 29.43 6.66 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.376 0.607 . . . . 0.0 110.242 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.32 -150.31 19.38 Favored Glycine 0 C--N 1.321 -0.305 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.414 HG11 HD12 ' A' ' 81' ' ' LEU . 1.7 t 38.3 39.97 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.911 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.1 m -115.34 137.99 51.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.444 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -161.89 85.9 0.62 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.13 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.575 ' N ' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -112.34 143.67 21.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.384 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 91' ' ' THR . 8.3 mtm180 -139.18 0.07 1.88 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.693 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -60.09 64.74 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.589 ' N ' ' O ' ' A' ' 89' ' ' ARG . 6.9 p -138.04 -126.28 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.909 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 61.76 -56.69 0.12 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.649 0.261 . . . . 0.0 111.594 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 91' ' ' THR . 11.4 t70 -66.95 104.43 1.37 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.252 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.528 HH21 ' CD ' ' A' ' 166' ' ' GLU . 30.4 mmm-85 -148.52 126.17 11.77 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.789 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.497 ' NE1' ' CG2' ' A' ' 97' ' ' VAL . 37.7 t-105 -117.71 118.22 31.49 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.22 104.76 14.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.097 -175.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.497 ' CG2' ' NE1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -110.74 139.13 35.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 174.22 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 15.4 m -111.36 154.06 25.11 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.43 -0.508 . . . . 0.0 112.368 -176.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.751 HD22 HG12 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -131.05 67.13 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.591 176.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.19 89.48 4.27 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.86 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.484 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.2 OUTLIER -142.75 -36.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 121.226 0.536 . . . . 0.0 110.42 177.486 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.658 ' OD1' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -64.45 13.41 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.56 -176.256 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.484 ' H ' ' C ' ' A' ' 101' ' ' VAL . 2.1 p80 -54.63 -20.1 7.41 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.723 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.533 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 32.6 p90 -107.2 3.65 25.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.712 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.85 81.39 16.52 Favored Pre-proline 0 CA--C 1.518 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 111.223 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.99 -44.38 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.685 2.257 . . . . 0.0 111.324 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -104.6 -31.13 9.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.346 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.36 36.25 0.47 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.086 0.47 . . . . 0.0 110.655 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.695 ' CD2' HD22 ' A' ' 157' ' ' LEU . 0.3 OUTLIER -117.9 135.9 53.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.938 178.186 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.481 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 1.2 m -127.68 126.83 42.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.841 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.419 HG13 ' CD1' ' A' ' 120' ' ' ILE . 7.4 t -104.09 126.97 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.409 ' NZ ' ' CB ' ' A' ' 119' ' ' GLU . 3.4 pttp -133.17 130.95 39.85 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.058 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 45.3 m -112.05 109.17 18.76 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.59 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.522 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 3.3 ttmm -114.43 99.89 7.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.257 -177.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 114' ' ' LYS . 15.6 t0 26.1 64.23 0.07 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.86 -19.81 52.07 Favored Glycine 0 N--CA 1.461 0.308 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 2.7 t -88.67 112.55 24.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.537 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.12 114.6 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 140' ' ' ARG . 46.1 mt-10 -127.46 133.57 49.9 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.266 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.751 HG12 HD22 ' A' ' 99' ' ' LEU . 4.0 mm -104.25 137.19 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.979 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -118.89 107.59 13.77 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.192 -178.133 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -135.17 115.03 1.32 Allowed Glycine 0 N--CA 1.461 0.357 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 159.58 41.22 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 104' ' ' PHE . 1.7 t60 -139.72 141.49 36.9 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.416 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.502 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.3 OUTLIER -81.45 150.22 28.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.063 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.531 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 4.9 tt0 -1.4 108.93 0.01 OUTLIER 'General case' 0 C--N 1.349 0.556 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -98.96 137.37 37.6 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.565 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -92.9 116.47 29.07 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -174.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 132' ' ' GLY . 4.6 m-20 -140.09 129.09 23.51 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 174.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -51.14 -26.68 7.04 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -104.45 29.1 6.35 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.539 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 129' ' ' ASP . . . 135.1 131.04 3.02 Favored Glycine 0 C--N 1.303 -1.261 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.158 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.41 ' HD1' ' H ' ' A' ' 129' ' ' ASP . 14.7 m-85 -92.35 107.85 19.52 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.634 HD13 ' NH2' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -125.93 117.53 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -174.289 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.531 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -109.17 149.57 29.16 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.401 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.634 ' NH2' HD13 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -133.16 172.43 12.67 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -174.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 23.7 p -141.13 131.75 25.55 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.426 ' CD2' HG11 ' A' ' 101' ' ' VAL . 7.3 m-85 -107.09 139.48 41.44 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.136 -0.225 . . . . 0.0 111.034 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.8 104.47 6.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.395 0.617 . . . . 0.0 110.364 175.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.6 ' HD3' HD23 ' A' ' 99' ' ' LEU . 12.5 ttt180 -108.01 100.54 9.88 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.48 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 6.6 ttpt -107.67 116.04 31.23 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.287 -175.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.569 ' OH ' ' NE ' ' A' ' 140' ' ' ARG . 19.9 m-30 -114.52 99.6 7.67 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.3 0.571 . . . . 0.0 110.144 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.497 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -86.29 89.03 7.73 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.377 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mp -112.1 91.52 16.03 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.656 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 15.3 Cg_exo -68.18 -56.41 0.2 Allowed 'Trans proline' 0 C--N 1.294 -2.311 0 C-N-CA 122.359 2.039 . . . . 0.0 113.831 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.656 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 37.4 Cg_endo -99.3 53.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 123.327 2.685 . . . . 0.0 112.408 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -171.45 -12.91 0.02 OUTLIER Glycine 0 CA--C 1.521 0.429 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.569 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.587 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 1.0 OUTLIER -130.26 125.11 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 117.68 0.74 . . . . 0.0 111.187 178.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.497 ' HB2' ' HD3' ' A' ' 170' ' ' PRO . 14.2 t70 -81.91 140.69 46.85 Favored Pre-proline 0 N--CA 1.478 0.962 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.293 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 5.8 Cg_exo -81.1 -26.45 3.46 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.027 1.818 . . . . 0.0 113.0 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.411 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 0.8 OUTLIER -91.19 -36.38 13.98 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -176.257 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.689 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 4.6 mt-30 -107.72 27.22 9.4 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -172.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 41.7 t -113.3 104.94 17.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.67 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.31 -161.77 0.89 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.717 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.1 132.07 2.94 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.335 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -100.82 139.81 35.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.591 177.459 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.695 HD22 ' CD2' ' A' ' 109' ' ' LEU . 42.1 tp -137.53 138.13 39.33 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.176 0.513 . . . . 0.0 110.981 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.729 ' HB2' HG22 ' A' ' 162' ' ' THR . 23.1 m -121.88 146.06 45.07 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.631 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 161' ' ' GLY . 75.4 Cg_exo -41.27 -34.8 1.86 Allowed 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.065 1.843 . . . . 0.0 110.897 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.411 ' CD ' ' H ' ' A' ' 160' ' ' GLU . 2.1 mp0 -65.31 2.86 0.75 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.076 177.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 158' ' ' SER . . . 67.09 21.2 71.62 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.894 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.729 HG22 ' HB2' ' A' ' 158' ' ' SER . 0.7 OUTLIER -77.24 106.82 9.21 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.568 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.2 tm? -106.94 101.52 10.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.752 -175.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.42 120.24 39.29 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 121.289 -0.165 . . . . 0.0 110.66 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 165' ' ' VAL . 1.5 m -100.93 99.18 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.528 ' CD ' HH21 ' A' ' 94' ' ' ARG . 1.4 pp20? -112.71 146.21 39.12 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.674 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 175.13 166.64 0.37 Allowed Pre-proline 0 N--CA 1.437 -1.103 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.206 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.586 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 72.8 Cg_endo -86.41 106.33 0.77 Allowed 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.803 2.335 . . . . 0.0 108.735 175.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.587 ' SD ' ' HA ' ' A' ' 148' ' ' VAL . 20.5 mmt -74.66 153.95 87.39 Favored Pre-proline 0 C--N 1.31 -1.126 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.554 -174.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 149' ' ' ASP . 38.4 Cg_endo -69.68 134.7 28.8 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.626 2.217 . . . . 0.0 111.684 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -63.49 -175.41 0.12 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.929 178.835 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.0 mp -64.97 57.79 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.913 0.387 . . . . 0.0 110.608 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 171' ' ' LYS . . . -61.03 -23.39 65.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.654 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 173' ' ' ALA . 25.3 p 54.7 110.52 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.57 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.23 -3.79 38.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.761 0.315 . . . . 0.0 110.711 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 82.0 p . . . . . 0 C--O 1.214 -0.802 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.52 -179.585 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 79' ' ' MET . . . . . 0.577 ' N ' ' OE1' ' B' ' 80' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.577 ' OE1' ' N ' ' B' ' 79' ' ' MET . 0.0 OUTLIER -126.57 8.57 7.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.643 179.691 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.607 HD22 ' N ' ' B' ' 81' ' ' LEU . 3.7 mm? -71.42 51.53 0.18 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.735 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -53.93 51.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.896 0.379 . . . . 0.0 110.638 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.82 134.95 24.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.217 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.97 29.72 2.71 Favored Glycine 0 N--CA 1.46 0.253 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 8.3 m -72.19 54.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.905 0.383 . . . . 0.0 110.402 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 2.2 m 55.3 -154.79 0.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.138 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' B' ' 89' ' ' ARG . 26.4 mt-10 -54.88 126.6 25.02 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.443 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' B' ' 90' ' ' HIS . 16.5 mm -69.48 59.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.056 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.532 ' O ' ' NH1' ' B' ' 89' ' ' ARG . 0.0 OUTLIER -63.77 59.45 0.02 OUTLIER 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.105 179.383 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 90' ' ' HIS . . . . . 0.571 ' CG ' ' H ' ' B' ' 91' ' ' THR . 7.9 t-80 -159.71 -168.17 2.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.023 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.571 ' H ' ' CG ' ' B' ' 90' ' ' HIS . 0.0 OUTLIER -66.22 72.06 0.07 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.16 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' B' ' 90' ' ' HIS . . . -58.42 -175.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.885 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' B' ' 94' ' ' ARG . 17.1 t70 -33.87 -57.9 0.45 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.976 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' ARG . . . . . 0.478 ' NH1' ' OE1' ' B' ' 166' ' ' GLU . 9.0 mmt85 17.7 110.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 124.265 0.978 . . . . 0.0 112.472 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' TRP . . . . . 0.685 ' HB2' ' SD ' ' B' ' 169' ' ' MET . 0.3 OUTLIER -55.51 151.11 10.89 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.133 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.607 ' HB2' ' NH1' ' B' ' 96' ' ' ARG . 16.3 ttm105 -150.13 109.4 3.96 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.684 -176.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 t -119.1 152.27 21.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 1.5 m -126.05 144.29 50.78 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -176.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.689 HD23 ' NE ' ' B' ' 140' ' ' ARG . 0.3 OUTLIER -115.39 54.64 0.79 Allowed 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.447 176.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.55 ' O ' HG22 ' B' ' 101' ' ' VAL . 0.1 OUTLIER -62.32 96.96 0.08 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.018 -178.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.55 HG22 ' O ' ' B' ' 100' ' ' ASP . 0.6 OUTLIER -162.0 -6.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 176.48 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.697 ' CB ' HD13 ' B' ' 109' ' ' LEU . 0.4 OUTLIER -90.5 10.15 26.52 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -175.019 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.504 ' N ' ' HA3' ' B' ' 161' ' ' GLY . 0.2 OUTLIER -39.63 -35.04 0.27 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.72 0.295 . . . . 0.0 111.155 179.472 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.6 -8.83 51.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' B' ' 102' ' ' ASN . . . -138.72 93.34 10.88 Favored Pre-proline 0 CA--C 1.515 -0.383 0 CA-C-O 120.696 0.284 . . . . 0.0 111.298 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -81.17 -48.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.967 0 C-N-CA 122.68 2.253 . . . . 0.0 110.933 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -90.29 -31.2 17.05 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.523 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.518 ' OE2' ' NZ ' ' B' ' 123' ' ' LYS . 2.8 mt-10 -84.63 45.09 1.1 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.369 0.604 . . . . 0.0 109.897 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.697 HD13 ' CB ' ' B' ' 102' ' ' ASN . 0.5 OUTLIER -129.44 135.98 49.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.013 178.321 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.96 121.73 22.06 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.571 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 1.5 t -98.99 131.78 45.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.814 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.443 ' HZ3' ' CD ' ' B' ' 119' ' ' GLU . 2.9 pttp -139.78 122.28 16.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.101 0.477 . . . . 0.0 111.755 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.7 117.54 34.27 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.558 ' O ' ' N ' ' B' ' 117' ' ' VAL . 1.3 ttpm? -128.96 112.01 13.62 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.348 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' ASP . . . . . 0.492 ' OD1' ' NZ ' ' B' ' 114' ' ' LYS . 0.3 OUTLIER 34.64 59.89 0.64 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.91 0.862 . . . . 0.0 112.481 176.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.91 -12.1 31.55 Favored Glycine 0 C--N 1.314 -0.657 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 1.028 HG22 HG23 ' B' ' 143' ' ' THR . 9.0 t -87.47 115.46 28.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.762 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 54.2 t -103.66 112.67 38.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.571 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.591 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 49.4 mt-10 -125.96 146.47 49.85 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.599 0.714 . . . . 0.0 111.546 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.532 ' HB ' HD22 ' B' ' 99' ' ' LEU . 1.3 mp -119.79 121.56 66.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.307 178.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -97.44 124.3 41.58 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.2 117.59 0.86 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' LYS . . . . . 0.518 ' NZ ' ' OE2' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -152.82 135.5 15.31 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.363 0.265 . . . . 0.0 110.489 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 124' ' ' HIS . . . . . 0.515 ' O ' ' CB ' ' B' ' 135' ' ' SER . 0.1 OUTLIER -111.96 123.55 50.49 Favored 'General case' 0 C--O 1.21 -0.989 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.343 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.477 ' H ' ' HG3' ' B' ' 125' ' ' GLU . 4.9 mt-10 -54.05 -21.43 8.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -176.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 178.61 131.11 0.07 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.989 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' ARG . . . . . 0.483 ' HD3' ' CE1' ' B' ' 124' ' ' HIS . 38.9 mtp180 -123.69 132.08 53.75 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.146 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -81.56 138.7 35.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.936 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ASP . . . . . 0.506 ' CG ' ' N ' ' B' ' 130' ' ' GLU . 9.2 t70 -157.37 165.89 34.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.205 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 130' ' ' GLU . . . . . 0.506 ' N ' ' CG ' ' B' ' 129' ' ' ASP . 0.7 OUTLIER -61.4 -28.28 69.14 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.639 -177.119 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 131' ' ' HIS . . . . . 0.48 ' O ' ' CE1' ' A' ' 142' ' ' TYR . 10.6 m-70 -74.78 -12.55 60.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.758 0.313 . . . . 0.0 111.013 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.74 -136.95 8.96 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -112.25 134.99 53.48 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 175.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' B' ' 127' ' ' ARG . 0.4 OUTLIER -146.75 125.76 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -176.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 135' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' B' ' 124' ' ' HIS . 0.6 OUTLIER -142.99 158.01 44.0 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.029 0.442 . . . . 0.0 111.283 174.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 136' ' ' ARG . . . . . 0.472 ' CZ ' ' CZ ' ' B' ' 138' ' ' PHE . 0.2 OUTLIER -141.77 173.7 11.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.865 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 31.9 p -123.74 129.91 51.82 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' PHE . . . . . 0.472 ' CZ ' ' CZ ' ' B' ' 136' ' ' ARG . 1.1 m-85 -104.86 122.35 45.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.936 -176.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 139' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 134' ' ' ILE . 0.0 OUTLIER -124.83 99.47 6.16 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.137 174.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 140' ' ' ARG . . . . . 0.689 ' NE ' HD23 ' B' ' 99' ' ' LEU . 0.0 OUTLIER -106.63 119.58 39.68 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.288 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 141' ' ' LYS . . . . . 0.591 ' HA ' ' HG2' ' B' ' 119' ' ' GLU . 2.7 ttpt -120.19 130.72 54.68 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.07 0.462 . . . . 0.0 111.206 -176.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 142' ' ' TYR . . . . . 0.572 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 7.8 m-85 -120.27 98.74 6.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.961 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 143' ' ' THR . . . . . 1.028 HG23 HG22 ' B' ' 117' ' ' VAL . 1.3 m -93.52 93.66 8.22 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -110.95 90.95 11.86 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.584 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' PRO . . . . . 0.611 ' HD2' ' CD ' ' B' ' 146' ' ' PRO . 16.2 Cg_exo -68.72 -41.19 6.18 Favored 'Trans proline' 0 C--N 1.279 -3.096 0 C-N-CA 122.06 1.84 . . . . 0.0 112.125 167.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 146' ' ' PRO . . . . . 0.611 ' CD ' ' HD2' ' B' ' 145' ' ' PRO . 74.2 Cg_exo -43.21 -11.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 123.325 2.683 . . . . 0.0 114.606 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 149.02 44.64 0.03 OUTLIER Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 118.239 -1.934 . . . . 0.0 115.447 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.29 116.56 52.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 118.73 -1.188 . . . . 0.0 110.667 173.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 149' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 19.3 t70 -80.02 140.33 53.71 Favored Pre-proline 0 C--O 1.221 -0.407 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.03 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 4.2 Cg_exo -81.4 -23.89 4.78 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.074 1.85 . . . . 0.0 112.9 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.15 -43.68 9.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.975 0.417 . . . . 0.0 112.072 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -94.93 18.97 10.94 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 42.5 t -108.83 104.94 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.088 0.471 . . . . 0.0 109.888 176.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.43 -175.38 3.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.237 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.01 132.79 8.46 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.717 -0.793 . . . . 0.0 112.291 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.56 139.84 40.39 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.222 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 157' ' ' LEU . . . . . 0.671 HD22 HD22 ' B' ' 109' ' ' LEU . 33.0 tp -131.08 143.12 50.43 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.416 ' OG ' ' HD2' ' B' ' 159' ' ' PRO . 0.2 OUTLIER -135.58 154.38 78.22 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.639 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.57 ' C ' ' H ' ' B' ' 161' ' ' GLY . 1.2 Cg_endo -44.8 -34.79 8.87 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.693 2.262 . . . . 0.0 111.491 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -68.74 24.12 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.034 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' GLY . . . . . 0.612 ' HA2' ' OD1' ' B' ' 102' ' ' ASN . . . 44.03 34.03 2.95 Favored Glycine 0 C--O 1.241 0.532 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.638 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 7.4 t -97.16 121.46 39.08 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.623 HD13 ' C ' ' B' ' 163' ' ' LEU . 1.8 tm? -115.84 103.86 11.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.953 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.59 121.72 39.82 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 121.13 -0.228 . . . . 0.0 110.803 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.587 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.1 m -106.49 103.33 15.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 0.478 ' OE1' ' NH1' ' B' ' 94' ' ' ARG . 2.0 pp20? -113.22 151.84 30.5 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.278 -177.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 167' ' ' ALA . . . . . 0.632 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -174.62 154.25 1.89 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 0.0 111.628 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.06 -4.7 11.24 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 123.018 2.479 . . . . 0.0 109.906 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' MET . . . . . 0.685 ' SD ' ' HB2' ' B' ' 95' ' ' TRP . 0.0 OUTLIER 57.09 179.39 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.388 177.024 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 170' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' B' ' 169' ' ' MET . 31.7 Cg_exo -58.02 172.87 1.07 Allowed 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.642 2.228 . . . . 0.0 112.433 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 51.88 0.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.991 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' B' ' 170' ' ' PRO . 28.0 mt -64.64 -43.5 93.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.329 0.585 . . . . 0.0 109.848 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -153.24 -164.66 1.97 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.394 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.49 77.58 0.57 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.957 0.408 . . . . 0.0 110.222 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 175' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -174.61 0.1 Allowed 'General case' 0 C--O 1.242 0.664 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.405 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.214 -0.788 0 CA-C-O 118.11 -0.947 . . . . 0.0 110.147 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.493 ' N ' ' SD ' ' A' ' 79' ' ' MET . 2.1 mpt? . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 57.23 68.66 0.82 Allowed 'General case' 0 C--O 1.24 0.563 0 CA-C-O 120.873 0.368 . . . . 0.0 111.483 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.479 HD12 ' H ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -137.9 -103.87 0.19 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.479 ' H ' HD12 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -71.39 -48.04 52.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 176.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER 37.78 41.91 0.36 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.314 178.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.39 -51.74 0.44 Allowed Glycine 0 C--N 1.32 -0.34 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 85' ' ' VAL . 9.5 p -166.34 65.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.972 0.415 . . . . 0.0 110.871 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.557 ' C ' ' H ' ' A' ' 88' ' ' ILE . 0.7 OUTLIER -64.78 -169.31 0.04 OUTLIER 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.113 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -66.1 37.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.778 0.323 . . . . 0.0 111.297 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.557 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -101.36 8.92 8.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.753 178.319 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.52 ' NH1' ' O ' ' A' ' 88' ' ' ILE . 90.7 mmt-85 -134.64 172.62 12.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.665 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.461 ' ND1' ' N ' ' A' ' 90' ' ' HIS . 1.6 m80 50.48 23.43 1.29 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.7 p -54.33 -70.53 0.1 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.445 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.27 89.61 2.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.329 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.45 -67.47 0.54 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.26 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 94' ' ' ARG . 10.9 mmt180 53.73 100.38 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -177.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.566 ' CB ' ' SD ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -68.45 145.17 54.32 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.129 -179.479 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -138.66 105.96 5.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.487 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.22 155.11 13.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 175.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.62 148.64 51.53 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -174.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.656 HD23 ' NE ' ' A' ' 140' ' ' ARG . 0.7 OUTLIER -130.13 118.91 22.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.102 174.381 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.461 ' CG ' ' HE2' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -112.28 114.08 26.66 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.536 -178.359 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.581 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -161.14 -43.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 120.89 0.376 . . . . 0.0 111.445 179.549 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.683 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -60.27 17.0 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.581 ' H ' ' C ' ' A' ' 101' ' ' VAL . 12.0 m80 -52.67 -38.09 59.88 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -105.69 -15.14 15.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.645 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -118.13 81.93 17.22 Favored Pre-proline 0 CA--C 1.516 -0.346 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -74.36 -44.66 0.4 Allowed 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 122.612 2.208 . . . . 0.0 110.924 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -92.55 -31.47 15.19 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.759 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -89.44 45.86 1.32 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.151 0.5 . . . . 0.0 111.14 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.789 HD22 HD22 ' A' ' 157' ' ' LEU . 0.4 OUTLIER -133.34 130.29 38.64 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.185 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 m -128.61 124.56 36.16 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 120.783 0.325 . . . . 0.0 110.512 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.41 HG13 HD11 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -96.51 127.4 48.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.984 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.85 130.13 43.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.856 0.36 . . . . 0.0 111.406 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.91 104.0 13.37 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.625 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -109.43 103.32 12.21 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.528 -175.871 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.474 ' CG ' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER 36.06 41.44 0.13 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 177.075 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.03 -11.52 57.32 Favored Glycine 0 C--N 1.314 -0.651 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.716 HG22 HG23 ' A' ' 143' ' ' THR . 2.6 t -86.73 117.25 30.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.581 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 55.4 t -102.81 116.51 46.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.504 ' OE1' ' NZ ' ' A' ' 114' ' ' LYS . 2.2 mt-10 -133.51 140.2 47.09 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.272 0.558 . . . . 0.0 111.521 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.41 HD11 HG13 ' A' ' 111' ' ' VAL . 1.2 mp -111.44 115.54 50.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.154 177.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -92.0 118.67 31.0 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.776 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.17 129.99 4.28 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.118 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.72 159.28 44.63 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -133.68 162.13 32.79 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.36 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.523 ' O ' ' C ' ' A' ' 126' ' ' GLU . 1.5 tt0 -90.28 143.33 26.86 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.851 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.523 ' C ' ' O ' ' A' ' 125' ' ' GLU . 1.0 OUTLIER -18.12 105.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.645 0.591 . . . . 0.0 111.846 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.25 128.94 35.15 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 120.897 0.379 . . . . 0.0 110.428 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -75.32 118.48 18.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.357 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 132' ' ' GLY . 1.6 m-20 -150.82 116.33 5.43 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -49.4 -25.27 2.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.73 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -90.38 19.18 5.38 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.373 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 129' ' ' ASP . . . 137.1 129.5 2.77 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.014 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -92.2 109.71 21.08 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.47 159.34 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -169.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.9 t -155.06 154.81 33.02 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.762 170.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.55 172.27 15.76 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.928 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.5 p -125.97 128.36 47.38 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -102.68 142.25 34.14 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.352 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.55 103.02 3.63 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.086 0.47 . . . . 0.0 111.554 176.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.656 ' NE ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -104.16 119.63 39.37 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 174.336 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.5 ' NZ ' ' OE1' ' B' ' 126' ' ' GLU . 2.7 ttpt -118.4 123.58 45.59 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 123.21 0.319 . . . . 0.0 110.666 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.581 ' HB2' ' HB ' ' A' ' 118' ' ' VAL . 3.2 m-85 -112.96 99.16 7.66 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.993 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.716 HG23 HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -92.0 90.25 7.32 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.548 178.503 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.44 91.94 21.69 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.643 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 16.0 Cg_exo -67.47 -56.94 0.19 Allowed 'Trans proline' 0 C--N 1.288 -2.641 0 C-N-CA 122.349 2.033 . . . . 0.0 114.207 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.696 ' O ' HG22 ' A' ' 174' ' ' THR . 41.8 Cg_endo -100.61 56.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.482 0.815 0 C-N-CA 123.377 2.718 . . . . 0.0 113.035 -175.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.502 ' O ' ' HB3' ' A' ' 169' ' ' MET . . . -176.76 -14.35 0.02 OUTLIER Glycine 0 N--CA 1.466 0.634 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.713 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.03 132.21 68.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 117.539 0.67 . . . . 0.0 110.153 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 13.0 t70 -93.44 141.15 23.54 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.204 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 2.4 Cg_endo -82.66 -21.4 5.08 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.095 1.863 . . . . 0.0 112.7 -177.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.45 -41.69 10.71 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.386 -175.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -101.29 14.44 31.96 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -171.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.683 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 24.9 t -102.75 117.09 47.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.387 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.02 166.69 11.18 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.62 137.46 35.33 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.112 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.412 ' OG ' ' OG1' ' A' ' 164' ' ' THR . 0.0 OUTLIER -111.57 138.57 47.94 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.872 177.499 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.789 HD22 HD22 ' A' ' 109' ' ' LEU . 14.8 tp -125.13 121.77 35.18 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.388 0.43 . . . . 0.0 110.364 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 161' ' ' GLY . 0.2 OUTLIER -96.07 138.28 21.65 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -39.95 -33.19 0.7 Allowed 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.556 2.171 . . . . 0.0 111.185 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -59.23 -5.54 0.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.344 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.537 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . 76.69 34.41 43.87 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.4 t -109.89 118.76 37.33 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.605 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.1 tm? -104.25 108.65 20.14 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.597 -174.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.412 ' OG1' ' OG ' ' A' ' 156' ' ' SER . 3.4 p -95.43 127.94 41.88 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.605 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 165' ' ' VAL . 2.7 m -113.47 103.33 15.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 1.6 pp20? -119.11 141.82 48.45 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.201 -176.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.683 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . . . -174.48 157.85 2.44 Favored Pre-proline 0 C--N 1.332 -0.193 0 C-N-CA 120.024 -0.671 . . . . 0.0 112.618 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.424 ' HD3' ' NH1' ' A' ' 94' ' ' ARG . 61.6 Cg_endo -83.35 108.73 1.55 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.736 2.291 . . . . 0.0 108.84 172.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.566 ' SD ' ' CB ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -87.59 156.09 53.43 Favored Pre-proline 0 C--N 1.305 -1.337 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.745 -174.007 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.428 ' O ' ' NE2' ' A' ' 90' ' ' HIS . 3.0 Cg_endo -50.19 -51.12 11.6 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.673 2.248 . . . . 0.0 111.43 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.56 ' NZ ' ' O ' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -168.34 135.75 2.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.327 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.0 -47.14 87.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.18 0.514 . . . . 0.0 109.736 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.56 ' O ' ' NZ ' ' A' ' 171' ' ' LYS . . . -69.19 100.32 1.28 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.959 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -55.2 135.91 49.08 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.707 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.469 ' O ' ' NZ ' ' A' ' 171' ' ' LYS . 22.6 mt-30 63.38 172.53 0.16 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.051 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.43 ' OXT' ' NZ ' ' A' ' 171' ' ' LYS . 14.3 p . . . . . 0 C--O 1.208 -1.126 0 CA-C-O 117.988 -1.006 . . . . 0.0 111.085 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' MET . . . . . . . . . . . . . 1.6 ppp? . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -90.84 -95.21 0.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.99 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.755 HD22 ' C ' ' B' ' 81' ' ' LEU . 0.0 OUTLIER -149.17 164.21 35.39 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.517 177.583 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 82' ' ' SER . . . . . 0.435 ' N ' HD22 ' B' ' 81' ' ' LEU . 0.0 OUTLIER -146.0 -49.33 0.22 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.477 -178.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 83' ' ' SER . . . . . 0.425 ' O ' ' N ' ' B' ' 85' ' ' VAL . 0.9 OUTLIER 66.75 129.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.645 -179.511 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.15 49.49 0.39 Allowed Glycine 0 C--N 1.319 -0.382 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' B' ' 83' ' ' SER . 1.3 p -46.81 108.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' SER . . . . . 0.404 ' C ' ' N ' ' B' ' 88' ' ' ILE . 0.0 OUTLIER -124.94 -83.29 0.64 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.663 -176.295 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 51.92 14.38 0.31 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.954 0.407 . . . . 0.0 110.067 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.658 HG23 ' H ' ' B' ' 89' ' ' ARG . 4.6 tt -97.92 -57.31 4.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.643 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.658 ' H ' HG23 ' B' ' 88' ' ' ILE . 0.1 OUTLIER -83.93 -166.14 1.33 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.063 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 90' ' ' HIS . . . . . 0.439 ' ND1' ' N ' ' B' ' 90' ' ' HIS . 0.0 OUTLIER -65.9 6.53 0.36 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.448 177.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.512 ' H ' ' C ' ' B' ' 89' ' ' ARG . 0.7 OUTLIER -52.0 117.14 2.55 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.602 179.542 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 62.62 -149.49 0.36 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.975 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' B' ' 168' ' ' PRO . 0.1 OUTLIER -165.77 171.0 13.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.893 0.378 . . . . 0.0 111.245 -179.448 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 94' ' ' ARG . . . . . 0.473 HH11 ' HB3' ' B' ' 94' ' ' ARG . 0.2 OUTLIER -124.94 102.97 7.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.567 178.416 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 95' ' ' TRP . . . . . 0.672 ' HB2' ' SD ' ' B' ' 169' ' ' MET . 0.1 OUTLIER -63.83 139.99 58.82 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.192 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.401 ' HD2' HH11 ' B' ' 96' ' ' ARG . 19.7 ttm105 -134.45 99.08 4.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.138 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 t -105.87 152.21 7.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 9.0 m -129.17 144.26 51.15 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -175.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.888 HD22 HG12 ' B' ' 120' ' ' ILE . 0.5 OUTLIER -113.79 52.54 0.81 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.527 175.119 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -59.48 97.09 0.04 OUTLIER 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.9 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.514 HG11 ' HD3' ' B' ' 140' ' ' ARG . 7.2 p -167.93 -2.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.828 ' CB ' HD13 ' B' ' 109' ' ' LEU . 0.4 OUTLIER -90.99 11.95 21.27 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.616 178.227 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -59.16 -14.38 10.26 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.438 ' N ' ' C ' ' B' ' 102' ' ' ASN . 13.7 t80 -85.67 -9.97 56.41 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.603 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.68 98.12 0.48 Allowed Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.423 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.453 ' HA ' ' ND2' ' B' ' 102' ' ' ASN . 57.7 Cg_endo -76.3 -40.94 0.53 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.672 2.248 . . . . 0.0 111.875 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.17 -32.21 12.59 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.367 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.537 ' CD ' ' NZ ' ' B' ' 123' ' ' LYS . 1.9 mm-40 -89.8 49.67 1.76 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.485 0.659 . . . . 0.0 110.358 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.828 HD13 ' CB ' ' B' ' 102' ' ' ASN . 0.4 OUTLIER -129.36 135.22 48.44 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.575 178.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.7 121.95 34.92 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.609 HG13 HD12 ' B' ' 120' ' ' ILE . 0.5 OUTLIER -100.32 131.64 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.448 ' NZ ' ' OG1' ' B' ' 121' ' ' THR . 0.0 OUTLIER -134.89 124.12 24.51 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.354 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.6 m -94.63 116.32 28.62 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' B' ' 116' ' ' GLY . 1.5 ttmp? -120.02 143.8 47.88 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -22.85 71.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' B' ' 114' ' ' LYS . . . 83.07 -2.51 86.79 Favored Glycine 0 N--CA 1.472 1.09 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.624 HG13 HG23 ' B' ' 143' ' ' THR . 2.3 t -102.93 114.47 42.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.598 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 48.0 t -98.11 120.02 46.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.505 ' C ' HD13 ' B' ' 120' ' ' ILE . 33.7 mt-10 -133.5 136.14 44.89 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.179 0.514 . . . . 0.0 110.62 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.888 HG12 HD22 ' B' ' 99' ' ' LEU . 3.2 mm -111.82 138.07 41.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.622 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' THR . . . . . 0.448 ' OG1' ' NZ ' ' B' ' 112' ' ' LYS . 0.2 OUTLIER -115.89 120.28 38.71 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.133 -179.587 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.8 135.64 5.51 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.768 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' LYS . . . . . 0.537 ' NZ ' ' CD ' ' B' ' 108' ' ' GLU . 0.2 OUTLIER -150.2 159.08 44.7 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.219 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 124' ' ' HIS . . . . . 0.486 ' CG ' ' HD2' ' B' ' 127' ' ' ARG . 2.0 t60 -132.72 156.34 47.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.674 0.273 . . . . 0.0 110.273 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.546 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.6 OUTLIER -92.24 131.68 37.27 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.346 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 126' ' ' GLU . . . . . 0.569 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 1.5 tt0 -3.11 97.7 0.01 OUTLIER 'General case' 0 C--N 1.344 0.334 0 O-C-N 123.751 0.657 . . . . 0.0 112.47 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' ARG . . . . . 0.486 ' HD2' ' CG ' ' B' ' 124' ' ' HIS . 31.5 mtp180 -90.16 146.9 23.93 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.095 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -88.8 131.78 34.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.325 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -134.71 163.36 29.96 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.052 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.65 -14.12 60.56 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.042 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' HIS . . . . . 0.521 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 69.2 m-70 -114.04 29.03 8.31 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.491 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.71 -153.12 17.36 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 119.728 -1.225 . . . . 0.0 111.611 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -112.89 127.94 56.33 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' ILE . . . . . 0.506 HD11 ' NH2' ' B' ' 136' ' ' ARG . 0.1 OUTLIER -135.29 123.48 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -175.192 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 135' ' ' SER . . . . . 0.569 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.1 OUTLIER -134.32 160.43 37.94 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 174.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 136' ' ' ARG . . . . . 0.506 ' NH2' HD11 ' B' ' 134' ' ' ILE . 10.4 ptp85 -156.85 166.07 34.42 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.563 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 27.5 p -117.84 136.42 53.44 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' PHE . . . . . 0.497 ' CE2' ' HD2' ' B' ' 136' ' ' ARG . 11.1 m-85 -106.89 138.18 43.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.276 -177.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.15 126.18 10.56 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.951 174.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 140' ' ' ARG . . . . . 0.514 ' HD3' HG11 ' B' ' 101' ' ' VAL . 0.0 OUTLIER -131.23 112.92 13.23 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.553 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 141' ' ' LYS . . . . . 0.437 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 11.3 ttmt -101.28 119.08 38.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.931 0.395 . . . . 0.0 110.556 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 142' ' ' TYR . . . . . 0.598 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 4.3 m-85 -109.48 97.58 7.12 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.624 HG23 HG13 ' B' ' 117' ' ' VAL . 0.0 OUTLIER -91.66 96.59 10.53 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 177.559 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.87 90.23 12.78 Favored Pre-proline 0 CA--C 1.514 -0.409 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.429 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' PRO . . . . . 0.611 ' HD2' ' CD ' ' B' ' 146' ' ' PRO . 17.1 Cg_exo -68.49 -40.6 7.6 Favored 'Trans proline' 0 C--N 1.285 -2.793 0 C-N-CA 122.38 2.053 . . . . 0.0 112.127 168.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 146' ' ' PRO . . . . . 0.611 ' CD ' ' HD2' ' B' ' 145' ' ' PRO . 71.4 Cg_exo -43.07 -8.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 123.554 2.836 . . . . 0.0 114.194 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 134.69 64.77 0.07 OUTLIER Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 118.964 -1.588 . . . . 0.0 114.879 176.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' VAL . . . . . 0.416 ' O ' HG12 ' B' ' 148' ' ' VAL . 1.1 t -123.74 108.55 21.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.365 172.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 149' ' ' ASP . . . . . 0.485 ' O ' HG23 ' B' ' 153' ' ' VAL . 10.7 p-10 -76.9 127.89 82.79 Favored Pre-proline 0 N--CA 1.472 0.659 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.885 -176.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 3.0 Cg_exo -75.81 -30.47 6.03 Favored 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 122.156 1.904 . . . . 0.0 113.848 -173.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 1.2 p -76.64 -36.57 57.32 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.883 0.373 . . . . 0.0 110.889 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -101.74 1.81 37.78 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' VAL . . . . . 0.711 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 42.2 t -96.15 103.12 14.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.777 175.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.14 177.28 4.89 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.4 138.98 33.36 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.423 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.97 132.43 54.22 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.464 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 157' ' ' LEU . . . . . 0.713 HD11 ' OD1' ' B' ' 102' ' ' ASN . 25.0 tp -125.57 142.13 51.67 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.055 0.455 . . . . 0.0 110.744 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.475 ' O ' ' N ' ' B' ' 161' ' ' GLY . 0.2 OUTLIER -132.51 141.01 39.66 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.172 178.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' B' ' 161' ' ' GLY . 73.2 Cg_exo -38.35 -35.27 0.43 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 123.18 2.587 . . . . 0.0 112.448 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.57 -5.07 1.07 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.612 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 161' ' ' GLY . . . . . 0.68 ' HA2' ' OD1' ' B' ' 102' ' ' ASN . . . 76.08 33.0 51.21 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.662 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 15.1 t -98.7 114.97 27.7 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.14 0.495 . . . . 0.0 110.377 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.638 HD13 ' C ' ' B' ' 163' ' ' LEU . 1.9 tm? -109.2 102.93 11.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.103 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.94 126.96 43.59 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.509 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.6 m -108.33 108.05 24.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 174.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 0.8 OUTLIER -117.34 143.13 46.28 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.278 -174.295 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 167' ' ' ALA . . . . . 0.711 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -171.2 157.25 4.8 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-O 121.088 0.47 . . . . 0.0 111.995 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 168' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' B' ' 93' ' ' ASP . 83.6 Cg_endo -80.1 -18.07 10.22 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 123.443 2.762 . . . . 0.0 110.933 176.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 169' ' ' MET . . . . . 0.672 ' SD ' ' HB2' ' B' ' 95' ' ' TRP . 0.0 OUTLIER 60.36 158.09 0.11 Allowed Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.929 176.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 170' ' ' PRO . . . . . 0.409 ' HD2' ' O ' ' B' ' 147' ' ' GLY . 60.3 Cg_endo -82.64 11.77 3.11 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.707 2.272 . . . . 0.0 111.476 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 171' ' ' LYS . . . . . 0.4 ' CE ' ' O ' ' B' ' 168' ' ' PRO . 0.4 OUTLIER 38.6 54.76 1.91 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.359 0.599 . . . . 0.0 110.439 -179.366 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.68 50.86 0.13 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.267 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 173' ' ' ALA . . . . . 0.571 ' O ' ' N ' ' B' ' 175' ' ' GLN . . . 46.31 39.24 6.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.879 0.371 . . . . 0.0 110.37 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 174' ' ' THR . . . . . 0.422 HG23 ' CB ' ' B' ' 146' ' ' PRO . 1.9 m -63.0 57.87 0.01 OUTLIER 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.512 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 175' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' B' ' 173' ' ' ALA . 3.6 mt-30 -110.34 -36.12 5.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.348 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.207 -1.182 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.411 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -68.21 -4.64 14.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.366 . . . . 0.0 110.403 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.1 mt -66.46 71.58 0.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.637 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.17 -25.41 13.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.92 0.39 . . . . 0.0 110.005 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.87 157.49 33.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.916 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 144.04 -50.08 0.68 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.41 154.33 24.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.712 0.292 . . . . 0.0 110.39 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.3 m -66.08 111.7 3.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.447 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.513 ' CD ' HH21 ' A' ' 89' ' ' ARG . 12.9 mt-10 -59.02 143.42 48.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.236 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.48 ' O ' ' NH2' ' A' ' 94' ' ' ARG . 1.2 mt -39.84 -40.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.383 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.513 HH21 ' CD ' ' A' ' 87' ' ' GLU . 0.6 OUTLIER -60.6 -22.78 64.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.835 -179.167 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.482 ' CE1' ' H ' ' A' ' 87' ' ' GLU . 16.3 m170 -58.58 146.92 34.16 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.774 0.321 . . . . 0.0 110.571 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.52 50.88 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.116 0.484 . . . . 0.0 111.27 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 90' ' ' HIS . . . -90.3 104.4 16.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.351 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 48.52 93.93 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.658 0.599 . . . . 0.0 111.247 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.48 ' NH2' ' O ' ' A' ' 88' ' ' ILE . 11.7 mmt85 -140.24 133.23 29.35 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.732 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.661 ' CZ3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -91.64 151.98 20.45 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.207 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -144.64 98.87 3.26 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.432 -177.158 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.661 HG21 ' CZ3' ' A' ' 95' ' ' TRP . 2.0 t -111.65 150.66 13.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.1 139.48 51.17 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.779 HD22 HG12 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -115.08 74.0 0.86 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.741 175.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.531 ' C ' HG22 ' A' ' 101' ' ' VAL . 12.0 p-10 -70.8 112.96 7.4 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.579 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.531 HG22 ' C ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -173.25 -40.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.652 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.662 ' OD1' HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -41.32 -19.64 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.462 -1.699 . . . . 0.0 110.815 178.154 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 101' ' ' VAL . 1.5 t-80 -45.67 -33.89 3.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.41 ' CZ ' ' NH1' ' A' ' 136' ' ' ARG . 52.6 m-85 -83.94 12.37 6.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.7 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 102' ' ' ASN . . . -179.19 96.71 0.2 Allowed Pre-proline 0 C--N 1.333 -0.143 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.608 ' HA ' HD21 ' A' ' 102' ' ' ASN . 47.6 Cg_endo -70.99 -48.5 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.452 2.101 . . . . 0.0 111.209 176.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -99.44 -30.93 11.91 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.038 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.449 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 2.4 mp0 -81.63 47.98 1.13 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.02 0.438 . . . . 0.0 110.245 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.662 HD22 ' OD1' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -131.57 138.54 48.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.255 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.418 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 1.3 m -128.38 123.03 32.82 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.631 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.481 HG13 ' CD1' ' A' ' 120' ' ' ILE . 1.9 t -102.81 122.38 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.423 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -127.6 134.78 49.68 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.817 -178.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 m -102.84 118.06 36.01 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.628 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.2 OUTLIER -115.84 83.16 1.89 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.219 0.533 . . . . 0.0 110.335 -176.663 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.4 t0 30.46 68.24 0.1 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.445 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.34 -23.08 29.19 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.63 HG13 HG23 ' A' ' 143' ' ' THR . 2.7 t -87.97 117.3 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 42.1 t -101.42 116.45 45.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.497 ' OE1' ' NZ ' ' A' ' 114' ' ' LYS . 8.9 mt-10 -133.1 134.16 43.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.941 0.401 . . . . 0.0 111.206 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.779 HG12 HD22 ' A' ' 99' ' ' LEU . 4.4 mm -106.33 142.65 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.863 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.423 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -123.64 115.46 21.5 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.201 -178.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.16 127.8 2.51 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.222 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.41 130.13 27.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.536 ' ND1' ' N ' ' A' ' 125' ' ' GLU . 48.7 t-80 -92.6 161.44 14.59 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.222 0.534 . . . . 0.0 111.744 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.536 ' N ' ' ND1' ' A' ' 124' ' ' HIS . 0.0 OUTLIER -87.46 149.26 24.53 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.892 177.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.463 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 4.8 tt0 -28.72 98.79 0.01 OUTLIER 'General case' 0 C--N 1.348 0.542 0 CA-C-O 120.915 0.388 . . . . 0.0 111.21 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 2.3 mtp-105 -83.35 146.0 28.73 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.852 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -86.03 123.83 31.79 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.75 172.19 12.27 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.869 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.45 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -71.04 -37.59 72.55 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -175.537 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.473 ' O ' ' OH ' ' B' ' 142' ' ' TYR . 13.6 m-70 -114.98 42.85 2.09 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.18 -176.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.25 168.96 12.47 Favored Glycine 0 C--N 1.306 -1.114 0 C-N-CA 119.995 -1.097 . . . . 0.0 110.929 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -96.42 109.16 21.75 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 172.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.598 HD13 ' NH2' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -129.6 119.02 46.94 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -170.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 127' ' ' ARG . 4.1 m -127.15 154.74 44.39 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.598 ' NH2' HD13 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -141.51 -179.33 6.09 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.935 -175.708 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 27.8 p -129.34 123.4 31.67 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.504 ' CD2' HG11 ' A' ' 101' ' ' VAL . 4.4 m-85 -100.14 140.15 34.78 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.309 -176.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.72 117.53 11.65 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.489 0.662 . . . . 0.0 111.052 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.487 ' CD ' HD23 ' A' ' 99' ' ' LEU . 2.0 mtt180 -108.05 143.33 36.92 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.337 177.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.573 ' HZ3' ' HB2' ' A' ' 141' ' ' LYS . 7.7 ttmm -138.36 112.95 8.89 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.989 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.531 ' HB2' ' HB ' ' A' ' 118' ' ' VAL . 2.0 m-85 -114.72 99.83 7.8 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.102 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.63 HG23 HG13 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -91.06 91.31 8.23 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.673 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mp -112.24 89.99 13.19 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.717 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.624 ' HD2' ' CD ' ' A' ' 146' ' ' PRO . 11.8 Cg_exo -72.22 -50.88 0.23 Allowed 'Trans proline' 0 C--N 1.287 -2.708 0 C-N-CA 122.461 2.107 . . . . 0.0 113.591 171.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.624 ' CD ' ' HD2' ' A' ' 145' ' ' PRO . 24.7 Cg_exo -55.34 -14.53 9.48 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.67 2.247 . . . . 0.0 115.401 -174.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.68 43.07 0.13 Allowed Glycine 0 C--N 1.341 0.818 0 C-N-CA 116.833 -2.603 . . . . 0.0 116.378 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.541 HG21 ' CH2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -135.25 131.29 51.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 117.859 0.829 . . . . 0.0 110.561 171.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -95.59 143.59 26.37 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.321 -178.606 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 6.1 Cg_exo -80.32 -47.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.334 2.023 . . . . 0.0 113.231 -176.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -37.6 59.95 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.739 -175.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.638 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 1.9 mt-30 -93.42 11.68 27.58 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -172.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 40.7 t -108.64 115.25 48.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.938 0.399 . . . . 0.0 110.16 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.94 177.32 4.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.294 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.3 143.55 35.91 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.789 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.512 ' O ' HD22 ' A' ' 163' ' ' LEU . 0.9 OUTLIER -115.11 144.97 42.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.61 HD22 HD22 ' A' ' 109' ' ' LEU . 34.7 tp -138.14 136.86 37.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.808 0.337 . . . . 0.0 111.196 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.41 ' HB2' HG22 ' A' ' 162' ' ' THR . 0.3 OUTLIER -117.09 149.48 44.38 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.68 178.531 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -40.38 -43.91 4.12 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 123.205 2.603 . . . . 0.0 112.206 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -53.33 -14.94 0.83 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.832 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 102' ' ' ASN . . . 85.02 33.13 18.97 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.797 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.41 HG22 ' HB2' ' A' ' 158' ' ' SER . 2.0 t -96.18 128.51 43.15 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.576 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.8 tm? -118.15 107.78 14.38 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.857 -175.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.2 p -99.22 127.86 45.26 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 165' ' ' VAL . 4.4 m -105.26 98.34 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 173.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -114.33 141.39 47.66 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.671 -174.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 177.5 167.8 0.49 Allowed Pre-proline 0 C--O 1.234 0.281 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.34 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 88.5 Cg_endo -90.3 121.58 0.9 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 123.943 3.095 . . . . 0.0 109.404 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.16 166.38 11.34 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-O 121.073 0.463 . . . . 0.0 112.067 -173.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -49.97 -71.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.879 2.386 . . . . 0.0 112.188 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -175.53 162.29 2.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.101 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.556 HD22 ' N ' ' A' ' 172' ' ' LEU . 3.9 mm? -85.81 145.78 27.06 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -110.61 -121.41 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.482 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 176' ' ' SER . 0.0 OUTLIER -49.63 -46.08 49.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.723 0.297 . . . . 0.0 110.728 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 67.13 -65.83 0.21 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.674 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 174' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.211 -0.966 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.588 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -153.94 -81.16 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.106 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 51.2 mt 58.02 -157.13 0.31 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.765 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.28 176.58 9.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.851 0.357 . . . . 0.0 111.079 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' SER . . . . . 0.454 ' O ' HG23 ' B' ' 85' ' ' VAL . 0.3 OUTLIER -73.3 119.51 17.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.859 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 84' ' ' GLY . . . . . 0.454 ' C ' HG23 ' B' ' 85' ' ' VAL . . . 60.61 -138.28 48.4 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.926 -0.469 . . . . 0.0 111.926 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.454 HG23 ' C ' ' B' ' 84' ' ' GLY . 2.2 t 71.13 124.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 122.753 0.421 . . . . 0.0 110.676 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 1.7 m -65.96 84.39 0.08 Allowed 'General case' 0 C--O 1.243 0.711 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.17 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.13 -169.37 0.09 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.132 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.484 ' C ' ' H ' ' B' ' 90' ' ' HIS . 0.6 OUTLIER -42.53 131.46 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.41 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -68.91 44.91 0.05 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.966 0.412 . . . . 0.0 110.581 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' HIS . . . . . 0.484 ' H ' ' C ' ' B' ' 88' ' ' ILE . 0.1 OUTLIER -89.18 -50.29 6.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.452 178.681 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' B' ' 171' ' ' LYS . 9.2 t -172.71 -165.53 0.32 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.853 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.4 ' H ' ' CB ' ' B' ' 171' ' ' LYS . . . 35.33 62.51 0.58 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.102 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' B' ' 94' ' ' ARG . 9.6 p-10 -81.73 -125.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' ARG . . . . . 0.503 ' H ' ' CG ' ' B' ' 93' ' ' ASP . 9.0 mmt180 -149.75 97.95 2.68 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' TRP . . . . . 0.605 ' CZ3' HG21 ' B' ' 97' ' ' VAL . 0.0 OUTLIER -72.47 153.83 41.17 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.354 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -152.02 105.3 3.07 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.577 -174.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.605 HG21 ' CZ3' ' B' ' 95' ' ' TRP . 1.4 t -121.05 154.69 24.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 98' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 15.2 m -127.13 144.23 51.08 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.974 HD22 HG12 ' B' ' 120' ' ' ILE . 0.3 OUTLIER -114.05 122.78 47.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.53 174.114 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.548 ' C ' HG22 ' B' ' 101' ' ' VAL . 19.3 p-10 -112.72 114.75 27.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.119 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.626 ' C ' ' H ' ' B' ' 103' ' ' HIS . 0.1 OUTLIER -169.56 -56.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.793 0.806 . . . . 0.0 110.378 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.694 ' OD1' HD13 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -56.66 14.09 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.565 -177.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.626 ' H ' ' C ' ' B' ' 101' ' ' VAL . 19.2 m170 -46.68 -28.99 1.66 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.97 0.414 . . . . 0.0 110.331 178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.44 ' HB3' ' CD2' ' B' ' 124' ' ' HIS . 24.8 t80 -120.04 24.18 10.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.711 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.02 91.15 4.92 Favored Pre-proline 0 CA--C 1.513 -0.467 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.168 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.88 -45.99 0.11 Allowed 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.447 2.098 . . . . 0.0 110.86 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' B' ' 107' ' ' ASP . 8.2 p-10 -98.58 -31.25 12.05 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.77 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.85 48.97 1.53 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.779 0.8 . . . . 0.0 110.248 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.694 HD13 ' OD1' ' B' ' 102' ' ' ASN . 0.4 OUTLIER -138.2 139.34 39.25 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.663 178.067 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.545 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -132.05 113.52 13.46 Favored 'General case' 0 C--N 1.31 -1.116 0 O-C-N 123.352 0.407 . . . . 0.0 110.091 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.81 119.09 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -129.75 129.41 44.1 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.454 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.1 m -98.05 122.91 41.76 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.484 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 0.3 OUTLIER -111.99 -162.17 0.79 Allowed 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -178.286 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 115' ' ' ASP . . . . . 0.432 ' H ' ' HG2' ' B' ' 114' ' ' LYS . 2.8 p-10 -65.07 69.49 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.368 0.604 . . . . 0.0 112.174 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' B' ' 114' ' ' LYS . . . 78.25 -8.43 39.42 Favored Glycine 0 CA--C 1.499 -0.934 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' B' ' 114' ' ' LYS . 2.1 t -88.64 115.4 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.68 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 41.4 t -98.59 118.87 45.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.68 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 41.1 mt-10 -133.77 143.46 48.44 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.282 0.563 . . . . 0.0 110.835 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.974 HG12 HD22 ' B' ' 99' ' ' LEU . 2.4 mm -115.61 140.2 38.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.12 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.55 111.87 19.15 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.57 145.69 13.93 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.59 -177.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.51 159.72 43.78 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' HIS . . . . . 0.522 ' O ' ' HB3' ' B' ' 135' ' ' SER . 3.7 m-70 -116.92 137.51 52.17 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.208 -177.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.5 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.5 OUTLIER -69.67 138.0 52.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.306 178.66 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 126' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' B' ' 125' ' ' GLU . 1.0 OUTLIER -17.21 98.37 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 127' ' ' ARG . . . . . 0.405 ' NH1' ' CE1' ' B' ' 104' ' ' PHE . 6.8 mtp85 -83.77 149.54 26.37 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.289 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 128' ' ' GLN . . . . . 0.563 ' HG2' ' N ' ' B' ' 129' ' ' ASP . 34.1 tt0 -99.72 151.87 20.74 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.14 0.495 . . . . 0.0 111.174 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ASP . . . . . 0.563 ' N ' ' HG2' ' B' ' 128' ' ' GLN . 19.6 t70 -161.38 169.29 22.26 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.514 175.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' GLU . . . . . 0.498 ' N ' ' CG ' ' B' ' 129' ' ' ASP . 4.2 tp10 -80.65 -11.42 59.64 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.435 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' HIS . . . . . 0.418 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 55.5 m-70 -115.93 31.41 6.74 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.251 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.55 164.16 11.86 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.672 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' TYR . . . . . 0.415 ' CE2' ' HG3' ' B' ' 128' ' ' GLN . 69.5 m-85 -95.68 139.32 32.09 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.06 126.38 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -170.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 135' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' B' ' 124' ' ' HIS . 0.0 OUTLIER -128.98 157.78 40.71 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.685 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -154.06 159.59 41.61 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.336 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 21.4 p -112.96 138.1 50.35 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' PHE . . . . . 0.437 ' CD2' HG11 ' B' ' 101' ' ' VAL . 0.2 OUTLIER -118.59 149.13 41.88 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.822 -176.514 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.74 134.51 17.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.678 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 140' ' ' ARG . . . . . 0.408 ' CB ' ' HE1' ' B' ' 142' ' ' TYR . 0.0 OUTLIER -135.8 107.62 7.06 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.081 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 141' ' ' LYS . . . . . 0.68 ' HA ' ' HG2' ' B' ' 119' ' ' GLU . 32.2 ttmt -96.86 113.94 25.52 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.038 0.447 . . . . 0.0 110.996 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 142' ' ' TYR . . . . . 0.502 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 2.4 m-85 -104.29 98.86 8.6 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.195 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.492 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.2 OUTLIER -92.53 96.81 10.44 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.082 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.1 mp -113.25 90.48 16.78 Favored Pre-proline 0 CA--C 1.511 -0.538 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.12 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' PRO . . . . . 0.609 ' HD2' ' CD ' ' B' ' 146' ' ' PRO . 15.9 Cg_exo -69.88 -42.89 2.9 Favored 'Trans proline' 0 C--N 1.277 -3.2 0 C-N-CA 122.19 1.927 . . . . 0.0 112.679 169.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 146' ' ' PRO . . . . . 0.609 ' CD ' ' HD2' ' B' ' 145' ' ' PRO . 76.3 Cg_exo -42.82 -15.83 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 123.001 2.467 . . . . 0.0 114.333 -176.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 151.76 58.13 0.01 OUTLIER Glycine 0 C--N 1.343 0.972 0 C-N-CA 118.199 -1.953 . . . . 0.0 115.201 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 148' ' ' VAL . . . . . 0.461 HG21 ' CH2' ' B' ' 95' ' ' TRP . 0.9 OUTLIER -123.34 113.1 36.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.573 172.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 149' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 24.4 t70 -77.44 137.91 63.66 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.569 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 5.3 Cg_exo -81.12 -23.8 5.06 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.122 1.881 . . . . 0.0 112.891 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.33 -41.24 11.63 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.269 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -97.42 15.5 22.91 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' VAL . . . . . 0.664 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 30.6 t -103.91 117.2 49.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.01 171.1 7.8 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.29 130.79 33.49 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.423 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.441 ' CB ' ' HG1' ' B' ' 164' ' ' THR . 0.0 OUTLIER -100.05 134.79 42.44 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.652 176.546 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 157' ' ' LEU . . . . . 0.461 HD22 ' CD2' ' B' ' 109' ' ' LEU . 29.8 tp -128.36 131.55 48.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.939 0.399 . . . . 0.0 110.652 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.425 ' H ' HD12 ' B' ' 157' ' ' LEU . 0.2 OUTLIER -117.41 149.97 45.66 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.349 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.595 ' C ' ' H ' ' B' ' 161' ' ' GLY . 85.5 Cg_exo -42.6 -34.34 3.32 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.419 2.079 . . . . 0.0 110.686 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.97 29.56 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.38 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 161' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 34.98 34.1 0.04 OUTLIER Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.585 0.612 . . . . 0.0 112.927 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 162' ' ' THR . . . . . 0.411 ' O ' HG23 ' B' ' 162' ' ' THR . 9.0 t -97.2 117.06 30.55 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.617 HD13 ' C ' ' B' ' 163' ' ' LEU . 2.7 tm? -108.21 103.08 12.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.505 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 164' ' ' THR . . . . . 0.441 ' HG1' ' CB ' ' B' ' 156' ' ' SER . 0.5 OUTLIER -92.08 124.46 36.19 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 121.246 -0.181 . . . . 0.0 110.637 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.508 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.1 m -105.83 109.63 28.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 0.42 ' OE1' ' NH1' ' B' ' 94' ' ' ARG . 1.8 pp20? -120.2 154.99 34.05 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.601 -176.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 167' ' ' ALA . . . . . 0.664 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . 177.93 157.02 0.54 Allowed Pre-proline 0 CA--C 1.518 -0.25 0 CA-C-O 120.989 0.423 . . . . 0.0 111.212 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 168' ' ' PRO . . . . . 0.564 ' C ' ' HG3' ' B' ' 169' ' ' MET . 81.5 Cg_endo -80.41 -24.24 5.52 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.905 2.403 . . . . 0.0 110.043 174.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 169' ' ' MET . . . . . 0.564 ' HG3' ' C ' ' B' ' 168' ' ' PRO . 0.5 OUTLIER 41.42 176.23 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.528 -1.214 . . . . 0.0 113.131 175.469 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 170' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' B' ' 172' ' ' LEU . 7.4 Cg_exo -71.87 75.26 2.2 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.166 1.911 . . . . 0.0 109.257 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 171' ' ' LYS . . . . . 0.501 ' HG3' ' H ' ' B' ' 93' ' ' ASP . 0.1 OUTLIER -57.84 68.32 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.27 -175.056 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.553 ' N ' ' O ' ' B' ' 170' ' ' PRO . 10.9 mt -94.16 162.53 13.82 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 173' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' B' ' 175' ' ' GLN . . . -82.08 21.32 0.9 Allowed 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.994 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.64 41.22 0.03 OUTLIER 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.975 0.417 . . . . 0.0 111.373 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 175' ' ' GLN . . . . . 0.487 ' H ' ' C ' ' B' ' 173' ' ' ALA . 34.8 mt-30 -68.45 -60.63 2.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.216 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.204 -1.312 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.313 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.78 ' N ' ' HG ' ' A' ' 82' ' ' SER . 4.7 mpp? . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 81' ' ' LEU . 5.5 pm0 -55.11 -34.71 63.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.879 0.371 . . . . 0.0 110.367 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.4 ' N ' ' HG2' ' A' ' 80' ' ' GLN . 6.9 mp -95.14 -72.03 0.64 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.133 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.78 ' HG ' ' N ' ' A' ' 79' ' ' MET . 1.3 m 49.95 -146.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.87 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.37 175.19 5.56 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.58 37.65 0.32 Allowed Glycine 0 C--N 1.32 -0.345 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 87' ' ' GLU . 11.4 t -144.91 143.96 22.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.6 m 67.34 -56.41 0.45 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.361 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.562 ' O ' ' N ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -91.85 -78.61 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.218 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 64.81 -56.91 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.562 ' N ' ' O ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -112.59 78.07 1.1 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.28 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.494 ' NE2' ' OE2' ' A' ' 87' ' ' GLU . 10.0 m80 -53.84 -53.49 51.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.128 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.28 73.39 0.18 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.051 0.453 . . . . 0.0 110.642 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.78 159.22 1.71 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.744 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 168' ' ' PRO . 0.4 OUTLIER -62.57 138.11 58.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.791 179.095 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 8.8 mmm180 -102.61 113.66 27.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.896 0.379 . . . . 0.0 110.09 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.592 ' NE1' ' CG2' ' A' ' 97' ' ' VAL . 46.8 t-105 -86.7 142.87 27.88 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 -136.42 117.13 13.99 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.592 ' CG2' ' NE1' ' A' ' 95' ' ' TRP . 1.1 t -132.09 158.2 43.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.578 175.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 3.0 m -130.48 157.61 42.17 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -175.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.839 HD23 ' NE ' ' A' ' 140' ' ' ARG . 0.6 OUTLIER -136.79 94.52 2.99 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.632 175.458 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.591 ' C ' HG22 ' A' ' 101' ' ' VAL . 1.9 p-10 -97.08 119.38 35.45 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.312 -177.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.768 HG11 ' CD2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -174.34 -50.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.643 0.735 . . . . 0.0 110.649 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.801 ' ND2' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -54.52 17.68 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.708 -1.133 . . . . 0.0 113.761 -176.791 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.581 ' H ' ' C ' ' A' ' 101' ' ' VAL . 57.5 m-70 -39.33 -50.1 2.01 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.009 0.433 . . . . 0.0 111.198 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -92.05 -6.13 51.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.901 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -116.88 90.32 32.03 Favored Pre-proline 0 CA--C 1.511 -0.534 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.633 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.32 -51.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.461 2.107 . . . . 0.0 110.922 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 109' ' ' LEU . 12.9 t70 -95.02 -31.18 13.72 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.432 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.451 ' N ' ' CD ' ' A' ' 108' ' ' GLU . 20.0 mp0 -77.88 28.87 0.17 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.161 0.505 . . . . 0.0 110.927 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.801 HD13 ' ND2' ' A' ' 102' ' ' ASN . 0.8 OUTLIER -114.51 134.9 54.68 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 176.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.414 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -123.87 113.27 18.29 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.092 -178.84 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.4 129.13 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -140.35 134.22 30.6 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.138 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.56 119.94 35.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 176.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.607 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.3 OUTLIER -116.59 80.75 1.51 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.252 0.549 . . . . 0.0 110.059 -177.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.2 t70 29.5 65.54 0.12 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.717 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.77 -24.21 32.63 Favored Glycine 0 C--N 1.313 -0.707 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.607 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 2.2 t -88.16 115.76 28.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.239 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 59.1 t -101.98 115.65 44.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.698 ' CD ' ' HZ2' ' A' ' 141' ' ' LYS . 66.5 mt-10 -130.61 142.32 50.45 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.467 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.783 HG12 HD22 ' A' ' 99' ' ' LEU . 3.5 mm -111.81 142.51 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.763 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.25 117.85 26.24 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.648 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.09 135.61 5.33 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.925 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.0 144.92 25.2 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.066 0.946 . . . . 0.0 108.503 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.512 ' HB3' ' NH2' ' A' ' 127' ' ' ARG . 49.9 t60 -115.69 165.79 12.65 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.834 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.515 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.7 OUTLIER -90.16 132.54 35.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.689 -178.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.515 ' C ' ' O ' ' A' ' 125' ' ' GLU . 11.7 tt0 -7.58 111.82 0.01 OUTLIER 'General case' 0 C--N 1.348 0.509 0 C-N-CA 123.326 0.65 . . . . 0.0 112.638 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.512 ' NH2' ' HB3' ' A' ' 124' ' ' HIS . 26.4 mtm180 -107.63 112.96 25.93 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.039 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.23 133.87 52.44 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -140.37 172.14 13.15 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.743 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.57 -24.59 63.72 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.159 0.504 . . . . 0.0 111.18 -177.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -109.78 39.53 2.1 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.859 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.18 172.65 19.59 Favored Glycine 0 C--N 1.301 -1.367 0 C-N-CA 119.537 -1.316 . . . . 0.0 111.092 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -94.75 117.22 29.78 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 172.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.57 123.16 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -171.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.18 164.19 26.07 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.3 ptt180 -150.5 177.14 10.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.115 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 25.6 p -120.52 148.44 43.84 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.768 ' CD2' HG11 ' A' ' 101' ' ' VAL . 1.0 OUTLIER -121.81 128.5 51.75 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.296 -179.215 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.08 120.12 24.16 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.304 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.839 ' NE ' HD23 ' A' ' 99' ' ' LEU . 1.2 mmm180 -117.9 139.36 51.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.698 ' HZ2' ' CD ' ' A' ' 119' ' ' GLU . 12.9 ttmm -133.38 110.6 10.14 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.847 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.579 ' OH ' ' NH2' ' A' ' 140' ' ' ARG . 30.0 m-85 -106.07 99.26 8.86 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.485 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -90.54 89.14 7.43 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.528 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.3 mp -112.41 92.3 18.99 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.632 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 16.7 Cg_exo -67.65 -55.87 0.25 Allowed 'Trans proline' 0 C--N 1.288 -2.625 0 C-N-CA 122.139 1.893 . . . . 0.0 113.045 175.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.632 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 56.5 Cg_endo -100.93 76.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.329 -0.491 0 C-N-CA 123.271 2.647 . . . . 0.0 112.251 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 164.5 -17.43 0.11 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.49 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.81 126.75 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 117.599 0.699 . . . . 0.0 111.045 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.408 ' OD1' ' HG3' ' A' ' 152' ' ' GLN . 14.7 t70 -87.1 145.28 37.81 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.637 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.86 -28.79 2.42 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.872 1.715 . . . . 0.0 112.567 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.61 -41.31 10.83 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.632 -174.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.707 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 12.8 mt-30 -98.77 22.54 9.92 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -172.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.5 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 39.9 t -103.6 119.74 52.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.093 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.33 179.48 4.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.52 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 164' ' ' THR . 0.9 OUTLIER -158.81 124.86 4.5 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.419 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.454 ' O ' HD22 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -104.25 139.21 39.59 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.306 178.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.753 HD22 HD22 ' A' ' 109' ' ' LEU . 30.7 tp -131.62 135.35 46.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.315 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.474 ' H ' HD12 ' A' ' 157' ' ' LEU . 0.4 OUTLIER -121.56 150.97 56.12 Favored Pre-proline 0 C--N 1.313 -0.995 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' A' ' 161' ' ' GLY . 82.3 Cg_exo -41.28 -35.51 2.17 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.323 2.015 . . . . 0.0 110.738 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 1.8 mp0 -67.28 28.76 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.485 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.617 ' H ' ' C ' ' A' ' 159' ' ' PRO . . . 35.73 31.45 0.03 OUTLIER Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.636 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 162' ' ' THR . 14.0 t -91.35 115.29 27.91 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.604 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.9 tm? -109.05 104.03 13.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.687 -176.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 155' ' ' SER . 0.8 OUTLIER -95.28 123.39 38.77 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.597 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 165' ' ' VAL . 2.9 m -107.29 99.23 8.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 1.7 pp20? -118.38 150.83 38.88 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.822 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.707 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 174.08 167.74 0.31 Allowed Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.255 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.559 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 73.9 Cg_endo -88.1 117.48 1.07 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 123.619 2.879 . . . . 0.0 108.9 175.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.49 ' SD ' ' HB2' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -109.21 175.07 2.09 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.407 -172.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 169' ' ' MET . 14.1 Cg_exo -65.15 116.52 3.9 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.932 2.421 . . . . 0.0 110.692 178.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.27 99.94 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.658 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.67 178.52 6.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.169 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.03 -101.02 0.18 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.377 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.07 -161.59 0.76 Allowed 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.475 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.405 ' C ' ' HG ' ' A' ' 176' ' ' SER . 5.9 mm-40 57.65 -174.75 0.08 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.235 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.405 ' HG ' ' C ' ' A' ' 175' ' ' GLN . 0.7 OUTLIER . . . . . 0 C--O 1.212 -0.917 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.401 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' MET . . . . . . . . . . . . . 9.4 mmt . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -64.5 -15.54 61.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.682 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' B' ' 83' ' ' SER . 2.6 mp 58.94 -164.25 0.21 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.752 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.53 40.94 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.716 0.293 . . . . 0.0 110.835 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' SER . . . . . 0.484 ' H ' ' C ' ' B' ' 81' ' ' LEU . 0.7 OUTLIER -114.24 121.1 42.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.813 0.34 . . . . 0.0 110.325 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.34 -66.25 0.39 Allowed Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' B' ' 83' ' ' SER . 0.3 OUTLIER 40.09 36.64 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.928 0.394 . . . . 0.0 110.486 179.595 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -43.5 -43.13 5.26 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.87 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.87 178.32 3.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.84 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.491 ' O ' ' NE ' ' B' ' 89' ' ' ARG . 35.3 pt -60.15 -25.39 33.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.482 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.491 ' NE ' ' O ' ' B' ' 88' ' ' ILE . 0.0 OUTLIER -157.69 -95.33 0.03 OUTLIER 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.459 0.647 . . . . 0.0 110.119 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 90' ' ' HIS . . . . . 0.408 ' O ' ' C ' ' B' ' 91' ' ' THR . 0.2 OUTLIER -154.9 96.7 1.88 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.408 ' C ' ' O ' ' B' ' 90' ' ' HIS . 33.0 p 38.4 -109.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.064 -175.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 41.67 27.71 0.07 Allowed 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.069 0.461 . . . . 0.0 110.702 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' B' ' 168' ' ' PRO . 41.8 p-10 -106.95 22.28 16.23 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.562 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -107.05 137.67 44.69 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.602 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' TRP . . . . . 0.629 ' HB2' ' SD ' ' B' ' 169' ' ' MET . 28.2 t-105 -125.67 152.72 44.86 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -145.53 102.41 3.69 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.269 -177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.538 HG22 ' NE1' ' B' ' 95' ' ' TRP . 0.2 OUTLIER -116.0 157.88 16.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.021 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 98' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 2.3 m -130.25 148.84 52.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.501 HD22 ' HB ' ' B' ' 120' ' ' ILE . 0.3 OUTLIER -122.58 117.85 26.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.128 174.747 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.537 ' C ' HG22 ' B' ' 101' ' ' VAL . 0.1 OUTLIER -113.99 115.35 27.5 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.537 HG22 ' C ' ' B' ' 100' ' ' ASP . 0.1 OUTLIER -167.72 -34.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.237 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.614 ' OD1' ' HA2' ' B' ' 161' ' ' GLY . 0.4 OUTLIER -80.8 16.6 1.38 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -174.361 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.563 ' N ' ' HA3' ' B' ' 161' ' ' GLY . 11.5 m80 -43.03 -39.91 2.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.105 0.478 . . . . 0.0 110.174 177.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -92.41 -1.14 57.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.251 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ALA . . . . . 0.547 ' C ' HD22 ' B' ' 102' ' ' ASN . . . -135.11 77.47 55.43 Favored Pre-proline 0 CA--C 1.511 -0.538 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.9 -38.17 3.15 Favored 'Trans proline' 0 C--N 1.295 -2.272 0 C-N-CA 122.48 2.12 . . . . 0.0 110.92 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -96.04 -26.86 15.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.003 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -95.85 49.02 1.14 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.111 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.703 HD22 HD22 ' B' ' 157' ' ' LEU . 0.5 OUTLIER -125.18 143.69 50.82 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.174 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.465 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -139.04 112.37 8.14 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.371 -177.501 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.55 125.6 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -133.62 133.25 41.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.758 0.313 . . . . 0.0 111.293 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.16 122.58 39.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.553 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 2.5 ttpt -126.37 91.44 3.37 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-O 120.847 0.356 . . . . 0.0 110.881 -176.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' B' ' 117' ' ' VAL . 6.7 p-10 34.58 66.55 0.28 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.07 -15.59 8.38 Favored Glycine 0 C--N 1.307 -1.055 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.852 HG22 HG23 ' B' ' 143' ' ' THR . 7.2 t -87.44 114.36 26.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 42.8 t -99.25 121.05 49.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.135 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 76.8 mt-10 -130.27 140.11 50.71 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.303 0.573 . . . . 0.0 111.025 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.501 ' HB ' HD22 ' B' ' 99' ' ' LEU . 1.3 mp -114.96 117.04 54.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.093 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -97.83 120.0 37.44 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.02 -178.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -146.68 126.95 2.58 Favored Glycine 0 N--CA 1.452 -0.272 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.11 159.35 40.37 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' HIS . . . . . 0.499 ' ND1' ' HB2' ' B' ' 105' ' ' ALA . 3.6 m-70 -123.05 130.9 53.39 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.245 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' B' ' 126' ' ' GLU . 4.5 tp10 -70.79 137.62 49.71 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' GLU . . . . . 0.587 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 5.1 tt0 -11.91 99.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.481 0.488 . . . . 0.0 111.737 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' ARG . . . . . 0.607 ' HB2' ' NH1' ' B' ' 127' ' ' ARG . 0.2 OUTLIER -89.12 128.86 35.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.499 -178.401 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -75.53 127.43 33.08 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ASP . . . . . 0.52 ' HB2' HG22 ' B' ' 134' ' ' ILE . 0.3 OUTLIER -138.27 164.72 28.51 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -70.49 -36.0 73.58 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.965 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' HIS . . . . . 0.498 ' O ' ' OH ' ' A' ' 142' ' ' TYR . 73.0 m-70 -100.16 40.36 1.25 Allowed 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 120.669 0.271 . . . . 0.0 110.572 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 114.46 174.16 18.35 Favored Glycine 0 C--N 1.299 -1.473 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.251 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -95.09 114.7 26.53 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' ILE . . . . . 0.559 HD11 ' NH2' ' B' ' 136' ' ' ARG . 0.0 OUTLIER -127.35 118.6 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -173.031 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 135' ' ' SER . . . . . 0.587 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.3 OUTLIER -126.61 154.8 43.46 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.004 176.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 136' ' ' ARG . . . . . 0.559 ' NH2' HD11 ' B' ' 134' ' ' ILE . 9.8 ptp85 -144.85 163.59 33.62 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.943 0.401 . . . . 0.0 111.483 -177.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 30.3 p -117.79 130.3 56.21 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -104.06 144.04 32.09 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.456 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.39 113.71 6.63 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.75 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 140' ' ' ARG . . . . . 0.493 ' NH2' ' OH ' ' B' ' 142' ' ' TYR . 0.0 OUTLIER -121.13 119.15 31.57 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 141' ' ' LYS . . . . . 0.499 ' NZ ' ' OE1' ' A' ' 126' ' ' GLU . 11.9 ttmt -110.81 121.37 45.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.945 0.403 . . . . 0.0 110.747 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 142' ' ' TYR . . . . . 0.548 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 1.7 m-85 -109.28 99.53 8.78 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.975 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.852 HG23 HG22 ' B' ' 117' ' ' VAL . 0.3 OUTLIER -90.29 99.69 12.66 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.141 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 7.4 mp -109.59 94.54 16.75 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' B' ' 147' ' ' GLY . 24.7 Cg_exo -66.21 -38.56 20.8 Favored 'Trans proline' 0 C--N 1.287 -2.678 0 C-N-CA 123.151 2.567 . . . . 0.0 114.513 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 146' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' B' ' 145' ' ' PRO . 34.4 Cg_exo -42.91 -13.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 121.458 1.439 . . . . 0.0 111.746 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 113.66 42.62 0.86 Allowed Glycine 0 C--N 1.343 0.943 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.52 172.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 148' ' ' VAL . . . . . 0.471 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -57.13 101.32 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 149' ' ' ASP . . . . . 0.581 ' O ' HG23 ' B' ' 153' ' ' VAL . 14.5 t0 -41.77 119.12 2.01 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.869 -172.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 5.2 Cg_exo -74.96 -26.54 10.91 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.23 1.953 . . . . 0.0 112.027 -178.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.56 -32.41 16.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.007 -177.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 152' ' ' GLN . . . . . 0.427 ' O ' ' HB1' ' B' ' 167' ' ' ALA . 22.9 mt-30 -107.31 19.2 20.64 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 153' ' ' VAL . . . . . 0.581 HG23 ' O ' ' B' ' 149' ' ' ASP . 27.9 t -105.46 95.37 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.324 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.05 -173.9 4.24 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 155' ' ' SER . . . . . 0.42 ' HB3' HD11 ' B' ' 163' ' ' LEU . 0.5 OUTLIER -159.74 138.38 10.63 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.734 -0.786 . . . . 0.0 112.056 -179.271 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.434 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.0 OUTLIER -107.14 136.38 47.09 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.053 178.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 157' ' ' LEU . . . . . 0.703 HD22 HD22 ' B' ' 109' ' ' LEU . 25.5 tp -124.95 131.58 53.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.908 0.385 . . . . 0.0 110.413 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.421 ' HB3' HG22 ' B' ' 162' ' ' THR . 0.3 OUTLIER -111.39 152.99 44.28 Favored Pre-proline 0 C--N 1.315 -0.931 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.146 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.455 ' C ' ' H ' ' B' ' 161' ' ' GLY . 9.7 Cg_endo -53.25 -20.58 15.07 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.069 1.846 . . . . 0.0 110.613 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -77.5 27.1 0.16 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.217 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' GLY . . . . . 0.614 ' HA2' ' OD1' ' B' ' 102' ' ' ASN . . . 41.72 34.5 1.25 Allowed Glycine 0 N--CA 1.462 0.396 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.945 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 162' ' ' THR . . . . . 0.421 HG22 ' HB3' ' B' ' 158' ' ' SER . 15.1 t -104.32 124.44 49.18 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.646 HD13 ' C ' ' B' ' 163' ' ' LEU . 2.5 tm? -114.87 109.73 18.59 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.204 -174.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.9 129.06 42.06 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.708 0.231 . . . . 0.0 110.476 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.567 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.2 m -113.44 103.99 16.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 1.7 pp20? -118.22 141.41 48.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.894 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 167' ' ' ALA . . . . . 0.558 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -177.98 159.14 1.22 Allowed Pre-proline 0 N--CA 1.453 -0.281 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 168' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' B' ' 93' ' ' ASP . 88.9 Cg_endo -77.64 81.01 2.78 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 123.72 2.947 . . . . 0.0 109.94 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 169' ' ' MET . . . . . 0.629 ' SD ' ' HB2' ' B' ' 95' ' ' TRP . 0.0 OUTLIER -93.08 164.42 21.64 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.55 -175.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 170' ' ' PRO . . . . . 0.526 ' CD ' ' O ' ' B' ' 147' ' ' GLY . 85.2 Cg_endo -82.35 103.87 1.31 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 123.263 2.642 . . . . 0.0 111.648 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 171' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -69.95 47.92 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.147 0.499 . . . . 0.0 110.144 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' B' ' 174' ' ' THR . 1.9 mm? -69.06 -10.77 59.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.565 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.18 53.23 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.458 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 174' ' ' THR . . . . . 0.439 ' N ' ' O ' ' B' ' 172' ' ' LEU . 2.6 p -95.19 100.19 12.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.921 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 175' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -42.05 -33.15 0.53 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.789 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' B' ' 174' ' ' THR . 2.6 m . . . . . 0 C--O 1.209 -1.073 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.499 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.569 ' N ' ' OE1' ' A' ' 80' ' ' GLN . 14.2 tpp . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.569 ' OE1' ' N ' ' A' ' 79' ' ' MET . 0.9 OUTLIER -121.2 -58.34 1.8 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.008 179.041 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.24 -71.35 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.792 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' GLN . 3.9 m -49.2 -67.08 0.3 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.367 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.7 m -162.83 143.73 9.76 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.043 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.1 67.49 0.55 Allowed Glycine 0 C--N 1.319 -0.391 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.4 m -41.67 -37.22 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.684 0.278 . . . . 0.0 110.933 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.533 ' C ' ' H ' ' A' ' 88' ' ' ILE . 1.2 m 40.66 49.51 2.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.511 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.84 31.32 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.139 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.555 ' O ' ' N ' ' A' ' 90' ' ' HIS . 4.8 pt -80.99 58.04 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -61.91 58.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.176 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.555 ' N ' ' O ' ' A' ' 88' ' ' ILE . 10.0 m-70 -71.29 79.04 0.73 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.348 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.74 162.25 0.93 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.694 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -132.15 169.21 16.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.664 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 0.4 OUTLIER -60.75 -75.56 0.06 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.215 178.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 1.2 mmm180 70.27 118.42 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.047 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.541 ' HB2' ' HG3' ' A' ' 169' ' ' MET . 0.0 OUTLIER -61.52 113.25 2.58 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -109.61 100.02 9.12 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.902 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -106.77 135.47 45.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 2.4 m -108.82 141.2 41.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.842 0.353 . . . . 0.0 111.945 -176.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.672 HD22 ' HB ' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -119.41 56.31 0.93 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.518 175.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -62.0 109.96 1.43 Allowed 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.329 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.566 HG21 ' CD2' ' A' ' 138' ' ' PHE . 11.8 p -171.15 -17.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.641 ' OD1' HD11 ' A' ' 157' ' ' LEU . 0.8 OUTLIER -90.52 16.79 8.3 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.684 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.558 ' N ' ' HA3' ' A' ' 161' ' ' GLY . 0.0 OUTLIER -41.03 -34.24 0.4 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.829 0.347 . . . . 0.0 111.026 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -101.87 11.42 38.66 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.806 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -143.3 86.52 8.99 Favored Pre-proline 0 CA--C 1.512 -0.515 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.433 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.37 -42.8 0.42 Allowed 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 122.44 2.093 . . . . 0.0 111.338 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -98.08 -31.79 11.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.583 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 123' ' ' LYS . 2.7 mm-40 -81.31 51.16 1.57 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.448 0.642 . . . . 0.0 110.347 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.746 HD22 HD22 ' A' ' 157' ' ' LEU . 0.5 OUTLIER -137.63 124.83 21.67 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.69 178.08 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.49 115.12 21.04 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.616 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.448 HG13 HD11 ' A' ' 120' ' ' ILE . 1.7 t -96.97 123.23 49.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.28 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.482 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 1.6 pttm -133.51 135.14 44.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.826 0.346 . . . . 0.0 111.081 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -109.61 114.84 28.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.3 ttpp -118.98 80.01 1.48 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.772 0.32 . . . . 0.0 111.652 -176.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.9 t0 49.77 69.57 0.59 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.156 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.1 -20.52 9.86 Favored Glycine 0 C--N 1.32 -0.339 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.863 HG22 HG23 ' A' ' 143' ' ' THR . 16.7 t -86.86 111.26 21.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.634 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.4 t -102.7 112.49 36.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.553 ' HG2' ' HA ' ' A' ' 141' ' ' LYS . 40.6 mt-10 -124.41 133.55 53.36 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.351 0.596 . . . . 0.0 111.53 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.672 ' HB ' HD22 ' A' ' 99' ' ' LEU . 1.1 mp -108.05 118.54 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.926 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.482 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -97.7 122.81 41.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.501 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.31 134.0 4.6 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.626 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -131.5 159.76 37.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -125.71 136.88 53.68 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.96 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.533 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -88.81 134.77 33.82 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' A' ' 125' ' ' GLU . 2.8 tt0 -1.9 98.85 0.01 OUTLIER 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.759 0.662 . . . . 0.0 112.548 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 11.0 mtp-105 -96.47 139.44 32.58 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 120.907 0.384 . . . . 0.0 111.081 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -79.84 130.25 35.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.779 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.437 ' OD2' ' NH2' ' B' ' 140' ' ' ARG . 0.0 OUTLIER -136.56 144.66 44.32 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.168 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -47.78 -27.47 2.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.147 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.447 ' O ' ' CZ ' ' B' ' 142' ' ' TYR . 48.2 m80 -120.67 39.84 3.66 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.673 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.2 167.84 11.77 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.594 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 12.6 m-30 -96.36 113.77 25.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.7 HD11 HH11 ' A' ' 136' ' ' ARG . 0.0 OUTLIER -120.07 145.16 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -176.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -144.11 156.34 44.31 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.438 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.7 HH11 HD11 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -152.24 -178.45 6.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.825 0.345 . . . . 0.0 111.443 -175.176 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 26.4 p -139.76 134.0 31.24 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 175.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.566 ' CD2' HG21 ' A' ' 101' ' ' VAL . 46.9 m-85 -100.36 141.04 33.75 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.76 99.19 4.86 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.103 172.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.676 ' NH2' ' CD1' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -104.81 99.92 9.55 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.001 -179.428 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.553 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 13.8 ttpt -112.34 127.89 56.13 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.713 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.676 ' CD1' ' NH2' ' A' ' 140' ' ' ARG . 11.9 m-85 -127.25 100.02 5.9 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.515 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.863 HG23 HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -85.4 89.79 7.77 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.498 179.202 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.3 mp -108.69 93.4 12.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.332 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.63 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 16.7 Cg_exo -66.95 -54.93 0.36 Allowed 'Trans proline' 0 C--N 1.294 -2.332 0 C-N-CA 122.143 1.895 . . . . 0.0 112.798 175.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.63 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 57.6 Cg_endo -102.87 89.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.556 2.838 . . . . 0.0 111.729 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.86 -19.57 0.76 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.922 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.62 128.83 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 117.121 0.46 . . . . 0.0 110.511 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -92.88 143.13 26.42 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.044 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.54 -22.61 4.53 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.877 1.718 . . . . 0.0 112.362 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.67 -41.04 10.95 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.212 -175.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.606 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 3.6 mt-30 -106.5 23.77 13.67 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -172.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.481 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 42.8 t -110.67 111.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.921 0.391 . . . . 0.0 110.878 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.62 -178.0 3.47 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.92 139.3 26.15 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.048 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.54 137.66 47.94 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.413 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.746 HD22 HD22 ' A' ' 109' ' ' LEU . 31.4 tp -128.43 145.45 51.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.896 0.379 . . . . 0.0 110.726 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.29 155.23 81.79 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.815 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.55 ' C ' ' H ' ' A' ' 161' ' ' GLY . 91.8 Cg_exo -42.27 -42.58 7.63 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.905 2.403 . . . . 0.0 111.865 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -62.54 10.77 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.644 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.627 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 59.39 33.57 76.72 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 112.06 -0.416 . . . . 0.0 112.06 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 162' ' ' THR . 6.2 t -95.18 114.85 26.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.453 . . . . 0.0 109.919 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.611 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.1 tm? -108.49 104.78 14.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.875 -177.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.7 p -99.42 116.79 32.38 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 165' ' ' VAL . 3.5 m -95.45 99.69 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -115.02 138.31 51.01 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.022 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.606 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . -178.11 162.83 1.25 Allowed Pre-proline 0 C--N 1.32 -0.7 0 CA-C-O 121.313 0.578 . . . . 0.0 111.771 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 86.6 Cg_endo -87.77 109.16 0.65 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 123.257 2.638 . . . . 0.0 108.229 175.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.595 ' SD ' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -109.39 169.15 6.74 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.506 -173.004 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 169' ' ' MET . 19.5 Cg_endo -62.05 50.1 0.1 Allowed 'Trans proline' 0 N--CA 1.503 2.08 0 C-N-CA 123.222 2.615 . . . . 0.0 112.065 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 169' ' ' MET . 6.0 mtpm? -36.24 -55.6 0.79 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.93 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.5 mt -116.84 43.67 2.21 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.857 0.36 . . . . 0.0 111.144 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.548 ' HB2' ' HB2' ' A' ' 170' ' ' PRO . . . -69.13 -61.61 1.72 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.29 159.15 14.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.741 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.04 -173.96 1.14 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.209 -1.038 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.838 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' MET . . . . . 0.48 ' N ' ' OD2' ' B' ' 93' ' ' ASP . 4.3 ttp . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 61.35 168.49 0.1 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.661 0.267 . . . . 0.0 110.506 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.686 HD22 ' N ' ' B' ' 81' ' ' LEU . 2.0 mm? -77.92 -160.45 0.2 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' SER . . . . . 0.458 ' O ' ' N ' ' B' ' 84' ' ' GLY . 0.6 OUTLIER -70.29 164.01 25.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.752 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 6.4 m -67.74 53.77 0.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.061 0.458 . . . . 0.0 110.531 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' B' ' 82' ' ' SER . . . 158.48 80.48 0.03 OUTLIER Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 34.5 m 43.6 -155.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 122.613 0.365 . . . . 0.0 111.544 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' SER . . . . . 0.434 ' C ' ' H ' ' B' ' 88' ' ' ILE . 0.8 OUTLIER -75.45 69.18 2.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.775 0.322 . . . . 0.0 111.273 -178.119 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 87' ' ' GLU . . . . . 0.447 ' O ' ' NH2' ' B' ' 89' ' ' ARG . 6.3 tt0 -77.15 30.9 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.595 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ILE . . . . . 0.585 ' O ' ' NE ' ' B' ' 89' ' ' ARG . 6.9 mt 57.25 165.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.992 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.585 ' NE ' ' O ' ' B' ' 88' ' ' ILE . 0.0 OUTLIER 56.48 -5.99 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 178.06 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 90' ' ' HIS . . . . . 0.541 ' H ' ' C ' ' B' ' 88' ' ' ILE . 0.6 OUTLIER -38.39 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.003 0.43 . . . . 0.0 111.645 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.434 ' N ' ' O ' ' B' ' 89' ' ' ARG . 2.0 m -146.4 127.06 14.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.148 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -152.02 -84.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.911 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' B' ' 79' ' ' MET . 21.6 m-20 -62.63 87.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.933 0.396 . . . . 0.0 110.929 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' ARG . . . . . 0.485 ' NH2' ' OE2' ' B' ' 166' ' ' GLU . 7.9 mmm180 -129.99 144.77 51.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.587 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' TRP . . . . . 0.559 ' NE1' ' CG2' ' B' ' 97' ' ' VAL . 63.2 t-105 -115.8 113.9 24.03 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -119.83 104.72 10.45 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.579 -175.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.559 ' CG2' ' NE1' ' B' ' 95' ' ' TRP . 0.2 OUTLIER -112.59 158.12 13.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 98' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 16.1 m -134.31 142.52 47.3 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -176.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.771 HD23 HH11 ' B' ' 140' ' ' ARG . 0.4 OUTLIER -112.97 79.89 1.29 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.472 174.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.489 ' C ' HG22 ' B' ' 101' ' ' VAL . 5.0 p-10 -86.36 102.76 14.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.86 0.362 . . . . 0.0 111.143 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.489 HG22 ' C ' ' B' ' 100' ' ' ASP . 0.0 OUTLIER -163.94 -40.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.765 0.317 . . . . 0.0 111.463 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.619 ' ND2' ' CD1' ' B' ' 109' ' ' LEU . 0.0 OUTLIER -60.25 11.16 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -175.282 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.531 ' N ' ' HA3' ' B' ' 161' ' ' GLY . 3.1 p80 -52.4 -19.07 1.93 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.137 0.494 . . . . 0.0 109.87 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.432 ' CE2' ' NH2' ' B' ' 136' ' ' ARG . 47.9 p90 -94.48 -9.26 36.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.138 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.51 91.8 5.68 Favored Pre-proline 0 CA--C 1.516 -0.351 0 CA-C-O 120.826 0.346 . . . . 0.0 111.536 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.95 -49.77 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.471 2.114 . . . . 0.0 111.266 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -89.66 -31.2 17.62 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.225 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.502 ' OE2' ' NZ ' ' B' ' 123' ' ' LYS . 13.2 mt-10 -87.08 49.84 1.9 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.311 0.577 . . . . 0.0 110.135 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.858 HD22 HD22 ' B' ' 157' ' ' LEU . 0.4 OUTLIER -133.18 142.6 48.7 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.111 178.405 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.528 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -137.05 120.25 16.74 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.432 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.462 HG13 HD11 ' B' ' 120' ' ' ILE . 2.5 t -102.2 125.37 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.358 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.413 ' NZ ' ' HB2' ' B' ' 119' ' ' GLU . 14.6 pttp -136.4 142.11 43.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.665 0.269 . . . . 0.0 111.145 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.91 114.95 29.35 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.535 ' NZ ' ' CB ' ' B' ' 114' ' ' LYS . 0.0 OUTLIER -111.81 92.91 4.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.117 -177.411 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 29.5 t70 32.77 66.35 0.2 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.273 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.52 -21.93 19.29 Favored Glycine 0 N--CA 1.466 0.665 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.759 HG22 HG23 ' B' ' 143' ' ' THR . 5.9 t -87.79 120.43 36.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 54.3 t -106.49 123.73 61.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.442 ' OE2' ' NZ ' ' B' ' 114' ' ' LYS . 2.8 mt-10 -135.66 140.65 44.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.973 0.416 . . . . 0.0 110.767 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.49 ' HB ' HD22 ' B' ' 99' ' ' LEU . 1.2 mp -117.72 117.75 56.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.791 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -91.16 123.29 34.5 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.443 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.07 116.5 0.78 Allowed Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' LYS . . . . . 0.502 ' NZ ' ' OE2' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -140.86 126.3 18.8 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.282 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 124' ' ' HIS . . . . . 0.707 ' H ' ' CD2' ' B' ' 124' ' ' HIS . 0.2 OUTLIER -95.77 134.84 38.25 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.371 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' B' ' 126' ' ' GLU . 3.2 tp10 -69.36 136.41 51.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.383 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' GLU . . . . . 0.531 ' C ' ' O ' ' B' ' 125' ' ' GLU . 39.3 tt0 -1.62 98.39 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.797 0.685 . . . . 0.0 112.111 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -93.02 129.93 38.78 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.079 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -77.52 122.6 25.47 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ASP . . . . . 0.524 ' HB2' HG22 ' B' ' 134' ' ' ILE . 1.9 t70 -120.29 173.02 7.38 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.866 0.365 . . . . 0.0 110.766 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.58 -30.97 70.14 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -174.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' HIS . . . . . 0.529 ' O ' ' CE1' ' A' ' 142' ' ' TYR . 75.0 m-70 -110.82 24.68 12.64 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 132.84 -149.88 19.64 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 120.228 -0.987 . . . . 0.0 111.955 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' TYR . . . . . 0.554 ' O ' ' NH1' ' A' ' 140' ' ' ARG . 63.4 m-85 -111.18 125.16 53.5 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 134' ' ' ILE . . . . . 0.524 HG22 ' HB2' ' B' ' 129' ' ' ASP . 0.0 OUTLIER -145.96 121.56 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 120.659 0.266 . . . . 0.0 111.092 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 135' ' ' SER . . . . . 0.41 ' HB3' ' CD2' ' B' ' 124' ' ' HIS . 0.7 OUTLIER -150.51 157.75 43.37 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 178.417 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 136' ' ' ARG . . . . . 0.618 ' HD3' ' CE1' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -145.53 171.52 14.55 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.113 0.482 . . . . 0.0 111.65 -177.071 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 29.5 p -107.93 132.13 53.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.693 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' PHE . . . . . 0.618 ' CE1' ' HD3' ' B' ' 136' ' ' ARG . 0.3 OUTLIER -108.78 139.76 43.15 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.774 0.321 . . . . 0.0 110.903 -178.6 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.64 103.95 3.57 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.259 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 140' ' ' ARG . . . . . 0.771 HH11 HD23 ' B' ' 99' ' ' LEU . 0.0 OUTLIER -104.91 123.85 48.45 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 141' ' ' LYS . . . . . 0.41 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 1.5 ttpp -113.54 118.19 33.75 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 142' ' ' TYR . . . . . 0.644 ' OH ' ' NH1' ' B' ' 140' ' ' ARG . 2.1 m-30 -106.04 97.88 7.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.739 0.304 . . . . 0.0 110.192 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.759 HG23 HG22 ' B' ' 117' ' ' VAL . 0.2 OUTLIER -90.98 100.27 13.17 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.686 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -109.73 92.54 12.53 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.825 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' PRO . . . . . 0.575 ' O ' ' N ' ' B' ' 147' ' ' GLY . 24.6 Cg_exo -65.76 -39.85 19.07 Favored 'Trans proline' 0 C--N 1.287 -2.705 0 C-N-CA 122.527 2.151 . . . . 0.0 112.428 171.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 146' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 83.7 Cg_exo -41.59 -8.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 123.296 2.664 . . . . 0.0 113.506 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 116.4 69.65 0.43 Allowed Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.101 -1.047 . . . . 0.0 113.989 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 148' ' ' VAL . . . . . 0.449 ' O ' HG12 ' B' ' 148' ' ' VAL . 0.5 OUTLIER -112.76 112.4 40.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 149' ' ' ASP . . . . . 0.481 ' O ' HG23 ' B' ' 153' ' ' VAL . 19.1 t70 -64.39 135.51 96.38 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.692 -176.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 3.8 Cg_exo -78.58 -26.2 6.02 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.922 1.748 . . . . 0.0 113.188 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.93 -42.32 10.65 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -94.49 15.97 16.52 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -174.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' VAL . . . . . 0.699 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 37.1 t -101.34 89.6 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.442 177.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.41 178.43 8.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.38 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.78 133.65 10.27 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.472 -178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.567 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.0 OUTLIER -113.31 142.8 45.41 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.369 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 157' ' ' LEU . . . . . 0.858 HD22 HD22 ' B' ' 109' ' ' LEU . 35.0 tp -128.88 148.7 50.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 110.291 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.614 ' H ' HD12 ' B' ' 157' ' ' LEU . 0.3 OUTLIER -134.77 154.02 79.15 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.504 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.552 ' C ' ' H ' ' B' ' 161' ' ' GLY . 80.5 Cg_exo -41.05 -40.45 3.89 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.739 2.293 . . . . 0.0 111.239 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.27 17.64 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.376 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' GLY . . . . . 0.552 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 49.72 31.33 15.71 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 162' ' ' THR . . . . . 0.497 ' CG2' ' HB2' ' B' ' 158' ' ' SER . 15.0 t -90.57 120.77 31.92 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.604 HD13 ' C ' ' B' ' 163' ' ' LEU . 3.1 tm? -115.77 102.65 9.91 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.88 125.42 37.47 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.12 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.577 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.0 m -112.6 100.03 9.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 174.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 0.485 ' OE2' ' NH2' ' B' ' 94' ' ' ARG . 0.0 OUTLIER -110.01 132.74 53.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.937 -176.15 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 167' ' ' ALA . . . . . 0.699 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -164.0 150.24 9.65 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.65 67.19 6.47 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 123.867 3.045 . . . . 0.0 109.98 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' MET . . . . . 0.506 ' HG2' ' CB ' ' B' ' 95' ' ' TRP . 0.1 OUTLIER -46.91 158.71 0.41 Allowed Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.193 -176.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 170' ' ' PRO . . . . . 0.54 ' HB2' HD23 ' B' ' 172' ' ' LEU . 8.3 Cg_endo -51.73 148.44 21.76 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.873 2.382 . . . . 0.0 111.373 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 171' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.77 64.79 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.629 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' B' ' 170' ' ' PRO . 3.1 mm? -89.5 72.3 7.91 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.76 87.96 1.74 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.63 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.91 111.74 5.84 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 175' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -80.17 -85.83 0.09 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.24 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.208 -1.086 0 CA-C-O 118.289 -0.863 . . . . 0.0 111.424 -178.766 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.989 ' N ' ' HG ' ' A' ' 82' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -41.6 -81.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.986 0.422 . . . . 0.0 111.421 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.4 mt -54.64 -17.24 3.12 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.437 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.989 ' HG ' ' N ' ' A' ' 79' ' ' MET . 0.7 OUTLIER -85.91 -15.45 41.68 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.076 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 79' ' ' MET . 0.0 OUTLIER -97.11 -170.19 1.99 Allowed 'General case' 0 C--O 1.239 0.542 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.071 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.1 -54.71 0.81 Allowed Glycine 0 CA--C 1.518 0.279 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.38 150.75 34.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.9 m -166.59 90.16 0.39 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.112 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 89' ' ' ARG . 9.2 mm-40 -57.18 152.76 13.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.182 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.9 tt -66.13 58.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.417 0.627 . . . . 0.0 110.731 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 87' ' ' GLU . 11.7 mtp180 -77.38 133.14 38.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.069 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.432 ' ND1' ' N ' ' A' ' 91' ' ' THR . 1.8 t60 -154.94 133.2 11.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.903 0.383 . . . . 0.0 110.825 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.432 ' N ' ' ND1' ' A' ' 90' ' ' HIS . 0.0 OUTLIER -70.31 63.64 0.25 Allowed 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 90' ' ' HIS . . . -38.17 -38.05 0.31 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.087 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 168' ' ' PRO . 1.8 m-20 -59.48 90.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.04 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.454 ' NH1' ' OE1' ' A' ' 166' ' ' GLU . 6.5 mmt85 -128.5 117.2 20.91 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.715 ' CZ3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -86.13 160.12 19.33 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 96' ' ' ARG . 21.3 ttp-105 -151.37 99.66 2.66 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.128 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.715 HG21 ' CZ3' ' A' ' 95' ' ' TRP . 1.3 t -116.27 148.1 19.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 176.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.23 150.1 30.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.936 0.398 . . . . 0.0 111.878 -175.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.746 HD22 HG12 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -128.82 91.16 3.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.643 175.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.591 ' C ' HG22 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -81.56 124.78 29.8 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.477 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.591 HG22 ' C ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -178.72 -40.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-O 122.403 1.097 . . . . 0.0 108.434 178.538 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.87 ' HB2' HD13 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -58.92 -14.27 8.67 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 113.373 -1.739 . . . . 0.0 111.683 -178.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.572 ' CE1' ' HA ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -45.14 -22.78 0.12 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.567 -178.394 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.32 17.27 12.26 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.88 86.31 3.84 Favored Pre-proline 0 N--CA 1.467 0.409 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.875 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.533 ' HA ' HD21 ' A' ' 102' ' ' ASN . 51.3 Cg_endo -70.95 -47.28 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.511 2.141 . . . . 0.0 111.517 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -94.81 -30.46 14.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.347 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.545 ' OE2' ' NZ ' ' A' ' 123' ' ' LYS . 24.9 mt-10 -85.98 41.29 0.91 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.048 0.451 . . . . 0.0 110.822 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.87 HD13 ' HB2' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -129.2 133.89 47.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.047 178.799 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.4 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -127.73 129.06 46.46 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.245 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.3 t -109.47 120.88 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.614 ' NZ ' ' HB2' ' A' ' 119' ' ' GLU . 9.8 pttp -134.26 128.33 33.63 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.403 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -97.15 134.24 40.74 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.097 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 116' ' ' GLY . 0.3 OUTLIER -120.46 -176.74 3.29 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -57.28 69.85 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.303 0.573 . . . . 0.0 111.639 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 114' ' ' LYS . . . 83.69 -5.99 75.89 Favored Glycine 0 C--N 1.32 -0.356 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.672 HG13 HG23 ' A' ' 143' ' ' THR . 1.7 t -92.49 110.81 23.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.2 t -96.06 117.75 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.614 ' HB2' ' NZ ' ' A' ' 112' ' ' LYS . 81.6 mt-10 -129.48 133.6 47.36 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.114 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.746 HG12 HD22 ' A' ' 99' ' ' LEU . 4.6 mm -107.18 141.38 22.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.417 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -121.69 114.31 20.96 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.329 -178.015 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -144.85 130.07 3.76 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.899 -0.48 . . . . 0.0 111.899 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.545 ' NZ ' ' OE2' ' A' ' 108' ' ' GLU . 0.1 OUTLIER -151.13 132.28 14.41 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.129 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.531 ' ND1' ' HG2' ' A' ' 127' ' ' ARG . 54.6 t-80 -102.59 141.2 35.81 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -56.81 -33.78 67.05 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -176.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 0.3 OUTLIER 173.21 103.51 0.01 OUTLIER 'General case' 0 C--N 1.356 0.853 0 CA-C-N 118.748 0.704 . . . . 0.0 111.23 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.531 ' HG2' ' ND1' ' A' ' 124' ' ' HIS . 9.7 mtp-105 -94.42 149.21 21.46 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.589 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -83.54 136.87 34.1 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.61 ' HB3' HG22 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -136.65 151.32 49.17 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.252 0.548 . . . . 0.0 110.293 177.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.48 -29.8 7.24 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.119 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.587 ' H ' ' CG ' ' A' ' 129' ' ' ASP . 50.5 m-70 -120.17 40.5 3.44 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.851 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.17 172.97 13.28 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 119.689 -1.243 . . . . 0.0 112.092 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -96.1 126.79 41.57 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 172.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.61 HG22 ' HB3' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -130.43 123.92 56.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -170.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 3.1 m -131.57 147.04 52.5 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.199 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.442 ' NH1' ' CE2' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -143.75 170.48 15.79 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.755 -178.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 25.1 p -112.02 122.77 48.68 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.486 ' CD2' ' CG1' ' A' ' 101' ' ' VAL . 5.7 m-85 -95.78 128.78 42.96 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.765 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.58 105.65 5.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.886 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.476 ' NH2' ' OH ' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -104.67 105.14 15.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.864 178.137 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.454 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 14.2 ttmt -99.04 112.38 24.53 Favored 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 123.186 0.304 . . . . 0.0 110.75 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.703 ' CE1' ' HA3' ' B' ' 132' ' ' GLY . 5.9 m-30 -106.15 99.3 8.9 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.672 HG23 HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -87.74 89.32 7.95 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mp -113.33 91.35 19.33 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.645 ' HD2' ' HD3' ' A' ' 146' ' ' PRO . 13.2 Cg_exo -69.13 -57.27 0.13 Allowed 'Trans proline' 0 C--N 1.29 -2.529 0 C-N-CA 122.457 2.105 . . . . 0.0 114.641 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.645 ' HD3' ' HD2' ' A' ' 145' ' ' PRO . 12.6 Cg_endo -93.0 22.69 0.57 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 C-N-CA 122.969 2.446 . . . . 0.0 113.562 -174.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -142.22 -13.27 0.41 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 119.827 -1.178 . . . . 0.0 112.968 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.541 HG21 ' CH2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -131.75 128.19 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.713 0.756 . . . . 0.0 110.644 178.795 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 12.8 t70 -89.26 140.96 28.78 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.226 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 3.6 Cg_exo -82.35 -18.92 6.87 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.063 1.842 . . . . 0.0 112.991 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.46 -37.2 12.67 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.755 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 2.7 mt-30 -109.83 27.9 9.11 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.494 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 45.2 t -111.65 120.8 62.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.673 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.81 -173.72 2.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.318 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.48 153.17 31.06 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.215 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.491 ' O ' HD22 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -124.82 136.46 53.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.617 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.597 HD22 HD22 ' A' ' 109' ' ' LEU . 31.0 tp -124.89 110.91 14.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.84 0.353 . . . . 0.0 110.131 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.425 ' HB3' HG22 ' A' ' 162' ' ' THR . 0.3 OUTLIER -90.86 145.07 31.18 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.664 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.621 ' C ' ' H ' ' A' ' 161' ' ' GLY . 84.4 Cg_exo -41.02 -34.06 1.34 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.646 2.231 . . . . 0.0 110.753 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.61 27.61 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.387 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.621 ' H ' ' C ' ' A' ' 159' ' ' PRO . . . 38.41 33.96 0.21 Allowed Glycine 0 CA--C 1.53 1.008 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.601 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 158' ' ' SER . 9.8 t -102.03 125.37 48.7 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.576 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.1 tm? -107.04 110.01 22.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.786 -175.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.35 125.38 45.0 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.488 ' O ' HG23 ' A' ' 165' ' ' VAL . 1.2 m -106.69 107.28 22.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 1.5 pp20? -121.63 152.83 38.87 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.056 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.755 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 168.44 167.97 0.14 Allowed Pre-proline 0 C--O 1.238 0.463 0 CA-C-O 121.158 0.504 . . . . 0.0 112.213 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 37.7 Cg_endo -89.53 109.46 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 123.452 2.768 . . . . 0.0 109.168 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.548 ' CE ' ' H ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -107.18 170.8 5.26 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.874 -175.121 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 169' ' ' MET . 21.7 Cg_exo -54.91 -20.41 22.7 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.249 1.966 . . . . 0.0 110.688 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.1 tttt 72.95 143.39 0.07 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.222 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.48 106.61 3.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.223 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -130.17 -21.37 2.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.958 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 17.2 p -79.29 -94.36 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.208 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -85.17 -124.39 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.852 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.214 -0.777 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.069 179.769 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 79' ' ' MET . . . . . . . . . . . . . 15.6 mmm . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.573 ' C ' ' H ' ' B' ' 82' ' ' SER . 26.2 mt-30 -44.43 127.67 5.97 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' B' ' 81' ' ' LEU . 2.8 mm? 66.73 -35.65 0.25 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.947 0.403 . . . . 0.0 110.466 -177.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' SER . . . . . 0.573 ' H ' ' C ' ' B' ' 80' ' ' GLN . 0.9 OUTLIER 60.26 -157.37 0.33 Allowed 'General case' 0 C--O 1.239 0.55 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 178.474 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.98 139.99 48.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.154 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.58 86.57 0.27 Allowed Glycine 0 C--N 1.318 -0.453 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 5.4 m -61.32 165.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.142 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 90' ' ' HIS . 0.1 OUTLIER -65.08 -33.52 76.23 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.446 -178.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 65.83 -140.8 0.19 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.597 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 pt 32.27 45.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.926 0.393 . . . . 0.0 111.993 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 49.88 25.14 1.49 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.914 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' HIS . . . . . 0.426 ' O ' ' OG ' ' B' ' 86' ' ' SER . 62.1 t-80 -118.06 67.34 0.76 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.832 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.56 ' O ' ' HB2' ' B' ' 92' ' ' ALA . 76.7 p -81.76 -85.86 0.1 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' B' ' 91' ' ' THR . . . 163.83 -29.18 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.317 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.586 ' CG ' ' H ' ' B' ' 94' ' ' ARG . 5.0 p-10 -68.86 -93.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.772 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' ARG . . . . . 0.586 ' H ' ' CG ' ' B' ' 93' ' ' ASP . 24.5 mmt-85 11.17 84.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 123.727 0.642 . . . . 0.0 110.454 -177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' TRP . . . . . 0.526 ' HB2' ' HG3' ' B' ' 169' ' ' MET . 0.1 OUTLIER -62.31 141.13 58.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.339 -177.77 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 25.0 ttm105 -135.29 106.78 6.86 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.167 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.85 150.9 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 98' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 17.6 m -126.95 148.91 50.05 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -174.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.692 HD21 ' CE1' ' B' ' 142' ' ' TYR . 0.7 OUTLIER -123.9 55.03 1.29 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.465 174.426 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.25 93.95 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.835 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' B' ' 103' ' ' HIS . 2.6 t -145.15 -26.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.775 ' HB3' HD13 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -54.86 3.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.298 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.532 ' H ' ' C ' ' B' ' 101' ' ' VAL . 2.4 m-70 -41.91 -46.55 4.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.998 0.428 . . . . 0.0 110.848 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.06 8.32 38.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.144 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.07 89.75 2.06 Favored Pre-proline 0 CA--C 1.513 -0.444 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.58 -44.48 0.38 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.323 2.015 . . . . 0.0 110.866 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -98.15 -31.46 12.09 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.119 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.437 ' OE1' ' NZ ' ' B' ' 123' ' ' LYS . 4.4 mt-10 -83.09 37.99 0.57 Allowed 'General case' 0 C--O 1.242 0.676 0 CA-C-O 121.018 0.437 . . . . 0.0 110.728 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.818 HD22 HD22 ' B' ' 157' ' ' LEU . 0.4 OUTLIER -121.4 135.35 55.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.404 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.06 124.23 38.79 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 120.5 0.191 . . . . 0.0 110.852 -177.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.74 129.61 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.969 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -139.43 134.88 32.97 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.686 0.279 . . . . 0.0 110.759 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 5.2 m -102.94 108.0 19.02 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.801 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.568 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 21.5 ttmt -104.32 87.68 2.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.822 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 3.4 t70 30.66 67.35 0.12 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.655 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.41 -22.45 23.7 Favored Glycine 0 N--CA 1.466 0.693 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.568 ' HB ' ' HB3' ' B' ' 114' ' ' LYS . 8.8 t -87.55 109.77 19.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 56.1 t -96.65 127.05 49.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.974 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.571 ' CD ' ' HZ2' ' B' ' 141' ' ' LYS . 74.4 mt-10 -139.36 146.96 40.88 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.275 -178.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.57 HD12 ' O ' ' B' ' 119' ' ' GLU . 1.3 mp -121.46 131.23 73.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.434 177.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -104.01 120.38 40.93 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.669 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -140.42 129.2 4.1 Favored Glycine 0 N--CA 1.466 0.66 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' LYS . . . . . 0.437 ' NZ ' ' OE1' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -150.16 157.78 43.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -178.369 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 124' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' B' ' 126' ' ' GLU . 8.8 t-80 -145.02 127.91 16.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -56.01 -10.08 0.74 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -176.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' GLU . . . . . 0.61 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 0.5 OUTLIER 175.31 145.62 0.07 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 111.571 179.074 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 127' ' ' ARG . . . . . 0.596 ' NH1' ' HA ' ' B' ' 135' ' ' SER . 26.1 mtt85 -135.19 107.57 7.3 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.658 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -65.73 130.52 43.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.527 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.29 149.0 28.87 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -62.26 -31.46 72.03 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -92.27 25.17 3.03 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.488 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' GLY . . . . . 0.703 ' HA3' ' CE1' ' A' ' 142' ' ' TYR . . . 122.77 165.01 12.28 Favored Glycine 0 N--CA 1.429 -1.821 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.152 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -94.69 112.74 24.48 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' ILE . . . . . 0.523 HD11 ' NH1' ' B' ' 136' ' ' ARG . 0.0 OUTLIER -115.03 113.9 44.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.977 0.418 . . . . 0.0 111.864 -174.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 135' ' ' SER . . . . . 0.61 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.8 OUTLIER -116.71 152.32 34.54 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.876 175.661 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 136' ' ' ARG . . . . . 0.523 ' NH1' HD11 ' B' ' 134' ' ' ILE . 2.4 ptt180 -155.67 145.55 21.39 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.759 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 28.5 p -92.5 129.81 38.33 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' PHE . . . . . 0.442 ' CE2' ' NH1' ' A' ' 136' ' ' ARG . 15.1 m-85 -98.21 137.72 36.54 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -177.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.83 101.07 3.6 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.172 176.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 140' ' ' ARG . . . . . 0.569 HH22 ' HB2' ' A' ' 131' ' ' HIS . 0.1 OUTLIER -98.91 150.2 22.16 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 173.365 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 141' ' ' LYS . . . . . 0.571 ' HZ2' ' CD ' ' B' ' 119' ' ' GLU . 13.6 ttmm -140.42 122.67 15.87 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.486 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 142' ' ' TYR . . . . . 0.692 ' CE1' HD21 ' B' ' 99' ' ' LEU . 0.5 OUTLIER -114.92 99.0 7.15 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.484 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.0 OUTLIER -88.59 89.59 8.05 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.542 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.54 93.3 19.03 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.724 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' PRO . . . . . 0.589 ' CD ' ' HD3' ' B' ' 146' ' ' PRO . 16.5 Cg_exo -67.24 -54.97 0.33 Allowed 'Trans proline' 0 C--N 1.287 -2.667 0 C-N-CA 121.664 1.576 . . . . 0.0 112.345 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 146' ' ' PRO . . . . . 0.589 ' HD3' ' CD ' ' B' ' 145' ' ' PRO . 56.8 Cg_endo -98.72 89.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.103 2.535 . . . . 0.0 112.106 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.76 -20.55 1.29 Allowed Glycine 0 C--O 1.223 -0.534 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.669 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.26 122.92 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 117.579 0.69 . . . . 0.0 110.813 177.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 149' ' ' ASP . . . . . 0.448 ' OD1' ' HG3' ' B' ' 152' ' ' GLN . 12.0 t70 -93.58 148.08 34.81 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.05 -24.11 4.91 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.651 1.568 . . . . 0.0 112.756 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' THR . . . . . 0.436 ' N ' ' OD1' ' B' ' 149' ' ' ASP . 0.2 OUTLIER -91.36 -35.36 14.45 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.354 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 152' ' ' GLN . . . . . 0.677 ' O ' ' HB1' ' B' ' 167' ' ' ALA . 0.6 OUTLIER -103.53 14.49 31.15 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -175.342 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 39.1 t -107.9 120.46 59.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.438 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.83 -172.94 2.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.763 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.67 138.28 18.73 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.491 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.57 144.68 35.94 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.331 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 157' ' ' LEU . . . . . 0.818 HD22 HD22 ' B' ' 109' ' ' LEU . 15.4 tp -136.44 118.47 15.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.814 0.34 . . . . 0.0 110.249 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.446 ' N ' HD12 ' B' ' 157' ' ' LEU . 1.6 t -105.29 149.2 37.44 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 159' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -41.77 -26.39 0.43 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.64 2.227 . . . . 0.0 111.828 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 160' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' B' ' 160' ' ' GLU . 29.2 mp0 -66.04 -8.02 20.76 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.685 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 161' ' ' GLY . . . . . 0.594 ' O ' ' ND2' ' B' ' 102' ' ' ASN . . . 76.57 27.41 61.24 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 28.8 p -87.58 99.84 12.35 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.609 HD13 ' C ' ' B' ' 163' ' ' LEU . 1.3 tm? -96.35 92.86 6.54 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.31 127.0 41.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.452 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.574 ' O ' HG23 ' B' ' 165' ' ' VAL . 2.6 m -105.45 99.09 7.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.08 134.82 54.54 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.357 -176.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 167' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' B' ' 152' ' ' GLN . . . -170.46 160.99 6.22 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.28 0.562 . . . . 0.0 111.889 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 168' ' ' PRO . . . . . 0.466 ' HD2' ' HB1' ' B' ' 167' ' ' ALA . 57.0 Cg_endo -84.95 59.95 5.62 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 123.262 2.641 . . . . 0.0 109.237 176.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 169' ' ' MET . . . . . 0.634 ' O ' ' N ' ' B' ' 171' ' ' LYS . 0.2 OUTLIER -65.97 167.25 12.3 Favored Pre-proline 0 C--N 1.302 -1.477 0 CA-C-N 113.457 -1.701 . . . . 0.0 111.011 -176.418 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 170' ' ' PRO . . . . . 0.561 ' HB2' ' HB3' ' B' ' 173' ' ' ALA . 31.7 Cg_exo -51.39 63.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 123.415 2.743 . . . . 0.0 112.579 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 171' ' ' LYS . . . . . 0.634 ' N ' ' O ' ' B' ' 169' ' ' MET . 7.8 tptp -44.67 -52.92 7.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.736 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -51.4 -46.42 62.85 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.26 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' B' ' 170' ' ' PRO . . . -59.09 -36.61 75.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.69 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 174' ' ' THR . . . . . 0.555 ' OG1' ' NZ ' ' B' ' 171' ' ' LYS . 75.8 p -75.62 0.66 16.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.588 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 175' ' ' GLN . . . . . 0.583 ' O ' ' NZ ' ' B' ' 171' ' ' LYS . 43.3 mt-30 41.57 -138.75 0.15 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.01 -178.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.209 -1.038 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.637 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 5.0 ttm . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 81' ' ' LEU . 32.2 mt-30 -142.27 -163.72 1.66 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.697 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 80' ' ' GLN . 51.1 mt -28.57 -84.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.208 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER -134.02 31.72 3.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.172 -178.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.49 56.07 0.08 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.141 0.496 . . . . 0.0 110.36 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 86' ' ' SER . . . -178.27 173.58 46.01 Favored Glycine 0 C--N 1.316 -0.569 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 85' ' ' VAL . 29.0 m -36.19 91.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.961 0.41 . . . . 0.0 111.391 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 84' ' ' GLY . 0.9 OUTLIER -86.23 -18.71 31.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.291 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -4.96 26.9 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.559 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 88' ' ' ILE . 7.4 tt -34.9 101.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.31 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.576 ' NH2' ' O ' ' A' ' 91' ' ' THR . 0.6 OUTLIER 41.26 34.24 0.31 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.432 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' A' ' 91' ' ' THR . 0.1 OUTLIER -46.88 -28.55 1.62 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.015 0.436 . . . . 0.0 110.383 179.309 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.627 ' N ' ' ND1' ' A' ' 90' ' ' HIS . 0.2 OUTLIER -52.18 132.8 33.83 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.837 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -150.51 134.2 16.62 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -104.32 161.97 13.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.947 0.403 . . . . 0.0 110.566 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.18 144.52 47.04 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.466 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.69 ' NE1' HG22 ' A' ' 97' ' ' VAL . 54.1 t-105 -105.04 168.43 9.06 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.482 ' N ' ' CG ' ' A' ' 95' ' ' TRP . 1.7 ttm105 -150.51 108.72 3.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.368 -176.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.69 HG22 ' NE1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -116.44 150.06 18.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 174.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 14.7 m -131.52 157.64 43.03 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.573 HD22 ' HB ' ' A' ' 120' ' ' ILE . 0.7 OUTLIER -133.23 89.98 2.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.155 176.43 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -92.92 94.54 8.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.437 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -153.31 -23.51 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.696 ' CB ' HD13 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -83.17 9.28 10.89 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.195 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.608 ' N ' ' HA3' ' A' ' 161' ' ' GLY . 22.9 p-80 -48.53 -35.38 13.14 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.113 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -80.96 -3.4 51.45 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.832 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.491 ' C ' HD22 ' A' ' 102' ' ' ASN . . . -146.73 79.33 10.3 Favored Pre-proline 0 CA--C 1.512 -0.518 0 CA-C-O 120.772 0.32 . . . . 0.0 111.482 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.51 -39.81 11.67 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.513 2.142 . . . . 0.0 111.486 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -101.52 -31.66 10.77 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.978 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.404 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 22.6 mt-10 -79.28 46.17 0.7 Allowed 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.164 0.506 . . . . 0.0 110.05 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.696 HD13 ' CB ' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -133.21 135.66 45.18 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.471 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.7 116.85 17.85 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.153 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.93 124.95 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.517 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -127.97 136.76 51.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.999 0.428 . . . . 0.0 111.369 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.66 116.07 31.29 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.602 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 2.5 ttpt -111.41 80.76 1.35 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.356 0.598 . . . . 0.0 109.753 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 33.84 68.19 0.18 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.176 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.02 -23.59 25.8 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.611 HG22 HG23 ' A' ' 143' ' ' THR . 4.9 t -87.12 114.19 25.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.9 t -102.04 120.17 51.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.837 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.597 ' CD ' ' HD3' ' A' ' 141' ' ' LYS . 26.8 mt-10 -132.78 145.59 51.12 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.139 0.495 . . . . 0.0 110.948 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.573 ' HB ' HD22 ' A' ' 99' ' ' LEU . 1.1 mp -113.35 122.94 68.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.016 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.517 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -101.55 115.5 30.66 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.0 128.09 2.6 Favored Glycine 0 C--O 1.239 0.424 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.138 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.46 124.18 9.17 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.513 ' CD2' ' HG3' ' A' ' 127' ' ' ARG . 0.9 OUTLIER -91.04 151.99 20.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.045 0.45 . . . . 0.0 111.515 -177.708 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.559 ' O ' ' C ' ' A' ' 126' ' ' GLU . 6.1 tp10 -75.61 134.64 40.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.501 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.559 ' C ' ' O ' ' A' ' 125' ' ' GLU . 9.4 tt0 -2.65 97.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.808 0.693 . . . . 0.0 111.74 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.513 ' HG3' ' CD2' ' A' ' 124' ' ' HIS . 1.2 mtm-85 -92.27 134.4 34.93 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.135 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -78.32 129.81 35.46 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.21 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -131.24 167.5 19.09 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 130' ' ' GLU . 0.4 OUTLIER -69.03 -28.58 66.69 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -173.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.413 ' O ' ' OH ' ' B' ' 142' ' ' TYR . 75.1 m-70 -118.94 41.09 3.13 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.251 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.47 160.27 9.34 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.278 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' B' ' 141' ' ' LYS . 30.6 m-85 -95.21 121.1 36.51 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 172.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.99 126.2 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -169.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.525 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -126.38 154.28 43.79 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.669 174.403 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.44 179.34 7.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.266 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.6 p -139.75 127.1 21.37 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -100.86 136.19 41.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.95 101.54 6.36 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.505 174.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.583 ' HA ' ' NH1' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -101.69 141.36 34.67 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.718 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.597 ' HD3' ' CD ' ' A' ' 119' ' ' GLU . 2.7 ttpp -140.85 125.25 17.64 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.315 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.492 ' HE1' ' HE ' ' A' ' 140' ' ' ARG . 57.9 m-85 -120.44 99.13 6.38 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.611 HG23 HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -89.75 88.92 7.55 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.4 mp -112.43 92.74 20.24 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.634 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 17.0 Cg_exo -65.9 -58.36 0.19 Allowed 'Trans proline' 0 C--N 1.286 -2.753 0 C-N-CA 121.89 1.726 . . . . 0.0 113.497 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.634 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 5.7 Cg_endo -90.5 -13.31 2.34 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 122.774 2.316 . . . . 0.0 114.159 -175.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -104.38 3.0 43.17 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.722 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.47 136.09 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 118.024 0.912 . . . . 0.0 111.005 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 29.0 t70 -96.38 141.97 23.88 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.954 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 2.8 Cg_endo -82.69 -22.32 4.53 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.876 1.717 . . . . 0.0 112.547 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.84 -39.43 12.34 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.233 -174.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.65 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 9.7 mt-30 -106.33 22.63 15.45 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 19.9 t -109.53 109.39 28.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.977 0.418 . . . . 0.0 110.094 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -169.58 1.6 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.02 139.38 14.76 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.756 -0.778 . . . . 0.0 112.431 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.59 130.51 53.62 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.418 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.656 HD22 HD22 ' A' ' 109' ' ' LEU . 40.0 tp -123.75 109.2 13.37 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.989 0.423 . . . . 0.0 110.355 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.416 ' HB3' HG22 ' A' ' 162' ' ' THR . 0.2 OUTLIER -91.36 147.39 35.33 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.237 178.759 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 161' ' ' GLY . 87.4 Cg_exo -40.35 -38.52 2.37 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.599 2.199 . . . . 0.0 111.612 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -70.03 29.98 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.742 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.621 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 43.93 34.62 3.05 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.06 -0.518 . . . . 0.0 113.039 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 162' ' ' THR . 10.1 t -100.47 99.59 10.23 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.3 0.571 . . . . 0.0 109.598 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.611 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.9 tm? -91.12 106.16 18.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.803 -176.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.54 124.38 44.66 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 165' ' ' VAL . 3.1 m -105.54 100.59 10.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -114.28 139.66 49.24 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.06 -176.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.65 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 178.17 166.68 0.58 Allowed Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.999 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.634 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 60.6 Cg_endo -81.39 108.75 2.0 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.074 2.516 . . . . 0.0 110.13 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.599 ' SD ' ' HB3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -92.89 147.76 34.59 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.825 -176.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.53 ' O ' HD12 ' A' ' 172' ' ' LEU . 21.6 Cg_endo -64.88 -1.39 4.15 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.713 2.275 . . . . 0.0 111.693 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 170' ' ' PRO . 5.0 mmtp 78.73 -104.57 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.098 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.53 HD12 ' O ' ' A' ' 170' ' ' PRO . 6.9 mp 51.14 34.11 10.54 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.004 0.43 . . . . 0.0 110.119 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.93 117.53 15.82 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.077 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 176' ' ' SER . 0.0 OUTLIER -54.71 -34.1 61.93 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.702 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 62.46 -65.83 0.09 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.751 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 174' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.208 -1.111 0 CA-C-O 118.375 -0.822 . . . . 0.0 110.48 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' MET . . . . . 0.544 ' N ' ' OE1' ' B' ' 80' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' B' ' 79' ' ' MET . 1.6 mm100 -77.8 35.89 0.21 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.008 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.481 ' HB2' ' SD ' ' B' ' 79' ' ' MET . 0.1 OUTLIER -59.36 125.16 22.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.157 179.526 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.91 80.17 0.2 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.215 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -43.98 -27.32 0.35 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.595 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -145.95 -66.22 0.01 OUTLIER Glycine 0 C--N 1.321 -0.286 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 5.3 m -123.16 167.79 16.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -47.22 114.56 0.89 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -37.56 -43.54 0.61 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.475 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 8.6 pt -142.58 149.24 19.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.446 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.423 ' H ' ' HG3' ' B' ' 89' ' ' ARG . 0.0 OUTLIER -97.84 144.61 27.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 90' ' ' HIS . . . . . 0.526 ' CG ' ' H ' ' B' ' 91' ' ' THR . 8.0 t-80 -106.94 -146.56 0.4 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.536 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.646 ' CB ' ' HZ1' ' B' ' 171' ' ' LYS . 0.6 OUTLIER -60.51 77.39 0.01 OUTLIER 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.128 0.489 . . . . 0.0 110.438 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 92' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' B' ' 90' ' ' HIS . . . -155.99 -53.41 0.08 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.832 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 t70 53.44 -132.02 2.0 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.557 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -121.82 105.3 10.24 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.33 118.09 14.79 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -114.21 113.39 24.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.829 -175.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.7 t -119.25 156.86 21.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 3.7 m -129.64 134.49 47.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -174.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.452 HD22 ' HB ' ' B' ' 120' ' ' ILE . 0.4 OUTLIER -103.16 97.23 7.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.632 175.206 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ASP . . . . . 0.537 ' C ' HG22 ' B' ' 101' ' ' VAL . 18.9 p-10 -88.75 103.25 15.79 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.677 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' VAL . . . . . 0.537 HG22 ' C ' ' B' ' 100' ' ' ASP . 0.1 OUTLIER -170.46 -39.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-O 121.833 0.825 . . . . 0.0 109.417 179.036 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 102' ' ' ASN . . . . . 0.624 HD21 ' HA ' ' B' ' 106' ' ' PRO . 0.2 OUTLIER -38.94 -26.45 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.148 -177.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -53.18 -23.76 9.19 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 119.592 -0.843 . . . . 0.0 108.927 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.546 ' HB3' ' CZ ' ' B' ' 136' ' ' ARG . 27.3 m-85 -71.81 -13.13 61.6 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.715 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' B' ' 109' ' ' LEU . . . -174.61 94.26 0.3 Allowed Pre-proline 0 C--O 1.223 -0.336 0 O-C-N 123.308 0.38 . . . . 0.0 111.708 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.624 ' HA ' HD21 ' B' ' 102' ' ' ASN . 41.3 Cg_endo -71.57 -44.39 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.493 2.128 . . . . 0.0 111.833 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -30.75 22.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.948 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' B' ' 123' ' ' LYS . 16.7 mt-10 -102.19 56.73 0.8 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.081 0.467 . . . . 0.0 110.985 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' LEU . . . . . 0.6 HD22 HD22 ' B' ' 157' ' ' LEU . 0.4 OUTLIER -127.9 145.58 50.91 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.43 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -141.31 116.72 10.14 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.916 -177.356 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.03 123.01 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.786 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' LYS . . . . . 0.453 ' NZ ' ' OG1' ' B' ' 121' ' ' THR . 6.1 pttm -130.9 119.69 22.53 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.237 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.35 120.14 23.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' LYS . . . . . 0.477 ' NZ ' ' OE1' ' B' ' 119' ' ' GLU . 0.8 OUTLIER -121.26 82.49 1.94 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.537 -174.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 32.8 t70 32.56 68.91 0.13 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.345 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' GLY . . . . . 0.462 ' HA2' HG12 ' B' ' 148' ' ' VAL . . . 86.52 -22.61 12.58 Favored Glycine 0 C--N 1.315 -0.598 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' VAL . . . . . 0.662 HG22 HG23 ' B' ' 143' ' ' THR . 6.4 t -87.42 120.71 37.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 72.5 t -107.7 108.44 25.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.319 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' GLU . . . . . 0.532 ' O ' HD12 ' B' ' 120' ' ' ILE . 2.9 mt-10 -124.5 146.77 48.78 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.966 0.412 . . . . 0.0 110.612 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ILE . . . . . 0.532 HD12 ' O ' ' B' ' 119' ' ' GLU . 1.3 mp -119.96 117.29 53.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.452 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' THR . . . . . 0.453 ' OG1' ' NZ ' ' B' ' 112' ' ' LYS . 0.2 OUTLIER -89.81 121.48 31.99 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.755 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -144.33 101.17 0.25 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -131.0 143.32 50.64 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.48 151.96 37.71 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.574 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' GLU . . . . . 0.467 ' O ' ' C ' ' B' ' 126' ' ' GLU . 4.0 mt-10 -91.17 126.84 36.37 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.642 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' GLU . . . . . 0.573 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 3.4 tt0 14.79 99.46 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' B' ' 134' ' ' ILE . 12.6 mtp180 -97.67 141.19 31.0 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.142 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 128' ' ' GLN . . . . . 0.48 ' HG2' ' N ' ' B' ' 129' ' ' ASP . 0.0 OUTLIER -86.74 136.91 32.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ASP . . . . . 0.522 ' CG ' ' N ' ' B' ' 130' ' ' GLU . 0.1 OUTLIER -133.45 169.26 17.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.845 174.658 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 130' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' B' ' 130' ' ' GLU . 0.0 OUTLIER -67.81 -31.98 72.21 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -174.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 131' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -111.29 20.24 17.51 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 147.08 178.25 22.24 Favored Glycine 0 C--N 1.307 -1.036 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.614 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -96.01 134.81 38.58 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' ILE . . . . . 0.519 HG23 ' O ' ' B' ' 134' ' ' ILE . 0.0 OUTLIER -145.97 116.41 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.886 0.375 . . . . 0.0 111.831 -175.831 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 135' ' ' SER . . . . . 0.573 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -132.81 156.66 46.72 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.055 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 136' ' ' ARG . . . . . 0.546 ' CZ ' ' HB3' ' B' ' 104' ' ' PHE . 0.0 OUTLIER -151.63 167.81 26.95 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.162 0.505 . . . . 0.0 111.932 -178.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 137' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' B' ' 123' ' ' LYS . 20.5 p -118.58 129.86 55.57 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.12 176.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -106.05 143.76 33.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.384 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.11 121.28 7.78 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.857 0.36 . . . . 0.0 111.493 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 140' ' ' ARG . . . . . 0.535 ' NH2' ' OH ' ' B' ' 142' ' ' TYR . 0.0 OUTLIER -118.02 144.57 45.45 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.023 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 141' ' ' LYS . . . . . 0.472 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 9.1 ttpp -133.01 124.66 28.11 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 123.136 0.272 . . . . 0.0 111.027 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 142' ' ' TYR . . . . . 0.535 ' OH ' ' NH2' ' B' ' 140' ' ' ARG . 3.1 m-85 -118.33 98.64 6.38 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.03 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 143' ' ' THR . . . . . 0.662 HG23 HG22 ' B' ' 117' ' ' VAL . 0.3 OUTLIER -90.42 100.88 13.64 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.016 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.43 96.72 16.87 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.073 -177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' B' ' 147' ' ' GLY . 36.8 Cg_exo -62.98 -41.92 26.56 Favored 'Trans proline' 0 C--N 1.286 -2.747 0 C-N-CA 123.223 2.615 . . . . 0.0 114.251 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 146' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 36.3 Cg_exo -43.23 -11.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.916 1.744 . . . . 0.0 112.304 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 147' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 109.11 44.13 1.12 Allowed Glycine 0 C--O 1.218 -0.87 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.209 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 148' ' ' VAL . . . . . 0.53 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -60.68 96.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 149' ' ' ASP . . . . . 0.509 ' CG ' ' HG3' ' B' ' 152' ' ' GLN . 10.3 t70 -50.66 129.16 26.92 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.183 -171.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 11.4 Cg_exo -71.16 -25.95 21.76 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.149 1.899 . . . . 0.0 113.053 -177.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.31 -49.87 6.29 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.363 0.602 . . . . 0.0 111.213 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 152' ' ' GLN . . . . . 0.509 ' HG3' ' CG ' ' B' ' 149' ' ' ASP . 6.0 mt-30 -79.57 10.59 3.76 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.582 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 153' ' ' VAL . . . . . 0.71 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 17.9 t -101.64 119.57 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.42 155.8 27.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 155' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' B' ' 164' ' ' THR . 1.2 m -132.99 132.77 42.29 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.399 -176.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 156' ' ' SER . . . . . 0.554 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.0 OUTLIER -108.47 145.17 35.08 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.477 178.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 157' ' ' LEU . . . . . 0.6 HD22 HD22 ' B' ' 109' ' ' LEU . 31.7 tp -130.96 128.42 40.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.336 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.479 ' O ' ' N ' ' B' ' 161' ' ' GLY . 0.6 OUTLIER -114.14 150.32 43.44 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.123 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 159' ' ' PRO . . . . . 0.538 ' C ' ' H ' ' B' ' 161' ' ' GLY . 87.3 Cg_exo -43.15 -34.14 4.05 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.782 2.321 . . . . 0.0 111.462 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.33 2.19 0.27 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.445 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 63.38 27.81 71.35 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.712 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 6.0 t -93.87 120.66 34.43 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 163' ' ' LEU . . . . . 0.627 HD13 ' C ' ' B' ' 163' ' ' LEU . 2.2 tm? -108.63 106.6 16.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.814 -176.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 164' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' B' ' 155' ' ' SER . 0.7 OUTLIER -95.5 127.99 42.0 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.106 -179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.546 ' O ' HG23 ' B' ' 165' ' ' VAL . 2.6 m -112.99 107.58 23.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -121.57 144.7 48.58 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.439 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' ALA . . . . . 0.71 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -168.61 152.7 5.74 Favored Pre-proline 0 C--O 1.235 0.29 0 C-N-CA 120.463 -0.495 . . . . 0.0 112.16 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -87.68 47.98 1.52 Allowed 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 123.364 2.709 . . . . 0.0 109.59 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' MET . . . . . 0.473 ' CB ' ' HD2' ' B' ' 170' ' ' PRO . 3.1 ptm -49.64 163.92 0.37 Allowed Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.631 -176.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 170' ' ' PRO . . . . . 0.568 ' CG ' ' O ' ' B' ' 147' ' ' GLY . 6.6 Cg_endo -47.21 128.42 14.29 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 124.008 3.139 . . . . 0.0 112.442 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 171' ' ' LYS . . . . . 0.646 ' HZ1' ' CB ' ' B' ' 91' ' ' THR . 2.4 tmtm? -69.05 55.4 0.09 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' B' ' 170' ' ' PRO . 0.3 OUTLIER -76.92 29.21 0.13 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.176 0.512 . . . . 0.0 110.199 179.418 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 173' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' B' ' 171' ' ' LYS . . . -77.54 45.51 0.49 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.192 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.12 132.02 50.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.192 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 175' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' B' ' 173' ' ' ALA . 8.7 mm-40 -77.84 109.84 12.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.199 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 176' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' B' ' 175' ' ' GLN . 1.6 m . . . . . 0 C--O 1.209 -1.045 0 CA-C-O 118.362 -0.828 . . . . 0.0 110.974 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.4 mmm-85 . . . . . 0 N--CA 1.469 0.485 0 CA-C-O 121.296 0.57 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.678 ' CZ3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -96.58 158.82 15.25 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.969 177.07 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -151.88 104.14 2.98 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.508 -177.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.678 HG21 ' CZ3' ' A' ' 95' ' ' TRP . 0.8 OUTLIER -121.14 152.46 24.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.133 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 4.4 m -122.45 140.81 52.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.579 HD22 ' HB ' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -117.49 63.92 0.74 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.31 174.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.15 108.27 3.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.617 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.626 HG11 ' CD1' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -159.36 -31.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 120.751 0.31 . . . . 0.0 110.94 176.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.973 ' HB3' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -56.55 5.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -177.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.472 ' H ' ' C ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -61.73 -30.98 71.13 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 118.824 -1.15 . . . . 0.0 108.284 176.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.491 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 14.9 m-85 -88.93 5.19 45.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.943 176.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.479 ' HB1' ' HB2' ' A' ' 108' ' ' GLU . . . -167.39 92.36 0.7 Allowed Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.9 -48.58 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.432 2.088 . . . . 0.0 111.159 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 109' ' ' LEU . 1.6 t70 -98.26 -31.9 11.83 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.479 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 54.7 mp0 -75.73 36.74 0.14 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.289 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.973 HD13 ' HB3' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -125.25 138.42 54.1 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.58 112.6 11.61 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.22 129.58 39.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.87 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.458 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.1 OUTLIER -136.52 125.2 23.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.934 0.397 . . . . 0.0 111.359 -179.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.0 m -108.18 115.0 29.31 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.3 91.77 3.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.888 0.375 . . . . 0.0 111.686 -176.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.7 t0 40.18 69.24 0.33 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.243 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.08 -17.61 16.66 Favored Glycine 0 C--N 1.312 -0.771 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.6 t -88.68 109.65 20.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.008 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.7 t -98.71 115.21 38.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.851 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.638 ' CD ' ' NZ ' ' A' ' 141' ' ' LYS . 0.3 OUTLIER -125.66 139.4 53.59 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.337 0.589 . . . . 0.0 110.711 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.579 ' HB ' HD22 ' A' ' 99' ' ' LEU . 1.2 mp -116.32 111.24 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.912 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.458 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -91.84 116.24 28.74 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.821 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.37 125.7 2.0 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.163 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 137' ' ' CYS . 0.0 OUTLIER -134.95 137.87 43.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 177.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' A' ' 104' ' ' PHE . 29.7 t60 -80.11 168.28 19.33 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.643 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.481 ' O ' ' C ' ' A' ' 126' ' ' GLU . 2.4 tp10 -113.41 131.85 55.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.315 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 125' ' ' GLU . 5.3 tt0 -19.3 99.8 0.02 OUTLIER 'General case' 0 C--N 1.349 0.548 0 O-C-N 123.563 0.539 . . . . 0.0 111.995 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.462 ' HB2' ' H ' ' A' ' 134' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.84 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.701 0 N-CA-C 112.654 -0.178 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 8.8 m-30 -94.97 109.42 21.44 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.462 ' H ' ' HB2' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -117.39 154.82 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -175.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.78 152.38 26.87 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.441 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.419 ' NH2' ' CE2' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -143.8 175.35 10.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.687 -177.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 32.0 p -137.68 133.86 34.73 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.626 ' CD1' HG11 ' A' ' 101' ' ' VAL . 1.6 m-85 -107.54 138.97 42.8 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.472 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.84 114.68 7.74 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.718 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.558 ' NH2' ' OH ' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -120.22 126.04 49.64 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.638 ' NZ ' ' CD ' ' A' ' 119' ' ' GLU . 2.0 ttmm -120.06 107.44 13.07 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 120.756 0.312 . . . . 0.0 111.091 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.558 ' OH ' ' NH2' ' A' ' 140' ' ' ARG . 4.2 m-30 -103.1 99.13 8.99 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.511 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.1 OUTLIER -87.56 88.93 7.81 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 mp -113.23 90.79 17.38 Favored Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.657 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 15.8 Cg_exo -67.93 -57.43 0.16 Allowed 'Trans proline' 0 C--N 1.287 -2.689 0 C-N-CA 122.164 1.91 . . . . 0.0 113.537 175.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.657 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 28.8 Cg_endo -98.45 43.65 0.09 OUTLIER 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.61 2.873 . . . . 0.0 112.413 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.33 -8.25 0.04 OUTLIER Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.137 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.549 ' CG2' ' CZ2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -138.37 127.09 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 117.4 0.6 . . . . 0.0 111.129 178.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.421 ' OD2' ' N ' ' A' ' 152' ' ' GLN . 13.7 t70 -87.89 138.49 31.15 Favored Pre-proline 0 N--CA 1.484 1.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.057 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -81.99 -21.77 5.54 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.016 1.811 . . . . 0.0 113.075 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.14 -37.92 13.07 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.421 ' N ' ' OD2' ' A' ' 149' ' ' ASP . 27.0 mt-30 -103.61 11.76 35.75 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 22.5 t -95.04 118.48 41.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.844 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.9 173.35 6.47 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.5 p -141.68 137.43 31.75 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.961 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.23 133.41 52.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.996 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.628 HD22 HD22 ' A' ' 109' ' ' LEU . 33.9 tp -131.1 136.99 48.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.097 0.475 . . . . 0.0 110.331 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.581 ' H ' HD12 ' A' ' 157' ' ' LEU . 1.8 t -123.71 146.56 50.76 Favored Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.825 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -40.01 -34.07 0.87 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.683 2.255 . . . . 0.0 111.676 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -62.29 -7.44 4.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.641 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.564 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . 76.31 33.61 48.31 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 112.22 -0.352 . . . . 0.0 112.22 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.2 t -100.63 116.74 33.26 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.579 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.4 tm? -110.56 99.86 8.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.543 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.68 127.6 40.76 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 121.343 -0.143 . . . . 0.0 110.714 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 165' ' ' VAL . 3.2 m -108.51 103.13 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.68 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 2.7 pp20? -114.34 147.58 38.9 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.786 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.68 ' HB2' ' O ' ' A' ' 166' ' ' GLU . . . 166.19 166.33 0.1 OUTLIER Pre-proline 0 CA--C 1.515 -0.371 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.785 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.663 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 84.1 Cg_endo -82.18 133.15 7.47 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 123.804 3.003 . . . . 0.0 109.665 173.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.442 ' SD ' ' N ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -128.69 146.92 62.18 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -174.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo . . . . . 0 N--CA 1.494 1.556 0 C-N-CA 123.461 2.774 . . . . 0.0 111.843 177.746 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . 0.601 HH12 ' CD ' ' B' ' 166' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.514 -0.431 0 CA-C-O 120.587 0.232 . . . . 0.0 110.923 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' TRP . . . . . 0.781 ' NE1' HG22 ' B' ' 97' ' ' VAL . 14.6 t-105 -114.16 155.49 25.97 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 39.8 ttt85 -134.96 98.74 4.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.239 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.781 HG22 ' NE1' ' B' ' 95' ' ' TRP . 0.2 OUTLIER -101.49 151.13 5.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 2.5 m -128.28 143.41 51.02 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.467 HD22 ' HB ' ' B' ' 120' ' ' ILE . 0.4 OUTLIER -119.3 137.15 53.88 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.297 174.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.563 ' C ' HG22 ' B' ' 101' ' ' VAL . 9.7 p-10 -122.89 116.16 23.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.373 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.563 HG22 ' C ' ' B' ' 100' ' ' ASP . 0.0 OUTLIER -171.37 -45.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 120.785 0.326 . . . . 0.0 111.663 178.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.88 ' HB3' HD13 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -53.38 -1.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -175.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' HIS . . . . . 0.467 ' CE1' ' N ' ' B' ' 101' ' ' VAL . 0.1 OUTLIER -62.13 -26.12 68.13 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 118.51 -1.276 . . . . 0.0 108.409 175.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -84.42 -13.0 53.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.798 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' B' ' 102' ' ' ASN . . . -164.66 97.81 0.88 Allowed Pre-proline 0 CA--C 1.516 -0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.154 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.07 -42.74 0.37 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.352 2.035 . . . . 0.0 111.039 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.83 -31.43 13.72 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.485 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 37.33 0.74 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.367 0.603 . . . . 0.0 110.444 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.88 HD13 ' HB3' ' B' ' 102' ' ' ASN . 0.5 OUTLIER -117.11 146.62 43.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.444 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 1.2 m -136.88 120.94 17.72 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.889 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.416 HG13 HD11 ' B' ' 120' ' ' ILE . 0.5 OUTLIER -99.77 121.47 50.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.541 ' NZ ' ' HB2' ' B' ' 119' ' ' GLU . 14.8 pttp -132.47 120.94 22.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.107 0.48 . . . . 0.0 111.333 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.7 117.56 28.66 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' LYS . . . . . 0.575 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 1.3 ttmt -116.11 91.34 3.57 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.898 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' B' ' 114' ' ' LYS . 0.9 OUTLIER 28.73 63.98 0.12 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.457 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.52 -21.14 42.54 Favored Glycine 0 C--N 1.316 -0.534 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.607 HG22 HG23 ' B' ' 143' ' ' THR . 2.8 t -87.65 119.41 35.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.301 177.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 75.4 t -106.51 114.85 46.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.541 ' HB2' ' NZ ' ' B' ' 112' ' ' LYS . 1.1 mt-10 -130.45 145.14 51.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.227 0.537 . . . . 0.0 110.62 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.595 HG23 HD11 ' B' ' 109' ' ' LEU . 1.3 mp -116.94 118.98 60.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.791 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -95.7 123.87 39.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.341 -178.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -147.22 118.49 1.02 Allowed Glycine 0 C--N 1.333 0.393 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.56 143.31 24.58 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -123.97 158.6 31.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.91 0.386 . . . . 0.0 111.409 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.517 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.9 OUTLIER -95.35 145.1 25.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.284 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . 0.629 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 0.6 OUTLIER -1.65 96.94 0.01 OUTLIER 'General case' 0 C--O 1.238 0.485 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 127' ' ' ARG . 1.5 mtm180 -97.97 143.78 28.18 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.037 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -71.76 157.62 37.58 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' B' ' 130' ' ' GLU . 0.8 OUTLIER -157.19 168.96 25.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.036 0.446 . . . . 0.0 110.774 -178.495 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . 0.521 ' N ' ' CG ' ' B' ' 129' ' ' ASP . 0.9 OUTLIER -63.42 -34.84 78.62 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.609 -177.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' HIS . . . . . 0.476 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 82.2 m-70 -121.54 39.9 3.73 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.006 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 142' ' ' TYR . . . 135.65 -162.67 24.94 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.434 -1.365 . . . . 0.0 112.475 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -114.15 120.72 41.49 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . 0.471 HG22 ' HB3' ' B' ' 129' ' ' ASP . 0.0 OUTLIER -134.63 121.84 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -172.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . 0.629 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -124.99 144.56 50.32 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 174.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -137.31 160.65 38.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.971 0.415 . . . . 0.0 111.296 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 22.4 p -120.37 133.47 55.43 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.99 137.05 52.45 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.816 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.75 123.41 15.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.044 177.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.45 124.18 42.3 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 174.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . 0.428 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 3.5 ttpp -117.15 127.1 53.79 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.716 0.293 . . . . 0.0 110.757 -175.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' TYR . . . . . 0.531 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 4.3 m-85 -116.71 97.98 6.28 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . 0.607 HG23 HG22 ' B' ' 117' ' ' VAL . 0.3 OUTLIER -92.19 98.22 11.39 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . 0.423 ' C ' ' HD2' ' B' ' 146' ' ' PRO . 7.1 mp -109.98 91.69 11.5 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' B' ' 143' ' ' THR . 28.0 Cg_exo -64.73 -36.68 39.84 Favored 'Trans proline' 0 C--N 1.287 -2.708 0 C-N-CA 122.909 2.406 . . . . 0.0 113.303 175.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 65.4 Cg_exo -43.08 -12.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 122.142 1.895 . . . . 0.0 111.962 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 112.0 48.09 0.68 Allowed Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.607 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' VAL . . . . . 0.508 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -68.39 97.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 174.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . 0.506 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 0.1 OUTLIER -51.81 125.7 30.72 Favored Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.396 -170.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 2.8 Cg_exo -76.35 -29.43 6.19 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.375 2.05 . . . . 0.0 112.012 -177.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.8 -28.59 61.72 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.243 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' GLN . . . . . 0.558 ' O ' ' HB1' ' B' ' 167' ' ' ALA . 2.1 mt-30 -113.19 12.64 19.07 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -173.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . 0.474 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 25.1 t -106.28 113.77 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.127 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.93 173.76 6.22 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.31 135.57 27.07 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.22 140.9 39.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.586 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . 0.665 HD22 HD22 ' B' ' 109' ' ' LEU . 13.0 tp -134.86 126.62 29.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.619 0.247 . . . . 0.0 110.775 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . 0.541 ' N ' HD12 ' B' ' 157' ' ' LEU . 1.5 t -114.0 148.9 40.98 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -40.97 -27.48 0.32 Allowed 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.982 2.455 . . . . 0.0 111.985 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . 0.515 ' H ' ' CD ' ' B' ' 160' ' ' GLU . 4.3 mp0 -63.58 -9.53 13.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.297 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' GLY . . . . . 0.52 ' O ' ' ND2' ' B' ' 102' ' ' ASN . . . 78.66 23.96 63.57 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 40.2 p -88.24 102.55 14.93 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.064 -0.568 . . . . 0.0 109.512 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.642 HD13 ' C ' ' B' ' 163' ' ' LEU . 1.7 tm? -99.91 95.1 6.66 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.68 126.51 35.01 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.676 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.599 ' O ' HG23 ' B' ' 165' ' ' VAL . 2.7 m -108.67 99.61 9.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 0.601 ' CD ' HH12 ' B' ' 94' ' ' ARG . 0.1 OUTLIER -108.26 135.63 49.25 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.988 -175.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' B' ' 152' ' ' GLN . . . 176.85 167.42 0.45 Allowed Pre-proline 0 N--CA 1.445 -0.697 0 C-N-CA 119.533 -0.867 . . . . 0.0 113.128 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' PRO . . . . . 0.451 ' HD2' ' HB1' ' B' ' 167' ' ' ALA . 1.3 Cg_endo -80.97 134.96 9.67 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 124.097 3.198 . . . . 0.0 109.467 174.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.699 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.378 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.423 ' NH2' ' OE2' ' A' ' 166' ' ' GLU . 4.3 mmm-85 . . . . . 0 C--O 1.236 0.386 0 CA-C-O 120.392 0.139 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.653 ' CZ3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -77.38 158.61 30.0 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 174.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.1 ttm-85 -152.84 99.21 2.41 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.146 -175.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.653 HG21 ' CZ3' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -119.83 157.83 21.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 176.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 27.7 m -131.4 144.55 51.28 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.878 HD22 HG13 ' A' ' 120' ' ' ILE . 1.4 mp -117.1 65.39 0.72 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.066 173.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.58 93.55 3.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.906 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' A' ' 103' ' ' HIS . 1.6 t -150.52 -43.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 121.14 0.495 . . . . 0.0 110.967 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.56 ' CG ' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -54.47 13.6 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -175.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.555 ' H ' ' C ' ' A' ' 101' ' ' VAL . 8.3 t-160 -49.72 -21.24 1.01 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.874 0.369 . . . . 0.0 110.453 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -101.98 1.67 36.93 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.821 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -141.93 89.21 8.99 Favored Pre-proline 0 CA--C 1.517 -0.313 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.755 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.5 -41.66 0.79 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.467 2.111 . . . . 0.0 111.456 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.429 ' C ' ' H ' ' A' ' 109' ' ' LEU . 14.3 t70 -105.22 -31.93 8.88 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.071 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -80.32 40.8 0.5 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.451 0.644 . . . . 0.0 110.441 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.85 HD22 HD22 ' A' ' 157' ' ' LEU . 0.7 OUTLIER -124.7 141.61 51.98 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.471 176.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.52 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -141.18 115.72 9.54 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.772 0.32 . . . . 0.0 110.819 -178.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.0 t -92.37 131.52 39.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.405 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.39 132.46 31.48 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.527 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.1 m -107.5 115.97 31.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.133 178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.441 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -117.74 79.25 1.33 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.05 0.452 . . . . 0.0 111.085 -177.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.8 t70 45.14 69.55 0.43 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.083 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.46 -22.25 14.06 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.5 HG22 HG23 ' A' ' 143' ' ' THR . 21.6 t -87.1 113.16 24.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 65.2 t -102.28 112.79 36.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 141' ' ' LYS . 42.4 mt-10 -125.93 149.04 49.04 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.283 0.563 . . . . 0.0 111.095 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.878 HG13 HD22 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -122.47 143.13 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.218 178.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -121.31 106.79 11.8 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.095 -178.262 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -138.51 128.77 4.26 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.32 128.83 11.41 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.702 0.401 . . . . 0.0 110.362 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.453 ' CD2' ' HA ' ' A' ' 135' ' ' SER . 1.4 p-80 -100.0 137.16 38.83 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 41.4 mt-10 -60.82 -27.48 68.09 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -174.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 0.8 OUTLIER 172.52 120.76 0.02 OUTLIER 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.329 0.513 . . . . 0.0 111.837 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.739 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.844 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.233 175.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.65 ' HA3' ' CE1' ' B' ' 142' ' ' TYR . . . . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 114.295 0.478 . . . . 0.0 114.295 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -95.07 109.84 21.84 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.677 HD12 ' NH1' ' B' ' 140' ' ' ARG . 0.0 OUTLIER -120.66 157.19 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -172.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.453 ' HA ' ' CD2' ' A' ' 124' ' ' HIS . 3.6 t -155.4 154.1 31.42 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.773 173.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.477 ' NH1' ' CZ ' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -147.0 174.74 11.25 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.336 -179.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 25.0 p -128.93 125.47 37.57 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -95.8 128.96 43.13 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.99 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.29 105.84 8.17 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.304 176.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.586 ' HG3' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -101.08 149.6 23.79 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.316 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.523 ' NZ ' ' OE1' ' B' ' 126' ' ' GLU . 1.6 ttpt -149.91 102.58 3.14 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.068 0.461 . . . . 0.0 110.506 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.56 ' OH ' ' NH1' ' A' ' 140' ' ' ARG . 10.6 m-85 -97.57 100.66 12.08 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.437 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.5 HG23 HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -88.51 89.37 7.96 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.192 0.52 . . . . 0.0 109.784 179.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.92 92.18 29.42 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.625 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 15.1 Cg_exo -68.02 -58.31 0.13 Allowed 'Trans proline' 0 C--N 1.285 -2.776 0 C-N-CA 122.141 1.894 . . . . 0.0 113.965 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.625 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 48.0 Cg_endo -100.51 51.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 123.406 2.737 . . . . 0.0 112.781 -175.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.67 -13.38 0.02 OUTLIER Glycine 0 N--CA 1.463 0.454 0 C-N-CA 120.237 -0.983 . . . . 0.0 112.269 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.629 HG21 ' CH2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -128.64 127.3 66.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.42 0.61 . . . . 0.0 110.861 178.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 18.8 t70 -83.5 140.75 41.63 Favored Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.557 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 3.0 Cg_exo -82.17 -25.04 3.53 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.18 1.92 . . . . 0.0 112.545 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.97 -36.68 13.29 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -175.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.763 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 8.9 mt-30 -109.29 31.84 5.43 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -173.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.41 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 39.5 t -115.47 124.88 72.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.716 177.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.69 -178.42 4.14 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.71 140.88 30.23 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.048 -0.661 . . . . 0.0 112.38 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -104.98 131.67 52.19 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.242 176.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.85 HD22 HD22 ' A' ' 109' ' ' LEU . 26.1 tp -129.87 125.52 35.81 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.021 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.587 ' HB3' ' OG1' ' A' ' 162' ' ' THR . 0.0 OUTLIER -106.04 162.23 20.37 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.4 -9.55 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.211 1.941 . . . . 0.0 110.786 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 158' ' ' SER . 3.6 mp0 -87.13 0.37 55.39 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.519 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.53 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . 68.52 15.5 68.45 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -175.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.587 ' OG1' ' HB3' ' A' ' 158' ' ' SER . 3.0 p -74.0 99.25 3.24 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.616 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.7 tm? -102.08 92.12 4.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.871 -176.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.98 125.9 35.18 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.28 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 165' ' ' VAL . 5.3 m -103.3 103.03 14.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.595 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -119.41 148.72 42.9 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.12 -176.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.763 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 170.2 167.32 0.19 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.232 0.539 . . . . 0.0 112.138 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.568 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 60.9 Cg_endo -89.67 109.12 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.508 2.805 . . . . 0.0 110.065 176.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.3 169.91 14.89 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.136 -177.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo . . . . . 0 N--CA 1.499 1.814 0 C-N-CA 123.281 2.654 . . . . 0.0 112.675 -178.196 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . 0.516 ' NH1' ' OE1' ' B' ' 166' ' ' GLU . 8.4 mmt85 . . . . . 0 N--CA 1.466 0.329 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' TRP . . . . . 0.499 ' O ' ' HA ' ' B' ' 166' ' ' GLU . 0.0 OUTLIER -72.48 145.85 47.26 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.036 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.415 ' HD3' HH11 ' B' ' 96' ' ' ARG . 11.2 ttm180 -133.84 109.05 8.82 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.387 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.14 156.23 18.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 3.3 m -134.2 149.89 51.03 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -174.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.709 HD22 ' CG1' ' B' ' 120' ' ' ILE . 0.5 OUTLIER -122.41 96.09 4.9 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.334 174.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.476 ' CG ' ' HE2' ' B' ' 103' ' ' HIS . 18.3 t70 -97.18 93.6 6.64 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.277 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.45 HG11 ' CE2' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -162.92 6.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-O 120.858 0.361 . . . . 0.0 111.103 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.841 ' HB2' HD13 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -90.46 -10.08 45.06 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -173.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' HIS . . . . . 0.476 ' HE2' ' CG ' ' B' ' 100' ' ' ASP . 0.8 OUTLIER -42.73 -29.01 0.27 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.611 ' HB2' ' CE1' ' B' ' 124' ' ' HIS . 59.6 m-85 -101.25 25.35 8.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -170.28 93.75 0.48 Allowed Pre-proline 0 C--O 1.223 -0.297 0 CA-C-O 120.673 0.273 . . . . 0.0 111.633 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.6 -60.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.436 2.091 . . . . 0.0 111.558 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' B' ' 109' ' ' LEU . 19.7 t70 -91.74 -30.98 15.96 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.945 0.403 . . . . 0.0 110.458 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -73.68 32.9 0.08 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.376 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.841 HD13 ' HB2' ' B' ' 102' ' ' ASN . 0.4 OUTLIER -128.54 128.71 44.82 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.543 177.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.4 130.15 50.15 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.974 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.566 HG13 ' CD1' ' B' ' 120' ' ' ILE . 1.9 t -105.09 114.08 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.02 134.46 54.84 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.518 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.02 115.46 29.01 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.535 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' LYS . . . . . 0.543 ' NZ ' ' OE2' ' B' ' 119' ' ' GLU . 0.0 OUTLIER -113.66 -171.43 1.89 Allowed 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -64.53 70.25 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' B' ' 114' ' ' LYS . . . 78.97 -8.32 45.32 Favored Glycine 0 CA--C 1.498 -1.008 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.52 HG22 HG23 ' B' ' 143' ' ' THR . 2.0 t -88.45 112.23 23.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.424 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 78.4 t -97.09 110.61 25.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.543 ' OE2' ' NZ ' ' B' ' 114' ' ' LYS . 29.5 mt-10 -126.76 117.36 22.52 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.168 0.509 . . . . 0.0 111.448 -176.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.709 ' CG1' HD22 ' B' ' 99' ' ' LEU . 6.1 mm -88.25 135.61 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.209 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.9 OUTLIER -115.7 111.51 20.7 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.445 -178.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.28 132.33 5.28 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -135.66 128.63 31.41 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . 0.611 ' CE1' ' HB2' ' B' ' 104' ' ' PHE . 28.3 m-70 -91.66 140.73 29.43 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.554 -177.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.5 OUTLIER -87.96 143.96 26.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.924 -178.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . 0.523 ' OE1' ' NZ ' ' A' ' 141' ' ' LYS . 2.5 tt0 -17.46 102.21 0.02 OUTLIER 'General case' 0 C--N 1.351 0.632 0 O-C-N 123.447 0.467 . . . . 0.0 112.068 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' ARG . . . . . 0.406 ' NH1' ' CE1' ' B' ' 104' ' ' PHE . 0.0 OUTLIER -94.86 149.98 20.67 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.055 -179.279 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -97.02 114.18 25.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.748 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.91 166.51 23.14 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -57.84 -26.9 62.67 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.955 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' HIS . . . . . 0.533 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 60.4 m-70 -80.07 14.31 1.91 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.652 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.78 -138.99 14.2 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -100.26 147.8 25.35 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . 0.535 HG23 ' O ' ' B' ' 134' ' ' ILE . 0.0 OUTLIER -156.04 117.54 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -175.244 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -131.04 153.3 49.42 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . 0.415 ' NH1' HD11 ' B' ' 134' ' ' ILE . 2.0 ptt180 -155.91 156.99 35.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.043 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 28.1 p -100.71 136.83 39.96 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . 0.477 ' CZ ' ' NH1' ' A' ' 136' ' ' ARG . 0.6 OUTLIER -114.64 123.51 49.49 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.6 118.2 20.66 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.281 0.563 . . . . 0.0 110.893 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . 0.677 ' NH1' HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -115.88 121.51 42.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . 0.49 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 3.6 ttpp -112.85 116.34 29.88 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 123.244 0.34 . . . . 0.0 110.958 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' TYR . . . . . 0.65 ' CE1' ' HA3' ' A' ' 132' ' ' GLY . 5.3 m-30 -107.56 97.54 7.26 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . 0.594 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.2 OUTLIER -90.77 96.67 10.76 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 175.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . 0.479 ' C ' ' HD2' ' B' ' 146' ' ' PRO . 7.0 mp -108.44 94.46 13.71 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.821 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . 0.598 ' N ' ' HD2' ' B' ' 146' ' ' PRO . 24.0 Cg_exo -66.33 -34.42 35.21 Favored 'Trans proline' 0 C--N 1.287 -2.704 0 C-N-CA 122.636 2.224 . . . . 0.0 113.316 175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' B' ' 145' ' ' PRO . 27.7 Cg_exo -43.76 -10.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.991 1.794 . . . . 0.0 112.293 -178.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 111.36 44.65 0.9 Allowed Glycine 0 C--N 1.339 0.729 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.69 174.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' VAL . . . . . 0.498 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -68.51 101.83 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 175.141 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . 0.501 ' O ' HG23 ' B' ' 153' ' ' VAL . 13.5 t70 -52.31 126.4 36.97 Favored Pre-proline 0 C--O 1.221 -0.431 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.07 -172.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 5.1 Cg_exo -79.34 -18.98 10.67 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.11 1.873 . . . . 0.0 112.098 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.57 -38.25 12.61 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.558 -178.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' GLN . . . . . 0.453 ' N ' ' OD1' ' B' ' 149' ' ' ASP . 14.4 mt-30 -100.83 17.52 21.89 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . 0.501 HG23 ' O ' ' B' ' 149' ' ' ASP . 49.8 t -108.95 91.11 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.689 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.68 -166.08 1.51 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' B' ' 164' ' ' THR . 0.4 OUTLIER -163.57 142.54 8.08 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.751 -179.101 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . 0.6 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.0 OUTLIER -111.81 144.63 40.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.028 178.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . 0.624 HD22 HD22 ' B' ' 109' ' ' LEU . 42.1 tp -130.76 117.09 18.89 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . 0.403 ' HB3' HG22 ' B' ' 162' ' ' THR . 0.3 OUTLIER -103.57 152.01 38.78 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.813 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' PRO . . . . . 0.613 ' C ' ' H ' ' B' ' 161' ' ' GLY . 94.5 Cg_exo -44.11 -32.82 5.12 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.45 2.1 . . . . 0.0 110.972 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -68.5 22.04 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.087 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' GLY . . . . . 0.613 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 41.91 27.28 0.36 Allowed Glycine 0 CA--C 1.523 0.561 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.627 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' THR . . . . . 0.403 HG22 ' HB3' ' B' ' 158' ' ' SER . 9.0 t -88.14 118.55 27.8 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.656 HD13 ' C ' ' B' ' 163' ' ' LEU . 2.9 tm? -105.97 103.93 13.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.831 -177.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' B' ' 155' ' ' SER . 0.7 OUTLIER -94.53 125.49 39.21 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.033 0.208 . . . . 0.0 111.341 -179.051 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.567 ' O ' HG23 ' B' ' 165' ' ' VAL . 2.7 m -111.81 105.65 19.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 173.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 0.516 ' OE1' ' NH1' ' B' ' 94' ' ' ARG . 0.0 OUTLIER -114.29 137.61 51.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.722 -176.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' B' ' 169' ' ' MET . . . -168.75 158.21 7.94 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' PRO . . . . . 0.432 ' HD2' ' HB1' ' B' ' 167' ' ' ALA . 72.0 Cg_endo -75.83 30.44 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 123.871 3.047 . . . . 0.0 110.329 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' MET . . . . . 0.489 ' H ' ' C ' ' B' ' 167' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.441 -0.915 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.759 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.401 ' NH1' ' HB3' ' A' ' 168' ' ' PRO . 85.0 mmt-85 . . . . . 0 C--O 1.237 0.414 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.02 140.14 32.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.1 ttp85 -131.71 117.65 18.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.977 0.418 . . . . 0.0 111.48 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.13 134.85 65.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.192 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.6 m -111.11 135.34 51.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.573 HD22 ' HB ' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -111.86 72.98 0.8 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.851 175.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.458 ' O ' HG22 ' A' ' 101' ' ' VAL . 9.1 p-10 -77.56 110.57 12.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.999 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.488 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -160.48 -49.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.251 0.548 . . . . 0.0 110.907 177.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.764 HD22 ' H ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -58.6 14.07 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -174.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.488 ' H ' ' C ' ' A' ' 101' ' ' VAL . 0.9 OUTLIER -43.31 -41.67 4.14 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.348 0.594 . . . . 0.0 110.11 178.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.2 -4.24 52.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.453 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -133.15 73.46 74.64 Favored Pre-proline 0 CA--C 1.511 -0.543 0 CA-C-O 120.938 0.399 . . . . 0.0 112.031 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.5 -40.24 5.98 Favored 'Trans proline' 0 C--N 1.299 -2.073 0 C-N-CA 122.54 2.16 . . . . 0.0 111.565 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -99.74 -27.52 13.61 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.638 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.544 ' OE1' ' NZ ' ' A' ' 123' ' ' LYS . 70.5 mm-40 -88.53 35.41 0.77 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.092 0.472 . . . . 0.0 110.627 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -122.47 132.8 54.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.628 179.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 114.99 20.18 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-O 120.718 0.294 . . . . 0.0 110.609 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.505 HG13 HD11 ' A' ' 120' ' ' ILE . 2.4 t -95.7 130.17 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 pttm -140.23 128.78 22.86 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.606 -0.437 . . . . 0.0 111.462 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.07 115.3 24.37 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.59 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.4 OUTLIER -110.86 73.0 0.8 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.18 0.514 . . . . 0.0 110.27 -177.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER 34.54 67.98 0.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.389 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.56 -23.62 27.16 Favored Glycine 0 N--CA 1.465 0.611 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.636 HG22 HG23 ' A' ' 143' ' ' THR . 3.5 t -87.23 113.05 24.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 67.3 t -100.55 112.78 34.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.51 ' HG2' ' HB2' ' A' ' 141' ' ' LYS . 37.1 mt-10 -128.89 142.82 50.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.427 0.632 . . . . 0.0 111.628 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.573 ' HB ' HD22 ' A' ' 99' ' ' LEU . 1.1 mp -116.27 115.74 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.39 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -93.45 116.9 29.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.569 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.18 136.9 5.88 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.881 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.544 ' NZ ' ' OE1' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -128.19 159.31 35.58 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.151 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -97.72 135.27 39.74 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.738 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.47 ' O ' ' C ' ' A' ' 126' ' ' GLU . 6.1 tp10 -68.25 135.73 52.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 125' ' ' GLU . 10.6 tt0 -34.83 99.03 0.02 OUTLIER 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.77 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.757 -176.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.588 0 N-CA-C 112.686 -0.166 . . . . 0.0 112.686 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -94.57 109.64 21.52 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -119.33 137.99 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -172.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.412 ' OG ' ' N ' ' A' ' 136' ' ' ARG . 6.3 t -142.75 171.28 14.27 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.013 170.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.48 HH11 ' HD3' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -161.92 -176.82 5.43 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.868 -177.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.5 p -138.61 121.61 16.71 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -98.03 132.41 43.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.712 0.292 . . . . 0.0 111.501 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.63 101.17 7.31 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.497 ' NH1' ' OH ' ' A' ' 142' ' ' TYR . 1.9 ttt-85 -107.33 103.63 13.03 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.51 ' HB2' ' HG2' ' A' ' 119' ' ' GLU . 7.5 ttpt -112.72 129.83 56.27 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.033 0.444 . . . . 0.0 112.124 -175.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.497 ' OH ' ' NH1' ' A' ' 140' ' ' ARG . 22.3 m-85 -118.11 99.79 7.11 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.595 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.636 HG23 HG22 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -90.76 89.97 7.73 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.93 92.98 15.98 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.623 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 18.6 Cg_exo -65.77 -55.4 0.43 Allowed 'Trans proline' 0 C--N 1.289 -2.567 0 C-N-CA 121.86 1.706 . . . . 0.0 112.632 175.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.623 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 50.6 Cg_endo -103.84 92.06 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.78 2.986 . . . . 0.0 111.517 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.94 -16.31 1.19 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.216 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.771 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 0.9 OUTLIER -131.34 129.52 62.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-N 117.332 0.566 . . . . 0.0 111.077 177.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 13.4 t70 -94.37 143.55 26.52 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.165 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.456 ' HB3' ' HA ' ' A' ' 115' ' ' ASP . 3.3 Cg_exo -81.96 -26.02 3.18 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.823 1.682 . . . . 0.0 112.928 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.14 -37.35 16.25 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.735 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 4.8 mt-30 -107.2 27.99 8.51 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -172.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.572 HG22 ' HE3' ' A' ' 169' ' ' MET . 51.2 t -116.08 113.11 42.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.15 176.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.01 -173.01 2.2 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.29 131.82 11.34 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.837 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.76 139.67 39.98 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.728 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.641 HD22 HD22 ' A' ' 109' ' ' LEU . 14.9 tp -133.95 129.29 36.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.016 0.436 . . . . 0.0 110.85 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.593 ' N ' HD12 ' A' ' 157' ' ' LEU . 0.2 OUTLIER -113.9 148.97 41.06 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.969 178.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 161' ' ' GLY . 76.9 Cg_exo -40.04 -33.88 0.86 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.807 2.338 . . . . 0.0 112.11 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -74.21 31.43 0.08 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.396 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.51 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 43.91 25.83 0.71 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.388 -0.369 . . . . 0.0 112.992 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.4 t -87.58 101.51 13.7 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 117.228 0.514 . . . . 0.0 109.693 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.597 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.5 tm? -100.92 102.37 13.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.051 -177.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 p -97.62 123.05 41.37 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.703 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 165' ' ' VAL . 1.4 m -101.85 98.97 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.405 ' H ' ' HG2' ' A' ' 166' ' ' GLU . 0.1 OUTLIER -118.03 136.72 53.37 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.229 -174.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.791 ' HB3' ' HE3' ' A' ' 169' ' ' MET . . . -176.42 166.42 1.57 Allowed Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.068 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.545 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 58.6 Cg_endo -85.49 109.36 1.12 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.169 2.579 . . . . 0.0 110.126 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.791 ' HE3' ' HB3' ' A' ' 167' ' ' ALA . 37.8 mmt -87.22 152.69 53.2 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.79 -174.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo . . . . . 0 N--CA 1.495 1.607 0 C-N-CA 122.906 2.404 . . . . 0.0 111.708 178.413 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' TRP . . . . . 0.44 ' HB2' ' CG ' ' B' ' 169' ' ' MET . 0.6 OUTLIER -81.3 128.16 33.51 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.891 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -127.47 101.93 6.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.583 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.22 156.6 17.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 4.8 p -124.92 151.41 45.43 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.845 HD22 HG13 ' B' ' 120' ' ' ILE . 0.6 OUTLIER -122.85 43.47 2.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.777 172.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.77 97.81 0.11 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.635 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.432 ' C ' ' H ' ' B' ' 103' ' ' HIS . 2.5 t -158.62 -28.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.401 0.619 . . . . 0.0 109.486 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.599 HD21 ' C ' ' B' ' 105' ' ' ALA . 17.0 t30 -66.92 8.94 0.22 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.741 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' HIS . . . . . 0.432 ' H ' ' C ' ' B' ' 101' ' ' VAL . 25.9 m80 -39.64 -21.88 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' B' ' 102' ' ' ASN . 28.0 p90 -92.36 -34.56 14.13 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -176.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . 0.599 ' C ' HD21 ' B' ' 102' ' ' ASN . . . -113.52 76.64 2.91 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.3 -39.13 49.41 Favored 'Trans proline' 0 C--N 1.295 -2.259 0 C-N-CA 122.359 2.039 . . . . 0.0 112.237 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -102.0 -27.31 13.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.79 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.563 ' OE1' ' NZ ' ' B' ' 123' ' ' LYS . 32.3 mt-10 -92.69 41.58 1.08 Allowed 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.804 0.335 . . . . 0.0 111.206 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.739 HD22 HD22 ' B' ' 157' ' ' LEU . 0.4 OUTLIER -123.51 136.36 54.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.242 179.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.414 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -128.86 131.23 47.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.737 -179.352 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.01 119.46 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.37 135.26 53.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 0.0 111.312 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.66 115.33 29.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.369 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' LYS . . . . . 0.521 ' HD2' ' HB ' ' B' ' 117' ' ' VAL . 0.0 OUTLIER -116.0 90.5 3.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.377 -177.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 18.9 t0 33.48 69.21 0.14 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.07 -21.44 16.07 Favored Glycine 0 C--N 1.316 -0.572 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.642 HG22 HG23 ' B' ' 143' ' ' THR . 3.8 t -87.49 112.59 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.59 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 75.4 t -97.98 119.8 46.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.497 ' OE2' ' NZ ' ' B' ' 114' ' ' LYS . 33.7 mt-10 -133.96 139.88 46.39 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.49 0.662 . . . . 0.0 111.134 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.845 HG13 HD22 ' B' ' 99' ' ' LEU . 1.0 OUTLIER -116.78 137.46 50.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.494 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.82 119.53 35.69 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.281 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -142.87 124.7 2.42 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' LYS . . . . . 0.563 ' NZ ' ' OE1' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -150.66 140.51 21.86 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -116.94 157.94 24.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.224 0.535 . . . . 0.0 112.397 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.452 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.8 OUTLIER -68.52 145.49 53.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.275 179.082 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . 0.581 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 4.9 tt0 -29.98 102.1 0.02 OUTLIER 'General case' 0 C--N 1.349 0.546 0 CA-C-O 120.832 0.349 . . . . 0.0 111.174 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' B' ' 134' ' ' ILE . 0.2 OUTLIER -89.65 136.37 33.07 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.913 -177.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -90.7 117.28 29.22 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 172.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . 0.465 ' HB2' HG22 ' B' ' 134' ' ' ILE . 0.6 OUTLIER -125.75 171.95 10.23 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.134 178.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -56.45 -31.78 64.3 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -174.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' HIS . . . . . 0.444 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 74.0 m80 -111.73 36.39 3.3 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -175.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 121.85 -173.29 15.74 Favored Glycine 0 C--N 1.305 -1.18 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.426 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' B' ' 127' ' ' ARG . 13.6 m-30 -95.94 118.92 33.5 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . 0.512 HG23 ' O ' ' B' ' 134' ' ' ILE . 0.1 OUTLIER -133.74 112.26 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -173.173 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . 0.581 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -127.9 164.1 23.0 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.032 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . 0.498 ' NH2' ' O ' ' B' ' 134' ' ' ILE . 0.0 OUTLIER -161.76 161.94 29.43 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.588 -176.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 26.8 p -113.47 128.16 56.35 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -107.99 137.93 45.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -176.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.55 123.64 19.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.282 0.563 . . . . 0.0 111.046 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . 0.617 ' NH2' ' O ' ' B' ' 99' ' ' LEU . 0.0 OUTLIER -124.54 118.65 27.05 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . 0.468 ' HB2' ' HG2' ' B' ' 119' ' ' GLU . 1.1 ttpp -114.11 124.65 52.61 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.823 0.344 . . . . 0.0 110.874 -175.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' TYR . . . . . 0.59 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 3.3 m-85 -114.27 98.27 6.83 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.245 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . 0.642 HG23 HG22 ' B' ' 117' ' ' VAL . 0.3 OUTLIER -91.33 101.49 14.18 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 mp -107.35 96.49 16.09 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' B' ' 143' ' ' THR . 36.0 Cg_exo -62.26 -38.18 56.53 Favored 'Trans proline' 0 C--N 1.286 -2.76 0 C-N-CA 123.375 2.717 . . . . 0.0 114.198 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 50.1 Cg_exo -47.34 -8.61 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.619 1.546 . . . . 0.0 111.515 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 97.83 56.73 1.07 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.2 -0.524 . . . . 0.0 111.979 175.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' VAL . . . . . 0.51 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -69.86 100.76 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 176.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . 0.504 ' O ' HG23 ' B' ' 153' ' ' VAL . 0.9 OUTLIER -33.83 120.23 0.5 Allowed Pre-proline 0 C--O 1.219 -0.509 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.411 -173.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 8.5 Cg_exo -71.86 -42.39 1.67 Allowed 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.425 2.083 . . . . 0.0 111.841 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -47.6 25.23 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.642 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' GLN . . . . . 0.665 ' O ' ' HB1' ' B' ' 167' ' ' ALA . 0.4 OUTLIER -85.35 18.69 2.57 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.629 -1.169 . . . . 0.0 113.473 -172.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' B' ' 167' ' ' ALA . 33.4 t -114.0 106.65 21.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.471 177.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.44 -169.31 1.7 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -162.72 146.47 11.37 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.612 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . 0.639 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.7 OUTLIER -120.67 144.77 48.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.684 177.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . 0.739 HD22 HD22 ' B' ' 109' ' ' LEU . 23.5 tp -134.9 148.65 50.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.342 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.02 156.81 79.64 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' PRO . . . . . 0.591 ' C ' ' H ' ' B' ' 161' ' ' GLY . 75.5 Cg_exo -39.61 -43.43 3.05 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.702 2.268 . . . . 0.0 111.402 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -66.97 26.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.21 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' GLY . . . . . 0.599 ' HA2' HD11 ' B' ' 157' ' ' LEU . . . 41.65 24.48 0.15 Allowed Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.734 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' THR . . . . . 0.516 ' O ' HD12 ' B' ' 157' ' ' LEU . 11.6 t -77.03 130.4 37.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.639 HD22 ' O ' ' B' ' 156' ' ' SER . 2.7 tm? -126.46 105.39 8.73 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.145 -175.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.28 121.8 38.46 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.575 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.2 m -105.51 98.94 7.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 0.0 OUTLIER -116.43 127.3 54.48 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.504 -175.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' B' ' 152' ' ' GLN . . . -171.1 158.06 5.07 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -82.49 126.47 4.75 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.478 2.785 . . . . 0.0 110.005 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' MET . . . . . 0.534 ' N ' ' SD ' ' B' ' 169' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.0 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.993 -176.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.528 HH21 ' CD ' ' A' ' 166' ' ' GLU . 30.4 mmm-85 . . . . . 0 C--O 1.238 0.483 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.497 ' NE1' ' CG2' ' A' ' 97' ' ' VAL . 37.7 t-105 -117.71 118.22 31.49 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.22 104.76 14.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.097 -175.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.497 ' CG2' ' NE1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -110.74 139.13 35.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 174.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 15.4 m -111.36 154.06 25.11 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.43 -0.508 . . . . 0.0 112.368 -176.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.751 HD22 HG12 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -131.05 67.13 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.591 176.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.19 89.48 4.27 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.86 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.484 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.2 OUTLIER -142.75 -36.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 121.226 0.536 . . . . 0.0 110.42 177.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.658 ' OD1' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -64.45 13.41 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.56 -176.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.484 ' H ' ' C ' ' A' ' 101' ' ' VAL . 2.1 p80 -54.63 -20.1 7.41 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.723 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.533 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 32.6 p90 -107.2 3.65 25.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.712 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.85 81.39 16.52 Favored Pre-proline 0 CA--C 1.518 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 111.223 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.99 -44.38 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.685 2.257 . . . . 0.0 111.324 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -104.6 -31.13 9.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.346 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.36 36.25 0.47 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.086 0.47 . . . . 0.0 110.655 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.695 ' CD2' HD22 ' A' ' 157' ' ' LEU . 0.3 OUTLIER -117.9 135.9 53.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.938 178.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.481 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 1.2 m -127.68 126.83 42.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.841 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.419 HG13 ' CD1' ' A' ' 120' ' ' ILE . 7.4 t -104.09 126.97 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.409 ' NZ ' ' CB ' ' A' ' 119' ' ' GLU . 3.4 pttp -133.17 130.95 39.85 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.058 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 45.3 m -112.05 109.17 18.76 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.59 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.522 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 3.3 ttmm -114.43 99.89 7.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.257 -177.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 114' ' ' LYS . 15.6 t0 26.1 64.23 0.07 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.86 -19.81 52.07 Favored Glycine 0 N--CA 1.461 0.308 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 2.7 t -88.67 112.55 24.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.537 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.12 114.6 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 140' ' ' ARG . 46.1 mt-10 -127.46 133.57 49.9 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.266 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.751 HG12 HD22 ' A' ' 99' ' ' LEU . 4.0 mm -104.25 137.19 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.979 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -118.89 107.59 13.77 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.192 -178.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -135.17 115.03 1.32 Allowed Glycine 0 N--CA 1.461 0.357 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 159.58 41.22 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 104' ' ' PHE . 1.7 t60 -139.72 141.49 36.9 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.416 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.502 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.3 OUTLIER -81.45 150.22 28.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.063 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.531 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 4.9 tt0 -1.4 108.93 0.01 OUTLIER 'General case' 0 C--N 1.349 0.556 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? . . . . . 0 C--O 1.233 0.197 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.565 176.172 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.45 ' HA3' ' CZ ' ' B' ' 142' ' ' TYR . . . . . . . . 0 C--O 1.221 -0.718 0 N-CA-C 112.158 -0.377 . . . . 0.0 112.158 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -92.35 107.85 19.52 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 175.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.634 HD13 ' NH2' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -125.93 117.53 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -174.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.531 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -109.17 149.57 29.16 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.401 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.634 ' NH2' HD13 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -133.16 172.43 12.67 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -174.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 23.7 p -141.13 131.75 25.55 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.426 ' CD2' HG11 ' A' ' 101' ' ' VAL . 7.3 m-85 -107.09 139.48 41.44 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.136 -0.225 . . . . 0.0 111.034 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.8 104.47 6.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.395 0.617 . . . . 0.0 110.364 175.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.6 ' HD3' HD23 ' A' ' 99' ' ' LEU . 12.5 ttt180 -108.01 100.54 9.88 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.48 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 6.6 ttpt -107.67 116.04 31.23 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.287 -175.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.569 ' OH ' ' NE ' ' A' ' 140' ' ' ARG . 19.9 m-30 -114.52 99.6 7.67 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.3 0.571 . . . . 0.0 110.144 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.497 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -86.29 89.03 7.73 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.377 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mp -112.1 91.52 16.03 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.656 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 15.3 Cg_exo -68.18 -56.41 0.2 Allowed 'Trans proline' 0 C--N 1.294 -2.311 0 C-N-CA 122.359 2.039 . . . . 0.0 113.831 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.656 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 37.4 Cg_endo -99.3 53.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 123.327 2.685 . . . . 0.0 112.408 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -171.45 -12.91 0.02 OUTLIER Glycine 0 CA--C 1.521 0.429 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.569 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.587 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 1.0 OUTLIER -130.26 125.11 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 117.68 0.74 . . . . 0.0 111.187 178.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.497 ' HB2' ' HD3' ' A' ' 170' ' ' PRO . 14.2 t70 -81.91 140.69 46.85 Favored Pre-proline 0 N--CA 1.478 0.962 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.293 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 5.8 Cg_exo -81.1 -26.45 3.46 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.027 1.818 . . . . 0.0 113.0 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.411 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 0.8 OUTLIER -91.19 -36.38 13.98 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -176.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.689 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 4.6 mt-30 -107.72 27.22 9.4 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -172.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 41.7 t -113.3 104.94 17.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.67 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.31 -161.77 0.89 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.717 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.1 132.07 2.94 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.335 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -100.82 139.81 35.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.591 177.459 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.695 HD22 ' CD2' ' A' ' 109' ' ' LEU . 42.1 tp -137.53 138.13 39.33 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.176 0.513 . . . . 0.0 110.981 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.729 ' HB2' HG22 ' A' ' 162' ' ' THR . 23.1 m -121.88 146.06 45.07 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.631 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 161' ' ' GLY . 75.4 Cg_exo -41.27 -34.8 1.86 Allowed 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.065 1.843 . . . . 0.0 110.897 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.411 ' CD ' ' H ' ' A' ' 160' ' ' GLU . 2.1 mp0 -65.31 2.86 0.75 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.076 177.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 158' ' ' SER . . . 67.09 21.2 71.62 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.894 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.729 HG22 ' HB2' ' A' ' 158' ' ' SER . 0.7 OUTLIER -77.24 106.82 9.21 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.568 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.2 tm? -106.94 101.52 10.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.752 -175.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.42 120.24 39.29 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 121.289 -0.165 . . . . 0.0 110.66 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 165' ' ' VAL . 1.5 m -100.93 99.18 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.528 ' CD ' HH21 ' A' ' 94' ' ' ARG . 1.4 pp20? -112.71 146.21 39.12 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.674 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 175.13 166.64 0.37 Allowed Pre-proline 0 N--CA 1.437 -1.103 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.206 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.586 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 72.8 Cg_endo -86.41 106.33 0.77 Allowed 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.803 2.335 . . . . 0.0 108.735 175.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.587 ' SD ' ' HA ' ' A' ' 148' ' ' VAL . 20.5 mmt -74.66 153.95 87.39 Favored Pre-proline 0 C--N 1.31 -1.126 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.554 -174.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 149' ' ' ASP . 38.4 Cg_endo . . . . . 0 C--N 1.303 -1.854 0 C-N-CA 122.626 2.217 . . . . 0.0 111.684 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . 0.478 ' NH1' ' OE1' ' B' ' 166' ' ' GLU . 9.0 mmt85 . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' TRP . . . . . 0.685 ' HB2' ' SD ' ' B' ' 169' ' ' MET . 0.3 OUTLIER -55.51 151.11 10.89 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.607 ' HB2' ' NH1' ' B' ' 96' ' ' ARG . 16.3 ttm105 -150.13 109.4 3.96 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.684 -176.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 t -119.1 152.27 21.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 1.5 m -126.05 144.29 50.78 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -176.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.689 HD23 ' NE ' ' B' ' 140' ' ' ARG . 0.3 OUTLIER -115.39 54.64 0.79 Allowed 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.447 176.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.55 ' O ' HG22 ' B' ' 101' ' ' VAL . 0.1 OUTLIER -62.32 96.96 0.08 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.018 -178.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.55 HG22 ' O ' ' B' ' 100' ' ' ASP . 0.6 OUTLIER -162.0 -6.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 176.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.697 ' CB ' HD13 ' B' ' 109' ' ' LEU . 0.4 OUTLIER -90.5 10.15 26.52 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -175.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' HIS . . . . . 0.504 ' N ' ' HA3' ' B' ' 161' ' ' GLY . 0.2 OUTLIER -39.63 -35.04 0.27 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.72 0.295 . . . . 0.0 111.155 179.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.6 -8.83 51.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' B' ' 102' ' ' ASN . . . -138.72 93.34 10.88 Favored Pre-proline 0 CA--C 1.515 -0.383 0 CA-C-O 120.696 0.284 . . . . 0.0 111.298 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -81.17 -48.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.967 0 C-N-CA 122.68 2.253 . . . . 0.0 110.933 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -90.29 -31.2 17.05 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.523 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.518 ' OE2' ' NZ ' ' B' ' 123' ' ' LYS . 2.8 mt-10 -84.63 45.09 1.1 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.369 0.604 . . . . 0.0 109.897 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.697 HD13 ' CB ' ' B' ' 102' ' ' ASN . 0.5 OUTLIER -129.44 135.98 49.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.013 178.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.96 121.73 22.06 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.571 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 1.5 t -98.99 131.78 45.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.814 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.443 ' HZ3' ' CD ' ' B' ' 119' ' ' GLU . 2.9 pttp -139.78 122.28 16.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.101 0.477 . . . . 0.0 111.755 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.7 117.54 34.27 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' LYS . . . . . 0.558 ' O ' ' N ' ' B' ' 117' ' ' VAL . 1.3 ttpm? -128.96 112.01 13.62 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.348 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . 0.492 ' OD1' ' NZ ' ' B' ' 114' ' ' LYS . 0.3 OUTLIER 34.64 59.89 0.64 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.91 0.862 . . . . 0.0 112.481 176.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.91 -12.1 31.55 Favored Glycine 0 C--N 1.314 -0.657 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 1.028 HG22 HG23 ' B' ' 143' ' ' THR . 9.0 t -87.47 115.46 28.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.762 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 54.2 t -103.66 112.67 38.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.571 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.591 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 49.4 mt-10 -125.96 146.47 49.85 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.599 0.714 . . . . 0.0 111.546 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.532 ' HB ' HD22 ' B' ' 99' ' ' LEU . 1.3 mp -119.79 121.56 66.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.307 178.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -97.44 124.3 41.58 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.2 117.59 0.86 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' LYS . . . . . 0.518 ' NZ ' ' OE2' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -152.82 135.5 15.31 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.363 0.265 . . . . 0.0 110.489 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . 0.515 ' O ' ' CB ' ' B' ' 135' ' ' SER . 0.1 OUTLIER -111.96 123.55 50.49 Favored 'General case' 0 C--O 1.21 -0.989 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.477 ' H ' ' HG3' ' B' ' 125' ' ' GLU . 4.9 mt-10 -54.05 -21.43 8.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -176.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 178.61 131.11 0.07 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.989 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' ARG . . . . . 0.483 ' HD3' ' CE1' ' B' ' 124' ' ' HIS . 38.9 mtp180 -123.69 132.08 53.75 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.146 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -81.56 138.7 35.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.936 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . 0.506 ' CG ' ' N ' ' B' ' 130' ' ' GLU . 9.2 t70 -157.37 165.89 34.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.205 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . 0.506 ' N ' ' CG ' ' B' ' 129' ' ' ASP . 0.7 OUTLIER -61.4 -28.28 69.14 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.639 -177.119 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' HIS . . . . . 0.48 ' O ' ' CE1' ' A' ' 142' ' ' TYR . 10.6 m-70 -74.78 -12.55 60.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.758 0.313 . . . . 0.0 111.013 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.74 -136.95 8.96 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -112.25 134.99 53.48 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 175.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' B' ' 127' ' ' ARG . 0.4 OUTLIER -146.75 125.76 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -176.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' B' ' 124' ' ' HIS . 0.6 OUTLIER -142.99 158.01 44.0 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.029 0.442 . . . . 0.0 111.283 174.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . 0.472 ' CZ ' ' CZ ' ' B' ' 138' ' ' PHE . 0.2 OUTLIER -141.77 173.7 11.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.865 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 31.9 p -123.74 129.91 51.82 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . 0.472 ' CZ ' ' CZ ' ' B' ' 136' ' ' ARG . 1.1 m-85 -104.86 122.35 45.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.936 -176.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 134' ' ' ILE . 0.0 OUTLIER -124.83 99.47 6.16 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.137 174.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . 0.689 ' NE ' HD23 ' B' ' 99' ' ' LEU . 0.0 OUTLIER -106.63 119.58 39.68 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.288 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . 0.591 ' HA ' ' HG2' ' B' ' 119' ' ' GLU . 2.7 ttpt -120.19 130.72 54.68 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.07 0.462 . . . . 0.0 111.206 -176.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' TYR . . . . . 0.572 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 7.8 m-85 -120.27 98.74 6.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.961 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . 1.028 HG23 HG22 ' B' ' 117' ' ' VAL . 1.3 m -93.52 93.66 8.22 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -110.95 90.95 11.86 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.584 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . 0.611 ' HD2' ' CD ' ' B' ' 146' ' ' PRO . 16.2 Cg_exo -68.72 -41.19 6.18 Favored 'Trans proline' 0 C--N 1.279 -3.096 0 C-N-CA 122.06 1.84 . . . . 0.0 112.125 167.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' PRO . . . . . 0.611 ' CD ' ' HD2' ' B' ' 145' ' ' PRO . 74.2 Cg_exo -43.21 -11.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 123.325 2.683 . . . . 0.0 114.606 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 149.02 44.64 0.03 OUTLIER Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 118.239 -1.934 . . . . 0.0 115.447 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.29 116.56 52.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 118.73 -1.188 . . . . 0.0 110.667 173.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 19.3 t70 -80.02 140.33 53.71 Favored Pre-proline 0 C--O 1.221 -0.407 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.03 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 4.2 Cg_exo -81.4 -23.89 4.78 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.074 1.85 . . . . 0.0 112.9 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.15 -43.68 9.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.975 0.417 . . . . 0.0 112.072 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -94.93 18.97 10.94 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 42.5 t -108.83 104.94 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.088 0.471 . . . . 0.0 109.888 176.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.43 -175.38 3.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.237 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.01 132.79 8.46 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.717 -0.793 . . . . 0.0 112.291 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . 0.453 ' HG ' ' HG1' ' B' ' 164' ' ' THR . 0.0 OUTLIER -106.56 139.84 40.39 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.222 179.383 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . 0.671 HD22 HD22 ' B' ' 109' ' ' LEU . 33.0 tp -131.08 143.12 50.43 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . 0.416 ' OG ' ' HD2' ' B' ' 159' ' ' PRO . 0.2 OUTLIER -135.58 154.38 78.22 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.639 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' PRO . . . . . 0.57 ' C ' ' H ' ' B' ' 161' ' ' GLY . 1.2 Cg_endo -44.8 -34.79 8.87 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.693 2.262 . . . . 0.0 111.491 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -68.74 24.12 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.034 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' GLY . . . . . 0.612 ' HA2' ' OD1' ' B' ' 102' ' ' ASN . . . 44.03 34.03 2.95 Favored Glycine 0 C--O 1.241 0.532 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.638 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 7.4 t -97.16 121.46 39.08 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.623 HD13 ' C ' ' B' ' 163' ' ' LEU . 1.8 tm? -115.84 103.86 11.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.953 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 0.453 ' HG1' ' HG ' ' B' ' 156' ' ' SER . 0.8 OUTLIER -97.59 121.72 39.82 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 121.13 -0.228 . . . . 0.0 110.803 179.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.587 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.1 m -106.49 103.33 15.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 0.478 ' OE1' ' NH1' ' B' ' 94' ' ' ARG . 2.0 pp20? -113.22 151.84 30.5 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.278 -177.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' ALA . . . . . 0.632 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -174.62 154.25 1.89 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 0.0 111.628 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.06 -4.7 11.24 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 123.018 2.479 . . . . 0.0 109.906 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' MET . . . . . 0.685 ' SD ' ' HB2' ' B' ' 95' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.388 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 94' ' ' ARG . 10.9 mmt180 . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.566 ' CB ' ' SD ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -68.45 145.17 54.32 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.129 -179.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -138.66 105.96 5.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.487 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.22 155.11 13.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 175.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.62 148.64 51.53 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -174.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.656 HD23 ' NE ' ' A' ' 140' ' ' ARG . 0.7 OUTLIER -130.13 118.91 22.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.102 174.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.461 ' CG ' ' HE2' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -112.28 114.08 26.66 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.536 -178.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.581 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -161.14 -43.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 120.89 0.376 . . . . 0.0 111.445 179.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.683 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -60.27 17.0 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.581 ' H ' ' C ' ' A' ' 101' ' ' VAL . 12.0 m80 -52.67 -38.09 59.88 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -105.69 -15.14 15.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.645 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -118.13 81.93 17.22 Favored Pre-proline 0 CA--C 1.516 -0.346 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -74.36 -44.66 0.4 Allowed 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 122.612 2.208 . . . . 0.0 110.924 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -92.55 -31.47 15.19 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.759 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -89.44 45.86 1.32 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.151 0.5 . . . . 0.0 111.14 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.789 HD22 HD22 ' A' ' 157' ' ' LEU . 0.4 OUTLIER -133.34 130.29 38.64 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 m -128.61 124.56 36.16 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 120.783 0.325 . . . . 0.0 110.512 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.41 HG13 HD11 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -96.51 127.4 48.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.984 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.85 130.13 43.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.856 0.36 . . . . 0.0 111.406 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.91 104.0 13.37 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.625 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -109.43 103.32 12.21 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.528 -175.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.474 ' CG ' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER 36.06 41.44 0.13 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 177.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.03 -11.52 57.32 Favored Glycine 0 C--N 1.314 -0.651 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.716 HG22 HG23 ' A' ' 143' ' ' THR . 2.6 t -86.73 117.25 30.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.581 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 55.4 t -102.81 116.51 46.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.504 ' OE1' ' NZ ' ' A' ' 114' ' ' LYS . 2.2 mt-10 -133.51 140.2 47.09 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.272 0.558 . . . . 0.0 111.521 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.41 HD11 HG13 ' A' ' 111' ' ' VAL . 1.2 mp -111.44 115.54 50.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.154 177.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -92.0 118.67 31.0 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.776 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.17 129.99 4.28 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.118 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.72 159.28 44.63 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -133.68 162.13 32.79 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.36 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.523 ' O ' ' C ' ' A' ' 126' ' ' GLU . 1.5 tt0 -90.28 143.33 26.86 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.851 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.523 ' C ' ' O ' ' A' ' 125' ' ' GLU . 1.0 OUTLIER -18.12 105.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.645 0.591 . . . . 0.0 111.846 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.514 -0.436 0 CA-C-O 120.897 0.379 . . . . 0.0 110.428 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.463 ' HA3' ' CZ ' ' B' ' 142' ' ' TYR . . . . . . . . 0 N--CA 1.439 -1.102 0 N-CA-C 112.014 -0.435 . . . . 0.0 112.014 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -92.2 109.71 21.08 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.47 159.34 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -169.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.9 t -155.06 154.81 33.02 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.762 170.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.55 172.27 15.76 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.928 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.5 p -125.97 128.36 47.38 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -102.68 142.25 34.14 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.352 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.55 103.02 3.63 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.086 0.47 . . . . 0.0 111.554 176.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.656 ' NE ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -104.16 119.63 39.37 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 174.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.5 ' NZ ' ' OE1' ' B' ' 126' ' ' GLU . 2.7 ttpt -118.4 123.58 45.59 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 123.21 0.319 . . . . 0.0 110.666 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.581 ' HB2' ' HB ' ' A' ' 118' ' ' VAL . 3.2 m-85 -112.96 99.16 7.66 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.993 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.716 HG23 HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -92.0 90.25 7.32 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.548 178.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.44 91.94 21.69 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.643 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 16.0 Cg_exo -67.47 -56.94 0.19 Allowed 'Trans proline' 0 C--N 1.288 -2.641 0 C-N-CA 122.349 2.033 . . . . 0.0 114.207 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.643 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 41.8 Cg_endo -100.61 56.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.482 0.815 0 C-N-CA 123.377 2.718 . . . . 0.0 113.035 -175.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.502 ' O ' ' HB3' ' A' ' 169' ' ' MET . . . -176.76 -14.35 0.02 OUTLIER Glycine 0 N--CA 1.466 0.634 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.713 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.03 132.21 68.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 117.539 0.67 . . . . 0.0 110.153 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 13.0 t70 -93.44 141.15 23.54 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.204 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 2.4 Cg_endo -82.66 -21.4 5.08 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.095 1.863 . . . . 0.0 112.7 -177.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.45 -41.69 10.71 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.386 -175.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -101.29 14.44 31.96 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -171.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.683 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 24.9 t -102.75 117.09 47.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.387 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.02 166.69 11.18 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.62 137.46 35.33 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.112 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.412 ' OG ' ' OG1' ' A' ' 164' ' ' THR . 0.0 OUTLIER -111.57 138.57 47.94 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.872 177.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.789 HD22 HD22 ' A' ' 109' ' ' LEU . 14.8 tp -125.13 121.77 35.18 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.388 0.43 . . . . 0.0 110.364 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 161' ' ' GLY . 0.2 OUTLIER -96.07 138.28 21.65 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -39.95 -33.19 0.7 Allowed 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.556 2.171 . . . . 0.0 111.185 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -59.23 -5.54 0.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.344 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.537 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . 76.69 34.41 43.87 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.4 t -109.89 118.76 37.33 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.605 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.1 tm? -104.25 108.65 20.14 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.597 -174.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.412 ' OG1' ' OG ' ' A' ' 156' ' ' SER . 3.4 p -95.43 127.94 41.88 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.605 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 165' ' ' VAL . 2.7 m -113.47 103.33 15.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 1.6 pp20? -119.11 141.82 48.45 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.201 -176.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.683 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . . . -174.48 157.85 2.44 Favored Pre-proline 0 C--N 1.332 -0.193 0 C-N-CA 120.024 -0.671 . . . . 0.0 112.618 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.424 ' HD3' ' NH1' ' A' ' 94' ' ' ARG . 61.6 Cg_endo -83.35 108.73 1.55 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.736 2.291 . . . . 0.0 108.84 172.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.566 ' SD ' ' CB ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -87.59 156.09 53.43 Favored Pre-proline 0 C--N 1.305 -1.337 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.745 -174.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 C--N 1.312 -1.351 0 C-N-CA 122.673 2.248 . . . . 0.0 111.43 179.677 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . 0.473 HH11 ' HB3' ' B' ' 94' ' ' ARG . 0.2 OUTLIER . . . . . 0 CA--C 1.516 -0.361 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' TRP . . . . . 0.672 ' HB2' ' SD ' ' B' ' 169' ' ' MET . 0.1 OUTLIER -63.83 139.99 58.82 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.401 ' HD2' HH11 ' B' ' 96' ' ' ARG . 19.7 ttm105 -134.45 99.08 4.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.138 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 t -105.87 152.21 7.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 9.0 m -129.17 144.26 51.15 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -175.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.888 HD22 HG12 ' B' ' 120' ' ' ILE . 0.5 OUTLIER -113.79 52.54 0.81 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.527 175.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -59.48 97.09 0.04 OUTLIER 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.9 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.514 HG11 ' HD3' ' B' ' 140' ' ' ARG . 7.2 p -167.93 -2.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.828 ' CB ' HD13 ' B' ' 109' ' ' LEU . 0.4 OUTLIER -90.99 11.95 21.27 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.616 178.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -59.16 -14.38 10.26 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.438 ' N ' ' C ' ' B' ' 102' ' ' ASN . 13.7 t80 -85.67 -9.97 56.41 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.603 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.68 98.12 0.48 Allowed Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.423 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.453 ' HA ' ' ND2' ' B' ' 102' ' ' ASN . 57.7 Cg_endo -76.3 -40.94 0.53 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.672 2.248 . . . . 0.0 111.875 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.17 -32.21 12.59 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.367 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.537 ' CD ' ' NZ ' ' B' ' 123' ' ' LYS . 1.9 mm-40 -89.8 49.67 1.76 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.485 0.659 . . . . 0.0 110.358 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.828 HD13 ' CB ' ' B' ' 102' ' ' ASN . 0.4 OUTLIER -129.36 135.22 48.44 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.575 178.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.7 121.95 34.92 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.609 HG13 HD12 ' B' ' 120' ' ' ILE . 0.5 OUTLIER -100.32 131.64 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.448 ' NZ ' ' OG1' ' B' ' 121' ' ' THR . 0.0 OUTLIER -134.89 124.12 24.51 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.354 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.6 m -94.63 116.32 28.62 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' B' ' 116' ' ' GLY . 1.5 ttmp? -120.02 143.8 47.88 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -22.85 71.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' B' ' 114' ' ' LYS . . . 83.07 -2.51 86.79 Favored Glycine 0 N--CA 1.472 1.09 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.624 HG13 HG23 ' B' ' 143' ' ' THR . 2.3 t -102.93 114.47 42.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.598 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 48.0 t -98.11 120.02 46.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.505 ' C ' HD13 ' B' ' 120' ' ' ILE . 33.7 mt-10 -133.5 136.14 44.89 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.179 0.514 . . . . 0.0 110.62 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.888 HG12 HD22 ' B' ' 99' ' ' LEU . 3.2 mm -111.82 138.07 41.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.622 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . 0.448 ' OG1' ' NZ ' ' B' ' 112' ' ' LYS . 0.2 OUTLIER -115.89 120.28 38.71 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.133 -179.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.8 135.64 5.51 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.768 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' LYS . . . . . 0.537 ' NZ ' ' CD ' ' B' ' 108' ' ' GLU . 0.2 OUTLIER -150.2 159.08 44.7 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.219 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . 0.486 ' CG ' ' HD2' ' B' ' 127' ' ' ARG . 2.0 t60 -132.72 156.34 47.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.674 0.273 . . . . 0.0 110.273 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.546 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.6 OUTLIER -92.24 131.68 37.27 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.346 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . 0.569 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 1.5 tt0 -3.11 97.7 0.01 OUTLIER 'General case' 0 C--N 1.344 0.334 0 O-C-N 123.751 0.657 . . . . 0.0 112.47 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' ARG . . . . . 0.486 ' HD2' ' CG ' ' B' ' 124' ' ' HIS . 31.5 mtp180 -90.16 146.9 23.93 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.095 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -88.8 131.78 34.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.325 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -134.71 163.36 29.96 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.052 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.65 -14.12 60.56 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.042 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' HIS . . . . . 0.521 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 69.2 m-70 -114.04 29.03 8.31 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.491 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.71 -153.12 17.36 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 119.728 -1.225 . . . . 0.0 111.611 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -112.89 127.94 56.33 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . 0.506 HD11 ' NH2' ' B' ' 136' ' ' ARG . 0.1 OUTLIER -135.29 123.48 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -175.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . 0.569 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.1 OUTLIER -134.32 160.43 37.94 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 174.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . 0.506 ' NH2' HD11 ' B' ' 134' ' ' ILE . 10.4 ptp85 -156.85 166.07 34.42 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.563 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 27.5 p -117.84 136.42 53.44 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . 0.497 ' CE2' ' HD2' ' B' ' 136' ' ' ARG . 11.1 m-85 -106.89 138.18 43.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.276 -177.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.15 126.18 10.56 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.951 174.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . 0.514 ' HD3' HG11 ' B' ' 101' ' ' VAL . 0.0 OUTLIER -131.23 112.92 13.23 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . 0.437 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 11.3 ttmt -101.28 119.08 38.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.931 0.395 . . . . 0.0 110.556 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' TYR . . . . . 0.598 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 4.3 m-85 -109.48 97.58 7.12 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . 0.624 HG23 HG13 ' B' ' 117' ' ' VAL . 0.0 OUTLIER -91.66 96.59 10.53 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 177.559 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.87 90.23 12.78 Favored Pre-proline 0 CA--C 1.514 -0.409 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.429 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . 0.611 ' HD2' ' CD ' ' B' ' 146' ' ' PRO . 17.1 Cg_exo -68.49 -40.6 7.6 Favored 'Trans proline' 0 C--N 1.285 -2.793 0 C-N-CA 122.38 2.053 . . . . 0.0 112.127 168.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' PRO . . . . . 0.611 ' CD ' ' HD2' ' B' ' 145' ' ' PRO . 71.4 Cg_exo -43.07 -8.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 123.554 2.836 . . . . 0.0 114.194 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 134.69 64.77 0.07 OUTLIER Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 118.964 -1.588 . . . . 0.0 114.879 176.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' VAL . . . . . 0.416 ' O ' HG12 ' B' ' 148' ' ' VAL . 1.1 t -123.74 108.55 21.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.365 172.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . 0.485 ' O ' HG23 ' B' ' 153' ' ' VAL . 10.7 p-10 -76.9 127.89 82.79 Favored Pre-proline 0 N--CA 1.472 0.659 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.885 -176.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 3.0 Cg_exo -75.81 -30.47 6.03 Favored 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 122.156 1.904 . . . . 0.0 113.848 -173.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 1.2 p -76.64 -36.57 57.32 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.883 0.373 . . . . 0.0 110.889 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -101.74 1.81 37.78 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . 0.711 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 42.2 t -96.15 103.12 14.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.777 175.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.14 177.28 4.89 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.4 138.98 33.36 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.423 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.97 132.43 54.22 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.464 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . 0.713 HD11 ' OD1' ' B' ' 102' ' ' ASN . 25.0 tp -125.57 142.13 51.67 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.055 0.455 . . . . 0.0 110.744 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . 0.475 ' O ' ' N ' ' B' ' 161' ' ' GLY . 0.2 OUTLIER -132.51 141.01 39.66 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.172 178.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' B' ' 161' ' ' GLY . 73.2 Cg_exo -38.35 -35.27 0.43 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 123.18 2.587 . . . . 0.0 112.448 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.57 -5.07 1.07 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.612 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' GLY . . . . . 0.68 ' HA2' ' OD1' ' B' ' 102' ' ' ASN . . . 76.08 33.0 51.21 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.662 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 15.1 t -98.7 114.97 27.7 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.14 0.495 . . . . 0.0 110.377 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.638 HD13 ' C ' ' B' ' 163' ' ' LEU . 1.9 tm? -109.2 102.93 11.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.103 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.94 126.96 43.59 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.509 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.6 m -108.33 108.05 24.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 174.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 0.8 OUTLIER -117.34 143.13 46.28 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.278 -174.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' ALA . . . . . 0.711 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -171.2 157.25 4.8 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-O 121.088 0.47 . . . . 0.0 111.995 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.1 -18.07 10.22 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 123.443 2.762 . . . . 0.0 110.933 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' MET . . . . . 0.672 ' SD ' ' HB2' ' B' ' 95' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.929 176.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 . . . . . 0 CA--C 1.5 -0.975 0 CA-C-O 120.677 0.275 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.661 ' CZ3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -91.64 151.98 20.45 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.207 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -144.64 98.87 3.26 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.432 -177.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.661 HG21 ' CZ3' ' A' ' 95' ' ' TRP . 2.0 t -111.65 150.66 13.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.1 139.48 51.17 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.779 HD22 HG12 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -115.08 74.0 0.86 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.741 175.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.531 ' C ' HG22 ' A' ' 101' ' ' VAL . 12.0 p-10 -70.8 112.96 7.4 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.579 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.531 HG22 ' C ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -173.25 -40.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.662 ' OD1' HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -41.32 -19.64 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.462 -1.699 . . . . 0.0 110.815 178.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 101' ' ' VAL . 5.0 t60 -45.67 -33.89 3.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.41 ' CZ ' ' NH1' ' A' ' 136' ' ' ARG . 52.6 m-85 -83.94 12.37 6.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.7 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 102' ' ' ASN . . . -179.19 96.71 0.2 Allowed Pre-proline 0 C--N 1.333 -0.143 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.608 ' HA ' HD21 ' A' ' 102' ' ' ASN . 47.6 Cg_endo -70.99 -48.5 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.452 2.101 . . . . 0.0 111.209 176.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -99.44 -30.93 11.91 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.038 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.449 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 2.4 mp0 -81.63 47.98 1.13 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.02 0.438 . . . . 0.0 110.245 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.662 HD22 ' OD1' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -131.57 138.54 48.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.255 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.418 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 1.3 m -128.38 123.03 32.82 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.631 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.481 HG13 ' CD1' ' A' ' 120' ' ' ILE . 1.9 t -102.81 122.38 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.423 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -127.6 134.78 49.68 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.817 -178.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 m -102.84 118.06 36.01 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.628 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.2 OUTLIER -115.84 83.16 1.89 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.219 0.533 . . . . 0.0 110.335 -176.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.4 t0 30.46 68.24 0.1 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.445 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.34 -23.08 29.19 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.63 HG13 HG23 ' A' ' 143' ' ' THR . 2.7 t -87.97 117.3 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 42.1 t -101.42 116.45 45.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.497 ' OE1' ' NZ ' ' A' ' 114' ' ' LYS . 8.9 mt-10 -133.1 134.16 43.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.941 0.401 . . . . 0.0 111.206 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.779 HG12 HD22 ' A' ' 99' ' ' LEU . 4.4 mm -106.33 142.65 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.863 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.423 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -123.64 115.46 21.5 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.201 -178.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.16 127.8 2.51 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.222 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.41 130.13 27.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.536 ' ND1' ' N ' ' A' ' 125' ' ' GLU . 48.7 t-80 -92.6 161.44 14.59 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.222 0.534 . . . . 0.0 111.744 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.536 ' N ' ' ND1' ' A' ' 124' ' ' HIS . 0.0 OUTLIER -87.46 149.26 24.53 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.892 177.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.463 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 4.8 tt0 -28.72 98.79 0.01 OUTLIER 'General case' 0 C--N 1.348 0.542 0 CA-C-O 120.915 0.388 . . . . 0.0 111.21 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 2.3 mtp-105 . . . . . 0 CA--C 1.506 -0.717 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.852 -178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.093 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -96.42 109.16 21.75 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 172.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.598 HD13 ' NH2' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -129.6 119.02 46.94 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -170.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 127' ' ' ARG . 4.1 m -127.15 154.74 44.39 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.598 ' NH2' HD13 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -141.51 -179.33 6.09 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.935 -175.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 27.8 p -129.34 123.4 31.67 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.504 ' CD2' HG11 ' A' ' 101' ' ' VAL . 4.4 m-85 -100.14 140.15 34.78 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.309 -176.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.72 117.53 11.65 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.489 0.662 . . . . 0.0 111.052 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.487 ' CD ' HD23 ' A' ' 99' ' ' LEU . 2.0 mtt180 -108.05 143.33 36.92 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.337 177.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.573 ' HZ3' ' HB2' ' A' ' 141' ' ' LYS . 7.7 ttmm -138.36 112.95 8.89 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.989 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.531 ' HB2' ' HB ' ' A' ' 118' ' ' VAL . 2.0 m-85 -114.72 99.83 7.8 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.102 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.63 HG23 HG13 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -91.06 91.31 8.23 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mp -112.24 89.99 13.19 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.717 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.624 ' HD2' ' CD ' ' A' ' 146' ' ' PRO . 11.8 Cg_exo -72.22 -50.88 0.23 Allowed 'Trans proline' 0 C--N 1.287 -2.708 0 C-N-CA 122.461 2.107 . . . . 0.0 113.591 171.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.624 ' CD ' ' HD2' ' A' ' 145' ' ' PRO . 24.7 Cg_exo -55.34 -14.53 9.48 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.67 2.247 . . . . 0.0 115.401 -174.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.68 43.07 0.13 Allowed Glycine 0 C--N 1.341 0.818 0 C-N-CA 116.833 -2.603 . . . . 0.0 116.378 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.541 HG21 ' CH2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -135.25 131.29 51.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 117.859 0.829 . . . . 0.0 110.561 171.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -95.59 143.59 26.37 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.321 -178.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 6.1 Cg_exo -80.32 -47.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.334 2.023 . . . . 0.0 113.231 -176.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -37.6 59.95 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.739 -175.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.638 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -93.42 11.68 27.58 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -172.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 40.7 t -108.64 115.25 48.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.938 0.399 . . . . 0.0 110.16 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.94 177.32 4.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.294 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.3 143.55 35.91 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.789 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.512 ' O ' HD22 ' A' ' 163' ' ' LEU . 0.9 OUTLIER -115.11 144.97 42.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.61 HD22 HD22 ' A' ' 109' ' ' LEU . 34.7 tp -138.14 136.86 37.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.808 0.337 . . . . 0.0 111.196 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.41 ' HB2' HG22 ' A' ' 162' ' ' THR . 0.3 OUTLIER -117.09 149.48 44.38 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.68 178.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -40.38 -43.91 4.12 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 123.205 2.603 . . . . 0.0 112.206 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -53.33 -14.94 0.83 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.832 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 102' ' ' ASN . . . 85.02 33.13 18.97 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.797 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.41 HG22 ' HB2' ' A' ' 158' ' ' SER . 2.0 t -96.18 128.51 43.15 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.576 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.8 tm? -118.15 107.78 14.38 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.857 -175.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.2 p -99.22 127.86 45.26 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 165' ' ' VAL . 4.4 m -105.26 98.34 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 173.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -114.33 141.39 47.66 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.671 -174.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 177.5 167.8 0.49 Allowed Pre-proline 0 C--O 1.234 0.281 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.34 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 88.5 Cg_endo -90.3 121.58 0.9 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 123.943 3.095 . . . . 0.0 109.404 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.16 166.38 11.34 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-O 121.073 0.463 . . . . 0.0 112.067 -173.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo . . . . . 0 C--N 1.309 -1.518 0 C-N-CA 122.879 2.386 . . . . 0.0 112.188 -179.478 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . 0.474 HH11 ' HD2' ' B' ' 94' ' ' ARG . 9.0 mmt180 . . . . . 0 C--O 1.237 0.433 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' TRP . . . . . 0.605 ' CZ3' HG21 ' B' ' 97' ' ' VAL . 0.0 OUTLIER -72.47 153.83 41.17 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -152.02 105.3 3.07 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.577 -174.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.605 HG21 ' CZ3' ' B' ' 95' ' ' TRP . 1.4 t -121.05 154.69 24.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 15.2 m -127.13 144.23 51.08 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.974 HD22 HG12 ' B' ' 120' ' ' ILE . 0.3 OUTLIER -114.05 122.78 47.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.53 174.114 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.548 ' C ' HG22 ' B' ' 101' ' ' VAL . 19.3 p-10 -112.72 114.75 27.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.119 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.626 ' C ' ' H ' ' B' ' 103' ' ' HIS . 0.1 OUTLIER -169.56 -56.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.793 0.806 . . . . 0.0 110.378 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.694 ' OD1' HD13 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -56.66 14.09 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.565 -177.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' HIS . . . . . 0.626 ' H ' ' C ' ' B' ' 101' ' ' VAL . 19.2 m170 -46.68 -28.99 1.66 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.97 0.414 . . . . 0.0 110.331 178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.44 ' HB3' ' CD2' ' B' ' 124' ' ' HIS . 24.8 t80 -120.04 24.18 10.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.711 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.02 91.15 4.92 Favored Pre-proline 0 CA--C 1.513 -0.467 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.168 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.88 -45.99 0.11 Allowed 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.447 2.098 . . . . 0.0 110.86 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' B' ' 107' ' ' ASP . 8.2 p-10 -98.58 -31.25 12.05 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.77 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.85 48.97 1.53 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.779 0.8 . . . . 0.0 110.248 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.694 HD13 ' OD1' ' B' ' 102' ' ' ASN . 0.4 OUTLIER -138.2 139.34 39.25 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.663 178.067 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.545 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -132.05 113.52 13.46 Favored 'General case' 0 C--N 1.31 -1.116 0 O-C-N 123.352 0.407 . . . . 0.0 110.091 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.81 119.09 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -129.75 129.41 44.1 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.454 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.1 m -98.05 122.91 41.76 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' LYS . . . . . 0.484 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 0.3 OUTLIER -111.99 -162.17 0.79 Allowed 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -178.286 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . 0.432 ' H ' ' HG2' ' B' ' 114' ' ' LYS . 2.8 p-10 -65.07 69.49 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.368 0.604 . . . . 0.0 112.174 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' B' ' 114' ' ' LYS . . . 78.25 -8.43 39.42 Favored Glycine 0 CA--C 1.499 -0.934 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' B' ' 114' ' ' LYS . 2.1 t -88.64 115.4 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.68 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 41.4 t -98.59 118.87 45.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.68 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 41.1 mt-10 -133.77 143.46 48.44 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.282 0.563 . . . . 0.0 110.835 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.974 HG12 HD22 ' B' ' 99' ' ' LEU . 2.4 mm -115.61 140.2 38.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.12 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.55 111.87 19.15 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.57 145.69 13.93 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.59 -177.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.51 159.72 43.78 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . 0.522 ' O ' ' HB3' ' B' ' 135' ' ' SER . 3.7 m-70 -116.92 137.51 52.17 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.208 -177.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.5 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.5 OUTLIER -69.67 138.0 52.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.306 178.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' B' ' 125' ' ' GLU . 1.0 OUTLIER -17.21 98.37 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' ARG . . . . . 0.405 ' NH1' ' CE1' ' B' ' 104' ' ' PHE . 6.8 mtp85 -83.77 149.54 26.37 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.289 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' GLN . . . . . 0.563 ' HG2' ' N ' ' B' ' 129' ' ' ASP . 3.9 tt0 -99.72 151.87 20.74 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.14 0.495 . . . . 0.0 111.174 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . 0.563 ' N ' ' HG2' ' B' ' 128' ' ' GLN . 19.6 t70 -161.38 169.29 22.26 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.514 175.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . 0.498 ' N ' ' CG ' ' B' ' 129' ' ' ASP . 4.2 tp10 -80.65 -11.42 59.64 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.435 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' HIS . . . . . 0.418 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 55.5 m-70 -115.93 31.41 6.74 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.251 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.55 164.16 11.86 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.672 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' TYR . . . . . 0.415 ' CE2' ' HG3' ' B' ' 128' ' ' GLN . 69.5 m-85 -95.68 139.32 32.09 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.06 126.38 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -170.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' B' ' 124' ' ' HIS . 0.0 OUTLIER -128.98 157.78 40.71 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -154.06 159.59 41.61 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.336 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 21.4 p -112.96 138.1 50.35 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . 0.437 ' CD2' HG11 ' B' ' 101' ' ' VAL . 0.2 OUTLIER -118.59 149.13 41.88 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.822 -176.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.74 134.51 17.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.678 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . 0.408 ' CB ' ' HE1' ' B' ' 142' ' ' TYR . 0.0 OUTLIER -135.8 107.62 7.06 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . 0.68 ' HA ' ' HG2' ' B' ' 119' ' ' GLU . 32.2 ttmt -96.86 113.94 25.52 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.038 0.447 . . . . 0.0 110.996 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' TYR . . . . . 0.502 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 2.4 m-85 -104.29 98.86 8.6 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.195 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . 0.492 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.2 OUTLIER -92.53 96.81 10.44 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.1 mp -113.25 90.48 16.78 Favored Pre-proline 0 CA--C 1.511 -0.538 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.12 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . 0.609 ' HD2' ' CD ' ' B' ' 146' ' ' PRO . 15.9 Cg_exo -69.88 -42.89 2.9 Favored 'Trans proline' 0 C--N 1.277 -3.2 0 C-N-CA 122.19 1.927 . . . . 0.0 112.679 169.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' PRO . . . . . 0.609 ' CD ' ' HD2' ' B' ' 145' ' ' PRO . 76.3 Cg_exo -42.82 -15.83 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 123.001 2.467 . . . . 0.0 114.333 -176.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 151.76 58.13 0.01 OUTLIER Glycine 0 C--N 1.343 0.972 0 C-N-CA 118.199 -1.953 . . . . 0.0 115.201 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' VAL . . . . . 0.461 HG21 ' CH2' ' B' ' 95' ' ' TRP . 0.9 OUTLIER -123.34 113.1 36.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.573 172.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 24.4 t70 -77.44 137.91 63.66 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.569 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 5.3 Cg_exo -81.12 -23.8 5.06 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.122 1.881 . . . . 0.0 112.891 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.33 -41.24 11.63 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.269 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -97.42 15.5 22.91 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . 0.664 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 30.6 t -103.91 117.2 49.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.01 171.1 7.8 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.29 130.79 33.49 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.423 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . 0.441 ' CB ' ' HG1' ' B' ' 164' ' ' THR . 0.0 OUTLIER -100.05 134.79 42.44 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.652 176.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . 0.461 HD22 ' CD2' ' B' ' 109' ' ' LEU . 29.8 tp -128.36 131.55 48.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.939 0.399 . . . . 0.0 110.652 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . 0.425 ' H ' HD12 ' B' ' 157' ' ' LEU . 0.2 OUTLIER -117.41 149.97 45.66 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.349 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' PRO . . . . . 0.595 ' C ' ' H ' ' B' ' 161' ' ' GLY . 85.5 Cg_exo -42.6 -34.34 3.32 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.419 2.079 . . . . 0.0 110.686 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.97 29.56 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.38 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 34.98 34.1 0.04 OUTLIER Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.585 0.612 . . . . 0.0 112.927 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' THR . . . . . 0.411 ' O ' HG23 ' B' ' 162' ' ' THR . 9.0 t -97.2 117.06 30.55 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.617 HD13 ' C ' ' B' ' 163' ' ' LEU . 2.7 tm? -108.21 103.08 12.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.505 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 0.441 ' HG1' ' CB ' ' B' ' 156' ' ' SER . 0.5 OUTLIER -92.08 124.46 36.19 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 121.246 -0.181 . . . . 0.0 110.637 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.508 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.1 m -105.83 109.63 28.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 0.42 ' OE1' ' NH1' ' B' ' 94' ' ' ARG . 1.8 pp20? -120.2 154.99 34.05 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.601 -176.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' ALA . . . . . 0.664 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . 177.93 157.02 0.54 Allowed Pre-proline 0 CA--C 1.518 -0.25 0 CA-C-O 120.989 0.423 . . . . 0.0 111.212 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' PRO . . . . . 0.564 ' C ' ' HG3' ' B' ' 169' ' ' MET . 81.5 Cg_endo -80.41 -24.24 5.52 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.905 2.403 . . . . 0.0 110.043 174.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' MET . . . . . 0.564 ' HG3' ' C ' ' B' ' 168' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.544 0.74 0 CA-C-N 114.528 -1.214 . . . . 0.0 113.131 175.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 8.8 mmm180 . . . . . 0 CA--C 1.51 -0.559 0 CA-C-O 120.896 0.379 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.592 ' NE1' ' CG2' ' A' ' 97' ' ' VAL . 46.8 t-105 -86.7 142.87 27.88 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 -136.42 117.13 13.99 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.592 ' CG2' ' NE1' ' A' ' 95' ' ' TRP . 1.1 t -132.09 158.2 43.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.578 175.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 3.0 m -130.48 157.61 42.17 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -175.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.839 HD23 ' NE ' ' A' ' 140' ' ' ARG . 0.6 OUTLIER -136.79 94.52 2.99 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.632 175.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.591 ' C ' HG22 ' A' ' 101' ' ' VAL . 1.9 p-10 -97.08 119.38 35.45 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.312 -177.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.768 HG11 ' CD2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -174.34 -50.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.643 0.735 . . . . 0.0 110.649 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.65 ' OD1' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -54.52 17.68 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.708 -1.133 . . . . 0.0 113.761 -176.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.581 ' H ' ' C ' ' A' ' 101' ' ' VAL . 57.5 m-70 -39.33 -50.1 2.01 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.009 0.433 . . . . 0.0 111.198 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -92.05 -6.13 51.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.901 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -116.88 90.32 32.03 Favored Pre-proline 0 CA--C 1.511 -0.534 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.633 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.32 -51.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.461 2.107 . . . . 0.0 110.922 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 109' ' ' LEU . 12.9 t70 -95.02 -31.18 13.72 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.432 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.451 ' N ' ' CD ' ' A' ' 108' ' ' GLU . 20.0 mp0 -77.88 28.87 0.17 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.161 0.505 . . . . 0.0 110.927 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.753 HD22 HD22 ' A' ' 157' ' ' LEU . 0.8 OUTLIER -114.51 134.9 54.68 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 176.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.414 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -123.87 113.27 18.29 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.092 -178.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.4 129.13 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -140.35 134.22 30.6 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.138 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.56 119.94 35.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 176.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.607 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.3 OUTLIER -116.59 80.75 1.51 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.252 0.549 . . . . 0.0 110.059 -177.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.2 t70 29.5 65.54 0.12 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.717 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.77 -24.21 32.63 Favored Glycine 0 C--N 1.313 -0.707 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.607 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 2.2 t -88.16 115.76 28.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.239 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 59.1 t -101.98 115.65 44.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.698 ' CD ' ' HZ2' ' A' ' 141' ' ' LYS . 66.5 mt-10 -130.61 142.32 50.45 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.467 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.783 HG12 HD22 ' A' ' 99' ' ' LEU . 3.5 mm -111.81 142.51 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.763 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.25 117.85 26.24 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.648 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.09 135.61 5.33 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.925 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.0 144.92 25.2 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.066 0.946 . . . . 0.0 108.503 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.512 ' HB3' ' NH2' ' A' ' 127' ' ' ARG . 49.9 t60 -115.69 165.79 12.65 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.834 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.515 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.7 OUTLIER -90.16 132.54 35.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.689 -178.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.515 ' C ' ' O ' ' A' ' 125' ' ' GLU . 11.7 tt0 -7.58 111.82 0.01 OUTLIER 'General case' 0 C--N 1.348 0.509 0 C-N-CA 123.326 0.65 . . . . 0.0 112.638 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.512 ' NH2' ' HB3' ' A' ' 124' ' ' HIS . 26.4 mtm180 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.039 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.205 0 N-CA-C 111.092 -0.803 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -94.75 117.22 29.78 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 172.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.57 123.16 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -171.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.18 164.19 26.07 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.3 ptt180 -150.5 177.14 10.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.115 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 25.6 p -120.52 148.44 43.84 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.768 ' CD2' HG11 ' A' ' 101' ' ' VAL . 1.0 OUTLIER -121.81 128.5 51.75 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.296 -179.215 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.08 120.12 24.16 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.304 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.839 ' NE ' HD23 ' A' ' 99' ' ' LEU . 1.2 mmm180 -117.9 139.36 51.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.698 ' HZ2' ' CD ' ' A' ' 119' ' ' GLU . 12.9 ttmm -133.38 110.6 10.14 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.847 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.579 ' OH ' ' NH2' ' A' ' 140' ' ' ARG . 30.0 m-85 -106.07 99.26 8.86 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.485 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -90.54 89.14 7.43 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.528 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.3 mp -112.41 92.3 18.99 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.632 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 16.7 Cg_exo -67.65 -55.87 0.25 Allowed 'Trans proline' 0 C--N 1.288 -2.625 0 C-N-CA 122.139 1.893 . . . . 0.0 113.045 175.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.632 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 56.5 Cg_endo -100.93 76.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.329 -0.491 0 C-N-CA 123.271 2.647 . . . . 0.0 112.251 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 164.5 -17.43 0.11 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.49 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.81 126.75 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 117.599 0.699 . . . . 0.0 111.045 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.408 ' OD1' ' HG3' ' A' ' 152' ' ' GLN . 14.7 t70 -87.1 145.28 37.81 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.637 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.86 -28.79 2.42 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.872 1.715 . . . . 0.0 112.567 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.61 -41.31 10.83 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.632 -174.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.707 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 3.2 mt-30 -98.77 22.54 9.92 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -172.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.5 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 39.9 t -103.6 119.74 52.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.093 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.33 179.48 4.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.52 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 164' ' ' THR . 0.9 OUTLIER -158.81 124.86 4.5 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.419 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.454 ' O ' HD22 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -104.25 139.21 39.59 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.306 178.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.753 HD22 HD22 ' A' ' 109' ' ' LEU . 30.7 tp -131.62 135.35 46.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.315 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.474 ' H ' HD12 ' A' ' 157' ' ' LEU . 0.4 OUTLIER -121.56 150.97 56.12 Favored Pre-proline 0 C--N 1.313 -0.995 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' A' ' 161' ' ' GLY . 82.3 Cg_exo -41.28 -35.51 2.17 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.323 2.015 . . . . 0.0 110.738 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 1.8 mp0 -67.28 28.76 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.485 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.617 ' H ' ' C ' ' A' ' 159' ' ' PRO . . . 35.73 31.45 0.03 OUTLIER Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.636 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 162' ' ' THR . 14.0 t -91.35 115.29 27.91 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.604 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.9 tm? -109.05 104.03 13.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.687 -176.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 155' ' ' SER . 0.8 OUTLIER -95.28 123.39 38.77 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.597 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 165' ' ' VAL . 2.9 m -107.29 99.23 8.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 1.7 pp20? -118.38 150.83 38.88 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.822 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.707 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 174.08 167.74 0.31 Allowed Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.255 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.559 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 73.9 Cg_endo -88.1 117.48 1.07 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 123.619 2.879 . . . . 0.0 108.9 175.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.49 ' SD ' ' HB2' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -109.21 175.07 2.09 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.407 -172.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 169' ' ' MET . 14.1 Cg_exo . . . . . 0 C--N 1.311 -1.442 0 C-N-CA 122.932 2.421 . . . . 0.0 110.692 178.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? . . . . . 0 CA--C 1.5 -0.943 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' TRP . . . . . 0.629 ' HB2' ' SD ' ' B' ' 169' ' ' MET . 28.2 t-105 -125.67 152.72 44.86 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -145.53 102.41 3.69 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.269 -177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.538 HG22 ' NE1' ' B' ' 95' ' ' TRP . 0.2 OUTLIER -116.0 157.88 16.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.021 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 2.3 m -130.25 148.84 52.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.501 HD22 ' HB ' ' B' ' 120' ' ' ILE . 0.3 OUTLIER -122.58 117.85 26.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.128 174.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.537 ' C ' HG22 ' B' ' 101' ' ' VAL . 0.1 OUTLIER -113.99 115.35 27.5 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.537 HG22 ' C ' ' B' ' 100' ' ' ASP . 0.1 OUTLIER -167.72 -34.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.237 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.614 ' OD1' ' HA2' ' B' ' 161' ' ' GLY . 0.4 OUTLIER -80.8 16.6 1.38 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -174.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' HIS . . . . . 0.563 ' N ' ' HA3' ' B' ' 161' ' ' GLY . 11.5 m80 -43.03 -39.91 2.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.105 0.478 . . . . 0.0 110.174 177.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -92.41 -1.14 57.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.251 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . 0.547 ' C ' HD22 ' B' ' 102' ' ' ASN . . . -135.11 77.47 55.43 Favored Pre-proline 0 CA--C 1.511 -0.538 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.9 -38.17 3.15 Favored 'Trans proline' 0 C--N 1.295 -2.272 0 C-N-CA 122.48 2.12 . . . . 0.0 110.92 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -96.04 -26.86 15.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.003 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -95.85 49.02 1.14 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.111 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.703 HD22 HD22 ' B' ' 157' ' ' LEU . 0.5 OUTLIER -125.18 143.69 50.82 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.174 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.465 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -139.04 112.37 8.14 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.371 -177.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.55 125.6 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -133.62 133.25 41.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.758 0.313 . . . . 0.0 111.293 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.16 122.58 39.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' LYS . . . . . 0.553 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 2.5 ttpt -126.37 91.44 3.37 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-O 120.847 0.356 . . . . 0.0 110.881 -176.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' B' ' 117' ' ' VAL . 6.7 p-10 34.58 66.55 0.28 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.07 -15.59 8.38 Favored Glycine 0 C--N 1.307 -1.055 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.852 HG22 HG23 ' B' ' 143' ' ' THR . 7.2 t -87.44 114.36 26.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 42.8 t -99.25 121.05 49.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.135 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 76.8 mt-10 -130.27 140.11 50.71 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.303 0.573 . . . . 0.0 111.025 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.501 ' HB ' HD22 ' B' ' 99' ' ' LEU . 1.3 mp -114.96 117.04 54.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.093 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -97.83 120.0 37.44 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.02 -178.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -146.68 126.95 2.58 Favored Glycine 0 N--CA 1.452 -0.272 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.11 159.35 40.37 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . 0.499 ' ND1' ' HB2' ' B' ' 105' ' ' ALA . 3.6 m-70 -123.05 130.9 53.39 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.245 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' B' ' 126' ' ' GLU . 4.5 tp10 -70.79 137.62 49.71 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . 0.587 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 5.1 tt0 -11.91 99.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.481 0.488 . . . . 0.0 111.737 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' ARG . . . . . 0.607 ' HB2' ' NH1' ' B' ' 127' ' ' ARG . 0.2 OUTLIER -89.12 128.86 35.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.499 -178.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -75.53 127.43 33.08 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . 0.52 ' HB2' HG22 ' B' ' 134' ' ' ILE . 0.3 OUTLIER -138.27 164.72 28.51 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -70.49 -36.0 73.58 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.965 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' HIS . . . . . 0.498 ' O ' ' OH ' ' A' ' 142' ' ' TYR . 73.0 m-70 -100.16 40.36 1.25 Allowed 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 120.669 0.271 . . . . 0.0 110.572 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 114.46 174.16 18.35 Favored Glycine 0 C--N 1.299 -1.473 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.251 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -95.09 114.7 26.53 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . 0.559 HD11 ' NH2' ' B' ' 136' ' ' ARG . 0.0 OUTLIER -127.35 118.6 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -173.031 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . 0.587 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.3 OUTLIER -126.61 154.8 43.46 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.004 176.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . 0.559 ' NH2' HD11 ' B' ' 134' ' ' ILE . 9.8 ptp85 -144.85 163.59 33.62 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.943 0.401 . . . . 0.0 111.483 -177.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 30.3 p -117.79 130.3 56.21 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -104.06 144.04 32.09 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.456 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.39 113.71 6.63 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.75 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . 0.493 ' NH2' ' OH ' ' B' ' 142' ' ' TYR . 0.0 OUTLIER -121.13 119.15 31.57 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . 0.499 ' NZ ' ' OE1' ' A' ' 126' ' ' GLU . 11.9 ttmt -110.81 121.37 45.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.945 0.403 . . . . 0.0 110.747 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' TYR . . . . . 0.548 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 1.7 m-85 -109.28 99.53 8.78 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.975 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . 0.852 HG23 HG22 ' B' ' 117' ' ' VAL . 0.3 OUTLIER -90.29 99.69 12.66 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.141 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 7.4 mp -109.59 94.54 16.75 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' B' ' 147' ' ' GLY . 24.7 Cg_exo -66.21 -38.56 20.8 Favored 'Trans proline' 0 C--N 1.287 -2.678 0 C-N-CA 123.151 2.567 . . . . 0.0 114.513 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' B' ' 145' ' ' PRO . 34.4 Cg_exo -42.91 -13.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 121.458 1.439 . . . . 0.0 111.746 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 113.66 42.62 0.86 Allowed Glycine 0 C--N 1.343 0.943 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.52 172.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' VAL . . . . . 0.471 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -57.13 101.32 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . 0.581 ' O ' HG23 ' B' ' 153' ' ' VAL . 14.5 t0 -41.77 119.12 2.01 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.869 -172.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 5.2 Cg_exo -74.96 -26.54 10.91 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.23 1.953 . . . . 0.0 112.027 -178.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.56 -32.41 16.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.007 -177.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' GLN . . . . . 0.427 ' O ' ' HB1' ' B' ' 167' ' ' ALA . 22.9 mt-30 -107.31 19.2 20.64 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . 0.581 HG23 ' O ' ' B' ' 149' ' ' ASP . 27.9 t -105.46 95.37 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.324 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.05 -173.9 4.24 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . 0.42 ' HB3' HD11 ' B' ' 163' ' ' LEU . 0.5 OUTLIER -159.74 138.38 10.63 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.734 -0.786 . . . . 0.0 112.056 -179.271 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . 0.434 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.0 OUTLIER -107.14 136.38 47.09 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.053 178.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . 0.703 HD22 HD22 ' B' ' 109' ' ' LEU . 25.5 tp -124.95 131.58 53.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.908 0.385 . . . . 0.0 110.413 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . 0.421 ' HB3' HG22 ' B' ' 162' ' ' THR . 0.3 OUTLIER -111.39 152.99 44.28 Favored Pre-proline 0 C--N 1.315 -0.931 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' PRO . . . . . 0.455 ' C ' ' H ' ' B' ' 161' ' ' GLY . 9.7 Cg_endo -53.25 -20.58 15.07 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.069 1.846 . . . . 0.0 110.613 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -77.5 27.1 0.16 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.217 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' GLY . . . . . 0.614 ' HA2' ' OD1' ' B' ' 102' ' ' ASN . . . 41.72 34.5 1.25 Allowed Glycine 0 N--CA 1.462 0.396 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.945 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' THR . . . . . 0.421 HG22 ' HB3' ' B' ' 158' ' ' SER . 15.1 t -104.32 124.44 49.18 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.646 HD13 ' C ' ' B' ' 163' ' ' LEU . 2.5 tm? -114.87 109.73 18.59 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.204 -174.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.9 129.06 42.06 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.708 0.231 . . . . 0.0 110.476 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.567 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.2 m -113.44 103.99 16.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 1.7 pp20? -118.22 141.41 48.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.894 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' ALA . . . . . 0.558 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -177.98 159.14 1.22 Allowed Pre-proline 0 N--CA 1.453 -0.281 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' PRO . . . . . 0.472 ' HD2' ' HB1' ' B' ' 167' ' ' ALA . 88.9 Cg_endo -77.64 81.01 2.78 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 123.72 2.947 . . . . 0.0 109.94 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' MET . . . . . 0.629 ' SD ' ' HB2' ' B' ' 95' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.31 -1.147 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.55 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 . . . . . 0 CA--C 1.517 -0.292 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.541 ' HB2' ' HG3' ' A' ' 169' ' ' MET . 0.0 OUTLIER -61.52 113.25 2.58 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -109.61 100.02 9.12 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.902 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -106.77 135.47 45.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 2.4 m -108.82 141.2 41.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.842 0.353 . . . . 0.0 111.945 -176.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.672 HD22 ' HB ' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -119.41 56.31 0.93 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.518 175.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -62.0 109.96 1.43 Allowed 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.329 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.566 HG21 ' CD2' ' A' ' 138' ' ' PHE . 11.8 p -171.15 -17.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.641 ' OD1' HD11 ' A' ' 157' ' ' LEU . 0.8 OUTLIER -90.52 16.79 8.3 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.684 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.558 ' N ' ' HA3' ' A' ' 161' ' ' GLY . 0.0 OUTLIER -41.03 -34.24 0.4 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.829 0.347 . . . . 0.0 111.026 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -101.87 11.42 38.66 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.806 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -143.3 86.52 8.99 Favored Pre-proline 0 CA--C 1.512 -0.515 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.433 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.37 -42.8 0.42 Allowed 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 122.44 2.093 . . . . 0.0 111.338 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -98.08 -31.79 11.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.583 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 123' ' ' LYS . 2.7 mm-40 -81.31 51.16 1.57 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.448 0.642 . . . . 0.0 110.347 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.746 HD22 HD22 ' A' ' 157' ' ' LEU . 0.5 OUTLIER -137.63 124.83 21.67 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.69 178.08 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.49 115.12 21.04 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.616 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.448 HG13 HD11 ' A' ' 120' ' ' ILE . 1.7 t -96.97 123.23 49.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.28 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.482 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 1.6 pttm -133.51 135.14 44.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.826 0.346 . . . . 0.0 111.081 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -109.61 114.84 28.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.3 ttpp -118.98 80.01 1.48 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.772 0.32 . . . . 0.0 111.652 -176.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.9 t0 49.77 69.57 0.59 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.156 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.1 -20.52 9.86 Favored Glycine 0 C--N 1.32 -0.339 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.863 HG22 HG23 ' A' ' 143' ' ' THR . 16.7 t -86.86 111.26 21.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.634 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.4 t -102.7 112.49 36.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.553 ' HG2' ' HA ' ' A' ' 141' ' ' LYS . 40.6 mt-10 -124.41 133.55 53.36 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.351 0.596 . . . . 0.0 111.53 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.672 ' HB ' HD22 ' A' ' 99' ' ' LEU . 1.1 mp -108.05 118.54 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.926 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.482 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -97.7 122.81 41.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.501 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.31 134.0 4.6 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.626 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -131.5 159.76 37.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -125.71 136.88 53.68 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.96 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.533 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -88.81 134.77 33.82 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' A' ' 125' ' ' GLU . 2.8 tt0 -1.9 98.85 0.01 OUTLIER 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.759 0.662 . . . . 0.0 112.548 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 11.0 mtp-105 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 120.907 0.384 . . . . 0.0 111.081 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.982 0 CA-C-O 121.257 0.365 . . . . 0.0 113.594 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 12.6 m-30 -96.36 113.77 25.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.7 HD11 HH11 ' A' ' 136' ' ' ARG . 0.0 OUTLIER -120.07 145.16 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -176.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -144.11 156.34 44.31 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.7 HH11 HD11 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -152.24 -178.45 6.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.825 0.345 . . . . 0.0 111.443 -175.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 26.4 p -139.76 134.0 31.24 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 175.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.566 ' CD2' HG21 ' A' ' 101' ' ' VAL . 46.9 m-85 -100.36 141.04 33.75 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.76 99.19 4.86 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.103 172.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.676 ' NH2' ' CD1' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -104.81 99.92 9.55 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.001 -179.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.553 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 13.8 ttpt -112.34 127.89 56.13 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.713 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.676 ' CD1' ' NH2' ' A' ' 140' ' ' ARG . 11.9 m-85 -127.25 100.02 5.9 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.515 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.863 HG23 HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -85.4 89.79 7.77 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.498 179.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.3 mp -108.69 93.4 12.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.332 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.63 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 16.7 Cg_exo -66.95 -54.93 0.36 Allowed 'Trans proline' 0 C--N 1.294 -2.332 0 C-N-CA 122.143 1.895 . . . . 0.0 112.798 175.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.63 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 57.6 Cg_endo -102.87 89.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.556 2.838 . . . . 0.0 111.729 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.86 -19.57 0.76 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.922 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.62 128.83 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 117.121 0.46 . . . . 0.0 110.511 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -92.88 143.13 26.42 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.044 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.54 -22.61 4.53 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.877 1.718 . . . . 0.0 112.362 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.67 -41.04 10.95 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.212 -175.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.606 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 3.6 mt-30 -106.5 23.77 13.67 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -172.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.481 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 42.8 t -110.67 111.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.921 0.391 . . . . 0.0 110.878 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.62 -178.0 3.47 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.92 139.3 26.15 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.048 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.54 137.66 47.94 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.413 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.746 HD22 HD22 ' A' ' 109' ' ' LEU . 31.4 tp -128.43 145.45 51.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.896 0.379 . . . . 0.0 110.726 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.29 155.23 81.79 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.815 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.55 ' C ' ' H ' ' A' ' 161' ' ' GLY . 91.8 Cg_exo -42.27 -42.58 7.63 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.905 2.403 . . . . 0.0 111.865 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -62.54 10.77 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.644 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.627 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 59.39 33.57 76.72 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 112.06 -0.416 . . . . 0.0 112.06 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 162' ' ' THR . 6.2 t -95.18 114.85 26.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.453 . . . . 0.0 109.919 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.611 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.1 tm? -108.49 104.78 14.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.875 -177.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.7 p -99.42 116.79 32.38 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 165' ' ' VAL . 3.5 m -95.45 99.69 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -115.02 138.31 51.01 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.022 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.606 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . -178.11 162.83 1.25 Allowed Pre-proline 0 C--N 1.32 -0.7 0 CA-C-O 121.313 0.578 . . . . 0.0 111.771 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 86.6 Cg_endo -87.77 109.16 0.65 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 123.257 2.638 . . . . 0.0 108.229 175.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.595 ' SD ' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -109.39 169.15 6.74 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.506 -173.004 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 169' ' ' MET . 19.5 Cg_endo . . . . . 0 N--CA 1.503 2.08 0 C-N-CA 123.222 2.615 . . . . 0.0 112.065 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . 0.485 ' NH2' ' OE2' ' B' ' 166' ' ' GLU . 7.9 mmm180 . . . . . 0 CA--C 1.512 -0.519 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' TRP . . . . . 0.559 ' NE1' ' CG2' ' B' ' 97' ' ' VAL . 63.2 t-105 -115.8 113.9 24.03 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -119.83 104.72 10.45 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.579 -175.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.559 ' CG2' ' NE1' ' B' ' 95' ' ' TRP . 0.2 OUTLIER -112.59 158.12 13.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 16.1 m -134.31 142.52 47.3 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -176.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.771 HD23 HH11 ' B' ' 140' ' ' ARG . 0.4 OUTLIER -112.97 79.89 1.29 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.472 174.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.489 ' C ' HG22 ' B' ' 101' ' ' VAL . 5.0 p-10 -86.36 102.76 14.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.86 0.362 . . . . 0.0 111.143 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.489 HG22 ' C ' ' B' ' 100' ' ' ASP . 0.0 OUTLIER -163.94 -40.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.765 0.317 . . . . 0.0 111.463 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' B' ' 161' ' ' GLY . 0.0 OUTLIER -60.25 11.16 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -175.282 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' HIS . . . . . 0.531 ' N ' ' HA3' ' B' ' 161' ' ' GLY . 3.1 p80 -52.4 -19.07 1.93 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.137 0.494 . . . . 0.0 109.87 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.432 ' CE2' ' NH2' ' B' ' 136' ' ' ARG . 47.9 p90 -94.48 -9.26 36.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.138 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.51 91.8 5.68 Favored Pre-proline 0 CA--C 1.516 -0.351 0 CA-C-O 120.826 0.346 . . . . 0.0 111.536 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.95 -49.77 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.471 2.114 . . . . 0.0 111.266 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -89.66 -31.2 17.62 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.225 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.502 ' OE2' ' NZ ' ' B' ' 123' ' ' LYS . 13.2 mt-10 -87.08 49.84 1.9 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.311 0.577 . . . . 0.0 110.135 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.858 HD22 HD22 ' B' ' 157' ' ' LEU . 0.4 OUTLIER -133.18 142.6 48.7 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.111 178.405 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.528 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -137.05 120.25 16.74 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.432 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.462 HG13 HD11 ' B' ' 120' ' ' ILE . 2.5 t -102.2 125.37 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.358 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.413 ' NZ ' ' HB2' ' B' ' 119' ' ' GLU . 14.6 pttp -136.4 142.11 43.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.665 0.269 . . . . 0.0 111.145 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.91 114.95 29.35 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' LYS . . . . . 0.535 ' NZ ' ' CB ' ' B' ' 114' ' ' LYS . 0.0 OUTLIER -111.81 92.91 4.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.117 -177.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 29.5 t70 32.77 66.35 0.2 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.273 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.52 -21.93 19.29 Favored Glycine 0 N--CA 1.466 0.665 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.759 HG22 HG23 ' B' ' 143' ' ' THR . 5.9 t -87.79 120.43 36.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 54.3 t -106.49 123.73 61.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.442 ' OE2' ' NZ ' ' B' ' 114' ' ' LYS . 2.8 mt-10 -135.66 140.65 44.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.973 0.416 . . . . 0.0 110.767 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.49 ' HB ' HD22 ' B' ' 99' ' ' LEU . 1.2 mp -117.72 117.75 56.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.791 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -91.16 123.29 34.5 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.443 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.07 116.5 0.78 Allowed Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' LYS . . . . . 0.502 ' NZ ' ' OE2' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -140.86 126.3 18.8 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.282 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . 0.707 ' H ' ' CD2' ' B' ' 124' ' ' HIS . 0.2 OUTLIER -95.77 134.84 38.25 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.371 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' B' ' 126' ' ' GLU . 3.2 tp10 -69.36 136.41 51.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.383 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . 0.531 ' C ' ' O ' ' B' ' 125' ' ' GLU . 39.3 tt0 -1.62 98.39 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.797 0.685 . . . . 0.0 112.111 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -93.02 129.93 38.78 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.079 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -77.52 122.6 25.47 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . 0.524 ' HB2' HG22 ' B' ' 134' ' ' ILE . 1.9 t70 -120.29 173.02 7.38 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.866 0.365 . . . . 0.0 110.766 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.58 -30.97 70.14 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -174.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' HIS . . . . . 0.529 ' O ' ' CE1' ' A' ' 142' ' ' TYR . 75.0 m-70 -110.82 24.68 12.64 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 132.84 -149.88 19.64 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 120.228 -0.987 . . . . 0.0 111.955 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' TYR . . . . . 0.554 ' O ' ' NH1' ' A' ' 140' ' ' ARG . 63.4 m-85 -111.18 125.16 53.5 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . 0.524 HG22 ' HB2' ' B' ' 129' ' ' ASP . 0.0 OUTLIER -145.96 121.56 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 120.659 0.266 . . . . 0.0 111.092 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . 0.41 ' HB3' ' CD2' ' B' ' 124' ' ' HIS . 0.7 OUTLIER -150.51 157.75 43.37 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 178.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . 0.618 ' HD3' ' CE1' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -145.53 171.52 14.55 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.113 0.482 . . . . 0.0 111.65 -177.071 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 29.5 p -107.93 132.13 53.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.693 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . 0.618 ' CE1' ' HD3' ' B' ' 136' ' ' ARG . 0.3 OUTLIER -108.78 139.76 43.15 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.774 0.321 . . . . 0.0 110.903 -178.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.64 103.95 3.57 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.259 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . 0.771 HH11 HD23 ' B' ' 99' ' ' LEU . 0.0 OUTLIER -104.91 123.85 48.45 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . 0.41 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 1.5 ttpp -113.54 118.19 33.75 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' TYR . . . . . 0.644 ' OH ' ' NH1' ' B' ' 140' ' ' ARG . 2.1 m-30 -106.04 97.88 7.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.739 0.304 . . . . 0.0 110.192 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . 0.759 HG23 HG22 ' B' ' 117' ' ' VAL . 0.2 OUTLIER -90.98 100.27 13.17 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -109.73 92.54 12.53 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.825 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . 0.575 ' O ' ' N ' ' B' ' 147' ' ' GLY . 24.6 Cg_exo -65.76 -39.85 19.07 Favored 'Trans proline' 0 C--N 1.287 -2.705 0 C-N-CA 122.527 2.151 . . . . 0.0 112.428 171.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 83.7 Cg_exo -41.59 -8.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 123.296 2.664 . . . . 0.0 113.506 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 116.4 69.65 0.43 Allowed Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.101 -1.047 . . . . 0.0 113.989 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' VAL . . . . . 0.449 ' O ' HG12 ' B' ' 148' ' ' VAL . 0.5 OUTLIER -112.76 112.4 40.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . 0.481 ' O ' HG23 ' B' ' 153' ' ' VAL . 19.1 t70 -64.39 135.51 96.38 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.692 -176.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 3.8 Cg_exo -78.58 -26.2 6.02 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.922 1.748 . . . . 0.0 113.188 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.93 -42.32 10.65 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -94.49 15.97 16.52 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -174.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . 0.699 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 37.1 t -101.34 89.6 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.442 177.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.41 178.43 8.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.38 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.78 133.65 10.27 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.472 -178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . 0.567 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.0 OUTLIER -113.31 142.8 45.41 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.369 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . 0.858 HD22 HD22 ' B' ' 109' ' ' LEU . 35.0 tp -128.88 148.7 50.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 110.291 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . 0.614 ' H ' HD12 ' B' ' 157' ' ' LEU . 0.3 OUTLIER -134.77 154.02 79.15 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.504 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' PRO . . . . . 0.552 ' C ' ' H ' ' B' ' 161' ' ' GLY . 80.5 Cg_exo -41.05 -40.45 3.89 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.739 2.293 . . . . 0.0 111.239 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.27 17.64 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.376 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' GLY . . . . . 0.552 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 49.72 31.33 15.71 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' THR . . . . . 0.497 ' CG2' ' HB2' ' B' ' 158' ' ' SER . 15.0 t -90.57 120.77 31.92 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.604 HD13 ' C ' ' B' ' 163' ' ' LEU . 3.1 tm? -115.77 102.65 9.91 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.88 125.42 37.47 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.12 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.577 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.0 m -112.6 100.03 9.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 174.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 0.485 ' OE2' ' NH2' ' B' ' 94' ' ' ARG . 0.0 OUTLIER -110.01 132.74 53.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.937 -176.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' ALA . . . . . 0.699 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -164.0 150.24 9.65 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.65 67.19 6.47 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 123.867 3.045 . . . . 0.0 109.98 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' MET . . . . . 0.506 ' HG2' ' CB ' ' B' ' 95' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.193 -176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.454 ' NH1' ' OE1' ' A' ' 166' ' ' GLU . 6.5 mmt85 . . . . . 0 CA--C 1.501 -0.917 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.715 ' CZ3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -86.13 160.12 19.33 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 96' ' ' ARG . 21.3 ttp-105 -151.37 99.66 2.66 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.128 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.715 HG21 ' CZ3' ' A' ' 95' ' ' TRP . 1.3 t -116.27 148.1 19.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 176.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.23 150.1 30.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.936 0.398 . . . . 0.0 111.878 -175.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.746 HD22 HG12 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -128.82 91.16 3.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.643 175.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.591 ' C ' HG22 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -81.56 124.78 29.8 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.477 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.591 HG22 ' C ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -178.72 -40.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-O 122.403 1.097 . . . . 0.0 108.434 178.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.87 ' HB2' HD13 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -58.92 -14.27 8.67 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 113.373 -1.739 . . . . 0.0 111.683 -178.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.572 ' CE1' ' HA ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -45.14 -22.78 0.12 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.567 -178.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.32 17.27 12.26 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.88 86.31 3.84 Favored Pre-proline 0 N--CA 1.467 0.409 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.875 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.533 ' HA ' HD21 ' A' ' 102' ' ' ASN . 51.3 Cg_endo -70.95 -47.28 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.511 2.141 . . . . 0.0 111.517 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -94.81 -30.46 14.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.347 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.545 ' OE2' ' NZ ' ' A' ' 123' ' ' LYS . 24.9 mt-10 -85.98 41.29 0.91 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.048 0.451 . . . . 0.0 110.822 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.87 HD13 ' HB2' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -129.2 133.89 47.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.047 178.799 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.4 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -127.73 129.06 46.46 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.245 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.3 t -109.47 120.88 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.614 ' NZ ' ' HB2' ' A' ' 119' ' ' GLU . 9.8 pttp -134.26 128.33 33.63 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.403 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -97.15 134.24 40.74 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.097 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 116' ' ' GLY . 0.3 OUTLIER -120.46 -176.74 3.29 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -57.28 69.85 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.303 0.573 . . . . 0.0 111.639 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 114' ' ' LYS . . . 83.69 -5.99 75.89 Favored Glycine 0 C--N 1.32 -0.356 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.672 HG13 HG23 ' A' ' 143' ' ' THR . 1.7 t -92.49 110.81 23.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.2 t -96.06 117.75 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.614 ' HB2' ' NZ ' ' A' ' 112' ' ' LYS . 81.6 mt-10 -129.48 133.6 47.36 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.114 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.746 HG12 HD22 ' A' ' 99' ' ' LEU . 4.6 mm -107.18 141.38 22.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.417 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -121.69 114.31 20.96 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.329 -178.015 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -144.85 130.07 3.76 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.899 -0.48 . . . . 0.0 111.899 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.545 ' NZ ' ' OE2' ' A' ' 108' ' ' GLU . 0.1 OUTLIER -151.13 132.28 14.41 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.531 ' ND1' ' HG2' ' A' ' 127' ' ' ARG . 54.6 t-80 -102.59 141.2 35.81 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -56.81 -33.78 67.05 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -176.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 0.3 OUTLIER 173.21 103.51 0.01 OUTLIER 'General case' 0 C--N 1.356 0.853 0 CA-C-N 118.748 0.704 . . . . 0.0 111.23 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.531 ' HG2' ' ND1' ' A' ' 124' ' ' HIS . 9.7 mtp-105 . . . . . 0 N--CA 1.47 0.568 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.589 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.138 0 N-CA-C 112.092 -0.403 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -96.1 126.79 41.57 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 172.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -130.43 123.92 56.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -170.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 3.1 m -131.57 147.04 52.5 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.199 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.442 ' NH1' ' CE2' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -143.75 170.48 15.79 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.755 -178.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 25.1 p -112.02 122.77 48.68 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.486 ' CD2' ' CG1' ' A' ' 101' ' ' VAL . 5.7 m-85 -95.78 128.78 42.96 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.765 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.58 105.65 5.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.886 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.476 ' NH2' ' OH ' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -104.67 105.14 15.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.864 178.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.454 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 14.2 ttmt -99.04 112.38 24.53 Favored 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 123.186 0.304 . . . . 0.0 110.75 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.703 ' CE1' ' HA3' ' B' ' 132' ' ' GLY . 5.9 m-30 -106.15 99.3 8.9 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.672 HG23 HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -87.74 89.32 7.95 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mp -113.33 91.35 19.33 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.645 ' HD2' ' HD3' ' A' ' 146' ' ' PRO . 13.2 Cg_exo -69.13 -57.27 0.13 Allowed 'Trans proline' 0 C--N 1.29 -2.529 0 C-N-CA 122.457 2.105 . . . . 0.0 114.641 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.645 ' HD3' ' HD2' ' A' ' 145' ' ' PRO . 12.6 Cg_endo -93.0 22.69 0.57 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 C-N-CA 122.969 2.446 . . . . 0.0 113.562 -174.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -142.22 -13.27 0.41 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 119.827 -1.178 . . . . 0.0 112.968 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.541 HG21 ' CH2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -131.75 128.19 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.713 0.756 . . . . 0.0 110.644 178.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 12.8 t70 -89.26 140.96 28.78 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.226 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 3.6 Cg_exo -82.35 -18.92 6.87 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.063 1.842 . . . . 0.0 112.991 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.46 -37.2 12.67 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.755 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 2.7 mt-30 -109.83 27.9 9.11 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.494 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 45.2 t -111.65 120.8 62.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.673 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.81 -173.72 2.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.318 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.48 153.17 31.06 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.215 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.491 ' O ' HD22 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -124.82 136.46 53.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.617 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.597 HD22 HD22 ' A' ' 109' ' ' LEU . 31.0 tp -124.89 110.91 14.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.84 0.353 . . . . 0.0 110.131 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.425 ' HB3' HG22 ' A' ' 162' ' ' THR . 0.3 OUTLIER -90.86 145.07 31.18 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.664 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.621 ' C ' ' H ' ' A' ' 161' ' ' GLY . 84.4 Cg_exo -41.02 -34.06 1.34 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.646 2.231 . . . . 0.0 110.753 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.61 27.61 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.387 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.621 ' H ' ' C ' ' A' ' 159' ' ' PRO . . . 38.41 33.96 0.21 Allowed Glycine 0 CA--C 1.53 1.008 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.601 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 158' ' ' SER . 9.8 t -102.03 125.37 48.7 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.576 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.1 tm? -107.04 110.01 22.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.786 -175.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.35 125.38 45.0 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.488 ' O ' HG23 ' A' ' 165' ' ' VAL . 1.2 m -106.69 107.28 22.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 1.5 pp20? -121.63 152.83 38.87 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.056 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.755 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 168.44 167.97 0.14 Allowed Pre-proline 0 C--O 1.238 0.463 0 CA-C-O 121.158 0.504 . . . . 0.0 112.213 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 37.7 Cg_endo -89.53 109.46 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 123.452 2.768 . . . . 0.0 109.168 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.548 ' CE ' ' H ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -107.18 170.8 5.26 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.874 -175.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 169' ' ' MET . 21.7 Cg_exo . . . . . 0 C--N 1.31 -1.448 0 C-N-CA 122.249 1.966 . . . . 0.0 110.688 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . 0.425 ' NE ' ' HB3' ' B' ' 168' ' ' PRO . 24.5 mmt-85 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.075 0.464 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' TRP . . . . . 0.526 ' HB2' ' HG3' ' B' ' 169' ' ' MET . 0.1 OUTLIER -62.31 141.13 58.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.339 -177.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 25.0 ttm105 -135.29 106.78 6.86 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.167 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.85 150.9 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 17.6 m -126.95 148.91 50.05 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -174.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.692 HD21 ' CE1' ' B' ' 142' ' ' TYR . 0.7 OUTLIER -123.9 55.03 1.29 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.465 174.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.25 93.95 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.835 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' B' ' 103' ' ' HIS . 2.6 t -145.15 -26.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.775 ' HB3' HD13 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -54.86 3.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' HIS . . . . . 0.532 ' H ' ' C ' ' B' ' 101' ' ' VAL . 2.4 m-70 -41.91 -46.55 4.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.998 0.428 . . . . 0.0 110.848 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.06 8.32 38.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.144 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.07 89.75 2.06 Favored Pre-proline 0 CA--C 1.513 -0.444 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.58 -44.48 0.38 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.323 2.015 . . . . 0.0 110.866 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -98.15 -31.46 12.09 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.119 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.437 ' OE1' ' NZ ' ' B' ' 123' ' ' LYS . 4.4 mt-10 -83.09 37.99 0.57 Allowed 'General case' 0 C--O 1.242 0.676 0 CA-C-O 121.018 0.437 . . . . 0.0 110.728 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.818 HD22 HD22 ' B' ' 157' ' ' LEU . 0.4 OUTLIER -121.4 135.35 55.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.06 124.23 38.79 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 120.5 0.191 . . . . 0.0 110.852 -177.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.74 129.61 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.969 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -139.43 134.88 32.97 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.686 0.279 . . . . 0.0 110.759 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 5.2 m -102.94 108.0 19.02 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.801 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' LYS . . . . . 0.568 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 21.5 ttmt -104.32 87.68 2.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.822 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 3.4 t70 30.66 67.35 0.12 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.655 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.41 -22.45 23.7 Favored Glycine 0 N--CA 1.466 0.693 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.568 ' HB ' ' HB3' ' B' ' 114' ' ' LYS . 8.8 t -87.55 109.77 19.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 56.1 t -96.65 127.05 49.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.974 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.571 ' CD ' ' HZ2' ' B' ' 141' ' ' LYS . 74.4 mt-10 -139.36 146.96 40.88 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.275 -178.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.57 HD12 ' O ' ' B' ' 119' ' ' GLU . 1.3 mp -121.46 131.23 73.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.434 177.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -104.01 120.38 40.93 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.669 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -140.42 129.2 4.1 Favored Glycine 0 N--CA 1.466 0.66 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' LYS . . . . . 0.437 ' NZ ' ' OE1' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -150.16 157.78 43.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -178.369 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' B' ' 126' ' ' GLU . 8.8 t-80 -145.02 127.91 16.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -56.01 -10.08 0.74 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -176.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . 0.61 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 0.5 OUTLIER 175.31 145.62 0.07 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 111.571 179.074 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' ARG . . . . . 0.596 ' NH1' ' HA ' ' B' ' 135' ' ' SER . 26.1 mtt85 -135.19 107.57 7.3 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.658 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -65.73 130.52 43.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.527 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.29 149.0 28.87 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -62.26 -31.46 72.03 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -92.27 25.17 3.03 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.488 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . 0.703 ' HA3' ' CE1' ' A' ' 142' ' ' TYR . . . 122.77 165.01 12.28 Favored Glycine 0 N--CA 1.429 -1.821 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.152 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -94.69 112.74 24.48 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . 0.523 HD11 ' NH1' ' B' ' 136' ' ' ARG . 0.0 OUTLIER -115.03 113.9 44.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.977 0.418 . . . . 0.0 111.864 -174.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . 0.61 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.8 OUTLIER -116.71 152.32 34.54 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.876 175.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . 0.523 ' NH1' HD11 ' B' ' 134' ' ' ILE . 2.4 ptt180 -155.67 145.55 21.39 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.759 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 28.5 p -92.5 129.81 38.33 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . 0.442 ' CE2' ' NH1' ' A' ' 136' ' ' ARG . 15.1 m-85 -98.21 137.72 36.54 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -177.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.83 101.07 3.6 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.172 176.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . 0.484 ' NH2' ' OH ' ' B' ' 142' ' ' TYR . 0.1 OUTLIER -98.91 150.2 22.16 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 173.365 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . 0.571 ' HZ2' ' CD ' ' B' ' 119' ' ' GLU . 13.6 ttmm -140.42 122.67 15.87 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.486 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' TYR . . . . . 0.692 ' CE1' HD21 ' B' ' 99' ' ' LEU . 0.5 OUTLIER -114.92 99.0 7.15 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . 0.484 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.0 OUTLIER -88.59 89.59 8.05 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.54 93.3 19.03 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.724 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . 0.589 ' CD ' ' HD3' ' B' ' 146' ' ' PRO . 16.5 Cg_exo -67.24 -54.97 0.33 Allowed 'Trans proline' 0 C--N 1.287 -2.667 0 C-N-CA 121.664 1.576 . . . . 0.0 112.345 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' PRO . . . . . 0.589 ' HD3' ' CD ' ' B' ' 145' ' ' PRO . 56.8 Cg_endo -98.72 89.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.103 2.535 . . . . 0.0 112.106 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.76 -20.55 1.29 Allowed Glycine 0 C--O 1.223 -0.534 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.669 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.26 122.92 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 117.579 0.69 . . . . 0.0 110.813 177.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . 0.448 ' OD1' ' HG3' ' B' ' 152' ' ' GLN . 12.0 t70 -93.58 148.08 34.81 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.05 -24.11 4.91 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.651 1.568 . . . . 0.0 112.756 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' THR . . . . . 0.436 ' N ' ' OD1' ' B' ' 149' ' ' ASP . 0.2 OUTLIER -91.36 -35.36 14.45 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' GLN . . . . . 0.677 ' O ' ' HB1' ' B' ' 167' ' ' ALA . 0.0 OUTLIER -103.53 14.49 31.15 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -175.342 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 39.1 t -107.9 120.46 59.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.438 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.83 -172.94 2.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.763 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.67 138.28 18.73 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.491 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.57 144.68 35.94 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.331 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . 0.818 HD22 HD22 ' B' ' 109' ' ' LEU . 15.4 tp -136.44 118.47 15.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.814 0.34 . . . . 0.0 110.249 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . 0.446 ' N ' HD12 ' B' ' 157' ' ' LEU . 1.6 t -105.29 149.2 37.44 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -41.77 -26.39 0.43 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.64 2.227 . . . . 0.0 111.828 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' B' ' 160' ' ' GLU . 29.2 mp0 -66.04 -8.02 20.76 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.685 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' GLY . . . . . 0.594 ' O ' ' ND2' ' B' ' 102' ' ' ASN . . . 76.57 27.41 61.24 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 28.8 p -87.58 99.84 12.35 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.609 HD13 ' C ' ' B' ' 163' ' ' LEU . 1.3 tm? -96.35 92.86 6.54 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.31 127.0 41.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.452 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.574 ' O ' HG23 ' B' ' 165' ' ' VAL . 2.6 m -105.45 99.09 7.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.08 134.82 54.54 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.357 -176.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' B' ' 152' ' ' GLN . . . -170.46 160.99 6.22 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.28 0.562 . . . . 0.0 111.889 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' PRO . . . . . 0.466 ' HD2' ' HB1' ' B' ' 167' ' ' ALA . 57.0 Cg_endo -84.95 59.95 5.62 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 123.262 2.641 . . . . 0.0 109.237 176.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' MET . . . . . 0.526 ' HG3' ' HB2' ' B' ' 95' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 CA-C-N 113.457 -1.701 . . . . 0.0 111.011 -176.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.514 -0.408 0 CA-C-O 120.59 0.233 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.69 ' NE1' HG22 ' A' ' 97' ' ' VAL . 54.1 t-105 -105.04 168.43 9.06 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.482 ' N ' ' CG ' ' A' ' 95' ' ' TRP . 1.7 ttm105 -150.51 108.72 3.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.368 -176.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.69 HG22 ' NE1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -116.44 150.06 18.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 174.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 14.7 m -131.52 157.64 43.03 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.573 HD22 ' HB ' ' A' ' 120' ' ' ILE . 0.7 OUTLIER -133.23 89.98 2.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.155 176.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -92.92 94.54 8.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.437 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -153.31 -23.51 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.696 ' CB ' HD13 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -83.17 9.28 10.89 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.195 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.608 ' N ' ' HA3' ' A' ' 161' ' ' GLY . 22.9 p-80 -48.53 -35.38 13.14 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.113 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -80.96 -3.4 51.45 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.832 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.491 ' C ' HD22 ' A' ' 102' ' ' ASN . . . -146.73 79.33 10.3 Favored Pre-proline 0 CA--C 1.512 -0.518 0 CA-C-O 120.772 0.32 . . . . 0.0 111.482 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.51 -39.81 11.67 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.513 2.142 . . . . 0.0 111.486 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -101.52 -31.66 10.77 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.978 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.404 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 22.6 mt-10 -79.28 46.17 0.7 Allowed 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.164 0.506 . . . . 0.0 110.05 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.696 HD13 ' CB ' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -133.21 135.66 45.18 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.471 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.7 116.85 17.85 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.153 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.93 124.95 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.517 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -127.97 136.76 51.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.999 0.428 . . . . 0.0 111.369 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.66 116.07 31.29 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.602 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 2.5 ttpt -111.41 80.76 1.35 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.356 0.598 . . . . 0.0 109.753 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 33.84 68.19 0.18 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.176 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.02 -23.59 25.8 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.611 HG22 HG23 ' A' ' 143' ' ' THR . 4.9 t -87.12 114.19 25.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.9 t -102.04 120.17 51.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.837 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.597 ' CD ' ' HD3' ' A' ' 141' ' ' LYS . 26.8 mt-10 -132.78 145.59 51.12 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.139 0.495 . . . . 0.0 110.948 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.573 ' HB ' HD22 ' A' ' 99' ' ' LEU . 1.1 mp -113.35 122.94 68.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.016 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.517 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -101.55 115.5 30.66 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.0 128.09 2.6 Favored Glycine 0 C--O 1.239 0.424 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.138 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.46 124.18 9.17 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.513 ' CD2' ' HG3' ' A' ' 127' ' ' ARG . 0.9 OUTLIER -91.04 151.99 20.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.045 0.45 . . . . 0.0 111.515 -177.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.559 ' O ' ' C ' ' A' ' 126' ' ' GLU . 6.1 tp10 -75.61 134.64 40.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.501 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.559 ' C ' ' O ' ' A' ' 125' ' ' GLU . 9.4 tt0 -2.65 97.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.808 0.693 . . . . 0.0 111.74 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.513 ' HG3' ' CD2' ' A' ' 124' ' ' HIS . 1.2 mtm-85 . . . . . 0 CA--C 1.514 -0.43 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.135 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.319 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' B' ' 141' ' ' LYS . 30.6 m-85 -95.21 121.1 36.51 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 172.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.99 126.2 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -169.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.525 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -126.38 154.28 43.79 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.669 174.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.44 179.34 7.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.266 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.6 p -139.75 127.1 21.37 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -100.86 136.19 41.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.95 101.54 6.36 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.505 174.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.583 ' HA ' ' NH1' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -101.69 141.36 34.67 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.597 ' HD3' ' CD ' ' A' ' 119' ' ' GLU . 2.7 ttpp -140.85 125.25 17.64 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.315 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.492 ' HE1' ' HE ' ' A' ' 140' ' ' ARG . 57.9 m-85 -120.44 99.13 6.38 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.611 HG23 HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -89.75 88.92 7.55 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.4 mp -112.43 92.74 20.24 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.634 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 17.0 Cg_exo -65.9 -58.36 0.19 Allowed 'Trans proline' 0 C--N 1.286 -2.753 0 C-N-CA 121.89 1.726 . . . . 0.0 113.497 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.634 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 5.7 Cg_endo -90.5 -13.31 2.34 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 122.774 2.316 . . . . 0.0 114.159 -175.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -104.38 3.0 43.17 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.722 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.47 136.09 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 118.024 0.912 . . . . 0.0 111.005 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 29.0 t70 -96.38 141.97 23.88 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.954 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 2.8 Cg_endo -82.69 -22.32 4.53 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.876 1.717 . . . . 0.0 112.547 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.84 -39.43 12.34 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.233 -174.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.65 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 9.7 mt-30 -106.33 22.63 15.45 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 19.9 t -109.53 109.39 28.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.977 0.418 . . . . 0.0 110.094 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -169.58 1.6 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.02 139.38 14.76 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.756 -0.778 . . . . 0.0 112.431 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.59 130.51 53.62 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.418 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.656 HD22 HD22 ' A' ' 109' ' ' LEU . 40.0 tp -123.75 109.2 13.37 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.989 0.423 . . . . 0.0 110.355 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.416 ' HB3' HG22 ' A' ' 162' ' ' THR . 0.2 OUTLIER -91.36 147.39 35.33 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.237 178.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 161' ' ' GLY . 87.4 Cg_exo -40.35 -38.52 2.37 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.599 2.199 . . . . 0.0 111.612 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -70.03 29.98 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.742 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.621 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 43.93 34.62 3.05 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.06 -0.518 . . . . 0.0 113.039 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 162' ' ' THR . 10.1 t -100.47 99.59 10.23 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.3 0.571 . . . . 0.0 109.598 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.611 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.9 tm? -91.12 106.16 18.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.803 -176.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.54 124.38 44.66 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 165' ' ' VAL . 3.1 m -105.54 100.59 10.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -114.28 139.66 49.24 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.06 -176.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.65 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 178.17 166.68 0.58 Allowed Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.999 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.634 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 60.6 Cg_endo -81.39 108.75 2.0 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.074 2.516 . . . . 0.0 110.13 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.599 ' SD ' ' HB3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -92.89 147.76 34.59 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.825 -176.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo . . . . . 0 C--N 1.305 -1.717 0 C-N-CA 122.713 2.275 . . . . 0.0 111.693 178.721 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.33 118.09 14.79 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -114.21 113.39 24.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.829 -175.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.7 t -119.25 156.86 21.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 3.7 m -129.64 134.49 47.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -174.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . 0.452 HD22 ' HB ' ' B' ' 120' ' ' ILE . 0.4 OUTLIER -103.16 97.23 7.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.632 175.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' ASP . . . . . 0.537 ' C ' HG22 ' B' ' 101' ' ' VAL . 18.9 p-10 -88.75 103.25 15.79 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.677 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' VAL . . . . . 0.537 HG22 ' C ' ' B' ' 100' ' ' ASP . 0.1 OUTLIER -170.46 -39.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-O 121.833 0.825 . . . . 0.0 109.417 179.036 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' ASN . . . . . 0.624 HD21 ' HA ' ' B' ' 106' ' ' PRO . 0.2 OUTLIER -38.94 -26.45 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.148 -177.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -53.18 -23.76 9.19 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 119.592 -0.843 . . . . 0.0 108.927 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.546 ' HB3' ' CZ ' ' B' ' 136' ' ' ARG . 27.3 m-85 -71.81 -13.13 61.6 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.715 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' B' ' 109' ' ' LEU . . . -174.61 94.26 0.3 Allowed Pre-proline 0 C--O 1.223 -0.336 0 O-C-N 123.308 0.38 . . . . 0.0 111.708 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.624 ' HA ' HD21 ' B' ' 102' ' ' ASN . 41.3 Cg_endo -71.57 -44.39 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.493 2.128 . . . . 0.0 111.833 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -30.75 22.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.948 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' B' ' 123' ' ' LYS . 16.7 mt-10 -102.19 56.73 0.8 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.081 0.467 . . . . 0.0 110.985 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' LEU . . . . . 0.6 HD22 HD22 ' B' ' 157' ' ' LEU . 0.4 OUTLIER -127.9 145.58 50.91 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.43 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -141.31 116.72 10.14 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.916 -177.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.03 123.01 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.786 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' LYS . . . . . 0.453 ' NZ ' ' OG1' ' B' ' 121' ' ' THR . 6.1 pttm -130.9 119.69 22.53 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.237 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.35 120.14 23.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' LYS . . . . . 0.477 ' NZ ' ' OE1' ' B' ' 119' ' ' GLU . 0.8 OUTLIER -121.26 82.49 1.94 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.537 -174.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 32.8 t70 32.56 68.91 0.13 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.345 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . 0.462 ' HA2' HG12 ' B' ' 148' ' ' VAL . . . 86.52 -22.61 12.58 Favored Glycine 0 C--N 1.315 -0.598 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' VAL . . . . . 0.662 HG22 HG23 ' B' ' 143' ' ' THR . 6.4 t -87.42 120.71 37.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 72.5 t -107.7 108.44 25.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.319 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' GLU . . . . . 0.532 ' O ' HD12 ' B' ' 120' ' ' ILE . 2.9 mt-10 -124.5 146.77 48.78 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.966 0.412 . . . . 0.0 110.612 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' ILE . . . . . 0.532 HD12 ' O ' ' B' ' 119' ' ' GLU . 1.3 mp -119.96 117.29 53.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.452 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' THR . . . . . 0.453 ' OG1' ' NZ ' ' B' ' 112' ' ' LYS . 0.2 OUTLIER -89.81 121.48 31.99 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.755 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -144.33 101.17 0.25 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -131.0 143.32 50.64 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' HIS . . . . . 0.457 ' CD2' ' CZ ' ' B' ' 127' ' ' ARG . 0.2 OUTLIER -119.48 151.96 37.71 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.574 -179.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' GLU . . . . . 0.467 ' O ' ' C ' ' B' ' 126' ' ' GLU . 4.0 mt-10 -91.17 126.84 36.37 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.642 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' GLU . . . . . 0.573 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 3.4 tt0 14.79 99.46 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' ARG . . . . . 0.457 ' CZ ' ' CD2' ' B' ' 124' ' ' HIS . 12.6 mtp180 -97.67 141.19 31.0 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.142 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' GLN . . . . . 0.48 ' HG2' ' N ' ' B' ' 129' ' ' ASP . 0.0 OUTLIER -86.74 136.91 32.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ASP . . . . . 0.522 ' CG ' ' N ' ' B' ' 130' ' ' GLU . 0.1 OUTLIER -133.45 169.26 17.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.845 174.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' B' ' 130' ' ' GLU . 0.0 OUTLIER -67.81 -31.98 72.21 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -174.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -111.29 20.24 17.51 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 147.08 178.25 22.24 Favored Glycine 0 C--N 1.307 -1.036 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.614 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -96.01 134.81 38.58 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . 0.519 HG23 ' O ' ' B' ' 134' ' ' ILE . 0.0 OUTLIER -145.97 116.41 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.886 0.375 . . . . 0.0 111.831 -175.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' SER . . . . . 0.573 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -132.81 156.66 46.72 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' ARG . . . . . 0.546 ' CZ ' ' HB3' ' B' ' 104' ' ' PHE . 0.0 OUTLIER -151.63 167.81 26.95 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.162 0.505 . . . . 0.0 111.932 -178.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' B' ' 123' ' ' LYS . 20.5 p -118.58 129.86 55.57 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.12 176.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -106.05 143.76 33.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.384 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.11 121.28 7.78 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.857 0.36 . . . . 0.0 111.493 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' ARG . . . . . 0.535 ' NH2' ' OH ' ' B' ' 142' ' ' TYR . 0.0 OUTLIER -118.02 144.57 45.45 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' LYS . . . . . 0.472 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 9.1 ttpp -133.01 124.66 28.11 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 123.136 0.272 . . . . 0.0 111.027 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' TYR . . . . . 0.535 ' OH ' ' NH2' ' B' ' 140' ' ' ARG . 3.1 m-85 -118.33 98.64 6.38 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.03 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' THR . . . . . 0.662 HG23 HG22 ' B' ' 117' ' ' VAL . 0.3 OUTLIER -90.42 100.88 13.64 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.43 96.72 16.87 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.073 -177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' B' ' 147' ' ' GLY . 36.8 Cg_exo -62.98 -41.92 26.56 Favored 'Trans proline' 0 C--N 1.286 -2.747 0 C-N-CA 123.223 2.615 . . . . 0.0 114.251 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 36.3 Cg_exo -43.23 -11.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.916 1.744 . . . . 0.0 112.304 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 109.11 44.13 1.12 Allowed Glycine 0 C--O 1.218 -0.87 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.209 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' VAL . . . . . 0.53 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -60.68 96.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . 0.509 ' CG ' ' HG3' ' B' ' 152' ' ' GLN . 10.3 t70 -50.66 129.16 26.92 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.183 -171.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 11.4 Cg_exo -71.16 -25.95 21.76 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.149 1.899 . . . . 0.0 113.053 -177.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.31 -49.87 6.29 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.363 0.602 . . . . 0.0 111.213 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' GLN . . . . . 0.509 ' HG3' ' CG ' ' B' ' 149' ' ' ASP . 1.7 mt-30 -79.57 10.59 3.76 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.582 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . 0.71 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 17.9 t -101.64 119.57 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.42 155.8 27.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' B' ' 164' ' ' THR . 1.2 m -132.99 132.77 42.29 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.399 -176.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' SER . . . . . 0.554 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.0 OUTLIER -108.47 145.17 35.08 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.477 178.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' LEU . . . . . 0.6 HD22 HD22 ' B' ' 109' ' ' LEU . 31.7 tp -130.96 128.42 40.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.336 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . 0.479 ' O ' ' N ' ' B' ' 161' ' ' GLY . 0.6 OUTLIER -114.14 150.32 43.44 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.123 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' PRO . . . . . 0.538 ' C ' ' H ' ' B' ' 161' ' ' GLY . 87.3 Cg_exo -43.15 -34.14 4.05 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.782 2.321 . . . . 0.0 111.462 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.33 2.19 0.27 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.445 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 63.38 27.81 71.35 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.712 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 6.0 t -93.87 120.66 34.43 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' LEU . . . . . 0.627 HD13 ' C ' ' B' ' 163' ' ' LEU . 2.2 tm? -108.63 106.6 16.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.814 -176.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' B' ' 155' ' ' SER . 0.7 OUTLIER -95.5 127.99 42.0 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.106 -179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' VAL . . . . . 0.546 ' O ' HG23 ' B' ' 165' ' ' VAL . 2.6 m -112.99 107.58 23.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -121.57 144.7 48.58 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.439 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' ALA . . . . . 0.71 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -168.61 152.7 5.74 Favored Pre-proline 0 C--O 1.235 0.29 0 C-N-CA 120.463 -0.495 . . . . 0.0 112.16 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -87.68 47.98 1.52 Allowed 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 123.364 2.709 . . . . 0.0 109.59 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' MET . . . . . . . . . . . . . 3.1 ptm . . . . . 0 C--N 1.316 -0.886 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.631 -176.336 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.516 ' SD ' ' N ' ' A' ' 81' ' ' LEU . 1.4 ppp? . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.585 ' CD ' ' H ' ' A' ' 80' ' ' GLN . 1.0 OUTLIER -53.37 -45.83 69.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.224 -178.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.516 ' N ' ' SD ' ' A' ' 79' ' ' MET . 7.4 mt 62.49 176.46 0.14 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.081 -178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 84' ' ' GLY . 0.7 OUTLIER -70.77 50.57 0.13 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.136 0.493 . . . . 0.0 110.268 178.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.47 65.52 0.05 OUTLIER 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.667 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 82' ' ' SER . . . -61.53 -37.17 93.72 Favored Glycine 0 CA--C 1.517 0.168 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.26 156.83 42.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 88' ' ' ILE . 1.4 m -100.6 73.96 1.65 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.896 0.379 . . . . 0.0 110.756 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -67.59 57.09 0.06 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.201 0.524 . . . . 0.0 110.031 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.527 ' O ' HG23 ' A' ' 88' ' ' ILE . 6.1 tp -82.86 82.66 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.936 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -110.72 97.49 6.89 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.879 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.497 ' O ' ' N ' ' A' ' 92' ' ' ALA . 2.7 t-80 -81.5 33.4 0.36 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.956 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -69.15 51.7 0.09 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 90' ' ' HIS . . . -114.01 72.15 0.77 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.88 -174.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.58 -42.25 96.3 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 172.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 24.4 mmm-85 68.65 135.94 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.399 176.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.678 ' CZ3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -96.58 158.82 15.25 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.969 177.07 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -151.88 104.14 2.98 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.508 -177.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.678 HG21 ' CZ3' ' A' ' 95' ' ' TRP . 0.8 OUTLIER -121.14 152.46 24.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.133 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 4.4 m -122.45 140.81 52.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -176.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.579 HD22 ' HB ' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -117.49 63.92 0.74 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.31 174.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.15 108.27 3.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.617 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.626 HG11 ' CD1' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -159.36 -31.86 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 120.751 0.31 . . . . 0.0 110.94 176.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.973 ' HB3' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -56.55 5.74 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -177.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.472 ' H ' ' C ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -61.73 -30.98 71.13 Favored 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 118.824 -1.15 . . . . 0.0 108.284 176.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.491 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 14.9 m-85 -88.93 5.19 45.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.943 176.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.479 ' HB1' ' HB2' ' A' ' 108' ' ' GLU . . . -167.39 92.36 0.7 Allowed Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -177.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.9 -48.58 0.22 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.432 2.088 . . . . 0.0 111.159 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 109' ' ' LEU . 1.6 t70 -98.26 -31.9 11.83 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.479 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 54.7 mp0 -75.73 36.74 0.14 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.289 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.973 HD13 ' HB3' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -125.25 138.42 54.1 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.58 112.6 11.61 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.22 129.58 39.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.87 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.458 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.1 OUTLIER -136.52 125.2 23.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.934 0.397 . . . . 0.0 111.359 -179.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.0 m -108.18 115.0 29.31 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.3 91.77 3.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.888 0.375 . . . . 0.0 111.686 -176.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.7 t0 40.18 69.24 0.33 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.243 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 82.08 -17.61 16.66 Favored Glycine 0 C--N 1.312 -0.771 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.6 t -88.68 109.65 20.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 119.859 -0.737 . . . . 0.0 110.008 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.7 t -98.71 115.21 38.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.851 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.638 ' CD ' ' NZ ' ' A' ' 141' ' ' LYS . 0.3 OUTLIER -125.66 139.4 53.59 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.337 0.589 . . . . 0.0 110.711 179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.579 ' HB ' HD22 ' A' ' 99' ' ' LEU . 1.2 mp -116.32 111.24 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.912 178.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.458 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -91.84 116.24 28.74 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.821 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.37 125.7 2.0 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.163 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 137' ' ' CYS . 0.0 OUTLIER -134.95 137.87 43.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 177.656 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' A' ' 104' ' ' PHE . 29.7 t60 -80.11 168.28 19.33 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.643 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.481 ' O ' ' C ' ' A' ' 126' ' ' GLU . 2.4 tp10 -113.41 131.85 55.85 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.315 -178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.481 ' C ' ' O ' ' A' ' 125' ' ' GLU . 5.3 tt0 -19.3 99.8 0.02 OUTLIER 'General case' 0 C--N 1.349 0.548 0 O-C-N 123.563 0.539 . . . . 0.0 111.995 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.462 ' HB2' ' H ' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -69.8 156.41 39.07 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.84 178.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -127.54 95.2 4.18 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -135.09 146.39 48.85 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.92 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.51 ' OE2' ' N ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -51.75 -22.57 3.68 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.794 -176.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.423 ' O ' ' OH ' ' B' ' 142' ' ' TYR . 87.1 m-70 -92.91 5.37 51.61 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.493 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 136.03 154.59 6.93 Favored Glycine 0 C--N 1.312 -0.769 0 C-N-CA 120.138 -1.029 . . . . 0.0 112.654 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 127' ' ' ARG . 8.8 m-30 -94.97 109.42 21.44 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.462 ' H ' ' HB2' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -117.39 154.82 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -175.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.78 152.38 26.87 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.441 172.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.419 ' NH2' ' CE2' ' A' ' 104' ' ' PHE . 0.0 OUTLIER -143.8 175.35 10.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.687 -177.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 32.0 p -137.68 133.86 34.73 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.626 ' CD1' HG11 ' A' ' 101' ' ' VAL . 1.6 m-85 -107.54 138.97 42.8 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.472 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.84 114.68 7.74 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.718 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.558 ' NH2' ' OH ' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -120.22 126.04 49.64 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 176.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.638 ' NZ ' ' CD ' ' A' ' 119' ' ' GLU . 2.0 ttmm -120.06 107.44 13.07 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 120.756 0.312 . . . . 0.0 111.091 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.558 ' OH ' ' NH2' ' A' ' 140' ' ' ARG . 4.2 m-30 -103.1 99.13 8.99 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.511 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.1 OUTLIER -87.56 88.93 7.81 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 mp -113.23 90.79 17.38 Favored Pre-proline 0 N--CA 1.45 -0.452 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.657 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 15.8 Cg_exo -67.93 -57.43 0.16 Allowed 'Trans proline' 0 C--N 1.287 -2.689 0 C-N-CA 122.164 1.91 . . . . 0.0 113.537 175.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.657 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 28.8 Cg_endo -98.45 43.65 0.09 OUTLIER 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.61 2.873 . . . . 0.0 112.413 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -160.33 -8.25 0.04 OUTLIER Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.137 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.549 ' CG2' ' CZ2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -138.37 127.09 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 117.4 0.6 . . . . 0.0 111.129 178.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.421 ' OD2' ' N ' ' A' ' 152' ' ' GLN . 13.7 t70 -87.89 138.49 31.15 Favored Pre-proline 0 N--CA 1.484 1.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.057 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -81.99 -21.77 5.54 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.016 1.811 . . . . 0.0 113.075 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.14 -37.92 13.07 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.421 ' N ' ' OD2' ' A' ' 149' ' ' ASP . 27.0 mt-30 -103.61 11.76 35.75 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 22.5 t -95.04 118.48 41.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.844 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.9 173.35 6.47 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 2.5 p -141.68 137.43 31.75 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.961 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.23 133.41 52.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.996 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.628 HD22 HD22 ' A' ' 109' ' ' LEU . 33.9 tp -131.1 136.99 48.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.097 0.475 . . . . 0.0 110.331 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.581 ' H ' HD12 ' A' ' 157' ' ' LEU . 1.8 t -123.71 146.56 50.76 Favored Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.825 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -40.01 -34.07 0.87 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.683 2.255 . . . . 0.0 111.676 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -62.29 -7.44 4.29 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.641 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.564 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . 76.31 33.61 48.31 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 112.22 -0.352 . . . . 0.0 112.22 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.2 t -100.63 116.74 33.26 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.579 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.4 tm? -110.56 99.86 8.77 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.543 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.68 127.6 40.76 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 121.343 -0.143 . . . . 0.0 110.714 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.602 ' O ' HG23 ' A' ' 165' ' ' VAL . 3.2 m -108.51 103.13 15.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.68 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 2.7 pp20? -114.34 147.58 38.9 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.786 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.68 ' HB2' ' O ' ' A' ' 166' ' ' GLU . . . 166.19 166.33 0.1 OUTLIER Pre-proline 0 CA--C 1.515 -0.371 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.785 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.663 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 84.1 Cg_endo -82.18 133.15 7.47 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 123.804 3.003 . . . . 0.0 109.665 173.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.442 ' SD ' ' N ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -128.69 146.92 62.18 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -174.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.401 ' HB2' HD23 ' A' ' 172' ' ' LEU . 17.9 Cg_endo -58.62 101.74 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 123.461 2.774 . . . . 0.0 111.843 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.04 84.66 0.13 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.401 HD23 ' HB2' ' A' ' 170' ' ' PRO . 2.5 mm? -101.04 165.44 11.31 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.394 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -119.14 101.7 8.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.049 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.79 -165.45 0.14 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.33 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -124.33 171.16 10.12 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.209 -1.031 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.659 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' MET . . . . . 0.555 ' O ' ' N ' ' B' ' 81' ' ' LEU . 2.8 mtp . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.424 ' O ' ' N ' ' B' ' 82' ' ' SER . 3.6 mp0 60.66 -63.22 0.07 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.975 0.417 . . . . 0.0 111.212 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' B' ' 79' ' ' MET . 2.0 mt -68.86 57.82 0.09 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.687 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . 0.424 ' N ' ' O ' ' B' ' 80' ' ' GLN . 75.7 m -47.57 -35.61 9.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.867 0.365 . . . . 0.0 110.163 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -24.9 48.0 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.887 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.02 -1.74 90.64 Favored Glycine 0 CA--C 1.522 0.471 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' B' ' 87' ' ' GLU . 4.3 m -134.19 -43.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.608 0.242 . . . . 0.0 110.889 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.95 -54.24 0.31 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.862 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.521 ' N ' ' O ' ' B' ' 85' ' ' VAL . 1.1 mm-40 -63.68 144.06 57.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.674 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.433 HG22 ' H ' ' B' ' 88' ' ' ILE . 0.5 OUTLIER -70.16 -43.11 79.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -109.92 140.42 43.91 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.452 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -140.53 159.92 41.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.035 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.89 88.77 2.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.967 0.413 . . . . 0.0 110.621 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -148.95 -159.37 1.03 Allowed 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.64 66.38 1.21 Allowed 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.732 0.301 . . . . 0.0 110.766 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . 0.601 HH12 ' CD ' ' B' ' 166' ' ' GLU . 0.1 OUTLIER -138.02 131.14 30.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.923 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' TRP . . . . . 0.781 ' NE1' HG22 ' B' ' 97' ' ' VAL . 14.6 t-105 -114.16 155.49 25.97 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 39.8 ttt85 -134.96 98.74 4.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.239 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.781 HG22 ' NE1' ' B' ' 95' ' ' TRP . 0.2 OUTLIER -101.49 151.13 5.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 2.5 m -128.28 143.41 51.02 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.467 HD22 ' HB ' ' B' ' 120' ' ' ILE . 0.4 OUTLIER -119.3 137.15 53.88 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.297 174.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.563 ' C ' HG22 ' B' ' 101' ' ' VAL . 9.7 p-10 -122.89 116.16 23.16 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.373 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.563 HG22 ' C ' ' B' ' 100' ' ' ASP . 0.0 OUTLIER -171.37 -45.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 120.785 0.326 . . . . 0.0 111.663 178.732 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.88 ' HB3' HD13 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -53.38 -1.09 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -175.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.467 ' CE1' ' N ' ' B' ' 101' ' ' VAL . 0.1 OUTLIER -62.13 -26.12 68.13 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 118.51 -1.276 . . . . 0.0 108.409 175.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -84.42 -13.0 53.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.798 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' B' ' 102' ' ' ASN . . . -164.66 97.81 0.88 Allowed Pre-proline 0 CA--C 1.516 -0.347 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.154 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.07 -42.74 0.37 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 C-N-CA 122.352 2.035 . . . . 0.0 111.039 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.83 -31.43 13.72 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.485 -178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.54 37.33 0.74 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.367 0.603 . . . . 0.0 110.444 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.88 HD13 ' HB3' ' B' ' 102' ' ' ASN . 0.5 OUTLIER -117.11 146.62 43.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.444 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 1.2 m -136.88 120.94 17.72 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.889 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.416 HG13 HD11 ' B' ' 120' ' ' ILE . 0.5 OUTLIER -99.77 121.47 50.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.541 ' NZ ' ' HB2' ' B' ' 119' ' ' GLU . 14.8 pttp -132.47 120.94 22.61 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.107 0.48 . . . . 0.0 111.333 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.7 117.56 28.66 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.575 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 1.3 ttmt -116.11 91.34 3.57 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.898 -175.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' B' ' 114' ' ' LYS . 0.9 OUTLIER 28.73 63.98 0.12 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.457 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.52 -21.14 42.54 Favored Glycine 0 C--N 1.316 -0.534 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.607 HG22 HG23 ' B' ' 143' ' ' THR . 2.8 t -87.65 119.41 35.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.301 177.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 75.4 t -106.51 114.85 46.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.541 ' HB2' ' NZ ' ' B' ' 112' ' ' LYS . 1.1 mt-10 -130.45 145.14 51.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.227 0.537 . . . . 0.0 110.62 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.595 HG23 HD11 ' B' ' 109' ' ' LEU . 1.3 mp -116.94 118.98 60.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.791 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -95.7 123.87 39.46 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.341 -178.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -147.22 118.49 1.02 Allowed Glycine 0 C--N 1.333 0.393 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.56 143.31 24.58 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -123.97 158.6 31.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.91 0.386 . . . . 0.0 111.409 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.517 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.9 OUTLIER -95.35 145.1 25.36 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.284 -179.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . 0.629 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 0.6 OUTLIER -1.65 96.94 0.01 OUTLIER 'General case' 0 C--O 1.238 0.485 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' B' ' 127' ' ' ARG . 1.5 mtm180 -97.97 143.78 28.18 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.037 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -71.76 157.62 37.58 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . 0.521 ' CG ' ' N ' ' B' ' 130' ' ' GLU . 0.8 OUTLIER -157.19 168.96 25.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.036 0.446 . . . . 0.0 110.774 -178.495 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . 0.521 ' N ' ' CG ' ' B' ' 129' ' ' ASP . 0.9 OUTLIER -63.42 -34.84 78.62 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.609 -177.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' HIS . . . . . 0.476 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 82.2 m-70 -121.54 39.9 3.73 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.006 -177.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . 0.526 ' HA3' ' CE1' ' A' ' 142' ' ' TYR . . . 135.65 -162.67 24.94 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.434 -1.365 . . . . 0.0 112.475 178.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -114.15 120.72 41.49 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 175.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . 0.471 HG22 ' HB3' ' B' ' 129' ' ' ASP . 0.0 OUTLIER -134.63 121.84 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -172.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . 0.629 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -124.99 144.56 50.32 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 174.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -137.31 160.65 38.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.971 0.415 . . . . 0.0 111.296 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 22.4 p -120.37 133.47 55.43 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.99 137.05 52.45 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.816 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.75 123.41 15.12 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.044 177.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.45 124.18 42.3 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 174.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . 0.428 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 3.5 ttpp -117.15 127.1 53.79 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.716 0.293 . . . . 0.0 110.757 -175.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' TYR . . . . . 0.531 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 4.3 m-85 -116.71 97.98 6.28 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.607 HG23 HG22 ' B' ' 117' ' ' VAL . 0.3 OUTLIER -92.19 98.22 11.39 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . 0.423 ' C ' ' HD2' ' B' ' 146' ' ' PRO . 7.1 mp -109.98 91.69 11.5 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' B' ' 143' ' ' THR . 28.0 Cg_exo -64.73 -36.68 39.84 Favored 'Trans proline' 0 C--N 1.287 -2.708 0 C-N-CA 122.909 2.406 . . . . 0.0 113.303 175.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 65.4 Cg_exo -43.08 -12.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 122.142 1.895 . . . . 0.0 111.962 -177.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 112.0 48.09 0.68 Allowed Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.607 173.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' VAL . . . . . 0.508 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -68.39 97.15 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 174.016 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . 0.506 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 0.1 OUTLIER -51.81 125.7 30.72 Favored Pre-proline 0 C--N 1.333 -0.133 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.396 -170.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 2.8 Cg_exo -76.35 -29.43 6.19 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.375 2.05 . . . . 0.0 112.012 -177.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.8 -28.59 61.72 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.243 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' GLN . . . . . 0.558 ' O ' ' HB1' ' B' ' 167' ' ' ALA . 2.1 mt-30 -113.19 12.64 19.07 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -173.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . 0.474 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 25.1 t -106.28 113.77 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.127 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.93 173.76 6.22 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.31 135.57 27.07 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.22 140.9 39.37 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.586 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . 0.665 HD22 HD22 ' B' ' 109' ' ' LEU . 13.0 tp -134.86 126.62 29.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.619 0.247 . . . . 0.0 110.775 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.541 ' N ' HD12 ' B' ' 157' ' ' LEU . 1.5 t -114.0 148.9 40.98 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -40.97 -27.48 0.32 Allowed 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.982 2.455 . . . . 0.0 111.985 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . 0.515 ' H ' ' CD ' ' B' ' 160' ' ' GLU . 4.3 mp0 -63.58 -9.53 13.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.297 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' GLY . . . . . 0.52 ' O ' ' ND2' ' B' ' 102' ' ' ASN . . . 78.66 23.96 63.57 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -177.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 40.2 p -88.24 102.55 14.93 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.064 -0.568 . . . . 0.0 109.512 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.642 HD13 ' C ' ' B' ' 163' ' ' LEU . 1.7 tm? -99.91 95.1 6.66 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.68 126.51 35.01 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 116.726 -0.215 . . . . 0.0 110.676 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.599 ' O ' HG23 ' B' ' 165' ' ' VAL . 2.7 m -108.67 99.61 9.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 174.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 0.601 ' CD ' HH12 ' B' ' 94' ' ' ARG . 0.1 OUTLIER -108.26 135.63 49.25 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.988 -175.636 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' B' ' 152' ' ' GLN . . . 176.85 167.42 0.45 Allowed Pre-proline 0 N--CA 1.445 -0.697 0 C-N-CA 119.533 -0.867 . . . . 0.0 113.128 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . 0.451 ' HD2' ' HB1' ' B' ' 167' ' ' ALA . 1.3 Cg_endo -80.97 134.96 9.67 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 124.097 3.198 . . . . 0.0 109.467 174.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.12 157.71 31.33 Favored Pre-proline 0 N--CA 1.445 -0.699 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.378 -178.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' PRO . . . . . 0.607 ' HB2' HD13 ' B' ' 172' ' ' LEU . 12.0 Cg_endo -55.3 112.74 1.13 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 123.467 2.778 . . . . 0.0 111.905 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -65.15 56.03 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.728 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' B' ' 170' ' ' PRO . 2.6 mp -87.04 -40.52 14.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.689 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' B' ' 172' ' ' LEU . . . 32.54 66.11 0.2 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.743 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' B' ' 175' ' ' GLN . 1.7 t -95.59 -125.35 0.12 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.168 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' GLN . . . . . 0.498 ' N ' ' OG1' ' B' ' 174' ' ' THR . 7.4 pt20 -80.53 -158.9 0.2 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.684 0.278 . . . . 0.0 110.684 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.209 -1.051 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.602 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.559 ' N ' ' O ' ' A' ' 85' ' ' VAL . 6.1 mmt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 82' ' ' SER . 27.9 mt-30 63.61 166.43 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.628 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.7 mt -68.22 56.69 0.07 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.19 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 80' ' ' GLN . 7.7 p -95.16 -102.0 0.15 Allowed 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.01 47.86 0.8 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.078 0.466 . . . . 0.0 109.788 176.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.09 -74.96 1.23 Allowed Glycine 0 CA--C 1.519 0.282 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 79' ' ' MET . 0.0 OUTLIER -149.66 -90.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.188 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.82 118.99 22.1 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.702 ' CD ' ' H ' ' A' ' 87' ' ' GLU . 1.7 pm0 -73.06 126.71 30.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.375 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.6 tt -114.71 153.17 16.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.099 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.428 ' HE ' ' HB3' ' A' ' 89' ' ' ARG . 11.7 mmm180 -119.49 150.7 39.81 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.208 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.462 ' O ' ' C ' ' A' ' 91' ' ' THR . 10.8 m-70 -51.99 122.4 8.35 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.504 HG21 ' NH1' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -28.77 111.72 0.06 Allowed 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.36 0.413 . . . . 0.0 112.113 -176.157 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.52 -161.95 0.32 Allowed 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.821 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 168' ' ' PRO . 4.2 m-20 -53.03 125.81 18.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.779 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.504 ' NH1' HG21 ' A' ' 91' ' ' THR . 4.3 mmm-85 -85.94 110.73 19.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.866 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.653 ' CZ3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -77.38 158.61 30.0 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 174.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.1 ttm-85 -152.84 99.21 2.41 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.146 -175.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.653 HG21 ' CZ3' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -119.83 157.83 21.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 176.579 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 27.7 m -131.4 144.55 51.28 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -175.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.878 HD22 HG13 ' A' ' 120' ' ' ILE . 1.4 mp -117.1 65.39 0.72 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.066 173.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -75.58 93.55 3.05 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.906 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' A' ' 103' ' ' HIS . 1.6 t -150.52 -43.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-O 121.14 0.495 . . . . 0.0 110.967 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.56 ' CG ' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -54.47 13.6 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 114.066 1.135 . . . . 0.0 114.066 -175.801 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.555 ' H ' ' C ' ' A' ' 101' ' ' VAL . 8.3 t-160 -49.72 -21.24 1.01 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.874 0.369 . . . . 0.0 110.453 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -101.98 1.67 36.93 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.821 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -141.93 89.21 8.99 Favored Pre-proline 0 CA--C 1.517 -0.313 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.755 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.5 -41.66 0.79 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.467 2.111 . . . . 0.0 111.456 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.429 ' C ' ' H ' ' A' ' 109' ' ' LEU . 14.3 t70 -105.22 -31.93 8.88 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.071 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -80.32 40.8 0.5 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.451 0.644 . . . . 0.0 110.441 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.85 HD22 HD22 ' A' ' 157' ' ' LEU . 0.7 OUTLIER -124.7 141.61 51.98 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.471 176.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.52 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -141.18 115.72 9.54 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.772 0.32 . . . . 0.0 110.819 -178.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 10.0 t -92.37 131.52 39.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.405 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.39 132.46 31.48 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.527 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.1 m -107.5 115.97 31.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.133 178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.441 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -117.74 79.25 1.33 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.05 0.452 . . . . 0.0 111.085 -177.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.8 t70 45.14 69.55 0.43 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.083 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.46 -22.25 14.06 Favored Glycine 0 N--CA 1.464 0.506 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.5 HG22 HG23 ' A' ' 143' ' ' THR . 21.6 t -87.1 113.16 24.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 65.2 t -102.28 112.79 36.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 141' ' ' LYS . 42.4 mt-10 -125.93 149.04 49.04 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.283 0.563 . . . . 0.0 111.095 -177.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.878 HG13 HD22 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -122.47 143.13 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.825 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.218 178.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -121.31 106.79 11.8 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.095 -178.262 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -138.51 128.77 4.26 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 111.551 -0.62 . . . . 0.0 111.551 -178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.32 128.83 11.41 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.702 0.401 . . . . 0.0 110.362 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.453 ' CD2' ' HA ' ' A' ' 135' ' ' SER . 1.4 p-80 -100.0 137.16 38.83 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 41.4 mt-10 -60.82 -27.48 68.09 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -174.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 0.8 OUTLIER 172.52 120.76 0.02 OUTLIER 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.329 0.513 . . . . 0.0 111.837 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.739 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -97.98 145.58 26.35 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.233 175.633 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -99.26 117.44 33.73 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 120.839 0.352 . . . . 0.0 110.922 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.43 ' OD2' ' NH1' ' A' ' 127' ' ' ARG . 8.9 m-20 -130.61 135.9 48.33 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.073 175.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.6 -26.21 1.4 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.719 -176.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.481 ' O ' ' CZ ' ' B' ' 142' ' ' TYR . 78.0 m80 -106.02 19.75 20.04 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.678 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.65 ' HA3' ' CE1' ' B' ' 142' ' ' TYR . . . 148.71 149.1 4.89 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 119.185 -1.483 . . . . 0.0 114.295 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -95.07 109.84 21.84 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.677 HD12 ' NH1' ' B' ' 140' ' ' ARG . 0.0 OUTLIER -120.66 157.19 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -172.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.453 ' HA ' ' CD2' ' A' ' 124' ' ' HIS . 3.6 t -155.4 154.1 31.42 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.773 173.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.477 ' NH1' ' CZ ' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -147.0 174.74 11.25 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.336 -179.158 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 25.0 p -128.93 125.47 37.57 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -95.8 128.96 43.13 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.99 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.29 105.84 8.17 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.304 176.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.586 ' HG3' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -101.08 149.6 23.79 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.316 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.523 ' NZ ' ' OE1' ' B' ' 126' ' ' GLU . 1.6 ttpt -149.91 102.58 3.14 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.068 0.461 . . . . 0.0 110.506 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.56 ' OH ' ' NH1' ' A' ' 140' ' ' ARG . 10.6 m-85 -97.57 100.66 12.08 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.437 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.5 HG23 HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -88.51 89.37 7.96 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.192 0.52 . . . . 0.0 109.784 179.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mp -114.92 92.18 29.42 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.625 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 15.1 Cg_exo -68.02 -58.31 0.13 Allowed 'Trans proline' 0 C--N 1.285 -2.776 0 C-N-CA 122.141 1.894 . . . . 0.0 113.965 177.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.625 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 48.0 Cg_endo -100.51 51.69 0.05 OUTLIER 'Trans proline' 0 N--CA 1.479 0.676 0 C-N-CA 123.406 2.737 . . . . 0.0 112.781 -175.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.67 -13.38 0.02 OUTLIER Glycine 0 N--CA 1.463 0.454 0 C-N-CA 120.237 -0.983 . . . . 0.0 112.269 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.629 HG21 ' CH2' ' A' ' 95' ' ' TRP . 1.0 OUTLIER -128.64 127.3 66.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 117.42 0.61 . . . . 0.0 110.861 178.523 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 18.8 t70 -83.5 140.75 41.63 Favored Pre-proline 0 N--CA 1.468 0.439 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.557 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 3.0 Cg_exo -82.17 -25.04 3.53 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.18 1.92 . . . . 0.0 112.545 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.97 -36.68 13.29 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -175.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.763 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 8.9 mt-30 -109.29 31.84 5.43 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -173.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.41 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 39.5 t -115.47 124.88 72.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.716 177.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.69 -178.42 4.14 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.71 140.88 30.23 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.048 -0.661 . . . . 0.0 112.38 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -104.98 131.67 52.19 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.242 176.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.85 HD22 HD22 ' A' ' 109' ' ' LEU . 26.1 tp -129.87 125.52 35.81 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.021 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.587 ' HB3' ' OG1' ' A' ' 162' ' ' THR . 0.0 OUTLIER -106.04 162.23 20.37 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 177.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.4 -9.55 1.01 Allowed 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.211 1.941 . . . . 0.0 110.786 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 158' ' ' SER . 3.6 mp0 -87.13 0.37 55.39 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.519 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.53 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . 68.52 15.5 68.45 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -175.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.587 ' OG1' ' HB3' ' A' ' 158' ' ' SER . 3.0 p -74.0 99.25 3.24 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.616 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.7 tm? -102.08 92.12 4.63 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.871 -176.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.98 125.9 35.18 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.28 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 165' ' ' VAL . 5.3 m -103.3 103.03 14.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.595 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -119.41 148.72 42.9 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.12 -176.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.763 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 170.2 167.32 0.19 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.232 0.539 . . . . 0.0 112.138 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.568 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 60.9 Cg_endo -89.67 109.12 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 123.508 2.805 . . . . 0.0 110.065 176.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.483 ' O ' ' N ' ' A' ' 171' ' ' LYS . 0.0 OUTLIER -72.3 169.91 14.89 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.136 -177.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.4 50.01 0.08 OUTLIER 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 123.281 2.654 . . . . 0.0 112.675 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 169' ' ' MET . 3.4 mmmp? -70.15 51.63 0.12 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.896 0.379 . . . . 0.0 110.198 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 174' ' ' THR . 0.8 OUTLIER -156.68 -57.48 0.09 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.091 179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.41 69.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.899 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.505 ' N ' ' O ' ' A' ' 172' ' ' LEU . 11.2 t -79.64 -157.06 0.12 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.639 -178.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -140.26 178.63 7.15 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.993 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.21 -0.991 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.5 179.858 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' MET . . . . . 0.415 ' N ' ' SD ' ' B' ' 79' ' ' MET . 14.6 mmm . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.473 ' O ' ' OG1' ' B' ' 91' ' ' THR . 14.2 mt-30 -58.96 93.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.551 HD12 ' H ' ' B' ' 82' ' ' SER . 0.4 OUTLIER -64.86 -121.81 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.363 -177.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . 0.551 ' H ' HD12 ' B' ' 81' ' ' LEU . 0.0 OUTLIER -135.48 -73.22 0.46 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.321 -0.399 . . . . 0.0 109.951 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.85 46.18 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.669 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' B' ' 82' ' ' SER . . . -92.5 166.18 29.12 Favored Glycine 0 C--N 1.322 -0.224 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 6.7 m -47.45 -39.6 6.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.872 0.368 . . . . 0.0 110.764 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.76 -19.64 65.13 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.221 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 55.11 48.51 19.49 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.146 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.452 ' O ' ' N ' ' B' ' 90' ' ' HIS . 9.9 mm -122.51 134.56 65.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.395 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.56 45.25 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.699 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' B' ' 88' ' ' ILE . 0.1 OUTLIER -55.0 -65.42 0.58 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.343 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' B' ' 80' ' ' GLN . 4.6 m -110.71 96.21 6.03 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.053 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -134.69 116.81 15.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.044 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -54.89 109.51 0.53 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.556 -178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . 0.516 ' NH1' ' OE1' ' B' ' 166' ' ' GLU . 8.4 mmt85 -148.54 89.51 1.71 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.595 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' TRP . . . . . 0.499 ' O ' ' HA ' ' B' ' 166' ' ' GLU . 0.0 OUTLIER -72.48 145.85 47.26 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.036 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.415 ' HD3' HH11 ' B' ' 96' ' ' ARG . 11.2 ttm180 -133.84 109.05 8.82 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.387 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.14 156.23 18.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 3.3 m -134.2 149.89 51.03 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -174.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.709 HD22 ' CG1' ' B' ' 120' ' ' ILE . 0.5 OUTLIER -122.41 96.09 4.9 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.334 174.69 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.476 ' CG ' ' HE2' ' B' ' 103' ' ' HIS . 18.3 t70 -97.18 93.6 6.64 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.277 -177.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.45 HG11 ' CE2' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -162.92 6.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-O 120.858 0.361 . . . . 0.0 111.103 179.874 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.841 ' HB2' HD13 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -90.46 -10.08 45.06 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -173.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.476 ' HE2' ' CG ' ' B' ' 100' ' ' ASP . 0.8 OUTLIER -42.73 -29.01 0.27 Allowed 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.611 ' HB2' ' CE1' ' B' ' 124' ' ' HIS . 59.6 m-85 -101.25 25.35 8.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -170.28 93.75 0.48 Allowed Pre-proline 0 C--O 1.223 -0.297 0 CA-C-O 120.673 0.273 . . . . 0.0 111.633 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.6 -60.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.436 2.091 . . . . 0.0 111.558 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' B' ' 109' ' ' LEU . 19.7 t70 -91.74 -30.98 15.96 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 120.945 0.403 . . . . 0.0 110.458 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -73.68 32.9 0.08 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.376 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.841 HD13 ' HB2' ' B' ' 102' ' ' ASN . 0.4 OUTLIER -128.54 128.71 44.82 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.543 177.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.4 130.15 50.15 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.974 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.566 HG13 ' CD1' ' B' ' 120' ' ' ILE . 1.9 t -105.09 114.08 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.02 134.46 54.84 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.518 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.02 115.46 29.01 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.535 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.543 ' NZ ' ' OE2' ' B' ' 119' ' ' GLU . 0.0 OUTLIER -113.66 -171.43 1.89 Allowed 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -64.53 70.25 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' B' ' 114' ' ' LYS . . . 78.97 -8.32 45.32 Favored Glycine 0 CA--C 1.498 -1.008 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -178.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.52 HG22 HG23 ' B' ' 143' ' ' THR . 2.0 t -88.45 112.23 23.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.424 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 78.4 t -97.09 110.61 25.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.543 ' OE2' ' NZ ' ' B' ' 114' ' ' LYS . 29.5 mt-10 -126.76 117.36 22.52 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.168 0.509 . . . . 0.0 111.448 -176.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.709 ' CG1' HD22 ' B' ' 99' ' ' LEU . 6.1 mm -88.25 135.61 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.209 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.9 OUTLIER -115.7 111.51 20.7 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.445 -178.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.28 132.33 5.28 Favored Glycine 0 C--N 1.335 0.489 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -135.66 128.63 31.41 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . 0.611 ' CE1' ' HB2' ' B' ' 104' ' ' PHE . 28.3 m-70 -91.66 140.73 29.43 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.554 -177.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.5 OUTLIER -87.96 143.96 26.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.924 -178.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . 0.523 ' OE1' ' NZ ' ' A' ' 141' ' ' LYS . 2.5 tt0 -17.46 102.21 0.02 OUTLIER 'General case' 0 C--N 1.351 0.632 0 O-C-N 123.447 0.467 . . . . 0.0 112.068 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' ARG . . . . . 0.406 ' NH1' ' CE1' ' B' ' 104' ' ' PHE . 0.0 OUTLIER -94.86 149.98 20.67 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.055 -179.279 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -97.02 114.18 25.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.748 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.91 166.51 23.14 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -57.84 -26.9 62.67 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.955 -177.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' HIS . . . . . 0.533 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 60.4 m-70 -80.07 14.31 1.91 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.652 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.78 -138.99 14.2 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -100.26 147.8 25.35 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . 0.535 HG23 ' O ' ' B' ' 134' ' ' ILE . 0.0 OUTLIER -156.04 117.54 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -175.244 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -131.04 153.3 49.42 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . 0.415 ' NH1' HD11 ' B' ' 134' ' ' ILE . 2.0 ptt180 -155.91 156.99 35.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.043 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 28.1 p -100.71 136.83 39.96 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . 0.477 ' CZ ' ' NH1' ' A' ' 136' ' ' ARG . 0.6 OUTLIER -114.64 123.51 49.49 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -178.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.6 118.2 20.66 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.281 0.563 . . . . 0.0 110.893 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . 0.677 ' NH1' HD12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -115.88 121.51 42.59 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . 0.49 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 3.6 ttpp -112.85 116.34 29.88 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 123.244 0.34 . . . . 0.0 110.958 -176.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' TYR . . . . . 0.65 ' CE1' ' HA3' ' A' ' 132' ' ' GLY . 5.3 m-30 -107.56 97.54 7.26 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.594 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.2 OUTLIER -90.77 96.67 10.76 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 175.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . 0.479 ' C ' ' HD2' ' B' ' 146' ' ' PRO . 7.0 mp -108.44 94.46 13.71 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.821 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . 0.598 ' N ' ' HD2' ' B' ' 146' ' ' PRO . 24.0 Cg_exo -66.33 -34.42 35.21 Favored 'Trans proline' 0 C--N 1.287 -2.704 0 C-N-CA 122.636 2.224 . . . . 0.0 113.316 175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' B' ' 145' ' ' PRO . 27.7 Cg_exo -43.76 -10.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.991 1.794 . . . . 0.0 112.293 -178.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 111.36 44.65 0.9 Allowed Glycine 0 C--N 1.339 0.729 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.69 174.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' VAL . . . . . 0.498 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -68.51 101.83 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 175.141 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . 0.501 ' O ' HG23 ' B' ' 153' ' ' VAL . 13.5 t70 -52.31 126.4 36.97 Favored Pre-proline 0 C--O 1.221 -0.431 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.07 -172.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 5.1 Cg_exo -79.34 -18.98 10.67 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.11 1.873 . . . . 0.0 112.098 -177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.57 -38.25 12.61 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.558 -178.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' GLN . . . . . 0.453 ' N ' ' OD1' ' B' ' 149' ' ' ASP . 14.4 mt-30 -100.83 17.52 21.89 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . 0.501 HG23 ' O ' ' B' ' 149' ' ' ASP . 49.8 t -108.95 91.11 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.689 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.68 -166.08 1.51 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' B' ' 164' ' ' THR . 0.4 OUTLIER -163.57 142.54 8.08 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.437 -0.905 . . . . 0.0 112.751 -179.101 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.6 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.0 OUTLIER -111.81 144.63 40.79 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.028 178.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . 0.624 HD22 HD22 ' B' ' 109' ' ' LEU . 42.1 tp -130.76 117.09 18.89 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.403 ' HB3' HG22 ' B' ' 162' ' ' THR . 0.3 OUTLIER -103.57 152.01 38.78 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.813 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.613 ' C ' ' H ' ' B' ' 161' ' ' GLY . 94.5 Cg_exo -44.11 -32.82 5.12 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.45 2.1 . . . . 0.0 110.972 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -68.5 22.04 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.087 176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' GLY . . . . . 0.613 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 41.91 27.28 0.36 Allowed Glycine 0 CA--C 1.523 0.561 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.627 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' THR . . . . . 0.403 HG22 ' HB3' ' B' ' 158' ' ' SER . 9.0 t -88.14 118.55 27.8 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.656 HD13 ' C ' ' B' ' 163' ' ' LEU . 2.9 tm? -105.97 103.93 13.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.831 -177.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' B' ' 155' ' ' SER . 0.7 OUTLIER -94.53 125.49 39.21 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 123.033 0.208 . . . . 0.0 111.341 -179.051 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.567 ' O ' HG23 ' B' ' 165' ' ' VAL . 2.7 m -111.81 105.65 19.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 173.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 0.516 ' OE1' ' NH1' ' B' ' 94' ' ' ARG . 0.0 OUTLIER -114.29 137.61 51.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.722 -176.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' B' ' 169' ' ' MET . . . -168.75 158.21 7.94 Favored Pre-proline 0 N--CA 1.453 -0.279 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . 0.432 ' HD2' ' HB1' ' B' ' 167' ' ' ALA . 72.0 Cg_endo -75.83 30.44 0.38 Allowed 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 123.871 3.047 . . . . 0.0 110.329 174.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' MET . . . . . 0.489 ' H ' ' C ' ' B' ' 167' ' ' ALA . 0.6 OUTLIER -67.97 159.0 81.89 Favored Pre-proline 0 N--CA 1.441 -0.915 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.759 -179.404 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -44.0 143.0 3.46 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 123.397 2.731 . . . . 0.0 111.904 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -91.44 27.91 1.84 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.295 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.433 HD12 ' N ' ' B' ' 175' ' ' GLN . 0.1 OUTLIER -123.5 97.62 5.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.83 0.348 . . . . 0.0 110.34 178.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . 0.419 ' O ' ' HG2' ' B' ' 146' ' ' PRO . . . -59.03 -66.74 0.46 Allowed 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.112 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.96 62.77 1.16 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.695 -178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' GLN . . . . . 0.433 ' N ' HD12 ' B' ' 172' ' ' LEU . 25.6 tp60 -52.1 -86.7 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.589 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . 0.414 ' HG ' HE21 ' B' ' 175' ' ' GLN . 2.5 m . . . . . 0 C--O 1.21 -1.009 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.55 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 1.037 ' N ' ' HG ' ' A' ' 83' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 120.589 0.233 . . . . 0.0 110.632 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.575 ' H ' ' HG ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -168.18 -145.54 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -178.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.481 ' H ' ' CD ' ' A' ' 80' ' ' GLN . 12.8 mt -56.06 -47.12 78.51 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.92 66.43 9.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 1.037 ' HG ' ' N ' ' A' ' 79' ' ' MET . 13.2 m -123.96 -34.29 3.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.759 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.74 30.19 0.28 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.583 ' H ' ' C ' ' A' ' 83' ' ' SER . 2.1 m -136.15 47.83 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.233 0.54 . . . . 0.0 109.568 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.87 127.43 28.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.377 -179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -60.95 135.01 57.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.193 -179.217 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.408 HG12 ' H ' ' A' ' 88' ' ' ILE . 0.3 OUTLIER -67.36 50.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-O 121.196 0.522 . . . . 0.0 109.983 178.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.585 ' NE ' ' H ' ' A' ' 90' ' ' HIS . 0.0 OUTLIER -163.34 153.99 16.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.808 -179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.585 ' H ' ' NE ' ' A' ' 89' ' ' ARG . 76.0 m-70 -97.09 152.06 19.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.868 0.366 . . . . 0.0 110.512 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.9 p -129.6 -165.12 1.48 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.298 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.595 ' O ' ' NH1' ' A' ' 94' ' ' ARG . . . -57.15 133.69 55.24 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 177.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.449 ' O ' ' NH1' ' A' ' 94' ' ' ARG . 3.0 t0 -73.41 -155.88 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.777 0.322 . . . . 0.0 110.854 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.595 ' NH1' ' O ' ' A' ' 92' ' ' ALA . 85.0 mmt-85 -143.5 101.81 3.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.07 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.02 140.14 32.06 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 47.1 ttp85 -131.71 117.65 18.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.977 0.418 . . . . 0.0 111.48 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.13 134.85 65.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.192 176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.6 m -111.11 135.34 51.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -175.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.573 HD22 ' HB ' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -111.86 72.98 0.8 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.851 175.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.458 ' O ' HG22 ' A' ' 101' ' ' VAL . 9.1 p-10 -77.56 110.57 12.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.999 -178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.488 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -160.48 -49.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-O 121.251 0.548 . . . . 0.0 110.907 177.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.764 HD22 ' H ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER -58.6 14.07 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -174.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.488 ' H ' ' C ' ' A' ' 101' ' ' VAL . 0.9 OUTLIER -43.31 -41.67 4.14 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.348 0.594 . . . . 0.0 110.11 178.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.2 -4.24 52.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.453 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -133.15 73.46 74.64 Favored Pre-proline 0 CA--C 1.511 -0.543 0 CA-C-O 120.938 0.399 . . . . 0.0 112.031 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.5 -40.24 5.98 Favored 'Trans proline' 0 C--N 1.299 -2.073 0 C-N-CA 122.54 2.16 . . . . 0.0 111.565 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -99.74 -27.52 13.61 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.638 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.544 ' OE1' ' NZ ' ' A' ' 123' ' ' LYS . 70.5 mm-40 -88.53 35.41 0.77 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.092 0.472 . . . . 0.0 110.627 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 102' ' ' ASN . 0.3 OUTLIER -122.47 132.8 54.51 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.628 179.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.48 114.99 20.18 Favored 'General case' 0 C--O 1.247 0.964 0 CA-C-O 120.718 0.294 . . . . 0.0 110.609 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.505 HG13 HD11 ' A' ' 120' ' ' ILE . 2.4 t -95.7 130.17 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 pttm -140.23 128.78 22.86 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.606 -0.437 . . . . 0.0 111.462 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.07 115.3 24.37 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.59 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.4 OUTLIER -110.86 73.0 0.8 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.18 0.514 . . . . 0.0 110.27 -177.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER 34.54 67.98 0.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.389 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.56 -23.62 27.16 Favored Glycine 0 N--CA 1.465 0.611 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.636 HG22 HG23 ' A' ' 143' ' ' THR . 3.5 t -87.23 113.05 24.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 67.3 t -100.55 112.78 34.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.51 ' HG2' ' HB2' ' A' ' 141' ' ' LYS . 37.1 mt-10 -128.89 142.82 50.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 121.427 0.632 . . . . 0.0 111.628 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.573 ' HB ' HD22 ' A' ' 99' ' ' LEU . 1.1 mp -116.27 115.74 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.39 178.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.3 OUTLIER -93.45 116.9 29.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.569 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.18 136.9 5.88 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.881 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.544 ' NZ ' ' OE1' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -128.19 159.31 35.58 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.151 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -97.72 135.27 39.74 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.738 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.47 ' O ' ' C ' ' A' ' 126' ' ' GLU . 6.1 tp10 -68.25 135.73 52.42 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 176.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.47 ' C ' ' O ' ' A' ' 125' ' ' GLU . 10.6 tt0 -34.83 99.03 0.02 OUTLIER 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.77 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -81.71 155.56 25.46 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.757 -176.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -116.59 110.45 18.55 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.592 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -127.92 136.77 51.81 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.036 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 130' ' ' GLU . 0.7 OUTLIER -47.83 -24.85 1.09 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.959 -178.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.418 ' CD2' ' N ' ' A' ' 131' ' ' HIS . 9.8 m-70 -97.76 10.24 40.58 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.953 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 140.66 154.41 6.23 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.686 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 11.6 m-30 -94.57 109.64 21.52 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 172.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 0.1 OUTLIER -119.33 137.99 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -172.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.412 ' OG ' ' N ' ' A' ' 136' ' ' ARG . 6.3 t -142.75 171.28 14.27 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.013 170.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.48 HH11 ' HD3' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -161.92 -176.82 5.43 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.868 -177.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.5 p -138.61 121.61 16.71 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -98.03 132.41 43.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.712 0.292 . . . . 0.0 111.501 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.63 101.17 7.31 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 173.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.497 ' NH1' ' OH ' ' A' ' 142' ' ' TYR . 1.9 ttt-85 -107.33 103.63 13.03 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.51 ' HB2' ' HG2' ' A' ' 119' ' ' GLU . 7.5 ttpt -112.72 129.83 56.27 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.033 0.444 . . . . 0.0 112.124 -175.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.497 ' OH ' ' NH1' ' A' ' 140' ' ' ARG . 22.3 m-85 -118.11 99.79 7.11 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.595 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.636 HG23 HG22 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -90.76 89.97 7.73 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.93 92.98 15.98 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.623 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 18.6 Cg_exo -65.77 -55.4 0.43 Allowed 'Trans proline' 0 C--N 1.289 -2.567 0 C-N-CA 121.86 1.706 . . . . 0.0 112.632 175.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.623 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 50.6 Cg_endo -103.84 92.06 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 123.78 2.986 . . . . 0.0 111.517 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.94 -16.31 1.19 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.216 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.771 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 0.9 OUTLIER -131.34 129.52 62.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-N 117.332 0.566 . . . . 0.0 111.077 177.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 13.4 t70 -94.37 143.55 26.52 Favored Pre-proline 0 N--CA 1.473 0.703 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.165 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.456 ' HB3' ' HA ' ' A' ' 115' ' ' ASP . 3.3 Cg_exo -81.96 -26.02 3.18 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.823 1.682 . . . . 0.0 112.928 -177.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.14 -37.35 16.25 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.735 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 4.8 mt-30 -107.2 27.99 8.51 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -172.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.572 HG22 ' HE3' ' A' ' 169' ' ' MET . 51.2 t -116.08 113.11 42.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.15 176.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.01 -173.01 2.2 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.29 131.82 11.34 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.837 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.76 139.67 39.98 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.728 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.641 HD22 HD22 ' A' ' 109' ' ' LEU . 14.9 tp -133.95 129.29 36.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.016 0.436 . . . . 0.0 110.85 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.593 ' N ' HD12 ' A' ' 157' ' ' LEU . 0.2 OUTLIER -113.9 148.97 41.06 Favored Pre-proline 0 C--N 1.31 -1.11 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.969 178.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 161' ' ' GLY . 76.9 Cg_exo -40.04 -33.88 0.86 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.807 2.338 . . . . 0.0 112.11 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -74.21 31.43 0.08 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.396 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.51 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 43.91 25.83 0.71 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 116.388 -0.369 . . . . 0.0 112.992 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 3.4 t -87.58 101.51 13.7 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 117.228 0.514 . . . . 0.0 109.693 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.597 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.5 tm? -100.92 102.37 13.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.051 -177.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 24.5 p -97.62 123.05 41.37 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.703 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 165' ' ' VAL . 1.4 m -101.85 98.97 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.405 ' H ' ' HG2' ' A' ' 166' ' ' GLU . 0.1 OUTLIER -118.03 136.72 53.37 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.229 -174.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.791 ' HB3' ' HE3' ' A' ' 169' ' ' MET . . . -176.42 166.42 1.57 Allowed Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.068 -177.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.545 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 58.6 Cg_endo -85.49 109.36 1.12 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 123.169 2.579 . . . . 0.0 110.126 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.791 ' HE3' ' HB3' ' A' ' 167' ' ' ALA . 37.8 mmt -87.22 152.69 53.2 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.79 -174.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -67.11 -165.89 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.906 2.404 . . . . 0.0 111.708 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -96.11 179.75 4.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.42 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.536 ' O ' ' N ' ' A' ' 174' ' ' THR . 0.5 OUTLIER 49.34 48.4 21.17 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.039 0.447 . . . . 0.0 110.94 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.12 58.9 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.266 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.536 ' N ' ' O ' ' A' ' 172' ' ' LEU . 7.3 m 70.75 138.57 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.191 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -76.84 0.06 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.599 -178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 C--O 1.212 -0.907 0 CA-C-O 118.228 -0.892 . . . . 0.0 111.106 179.806 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' MET . . . . . 1.144 ' N ' ' HG ' ' B' ' 82' ' ' SER . 7.9 mtt . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -66.84 -61.84 1.75 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -109.08 68.79 0.69 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . 1.144 ' HG ' ' N ' ' B' ' 79' ' ' MET . 1.5 m -72.89 -25.65 61.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.083 -178.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.42 171.86 1.32 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.026 0.441 . . . . 0.0 110.902 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.13 -45.6 0.02 OUTLIER Glycine 0 C--N 1.321 -0.293 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 m -68.92 -32.77 55.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.22 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.83 -68.23 0.19 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.942 0.401 . . . . 0.0 110.578 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 54.32 12.59 0.52 Allowed 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.713 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 1.2 mt -69.58 54.27 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.545 0 CA-C-O 121.386 0.612 . . . . 0.0 110.214 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.455 ' O ' ' N ' ' B' ' 91' ' ' THR . 0.4 OUTLIER -131.32 78.55 1.84 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.344 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -66.85 48.18 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.18 -178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.455 ' N ' ' O ' ' B' ' 89' ' ' ARG . 0.6 OUTLIER -74.13 -80.22 0.08 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.127 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -166.72 129.39 1.83 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.683 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -174.56 -179.28 1.49 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.052 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 65.1 120.86 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 O-C-N 123.727 0.642 . . . . 0.0 109.693 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' TRP . . . . . 0.44 ' HB2' ' CG ' ' B' ' 169' ' ' MET . 0.6 OUTLIER -81.3 128.16 33.51 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.891 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -127.47 101.93 6.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.583 -178.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.22 156.6 17.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 4.8 p -124.92 151.41 45.43 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.845 HD22 HG13 ' B' ' 120' ' ' ILE . 0.6 OUTLIER -122.85 43.47 2.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.777 172.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.77 97.81 0.11 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.635 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.432 ' C ' ' H ' ' B' ' 103' ' ' HIS . 2.5 t -158.62 -28.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.401 0.619 . . . . 0.0 109.486 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.599 HD21 ' C ' ' B' ' 105' ' ' ALA . 17.0 t30 -66.92 8.94 0.22 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.741 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.432 ' H ' ' C ' ' B' ' 101' ' ' VAL . 25.9 m80 -39.64 -21.88 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' B' ' 102' ' ' ASN . 28.0 p90 -92.36 -34.56 14.13 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -176.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . 0.599 ' C ' HD21 ' B' ' 102' ' ' ASN . . . -113.52 76.64 2.91 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -176.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.3 -39.13 49.41 Favored 'Trans proline' 0 C--N 1.295 -2.259 0 C-N-CA 122.359 2.039 . . . . 0.0 112.237 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -102.0 -27.31 13.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.79 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.563 ' OE1' ' NZ ' ' B' ' 123' ' ' LYS . 32.3 mt-10 -92.69 41.58 1.08 Allowed 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.804 0.335 . . . . 0.0 111.206 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.739 HD22 HD22 ' B' ' 157' ' ' LEU . 0.4 OUTLIER -123.51 136.36 54.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.242 179.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.414 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -128.86 131.23 47.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.737 -179.352 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.01 119.46 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -124.37 135.26 53.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 0.0 111.312 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -107.66 115.33 29.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.369 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.521 ' HD2' ' HB ' ' B' ' 117' ' ' VAL . 0.0 OUTLIER -116.0 90.5 3.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.377 -177.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 18.9 t0 33.48 69.21 0.14 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.07 -21.44 16.07 Favored Glycine 0 C--N 1.316 -0.572 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.642 HG22 HG23 ' B' ' 143' ' ' THR . 3.8 t -87.49 112.59 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.59 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 75.4 t -97.98 119.8 46.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.497 ' OE2' ' NZ ' ' B' ' 114' ' ' LYS . 33.7 mt-10 -133.96 139.88 46.39 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.49 0.662 . . . . 0.0 111.134 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.845 HG13 HD22 ' B' ' 99' ' ' LEU . 1.0 OUTLIER -116.78 137.46 50.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.494 -179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.82 119.53 35.69 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.226 -1.352 . . . . 0.0 110.281 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -142.87 124.7 2.42 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' LYS . . . . . 0.563 ' NZ ' ' OE1' ' B' ' 108' ' ' GLU . 0.0 OUTLIER -150.66 140.51 21.86 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -116.94 157.94 24.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.224 0.535 . . . . 0.0 112.397 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.452 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.8 OUTLIER -68.52 145.49 53.97 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.275 179.082 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . 0.581 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 4.9 tt0 -29.98 102.1 0.02 OUTLIER 'General case' 0 C--N 1.349 0.546 0 CA-C-O 120.832 0.349 . . . . 0.0 111.174 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' B' ' 134' ' ' ILE . 0.2 OUTLIER -89.65 136.37 33.07 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.913 -177.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -90.7 117.28 29.22 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 172.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . 0.465 ' HB2' HG22 ' B' ' 134' ' ' ILE . 0.6 OUTLIER -125.75 171.95 10.23 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.134 178.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -56.45 -31.78 64.3 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -174.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' HIS . . . . . 0.444 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 74.0 m80 -111.73 36.39 3.3 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -175.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 121.85 -173.29 15.74 Favored Glycine 0 C--N 1.305 -1.18 0 C-N-CA 120.355 -0.926 . . . . 0.0 111.426 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' B' ' 127' ' ' ARG . 13.6 m-30 -95.94 118.92 33.5 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 173.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . 0.512 HG23 ' O ' ' B' ' 134' ' ' ILE . 0.1 OUTLIER -133.74 112.26 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -173.173 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . 0.581 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -127.9 164.1 23.0 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 174.032 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . 0.498 ' NH2' ' O ' ' B' ' 134' ' ' ILE . 0.0 OUTLIER -161.76 161.94 29.43 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.588 -176.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 26.8 p -113.47 128.16 56.35 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -107.99 137.93 45.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -176.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.55 123.64 19.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.282 0.563 . . . . 0.0 111.046 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . 0.617 ' NH2' ' O ' ' B' ' 99' ' ' LEU . 0.0 OUTLIER -124.54 118.65 27.05 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 175.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . 0.468 ' HB2' ' HG2' ' B' ' 119' ' ' GLU . 1.1 ttpp -114.11 124.65 52.61 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.823 0.344 . . . . 0.0 110.874 -175.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' TYR . . . . . 0.59 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 3.3 m-85 -114.27 98.27 6.83 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.245 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.642 HG23 HG22 ' B' ' 117' ' ' VAL . 0.3 OUTLIER -91.33 101.49 14.18 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 5.7 mp -107.35 96.49 16.09 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' B' ' 143' ' ' THR . 36.0 Cg_exo -62.26 -38.18 56.53 Favored 'Trans proline' 0 C--N 1.286 -2.76 0 C-N-CA 123.375 2.717 . . . . 0.0 114.198 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 50.1 Cg_exo -47.34 -8.61 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 C-N-CA 121.619 1.546 . . . . 0.0 111.515 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 97.83 56.73 1.07 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.2 -0.524 . . . . 0.0 111.979 175.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' VAL . . . . . 0.51 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -69.86 100.76 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.274 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 176.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . 0.504 ' O ' HG23 ' B' ' 153' ' ' VAL . 0.9 OUTLIER -33.83 120.23 0.5 Allowed Pre-proline 0 C--O 1.219 -0.509 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.411 -173.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 8.5 Cg_exo -71.86 -42.39 1.67 Allowed 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.425 2.083 . . . . 0.0 111.841 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.77 -47.6 25.23 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.642 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' GLN . . . . . 0.665 ' O ' ' HB1' ' B' ' 167' ' ' ALA . 0.4 OUTLIER -85.35 18.69 2.57 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.629 -1.169 . . . . 0.0 113.473 -172.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' B' ' 167' ' ' ALA . 33.4 t -114.0 106.65 21.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.471 177.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.44 -169.31 1.7 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -162.72 146.47 11.37 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.612 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.639 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.7 OUTLIER -120.67 144.77 48.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.684 177.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . 0.739 HD22 HD22 ' B' ' 109' ' ' LEU . 23.5 tp -134.9 148.65 50.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.342 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.02 156.81 79.64 Favored Pre-proline 0 C--N 1.318 -0.776 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.591 ' C ' ' H ' ' B' ' 161' ' ' GLY . 75.5 Cg_exo -39.61 -43.43 3.05 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.702 2.268 . . . . 0.0 111.402 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -66.97 26.61 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.21 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' GLY . . . . . 0.599 ' HA2' HD11 ' B' ' 157' ' ' LEU . . . 41.65 24.48 0.15 Allowed Glycine 0 CA--C 1.531 1.04 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.734 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' THR . . . . . 0.516 ' O ' HD12 ' B' ' 157' ' ' LEU . 11.6 t -77.03 130.4 37.38 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 175.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.639 HD22 ' O ' ' B' ' 156' ' ' SER . 2.7 tm? -126.46 105.39 8.73 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.145 -175.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.28 121.8 38.46 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.575 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.2 m -105.51 98.94 7.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 0.0 OUTLIER -116.43 127.3 54.48 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.504 -175.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' B' ' 152' ' ' GLN . . . -171.1 158.06 5.07 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -82.49 126.47 4.75 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 123.478 2.785 . . . . 0.0 110.005 176.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' MET . . . . . 0.638 ' CB ' ' HD2' ' B' ' 170' ' ' PRO . 0.0 OUTLIER -123.99 176.43 2.27 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.993 -176.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' B' ' 169' ' ' MET . 21.4 Cg_exo -25.78 97.71 0.01 OUTLIER 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 124.317 3.344 . . . . 0.0 112.074 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -51.5 -23.66 4.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.952 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.55 152.09 40.04 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.927 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . 0.483 ' C ' ' H ' ' B' ' 175' ' ' GLN . . . -86.3 164.04 17.35 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.577 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 20.8 p -68.77 44.71 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.04 0.448 . . . . 0.0 110.709 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' GLN . . . . . 0.483 ' H ' ' C ' ' B' ' 173' ' ' ALA . 15.9 mt-30 -148.64 171.32 16.36 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.773 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' B' ' 175' ' ' GLN . 62.0 p . . . . . 0 C--O 1.206 -1.21 0 CA-C-O 118.493 -0.765 . . . . 0.0 111.635 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -93.03 -146.34 0.23 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.414 HD12 HG11 ' A' ' 85' ' ' VAL . 43.3 mt -103.75 162.53 13.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.9 m -161.89 -179.29 7.06 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.377 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 52.26 29.43 6.66 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.376 0.607 . . . . 0.0 110.242 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 162.32 -150.31 19.38 Favored Glycine 0 C--N 1.321 -0.305 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.414 HG11 HD12 ' A' ' 81' ' ' LEU . 1.7 t 38.3 39.97 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.911 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.1 m -115.34 137.99 51.45 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.444 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -161.89 85.9 0.62 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.13 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.575 ' N ' HD13 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -112.34 143.67 21.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.384 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 91' ' ' THR . 8.3 mtm180 -139.18 0.07 1.88 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.693 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -60.09 64.74 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.589 ' N ' ' O ' ' A' ' 89' ' ' ARG . 6.9 p -138.04 -126.28 0.13 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.909 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 61.76 -56.69 0.12 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.649 0.261 . . . . 0.0 111.594 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 91' ' ' THR . 11.4 t70 -66.95 104.43 1.37 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.252 -178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.528 HH21 ' CD ' ' A' ' 166' ' ' GLU . 30.4 mmm-85 -148.52 126.17 11.77 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.789 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.497 ' NE1' ' CG2' ' A' ' 97' ' ' VAL . 37.7 t-105 -117.71 118.22 31.49 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -108.22 104.76 14.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.097 -175.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.497 ' CG2' ' NE1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -110.74 139.13 35.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 174.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 15.4 m -111.36 154.06 25.11 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.43 -0.508 . . . . 0.0 112.368 -176.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.751 HD22 HG12 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -131.05 67.13 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.591 176.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.19 89.48 4.27 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.86 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.484 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.2 OUTLIER -142.75 -36.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 121.226 0.536 . . . . 0.0 110.42 177.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.658 ' OD1' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -64.45 13.41 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.56 -176.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.484 ' H ' ' C ' ' A' ' 101' ' ' VAL . 2.1 p80 -54.63 -20.1 7.41 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.723 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.533 ' O ' ' ND1' ' A' ' 124' ' ' HIS . 32.6 p90 -107.2 3.65 25.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.712 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -140.85 81.39 16.52 Favored Pre-proline 0 CA--C 1.518 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 111.223 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.99 -44.38 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.685 2.257 . . . . 0.0 111.324 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -104.6 -31.13 9.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.346 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.36 36.25 0.47 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.086 0.47 . . . . 0.0 110.655 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.695 ' CD2' HD22 ' A' ' 157' ' ' LEU . 0.3 OUTLIER -117.9 135.9 53.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.938 178.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.481 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 1.2 m -127.68 126.83 42.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.841 177.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.419 HG13 ' CD1' ' A' ' 120' ' ' ILE . 7.4 t -104.09 126.97 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.409 ' NZ ' ' CB ' ' A' ' 119' ' ' GLU . 3.4 pttp -133.17 130.95 39.85 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 120.27 -0.572 . . . . 0.0 112.058 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 45.3 m -112.05 109.17 18.76 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.59 178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.522 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 3.3 ttmm -114.43 99.89 7.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.257 -177.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 114' ' ' LYS . 15.6 t0 26.1 64.23 0.07 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 94.86 -19.81 52.07 Favored Glycine 0 N--CA 1.461 0.308 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 177.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 2.7 t -88.67 112.55 24.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.537 178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.12 114.6 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 140' ' ' ARG . 46.1 mt-10 -127.46 133.57 49.9 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.266 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.751 HG12 HD22 ' A' ' 99' ' ' LEU . 4.0 mm -104.25 137.19 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.277 0 CA-C-N 115.295 -0.866 . . . . 0.0 108.979 176.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -118.89 107.59 13.77 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.192 -178.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -135.17 115.03 1.32 Allowed Glycine 0 N--CA 1.461 0.357 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 159.58 41.22 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.533 ' ND1' ' O ' ' A' ' 104' ' ' PHE . 1.7 t60 -139.72 141.49 36.9 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.416 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.502 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.3 OUTLIER -81.45 150.22 28.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.063 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.531 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 4.9 tt0 -1.4 108.93 0.01 OUTLIER 'General case' 0 C--N 1.349 0.556 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -98.96 137.37 37.6 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.565 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -92.9 116.47 29.07 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -174.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 132' ' ' GLY . 4.6 m-20 -140.09 129.09 23.51 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 174.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -51.14 -26.68 7.04 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -104.45 29.1 6.35 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.539 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 129' ' ' ASP . . . 135.1 131.04 3.02 Favored Glycine 0 C--N 1.303 -1.261 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.158 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.41 ' HD1' ' H ' ' A' ' 129' ' ' ASP . 14.7 m-85 -92.35 107.85 19.52 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.634 HD13 ' NH2' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -125.93 117.53 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -174.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.531 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -109.17 149.57 29.16 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 174.401 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.634 ' NH2' HD13 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -133.16 172.43 12.67 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -174.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 23.7 p -141.13 131.75 25.55 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.426 ' CD2' HG11 ' A' ' 101' ' ' VAL . 7.3 m-85 -107.09 139.48 41.44 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 121.136 -0.225 . . . . 0.0 111.034 -177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.8 104.47 6.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.395 0.617 . . . . 0.0 110.364 175.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.6 ' HD3' HD23 ' A' ' 99' ' ' LEU . 12.5 ttt180 -108.01 100.54 9.88 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.48 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 6.6 ttpt -107.67 116.04 31.23 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.287 -175.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.569 ' OH ' ' NE ' ' A' ' 140' ' ' ARG . 19.9 m-30 -114.52 99.6 7.67 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.3 0.571 . . . . 0.0 110.144 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.497 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -86.29 89.03 7.73 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.377 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.7 mp -112.1 91.52 16.03 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.656 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 15.3 Cg_exo -68.18 -56.41 0.2 Allowed 'Trans proline' 0 C--N 1.294 -2.311 0 C-N-CA 122.359 2.039 . . . . 0.0 113.831 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.656 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 37.4 Cg_endo -99.3 53.61 0.06 OUTLIER 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 123.327 2.685 . . . . 0.0 112.408 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -171.45 -12.91 0.02 OUTLIER Glycine 0 CA--C 1.521 0.429 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.569 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.587 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 1.0 OUTLIER -130.26 125.11 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-N 117.68 0.74 . . . . 0.0 111.187 178.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.497 ' HB2' ' HD3' ' A' ' 170' ' ' PRO . 14.2 t70 -81.91 140.69 46.85 Favored Pre-proline 0 N--CA 1.478 0.962 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.293 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 5.8 Cg_exo -81.1 -26.45 3.46 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.027 1.818 . . . . 0.0 113.0 -178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.411 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 0.8 OUTLIER -91.19 -36.38 13.98 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -176.257 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.689 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 4.6 mt-30 -107.72 27.22 9.4 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -172.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 41.7 t -113.3 104.94 17.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.67 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.31 -161.77 0.89 Allowed 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.717 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.1 132.07 2.94 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.08 -0.648 . . . . 0.0 112.335 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 163' ' ' LEU . 0.0 OUTLIER -100.82 139.81 35.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.591 177.459 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.695 HD22 ' CD2' ' A' ' 109' ' ' LEU . 42.1 tp -137.53 138.13 39.33 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.176 0.513 . . . . 0.0 110.981 178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.729 ' HB2' HG22 ' A' ' 162' ' ' THR . 23.1 m -121.88 146.06 45.07 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.631 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.424 ' C ' ' H ' ' A' ' 161' ' ' GLY . 75.4 Cg_exo -41.27 -34.8 1.86 Allowed 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.065 1.843 . . . . 0.0 110.897 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.411 ' CD ' ' H ' ' A' ' 160' ' ' GLU . 2.1 mp0 -65.31 2.86 0.75 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.076 177.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 158' ' ' SER . . . 67.09 21.2 71.62 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.894 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.729 HG22 ' HB2' ' A' ' 158' ' ' SER . 0.7 OUTLIER -77.24 106.82 9.21 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.568 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.2 tm? -106.94 101.52 10.94 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.752 -175.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.42 120.24 39.29 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 121.289 -0.165 . . . . 0.0 110.66 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 165' ' ' VAL . 1.5 m -100.93 99.18 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.528 ' CD ' HH21 ' A' ' 94' ' ' ARG . 1.4 pp20? -112.71 146.21 39.12 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.674 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 175.13 166.64 0.37 Allowed Pre-proline 0 N--CA 1.437 -1.103 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.206 -179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.586 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 72.8 Cg_endo -86.41 106.33 0.77 Allowed 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 122.803 2.335 . . . . 0.0 108.735 175.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.587 ' SD ' ' HA ' ' A' ' 148' ' ' VAL . 20.5 mmt -74.66 153.95 87.39 Favored Pre-proline 0 C--N 1.31 -1.126 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.554 -174.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 149' ' ' ASP . 38.4 Cg_endo -69.68 134.7 28.8 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.626 2.217 . . . . 0.0 111.684 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.564 ' O ' ' N ' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -63.49 -175.41 0.12 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.929 178.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.0 mp -64.97 57.79 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.913 0.387 . . . . 0.0 110.608 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.564 ' N ' ' O ' ' A' ' 171' ' ' LYS . . . -61.03 -23.39 65.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.654 -179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 173' ' ' ALA . 25.3 p 54.7 110.52 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.57 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -76.23 -3.79 38.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.761 0.315 . . . . 0.0 110.711 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 82.0 p . . . . . 0 C--O 1.214 -0.802 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.52 -179.585 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' MET . . . . . 0.577 ' N ' ' OE1' ' B' ' 80' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.577 ' OE1' ' N ' ' B' ' 79' ' ' MET . 0.0 OUTLIER -126.57 8.57 7.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.643 179.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.607 HD22 ' N ' ' B' ' 81' ' ' LEU . 3.7 mm? -71.42 51.53 0.18 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.735 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -53.93 51.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.896 0.379 . . . . 0.0 110.638 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.82 134.95 24.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.217 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -136.97 29.72 2.71 Favored Glycine 0 N--CA 1.46 0.253 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 8.3 m -72.19 54.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.905 0.383 . . . . 0.0 110.402 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 2.2 m 55.3 -154.79 0.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.138 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' B' ' 89' ' ' ARG . 26.4 mt-10 -54.88 126.6 25.02 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.443 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' B' ' 90' ' ' HIS . 16.5 mm -69.48 59.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.056 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.532 ' O ' ' NH1' ' B' ' 89' ' ' ARG . 0.0 OUTLIER -63.77 59.45 0.02 OUTLIER 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.105 179.383 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' HIS . . . . . 0.571 ' CG ' ' H ' ' B' ' 91' ' ' THR . 7.9 t-80 -159.71 -168.17 2.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.023 -178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.571 ' H ' ' CG ' ' B' ' 90' ' ' HIS . 0.0 OUTLIER -66.22 72.06 0.07 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 178.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' B' ' 90' ' ' HIS . . . -58.42 -175.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.885 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' B' ' 94' ' ' ARG . 17.1 t70 -33.87 -57.9 0.45 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.976 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . 0.478 ' NH1' ' OE1' ' B' ' 166' ' ' GLU . 9.0 mmt85 17.7 110.96 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 124.265 0.978 . . . . 0.0 112.472 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' TRP . . . . . 0.685 ' HB2' ' SD ' ' B' ' 169' ' ' MET . 0.3 OUTLIER -55.51 151.11 10.89 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.133 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.607 ' HB2' ' NH1' ' B' ' 96' ' ' ARG . 16.3 ttm105 -150.13 109.4 3.96 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.684 -176.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 t -119.1 152.27 21.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 1.5 m -126.05 144.29 50.78 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -176.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.689 HD23 ' NE ' ' B' ' 140' ' ' ARG . 0.3 OUTLIER -115.39 54.64 0.79 Allowed 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.447 176.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.55 ' O ' HG22 ' B' ' 101' ' ' VAL . 0.1 OUTLIER -62.32 96.96 0.08 Allowed 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.018 -178.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.55 HG22 ' O ' ' B' ' 100' ' ' ASP . 0.6 OUTLIER -162.0 -6.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 176.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.697 ' CB ' HD13 ' B' ' 109' ' ' LEU . 0.4 OUTLIER -90.5 10.15 26.52 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -175.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.504 ' N ' ' HA3' ' B' ' 161' ' ' GLY . 0.2 OUTLIER -39.63 -35.04 0.27 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.72 0.295 . . . . 0.0 111.155 179.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.6 -8.83 51.75 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' B' ' 102' ' ' ASN . . . -138.72 93.34 10.88 Favored Pre-proline 0 CA--C 1.515 -0.383 0 CA-C-O 120.696 0.284 . . . . 0.0 111.298 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -81.17 -48.43 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.967 0 C-N-CA 122.68 2.253 . . . . 0.0 110.933 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -90.29 -31.2 17.05 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.523 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.518 ' OE2' ' NZ ' ' B' ' 123' ' ' LYS . 2.8 mt-10 -84.63 45.09 1.1 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.369 0.604 . . . . 0.0 109.897 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.697 HD13 ' CB ' ' B' ' 102' ' ' ASN . 0.5 OUTLIER -129.44 135.98 49.34 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.013 178.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.96 121.73 22.06 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.571 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 1.5 t -98.99 131.78 45.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.814 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.443 ' HZ3' ' CD ' ' B' ' 119' ' ' GLU . 2.9 pttp -139.78 122.28 16.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.101 0.477 . . . . 0.0 111.755 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -99.7 117.54 34.27 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.558 ' O ' ' N ' ' B' ' 117' ' ' VAL . 1.3 ttpm? -128.96 112.01 13.62 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.348 -178.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . 0.492 ' OD1' ' NZ ' ' B' ' 114' ' ' LYS . 0.3 OUTLIER 34.64 59.89 0.64 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.91 0.862 . . . . 0.0 112.481 176.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.91 -12.1 31.55 Favored Glycine 0 C--N 1.314 -0.657 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 1.028 HG22 HG23 ' B' ' 143' ' ' THR . 9.0 t -87.47 115.46 28.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.762 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 54.2 t -103.66 112.67 38.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.571 -178.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.591 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 49.4 mt-10 -125.96 146.47 49.85 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.599 0.714 . . . . 0.0 111.546 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.532 ' HB ' HD22 ' B' ' 99' ' ' LEU . 1.3 mp -119.79 121.56 66.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.307 178.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -97.44 124.3 41.58 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.2 117.59 0.86 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' LYS . . . . . 0.518 ' NZ ' ' OE2' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -152.82 135.5 15.31 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.363 0.265 . . . . 0.0 110.489 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . 0.515 ' O ' ' CB ' ' B' ' 135' ' ' SER . 0.1 OUTLIER -111.96 123.55 50.49 Favored 'General case' 0 C--O 1.21 -0.989 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 177.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.477 ' H ' ' HG3' ' B' ' 125' ' ' GLU . 4.9 mt-10 -54.05 -21.43 8.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -176.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 178.61 131.11 0.07 Allowed 'General case' 0 C--O 1.235 0.294 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.989 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' ARG . . . . . 0.483 ' HD3' ' CE1' ' B' ' 124' ' ' HIS . 38.9 mtp180 -123.69 132.08 53.75 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.146 176.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -81.56 138.7 35.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.936 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . 0.506 ' CG ' ' N ' ' B' ' 130' ' ' GLU . 9.2 t70 -157.37 165.89 34.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.205 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . 0.506 ' N ' ' CG ' ' B' ' 129' ' ' ASP . 0.7 OUTLIER -61.4 -28.28 69.14 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.639 -177.119 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' HIS . . . . . 0.48 ' O ' ' CE1' ' A' ' 142' ' ' TYR . 10.6 m-70 -74.78 -12.55 60.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.758 0.313 . . . . 0.0 111.013 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.74 -136.95 8.96 Favored Glycine 0 CA--C 1.54 1.621 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 15.8 m-30 -112.25 134.99 53.48 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 175.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' B' ' 127' ' ' ARG . 0.4 OUTLIER -146.75 125.76 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -176.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' B' ' 124' ' ' HIS . 0.6 OUTLIER -142.99 158.01 44.0 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.029 0.442 . . . . 0.0 111.283 174.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . 0.472 ' CZ ' ' CZ ' ' B' ' 138' ' ' PHE . 0.2 OUTLIER -141.77 173.7 11.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.865 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 31.9 p -123.74 129.91 51.82 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . 0.472 ' CZ ' ' CZ ' ' B' ' 136' ' ' ARG . 1.1 m-85 -104.86 122.35 45.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.936 -176.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 134' ' ' ILE . 0.0 OUTLIER -124.83 99.47 6.16 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.137 174.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . 0.689 ' NE ' HD23 ' B' ' 99' ' ' LEU . 0.0 OUTLIER -106.63 119.58 39.68 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.288 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . 0.591 ' HA ' ' HG2' ' B' ' 119' ' ' GLU . 2.7 ttpt -120.19 130.72 54.68 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.07 0.462 . . . . 0.0 111.206 -176.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' TYR . . . . . 0.572 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 7.8 m-85 -120.27 98.74 6.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.961 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 1.028 HG23 HG22 ' B' ' 117' ' ' VAL . 1.3 m -93.52 93.66 8.22 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -110.95 90.95 11.86 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.584 -177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . 0.611 ' HD2' ' CD ' ' B' ' 146' ' ' PRO . 16.2 Cg_exo -68.72 -41.19 6.18 Favored 'Trans proline' 0 C--N 1.279 -3.096 0 C-N-CA 122.06 1.84 . . . . 0.0 112.125 167.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' PRO . . . . . 0.611 ' CD ' ' HD2' ' B' ' 145' ' ' PRO . 74.2 Cg_exo -43.21 -11.15 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 123.325 2.683 . . . . 0.0 114.606 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 149.02 44.64 0.03 OUTLIER Glycine 0 CA--C 1.503 -0.716 0 C-N-CA 118.239 -1.934 . . . . 0.0 115.447 176.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.29 116.56 52.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 118.73 -1.188 . . . . 0.0 110.667 173.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 19.3 t70 -80.02 140.33 53.71 Favored Pre-proline 0 C--O 1.221 -0.407 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.03 -176.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 4.2 Cg_exo -81.4 -23.89 4.78 Favored 'Trans proline' 0 N--CA 1.491 1.37 0 C-N-CA 122.074 1.85 . . . . 0.0 112.9 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.15 -43.68 9.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.975 0.417 . . . . 0.0 112.072 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -94.93 18.97 10.94 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . 0.632 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 42.5 t -108.83 104.94 17.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.088 0.471 . . . . 0.0 109.888 176.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.43 -175.38 3.19 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.237 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -158.01 132.79 8.46 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.717 -0.793 . . . . 0.0 112.291 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.56 139.84 40.39 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.222 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . 0.671 HD22 HD22 ' B' ' 109' ' ' LEU . 33.0 tp -131.08 143.12 50.43 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.416 ' OG ' ' HD2' ' B' ' 159' ' ' PRO . 0.2 OUTLIER -135.58 154.38 78.22 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.639 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.57 ' C ' ' H ' ' B' ' 161' ' ' GLY . 1.2 Cg_endo -44.8 -34.79 8.87 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.693 2.262 . . . . 0.0 111.491 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -68.74 24.12 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.034 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' GLY . . . . . 0.612 ' HA2' ' OD1' ' B' ' 102' ' ' ASN . . . 44.03 34.03 2.95 Favored Glycine 0 C--O 1.241 0.532 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.638 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 7.4 t -97.16 121.46 39.08 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 177.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.623 HD13 ' C ' ' B' ' 163' ' ' LEU . 1.8 tm? -115.84 103.86 11.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.953 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.59 121.72 39.82 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 121.13 -0.228 . . . . 0.0 110.803 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.587 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.1 m -106.49 103.33 15.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 174.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 0.478 ' OE1' ' NH1' ' B' ' 94' ' ' ARG . 2.0 pp20? -113.22 151.84 30.5 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.278 -177.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . 0.632 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -174.62 154.25 1.89 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 0.0 111.628 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -83.06 -4.7 11.24 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 123.018 2.479 . . . . 0.0 109.906 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' MET . . . . . 0.685 ' SD ' ' HB2' ' B' ' 95' ' ' TRP . 0.0 OUTLIER 57.09 179.39 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.388 177.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' B' ' 169' ' ' MET . 31.7 Cg_exo -58.02 172.87 1.07 Allowed 'Trans proline' 0 N--CA 1.499 1.831 0 C-N-CA 122.642 2.228 . . . . 0.0 112.433 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.34 51.88 0.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.991 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' B' ' 170' ' ' PRO . 28.0 mt -64.64 -43.5 93.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.329 0.585 . . . . 0.0 109.848 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -153.24 -164.66 1.97 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.394 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.49 77.58 0.57 Allowed 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 120.957 0.408 . . . . 0.0 110.222 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -174.61 0.1 Allowed 'General case' 0 C--O 1.242 0.664 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.405 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.214 -0.788 0 CA-C-O 118.11 -0.947 . . . . 0.0 110.147 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.493 ' N ' ' SD ' ' A' ' 79' ' ' MET . 2.1 mpt? . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 57.23 68.66 0.82 Allowed 'General case' 0 C--O 1.24 0.563 0 CA-C-O 120.873 0.368 . . . . 0.0 111.483 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.479 HD12 ' H ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -137.9 -103.87 0.19 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.479 ' H ' HD12 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -71.39 -48.04 52.37 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 176.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER 37.78 41.91 0.36 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.314 178.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.39 -51.74 0.44 Allowed Glycine 0 C--N 1.32 -0.34 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 85' ' ' VAL . 9.5 p -166.34 65.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.972 0.415 . . . . 0.0 110.871 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.557 ' C ' ' H ' ' A' ' 88' ' ' ILE . 0.7 OUTLIER -64.78 -169.31 0.04 OUTLIER 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -66.1 37.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.778 0.323 . . . . 0.0 111.297 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.557 ' H ' ' C ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -101.36 8.92 8.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.753 178.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.52 ' NH1' ' O ' ' A' ' 88' ' ' ILE . 90.7 mmt-85 -134.64 172.62 12.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.665 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.461 ' ND1' ' N ' ' A' ' 90' ' ' HIS . 1.6 m80 50.48 23.43 1.29 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.7 p -54.33 -70.53 0.1 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.445 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.27 89.61 2.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.329 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.45 -67.47 0.54 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.26 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 94' ' ' ARG . 10.9 mmt180 53.73 100.38 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -177.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.566 ' CB ' ' SD ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -68.45 145.17 54.32 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.129 -179.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -138.66 105.96 5.51 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.487 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -112.22 155.11 13.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 175.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.62 148.64 51.53 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -174.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.656 HD23 ' NE ' ' A' ' 140' ' ' ARG . 0.7 OUTLIER -130.13 118.91 22.19 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.102 174.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.461 ' CG ' ' HE2' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -112.28 114.08 26.66 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.536 -178.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.581 ' C ' ' H ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER -161.14 -43.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-O 120.89 0.376 . . . . 0.0 111.445 179.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.683 ' H ' ' ND2' ' A' ' 102' ' ' ASN . 0.0 OUTLIER -60.27 17.0 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.018 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.581 ' H ' ' C ' ' A' ' 101' ' ' VAL . 12.0 m80 -52.67 -38.09 59.88 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -105.69 -15.14 15.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.645 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -118.13 81.93 17.22 Favored Pre-proline 0 CA--C 1.516 -0.346 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -74.36 -44.66 0.4 Allowed 'Trans proline' 0 C--N 1.301 -1.934 0 C-N-CA 122.612 2.208 . . . . 0.0 110.924 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -92.55 -31.47 15.19 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.759 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -89.44 45.86 1.32 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.151 0.5 . . . . 0.0 111.14 -178.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.789 HD22 HD22 ' A' ' 157' ' ' LEU . 0.4 OUTLIER -133.34 130.29 38.64 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.1 m -128.61 124.56 36.16 Favored 'General case' 0 C--O 1.248 0.999 0 CA-C-O 120.783 0.325 . . . . 0.0 110.512 -177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.41 HG13 HD11 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -96.51 127.4 48.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.984 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.85 130.13 43.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.856 0.36 . . . . 0.0 111.406 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.91 104.0 13.37 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.625 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -109.43 103.32 12.21 Favored 'General case' 0 C--O 1.213 -0.831 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.528 -175.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.474 ' CG ' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER 36.06 41.44 0.13 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 177.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.03 -11.52 57.32 Favored Glycine 0 C--N 1.314 -0.651 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.716 HG22 HG23 ' A' ' 143' ' ' THR . 2.6 t -86.73 117.25 30.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.581 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 55.4 t -102.81 116.51 46.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.504 ' OE1' ' NZ ' ' A' ' 114' ' ' LYS . 2.2 mt-10 -133.51 140.2 47.09 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 121.272 0.558 . . . . 0.0 111.521 -178.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.41 HD11 HG13 ' A' ' 111' ' ' VAL . 1.2 mp -111.44 115.54 50.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.154 177.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -92.0 118.67 31.0 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.776 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.17 129.99 4.28 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.118 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.72 159.28 44.63 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -133.68 162.13 32.79 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.36 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.523 ' O ' ' C ' ' A' ' 126' ' ' GLU . 1.5 tt0 -90.28 143.33 26.86 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.851 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.523 ' C ' ' O ' ' A' ' 125' ' ' GLU . 1.0 OUTLIER -18.12 105.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.645 0.591 . . . . 0.0 111.846 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.25 128.94 35.15 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 120.897 0.379 . . . . 0.0 110.428 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -75.32 118.48 18.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.357 -176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 132' ' ' GLY . 1.6 m-20 -150.82 116.33 5.43 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -49.4 -25.27 2.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.73 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -90.38 19.18 5.38 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.373 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 129' ' ' ASP . . . 137.1 129.5 2.77 Favored Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.014 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -92.2 109.71 21.08 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.47 159.34 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -169.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.9 t -155.06 154.81 33.02 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.762 170.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.55 172.27 15.76 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.928 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 26.5 p -125.97 128.36 47.38 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -102.68 142.25 34.14 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.352 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.55 103.02 3.63 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.086 0.47 . . . . 0.0 111.554 176.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.656 ' NE ' HD23 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -104.16 119.63 39.37 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 174.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.5 ' NZ ' ' OE1' ' B' ' 126' ' ' GLU . 2.7 ttpt -118.4 123.58 45.59 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 123.21 0.319 . . . . 0.0 110.666 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.581 ' HB2' ' HB ' ' A' ' 118' ' ' VAL . 3.2 m-85 -112.96 99.16 7.66 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.993 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.716 HG23 HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -92.0 90.25 7.32 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.548 178.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.44 91.94 21.69 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.643 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 16.0 Cg_exo -67.47 -56.94 0.19 Allowed 'Trans proline' 0 C--N 1.288 -2.641 0 C-N-CA 122.349 2.033 . . . . 0.0 114.207 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.696 ' O ' HG22 ' A' ' 174' ' ' THR . 41.8 Cg_endo -100.61 56.34 0.04 OUTLIER 'Trans proline' 0 N--CA 1.482 0.815 0 C-N-CA 123.377 2.718 . . . . 0.0 113.035 -175.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.502 ' O ' ' HB3' ' A' ' 169' ' ' MET . . . -176.76 -14.35 0.02 OUTLIER Glycine 0 N--CA 1.466 0.634 0 C-N-CA 119.985 -1.102 . . . . 0.0 112.713 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.03 132.21 68.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 117.539 0.67 . . . . 0.0 110.153 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 13.0 t70 -93.44 141.15 23.54 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.204 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 2.4 Cg_endo -82.66 -21.4 5.08 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.095 1.863 . . . . 0.0 112.7 -177.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.45 -41.69 10.71 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.386 -175.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -101.29 14.44 31.96 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -171.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.683 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 24.9 t -102.75 117.09 47.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.387 177.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.02 166.69 11.18 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.62 137.46 35.33 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.112 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.412 ' OG ' ' OG1' ' A' ' 164' ' ' THR . 0.0 OUTLIER -111.57 138.57 47.94 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.872 177.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.789 HD22 HD22 ' A' ' 109' ' ' LEU . 14.8 tp -125.13 121.77 35.18 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.388 0.43 . . . . 0.0 110.364 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 161' ' ' GLY . 0.2 OUTLIER -96.07 138.28 21.65 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -39.95 -33.19 0.7 Allowed 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 122.556 2.171 . . . . 0.0 111.185 -179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -59.23 -5.54 0.74 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.344 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.537 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . 76.69 34.41 43.87 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 11.4 t -109.89 118.76 37.33 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.605 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.1 tm? -104.25 108.65 20.14 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.597 -174.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.412 ' OG1' ' OG ' ' A' ' 156' ' ' SER . 3.4 p -95.43 127.94 41.88 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.605 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.58 ' O ' HG23 ' A' ' 165' ' ' VAL . 2.7 m -113.47 103.33 15.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 1.6 pp20? -119.11 141.82 48.45 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.201 -176.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.683 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . . . -174.48 157.85 2.44 Favored Pre-proline 0 C--N 1.332 -0.193 0 C-N-CA 120.024 -0.671 . . . . 0.0 112.618 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.424 ' HD3' ' NH1' ' A' ' 94' ' ' ARG . 61.6 Cg_endo -83.35 108.73 1.55 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.736 2.291 . . . . 0.0 108.84 172.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.566 ' SD ' ' CB ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -87.59 156.09 53.43 Favored Pre-proline 0 C--N 1.305 -1.337 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.745 -174.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.428 ' O ' ' NE2' ' A' ' 90' ' ' HIS . 3.0 Cg_endo -50.19 -51.12 11.6 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.673 2.248 . . . . 0.0 111.43 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.56 ' NZ ' ' O ' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -168.34 135.75 2.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.327 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.0 -47.14 87.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.18 0.514 . . . . 0.0 109.736 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.56 ' O ' ' NZ ' ' A' ' 171' ' ' LYS . . . -69.19 100.32 1.28 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.959 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -55.2 135.91 49.08 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.469 ' O ' ' NZ ' ' A' ' 171' ' ' LYS . 22.6 mt-30 63.38 172.53 0.16 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.051 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.43 ' OXT' ' NZ ' ' A' ' 171' ' ' LYS . 14.3 p . . . . . 0 C--O 1.208 -1.126 0 CA-C-O 117.988 -1.006 . . . . 0.0 111.085 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' MET . . . . . . . . . . . . . 1.6 ppp? . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.84 -95.21 0.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.99 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.755 HD22 ' C ' ' B' ' 81' ' ' LEU . 0.0 OUTLIER -149.17 164.21 35.39 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.517 177.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . 0.435 ' N ' HD22 ' B' ' 81' ' ' LEU . 0.0 OUTLIER -146.0 -49.33 0.22 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.477 -178.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . 0.425 ' O ' ' N ' ' B' ' 85' ' ' VAL . 0.9 OUTLIER 66.75 129.53 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.645 -179.511 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -68.15 49.49 0.39 Allowed Glycine 0 C--N 1.319 -0.382 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.425 ' N ' ' O ' ' B' ' 83' ' ' SER . 1.3 p -46.81 108.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . 0.404 ' C ' ' N ' ' B' ' 88' ' ' ILE . 0.0 OUTLIER -124.94 -83.29 0.64 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.663 -176.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 51.92 14.38 0.31 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.954 0.407 . . . . 0.0 110.067 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.658 HG23 ' H ' ' B' ' 89' ' ' ARG . 4.6 tt -97.92 -57.31 4.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.643 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.658 ' H ' HG23 ' B' ' 88' ' ' ILE . 0.1 OUTLIER -83.93 -166.14 1.33 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 177.063 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' HIS . . . . . 0.439 ' ND1' ' N ' ' B' ' 90' ' ' HIS . 0.0 OUTLIER -65.9 6.53 0.36 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.448 177.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.512 ' H ' ' C ' ' B' ' 89' ' ' ARG . 0.7 OUTLIER -52.0 117.14 2.55 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.602 179.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 62.62 -149.49 0.36 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.975 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' B' ' 168' ' ' PRO . 0.1 OUTLIER -165.77 171.0 13.36 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.893 0.378 . . . . 0.0 111.245 -179.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . 0.473 HH11 ' HB3' ' B' ' 94' ' ' ARG . 0.2 OUTLIER -124.94 102.97 7.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.567 178.416 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' TRP . . . . . 0.672 ' HB2' ' SD ' ' B' ' 169' ' ' MET . 0.1 OUTLIER -63.83 139.99 58.82 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.401 ' HD2' HH11 ' B' ' 96' ' ' ARG . 19.7 ttm105 -134.45 99.08 4.26 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.138 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.4 t -105.87 152.21 7.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 9.0 m -129.17 144.26 51.15 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -175.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.888 HD22 HG12 ' B' ' 120' ' ' ILE . 0.5 OUTLIER -113.79 52.54 0.81 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.527 175.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -59.48 97.09 0.04 OUTLIER 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.9 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.514 HG11 ' HD3' ' B' ' 140' ' ' ARG . 7.2 p -167.93 -2.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.828 ' CB ' HD13 ' B' ' 109' ' ' LEU . 0.4 OUTLIER -90.99 11.95 21.27 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.616 178.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -59.16 -14.38 10.26 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 172.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.438 ' N ' ' C ' ' B' ' 102' ' ' ASN . 13.7 t80 -85.67 -9.97 56.41 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.603 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.68 98.12 0.48 Allowed Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.423 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.453 ' HA ' ' ND2' ' B' ' 102' ' ' ASN . 57.7 Cg_endo -76.3 -40.94 0.53 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.672 2.248 . . . . 0.0 111.875 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.17 -32.21 12.59 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.367 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.537 ' CD ' ' NZ ' ' B' ' 123' ' ' LYS . 1.9 mm-40 -89.8 49.67 1.76 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.485 0.659 . . . . 0.0 110.358 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.828 HD13 ' CB ' ' B' ' 102' ' ' ASN . 0.4 OUTLIER -129.36 135.22 48.44 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.575 178.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.7 121.95 34.92 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.609 HG13 HD12 ' B' ' 120' ' ' ILE . 0.5 OUTLIER -100.32 131.64 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.448 ' NZ ' ' OG1' ' B' ' 121' ' ' THR . 0.0 OUTLIER -134.89 124.12 24.51 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.354 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 1.6 m -94.63 116.32 28.62 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.609 ' O ' ' N ' ' B' ' 116' ' ' GLY . 1.5 ttmp? -120.02 143.8 47.88 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -22.85 71.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' B' ' 114' ' ' LYS . . . 83.07 -2.51 86.79 Favored Glycine 0 N--CA 1.472 1.09 0 N-CA-C 111.151 -0.779 . . . . 0.0 111.151 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.624 HG13 HG23 ' B' ' 143' ' ' THR . 2.3 t -102.93 114.47 42.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.598 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 48.0 t -98.11 120.02 46.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.505 ' C ' HD13 ' B' ' 120' ' ' ILE . 33.7 mt-10 -133.5 136.14 44.89 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-O 121.179 0.514 . . . . 0.0 110.62 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.888 HG12 HD22 ' B' ' 99' ' ' LEU . 3.2 mm -111.82 138.07 41.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.622 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . 0.448 ' OG1' ' NZ ' ' B' ' 112' ' ' LYS . 0.2 OUTLIER -115.89 120.28 38.71 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.133 -179.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -148.8 135.64 5.51 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.768 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' LYS . . . . . 0.537 ' NZ ' ' CD ' ' B' ' 108' ' ' GLU . 0.2 OUTLIER -150.2 159.08 44.7 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.219 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . 0.486 ' CG ' ' HD2' ' B' ' 127' ' ' ARG . 2.0 t60 -132.72 156.34 47.19 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.674 0.273 . . . . 0.0 110.273 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.546 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.6 OUTLIER -92.24 131.68 37.27 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.346 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . 0.569 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 1.5 tt0 -3.11 97.7 0.01 OUTLIER 'General case' 0 C--N 1.344 0.334 0 O-C-N 123.751 0.657 . . . . 0.0 112.47 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' ARG . . . . . 0.486 ' HD2' ' CG ' ' B' ' 124' ' ' HIS . 31.5 mtp180 -90.16 146.9 23.93 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.095 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -88.8 131.78 34.92 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.325 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -134.71 163.36 29.96 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.052 176.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.65 -14.12 60.56 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.042 -178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' HIS . . . . . 0.521 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 69.2 m-70 -114.04 29.03 8.31 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.491 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.71 -153.12 17.36 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 119.728 -1.225 . . . . 0.0 111.611 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -112.89 127.94 56.33 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . 0.506 HD11 ' NH2' ' B' ' 136' ' ' ARG . 0.1 OUTLIER -135.29 123.48 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -175.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . 0.569 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.1 OUTLIER -134.32 160.43 37.94 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 174.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . 0.506 ' NH2' HD11 ' B' ' 134' ' ' ILE . 10.4 ptp85 -156.85 166.07 34.42 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.843 0.354 . . . . 0.0 111.563 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 27.5 p -117.84 136.42 53.44 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . 0.497 ' CE2' ' HD2' ' B' ' 136' ' ' ARG . 11.1 m-85 -106.89 138.18 43.55 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.826 -0.17 . . . . 0.0 111.276 -177.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.15 126.18 10.56 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.951 174.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . 0.514 ' HD3' HG11 ' B' ' 101' ' ' VAL . 0.0 OUTLIER -131.23 112.92 13.23 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 177.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . 0.437 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 11.3 ttmt -101.28 119.08 38.23 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.931 0.395 . . . . 0.0 110.556 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' TYR . . . . . 0.598 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 4.3 m-85 -109.48 97.58 7.12 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.624 HG23 HG13 ' B' ' 117' ' ' VAL . 0.0 OUTLIER -91.66 96.59 10.53 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 177.559 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -111.87 90.23 12.78 Favored Pre-proline 0 CA--C 1.514 -0.409 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.429 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . 0.611 ' HD2' ' CD ' ' B' ' 146' ' ' PRO . 17.1 Cg_exo -68.49 -40.6 7.6 Favored 'Trans proline' 0 C--N 1.285 -2.793 0 C-N-CA 122.38 2.053 . . . . 0.0 112.127 168.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' PRO . . . . . 0.611 ' CD ' ' HD2' ' B' ' 145' ' ' PRO . 71.4 Cg_exo -43.07 -8.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 123.554 2.836 . . . . 0.0 114.194 -177.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 134.69 64.77 0.07 OUTLIER Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 118.964 -1.588 . . . . 0.0 114.879 176.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' VAL . . . . . 0.416 ' O ' HG12 ' B' ' 148' ' ' VAL . 1.1 t -123.74 108.55 21.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.365 172.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . 0.485 ' O ' HG23 ' B' ' 153' ' ' VAL . 10.7 p-10 -76.9 127.89 82.79 Favored Pre-proline 0 N--CA 1.472 0.659 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.885 -176.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 3.0 Cg_exo -75.81 -30.47 6.03 Favored 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 122.156 1.904 . . . . 0.0 113.848 -173.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 1.2 p -76.64 -36.57 57.32 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.883 0.373 . . . . 0.0 110.889 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -101.74 1.81 37.78 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . 0.711 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 42.2 t -96.15 103.12 14.32 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.777 175.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.14 177.28 4.89 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.4 138.98 33.36 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.423 -177.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.97 132.43 54.22 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.464 177.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . 0.713 HD11 ' OD1' ' B' ' 102' ' ' ASN . 25.0 tp -125.57 142.13 51.67 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.055 0.455 . . . . 0.0 110.744 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.475 ' O ' ' N ' ' B' ' 161' ' ' GLY . 0.2 OUTLIER -132.51 141.01 39.66 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.172 178.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' B' ' 161' ' ' GLY . 73.2 Cg_exo -38.35 -35.27 0.43 Allowed 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 123.18 2.587 . . . . 0.0 112.448 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -60.57 -5.07 1.07 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.612 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' GLY . . . . . 0.68 ' HA2' ' OD1' ' B' ' 102' ' ' ASN . . . 76.08 33.0 51.21 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.662 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 15.1 t -98.7 114.97 27.7 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.14 0.495 . . . . 0.0 110.377 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.638 HD13 ' C ' ' B' ' 163' ' ' LEU . 1.9 tm? -109.2 102.93 11.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.103 -178.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.94 126.96 43.59 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.509 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.6 m -108.33 108.05 24.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 174.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 0.8 OUTLIER -117.34 143.13 46.28 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.278 -174.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . 0.711 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -171.2 157.25 4.8 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-O 121.088 0.47 . . . . 0.0 111.995 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' B' ' 93' ' ' ASP . 83.6 Cg_endo -80.1 -18.07 10.22 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 123.443 2.762 . . . . 0.0 110.933 176.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' MET . . . . . 0.672 ' SD ' ' HB2' ' B' ' 95' ' ' TRP . 0.0 OUTLIER 60.36 158.09 0.11 Allowed Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.929 176.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' PRO . . . . . 0.409 ' HD2' ' O ' ' B' ' 147' ' ' GLY . 60.3 Cg_endo -82.64 11.77 3.11 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.707 2.272 . . . . 0.0 111.476 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' LYS . . . . . 0.4 ' CE ' ' O ' ' B' ' 168' ' ' PRO . 0.4 OUTLIER 38.6 54.76 1.91 Allowed 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.359 0.599 . . . . 0.0 110.439 -179.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.68 50.86 0.13 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.267 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . 0.571 ' O ' ' N ' ' B' ' 175' ' ' GLN . . . 46.31 39.24 6.05 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.879 0.371 . . . . 0.0 110.37 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . 0.422 HG23 ' CB ' ' B' ' 146' ' ' PRO . 1.9 m -63.0 57.87 0.01 OUTLIER 'General case' 0 C--O 1.241 0.644 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.512 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' B' ' 173' ' ' ALA . 0.1 OUTLIER -110.34 -36.12 5.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.348 -179.382 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.207 -1.182 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.411 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -68.21 -4.64 14.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.87 0.366 . . . . 0.0 110.403 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 82.1 mt -66.46 71.58 0.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.637 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.17 -25.41 13.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.92 0.39 . . . . 0.0 110.005 178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.87 157.49 33.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.916 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 144.04 -50.08 0.68 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.41 154.33 24.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.712 0.292 . . . . 0.0 110.39 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.3 m -66.08 111.7 3.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.447 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.513 ' CD ' HH21 ' A' ' 89' ' ' ARG . 12.9 mt-10 -59.02 143.42 48.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.236 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.48 ' O ' ' NH2' ' A' ' 94' ' ' ARG . 1.2 mt -39.84 -40.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.383 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.513 HH21 ' CD ' ' A' ' 87' ' ' GLU . 0.6 OUTLIER -60.6 -22.78 64.13 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.835 -179.167 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.482 ' CE1' ' H ' ' A' ' 87' ' ' GLU . 16.3 m170 -58.58 146.92 34.16 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.774 0.321 . . . . 0.0 110.571 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.52 50.88 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.116 0.484 . . . . 0.0 111.27 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 90' ' ' HIS . . . -90.3 104.4 16.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.351 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 48.52 93.93 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.658 0.599 . . . . 0.0 111.247 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.48 ' NH2' ' O ' ' A' ' 88' ' ' ILE . 11.7 mmt85 -140.24 133.23 29.35 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.732 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.661 ' CZ3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -91.64 151.98 20.45 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.207 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -144.64 98.87 3.26 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.432 -177.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.661 HG21 ' CZ3' ' A' ' 95' ' ' TRP . 2.0 t -111.65 150.66 13.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.1 139.48 51.17 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.779 HD22 HG12 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -115.08 74.0 0.86 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.741 175.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.531 ' C ' HG22 ' A' ' 101' ' ' VAL . 12.0 p-10 -70.8 112.96 7.4 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.579 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.531 HG22 ' C ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -173.25 -40.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.662 ' OD1' HD22 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -41.32 -19.64 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.462 -1.699 . . . . 0.0 110.815 178.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.483 ' N ' ' O ' ' A' ' 101' ' ' VAL . 5.0 t60 -45.67 -33.89 3.2 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.41 ' CZ ' ' NH1' ' A' ' 136' ' ' ARG . 52.6 m-85 -83.94 12.37 6.31 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.7 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 102' ' ' ASN . . . -179.19 96.71 0.2 Allowed Pre-proline 0 C--N 1.333 -0.143 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.608 ' HA ' HD21 ' A' ' 102' ' ' ASN . 47.6 Cg_endo -70.99 -48.5 0.46 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.452 2.101 . . . . 0.0 111.209 176.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -99.44 -30.93 11.91 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.038 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.449 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 2.4 mp0 -81.63 47.98 1.13 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.02 0.438 . . . . 0.0 110.245 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.662 HD22 ' OD1' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -131.57 138.54 48.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.255 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.418 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 1.3 m -128.38 123.03 32.82 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.631 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.481 HG13 ' CD1' ' A' ' 120' ' ' ILE . 1.9 t -102.81 122.38 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.423 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -127.6 134.78 49.68 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.817 -178.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.3 m -102.84 118.06 36.01 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.628 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.2 OUTLIER -115.84 83.16 1.89 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.219 0.533 . . . . 0.0 110.335 -176.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.4 t0 30.46 68.24 0.1 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.445 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.34 -23.08 29.19 Favored Glycine 0 C--N 1.317 -0.512 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.63 HG13 HG23 ' A' ' 143' ' ' THR . 2.7 t -87.97 117.3 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 42.1 t -101.42 116.45 45.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.497 ' OE1' ' NZ ' ' A' ' 114' ' ' LYS . 8.9 mt-10 -133.1 134.16 43.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.941 0.401 . . . . 0.0 111.206 -176.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.779 HG12 HD22 ' A' ' 99' ' ' LEU . 4.4 mm -106.33 142.65 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.863 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.423 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -123.64 115.46 21.5 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.201 -178.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.16 127.8 2.51 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.222 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.41 130.13 27.94 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.536 ' ND1' ' N ' ' A' ' 125' ' ' GLU . 48.7 t-80 -92.6 161.44 14.59 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.222 0.534 . . . . 0.0 111.744 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.536 ' N ' ' ND1' ' A' ' 124' ' ' HIS . 0.0 OUTLIER -87.46 149.26 24.53 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.892 177.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.463 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 4.8 tt0 -28.72 98.79 0.01 OUTLIER 'General case' 0 C--N 1.348 0.542 0 CA-C-O 120.915 0.388 . . . . 0.0 111.21 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 2.3 mtp-105 -83.35 146.0 28.73 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.852 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -86.03 123.83 31.79 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 170.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -130.75 172.19 12.27 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.869 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.45 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -71.04 -37.59 72.55 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -175.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.473 ' O ' ' OH ' ' B' ' 142' ' ' TYR . 13.6 m-70 -114.98 42.85 2.09 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.18 -176.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.25 168.96 12.47 Favored Glycine 0 C--N 1.306 -1.114 0 C-N-CA 119.995 -1.097 . . . . 0.0 110.929 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -96.42 109.16 21.75 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 172.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.598 HD13 ' NH2' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -129.6 119.02 46.94 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -170.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 127' ' ' ARG . 4.1 m -127.15 154.74 44.39 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 172.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.598 ' NH2' HD13 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -141.51 -179.33 6.09 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.935 -175.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 27.8 p -129.34 123.4 31.67 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.504 ' CD2' HG11 ' A' ' 101' ' ' VAL . 4.4 m-85 -100.14 140.15 34.78 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.309 -176.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.72 117.53 11.65 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.489 0.662 . . . . 0.0 111.052 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.487 ' CD ' HD23 ' A' ' 99' ' ' LEU . 2.0 mtt180 -108.05 143.33 36.92 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.337 177.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.573 ' HZ3' ' HB2' ' A' ' 141' ' ' LYS . 7.7 ttmm -138.36 112.95 8.89 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.989 -178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.531 ' HB2' ' HB ' ' A' ' 118' ' ' VAL . 2.0 m-85 -114.72 99.83 7.8 Favored 'General case' 0 CA--C 1.502 -0.875 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.102 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.63 HG23 HG13 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -91.06 91.31 8.23 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 mp -112.24 89.99 13.19 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.717 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.624 ' HD2' ' CD ' ' A' ' 146' ' ' PRO . 11.8 Cg_exo -72.22 -50.88 0.23 Allowed 'Trans proline' 0 C--N 1.287 -2.708 0 C-N-CA 122.461 2.107 . . . . 0.0 113.591 171.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.624 ' CD ' ' HD2' ' A' ' 145' ' ' PRO . 24.7 Cg_exo -55.34 -14.53 9.48 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.67 2.247 . . . . 0.0 115.401 -174.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -174.68 43.07 0.13 Allowed Glycine 0 C--N 1.341 0.818 0 C-N-CA 116.833 -2.603 . . . . 0.0 116.378 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.541 HG21 ' CH2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -135.25 131.29 51.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 117.859 0.829 . . . . 0.0 110.561 171.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 0.4 OUTLIER -95.59 143.59 26.37 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.321 -178.606 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 6.1 Cg_exo -80.32 -47.19 0.08 OUTLIER 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.334 2.023 . . . . 0.0 113.231 -176.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.53 -37.6 59.95 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.739 -175.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.638 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -93.42 11.68 27.58 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -172.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 40.7 t -108.64 115.25 48.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.938 0.399 . . . . 0.0 110.16 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.94 177.32 4.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.294 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.3 143.55 35.91 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.789 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.512 ' O ' HD22 ' A' ' 163' ' ' LEU . 0.9 OUTLIER -115.11 144.97 42.84 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 176.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.61 HD22 HD22 ' A' ' 109' ' ' LEU . 34.7 tp -138.14 136.86 37.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.808 0.337 . . . . 0.0 111.196 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.41 ' HB2' HG22 ' A' ' 162' ' ' THR . 0.3 OUTLIER -117.09 149.48 44.38 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.68 178.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -40.38 -43.91 4.12 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 123.205 2.603 . . . . 0.0 112.206 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -53.33 -14.94 0.83 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.832 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 102' ' ' ASN . . . 85.02 33.13 18.97 Favored Glycine 0 CA--C 1.529 0.914 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.797 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.41 HG22 ' HB2' ' A' ' 158' ' ' SER . 2.0 t -96.18 128.51 43.15 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.576 HD13 ' C ' ' A' ' 163' ' ' LEU . 1.8 tm? -118.15 107.78 14.38 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.857 -175.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.2 p -99.22 127.86 45.26 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 165' ' ' VAL . 4.4 m -105.26 98.34 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 173.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 95' ' ' TRP . 0.3 OUTLIER -114.33 141.39 47.66 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.671 -174.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 177.5 167.8 0.49 Allowed Pre-proline 0 C--O 1.234 0.281 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.34 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 88.5 Cg_endo -90.3 121.58 0.9 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 123.943 3.095 . . . . 0.0 109.404 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.16 166.38 11.34 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-O 121.073 0.463 . . . . 0.0 112.067 -173.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -49.97 -71.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.879 2.386 . . . . 0.0 112.188 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 9.0 mttp -175.53 162.29 2.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.101 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.556 HD22 ' N ' ' A' ' 172' ' ' LEU . 3.9 mm? -85.81 145.78 27.06 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 178.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -110.61 -121.41 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.482 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 176' ' ' SER . 0.0 OUTLIER -49.63 -46.08 49.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.723 0.297 . . . . 0.0 110.728 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.13 -65.83 0.21 Allowed 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.674 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 174' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.211 -0.966 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.588 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -153.94 -81.16 0.09 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.106 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 51.2 mt 58.02 -157.13 0.31 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.765 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.28 176.58 9.63 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.851 0.357 . . . . 0.0 111.079 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . 0.454 ' O ' HG23 ' B' ' 85' ' ' VAL . 0.3 OUTLIER -73.3 119.51 17.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.859 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . 0.454 ' C ' HG23 ' B' ' 85' ' ' VAL . . . 60.61 -138.28 48.4 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.926 -0.469 . . . . 0.0 111.926 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.454 HG23 ' C ' ' B' ' 84' ' ' GLY . 2.2 t 71.13 124.0 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 122.753 0.421 . . . . 0.0 110.676 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 1.7 m -65.96 84.39 0.08 Allowed 'General case' 0 C--O 1.243 0.711 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.17 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.13 -169.37 0.09 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.132 -178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.484 ' C ' ' H ' ' B' ' 90' ' ' HIS . 0.6 OUTLIER -42.53 131.46 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.41 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -68.91 44.91 0.05 OUTLIER 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.966 0.412 . . . . 0.0 110.581 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' HIS . . . . . 0.484 ' H ' ' C ' ' B' ' 88' ' ' ILE . 0.1 OUTLIER -89.18 -50.29 6.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.452 178.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' B' ' 171' ' ' LYS . 9.2 t -172.71 -165.53 0.32 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.853 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.4 ' H ' ' CB ' ' B' ' 171' ' ' LYS . . . 35.33 62.51 0.58 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.122 -0.49 . . . . 0.0 112.102 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.503 ' CG ' ' H ' ' B' ' 94' ' ' ARG . 9.6 p-10 -81.73 -125.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . 0.503 ' H ' ' CG ' ' B' ' 93' ' ' ASP . 9.0 mmt180 -149.75 97.95 2.68 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 177.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' TRP . . . . . 0.605 ' CZ3' HG21 ' B' ' 97' ' ' VAL . 0.0 OUTLIER -72.47 153.83 41.17 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 177.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -152.02 105.3 3.07 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.577 -174.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.605 HG21 ' CZ3' ' B' ' 95' ' ' TRP . 1.4 t -121.05 154.69 24.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 15.2 m -127.13 144.23 51.08 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -174.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.974 HD22 HG12 ' B' ' 120' ' ' ILE . 0.3 OUTLIER -114.05 122.78 47.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.53 174.114 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.548 ' C ' HG22 ' B' ' 101' ' ' VAL . 19.3 p-10 -112.72 114.75 27.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.119 -176.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.626 ' C ' ' H ' ' B' ' 103' ' ' HIS . 0.1 OUTLIER -169.56 -56.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.793 0.806 . . . . 0.0 110.378 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.694 ' OD1' HD13 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -56.66 14.09 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.481 -1.236 . . . . 0.0 112.565 -177.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.626 ' H ' ' C ' ' B' ' 101' ' ' VAL . 19.2 m170 -46.68 -28.99 1.66 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.97 0.414 . . . . 0.0 110.331 178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.44 ' HB3' ' CD2' ' B' ' 124' ' ' HIS . 24.8 t80 -120.04 24.18 10.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.711 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.02 91.15 4.92 Favored Pre-proline 0 CA--C 1.513 -0.467 0 C-N-CA 120.578 -0.449 . . . . 0.0 112.168 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.88 -45.99 0.11 Allowed 'Trans proline' 0 C--N 1.303 -1.824 0 C-N-CA 122.447 2.098 . . . . 0.0 110.86 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' B' ' 107' ' ' ASP . 8.2 p-10 -98.58 -31.25 12.05 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.77 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.85 48.97 1.53 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.779 0.8 . . . . 0.0 110.248 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.694 HD13 ' OD1' ' B' ' 102' ' ' ASN . 0.4 OUTLIER -138.2 139.34 39.25 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.663 178.067 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.545 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -132.05 113.52 13.46 Favored 'General case' 0 C--N 1.31 -1.116 0 O-C-N 123.352 0.407 . . . . 0.0 110.091 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -97.81 119.09 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -129.75 129.41 44.1 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.454 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 2.1 m -98.05 122.91 41.76 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.484 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 0.3 OUTLIER -111.99 -162.17 0.79 Allowed 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -178.286 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . 0.432 ' H ' ' HG2' ' B' ' 114' ' ' LYS . 2.8 p-10 -65.07 69.49 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.368 0.604 . . . . 0.0 112.174 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' B' ' 114' ' ' LYS . . . 78.25 -8.43 39.42 Favored Glycine 0 CA--C 1.499 -0.934 0 N-CA-C 108.756 -1.738 . . . . 0.0 108.756 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' B' ' 114' ' ' LYS . 2.1 t -88.64 115.4 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.68 177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 41.4 t -98.59 118.87 45.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.68 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 41.1 mt-10 -133.77 143.46 48.44 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.282 0.563 . . . . 0.0 110.835 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.974 HG12 HD22 ' B' ' 99' ' ' LEU . 2.4 mm -115.61 140.2 38.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.12 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.55 111.87 19.15 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.57 145.69 13.93 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.59 -177.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.51 159.72 43.78 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . 0.522 ' O ' ' HB3' ' B' ' 135' ' ' SER . 3.7 m-70 -116.92 137.51 52.17 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.208 -177.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.5 ' O ' ' C ' ' B' ' 126' ' ' GLU . 0.5 OUTLIER -69.67 138.0 52.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.306 178.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' B' ' 125' ' ' GLU . 1.0 OUTLIER -17.21 98.37 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' ARG . . . . . 0.405 ' NH1' ' CE1' ' B' ' 104' ' ' PHE . 6.8 mtp85 -83.77 149.54 26.37 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.289 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' GLN . . . . . 0.563 ' HG2' ' N ' ' B' ' 129' ' ' ASP . 3.9 tt0 -99.72 151.87 20.74 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.14 0.495 . . . . 0.0 111.174 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . 0.563 ' N ' ' HG2' ' B' ' 128' ' ' GLN . 19.6 t70 -161.38 169.29 22.26 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.514 175.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . 0.498 ' N ' ' CG ' ' B' ' 129' ' ' ASP . 4.2 tp10 -80.65 -11.42 59.64 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.435 -178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' HIS . . . . . 0.418 ' O ' ' CZ ' ' A' ' 142' ' ' TYR . 55.5 m-70 -115.93 31.41 6.74 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.251 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.55 164.16 11.86 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 120.303 -0.951 . . . . 0.0 112.672 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' TYR . . . . . 0.415 ' CE2' ' HG3' ' B' ' 128' ' ' GLN . 69.5 m-85 -95.68 139.32 32.09 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 173.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -149.06 126.38 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -170.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . 0.522 ' HB3' ' O ' ' B' ' 124' ' ' HIS . 0.0 OUTLIER -128.98 157.78 40.71 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -154.06 159.59 41.61 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.336 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 21.4 p -112.96 138.1 50.35 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . 0.437 ' CD2' HG11 ' B' ' 101' ' ' VAL . 0.2 OUTLIER -118.59 149.13 41.88 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.822 -176.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.74 134.51 17.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.678 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . 0.408 ' CB ' ' HE1' ' B' ' 142' ' ' TYR . 0.0 OUTLIER -135.8 107.62 7.06 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 177.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . 0.68 ' HA ' ' HG2' ' B' ' 119' ' ' GLU . 32.2 ttmt -96.86 113.94 25.52 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.038 0.447 . . . . 0.0 110.996 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' TYR . . . . . 0.502 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 2.4 m-85 -104.29 98.86 8.6 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.195 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.492 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.2 OUTLIER -92.53 96.81 10.44 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 177.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.1 mp -113.25 90.48 16.78 Favored Pre-proline 0 CA--C 1.511 -0.538 0 C-N-CA 120.326 -0.55 . . . . 0.0 111.12 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . 0.609 ' HD2' ' CD ' ' B' ' 146' ' ' PRO . 15.9 Cg_exo -69.88 -42.89 2.9 Favored 'Trans proline' 0 C--N 1.277 -3.2 0 C-N-CA 122.19 1.927 . . . . 0.0 112.679 169.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' PRO . . . . . 0.609 ' CD ' ' HD2' ' B' ' 145' ' ' PRO . 76.3 Cg_exo -42.82 -15.83 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 123.001 2.467 . . . . 0.0 114.333 -176.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 151.76 58.13 0.01 OUTLIER Glycine 0 C--N 1.343 0.972 0 C-N-CA 118.199 -1.953 . . . . 0.0 115.201 177.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' VAL . . . . . 0.461 HG21 ' CH2' ' B' ' 95' ' ' TRP . 0.9 OUTLIER -123.34 113.1 36.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.573 172.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 24.4 t70 -77.44 137.91 63.66 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.569 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 5.3 Cg_exo -81.12 -23.8 5.06 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.122 1.881 . . . . 0.0 112.891 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.33 -41.24 11.63 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.269 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -97.42 15.5 22.91 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . 0.664 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 30.6 t -103.91 117.2 49.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.01 171.1 7.8 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.29 130.79 33.49 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.423 -178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.441 ' CB ' ' HG1' ' B' ' 164' ' ' THR . 0.0 OUTLIER -100.05 134.79 42.44 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.652 176.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . 0.461 HD22 ' CD2' ' B' ' 109' ' ' LEU . 29.8 tp -128.36 131.55 48.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.939 0.399 . . . . 0.0 110.652 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.425 ' H ' HD12 ' B' ' 157' ' ' LEU . 0.2 OUTLIER -117.41 149.97 45.66 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.349 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.595 ' C ' ' H ' ' B' ' 161' ' ' GLY . 85.5 Cg_exo -42.6 -34.34 3.32 Favored 'Trans proline' 0 N--CA 1.49 1.3 0 C-N-CA 122.419 2.079 . . . . 0.0 110.686 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.97 29.56 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.38 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 34.98 34.1 0.04 OUTLIER Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.585 0.612 . . . . 0.0 112.927 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' THR . . . . . 0.411 ' O ' HG23 ' B' ' 162' ' ' THR . 9.0 t -97.2 117.06 30.55 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.617 HD13 ' C ' ' B' ' 163' ' ' LEU . 2.7 tm? -108.21 103.08 12.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.505 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 0.441 ' HG1' ' CB ' ' B' ' 156' ' ' SER . 0.5 OUTLIER -92.08 124.46 36.19 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 121.246 -0.181 . . . . 0.0 110.637 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.508 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.1 m -105.83 109.63 28.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 174.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 0.42 ' OE1' ' NH1' ' B' ' 94' ' ' ARG . 1.8 pp20? -120.2 154.99 34.05 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.601 -176.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . 0.664 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . 177.93 157.02 0.54 Allowed Pre-proline 0 CA--C 1.518 -0.25 0 CA-C-O 120.989 0.423 . . . . 0.0 111.212 -177.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . 0.564 ' C ' ' HG3' ' B' ' 169' ' ' MET . 81.5 Cg_endo -80.41 -24.24 5.52 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.905 2.403 . . . . 0.0 110.043 174.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' MET . . . . . 0.564 ' HG3' ' C ' ' B' ' 168' ' ' PRO . 0.5 OUTLIER 41.42 176.23 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 114.528 -1.214 . . . . 0.0 113.131 175.469 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' B' ' 172' ' ' LEU . 7.4 Cg_exo -71.87 75.26 2.2 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.166 1.911 . . . . 0.0 109.257 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' LYS . . . . . 0.501 ' HG3' ' H ' ' B' ' 93' ' ' ASP . 0.1 OUTLIER -57.84 68.32 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.27 -175.056 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.553 ' N ' ' O ' ' B' ' 170' ' ' PRO . 10.9 mt -94.16 162.53 13.82 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' B' ' 175' ' ' GLN . . . -82.08 21.32 0.9 Allowed 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.994 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.64 41.22 0.03 OUTLIER 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.975 0.417 . . . . 0.0 111.373 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' GLN . . . . . 0.487 ' H ' ' C ' ' B' ' 173' ' ' ALA . 34.8 mt-30 -68.45 -60.63 2.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.216 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.204 -1.312 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.313 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.78 ' N ' ' HG ' ' A' ' 82' ' ' SER . 4.7 mpp? . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 81' ' ' LEU . 5.5 pm0 -55.11 -34.71 63.93 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.879 0.371 . . . . 0.0 110.367 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.4 ' N ' ' HG2' ' A' ' 80' ' ' GLN . 6.9 mp -95.14 -72.03 0.64 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.133 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.78 ' HG ' ' N ' ' A' ' 79' ' ' MET . 1.3 m 49.95 -146.52 0.39 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.87 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.37 175.19 5.56 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.58 37.65 0.32 Allowed Glycine 0 C--N 1.32 -0.345 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 87' ' ' GLU . 11.4 t -144.91 143.96 22.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.6 m 67.34 -56.41 0.45 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.361 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.562 ' O ' ' N ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -91.85 -78.61 0.4 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.218 -179.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 64.81 -56.91 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.562 ' N ' ' O ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -112.59 78.07 1.1 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 175.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.494 ' NE2' ' OE2' ' A' ' 87' ' ' GLU . 10.0 m80 -53.84 -53.49 51.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.128 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 46.28 73.39 0.18 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.051 0.453 . . . . 0.0 110.642 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.78 159.22 1.71 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.744 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 168' ' ' PRO . 0.4 OUTLIER -62.57 138.11 58.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.791 179.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.446 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 8.8 mmm180 -102.61 113.66 27.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.896 0.379 . . . . 0.0 110.09 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.592 ' NE1' ' CG2' ' A' ' 97' ' ' VAL . 46.8 t-105 -86.7 142.87 27.88 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 52.2 ttm-85 -136.42 117.13 13.99 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -174.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.592 ' CG2' ' NE1' ' A' ' 95' ' ' TRP . 1.1 t -132.09 158.2 43.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.578 175.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 3.0 m -130.48 157.61 42.17 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -175.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.839 HD23 ' NE ' ' A' ' 140' ' ' ARG . 0.6 OUTLIER -136.79 94.52 2.99 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.632 175.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.591 ' C ' HG22 ' A' ' 101' ' ' VAL . 1.9 p-10 -97.08 119.38 35.45 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.312 -177.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.768 HG11 ' CD2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -174.34 -50.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.643 0.735 . . . . 0.0 110.649 179.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.65 ' OD1' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -54.52 17.68 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.708 -1.133 . . . . 0.0 113.761 -176.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.581 ' H ' ' C ' ' A' ' 101' ' ' VAL . 57.5 m-70 -39.33 -50.1 2.01 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.009 0.433 . . . . 0.0 111.198 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -92.05 -6.13 51.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.901 -177.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -116.88 90.32 32.03 Favored Pre-proline 0 CA--C 1.511 -0.534 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.633 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.32 -51.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 122.461 2.107 . . . . 0.0 110.922 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 109' ' ' LEU . 12.9 t70 -95.02 -31.18 13.72 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.432 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.451 ' N ' ' CD ' ' A' ' 108' ' ' GLU . 20.0 mp0 -77.88 28.87 0.17 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.161 0.505 . . . . 0.0 110.927 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.753 HD22 HD22 ' A' ' 157' ' ' LEU . 0.8 OUTLIER -114.51 134.9 54.68 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 176.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.414 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -123.87 113.27 18.29 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.092 -178.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.5 t -99.4 129.13 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -140.35 134.22 30.6 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.138 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.56 119.94 35.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 176.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.607 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.3 OUTLIER -116.59 80.75 1.51 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.252 0.549 . . . . 0.0 110.059 -177.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 1.2 t70 29.5 65.54 0.12 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.717 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.77 -24.21 32.63 Favored Glycine 0 C--N 1.313 -0.707 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.607 ' HB ' ' HB3' ' A' ' 114' ' ' LYS . 2.2 t -88.16 115.76 28.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.239 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' A' ' 142' ' ' TYR . 59.1 t -101.98 115.65 44.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.698 ' CD ' ' HZ2' ' A' ' 141' ' ' LYS . 66.5 mt-10 -130.61 142.32 50.45 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.467 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.783 HG12 HD22 ' A' ' 99' ' ' LEU . 3.5 mm -111.81 142.51 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.763 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -123.25 117.85 26.24 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.648 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.09 135.61 5.33 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.925 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.0 144.92 25.2 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.066 0.946 . . . . 0.0 108.503 178.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.512 ' HB3' ' NH2' ' A' ' 127' ' ' ARG . 49.9 t60 -115.69 165.79 12.65 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.834 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.515 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.7 OUTLIER -90.16 132.54 35.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.689 -178.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.515 ' C ' ' O ' ' A' ' 125' ' ' GLU . 11.7 tt0 -7.58 111.82 0.01 OUTLIER 'General case' 0 C--N 1.348 0.509 0 C-N-CA 123.326 0.65 . . . . 0.0 112.638 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.512 ' NH2' ' HB3' ' A' ' 124' ' ' HIS . 26.4 mtm180 -107.63 112.96 25.93 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.039 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.23 133.87 52.44 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -140.37 172.14 13.15 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.743 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.57 -24.59 63.72 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.159 0.504 . . . . 0.0 111.18 -177.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -109.78 39.53 2.1 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.859 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 111.18 172.65 19.59 Favored Glycine 0 C--N 1.301 -1.367 0 C-N-CA 119.537 -1.316 . . . . 0.0 111.092 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 6.4 m-30 -94.75 117.22 29.78 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 172.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.57 123.16 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -171.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.18 164.19 26.07 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 170.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.3 ptt180 -150.5 177.14 10.29 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.115 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 25.6 p -120.52 148.44 43.84 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.768 ' CD2' HG11 ' A' ' 101' ' ' VAL . 1.0 OUTLIER -121.81 128.5 51.75 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.296 -179.215 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.08 120.12 24.16 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.304 175.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.839 ' NE ' HD23 ' A' ' 99' ' ' LEU . 1.2 mmm180 -117.9 139.36 51.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.698 ' HZ2' ' CD ' ' A' ' 119' ' ' GLU . 12.9 ttmm -133.38 110.6 10.14 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.847 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.579 ' OH ' ' NH2' ' A' ' 140' ' ' ARG . 30.0 m-85 -106.07 99.26 8.86 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.485 ' O ' ' HD3' ' A' ' 145' ' ' PRO . 0.2 OUTLIER -90.54 89.14 7.43 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.528 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.3 mp -112.41 92.3 18.99 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.632 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 16.7 Cg_exo -67.65 -55.87 0.25 Allowed 'Trans proline' 0 C--N 1.288 -2.625 0 C-N-CA 122.139 1.893 . . . . 0.0 113.045 175.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.632 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 56.5 Cg_endo -100.93 76.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.329 -0.491 0 C-N-CA 123.271 2.647 . . . . 0.0 112.251 -177.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 164.5 -17.43 0.11 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.272 -0.966 . . . . 0.0 112.49 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.81 126.75 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 117.599 0.699 . . . . 0.0 111.045 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.408 ' OD1' ' HG3' ' A' ' 152' ' ' GLN . 14.7 t70 -87.1 145.28 37.81 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.637 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -80.86 -28.79 2.42 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.872 1.715 . . . . 0.0 112.567 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.61 -41.31 10.83 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.632 -174.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.707 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 3.2 mt-30 -98.77 22.54 9.92 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -172.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.5 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 39.9 t -103.6 119.74 52.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.093 176.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -102.33 179.48 4.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.52 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 164' ' ' THR . 0.9 OUTLIER -158.81 124.86 4.5 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.419 -179.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.454 ' O ' HD22 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -104.25 139.21 39.59 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.306 178.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.753 HD22 HD22 ' A' ' 109' ' ' LEU . 30.7 tp -131.62 135.35 46.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.315 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.474 ' H ' HD12 ' A' ' 157' ' ' LEU . 0.4 OUTLIER -121.56 150.97 56.12 Favored Pre-proline 0 C--N 1.313 -0.995 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.617 ' C ' ' H ' ' A' ' 161' ' ' GLY . 82.3 Cg_exo -41.28 -35.51 2.17 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.323 2.015 . . . . 0.0 110.738 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 1.8 mp0 -67.28 28.76 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.485 176.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.617 ' H ' ' C ' ' A' ' 159' ' ' PRO . . . 35.73 31.45 0.03 OUTLIER Glycine 0 C--N 1.334 0.425 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.636 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 162' ' ' THR . 14.0 t -91.35 115.29 27.91 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 176.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.604 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.9 tm? -109.05 104.03 13.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.687 -176.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 155' ' ' SER . 0.8 OUTLIER -95.28 123.39 38.77 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.597 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.628 ' O ' HG23 ' A' ' 165' ' ' VAL . 2.9 m -107.29 99.23 8.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.553 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 1.7 pp20? -118.38 150.83 38.88 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.822 -178.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.707 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 174.08 167.74 0.31 Allowed Pre-proline 0 N--CA 1.449 -0.524 0 C-N-CA 120.229 -0.588 . . . . 0.0 112.255 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.559 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 73.9 Cg_endo -88.1 117.48 1.07 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 123.619 2.879 . . . . 0.0 108.9 175.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.49 ' SD ' ' HB2' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -109.21 175.07 2.09 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.407 -172.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.489 ' CD ' ' CB ' ' A' ' 169' ' ' MET . 14.1 Cg_exo -65.15 116.52 3.9 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.932 2.421 . . . . 0.0 110.692 178.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.27 99.94 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.658 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.67 178.52 6.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.169 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -138.03 -101.02 0.18 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.377 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.07 -161.59 0.76 Allowed 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.475 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.405 ' C ' ' HG ' ' A' ' 176' ' ' SER . 2.3 mm100 57.65 -174.75 0.08 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.235 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.405 ' HG ' ' C ' ' A' ' 175' ' ' GLN . 0.7 OUTLIER . . . . . 0 C--O 1.212 -0.917 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.401 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' MET . . . . . . . . . . . . . 9.4 mmt . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -64.5 -15.54 61.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.682 179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' B' ' 83' ' ' SER . 2.6 mp 58.94 -164.25 0.21 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.752 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.53 40.94 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.716 0.293 . . . . 0.0 110.835 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . 0.484 ' H ' ' C ' ' B' ' 81' ' ' LEU . 0.7 OUTLIER -114.24 121.1 42.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.813 0.34 . . . . 0.0 110.325 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.34 -66.25 0.39 Allowed Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.424 ' N ' ' O ' ' B' ' 83' ' ' SER . 0.3 OUTLIER 40.09 36.64 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.928 0.394 . . . . 0.0 110.486 179.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -43.5 -43.13 5.26 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.87 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.87 178.32 3.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.84 178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.491 ' O ' ' NE ' ' B' ' 89' ' ' ARG . 35.3 pt -60.15 -25.39 33.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.482 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.491 ' NE ' ' O ' ' B' ' 88' ' ' ILE . 0.0 OUTLIER -157.69 -95.33 0.03 OUTLIER 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.459 0.647 . . . . 0.0 110.119 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' HIS . . . . . 0.408 ' O ' ' C ' ' B' ' 91' ' ' THR . 0.2 OUTLIER -154.9 96.7 1.88 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.408 ' C ' ' O ' ' B' ' 90' ' ' HIS . 33.0 p 38.4 -109.95 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.064 -175.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . 41.67 27.71 0.07 Allowed 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.069 0.461 . . . . 0.0 110.702 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' B' ' 168' ' ' PRO . 41.8 p-10 -106.95 22.28 16.23 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.562 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -107.05 137.67 44.69 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.602 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' TRP . . . . . 0.629 ' HB2' ' SD ' ' B' ' 169' ' ' MET . 28.2 t-105 -125.67 152.72 44.86 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -145.53 102.41 3.69 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.269 -177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.538 HG22 ' NE1' ' B' ' 95' ' ' TRP . 0.2 OUTLIER -116.0 157.88 16.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.021 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 2.3 m -130.25 148.84 52.13 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -177.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.501 HD22 ' HB ' ' B' ' 120' ' ' ILE . 0.3 OUTLIER -122.58 117.85 26.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.128 174.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.537 ' C ' HG22 ' B' ' 101' ' ' VAL . 0.1 OUTLIER -113.99 115.35 27.5 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.537 HG22 ' C ' ' B' ' 100' ' ' ASP . 0.1 OUTLIER -167.72 -34.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.237 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.614 ' OD1' ' HA2' ' B' ' 161' ' ' GLY . 0.4 OUTLIER -80.8 16.6 1.38 Allowed 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -174.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.563 ' N ' ' HA3' ' B' ' 161' ' ' GLY . 11.5 m80 -43.03 -39.91 2.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.105 0.478 . . . . 0.0 110.174 177.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -92.41 -1.14 57.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.251 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . 0.547 ' C ' HD22 ' B' ' 102' ' ' ASN . . . -135.11 77.47 55.43 Favored Pre-proline 0 CA--C 1.511 -0.538 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.9 -38.17 3.15 Favored 'Trans proline' 0 C--N 1.295 -2.272 0 C-N-CA 122.48 2.12 . . . . 0.0 110.92 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -96.04 -26.86 15.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.003 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . . . . . . . . . 67.3 mt-10 -95.85 49.02 1.14 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.111 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.703 HD22 HD22 ' B' ' 157' ' ' LEU . 0.5 OUTLIER -125.18 143.69 50.82 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.174 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.465 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -139.04 112.37 8.14 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.371 -177.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.55 125.6 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -133.62 133.25 41.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.758 0.313 . . . . 0.0 111.293 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.16 122.58 39.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.553 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 2.5 ttpt -126.37 91.44 3.37 Favored 'General case' 0 C--O 1.21 -0.981 0 CA-C-O 120.847 0.356 . . . . 0.0 110.881 -176.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' B' ' 117' ' ' VAL . 6.7 p-10 34.58 66.55 0.28 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.07 -15.59 8.38 Favored Glycine 0 C--N 1.307 -1.055 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.852 HG22 HG23 ' B' ' 143' ' ' THR . 7.2 t -87.44 114.36 26.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 42.8 t -99.25 121.05 49.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.135 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' B' ' 141' ' ' LYS . 76.8 mt-10 -130.27 140.11 50.71 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.303 0.573 . . . . 0.0 111.025 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.501 ' HB ' HD22 ' B' ' 99' ' ' LEU . 1.3 mp -114.96 117.04 54.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.093 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -97.83 120.0 37.44 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.02 -178.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -146.68 126.95 2.58 Favored Glycine 0 N--CA 1.452 -0.272 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.11 159.35 40.37 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . 0.499 ' ND1' ' HB2' ' B' ' 105' ' ' ALA . 3.6 m-70 -123.05 130.9 53.39 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.245 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' B' ' 126' ' ' GLU . 4.5 tp10 -70.79 137.62 49.71 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . 0.587 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 5.1 tt0 -11.91 99.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.481 0.488 . . . . 0.0 111.737 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' ARG . . . . . 0.607 ' HB2' ' NH1' ' B' ' 127' ' ' ARG . 0.2 OUTLIER -89.12 128.86 35.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.499 -178.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -75.53 127.43 33.08 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 175.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . 0.52 ' HB2' HG22 ' B' ' 134' ' ' ILE . 0.3 OUTLIER -138.27 164.72 28.51 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -70.49 -36.0 73.58 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.965 -176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' HIS . . . . . 0.498 ' O ' ' OH ' ' A' ' 142' ' ' TYR . 73.0 m-70 -100.16 40.36 1.25 Allowed 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 120.669 0.271 . . . . 0.0 110.572 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 114.46 174.16 18.35 Favored Glycine 0 C--N 1.299 -1.473 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.251 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -95.09 114.7 26.53 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 174.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . 0.559 HD11 ' NH2' ' B' ' 136' ' ' ARG . 0.0 OUTLIER -127.35 118.6 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -173.031 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . 0.587 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.3 OUTLIER -126.61 154.8 43.46 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.004 176.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . 0.559 ' NH2' HD11 ' B' ' 134' ' ' ILE . 9.8 ptp85 -144.85 163.59 33.62 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.943 0.401 . . . . 0.0 111.483 -177.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 30.3 p -117.79 130.3 56.21 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -104.06 144.04 32.09 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.456 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.39 113.71 6.63 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.75 175.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . 0.493 ' NH2' ' OH ' ' B' ' 142' ' ' TYR . 0.0 OUTLIER -121.13 119.15 31.57 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 174.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . 0.499 ' NZ ' ' OE1' ' A' ' 126' ' ' GLU . 11.9 ttmt -110.81 121.37 45.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.945 0.403 . . . . 0.0 110.747 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' TYR . . . . . 0.548 ' HB2' ' HB ' ' B' ' 118' ' ' VAL . 1.7 m-85 -109.28 99.53 8.78 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.975 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.852 HG23 HG22 ' B' ' 117' ' ' VAL . 0.3 OUTLIER -90.29 99.69 12.66 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.141 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 7.4 mp -109.59 94.54 16.75 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' B' ' 147' ' ' GLY . 24.7 Cg_exo -66.21 -38.56 20.8 Favored 'Trans proline' 0 C--N 1.287 -2.678 0 C-N-CA 123.151 2.567 . . . . 0.0 114.513 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' B' ' 145' ' ' PRO . 34.4 Cg_exo -42.91 -13.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 1.026 0 C-N-CA 121.458 1.439 . . . . 0.0 111.746 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 113.66 42.62 0.86 Allowed Glycine 0 C--N 1.343 0.943 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.52 172.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' VAL . . . . . 0.471 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -57.13 101.32 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 177.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . 0.581 ' O ' HG23 ' B' ' 153' ' ' VAL . 14.5 t0 -41.77 119.12 2.01 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 115.212 -0.903 . . . . 0.0 111.869 -172.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 5.2 Cg_exo -74.96 -26.54 10.91 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.23 1.953 . . . . 0.0 112.027 -178.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.56 -32.41 16.31 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.991 -0.549 . . . . 0.0 112.007 -177.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' GLN . . . . . 0.427 ' O ' ' HB1' ' B' ' 167' ' ' ALA . 22.9 mt-30 -107.31 19.2 20.64 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . 0.581 HG23 ' O ' ' B' ' 149' ' ' ASP . 27.9 t -105.46 95.37 3.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.324 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.05 -173.9 4.24 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . 0.42 ' HB3' HD11 ' B' ' 163' ' ' LEU . 0.5 OUTLIER -159.74 138.38 10.63 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.734 -0.786 . . . . 0.0 112.056 -179.271 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.434 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.0 OUTLIER -107.14 136.38 47.09 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.053 178.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . 0.703 HD22 HD22 ' B' ' 109' ' ' LEU . 25.5 tp -124.95 131.58 53.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.908 0.385 . . . . 0.0 110.413 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.421 ' HB3' HG22 ' B' ' 162' ' ' THR . 0.3 OUTLIER -111.39 152.99 44.28 Favored Pre-proline 0 C--N 1.315 -0.931 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.455 ' C ' ' H ' ' B' ' 161' ' ' GLY . 9.7 Cg_endo -53.25 -20.58 15.07 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.069 1.846 . . . . 0.0 110.613 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -77.5 27.1 0.16 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.217 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' GLY . . . . . 0.614 ' HA2' ' OD1' ' B' ' 102' ' ' ASN . . . 41.72 34.5 1.25 Allowed Glycine 0 N--CA 1.462 0.396 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.945 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' THR . . . . . 0.421 HG22 ' HB3' ' B' ' 158' ' ' SER . 15.1 t -104.32 124.44 49.18 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.646 HD13 ' C ' ' B' ' 163' ' ' LEU . 2.5 tm? -114.87 109.73 18.59 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.204 -174.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.9 129.06 42.06 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 117.708 0.231 . . . . 0.0 110.476 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.567 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.2 m -113.44 103.99 16.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 174.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' B' ' 95' ' ' TRP . 1.7 pp20? -118.22 141.41 48.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.894 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . 0.558 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -177.98 159.14 1.22 Allowed Pre-proline 0 N--CA 1.453 -0.281 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' B' ' 93' ' ' ASP . 88.9 Cg_endo -77.64 81.01 2.78 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 123.72 2.947 . . . . 0.0 109.94 175.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' MET . . . . . 0.629 ' SD ' ' HB2' ' B' ' 95' ' ' TRP . 0.0 OUTLIER -93.08 164.42 21.64 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 114.757 -1.11 . . . . 0.0 111.55 -175.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' PRO . . . . . 0.526 ' CD ' ' O ' ' B' ' 147' ' ' GLY . 85.2 Cg_endo -82.35 103.87 1.31 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 123.263 2.642 . . . . 0.0 111.648 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' LYS . . . . . . . . . . . . . 10.2 tptm -69.95 47.92 0.09 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.147 0.499 . . . . 0.0 110.144 178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' B' ' 174' ' ' THR . 1.9 mm? -69.06 -10.77 59.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.565 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.18 53.23 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.458 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . 0.439 ' N ' ' O ' ' B' ' 172' ' ' LEU . 2.6 p -95.19 100.19 12.03 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.921 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -42.05 -33.15 0.53 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.789 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' B' ' 174' ' ' THR . 2.6 m . . . . . 0 C--O 1.209 -1.073 0 CA-C-O 118.129 -0.939 . . . . 0.0 111.499 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.569 ' N ' ' OE1' ' A' ' 80' ' ' GLN . 14.2 tpp . . . . . 0 N--CA 1.484 1.244 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.569 ' OE1' ' N ' ' A' ' 79' ' ' MET . 0.9 OUTLIER -121.2 -58.34 1.8 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.008 179.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.24 -71.35 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.792 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 80' ' ' GLN . 3.9 m -49.2 -67.08 0.3 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.367 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.7 m -162.83 143.73 9.76 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.043 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.1 67.49 0.55 Allowed Glycine 0 C--N 1.319 -0.391 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.4 m -41.67 -37.22 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.684 0.278 . . . . 0.0 110.933 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.533 ' C ' ' H ' ' A' ' 88' ' ' ILE . 1.2 m 40.66 49.51 2.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.511 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.84 31.32 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.139 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.555 ' O ' ' N ' ' A' ' 90' ' ' HIS . 4.8 pt -80.99 58.04 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -61.91 58.45 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.176 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.555 ' N ' ' O ' ' A' ' 88' ' ' ILE . 10.0 m-70 -71.29 79.04 0.73 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.348 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.74 162.25 0.93 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.694 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -132.15 169.21 16.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.664 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.411 ' O ' ' HB2' ' A' ' 94' ' ' ARG . 0.4 OUTLIER -60.75 -75.56 0.06 Allowed 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.215 178.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 93' ' ' ASP . 1.2 mmm180 70.27 118.42 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.047 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.541 ' HB2' ' HG3' ' A' ' 169' ' ' MET . 0.0 OUTLIER -61.52 113.25 2.58 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -109.61 100.02 9.12 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.902 -175.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -106.77 135.47 45.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 2.4 m -108.82 141.2 41.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.842 0.353 . . . . 0.0 111.945 -176.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.672 HD22 ' HB ' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -119.41 56.31 0.93 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.518 175.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -62.0 109.96 1.43 Allowed 'General case' 0 C--O 1.24 0.557 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.329 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.566 HG21 ' CD2' ' A' ' 138' ' ' PHE . 11.8 p -171.15 -17.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.641 ' OD1' HD11 ' A' ' 157' ' ' LEU . 0.8 OUTLIER -90.52 16.79 8.3 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.684 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.558 ' N ' ' HA3' ' A' ' 161' ' ' GLY . 0.0 OUTLIER -41.03 -34.24 0.4 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.829 0.347 . . . . 0.0 111.026 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -101.87 11.42 38.66 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.806 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' A' ' 102' ' ' ASN . . . -143.3 86.52 8.99 Favored Pre-proline 0 CA--C 1.512 -0.515 0 C-N-CA 120.899 -0.321 . . . . 0.0 111.433 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.37 -42.8 0.42 Allowed 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 122.44 2.093 . . . . 0.0 111.338 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -98.08 -31.79 11.95 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.583 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 123' ' ' LYS . 2.7 mm-40 -81.31 51.16 1.57 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.448 0.642 . . . . 0.0 110.347 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.746 HD22 HD22 ' A' ' 157' ' ' LEU . 0.5 OUTLIER -137.63 124.83 21.67 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.69 178.08 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.49 115.12 21.04 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.616 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.448 HG13 HD11 ' A' ' 120' ' ' ILE . 1.7 t -96.97 123.23 49.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.28 -178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.482 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 1.6 pttm -133.51 135.14 44.23 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.826 0.346 . . . . 0.0 111.081 178.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 m -109.61 114.84 28.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.3 ttpp -118.98 80.01 1.48 Allowed 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.772 0.32 . . . . 0.0 111.652 -176.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 27.9 t0 49.77 69.57 0.59 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.156 176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.1 -20.52 9.86 Favored Glycine 0 C--N 1.32 -0.339 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.863 HG22 HG23 ' A' ' 143' ' ' THR . 16.7 t -86.86 111.26 21.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.634 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 70.4 t -102.7 112.49 36.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.553 ' HG2' ' HA ' ' A' ' 141' ' ' LYS . 40.6 mt-10 -124.41 133.55 53.36 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.351 0.596 . . . . 0.0 111.53 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.672 ' HB ' HD22 ' A' ' 99' ' ' LEU . 1.1 mp -108.05 118.54 55.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.926 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.482 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -97.7 122.81 41.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.501 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.31 134.0 4.6 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.626 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 108' ' ' GLU . 0.0 OUTLIER -131.5 159.76 37.2 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -125.71 136.88 53.68 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.96 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.533 ' O ' ' C ' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -88.81 134.77 33.82 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.533 ' C ' ' O ' ' A' ' 125' ' ' GLU . 2.8 tt0 -1.9 98.85 0.01 OUTLIER 'General case' 0 C--O 1.24 0.563 0 O-C-N 123.759 0.662 . . . . 0.0 112.548 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 127' ' ' ARG . 11.0 mtp-105 -96.47 139.44 32.58 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 120.907 0.384 . . . . 0.0 111.081 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -79.84 130.25 35.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.779 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.437 ' OD2' ' NH2' ' B' ' 140' ' ' ARG . 0.0 OUTLIER -136.56 144.66 44.32 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.168 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -47.78 -27.47 2.04 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.147 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.447 ' O ' ' CZ ' ' B' ' 142' ' ' TYR . 42.1 m-70 -120.67 39.84 3.66 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 121.031 -0.267 . . . . 0.0 111.673 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.2 167.84 11.77 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.594 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 12.6 m-30 -96.36 113.77 25.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 174.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.7 HD11 HH11 ' A' ' 136' ' ' ARG . 0.0 OUTLIER -120.07 145.16 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -176.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -144.11 156.34 44.31 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 172.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.7 HH11 HD11 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -152.24 -178.45 6.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.825 0.345 . . . . 0.0 111.443 -175.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 123' ' ' LYS . 26.4 p -139.76 134.0 31.24 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 175.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.566 ' CD2' HG21 ' A' ' 101' ' ' VAL . 46.9 m-85 -100.36 141.04 33.75 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.76 99.19 4.86 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.103 172.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.676 ' NH2' ' CD1' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -104.81 99.92 9.55 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.001 -179.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.553 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 13.8 ttpt -112.34 127.89 56.13 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.713 -177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.676 ' CD1' ' NH2' ' A' ' 140' ' ' ARG . 11.9 m-85 -127.25 100.02 5.9 Favored 'General case' 0 CA--C 1.506 -0.727 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.515 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.863 HG23 HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -85.4 89.79 7.77 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.498 179.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.3 mp -108.69 93.4 12.02 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.332 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.63 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 16.7 Cg_exo -66.95 -54.93 0.36 Allowed 'Trans proline' 0 C--N 1.294 -2.332 0 C-N-CA 122.143 1.895 . . . . 0.0 112.798 175.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.63 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 57.6 Cg_endo -102.87 89.16 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.556 2.838 . . . . 0.0 111.729 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 152.86 -19.57 0.76 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.922 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.62 128.83 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 117.121 0.46 . . . . 0.0 110.511 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -92.88 143.13 26.42 Favored Pre-proline 0 N--CA 1.473 0.678 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.044 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.54 -22.61 4.53 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 121.877 1.718 . . . . 0.0 112.362 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.67 -41.04 10.95 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.377 -0.828 . . . . 0.0 112.212 -175.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.606 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 3.6 mt-30 -106.5 23.77 13.67 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -172.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.481 ' HA ' ' HB2' ' A' ' 167' ' ' ALA . 42.8 t -110.67 111.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.921 0.391 . . . . 0.0 110.878 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.62 -178.0 3.47 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.92 139.3 26.15 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.195 -0.602 . . . . 0.0 112.048 -178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.54 137.66 47.94 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.413 177.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.746 HD22 HD22 ' A' ' 109' ' ' LEU . 31.4 tp -128.43 145.45 51.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.896 0.379 . . . . 0.0 110.726 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.29 155.23 81.79 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.815 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.55 ' C ' ' H ' ' A' ' 161' ' ' GLY . 91.8 Cg_exo -42.27 -42.58 7.63 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.905 2.403 . . . . 0.0 111.865 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -62.54 10.77 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.644 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.627 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 59.39 33.57 76.72 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 112.06 -0.416 . . . . 0.0 112.06 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 162' ' ' THR . 6.2 t -95.18 114.85 26.69 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.05 0.453 . . . . 0.0 109.919 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.611 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.1 tm? -108.49 104.78 14.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.875 -177.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 23.7 p -99.42 116.79 32.38 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 165' ' ' VAL . 3.5 m -95.45 99.69 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 174.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -115.02 138.31 51.01 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.022 -175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.606 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . -178.11 162.83 1.25 Allowed Pre-proline 0 C--N 1.32 -0.7 0 CA-C-O 121.313 0.578 . . . . 0.0 111.771 -177.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.503 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 86.6 Cg_endo -87.77 109.16 0.65 Allowed 'Trans proline' 0 C--N 1.299 -2.035 0 C-N-CA 123.257 2.638 . . . . 0.0 108.229 175.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.595 ' SD ' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -109.39 169.15 6.74 Favored Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.506 -173.004 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 169' ' ' MET . 19.5 Cg_endo -62.05 50.1 0.1 Allowed 'Trans proline' 0 N--CA 1.503 2.08 0 C-N-CA 123.222 2.615 . . . . 0.0 112.065 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 169' ' ' MET . 6.0 mtpm? -36.24 -55.6 0.79 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.93 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 5.5 mt -116.84 43.67 2.21 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.857 0.36 . . . . 0.0 111.144 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.548 ' HB2' ' HB2' ' A' ' 170' ' ' PRO . . . -69.13 -61.61 1.72 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.29 159.15 14.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.741 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.04 -173.96 1.14 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 177.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.209 -1.038 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.838 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' MET . . . . . 0.48 ' N ' ' OD2' ' B' ' 93' ' ' ASP . 4.3 ttp . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 61.35 168.49 0.1 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.661 0.267 . . . . 0.0 110.506 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.686 HD22 ' N ' ' B' ' 81' ' ' LEU . 2.0 mm? -77.92 -160.45 0.2 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . 0.458 ' O ' ' N ' ' B' ' 84' ' ' GLY . 0.6 OUTLIER -70.29 164.01 25.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 6.4 m -67.74 53.77 0.06 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.061 0.458 . . . . 0.0 110.531 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' B' ' 82' ' ' SER . . . 158.48 80.48 0.03 OUTLIER Glycine 0 CA--C 1.52 0.386 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 34.5 m 43.6 -155.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 C-N-CA 122.613 0.365 . . . . 0.0 111.544 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . 0.434 ' C ' ' H ' ' B' ' 88' ' ' ILE . 0.8 OUTLIER -75.45 69.18 2.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.775 0.322 . . . . 0.0 111.273 -178.119 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . 0.447 ' O ' ' NH2' ' B' ' 89' ' ' ARG . 6.3 tt0 -77.15 30.9 0.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.595 178.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . 0.585 ' O ' ' NE ' ' B' ' 89' ' ' ARG . 6.9 mt 57.25 165.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.992 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.585 ' NE ' ' O ' ' B' ' 88' ' ' ILE . 0.0 OUTLIER 56.48 -5.99 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 178.06 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' HIS . . . . . 0.541 ' H ' ' C ' ' B' ' 88' ' ' ILE . 0.6 OUTLIER -38.39 94.2 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.003 0.43 . . . . 0.0 111.645 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.434 ' N ' ' O ' ' B' ' 89' ' ' ARG . 2.0 m -146.4 127.06 14.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.148 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . . . . . . . . . . . -152.02 -84.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.911 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' B' ' 79' ' ' MET . 21.6 m-20 -62.63 87.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.933 0.396 . . . . 0.0 110.929 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . 0.485 ' NH2' ' OE2' ' B' ' 166' ' ' GLU . 7.9 mmm180 -129.99 144.77 51.51 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.587 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' TRP . . . . . 0.559 ' NE1' ' CG2' ' B' ' 97' ' ' VAL . 63.2 t-105 -115.8 113.9 24.03 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -119.83 104.72 10.45 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.579 -175.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.559 ' CG2' ' NE1' ' B' ' 95' ' ' TRP . 0.2 OUTLIER -112.59 158.12 13.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 16.1 m -134.31 142.52 47.3 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -176.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.771 HD23 HH11 ' B' ' 140' ' ' ARG . 0.4 OUTLIER -112.97 79.89 1.29 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.472 174.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.489 ' C ' HG22 ' B' ' 101' ' ' VAL . 5.0 p-10 -86.36 102.76 14.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.86 0.362 . . . . 0.0 111.143 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.489 HG22 ' C ' ' B' ' 100' ' ' ASP . 0.0 OUTLIER -163.94 -40.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.765 0.317 . . . . 0.0 111.463 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' B' ' 161' ' ' GLY . 0.0 OUTLIER -60.25 11.16 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -175.282 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.531 ' N ' ' HA3' ' B' ' 161' ' ' GLY . 3.1 p80 -52.4 -19.07 1.93 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.137 0.494 . . . . 0.0 109.87 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.432 ' CE2' ' NH2' ' B' ' 136' ' ' ARG . 47.9 p90 -94.48 -9.26 36.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.138 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.51 91.8 5.68 Favored Pre-proline 0 CA--C 1.516 -0.351 0 CA-C-O 120.826 0.346 . . . . 0.0 111.536 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.95 -49.77 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.471 2.114 . . . . 0.0 111.266 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -89.66 -31.2 17.62 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.225 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.502 ' OE2' ' NZ ' ' B' ' 123' ' ' LYS . 13.2 mt-10 -87.08 49.84 1.9 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.311 0.577 . . . . 0.0 110.135 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.858 HD22 HD22 ' B' ' 157' ' ' LEU . 0.4 OUTLIER -133.18 142.6 48.7 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.111 178.405 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.528 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -137.05 120.25 16.74 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.432 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.462 HG13 HD11 ' B' ' 120' ' ' ILE . 2.5 t -102.2 125.37 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.358 -178.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.413 ' NZ ' ' HB2' ' B' ' 119' ' ' GLU . 14.6 pttp -136.4 142.11 43.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.665 0.269 . . . . 0.0 111.145 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.91 114.95 29.35 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.535 ' NZ ' ' CB ' ' B' ' 114' ' ' LYS . 0.0 OUTLIER -111.81 92.91 4.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.117 -177.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 29.5 t70 32.77 66.35 0.2 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.273 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.52 -21.93 19.29 Favored Glycine 0 N--CA 1.466 0.665 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.759 HG22 HG23 ' B' ' 143' ' ' THR . 5.9 t -87.79 120.43 36.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.606 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 54.3 t -106.49 123.73 61.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.442 ' OE2' ' NZ ' ' B' ' 114' ' ' LYS . 2.8 mt-10 -135.66 140.65 44.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.973 0.416 . . . . 0.0 110.767 -178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.49 ' HB ' HD22 ' B' ' 99' ' ' LEU . 1.2 mp -117.72 117.75 56.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.791 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -91.16 123.29 34.5 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.443 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.07 116.5 0.78 Allowed Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' LYS . . . . . 0.502 ' NZ ' ' OE2' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -140.86 126.3 18.8 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.282 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . 0.707 ' H ' ' CD2' ' B' ' 124' ' ' HIS . 0.2 OUTLIER -95.77 134.84 38.25 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.371 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.531 ' O ' ' C ' ' B' ' 126' ' ' GLU . 3.2 tp10 -69.36 136.41 51.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.383 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . 0.531 ' C ' ' O ' ' B' ' 125' ' ' GLU . 39.3 tt0 -1.62 98.39 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.797 0.685 . . . . 0.0 112.111 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' ARG . . . . . . . . . . . . . 3.7 mtm180 -93.02 129.93 38.78 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.079 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -77.52 122.6 25.47 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . 0.524 ' HB2' HG22 ' B' ' 134' ' ' ILE . 1.9 t70 -120.29 173.02 7.38 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.866 0.365 . . . . 0.0 110.766 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -60.58 -30.97 70.14 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -174.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' HIS . . . . . 0.529 ' O ' ' CE1' ' A' ' 142' ' ' TYR . 75.0 m-70 -110.82 24.68 12.64 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -177.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 132.84 -149.88 19.64 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 120.228 -0.987 . . . . 0.0 111.955 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' TYR . . . . . 0.554 ' O ' ' NH1' ' A' ' 140' ' ' ARG . 63.4 m-85 -111.18 125.16 53.5 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . 0.524 HG22 ' HB2' ' B' ' 129' ' ' ASP . 0.0 OUTLIER -145.96 121.56 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 120.659 0.266 . . . . 0.0 111.092 -176.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . 0.41 ' HB3' ' CD2' ' B' ' 124' ' ' HIS . 0.7 OUTLIER -150.51 157.75 43.37 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 178.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . 0.618 ' HD3' ' CE1' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -145.53 171.52 14.55 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.113 0.482 . . . . 0.0 111.65 -177.071 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 29.5 p -107.93 132.13 53.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.693 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . 0.618 ' CE1' ' HD3' ' B' ' 136' ' ' ARG . 0.3 OUTLIER -108.78 139.76 43.15 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.774 0.321 . . . . 0.0 110.903 -178.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.64 103.95 3.57 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.259 176.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . 0.771 HH11 HD23 ' B' ' 99' ' ' LEU . 0.0 OUTLIER -104.91 123.85 48.45 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 173.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . 0.41 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 1.5 ttpp -113.54 118.19 33.75 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' TYR . . . . . 0.644 ' OH ' ' NH1' ' B' ' 140' ' ' ARG . 2.1 m-30 -106.04 97.88 7.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.739 0.304 . . . . 0.0 110.192 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.759 HG23 HG22 ' B' ' 117' ' ' VAL . 0.2 OUTLIER -90.98 100.27 13.17 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.3 mp -109.73 92.54 12.53 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.825 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . 0.575 ' O ' ' N ' ' B' ' 147' ' ' GLY . 24.6 Cg_exo -65.76 -39.85 19.07 Favored 'Trans proline' 0 C--N 1.287 -2.705 0 C-N-CA 122.527 2.151 . . . . 0.0 112.428 171.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 83.7 Cg_exo -41.59 -8.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.498 1.754 0 C-N-CA 123.296 2.664 . . . . 0.0 113.506 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 116.4 69.65 0.43 Allowed Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.101 -1.047 . . . . 0.0 113.989 175.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' VAL . . . . . 0.449 ' O ' HG12 ' B' ' 148' ' ' VAL . 0.5 OUTLIER -112.76 112.4 40.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 172.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . 0.481 ' O ' HG23 ' B' ' 153' ' ' VAL . 19.1 t70 -64.39 135.51 96.38 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.692 -176.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 3.8 Cg_exo -78.58 -26.2 6.02 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 121.922 1.748 . . . . 0.0 113.188 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.93 -42.32 10.65 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -176.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -94.49 15.97 16.52 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -174.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . 0.699 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 37.1 t -101.34 89.6 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.442 177.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.41 178.43 8.31 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.38 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.78 133.65 10.27 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.472 -178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.567 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.0 OUTLIER -113.31 142.8 45.41 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.369 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . 0.858 HD22 HD22 ' B' ' 109' ' ' LEU . 35.0 tp -128.88 148.7 50.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 0.0 110.291 178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.614 ' H ' HD12 ' B' ' 157' ' ' LEU . 0.3 OUTLIER -134.77 154.02 79.15 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.916 -0.583 . . . . 0.0 109.504 -179.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.552 ' C ' ' H ' ' B' ' 161' ' ' GLY . 80.5 Cg_exo -41.05 -40.45 3.89 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.739 2.293 . . . . 0.0 111.239 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.27 17.64 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.376 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' GLY . . . . . 0.552 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 49.72 31.33 15.71 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' THR . . . . . 0.497 ' CG2' ' HB2' ' B' ' 158' ' ' SER . 15.0 t -90.57 120.77 31.92 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.604 HD13 ' C ' ' B' ' 163' ' ' LEU . 3.1 tm? -115.77 102.65 9.91 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.88 125.42 37.47 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 121.132 -0.227 . . . . 0.0 111.12 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.577 ' O ' HG23 ' B' ' 165' ' ' VAL . 3.0 m -112.6 100.03 9.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 174.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 0.485 ' OE2' ' NH2' ' B' ' 94' ' ' ARG . 0.0 OUTLIER -110.01 132.74 53.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.937 -176.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . 0.699 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -164.0 150.24 9.65 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -84.65 67.19 6.47 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 123.867 3.045 . . . . 0.0 109.98 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' MET . . . . . 0.506 ' HG2' ' CB ' ' B' ' 95' ' ' TRP . 0.1 OUTLIER -46.91 158.71 0.41 Allowed Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.193 -176.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' PRO . . . . . 0.54 ' HB2' HD23 ' B' ' 172' ' ' LEU . 8.3 Cg_endo -51.73 148.44 21.76 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.873 2.382 . . . . 0.0 111.373 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.77 64.79 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.629 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' B' ' 170' ' ' PRO . 3.1 mm? -89.5 72.3 7.91 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.76 87.96 1.74 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.63 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.91 111.74 5.84 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -80.17 -85.83 0.09 Allowed 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.24 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.208 -1.086 0 CA-C-O 118.289 -0.863 . . . . 0.0 111.424 -178.766 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.989 ' N ' ' HG ' ' A' ' 82' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 31.4 mm-40 -41.6 -81.25 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.986 0.422 . . . . 0.0 111.421 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 12.4 mt -54.64 -17.24 3.12 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.437 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.989 ' HG ' ' N ' ' A' ' 79' ' ' MET . 0.7 OUTLIER -85.91 -15.45 41.68 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.076 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.451 ' N ' ' O ' ' A' ' 79' ' ' MET . 0.0 OUTLIER -97.11 -170.19 1.99 Allowed 'General case' 0 C--O 1.239 0.542 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 179.071 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.1 -54.71 0.81 Allowed Glycine 0 CA--C 1.518 0.279 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.38 150.75 34.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.9 m -166.59 90.16 0.39 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.112 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 89' ' ' ARG . 9.2 mm-40 -57.18 152.76 13.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.182 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.9 tt -66.13 58.62 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.417 0.627 . . . . 0.0 110.731 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 87' ' ' GLU . 11.7 mtp180 -77.38 133.14 38.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.069 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.432 ' ND1' ' N ' ' A' ' 91' ' ' THR . 1.8 t60 -154.94 133.2 11.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.903 0.383 . . . . 0.0 110.825 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.432 ' N ' ' ND1' ' A' ' 90' ' ' HIS . 0.0 OUTLIER -70.31 63.64 0.25 Allowed 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 90' ' ' HIS . . . -38.17 -38.05 0.31 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.087 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 168' ' ' PRO . 1.8 m-20 -59.48 90.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.04 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.454 ' NH1' ' OE1' ' A' ' 166' ' ' GLU . 6.5 mmt85 -128.5 117.2 20.91 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.715 ' CZ3' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -86.13 160.12 19.33 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.5 ' CZ ' ' HB3' ' A' ' 96' ' ' ARG . 21.3 ttp-105 -151.37 99.66 2.66 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.128 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.715 HG21 ' CZ3' ' A' ' 95' ' ' TRP . 1.3 t -116.27 148.1 19.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 176.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.23 150.1 30.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.936 0.398 . . . . 0.0 111.878 -175.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.746 HD22 HG12 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -128.82 91.16 3.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.643 175.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.591 ' C ' HG22 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -81.56 124.78 29.8 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.477 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.591 HG22 ' C ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -178.72 -40.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-O 122.403 1.097 . . . . 0.0 108.434 178.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.87 ' HB2' HD13 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -58.92 -14.27 8.67 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 113.373 -1.739 . . . . 0.0 111.683 -178.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.572 ' CE1' ' HA ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -45.14 -22.78 0.12 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.567 -178.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.32 17.27 12.26 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.88 86.31 3.84 Favored Pre-proline 0 N--CA 1.467 0.409 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.875 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.533 ' HA ' HD21 ' A' ' 102' ' ' ASN . 51.3 Cg_endo -70.95 -47.28 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.511 2.141 . . . . 0.0 111.517 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -94.81 -30.46 14.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.347 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.545 ' OE2' ' NZ ' ' A' ' 123' ' ' LYS . 24.9 mt-10 -85.98 41.29 0.91 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.048 0.451 . . . . 0.0 110.822 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.87 HD13 ' HB2' ' A' ' 102' ' ' ASN . 0.4 OUTLIER -129.2 133.89 47.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.047 178.799 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.4 ' N ' ' HG ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -127.73 129.06 46.46 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.245 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.3 t -109.47 120.88 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.614 ' NZ ' ' HB2' ' A' ' 119' ' ' GLU . 9.8 pttp -134.26 128.33 33.63 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.403 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 2.6 m -97.15 134.24 40.74 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.097 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 116' ' ' GLY . 0.3 OUTLIER -120.46 -176.74 3.29 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 179.324 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -57.28 69.85 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.303 0.573 . . . . 0.0 111.639 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 114' ' ' LYS . . . 83.69 -5.99 75.89 Favored Glycine 0 C--N 1.32 -0.356 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.672 HG13 HG23 ' A' ' 143' ' ' THR . 1.7 t -92.49 110.81 23.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.552 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.2 t -96.06 117.75 40.93 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.614 ' HB2' ' NZ ' ' A' ' 112' ' ' LYS . 81.6 mt-10 -129.48 133.6 47.36 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.114 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.746 HG12 HD22 ' A' ' 99' ' ' LEU . 4.6 mm -107.18 141.38 22.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.417 177.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -121.69 114.31 20.96 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.329 -178.015 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -144.85 130.07 3.76 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.899 -0.48 . . . . 0.0 111.899 -178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.545 ' NZ ' ' OE2' ' A' ' 108' ' ' GLU . 0.1 OUTLIER -151.13 132.28 14.41 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.531 ' ND1' ' HG2' ' A' ' 127' ' ' ARG . 54.6 t-80 -102.59 141.2 35.81 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -56.81 -33.78 67.05 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -176.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 0.3 OUTLIER 173.21 103.51 0.01 OUTLIER 'General case' 0 C--N 1.356 0.853 0 CA-C-N 118.748 0.704 . . . . 0.0 111.23 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.531 ' HG2' ' ND1' ' A' ' 124' ' ' HIS . 9.7 mtp-105 -94.42 149.21 21.46 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.589 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -83.54 136.87 34.1 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.61 ' HB3' HG22 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -136.65 151.32 49.17 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.252 0.548 . . . . 0.0 110.293 177.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.48 -29.8 7.24 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.119 -178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.587 ' H ' ' CG ' ' A' ' 129' ' ' ASP . 50.5 m-70 -120.17 40.5 3.44 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.851 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 129.17 172.97 13.28 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 119.689 -1.243 . . . . 0.0 112.092 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -96.1 126.79 41.57 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 172.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.61 HG22 ' HB3' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -130.43 123.92 56.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -170.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 3.1 m -131.57 147.04 52.5 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.199 169.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.442 ' NH1' ' CE2' ' B' ' 138' ' ' PHE . 0.0 OUTLIER -143.75 170.48 15.79 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.755 -178.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 25.1 p -112.02 122.77 48.68 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 175.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.486 ' CD2' ' CG1' ' A' ' 101' ' ' VAL . 5.7 m-85 -95.78 128.78 42.96 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.765 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.58 105.65 5.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.886 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.476 ' NH2' ' OH ' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -104.67 105.14 15.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.864 178.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.454 ' HA ' ' HG2' ' A' ' 119' ' ' GLU . 14.2 ttmt -99.04 112.38 24.53 Favored 'General case' 0 CA--C 1.507 -0.681 0 O-C-N 123.186 0.304 . . . . 0.0 110.75 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.703 ' CE1' ' HA3' ' B' ' 132' ' ' GLY . 5.9 m-30 -106.15 99.3 8.9 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 178.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.672 HG23 HG13 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -87.74 89.32 7.95 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.8 mp -113.33 91.35 19.33 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.645 ' HD2' ' HD3' ' A' ' 146' ' ' PRO . 13.2 Cg_exo -69.13 -57.27 0.13 Allowed 'Trans proline' 0 C--N 1.29 -2.529 0 C-N-CA 122.457 2.105 . . . . 0.0 114.641 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.645 ' HD3' ' HD2' ' A' ' 145' ' ' PRO . 12.6 Cg_endo -93.0 22.69 0.57 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 C-N-CA 122.969 2.446 . . . . 0.0 113.562 -174.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -142.22 -13.27 0.41 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 119.827 -1.178 . . . . 0.0 112.968 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.541 HG21 ' CH2' ' A' ' 95' ' ' TRP . 0.9 OUTLIER -131.75 128.19 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.713 0.756 . . . . 0.0 110.644 178.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 12.8 t70 -89.26 140.96 28.78 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.226 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 3.6 Cg_exo -82.35 -18.92 6.87 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.063 1.842 . . . . 0.0 112.991 -178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.46 -37.2 12.67 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.755 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 2.7 mt-30 -109.83 27.9 9.11 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.494 ' HA ' ' CB ' ' A' ' 167' ' ' ALA . 45.2 t -111.65 120.8 62.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.673 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.81 -173.72 2.31 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.318 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -154.48 153.17 31.06 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.939 -0.704 . . . . 0.0 112.215 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.491 ' O ' HD22 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -124.82 136.46 53.84 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.617 178.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.597 HD22 HD22 ' A' ' 109' ' ' LEU . 31.0 tp -124.89 110.91 14.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.84 0.353 . . . . 0.0 110.131 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.425 ' HB3' HG22 ' A' ' 162' ' ' THR . 0.3 OUTLIER -90.86 145.07 31.18 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.664 179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.621 ' C ' ' H ' ' A' ' 161' ' ' GLY . 84.4 Cg_exo -41.02 -34.06 1.34 Allowed 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.646 2.231 . . . . 0.0 110.753 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -67.61 27.61 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.387 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.621 ' H ' ' C ' ' A' ' 159' ' ' PRO . . . 38.41 33.96 0.21 Allowed Glycine 0 CA--C 1.53 1.008 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.601 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 158' ' ' SER . 9.8 t -102.03 125.37 48.7 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.576 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.1 tm? -107.04 110.01 22.02 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.786 -175.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.35 125.38 45.0 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.488 ' O ' HG23 ' A' ' 165' ' ' VAL . 1.2 m -106.69 107.28 22.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 174.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 1.5 pp20? -121.63 152.83 38.87 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.056 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.755 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 168.44 167.97 0.14 Allowed Pre-proline 0 C--O 1.238 0.463 0 CA-C-O 121.158 0.504 . . . . 0.0 112.213 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.483 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 37.7 Cg_endo -89.53 109.46 0.44 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 123.452 2.768 . . . . 0.0 109.168 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.548 ' CE ' ' H ' ' A' ' 169' ' ' MET . 0.0 OUTLIER -107.18 170.8 5.26 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.874 -175.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 169' ' ' MET . 21.7 Cg_exo -54.91 -20.41 22.7 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.249 1.966 . . . . 0.0 110.688 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.1 tttt 72.95 143.39 0.07 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.222 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.48 106.61 3.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.223 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -130.17 -21.37 2.95 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.958 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 17.2 p -79.29 -94.36 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.208 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -85.17 -124.39 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.852 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.214 -0.777 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.069 179.769 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' MET . . . . . . . . . . . . . 15.6 mmm . . . . . 0 N--CA 1.484 1.228 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.573 ' C ' ' H ' ' B' ' 82' ' ' SER . 26.2 mt-30 -44.43 127.67 5.97 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' B' ' 81' ' ' LEU . 2.8 mm? 66.73 -35.65 0.25 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.947 0.403 . . . . 0.0 110.466 -177.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . 0.573 ' H ' ' C ' ' B' ' 80' ' ' GLN . 0.9 OUTLIER 60.26 -157.37 0.33 Allowed 'General case' 0 C--O 1.239 0.55 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 178.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.98 139.99 48.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.154 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.58 86.57 0.27 Allowed Glycine 0 C--N 1.318 -0.453 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 5.4 m -61.32 165.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.142 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 90' ' ' HIS . 0.1 OUTLIER -65.08 -33.52 76.23 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.446 -178.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 65.83 -140.8 0.19 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.597 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 pt 32.27 45.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 120.926 0.393 . . . . 0.0 111.993 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 49.88 25.14 1.49 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.914 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' HIS . . . . . 0.426 ' O ' ' OG ' ' B' ' 86' ' ' SER . 31.9 t60 -118.06 67.34 0.76 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.832 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.56 ' O ' ' HB2' ' B' ' 92' ' ' ALA . 76.7 p -81.76 -85.86 0.1 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' B' ' 91' ' ' THR . . . 163.83 -29.18 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.317 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.586 ' CG ' ' H ' ' B' ' 94' ' ' ARG . 5.0 p-10 -68.86 -93.68 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.772 -177.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . 0.586 ' H ' ' CG ' ' B' ' 93' ' ' ASP . 24.5 mmt-85 11.17 84.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 123.727 0.642 . . . . 0.0 110.454 -177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' TRP . . . . . 0.526 ' HB2' ' HG3' ' B' ' 169' ' ' MET . 0.1 OUTLIER -62.31 141.13 58.44 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.339 -177.77 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 25.0 ttm105 -135.29 106.78 6.86 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.167 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.85 150.9 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' B' ' 163' ' ' LEU . 17.6 m -126.95 148.91 50.05 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -174.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.692 HD21 ' CE1' ' B' ' 142' ' ' TYR . 0.7 OUTLIER -123.9 55.03 1.29 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.465 174.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.25 93.95 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.835 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' B' ' 103' ' ' HIS . 2.6 t -145.15 -26.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 178.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.775 ' HB3' HD13 ' B' ' 109' ' ' LEU . 0.0 OUTLIER -54.86 3.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -178.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.532 ' H ' ' C ' ' B' ' 101' ' ' VAL . 2.4 m-70 -41.91 -46.55 4.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.998 0.428 . . . . 0.0 110.848 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.06 8.32 38.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.144 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.07 89.75 2.06 Favored Pre-proline 0 CA--C 1.513 -0.444 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -74.58 -44.48 0.38 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 122.323 2.015 . . . . 0.0 110.866 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -98.15 -31.46 12.09 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.119 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.437 ' OE1' ' NZ ' ' B' ' 123' ' ' LYS . 4.4 mt-10 -83.09 37.99 0.57 Allowed 'General case' 0 C--O 1.242 0.676 0 CA-C-O 121.018 0.437 . . . . 0.0 110.728 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.818 HD22 HD22 ' B' ' 157' ' ' LEU . 0.4 OUTLIER -121.4 135.35 55.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.06 124.23 38.79 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 120.5 0.191 . . . . 0.0 110.852 -177.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.74 129.61 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.969 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -139.43 134.88 32.97 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.686 0.279 . . . . 0.0 110.759 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 5.2 m -102.94 108.0 19.02 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.801 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.568 ' HB3' ' HB ' ' B' ' 117' ' ' VAL . 21.5 ttmt -104.32 87.68 2.79 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.822 -177.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 3.4 t70 30.66 67.35 0.12 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.655 179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.41 -22.45 23.7 Favored Glycine 0 N--CA 1.466 0.693 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.568 ' HB ' ' HB3' ' B' ' 114' ' ' LYS . 8.8 t -87.55 109.77 19.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' B' ' 142' ' ' TYR . 56.1 t -96.65 127.05 49.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.974 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.571 ' CD ' ' HZ2' ' B' ' 141' ' ' LYS . 74.4 mt-10 -139.36 146.96 40.88 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.275 -178.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.57 HD12 ' O ' ' B' ' 119' ' ' GLU . 1.3 mp -121.46 131.23 73.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.434 177.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' B' ' 109' ' ' LEU . 0.3 OUTLIER -104.01 120.38 40.93 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.669 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -140.42 129.2 4.1 Favored Glycine 0 N--CA 1.466 0.66 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' LYS . . . . . 0.437 ' NZ ' ' OE1' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -150.16 157.78 43.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 -178.369 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . 0.472 ' ND1' ' O ' ' B' ' 126' ' ' GLU . 8.8 t-80 -145.02 127.91 16.4 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -56.01 -10.08 0.74 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -176.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . 0.61 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 0.5 OUTLIER 175.31 145.62 0.07 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 111.571 179.074 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' ARG . . . . . 0.596 ' NH1' ' HA ' ' B' ' 135' ' ' SER . 26.1 mtt85 -135.19 107.57 7.3 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.658 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -65.73 130.52 43.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.527 -177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.29 149.0 28.87 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -62.26 -31.46 72.03 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -92.27 25.17 3.03 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.488 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . 0.703 ' HA3' ' CE1' ' A' ' 142' ' ' TYR . . . 122.77 165.01 12.28 Favored Glycine 0 N--CA 1.429 -1.821 0 C-N-CA 120.41 -0.9 . . . . 0.0 111.152 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 13.9 m-30 -94.69 112.74 24.48 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . 0.523 HD11 ' NH1' ' B' ' 136' ' ' ARG . 0.0 OUTLIER -115.03 113.9 44.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.977 0.418 . . . . 0.0 111.864 -174.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . 0.61 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.8 OUTLIER -116.71 152.32 34.54 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.876 175.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . 0.523 ' NH1' HD11 ' B' ' 134' ' ' ILE . 2.4 ptt180 -155.67 145.55 21.39 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.759 -177.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 28.5 p -92.5 129.81 38.33 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . 0.442 ' CE2' ' NH1' ' A' ' 136' ' ' ARG . 15.1 m-85 -98.21 137.72 36.54 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -177.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.83 101.07 3.6 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.172 176.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . 0.569 HH22 ' HB2' ' A' ' 131' ' ' HIS . 0.1 OUTLIER -98.91 150.2 22.16 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 173.365 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . 0.571 ' HZ2' ' CD ' ' B' ' 119' ' ' GLU . 13.6 ttmm -140.42 122.67 15.87 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.486 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' TYR . . . . . 0.692 ' CE1' HD21 ' B' ' 99' ' ' LEU . 0.5 OUTLIER -114.92 99.0 7.15 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.484 ' O ' ' HD3' ' B' ' 145' ' ' PRO . 0.0 OUTLIER -88.59 89.59 8.05 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.54 93.3 19.03 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.724 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . 0.589 ' CD ' ' HD3' ' B' ' 146' ' ' PRO . 16.5 Cg_exo -67.24 -54.97 0.33 Allowed 'Trans proline' 0 C--N 1.287 -2.667 0 C-N-CA 121.664 1.576 . . . . 0.0 112.345 174.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' PRO . . . . . 0.589 ' HD3' ' CD ' ' B' ' 145' ' ' PRO . 56.8 Cg_endo -98.72 89.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.477 0.501 0 C-N-CA 123.103 2.535 . . . . 0.0 112.106 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . . . . . . . . . . . 148.76 -20.55 1.29 Allowed Glycine 0 C--O 1.223 -0.534 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.669 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.26 122.92 60.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 117.579 0.69 . . . . 0.0 110.813 177.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . 0.448 ' OD1' ' HG3' ' B' ' 152' ' ' GLN . 12.0 t70 -93.58 148.08 34.81 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.05 -24.11 4.91 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.651 1.568 . . . . 0.0 112.756 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' THR . . . . . 0.436 ' N ' ' OD1' ' B' ' 149' ' ' ASP . 0.2 OUTLIER -91.36 -35.36 14.45 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -176.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' GLN . . . . . 0.677 ' O ' ' HB1' ' B' ' 167' ' ' ALA . 0.0 OUTLIER -103.53 14.49 31.15 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -175.342 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 39.1 t -107.9 120.46 59.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.438 178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.83 -172.94 2.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.763 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.67 138.28 18.73 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.491 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.57 144.68 35.94 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.331 177.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . 0.818 HD22 HD22 ' B' ' 109' ' ' LEU . 15.4 tp -136.44 118.47 15.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.814 0.34 . . . . 0.0 110.249 178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.446 ' N ' HD12 ' B' ' 157' ' ' LEU . 1.6 t -105.29 149.2 37.44 Favored Pre-proline 0 C--N 1.315 -0.9 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -41.77 -26.39 0.43 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.64 2.227 . . . . 0.0 111.828 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' B' ' 160' ' ' GLU . 29.2 mp0 -66.04 -8.02 20.76 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.685 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' GLY . . . . . 0.594 ' O ' ' ND2' ' B' ' 102' ' ' ASN . . . 76.57 27.41 61.24 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -176.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 28.8 p -87.58 99.84 12.35 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.609 HD13 ' C ' ' B' ' 163' ' ' LEU . 1.3 tm? -96.35 92.86 6.54 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.31 127.0 41.01 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.452 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.574 ' O ' HG23 ' B' ' 165' ' ' VAL . 2.6 m -105.45 99.09 7.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.08 134.82 54.54 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.357 -176.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' B' ' 152' ' ' GLN . . . -170.46 160.99 6.22 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.28 0.562 . . . . 0.0 111.889 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . 0.466 ' HD2' ' HB1' ' B' ' 167' ' ' ALA . 57.0 Cg_endo -84.95 59.95 5.62 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 123.262 2.641 . . . . 0.0 109.237 176.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' MET . . . . . 0.634 ' O ' ' N ' ' B' ' 171' ' ' LYS . 0.2 OUTLIER -65.97 167.25 12.3 Favored Pre-proline 0 C--N 1.302 -1.477 0 CA-C-N 113.457 -1.701 . . . . 0.0 111.011 -176.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' PRO . . . . . 0.561 ' HB2' ' HB3' ' B' ' 173' ' ' ALA . 31.7 Cg_exo -51.39 63.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 123.415 2.743 . . . . 0.0 112.579 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' LYS . . . . . 0.634 ' N ' ' O ' ' B' ' 169' ' ' MET . 7.8 tptp -44.67 -52.92 7.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.736 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -51.4 -46.42 62.85 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.26 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' B' ' 170' ' ' PRO . . . -59.09 -36.61 75.41 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.69 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . 0.555 ' OG1' ' NZ ' ' B' ' 171' ' ' LYS . 75.8 p -75.62 0.66 16.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.588 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' GLN . . . . . 0.583 ' O ' ' NZ ' ' B' ' 171' ' ' LYS . 43.3 mt-30 41.57 -138.75 0.15 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.01 -178.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.209 -1.038 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.637 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 5.0 ttm . . . . . 0 N--CA 1.485 1.313 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 81' ' ' LEU . 32.2 mt-30 -142.27 -163.72 1.66 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.697 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 80' ' ' GLN . 51.1 mt -28.57 -84.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.208 -178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 84' ' ' GLY . 0.0 OUTLIER -134.02 31.72 3.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.172 -178.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.49 56.07 0.08 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.141 0.496 . . . . 0.0 110.36 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 86' ' ' SER . . . -178.27 173.58 46.01 Favored Glycine 0 C--N 1.316 -0.569 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 85' ' ' VAL . 29.0 m -36.19 91.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.961 0.41 . . . . 0.0 111.391 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 84' ' ' GLY . 0.9 OUTLIER -86.23 -18.71 31.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.291 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -4.96 26.9 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.559 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 88' ' ' ILE . 7.4 tt -34.9 101.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.31 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.576 ' NH2' ' O ' ' A' ' 91' ' ' THR . 0.6 OUTLIER 41.26 34.24 0.31 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.432 -179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' A' ' 91' ' ' THR . 0.1 OUTLIER -46.88 -28.55 1.62 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.015 0.436 . . . . 0.0 110.383 179.309 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.627 ' N ' ' ND1' ' A' ' 90' ' ' HIS . 0.2 OUTLIER -52.18 132.8 33.83 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.837 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -150.51 134.2 16.62 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -104.32 161.97 13.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.947 0.403 . . . . 0.0 110.566 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.18 144.52 47.04 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.466 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.69 ' NE1' HG22 ' A' ' 97' ' ' VAL . 54.1 t-105 -105.04 168.43 9.06 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.482 ' N ' ' CG ' ' A' ' 95' ' ' TRP . 1.7 ttm105 -150.51 108.72 3.75 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.368 -176.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.69 HG22 ' NE1' ' A' ' 95' ' ' TRP . 0.2 OUTLIER -116.44 150.06 18.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 174.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 163' ' ' LEU . 14.7 m -131.52 157.64 43.03 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -176.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.573 HD22 ' HB ' ' A' ' 120' ' ' ILE . 0.7 OUTLIER -133.23 89.98 2.68 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.155 176.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -92.92 94.54 8.98 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.437 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -153.31 -23.51 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.696 ' CB ' HD13 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -83.17 9.28 10.89 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -174.195 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.608 ' N ' ' HA3' ' A' ' 161' ' ' GLY . 22.9 p-80 -48.53 -35.38 13.14 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.113 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -80.96 -3.4 51.45 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.832 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.491 ' C ' HD22 ' A' ' 102' ' ' ASN . . . -146.73 79.33 10.3 Favored Pre-proline 0 CA--C 1.512 -0.518 0 CA-C-O 120.772 0.32 . . . . 0.0 111.482 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.51 -39.81 11.67 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 C-N-CA 122.513 2.142 . . . . 0.0 111.486 178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -101.52 -31.66 10.77 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.978 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.404 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 22.6 mt-10 -79.28 46.17 0.7 Allowed 'General case' 0 C--O 1.238 0.491 0 CA-C-O 121.164 0.506 . . . . 0.0 110.05 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.696 HD13 ' CB ' ' A' ' 102' ' ' ASN . 0.5 OUTLIER -133.21 135.66 45.18 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.471 179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.7 116.85 17.85 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.153 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.93 124.95 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.517 ' NZ ' ' OG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -127.97 136.76 51.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.999 0.428 . . . . 0.0 111.369 -179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.66 116.07 31.29 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.602 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 2.5 ttpt -111.41 80.76 1.35 Allowed 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.356 0.598 . . . . 0.0 109.753 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 33.84 68.19 0.18 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.176 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.02 -23.59 25.8 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.611 HG22 HG23 ' A' ' 143' ' ' THR . 4.9 t -87.12 114.19 25.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 177.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.9 t -102.04 120.17 51.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.837 -178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.597 ' CD ' ' HD3' ' A' ' 141' ' ' LYS . 26.8 mt-10 -132.78 145.59 51.12 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.139 0.495 . . . . 0.0 110.948 -178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.573 ' HB ' HD22 ' A' ' 99' ' ' LEU . 1.1 mp -113.35 122.94 68.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.377 -0.828 . . . . 0.0 110.016 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.517 ' OG1' ' NZ ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER -101.55 115.5 30.66 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.0 128.09 2.6 Favored Glycine 0 C--O 1.239 0.424 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.138 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.46 124.18 9.17 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.513 ' CD2' ' HG3' ' A' ' 127' ' ' ARG . 0.9 OUTLIER -91.04 151.99 20.82 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.045 0.45 . . . . 0.0 111.515 -177.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.559 ' O ' ' C ' ' A' ' 126' ' ' GLU . 6.1 tp10 -75.61 134.64 40.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.501 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.559 ' C ' ' O ' ' A' ' 125' ' ' GLU . 9.4 tt0 -2.65 97.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.808 0.693 . . . . 0.0 111.74 178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.513 ' HG3' ' CD2' ' A' ' 124' ' ' HIS . 1.2 mtm-85 -92.27 134.4 34.93 Favored 'General case' 0 CA--C 1.514 -0.43 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.135 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -78.32 129.81 35.46 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.21 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -131.24 167.5 19.09 Favored 'General case' 0 CA--C 1.5 -0.973 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 130' ' ' GLU . 0.4 OUTLIER -69.03 -28.58 66.69 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -173.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.413 ' O ' ' OH ' ' B' ' 142' ' ' TYR . 75.1 m-70 -118.94 41.09 3.13 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.742 -0.208 . . . . 0.0 111.251 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.47 160.27 9.34 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.278 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.421 ' O ' ' N ' ' B' ' 141' ' ' LYS . 30.6 m-85 -95.21 121.1 36.51 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 172.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.99 126.2 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -169.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.525 ' OG ' ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -126.38 154.28 43.79 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.669 174.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.44 179.34 7.32 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.266 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 31.6 p -139.75 127.1 21.37 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -100.86 136.19 41.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.95 101.54 6.36 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.505 174.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.583 ' HA ' ' NH1' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -101.69 141.36 34.67 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.597 ' HD3' ' CD ' ' A' ' 119' ' ' GLU . 2.7 ttpp -140.85 125.25 17.64 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.315 -176.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.492 ' HE1' ' HE ' ' A' ' 140' ' ' ARG . 57.9 m-85 -120.44 99.13 6.38 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.611 HG23 HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -89.75 88.92 7.55 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.4 mp -112.43 92.74 20.24 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.634 ' CD ' ' HD3' ' A' ' 146' ' ' PRO . 17.0 Cg_exo -65.9 -58.36 0.19 Allowed 'Trans proline' 0 C--N 1.286 -2.753 0 C-N-CA 121.89 1.726 . . . . 0.0 113.497 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.634 ' HD3' ' CD ' ' A' ' 145' ' ' PRO . 5.7 Cg_endo -90.5 -13.31 2.34 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 122.774 2.316 . . . . 0.0 114.159 -175.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -104.38 3.0 43.17 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 120.448 -0.882 . . . . 0.0 113.722 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.47 136.09 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 118.024 0.912 . . . . 0.0 111.005 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 150' ' ' PRO . 29.0 t70 -96.38 141.97 23.88 Favored Pre-proline 0 N--CA 1.471 0.619 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.954 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 149' ' ' ASP . 2.8 Cg_endo -82.69 -22.32 4.53 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 121.876 1.717 . . . . 0.0 112.547 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.84 -39.43 12.34 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.233 -174.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.65 ' O ' ' HB1' ' A' ' 167' ' ' ALA . 9.7 mt-30 -106.33 22.63 15.45 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -175.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 19.9 t -109.53 109.39 28.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.977 0.418 . . . . 0.0 110.094 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.86 -169.58 1.6 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.02 139.38 14.76 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.756 -0.778 . . . . 0.0 112.431 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.59 130.51 53.62 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.418 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.656 HD22 HD22 ' A' ' 109' ' ' LEU . 40.0 tp -123.75 109.2 13.37 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 120.989 0.423 . . . . 0.0 110.355 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.416 ' HB3' HG22 ' A' ' 162' ' ' THR . 0.2 OUTLIER -91.36 147.39 35.33 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.237 178.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 161' ' ' GLY . 87.4 Cg_exo -40.35 -38.52 2.37 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.599 2.199 . . . . 0.0 111.612 -179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -70.03 29.98 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.742 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.621 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 43.93 34.62 3.05 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 116.06 -0.518 . . . . 0.0 113.039 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 162' ' ' THR . 10.1 t -100.47 99.59 10.23 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.3 0.571 . . . . 0.0 109.598 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.611 HD13 ' C ' ' A' ' 163' ' ' LEU . 2.9 tm? -91.12 106.16 18.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.803 -176.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.54 124.38 44.66 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 165' ' ' VAL . 3.1 m -105.54 100.59 10.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -114.28 139.66 49.24 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.06 -176.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.65 ' HB1' ' O ' ' A' ' 152' ' ' GLN . . . 178.17 166.68 0.58 Allowed Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.218 -0.593 . . . . 0.0 111.999 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.634 ' HD2' ' HB1' ' A' ' 167' ' ' ALA . 60.6 Cg_endo -81.39 108.75 2.0 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.074 2.516 . . . . 0.0 110.13 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.599 ' SD ' ' HB3' ' A' ' 95' ' ' TRP . 0.0 OUTLIER -92.89 147.76 34.59 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.825 -176.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.53 ' O ' HD12 ' A' ' 172' ' ' LEU . 21.6 Cg_endo -64.88 -1.39 4.15 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.713 2.275 . . . . 0.0 111.693 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 170' ' ' PRO . 5.0 mmtp 78.73 -104.57 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.098 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.53 HD12 ' O ' ' A' ' 170' ' ' PRO . 6.9 mp 51.14 34.11 10.54 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.004 0.43 . . . . 0.0 110.119 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.93 117.53 15.82 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.077 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 176' ' ' SER . 0.0 OUTLIER -54.71 -34.1 61.93 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.702 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 62.46 -65.83 0.09 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.751 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.509 ' N ' ' O ' ' A' ' 174' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.208 -1.111 0 CA-C-O 118.375 -0.822 . . . . 0.0 110.48 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' MET . . . . . 0.544 ' N ' ' OE1' ' B' ' 80' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.544 ' OE1' ' N ' ' B' ' 79' ' ' MET . 1.6 mm100 -77.8 35.89 0.21 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.008 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.481 ' HB2' ' SD ' ' B' ' 79' ' ' MET . 0.1 OUTLIER -59.36 125.16 22.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.157 179.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.91 80.17 0.2 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.215 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -43.98 -27.32 0.35 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.595 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -145.95 -66.22 0.01 OUTLIER Glycine 0 C--N 1.321 -0.286 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 5.3 m -123.16 167.79 16.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -47.22 114.56 0.89 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -37.56 -43.54 0.61 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.475 -177.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ILE . . . . . . . . . . . . . 8.6 pt -142.58 149.24 19.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.446 177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.423 ' H ' ' HG3' ' B' ' 89' ' ' ARG . 0.0 OUTLIER -97.84 144.61 27.25 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' HIS . . . . . 0.526 ' CG ' ' H ' ' B' ' 91' ' ' THR . 8.0 t-80 -106.94 -146.56 0.4 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.536 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.646 ' CB ' ' HZ1' ' B' ' 171' ' ' LYS . 0.6 OUTLIER -60.51 77.39 0.01 OUTLIER 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.128 0.489 . . . . 0.0 110.438 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' B' ' 90' ' ' HIS . . . -155.99 -53.41 0.08 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.832 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . . . . . . . . . 4.7 t70 53.44 -132.02 2.0 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.557 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -121.82 105.3 10.24 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.33 118.09 14.79 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -114.21 113.39 24.59 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.829 -175.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . . . . . . . . . 1.7 t -119.25 156.86 21.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 174.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' SER . . . . . . . . . . . . . 3.7 m -129.64 134.49 47.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.343 0.498 . . . . 0.0 112.343 -174.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.452 HD22 ' HB ' ' B' ' 120' ' ' ILE . 0.4 OUTLIER -103.16 97.23 7.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.632 175.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ASP . . . . . 0.537 ' C ' HG22 ' B' ' 101' ' ' VAL . 18.9 p-10 -88.75 103.25 15.79 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.677 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' VAL . . . . . 0.537 HG22 ' C ' ' B' ' 100' ' ' ASP . 0.1 OUTLIER -170.46 -39.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-O 121.833 0.825 . . . . 0.0 109.417 179.036 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . 0.624 HD21 ' HA ' ' B' ' 106' ' ' PRO . 0.2 OUTLIER -38.94 -26.45 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.165 -1.379 . . . . 0.0 112.148 -177.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -53.18 -23.76 9.19 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 119.592 -0.843 . . . . 0.0 108.927 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.546 ' HB3' ' CZ ' ' B' ' 136' ' ' ARG . 27.3 m-85 -71.81 -13.13 61.6 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.715 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' B' ' 109' ' ' LEU . . . -174.61 94.26 0.3 Allowed Pre-proline 0 C--O 1.223 -0.336 0 O-C-N 123.308 0.38 . . . . 0.0 111.708 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.624 ' HA ' HD21 ' B' ' 102' ' ' ASN . 41.3 Cg_endo -71.57 -44.39 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.493 2.128 . . . . 0.0 111.833 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -30.75 22.04 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.948 -178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' B' ' 123' ' ' LYS . 16.7 mt-10 -102.19 56.73 0.8 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.081 0.467 . . . . 0.0 110.985 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' LEU . . . . . 0.6 HD22 HD22 ' B' ' 157' ' ' LEU . 0.4 OUTLIER -127.9 145.58 50.91 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 177.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.43 ' N ' ' HG ' ' B' ' 109' ' ' LEU . 0.2 OUTLIER -141.31 116.72 10.14 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.916 -177.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.03 123.01 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.786 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . 0.453 ' NZ ' ' OG1' ' B' ' 121' ' ' THR . 6.1 pttm -130.9 119.69 22.53 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.237 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.35 120.14 23.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' LYS . . . . . 0.477 ' NZ ' ' OE1' ' B' ' 119' ' ' GLU . 0.8 OUTLIER -121.26 82.49 1.94 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.537 -174.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 32.8 t70 32.56 68.91 0.13 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.345 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . 0.462 ' HA2' HG12 ' B' ' 148' ' ' VAL . . . 86.52 -22.61 12.58 Favored Glycine 0 C--N 1.315 -0.598 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 178.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' VAL . . . . . 0.662 HG22 HG23 ' B' ' 143' ' ' THR . 6.4 t -87.42 120.71 37.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 72.5 t -107.7 108.44 25.24 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.319 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' GLU . . . . . 0.532 ' O ' HD12 ' B' ' 120' ' ' ILE . 2.9 mt-10 -124.5 146.77 48.78 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.966 0.412 . . . . 0.0 110.612 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ILE . . . . . 0.532 HD12 ' O ' ' B' ' 119' ' ' GLU . 1.3 mp -119.96 117.29 53.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.452 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' THR . . . . . 0.453 ' OG1' ' NZ ' ' B' ' 112' ' ' LYS . 0.2 OUTLIER -89.81 121.48 31.99 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.755 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -144.33 101.17 0.25 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' B' ' 108' ' ' GLU . 0.1 OUTLIER -131.0 143.32 50.64 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' HIS . . . . . 0.457 ' CD2' ' CZ ' ' B' ' 127' ' ' ARG . 0.2 OUTLIER -119.48 151.96 37.71 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.574 -179.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' GLU . . . . . 0.467 ' O ' ' C ' ' B' ' 126' ' ' GLU . 4.0 mt-10 -91.17 126.84 36.37 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.642 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' GLU . . . . . 0.573 ' HA ' ' OG ' ' B' ' 135' ' ' SER . 3.4 tt0 14.79 99.46 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' ARG . . . . . 0.457 ' CZ ' ' CD2' ' B' ' 124' ' ' HIS . 12.6 mtp180 -97.67 141.19 31.0 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.142 176.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' GLN . . . . . 0.48 ' HG2' ' N ' ' B' ' 129' ' ' ASP . 0.0 OUTLIER -86.74 136.91 32.83 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.941 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . 0.522 ' CG ' ' N ' ' B' ' 130' ' ' GLU . 0.1 OUTLIER -133.45 169.26 17.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.403 -0.817 . . . . 0.0 108.845 174.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' B' ' 130' ' ' GLU . 0.0 OUTLIER -67.81 -31.98 72.21 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -174.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -111.29 20.24 17.51 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' GLY . . . . . . . . . . . . . . . 147.08 178.25 22.24 Favored Glycine 0 C--N 1.307 -1.036 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.614 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' TYR . . . . . . . . . . . . . 19.9 m-30 -96.01 134.81 38.58 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 175.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . 0.519 HG23 ' O ' ' B' ' 134' ' ' ILE . 0.0 OUTLIER -145.97 116.41 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.886 0.375 . . . . 0.0 111.831 -175.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' SER . . . . . 0.573 ' OG ' ' HA ' ' B' ' 126' ' ' GLU . 0.0 OUTLIER -132.81 156.66 46.72 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' ARG . . . . . 0.546 ' CZ ' ' HB3' ' B' ' 104' ' ' PHE . 0.0 OUTLIER -151.63 167.81 26.95 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.162 0.505 . . . . 0.0 111.932 -178.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' B' ' 123' ' ' LYS . 20.5 p -118.58 129.86 55.57 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.12 176.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -106.05 143.76 33.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.384 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.11 121.28 7.78 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.857 0.36 . . . . 0.0 111.493 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' ARG . . . . . 0.535 ' NH2' ' OH ' ' B' ' 142' ' ' TYR . 0.0 OUTLIER -118.02 144.57 45.45 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' LYS . . . . . 0.472 ' NZ ' ' OE2' ' A' ' 126' ' ' GLU . 9.1 ttpp -133.01 124.66 28.11 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 123.136 0.272 . . . . 0.0 111.027 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' TYR . . . . . 0.535 ' OH ' ' NH2' ' B' ' 140' ' ' ARG . 3.1 m-85 -118.33 98.64 6.38 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.03 178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' THR . . . . . 0.662 HG23 HG22 ' B' ' 117' ' ' VAL . 0.3 OUTLIER -90.42 100.88 13.64 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' LEU . . . . . . . . . . . . . 6.0 mp -107.43 96.72 16.87 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.073 -177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' B' ' 147' ' ' GLY . 36.8 Cg_exo -62.98 -41.92 26.56 Favored 'Trans proline' 0 C--N 1.286 -2.747 0 C-N-CA 123.223 2.615 . . . . 0.0 114.251 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' PRO . . . . . 0.465 ' CD ' ' N ' ' B' ' 145' ' ' PRO . 36.3 Cg_exo -43.23 -11.04 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 121.916 1.744 . . . . 0.0 112.304 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' B' ' 145' ' ' PRO . . . 109.11 44.13 1.12 Allowed Glycine 0 C--O 1.218 -0.87 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.209 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' VAL . . . . . 0.53 ' O ' ' CG1' ' B' ' 148' ' ' VAL . 0.4 OUTLIER -60.68 96.74 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . 0.509 ' CG ' ' HG3' ' B' ' 152' ' ' GLN . 10.3 t70 -50.66 129.16 26.92 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.183 -171.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 11.4 Cg_exo -71.16 -25.95 21.76 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.149 1.899 . . . . 0.0 113.053 -177.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.31 -49.87 6.29 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.363 0.602 . . . . 0.0 111.213 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' GLN . . . . . 0.509 ' HG3' ' CG ' ' B' ' 149' ' ' ASP . 1.7 mt-30 -79.57 10.59 3.76 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.582 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . 0.71 ' HA ' ' HB2' ' B' ' 167' ' ' ALA . 17.9 t -101.64 119.57 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.42 155.8 27.91 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' B' ' 164' ' ' THR . 1.2 m -132.99 132.77 42.29 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.399 -176.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' SER . . . . . 0.554 ' O ' HD22 ' B' ' 163' ' ' LEU . 0.0 OUTLIER -108.47 145.17 35.08 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.477 178.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' LEU . . . . . 0.6 HD22 HD22 ' B' ' 109' ' ' LEU . 31.7 tp -130.96 128.42 40.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.336 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.479 ' O ' ' N ' ' B' ' 161' ' ' GLY . 0.6 OUTLIER -114.14 150.32 43.44 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 179.123 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' PRO . . . . . 0.538 ' C ' ' H ' ' B' ' 161' ' ' GLY . 87.3 Cg_exo -43.15 -34.14 4.05 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.782 2.321 . . . . 0.0 111.462 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -62.33 2.19 0.27 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.445 177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' GLY . . . . . 0.538 ' H ' ' C ' ' B' ' 159' ' ' PRO . . . 63.38 27.81 71.35 Favored Glycine 0 N--CA 1.45 -0.412 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.712 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' THR . . . . . . . . . . . . . 6.0 t -93.87 120.66 34.43 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' LEU . . . . . 0.627 HD13 ' C ' ' B' ' 163' ' ' LEU . 2.2 tm? -108.63 106.6 16.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.814 -176.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' B' ' 155' ' ' SER . 0.7 OUTLIER -95.5 127.99 42.0 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.106 -179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.546 ' O ' HG23 ' B' ' 165' ' ' VAL . 2.6 m -112.99 107.58 23.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -121.57 144.7 48.58 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.439 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' ALA . . . . . 0.71 ' HB2' ' HA ' ' B' ' 153' ' ' VAL . . . -168.61 152.7 5.74 Favored Pre-proline 0 C--O 1.235 0.29 0 C-N-CA 120.463 -0.495 . . . . 0.0 112.16 -177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -87.68 47.98 1.52 Allowed 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 123.364 2.709 . . . . 0.0 109.59 174.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' MET . . . . . 0.473 ' CB ' ' HD2' ' B' ' 170' ' ' PRO . 3.1 ptm -49.64 163.92 0.37 Allowed Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 114.534 -1.212 . . . . 0.0 112.631 -176.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' PRO . . . . . 0.568 ' CG ' ' O ' ' B' ' 147' ' ' GLY . 6.6 Cg_endo -47.21 128.42 14.29 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 124.008 3.139 . . . . 0.0 112.442 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' LYS . . . . . 0.646 ' HZ1' ' CB ' ' B' ' 91' ' ' THR . 2.4 tmtm? -69.05 55.4 0.09 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' B' ' 170' ' ' PRO . 0.3 OUTLIER -76.92 29.21 0.13 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.176 0.512 . . . . 0.0 110.199 179.418 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' B' ' 171' ' ' LYS . . . -77.54 45.51 0.49 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.192 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.12 132.02 50.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.192 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' B' ' 173' ' ' ALA . 8.7 mm-40 -77.84 109.84 12.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.199 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' B' ' 175' ' ' GLN . 1.6 m . . . . . 0 C--O 1.209 -1.045 0 CA-C-O 118.362 -0.828 . . . . 0.0 110.974 -178.748 . . . . . . . . 1 1 . 1 stop_ save_